Citrus Sinensis ID: 004264
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 765 | 2.2.26 [Sep-21-2011] | |||||||
| O81832 | 783 | G-type lectin S-receptor- | yes | no | 0.954 | 0.932 | 0.499 | 0.0 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.947 | 0.889 | 0.470 | 0.0 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.968 | 0.871 | 0.419 | 0.0 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.933 | 0.842 | 0.435 | 0.0 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.971 | 0.906 | 0.415 | 1e-169 | |
| Q9SXB5 | 820 | G-type lectin S-receptor- | no | no | 0.972 | 0.907 | 0.407 | 1e-166 | |
| Q9LPZ9 | 830 | G-type lectin S-receptor- | no | no | 0.967 | 0.891 | 0.410 | 1e-162 | |
| O64770 | 804 | G-type lectin S-receptor- | no | no | 0.929 | 0.884 | 0.408 | 1e-158 | |
| O64781 | 831 | G-type lectin S-receptor- | no | no | 0.937 | 0.862 | 0.402 | 1e-157 | |
| O64777 | 806 | G-type lectin S-receptor- | no | no | 0.930 | 0.883 | 0.415 | 1e-157 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function desciption |
|---|
Score = 741 bits (1912), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/761 (49%), Positives = 518/761 (68%), Gaps = 31/761 (4%)
Query: 5 AVFIFFYLLILIF-IIEFSFAADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLG 63
A + L+I +F I + A D L + + + DG+T+VS SFE+GFFSPG S NRYLG
Sbjct: 3 ATNVLHLLIISLFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLG 62
Query: 64 IWYKS-SPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSSN-----SSRTL 117
IWYK S +TVVWVANR+ P+ D +G L S NGSL L N IWSS+ +L
Sbjct: 63 IWYKKISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASL 122
Query: 118 ENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLKTGFERYLTPWR 177
NP+ +LD+GNLV+R+ S ++Y+WQS DYP D LPGMK G N TG R+LT WR
Sbjct: 123 RNPIVQILDTGNLVVRN--SGDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWR 180
Query: 178 SADDPTPGEFSLRLDISALPELVIISGSRKEARSGPWNGQQFGGIPRVK-NSIFIPKLEH 236
+ DDP+ G ++ ++D + +P+ + S R+GPWNG +F G+P +K N I+ +
Sbjct: 181 AIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVF 240
Query: 237 TEDELYFTFRPFNDKVITRLLVNESGTLQRLVWNETSTEWRMLYSWPFDTCDSYAQCGAN 296
TE+E+Y+T++ N V+TR+ +N +G LQR W + W S D+CD Y CG+
Sbjct: 241 TEEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSY 300
Query: 297 DNCRISKTPICECLTGFISKSQDDWDSPE-TRRCVRKPS-DCPSGE-GFLKLPRMKLPEN 353
+C I+++P C CL GF++K+ W + + + CVR+ DC GE GFLK+ ++KLP+
Sbjct: 301 GSCNINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDT 360
Query: 354 Y--WSNKSMNLKECEAECTKNCSCRAYANSDVTGGGSGCLMWFGDLVDLRECSEGYIWGQ 411
W +K+M+L EC+ C +NC+C AY+ D+ GG GC++WFGDL+D+RE +E GQ
Sbjct: 361 RTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNEN---GQ 417
Query: 412 DFFIRVPSSE---LGLENWKV--------DIEVPLYDLATITTATNHFSEANMIGKGGFG 460
D ++R+ SSE L E+ +V D+E+P DL T++ AT+ FS N +G+GGFG
Sbjct: 418 DLYVRLASSEIETLQRESSRVSSRKQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFG 477
Query: 461 PVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520
PVY G L+ GQE+A KRLS+ S QG+EEF NE+ LI KLQHRNLV +LG C++E+ERMLI
Sbjct: 478 PVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLI 537
Query: 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNIL 580
YEY P+KSLD FIFD+ER + L W KR II GIARG+LYLH+DS+L++IHRDLKASN+L
Sbjct: 538 YEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVL 597
Query: 581 LDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLL 640
LD ++N KISDFGLAR GGD+ EA T RV GT+GYMSPEY DG S+KSDVFS GVL+
Sbjct: 598 LDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLV 657
Query: 641 VEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVE-SQVLRCIQVGL 699
+EIVSG+ NRGFR+ H+ NL+GHAW + + +A ++D + +S + S+VLR I +GL
Sbjct: 658 LEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGL 717
Query: 700 LCVQKLPEDRPDMSSVVFLLANDGVTLPQPRQPGFFTERGF 740
LCVQ+ P+DRP+M SVV L+ + + L PRQPGFF ER
Sbjct: 718 LCVQQDPKDRPNM-SVVVLMLSSEMLLLDPRQPGFFNERNL 757
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 678 bits (1750), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/801 (47%), Positives = 506/801 (63%), Gaps = 76/801 (9%)
Query: 28 LSSGKFITDGETLVSSFQSFELGFFS---PGNSTNRYLGIWYKSSPRTVVWVANRNHPIT 84
++ +F+ DG+TL S Q F+LGFFS +R+LG+WY P VVWVANRN+P+
Sbjct: 28 ITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWYME-PFAVVWVANRNNPLY 86
Query: 85 DKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTL-----ENPVAHLLDSGNLVLRDNISRS 139
+G L S+ G L L + E A+WSS+SS T NP+ + SGNL+ D
Sbjct: 87 GTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTANNPLLKISCSGNLISSD----G 142
Query: 140 SEEYMWQSFDYPSDTLLPGMKLGWNLKTGFERYLTPWRSADDPTPGEFSLRLDISALPEL 199
E +WQSFDYP +T+L GMKLG N KT E L+ W++ DP+PG+F+L LD LP+L
Sbjct: 143 EEAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLDTRGLPQL 202
Query: 200 VIISG--SRKEARSGPWNGQQFGGIPRV--KNSIFIPKLEHTEDELYFTFRPFNDKVITR 255
++ S R G WNG F G P + +NS+F K + E+ +++ P ++++R
Sbjct: 203 ILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQEVNYSWTP-RHRIVSR 261
Query: 256 LLVNESGTLQRLVWNETSTEWRMLYSWPFDTCDSYAQCGANDNCRIS--KTPICECLTGF 313
L++N +G L R + ++ + +W + + P D CD Y+ CGA C I+ TP C CL GF
Sbjct: 262 LVLNNTGKLHRFIQSKQN-QWILANTAPEDECDYYSICGAYAVCGINSKNTPSCSCLQGF 320
Query: 314 ISKSQDDWD-SPETRRCVRK-PSDCPSGEGFLKLPRMKLPENYWS----NKSMNLKECEA 367
KS W+ S CV + P++C + F+K P +KLP+ WS M L++C+
Sbjct: 321 KPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSWSWYDAKNEMTLEDCKI 380
Query: 368 ECTKNCSCRAYANSDVTGGGSGCLMWFGDLVDLRECSEGYIWGQDFFIRVPSSELGL--- 424
+C+ NCSC AYAN+D+ GG GCL+WFGDLVD+RE S +GQD +IR+ +++
Sbjct: 381 KCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSS---FGQDVYIRMGFAKIEFKGR 437
Query: 425 ----------------------------------ENWKV-----DIEVPLYDLATITTAT 445
EN++ D+++P++D TI+ AT
Sbjct: 438 EVVGMVVGSVVAIAVVLVVVFACFRKKIMKRYRGENFRKGIEEEDLDLPIFDRKTISIAT 497
Query: 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLV 505
+ FS N +G+GGFGPVY GKL GQEIA KRLS NSGQG+EEF NEV LI KLQHRNLV
Sbjct: 498 DDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLV 557
Query: 506 GLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
LLG CI+ +E MLIYEYMP+KSLD+FIFD RS L WKKR +II G+ARG+LYLHQDS
Sbjct: 558 RLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDS 617
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG 625
+L++IHRDLKA N+LLD ++NPKISDFGLA+ FGGD E+ T RV GT+GYM PEYA DG
Sbjct: 618 RLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDG 677
Query: 626 TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRAL-GLMDTCLED 684
S+KSDVFS GVL++EI++GK NRGFRH H NL+GH W +W + R + + LE+
Sbjct: 678 HFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKMWVEDREIEVPEEEWLEE 737
Query: 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGVTLPQPRQPGFFTERGFTVGA 744
+ V +VLRCI V LLCVQ+ PEDRP M+SVV + +D +LP P QPGFFT R V
Sbjct: 738 TSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDS-SLPHPTQPGFFTNR--NVPD 794
Query: 745 LSSHEKCHSENALSITIQEGR 765
+SS S+N +SIT+ +GR
Sbjct: 795 ISSSLSLRSQNEVSITMLQGR 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 654 bits (1687), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/830 (41%), Positives = 504/830 (60%), Gaps = 89/830 (10%)
Query: 21 FSFAADSLSSGKFIT--DGETLVSSFQSFELGFFSPGNSTNRYLGIWYKS-SPRTVVWVA 77
+S +A++LS+ + +T T+VS FELGFF PG + YLGIWYK+ S RT VWVA
Sbjct: 25 YSISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVA 84
Query: 78 NRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSSN-SSRTLENP-VAHLLDSGNLVLRDN 135
NR+ P++ G L S++ +L++L+Q + +WS+N + + +P VA LLD+GN VLRD+
Sbjct: 85 NRDTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRDS 143
Query: 136 ISRSSEEYMWQSFDYPSDTLLPGMKLGWNLKTGFERYLTPWRSADDPTPGEFSLRLDISA 195
+ + + +WQSFD+P+DTLLP MKLGW+ KTGF R++ W+S DDP+ G+FS +L+
Sbjct: 144 KNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEG 203
Query: 196 LPELVIISGSRKEARSGPWNGQQFGGIPRVKN-SIFIPKLEHTEDELYFTFRPFNDKVIT 254
PE+ + + + RSGPWNG +F G+P ++ + +++E+ ++FR V +
Sbjct: 204 FPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYS 263
Query: 255 RLLVNESGTLQRLVWNETSTEWRMLYSWPFDTCDSYAQCGANDNCRISKTPICECLTGFI 314
RL ++ SG LQR W ET+ W + P D CD Y +CG C + +P+C C+ GF
Sbjct: 264 RLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFK 323
Query: 315 SKSQDDWDSPE-TRRCVRKP-SDCPSGEGFLKLPRMKLPENYWS--NKSMNLKECEAECT 370
++ W + + CVRK C G+GF++L +MKLP+ + ++ + +KECE +C
Sbjct: 324 PRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCL 383
Query: 371 KNCSCRAYANSDVTGGGSGCLMWFGDLVDLRECSEGYIWGQDFFIRVPSSELGLEN---- 426
++C+C A+AN+D+ G GSGC+ W G+L D+R ++G GQD ++R+ +++L +
Sbjct: 384 RDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKG---GQDLYVRLAATDLEDKRNRSA 440
Query: 427 ----------------------WK------VDIEVPLYDLA----------TITTATNHF 448
WK + IE P+ D + ++ H
Sbjct: 441 KIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHI 500
Query: 449 SEAN--------------------------MIGKGGFGPVYMGKLSTGQEIAAKRLSKNS 482
S N +G+GGFG VY GKL GQE+A KRLSK S
Sbjct: 501 SRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTS 560
Query: 483 GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLL 542
QG +EF NEV LI +LQH NLV LL C++ E+MLIYEY+ + SLD +FD+ R+ L
Sbjct: 561 VQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKL 620
Query: 543 PWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602
W+ RF II GIARGLLYLHQDS+ ++IHRDLKASNILLD + PKISDFG+ARIFG D+
Sbjct: 621 NWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDE 680
Query: 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLI 662
EA T +V GT+GYMSPEYA DG SMKSDVFS GVLL+EI+S K N+GF + NL+
Sbjct: 681 TEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLL 740
Query: 663 GHAWLLWNDGRALGLMDTCLEDS---FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719
G W W +G+ L ++D + DS F + ++LRCIQ+GLLCVQ+ EDRP MS V+ +L
Sbjct: 741 GCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILML 800
Query: 720 ANDGVTLPQPRQPGFFTERGFTVGALSSHEKCHSE----NALSITIQEGR 765
++ T+PQP+ PG+ ER SS ++ E N +++++ + R
Sbjct: 801 GSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 652 bits (1681), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/799 (43%), Positives = 482/799 (60%), Gaps = 85/799 (10%)
Query: 21 FSFAADSLSSGKFIT--DGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSP-RTVVWVA 77
FS A + S+ + +T +T++S Q FELGFF+P +S+ YLGIWYK P RT VWVA
Sbjct: 23 FSVYASNFSATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVA 82
Query: 78 NRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSSN-SSRTLENPVA-HLLDSGNLVLRDN 135
NR++P++ NG L S+N +L++ +Q +WS+N + + +PVA LLD GN VLRD+
Sbjct: 83 NRDNPLSSSNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRDS 141
Query: 136 ISRSSEEYMWQSFDYPSDTLLPGMKLGWNLKTG-FERYLTPWRSADDPTPGEFSLRLDIS 194
+ ++WQSFD+P+DTLL MK+GW+ K+G F R L W++ DDP+ G+FS +L S
Sbjct: 142 KNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTS 201
Query: 195 ALPELVIISGSRKEARSGPWNGQQFGGIPRVKNSIFIPK-LEHTEDELYFTFRPFNDKVI 253
PE I + RSGPW G +F +P +K +I ++ +++R +
Sbjct: 202 GFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSYRVNKTNIY 261
Query: 254 TRLLVNESGTLQRLVWNETSTEWRMLYSWPFDTCDSYAQCGANDNCRISKTPICECLTGF 313
+ L ++ +G LQRL W E + W+ L+ P D CD+Y +CG C + +PIC C+ GF
Sbjct: 262 SILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKGF 321
Query: 314 ISKSQDDWDSPETRRCVRKPS-DCPSGEGFLKLPRMKLPENYWS--NKSMNLKECEAECT 370
++ ++ CVRK C +GF++L +M+LP+ + +K + LKECE C
Sbjct: 322 EPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCL 381
Query: 371 KNCSCRAYANSDVTGGGSGCLMWFGDLVDLRECSEGYIWGQDFFIRVPSSELG------- 423
K C+C A+AN+D+ GGSGC++W G L D+R ++G GQD ++RV + +L
Sbjct: 382 KGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKG---GQDLYVRVAAGDLEDKRIKSK 438
Query: 424 -------------------LENWK------VDIEVPLYDLA------------------- 439
WK + I+ P+ DL
Sbjct: 439 KIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTS 498
Query: 440 ----------------TITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSG 483
+ ATN+FS N +G+GGFG VY G L G+EIA KRLSK S
Sbjct: 499 KENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSS 558
Query: 484 QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLP 543
QG +EFMNEV LI KLQH NLV LLG C+++ E+MLIYEY+ + SLD +FD+ RS L
Sbjct: 559 QGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLN 618
Query: 544 WKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603
W+KRF II GIARGLLYLHQDS+ ++IHRDLKASN+LLD N+ PKISDFG+ARIFG ++
Sbjct: 619 WQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREET 678
Query: 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIG 663
EA T RV GT+GYMSPEYA DG SMKSDVFS GVLL+EI+SGK N+GF + NL+G
Sbjct: 679 EANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLG 738
Query: 664 HAWLLWNDGRALGLMD----TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719
W W +G+ L ++D L F ++LRCIQ+GLLCVQ+ EDRP MSSV+ +L
Sbjct: 739 FVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVML 798
Query: 720 ANDGVTLPQPRQPGFFTER 738
++ +PQP++PGF R
Sbjct: 799 GSETTAIPQPKRPGFCVGR 817
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 594 bits (1531), Expect = e-169, Method: Compositional matrix adjust.
Identities = 343/825 (41%), Positives = 486/825 (58%), Gaps = 82/825 (9%)
Query: 9 FFYLLIL-IFIIEFSFAAD-SLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWY 66
F +L+L F + S A + + SGK + D ET+VSSF++F GFFSP NST+RY GIWY
Sbjct: 10 FVCILVLSCFFLSVSLAQERAFFSGK-LNDSETIVSSFRTFRFGFFSPVNSTSRYAGIWY 68
Query: 67 KS-SPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSR--TLENPVAH 123
S S +TV+WVAN++ PI D +GV++ S +G+L++ + ++ +WS+N S + + VA
Sbjct: 69 NSVSVQTVIWVANKDKPINDSSGVISVSQDGNLVVTDGQRRVLWSTNVSTQASANSTVAE 128
Query: 124 LLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLKTGFERY-LTPWRSADDP 182
LLDSGNLVL++ SS+ Y+W+SF YP+D+ LP M +G N + G +T W+S DP
Sbjct: 129 LLDSGNLVLKE---ASSDAYLWESFKYPTDSWLPNMLVGTNARIGGGNVTITSWKSPSDP 185
Query: 183 TPGEFSLRLDISALPELVIISGSRKEA---RSGPWNGQQFGGIPRVKNSIFIPKLEHTED 239
+PG ++ L ++A PEL I++ + + RSGPWNGQ F G+P V +F+ + +D
Sbjct: 186 SPGSYTAALVLAAYPELFIMNNNNNNSTVWRSGPWNGQMFNGLPDVYAGVFLYRFIVNDD 245
Query: 240 -ELYFTFRPFNDKVITRLLVNESGTLQRLVWNETSTEWRMLYSWPFDTCDSYAQCGANDN 298
T ND + ++ G++ R W+ET W + P CD+Y +CG
Sbjct: 246 TNGSVTMSYANDSTLRYFYMDYRGSVIRRDWSETRRNWTVGLQVPATECDNYRRCGEFAT 305
Query: 299 CRISKTPICECLTGFISKSQDDWDSPE-TRRCVRK-PSDCP------SGEGFLKLPRMKL 350
C K P+C C+ GF ++ +W++ + C R+ P C S +GFL+L RMKL
Sbjct: 306 CNPRKNPLCSCIRGFRPRNLIEWNNGNWSGGCTRRVPLQCERQNNNGSADGFLRLRRMKL 365
Query: 351 PENYWSNKSMNLKECEAEC--TKNCSCRAY------------------------------ 378
P+ + + EC C T +C A+
Sbjct: 366 PD-FARRSEASEPECLRTCLQTCSCIAAAHGLGYGCMIWNGSLVDSQELSASGLDLYIRL 424
Query: 379 ANSDVT-------------GGG----SGCLMWFGDLVDLRECSEGYIWGQDFFIRVPSSE 421
A+S++ GG + C++ +V + + + F RV +
Sbjct: 425 AHSEIKTKDKRPILIGTILAGGIFVVAACVLLARRIVMKKRAKKKGRDAEQIFERVEALA 484
Query: 422 LGLENWKVDIEVPLYDLATITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKN 481
G N E+PL++ + ATN+FS N +G+GGFGPVY GKL GQEIA KRLS+
Sbjct: 485 GG--NKGKLKELPLFEFQVLAAATNNFSLRNKLGQGGFGPVYKGKLQEGQEIAVKRLSRA 542
Query: 482 SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKL 541
SGQGLEE +NEVV+I KLQHRNLV LLG CI +ERML+YE+MP KSLDY++FD R+KL
Sbjct: 543 SGQGLEELVNEVVVISKLQHRNLVKLLGCCIAGEERMLVYEFMPKKSLDYYLFDSRRAKL 602
Query: 542 LPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601
L WK RF+II GI RGLLYLH+DS+L++IHRDLKASNILLD NL PKISDFGLARIF G+
Sbjct: 603 LDWKTRFNIINGICRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGLARIFPGN 662
Query: 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNL 661
++EA T RV GT+GYM+PEYA G S KSDVFSLGV+L+EI+SG+ N L
Sbjct: 663 EDEANTRRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIISGRRN-------SNSTL 715
Query: 662 IGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721
+ + W +WN+G L+D + D E ++ +CI +GLLCVQ+ DRP +S+V +L++
Sbjct: 716 LAYVWSIWNEGEINSLVDPEIFDLLFEKEIHKCIHIGLLCVQEAANDRPSVSTVCSMLSS 775
Query: 722 DGVTLPQPRQPGFFTERGFTVGALSSHEKCH-SENALSITIQEGR 765
+ +P+P+QP F + S + S N ++IT GR
Sbjct: 776 EIADIPEPKQPAFISRNNVPEAESSENSDLKDSINNVTITDVTGR 820
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB5|Y1135_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11305 OS=Arabidopsis thaliana GN=At1g11305 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 585 bits (1508), Expect = e-166, Method: Compositional matrix adjust.
Identities = 336/825 (40%), Positives = 471/825 (57%), Gaps = 81/825 (9%)
Query: 8 IFFYLLILIFIIEFSFAADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYK 67
I L + F + S A + + D ET+VSSF++F GFFSP NSTNRY GIWY
Sbjct: 10 IVHVLSLSCFFLSVSLAHERALFSGTLNDSETIVSSFRTFRFGFFSPVNSTNRYAGIWYN 69
Query: 68 SSP-RTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSSN-SSRTLENP-VAHL 124
S P +TV+WVAN++ PI D +GV++ S +G+L++ + ++ +WS+N S+R N VA L
Sbjct: 70 SIPVQTVIWVANKDTPINDSSGVISISEDGNLVVTDGQRRVLWSTNVSTRASANSTVAEL 129
Query: 125 LDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLKTGFERY-LTPWRSADDPT 183
L+SGNLVL+D +++ Y+W+SF YP+D+ LP M +G N +TG +T W + DP+
Sbjct: 130 LESGNLVLKD---ANTDAYLWESFKYPTDSWLPNMLVGTNARTGGGNITITSWTNPSDPS 186
Query: 184 PGEFSLRLDISALPELVIISGSRKEA---RSGPWNGQQFGGIPRVKNSIFIPKLEHTED- 239
PG ++ L ++ PEL I + + A RSGPWNG F G+P V +F+ + + +D
Sbjct: 187 PGSYTAALVLAPYPELFIFNNNDNNATVWRSGPWNGLMFNGLPDVYPGLFLYRFKVNDDT 246
Query: 240 ELYFTFRPFNDKVITRLLVNESGTLQRLVWNETSTEWRMLYSWPFDTCDSYAQCGANDNC 299
T ND + L ++ G R W+E W + P CD Y++CG C
Sbjct: 247 NGSATMSYANDSTLRHLYLDYRGFAIRRDWSEARRNWTLGSQVPATECDIYSRCGQYTTC 306
Query: 300 RISKTPICECLTGFISKSQDDWDSPE-TRRCVRK-PSDCP------SGEGFLKLPRMKLP 351
K P C C+ GF ++ +W++ + C+RK P C S + FLKL RMK+P
Sbjct: 307 NPRKNPHCSCIKGFRPRNLIEWNNGNWSGGCIRKLPLQCERQNNKGSADRFLKLQRMKMP 366
Query: 352 ENYWSNKSMNLKECEAECTKNCSC---------------RAYANSDVT------------ 384
+ + + EC C ++CSC R+ +S V
Sbjct: 367 D-FARRSEASEPECFMTCLQSCSCIAFAHGLGYGCMIWNRSLVDSQVLSASGMDLSIRLA 425
Query: 385 ------------------GGG----SGCLMWFGDLVDLRECSEGYIWGQDFFIRVPSSEL 422
GG + C++ +V + + + F RV +
Sbjct: 426 HSEFKTQDRRPILIGTSLAGGIFVVATCVLLARRIVMKKRAKKKGTDAEQIFKRVEALAG 485
Query: 423 G-LENWKVDIEVPLYDLATITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKN 481
G E K E+PL++ + TAT++FS +N +G+GGFGPVY G L GQEIA KRLS+
Sbjct: 486 GSREKLK---ELPLFEFQVLATATDNFSLSNKLGQGGFGPVYKGMLLEGQEIAVKRLSQA 542
Query: 482 SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKL 541
SGQGLEE + EVV+I KLQHRNLV L G CI +ERML+YE+MP KSLD++IFD +KL
Sbjct: 543 SGQGLEELVTEVVVISKLQHRNLVKLFGCCIAGEERMLVYEFMPKKSLDFYIFDPREAKL 602
Query: 542 LPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601
L W RF II GI RGLLYLH+DS+L++IHRDLKASNILLD NL PKISDFGLARIF G+
Sbjct: 603 LDWNTRFEIINGICRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGLARIFPGN 662
Query: 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNL 661
++EA T RV GT+GYM+PEYA G S KSDVFSLGV+L+EI+SG+ N L
Sbjct: 663 EDEANTRRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIISGRRN-------SHSTL 715
Query: 662 IGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721
+ H W +WN+G G++D + D E ++ +C+ + LLCVQ DRP +S+V +L++
Sbjct: 716 LAHVWSIWNEGEINGMVDPEIFDQLFEKEIRKCVHIALLCVQDAANDRPSVSTVCMMLSS 775
Query: 722 DGVTLPQPRQPGFFTER-GFTVGALSSHEKCHSENALSITIQEGR 765
+ +P+P+QP F G S S N ++IT GR
Sbjct: 776 EVADIPEPKQPAFMPRNVGLEAEFSESIALKASINNVTITDVSGR 820
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ9|SD113_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-13 OS=Arabidopsis thaliana GN=SD113 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 573 bits (1477), Expect = e-162, Method: Compositional matrix adjust.
Identities = 339/826 (41%), Positives = 472/826 (57%), Gaps = 86/826 (10%)
Query: 17 FIIEFSFAADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSP-RTVVW 75
F + A D ++ D ET+VS+ +F GFFSP NST RY GIW+ + P +TVVW
Sbjct: 14 FSLRLCLATDVITFSSEFRDSETVVSNHSTFRFGFFSPVNSTGRYAGIWFNNIPVQTVVW 73
Query: 76 VANRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPV--AHLLDSGNLVLR 133
VAN N PI D +G+++ S G+L++++ WS+N + A LL++GNLVL
Sbjct: 74 VANSNSPINDSSGMVSISKEGNLVVMDGRGQVHWSTNVLVPVAANTFYARLLNTGNLVLL 133
Query: 134 DNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLKTGFERYLTPWRSADDPTPGEFSLRLDI 193
+ + +E +W+SF++P + LP M L + KTG L W+S DP+PG +S L
Sbjct: 134 -GTTNTGDEILWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFDPSPGRYSAGLIP 192
Query: 194 SALPELVIISGSRKEARSGPWNGQQFGGIPRVKNSIFIPKLEHTEDEL-YFTFRPFNDKV 252
PELV+ RSGPWNGQ F G+P + I + +L + D + + +
Sbjct: 193 LPFPELVVWKDDLLMWRSGPWNGQYFIGLPNMDYRINLFELTLSSDNRGSVSMSYAGNTL 252
Query: 253 ITRLLVNESGTLQRLVWNETSTEWRMLYSWPFDTCDSYAQCGANDNCRIS--KTPICECL 310
+ L++ G++ + WN EW+ P CD+YA CG +CR + TP C C+
Sbjct: 253 LYHFLLDSEGSVFQRDWNVAIQEWKTWLKVPSTKCDTYATCGQFASCRFNPGSTPPCMCI 312
Query: 311 TGFISKSQDDWDSPE-TRRCVRK-PSDCPS---------GEGFLKLPRMKLPENYWSNKS 359
GF +S +W++ T+ CVRK P C S +GF+++ +MK+P N
Sbjct: 313 RGFKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMKVPHNP-QRSG 371
Query: 360 MNLKECEAECTKNCSCRAYANSDVTGGGSGCLMWFGDLVDLRECSEGYIWGQDFFIRVPS 419
N ++C C KNCSC AY+ G GCL+W G+L+D++E S G F+IR+
Sbjct: 372 ANEQDCPESCLKNCSCTAYSFDR----GIGCLLWSGNLMDMQEFSGT---GVVFYIRLAD 424
Query: 420 SELG-------------------------LENWKV------------------------- 429
SE L WK+
Sbjct: 425 SEFKKRTNRSIVITVTLLVGAFLFAGTVVLALWKIAKHREKNRNTRLLNERMEALSSNDV 484
Query: 430 -DIEVPLYDLATI--------TTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSK 480
I V Y L + ATN+FS N +G+GGFG VY G+L G +IA KRLS+
Sbjct: 485 GAILVNQYKLKELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSR 544
Query: 481 NSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSK 540
SGQG+EEF+NEVV+I KLQHRNLV LLG CIE +ERML+YE+MP LD ++FD + +
Sbjct: 545 TSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQR 604
Query: 541 LLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600
LL WK RF+II GI RGL+YLH+DS+L++IHRDLKASNILLD NLNPKISDFGLARIF G
Sbjct: 605 LLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQG 664
Query: 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHN 660
+++E T RV GT+GYM+PEYA G S KSDVFSLGV+L+EIVSG+ N F + G N
Sbjct: 665 NEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPN 724
Query: 661 LIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720
L +AW LWN G + L+D + + E+++ RC+ VGLLCVQ DRP +++V+++L+
Sbjct: 725 LSAYAWKLWNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLS 784
Query: 721 NDGVTLPQPRQPGFFTERGFT-VGALSSHEKCHSENALSITIQEGR 765
++ LP+P+QP F RG + V + + S N +S+T GR
Sbjct: 785 SENSNLPEPKQPAFIPRRGTSEVESSGQSDPRASINNVSLTKITGR 830
|
Receptor-like serine/threonine-protein kinase that represses the disease resistance signaling pathway triggered in response to bacterial pathogen such as Pseudomonas syringae pv. tomato. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64770|Y1649_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61490 OS=Arabidopsis thaliana GN=At1g61490 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 559 bits (1441), Expect = e-158, Method: Compositional matrix adjust.
Identities = 321/786 (40%), Positives = 451/786 (57%), Gaps = 75/786 (9%)
Query: 8 IFFYLLILIFIIEFSFAADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYK 67
I F+ +L+F + F+ +++ ++ +TL SS +ELGFFSP NS N Y+GIW+K
Sbjct: 6 IVFFACLLLFTVLLRFSYAGITTESPLSVEQTLSSSNGIYELGFFSPNNSQNLYVGIWFK 65
Query: 68 SS-PRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLD 126
PR VVWVANR P TD + L S+NGSLLL N + +WS + A L D
Sbjct: 66 GIIPRVVVWVANRETPTTDTSANLAISSNGSLLLFNGKHGVVWSIGENFASNGSRAELTD 125
Query: 127 SGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLKTGFERYLTPWRSADDPTPGE 186
+GNLV+ DN +S +W+SF++ DT+LP L +NL TG +R LT W++ DP+PG
Sbjct: 126 NGNLVVIDN---ASGRTLWESFEHFGDTMLPFSSLMYNLATGEKRVLTSWKTDTDPSPGV 182
Query: 187 FSLRLDISALPELVIISGSRKEARSGPWNGQQFGGIPRVKNSIFIP--KLEHTEDELYFT 244
F ++ +++I+ GS + R+GPW +F GIP + ++ P + +FT
Sbjct: 183 FVGQITPQVPSQVLIMRGSTRYYRTGPWAKTRFTGIPLMDDTYASPFSLQQDANGSGFFT 242
Query: 245 F--RPFNDKVITRLLVNESGTLQRLVWNETSTEWRMLYSWPFDTCDSYAQCGANDNCRIS 302
+ R F ++R++++ G+++R N T+W + Y P ++CD Y CG C +S
Sbjct: 243 YFDRSFK---LSRIIISSEGSMKRFRHN--GTDWELSYMAPANSCDIYGVCGPFGLCIVS 297
Query: 303 KTPICECLTGFISKSQDDWDSPE-TRRCVRKPSDCPSGEG-------FLKLPRMKLPENY 354
C+CL GF+ S ++W T C R G F + +KLP+ Y
Sbjct: 298 VPLKCKCLKGFVPHSTEEWKRGNWTGGCARLTELHCQGNSTGKDVNIFHPVTNVKLPDFY 357
Query: 355 WSNKSMNLKECEAECTKNCSCRAYANSDVTGGGSGCLMWFGDLVDLRECSEGYIWGQDFF 414
S++ +EC C NCSC A+A G GCL+W +L+D + S G G+
Sbjct: 358 EYESSVDAEECHQSCLHNCSCLAFAYIH----GIGCLIWNQNLMDAVQFSAG---GEILS 410
Query: 415 IRVPSSELG----------------------------------------LENWKVDI--- 431
IR+ SELG + W+ D+
Sbjct: 411 IRLAHSELGGNKRNKIIVASTVSLSLFVILTSAAFGFWRYRVKHKAYTLKDAWRNDLKSK 470
Query: 432 EVP---LYDLATITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEE 488
EVP +++ TI TATN+FS +N +G+GGFG VY GKL G+EIA K+LS +SGQG EE
Sbjct: 471 EVPGLEFFEMNTIQTATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKQLSSSSGQGKEE 530
Query: 489 FMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRF 548
FMNE+VLI KLQHRNLV +LG CIE +E++LIYE+M +KSLD F+FD + + W KRF
Sbjct: 531 FMNEIVLISKLQHRNLVRVLGCCIEGEEKLLIYEFMLNKSLDTFVFDARKKLEVDWPKRF 590
Query: 549 SIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTE 608
I+ GIARGLLYLH+DS+L+VIHRDLK SNILLD +NPKISDFGLAR++ G + +T
Sbjct: 591 DIVQGIARGLLYLHRDSRLKVIHRDLKVSNILLDEKMNPKISDFGLARMYEGTQCQDKTR 650
Query: 609 RVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLL 668
RV GT GYMSPEYA G S KSD++S GVLL+EI+ G+ F + L+ +AW
Sbjct: 651 RVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRFSYGEEGKTLLAYAWES 710
Query: 669 WNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGVTLPQ 728
W + + + L+D L DS +V RC+Q+GLLCVQ P DRP+ ++ +L LP
Sbjct: 711 WGETKGIDLLDQDLADSCRPLEVGRCVQIGLLCVQHQPADRPNTLELLAMLTTTS-DLPS 769
Query: 729 PRQPGF 734
P+QP F
Sbjct: 770 PKQPTF 775
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64781|Y1639_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61390 OS=Arabidopsis thaliana GN=At1g61390 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 557 bits (1436), Expect = e-157, Method: Compositional matrix adjust.
Identities = 323/802 (40%), Positives = 456/802 (56%), Gaps = 85/802 (10%)
Query: 1 MKCLAVFIFFYLLILIFIIEFSFAADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNR 60
M+ + + IF LL+LI F +A + SS ++ G+TL S +ELGFFSP NS +
Sbjct: 19 MRKMGMVIFACLLLLIIFPTFGYADINTSSP--LSIGQTLSSPDGVYELGFFSPNNSRKQ 76
Query: 61 YLGIWYKS-SPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLEN 119
Y+GIW+K+ +P+ VVWVANR+ P+T LT S+NGSL+LL+ + IWS+ + T
Sbjct: 77 YVGIWFKNIAPQVVVWVANRDKPVTKTAANLTISSNGSLILLDGTQDVIWSTGEAFTSNK 136
Query: 120 PVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLKTGFERYLTPWRSA 179
A LLD+GNLV+ D++S + +W+SF+ +T+LP + +++ G R LT WRS
Sbjct: 137 CHAELLDTGNLVVIDDVSGKT---LWKSFENLGNTMLPQSSVMYDIPRGKNRVLTSWRSN 193
Query: 180 DDPTPGEFSLRLDISALPELVIISGSRKEARSGPWNGQQFGGIPRVKNSIFIPKL---EH 236
DP+PGEF+L P+ +I GS RSGPW +F GIP + S P +
Sbjct: 194 SDPSPGEFTLEFTPQVPPQGLIRRGSSPYWRSGPWAKTRFSGIPGIDASYVSPFTVLQDV 253
Query: 237 TEDELYFTFRPFNDKVITRLLVNESGTLQRLVWNETSTEWRMLYSWPFDTCDSYAQCGAN 296
+ F++ + ++ + + G + +++WN+ + W++ + P +CD Y CG
Sbjct: 254 AKGTASFSYSMLRNYKLSYVTLTSEGKM-KILWNDGKS-WKLHFEAPTSSCDLYRACGPF 311
Query: 297 DNCRISKTPICECLTGFISKSQDDWDSPE-TRRCVRKPS-DCPSG----------EGFLK 344
C S+ P C CL GF+ KS D+W T CVR+ C + + F
Sbjct: 312 GLCVRSRNPKCICLKGFVPKSDDEWKKGNWTSGCVRRTQLSCHTNSSTKTQGKETDSFYH 371
Query: 345 LPRMKLPENYWSNKSMNLKECEAECTKNCSCRAYANSDVTGGGSGCLMWFGDLVDLRECS 404
+ R+K P+ Y +N ++C +C NCSC A+A G GCL+W +LVD +
Sbjct: 372 MTRVKTPDLYQLAGFLNAEQCYQDCLGNCSCTAFAYI----SGIGCLVWNRELVDTVQFL 427
Query: 405 EGYIWGQDFFIRVPSSELGLEN-------------------------------------- 426
G+ +R+ SSEL N
Sbjct: 428 SD---GESLSLRLASSELAGSNRTKIILGTTVSLSIFVILVFAAYKSWRYRTKQNEPNPM 484
Query: 427 --------WKVDIE------VPLYDLATITTATNHFSEANMIGKGGFGPVYMGKLSTGQE 472
W D+E V L+D+ TI TATN+FS +N +G+GGFGPVY GKL G+E
Sbjct: 485 FIHSSQDAWAKDMEPQDVSGVNLFDMHTIRTATNNFSSSNKLGQGGFGPVYKGKLVDGKE 544
Query: 473 IAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYF 532
IA KRLS +SGQG +EFMNE+ LI KLQH+NLV LLG CI+ +E++LIYEY+ +KSLD F
Sbjct: 545 IAVKRLSSSSGQGTDEFMNEIRLISKLQHKNLVRLLGCCIKGEEKLLIYEYLVNKSLDVF 604
Query: 533 IFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDF 592
+FD + W+KRF+II G+ARGLLYLH+DS+L+VIHRDLK SNILLD + PKISDF
Sbjct: 605 LFDSTLKFEIDWQKRFNIIQGVARGLLYLHRDSRLRVIHRDLKVSNILLDEKMIPKISDF 664
Query: 593 GLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGF 652
GLAR+ G + T RV GT GYM+PEYA G S KSD++S GVLL+EI+ G+ F
Sbjct: 665 GLARMSQGTQYQDNTRRVVGTLGYMAPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRF 724
Query: 653 RHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDM 712
G L+ +AW W + + + L+D L DS ++V RC+Q+GLLCVQ P DRP+
Sbjct: 725 SEEG--KTLLAYAWESWCETKGVDLLDQALADSSHPAEVGRCVQIGLLCVQHQPADRPNT 782
Query: 713 SSVVFLLANDGVTLPQPRQPGF 734
++ +L LP P+QP F
Sbjct: 783 LELMSMLTTIS-ELPSPKQPTF 803
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64777|Y1643_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61430 OS=Arabidopsis thaliana GN=At1g61430 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 557 bits (1435), Expect = e-157, Method: Compositional matrix adjust.
Identities = 328/789 (41%), Positives = 436/789 (55%), Gaps = 77/789 (9%)
Query: 6 VFIFFYLLILIFIIEFSFAADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIW 65
+ F YL + FSFA + S I G+TL SS +ELGFFS NS N+YLGIW
Sbjct: 6 IVFFAYLPFFTIFMSFSFAGITKESPFSI--GQTLSSSNGVYELGFFSLNNSQNQYLGIW 63
Query: 66 YKSS-PRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHL 124
+KS P+ VVWVANR P+TD L S+NGSLLL N + +WS+ A L
Sbjct: 64 FKSIIPQVVVWVANREKPVTDSAANLGISSNGSLLLSNGKHGVVWSTGDIFASNGSRAEL 123
Query: 125 LDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLKTGFERYLTPWRSADDPTP 184
D GNLV D +S + +WQSF++ +TLLP + +NL G +R LT W+S DP+P
Sbjct: 124 TDHGNLVFIDKVSGRT---LWQSFEHLGNTLLPTSIMMYNLVAGEKRGLTAWKSYTDPSP 180
Query: 185 GEFSLRLDISALPELVIISGSRKEARSGPWNGQQFGGIPRVKNSIFIPKL--EHTEDELY 242
GEF + + +I+ GS + R+GPW +F G P++ S P + + Y
Sbjct: 181 GEFVALITPQVPSQGIIMRGSTRYYRTGPWAKTRFTGSPQMDESYTSPFILTQDVNGSGY 240
Query: 243 FTFRPFNDKVITRLLVNESGTLQRLVWNETSTEWRMLYSWPFDTCDSYAQCGANDNCRIS 302
F+F +R+++ GT++ LV N +W Y P ++CD Y CG C +S
Sbjct: 241 FSFVERGKP--SRMILTSEGTMKVLVHN--GMDWESTYEGPANSCDIYGVCGPFGLCVVS 296
Query: 303 KTPICECLTGFISKSQDDWDSPE-TRRCVRKP-------SDCPSGEGFLKLPRMKLPENY 354
P C+C GF+ K +W T CVR+ S F +P +K P+ Y
Sbjct: 297 IPPKCKCFKGFVPKFAKEWKKGNWTSGCVRRTELHCQGNSSGKDANVFYTVPNIKPPDFY 356
Query: 355 WSNKSMNLKECEAECTKNCSCRAYANSDVTGGGSGCLMWFGDLVDLRECSEGYIWGQDFF 414
S N +EC C NCSC A++ G GCLMW DL+D R+ S G+
Sbjct: 357 EYANSQNAEECHQNCLHNCSCLAFSYIP----GIGCLMWSKDLMDTRQFSAA---GELLS 409
Query: 415 IRVPSSELGLENWKVDI------------------------------------------- 431
IR+ SEL + K+ I
Sbjct: 410 IRLARSELDVNKRKMTIVASTVSLTLFVIFGFAAFGFWRCRVEHNAHISNDAWRNFLQSQ 469
Query: 432 EVP---LYDLATITTATNHFSEANMIGKGGFGPVYM---GKLSTGQEIAAKRLSKNSGQG 485
+VP +++ I TATN+FS +N +G GGFG VY GKL G+EIA KRLS +SGQG
Sbjct: 470 DVPGLEFFEMNAIQTATNNFSLSNKLGPGGFGSVYKARNGKLQDGREIAVKRLSSSSGQG 529
Query: 486 LEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWK 545
+EFMNE+VLI KLQHRNLV +LG C+E E++LIY ++ +KSLD F+FD + L W
Sbjct: 530 KQEFMNEIVLISKLQHRNLVRVLGCCVEGTEKLLIYGFLKNKSLDTFVFDARKKLELDWP 589
Query: 546 KRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605
KRF II GIARGLLYLH+DS+L+VIHRDLK SNILLD +NPKISDFGLAR+F G +
Sbjct: 590 KRFEIIEGIARGLLYLHRDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMFQGTQYQE 649
Query: 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHA 665
+T RV GT GYMSPEYA G S KSD++S GVLL+EI+SGK F + L+ +A
Sbjct: 650 KTRRVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIISGKKISSFSYGEEGKALLAYA 709
Query: 666 WLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGVT 725
W W + R + +D L DS S+V RC+Q+GLLCVQ P DRP+ ++ +L
Sbjct: 710 WECWCETREVNFLDQALADSSHPSEVGRCVQIGLLCVQHEPADRPNTLELLSMLTTTS-D 768
Query: 726 LPQPRQPGF 734
LP P++P F
Sbjct: 769 LPLPKKPTF 777
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 765 | ||||||
| 224115098 | 802 | predicted protein [Populus trichocarpa] | 0.998 | 0.952 | 0.616 | 0.0 | |
| 359493711 | 1081 | PREDICTED: G-type lectin S-receptor-like | 0.964 | 0.682 | 0.572 | 0.0 | |
| 147856585 | 741 | hypothetical protein VITISV_033399 [Viti | 0.951 | 0.982 | 0.573 | 0.0 | |
| 302143130 | 862 | unnamed protein product [Vitis vinifera] | 0.886 | 0.786 | 0.563 | 0.0 | |
| 359493721 | 804 | PREDICTED: G-type lectin S-receptor-like | 0.984 | 0.936 | 0.545 | 0.0 | |
| 224113153 | 785 | predicted protein [Populus trichocarpa] | 0.951 | 0.927 | 0.539 | 0.0 | |
| 224113157 | 786 | predicted protein [Populus trichocarpa] | 0.951 | 0.926 | 0.536 | 0.0 | |
| 224122958 | 812 | predicted protein [Populus trichocarpa] | 0.989 | 0.932 | 0.504 | 0.0 | |
| 356546914 | 788 | PREDICTED: G-type lectin S-receptor-like | 0.986 | 0.958 | 0.514 | 0.0 | |
| 224115102 | 784 | predicted protein [Populus trichocarpa] | 0.949 | 0.926 | 0.545 | 0.0 |
| >gi|224115098|ref|XP_002316939.1| predicted protein [Populus trichocarpa] gi|222860004|gb|EEE97551.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 964 bits (2491), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 495/803 (61%), Positives = 594/803 (73%), Gaps = 39/803 (4%)
Query: 1 MKCLAVFIFFYLLILIFIIEFSFAADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNR 60
M+ L FIFF L + + SF+AD ++ + DG+TL+S QSFELGFFSPG S R
Sbjct: 1 MESLPFFIFFSTLFIQSLHFLSFSADIITPDLPVKDGQTLISVSQSFELGFFSPGTSKYR 60
Query: 61 YLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENP 120
Y+GIWYK SP TVVWVANRN+P+TD GVLT N G+L+LL+Q K+ IWSSNSS + P
Sbjct: 61 YVGIWYKKSPETVVWVANRNNPLTDHFGVLTIDNRGNLVLLDQIKNIIWSSNSSSIIAGP 120
Query: 121 VAHLLDSGNLVLRDN-ISRSSEEYMWQSFDYPSDTLLPGMKLGWNLKTGFERYLTPWRSA 179
VA LLDSGNLV+RDN SR++E Y WQSFD PSDTLLPGMKLGWNLKTG ERYL WRS
Sbjct: 121 VAQLLDSGNLVVRDNGSSRNTESYRWQSFDQPSDTLLPGMKLGWNLKTGQERYLITWRSI 180
Query: 180 DDPTPGEFSLRLDISALPELVIISGSRKEARSGPWNGQQFGGIPRVKNSIFIPKLEHTED 239
DP+PG+F+ RLDI LP+L I+ GS K+ RSGPWNG FGG P+V NS+F P L ED
Sbjct: 181 SDPSPGDFTYRLDIHGLPQLFIVVGSVKKVRSGPWNGIFFGGTPKVHNSVFEPILVRNED 240
Query: 240 ELYFTFRPFNDKVITRLLVNESGTLQRLVWNETSTEWRMLYSWPFDTCDSYAQCGANDNC 299
E+Y+T+R N+ V +RL +N+SG ++RLV ++ W +YS P DTC++Y QCGAN C
Sbjct: 241 EIYYTYRLLNNSVCSRLTLNQSGAVERLVMYGQNSGWTTIYSVPVDTCENYGQCGANGIC 300
Query: 300 RISKTPICECLTGFISKSQDDWDSPE---TRRC-VRKPSDCPSGEGFLKLPRMKLPE--N 353
R +PICECL GF S +++ D +R+C R DC SGEGFLKLP +KLP+
Sbjct: 301 RTRTSPICECLKGFKSIPEEELDIQNFYGSRKCETRLTLDCQSGEGFLKLPGVKLPDLLE 360
Query: 354 YWSNKSMNLKECEAECTKNCSCRAYANSDVTGG--GSGCLMWFGDLVDLRECSEGYIWGQ 411
+ N+SMNLKECEAEC KNCSC A+A ++++GG GSGCLMWFG+L+D+RE S G GQ
Sbjct: 361 FRLNESMNLKECEAECFKNCSCSAFATTNLSGGGDGSGCLMWFGNLIDIREQS-GSTIGQ 419
Query: 412 DFFIRVPSSEL-----------------------------GLENWKVDIEVPLYDLATIT 442
D IRVP+SEL G++ K +E PL+DL TI
Sbjct: 420 DIHIRVPASELEMARSSKRKKMLKTALVASMSALLGIFVSGMDRRKEGMEAPLFDLDTIA 479
Query: 443 TATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHR 502
TATN+F+ ++IG GGFG VY GKL TGQEIA K+LS NSGQG+EEF NEVVLI KLQHR
Sbjct: 480 TATNNFAPDSIIGAGGFGSVYKGKLLTGQEIAVKKLSMNSGQGVEEFRNEVVLIAKLQHR 539
Query: 503 NLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLH 562
NLVGLLGSCI +ERMLIYEYMP+KSLDYFIFD ERS LL WK+RF II GIARGLLYLH
Sbjct: 540 NLVGLLGSCIHREERMLIYEYMPNKSLDYFIFDHERSALLGWKERFVIILGIARGLLYLH 599
Query: 563 QDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA 622
QDSKLQ++HRDLK SN+LLD NL PKISDFGLARI G D +E +T RV GT+GYM+PEYA
Sbjct: 600 QDSKLQIVHRDLKPSNVLLDSNLIPKISDFGLARISGDDGKETKTRRVIGTYGYMAPEYA 659
Query: 623 NDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682
DG S+KSDVFSLGVLL+EI+SGK NRGF HP H H+L+GHAWL+WN+GRA L+DT L
Sbjct: 660 IDGKFSVKSDVFSLGVLLLEIISGKKNRGFVHPDHHHHLLGHAWLMWNEGRASELIDTGL 719
Query: 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGVTLPQPRQPGFFTERGFTV 742
ED+ +SQ+LRCIQVGLLCVQKLPEDRP MS+VVF+LAN+G LPQP+QPGFF ERG
Sbjct: 720 EDTSGKSQLLRCIQVGLLCVQKLPEDRPVMSTVVFMLANEGAVLPQPKQPGFFIERGSVS 779
Query: 743 GALSSHEKCHSENALSITIQEGR 765
A S +E +S N +ITI E R
Sbjct: 780 EATSRNEDSYSTNEANITILEAR 802
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493711|ref|XP_002281022.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 892 bits (2304), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 452/789 (57%), Positives = 556/789 (70%), Gaps = 51/789 (6%)
Query: 25 ADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPIT 84
ADS+ + I+D ETLVSS QSFELGFFSPG+S NRYLGIWYK++P+T VWVANRN+PI
Sbjct: 296 ADSIRMDQSISDSETLVSSGQSFELGFFSPGSSKNRYLGIWYKNTPQTAVWVANRNNPIA 355
Query: 85 DKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYM 144
D GVLT NNG+L+LLNQ KS IWS N SR ENPVA LL++GNLVLRD + +S+ Y+
Sbjct: 356 DSYGVLTIINNGALVLLNQSKSVIWSPNLSRVPENPVAQLLETGNLVLRDGSNETSKSYI 415
Query: 145 WQSFDYPSDTLLPGMKLGWNLKTGFERYLTPWRSADDPTPGEFSLRLDISALPELVIISG 204
WQSFD PSDT+LPGMK+GWNLKTG +R LT W+S+DDP+ G+FS DI+ LP LV+ G
Sbjct: 416 WQSFDDPSDTMLPGMKVGWNLKTGLQRKLTSWKSSDDPSLGDFSYGFDINVLPYLVLGVG 475
Query: 205 SRKEARSGPWNGQQFGGIPRVKNSIFIPKLEHTEDELYFTFRPFNDKVITRLLVNESGTL 264
S K RSGPWNG +F G+ + NS++ DE+Y + N+K+I+RL +N SG L
Sbjct: 476 SSKIVRSGPWNGLEFNGVYVLDNSVYKAVFVANNDEVYALYESNNNKIISRLTLNHSGFL 535
Query: 265 QRLVWNETSTEWRMLYSWPFDTCDSYAQCGANDNCRISKTPICECLTGFISKSQDDWDSP 324
QRL+ + S+ W LYS P + C++Y CGAN CRI K ICECLTGF KSQ++WD
Sbjct: 536 QRLLLKKGSSVWDELYSIPSELCENYGHCGANGICRIGKLQICECLTGFTPKSQEEWDMF 595
Query: 325 ETRR-CVRK-PSDCPSGEGFLKLPRMKLPE--NYWSNKSMNLKECEAECTKNCSCRAYAN 380
T C R+ P DC EGF+K+ +KLP+ ++ ++L+EC+ C NCSC AYA
Sbjct: 596 NTSSGCTRRMPLDCQIEEGFVKVTGVKLPDLIDFHVIMGVSLRECKVSCLNNCSCTAYAY 655
Query: 381 SDVTGGGSGCLMWFGDLVDLRE-CSEGYIWGQDFFIRVPSSELGL--------------- 424
++ G G GCLMW GDL+D+RE SE + +D +IR+ +SELGL
Sbjct: 656 TNPNGSG-GCLMWSGDLIDIRELTSEKH--AEDIYIRMHTSELGLNTNQKKKKLVIILVI 712
Query: 425 ---------------------------ENWKVDIEVPLYDLATITTATNHFSEANMIGKG 457
E+ K ++E+PL+DL TI TATN+FS N IG G
Sbjct: 713 STFSGILTLGLSFWFRFWKKRTMGTDQESKKENLELPLFDLPTIATATNNFSNTNKIGAG 772
Query: 458 GFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDER 517
GFG VY G L G +A KRLSKNS QG++EF NE VLI KLQH+NLV LLG CI+ +ER
Sbjct: 773 GFGSVYKGNLPEGVAVAVKRLSKNSAQGVQEFKNEAVLIAKLQHKNLVRLLGCCIQGEER 832
Query: 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKAS 577
+L+YEYMP+KSLDYFIFD+ R LL W KR I+ GIARGLLYLHQDS+ Q+IHRDLK S
Sbjct: 833 ILLYEYMPNKSLDYFIFDQNRRALLAWDKRCEIVMGIARGLLYLHQDSRFQIIHRDLKTS 892
Query: 578 NILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLG 637
NILLD NLNPKISDFGLARIFG ++ E +T+R+ GT+GYMSPEY DG S+K DVFS G
Sbjct: 893 NILLDDNLNPKISDFGLARIFGENEMETRTKRIVGTYGYMSPEYVIDGHFSIKLDVFSFG 952
Query: 638 VLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQV 697
VLL+EIVSG+ NRGF HP H HNL+GHAWLLW RAL LMD CLEDS V SQVLRCIQV
Sbjct: 953 VLLLEIVSGEKNRGFSHPDHHHNLLGHAWLLWEQNRALELMDACLEDSCVASQVLRCIQV 1012
Query: 698 GLLCVQKLPEDRPDMSSVVFLLANDGVTLPQPRQPGFFTER-GFTVGALSSHEKCHSENA 756
GLLCVQ LP DRP MSSV+F+L N+G TLPQP+ PGFFTER +S + HSENA
Sbjct: 1013 GLLCVQNLPADRPAMSSVIFMLGNEGATLPQPKHPGFFTERSSVDTDTMSGKIELHSENA 1072
Query: 757 LSITIQEGR 765
++I++ +GR
Sbjct: 1073 VTISMLKGR 1081
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147856585|emb|CAN80325.1| hypothetical protein VITISV_033399 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 859 bits (2220), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/771 (57%), Positives = 545/771 (70%), Gaps = 43/771 (5%)
Query: 1 MKCLAVFIFFYLLILIFI-IEFSFAADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTN 59
M+ F FF I + + +EF AADS+ + I++GETLVSS QSFELGFFSPGNS N
Sbjct: 1 METHLFFAFFCAWICLSVPLEFCIAADSIRMHQSISNGETLVSSGQSFELGFFSPGNSNN 60
Query: 60 RYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLEN 119
YLGIWYK++P+TVVWVANRN+PITD VLT NNG L+LLN+ KS IWS N SR EN
Sbjct: 61 WYLGIWYKNTPQTVVWVANRNNPITDSYRVLTIINNG-LVLLNRTKSVIWSPNLSRVPEN 119
Query: 120 PVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLKTGFERYLTPWRSA 179
PVA LL++GNLVLRDN + SS+ Y+WQSFD+PSDTLLPGMK+G NLKTG +R LT WRSA
Sbjct: 120 PVAQLLETGNLVLRDNSNESSKSYIWQSFDHPSDTLLPGMKMGRNLKTGVQRNLTSWRSA 179
Query: 180 DDPTPGEFSLRLDISALPELVIISGSRKEARSGPWNGQQFGGIPRVKNSIFIPKLEHTED 239
DDP+ G+FSLR+DIS LP V+ +GS K+ RSGPWNG +F G+P +KN +F + ED
Sbjct: 180 DDPSLGDFSLRIDISVLPYFVLGTGSSKKVRSGPWNGIEFNGLPALKNEVFKSVFVYKED 239
Query: 240 ELYFTFRPFNDKVITRLLVNESGTLQRLVWNETSTEWRMLYSWPFDTCDSYAQCGANDNC 299
E+Y + N+ V T+L +N SG +QRL+ + S+EW LYS P + C++Y +CGAN C
Sbjct: 240 EVYAFYESHNNAVFTKLTLNHSGFVQRLLLKKGSSEWDELYSIPNELCENYGRCGANSIC 299
Query: 300 RISKTPICECLTGFISKSQDDWDSPETR-RCVRK-PSDCPSGEGFLKLPRMKLPE--NYW 355
R+ K ICECLTGF S+++W+ T C R+ P C S EGF+K+ +KLP+ ++
Sbjct: 300 RMGKLQICECLTGFTPXSEEEWNMFNTSGGCTRRMPLXCQSEEGFVKVTGVKLPDLIDFH 359
Query: 356 SNKSMNLKECEAECTKNCSCRAYANSDVTGGGSGCLMWFGDLVDLRECSEGYIWGQDFFI 415
S++L EC+A C NCSC AYA S++ G SGCLMW G+L+D+RE S +D +I
Sbjct: 360 VIMSVSLGECKALCLNNCSCTAYAYSNLN-GSSGCLMWSGNLIDIRELST-ETNKEDIYI 417
Query: 416 RVPSSELGLENWKVDIEVPLYDLATITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAA 475
R +SE GGFGPVY G L G +A
Sbjct: 418 RGHTSE----------------------------------PGGFGPVYKGNLXEGVAVAV 443
Query: 476 KRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFD 535
KRLSKNS QG++EF NEVVL+ KLQH+NLV LLG C++ +ER+L+YE MP+KSLDYFIFD
Sbjct: 444 KRLSKNSAQGVQEFNNEVVLMAKLQHKNLVRLLGCCVQGEERILLYEXMPNKSLDYFIFD 503
Query: 536 RERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA 595
+ R LL W KR I+ GIARGLLYLHQDS+ Q+IHRDLK SNILLD NLNPKISDFGLA
Sbjct: 504 QNRXALLAWDKRCEIVMGIARGLLYLHQDSRFQIIHRDLKTSNILLDDNLNPKISDFGLA 563
Query: 596 RIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHP 655
RIFG ++ E +T+R+ GTHGYMSPEY DG S KSDVFS GVLL+EIVSGK NRGF HP
Sbjct: 564 RIFGENEMETRTKRIIGTHGYMSPEYVIDGXFSXKSDVFSFGVLLLEIVSGKKNRGFSHP 623
Query: 656 GHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSV 715
H HNL+GHAWLLW +AL LMD CLEDS V SQVLRCIQVGLLCV+ LP DRP MSSV
Sbjct: 624 YHHHNLLGHAWLLWEQNKALELMDACLEDSCVASQVLRCIQVGLLCVKNLPADRPAMSSV 683
Query: 716 VFLLANDGVTLPQPRQPGFFTER-GFTVGALSSHEKCHSENALSITIQEGR 765
+F+L N+G TLPQP+ GFFTER +S + HSEN ++I+ +GR
Sbjct: 684 IFMLGNEGATLPQPKHXGFFTERCSVDTDTMSGKIELHSENEVTISKLKGR 734
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143130|emb|CBI20425.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 830 bits (2143), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/731 (56%), Positives = 516/731 (70%), Gaps = 53/731 (7%)
Query: 81 HPITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSS 140
+PI GVL+ N+G+L LLN+ K IWSS+SSR ENP A LL++GNLVLRD
Sbjct: 139 NPIEGSYGVLSIGNDGNLALLNKTKGIIWSSSSSRGAENPTAQLLETGNLVLRDESDVDP 198
Query: 141 EEYMWQSFDYPSDTLLPGMKLGWNLKTGFERYLTPWRSADDPTPGEFSLRLDISALPELV 200
E Y WQSFD+P DTLL GMK GWNLK G RYLT WR+A DP PG+F+ R+DI LP++V
Sbjct: 199 EIYTWQSFDFPCDTLLAGMKFGWNLKDGQNRYLTSWRNASDPAPGDFTWRIDIVGLPQMV 258
Query: 201 IISGSRKEARSGPWNGQQFGGIPRVKNSIFIPKLEHTEDELYFTFRPFNDKVITRLLVNE 260
+ GS K RSGPWNG F G+P +K + F L DE Y+++ + +ITRL ++E
Sbjct: 259 LRKGSEKMFRSGPWNGLSFNGLPLIKKTFFTSSLVDNADEFYYSYELDDKSIITRLTLDE 318
Query: 261 SGTLQRLVWNETSTEWRMLYSWPFDTCDSYAQCGANDNCRISKTPICECLTGFISKSQDD 320
G QRLV ++TS +W ++Y D CD Y +CGAN CRI+ PICECL GF+ KSQ++
Sbjct: 319 LGIYQRLVLSKTSKKWDIVYPLQDDLCDDYGRCGANSICRINDRPICECLEGFVPKSQEE 378
Query: 321 WDSPE-TRRCVRKPS-DCPSGEGFLKLPRMKLPE--NYWSNKSMNLKECEAECTKNCSCR 376
W+ T C+R+ DC GEGF++L +KLP+ +W +KSM LKECE EC +NCSC
Sbjct: 379 WEFQNWTSGCIRRTQLDCQKGEGFMELEGVKLPDLLEFWVSKSMTLKECEEECLRNCSCT 438
Query: 377 AYANSDVTGGGSGCLMWFGDLVDLRECSEGYIWGQDFFIRVPSSEL-------------- 422
AY NS+++ GGSGCL+WF DL+D+RE E Q+ +IR+P+SEL
Sbjct: 439 AYTNSNISEGGSGCLIWFRDLIDIREFHEDN--KQNIYIRMPASELELMNGSSQSKKRLV 496
Query: 423 ----------------------------GLENWKVDIEVPLYDLATITTATNHFSEANMI 454
G E K D+E+ L+DLATI++ATN+FS++N+I
Sbjct: 497 VVVVSSTASGVFILGLVLWFIVRKRKKRGSETEKEDLELQLFDLATISSATNNFSDSNLI 556
Query: 455 GKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE 514
GKGGFGPVY G L++GQEIA KRLS NSGQG +EF NEV+LI KLQHRNLV LLG C+EE
Sbjct: 557 GKGGFGPVYKGTLASGQEIAVKRLSNNSGQGFQEFKNEVILIAKLQHRNLVRLLGYCVEE 616
Query: 515 DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDL 574
ERML+YEYMP+KSLD FIFD+ERS LL W +RF I+ G+ARGLLYLHQDS+L++IHRDL
Sbjct: 617 -ERMLVYEYMPNKSLDCFIFDQERSMLLNWPRRFDIVMGVARGLLYLHQDSRLRIIHRDL 675
Query: 575 KASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVF 634
K SNILLD LNPKISDFG+AR+FGG EA+T+ V GT+GYMSPEYA DG S+KSDVF
Sbjct: 676 KTSNILLDSELNPKISDFGIARVFGGQQTEAKTKLVIGTYGYMSPEYAIDGKFSVKSDVF 735
Query: 635 SLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRC 694
S GVLL+EIVS K NRGF HP H HNL+GHAWLLWN+ + + LMD L+DS +ESQVLRC
Sbjct: 736 SFGVLLLEIVSSKKNRGFCHPDHHHNLLGHAWLLWNERKTMELMDAGLKDSCIESQVLRC 795
Query: 695 IQVGLLCVQKLPEDRPDMSSVVFLLANDGVTLPQPRQPGFFTERGFTVGALSSHEKCHSE 754
IQVGLLCVQKLP DRP MSS++F+L N+ TLPQP+QPGFF ER + + C++E
Sbjct: 796 IQVGLLCVQKLPVDRPTMSSIIFMLGNEEATLPQPKQPGFFFER----SSEGDDKGCYTE 851
Query: 755 NALSITIQEGR 765
N +++TI E R
Sbjct: 852 NTVTLTILEAR 862
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493721|ref|XP_002280717.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 825 bits (2132), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/774 (54%), Positives = 550/774 (71%), Gaps = 21/774 (2%)
Query: 6 VFIFFYLLILIFIIEFSFAADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIW 65
VF+F Y+ I I+ S A DS+++ + I DGET++S+ +FELGF G S N+YLGIW
Sbjct: 38 VFLFSYV---ISILRISTAVDSITANQHIKDGETIISAGGNFELGFVHLGTSKNQYLGIW 94
Query: 66 YKS-SPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHL 124
YK +PRTVVWVANR P+TD +GVL ++ GSL++LN IWSSNSSR+ NP A L
Sbjct: 95 YKKVTPRTVVWVANRELPVTDSSGVLKVTDQGSLVILNGSNGLIWSSNSSRSARNPTAQL 154
Query: 125 LDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLKTGFERYLTPWRSADDPTP 184
LDSGNLV++ + ++WQSFDYP DTLLPGMK G N TG +RYL+ W+S DDP+
Sbjct: 155 LDSGNLVIKSGNDSDPDNFLWQSFDYPGDTLLPGMKHGRNTVTGLDRYLSSWKSNDDPSK 214
Query: 185 GEFSLRLDISALPELVIISGSRKEARSGPWNGQQFGGIPRVK-NSIFIPKLEHTEDELYF 243
G+F+ LD S P+L + SGS RSGPWNG +F G P ++ N +F E E+YF
Sbjct: 215 GDFTYGLDPSGCPQLFLRSGSTVIFRSGPWNGIRFNGFPELRPNPVFNYSFVFNEKEMYF 274
Query: 244 TFRPFNDKVITRLLVNESGTLQRLVWNETSTEWRMLYSWPFDTCDSYAQCGANDNCRISK 303
T++ N V++RL++N +G +QRL+W + W + + D CDSYA CGA C I +
Sbjct: 275 TYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWNVYSTAYKDDCDSYALCGAYSTCNIHR 334
Query: 304 TPICECLTGFISKSQDDWDSPE-TRRCVRKPS-DCPSGEGFLKLPRMKLPE--NYWSNKS 359
+P C C+ GF+ K WD+ + + CVRK S DC G+GF+K +KLP+ N W N+S
Sbjct: 335 SPRCGCMKGFVPKFPYQWDTMDWSNGCVRKTSLDCQKGDGFVKCSGVKLPDTRNSWFNES 394
Query: 360 MNLKECEAECTKNCSCRAYANSDVTGGGSGCLMWFGDLVDLRECSEGYIWGQDFFIRVPS 419
MNLKEC + C +NCSC AY NSD+ GGGSGCL+WFGDL+D++E +E GQDF+IR+ +
Sbjct: 395 MNLKECASLCLRNCSCSAYTNSDIKGGGSGCLLWFGDLIDVKEFTEN---GQDFYIRMAA 451
Query: 420 SELGLEN-------WKVDIEVPLYDLATITTATNHFSEANMIGKGGFGPVYMGKLSTGQE 472
SEL L N + D+E+PL+DL TI AT++FS N +G+GGFGPVY G L G+E
Sbjct: 452 SELELNNEGAETNERQEDLELPLFDLDTILNATHNFSRNNKLGEGGFGPVYKGMLQDGKE 511
Query: 473 IAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYF 532
IA KRLSK S QGL+EF NEV+ I KLQHRNLV LLG CI +E+MLIYEYMP+KSL++F
Sbjct: 512 IAVKRLSKESNQGLDEFKNEVIYISKLQHRNLVKLLGCCIHGEEKMLIYEYMPNKSLNFF 571
Query: 533 IFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDF 592
IFD +S +L W KRF II GIARGLLYLHQDS+L++IHRDLKA N+LLD +NP+ISDF
Sbjct: 572 IFDGIQSMVLDWPKRFVIINGIARGLLYLHQDSRLRIIHRDLKADNVLLDNEMNPRISDF 631
Query: 593 GLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGF 652
G+AR FGG++ +A+T+RV GT+GYMSPEYA DG S+KSDVFS GVLL+EI+SGK NRGF
Sbjct: 632 GMARSFGGNETQARTKRVVGTYGYMSPEYAIDGVYSVKSDVFSFGVLLLEIISGKRNRGF 691
Query: 653 RHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDM 712
HP H NL+GHAW L+ + L L+D + D++ +S+VLR + VGLLCVQ+ P+DRP+M
Sbjct: 692 NHPDHDLNLLGHAWTLYMERTPLELIDASVGDTYNQSEVLRALNVGLLCVQRHPDDRPNM 751
Query: 713 SSVVFLLANDGVTLPQPRQPGFFTERG-FTVGALSSHEKCHSENALSITIQEGR 765
SSVV +L+++G L QP++PGFFTER +L S N +ITI EGR
Sbjct: 752 SSVVLMLSSEGA-LRQPKEPGFFTERNMLEADSLQCKHAVFSGNEHTITILEGR 804
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113153|ref|XP_002332643.1| predicted protein [Populus trichocarpa] gi|222832838|gb|EEE71315.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 807 bits (2085), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/749 (53%), Positives = 538/749 (71%), Gaps = 21/749 (2%)
Query: 7 FIFFYLLILIFIIEFSFAADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWY 66
F LIF ++FS A D+++ + ++DG+TLVS SFELGFFSPG S NRYLGIWY
Sbjct: 15 LTLFNTSFLIFQLKFSTALDTIAPSQSLSDGKTLVSREGSFELGFFSPGISKNRYLGIWY 74
Query: 67 KSSP-RTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVA-HL 124
K+ P RTV+WVANR +PI D +G+LT N +LLL++ +WSSNS+ ++P+ L
Sbjct: 75 KNIPLRTVLWVANRRNPIEDSSGLLTIDNTANLLLVSNRNVVVWSSNSTIVAKSPIVLQL 134
Query: 125 LDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLKTGFERYLTPWRSADDPTP 184
LDSGNLVLRD S S Y+WQSFD+PSDTL+PGMKLGW+L+TG ER L+ WRS+DDP+P
Sbjct: 135 LDSGNLVLRDEKSDSGR-YLWQSFDHPSDTLIPGMKLGWDLRTGLERRLSSWRSSDDPSP 193
Query: 185 GEFSLRLDISALPELVIISGSRKEARSGPWNGQQFGGIPR-VKNSIFIPKLEHTEDELYF 243
G+ + + + PE +I GS++ RSGPW G F G P V+N +F +EDE+Y
Sbjct: 194 GDLTWGIKLQNNPETIIWRGSQQYFRSGPWTGIAFTGAPELVQNPVFKLNFVSSEDEVYL 253
Query: 244 TFRPFNDKVITRLLVNESGTLQR-LVWNETSTEWRMLYSWPFDTCDSYAQCGANDNCRIS 302
++ N +R++VN++ + WNE + W + S P D+CD+YA CGAN NC I+
Sbjct: 254 SYNLKNISAFSRIVVNQTTNYREAYTWNEATQTWVLYASVPRDSCDNYASCGANGNCIIN 313
Query: 303 KTPICECLTGFISKSQDDWDSPE-TRRCVR-KPSDCPSGEGFLKLPRMKLPE--NYWSNK 358
PIC CL F KS + W+ + + CVR KP +C G+GF+K +K P+ + W NK
Sbjct: 314 DLPICRCLKKFKPKSPEKWNLMDWSDGCVRNKPLNCQKGDGFVKYLGLKWPDATHSWLNK 373
Query: 359 SMNLKECEAECTKNCSCRAYANSDVTGGGSGCLMWFGDLVDLRECSEGYIWGQDFFIRV- 417
SMNL EC A+C +NCSC AY+NSDV GGGSGC++W+G L+D+R+ G GQ+ +IR+
Sbjct: 374 SMNLNECRAKCLQNCSCMAYSNSDVRGGGSGCIIWYGGLIDIRQFPAG---GQELYIRMN 430
Query: 418 PS-SELGLENWKV------DIEVPLYDLATITTATNHFSEANMIGKGGFGPVYMGKLSTG 470
PS SE+ +N ++ D+E+P ++ A I ATN+FS N +G+GGFGPVY G L G
Sbjct: 431 PSESEMDQQNDQITDGENEDLELPQFEFAKIVNATNNFSIENKLGQGGFGPVYKGTLEDG 490
Query: 471 QEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLD 530
QEIA KRLS +SGQG +EF NEV+LI KLQHRNLV LLG I+ +ER+L+YEYMP+KSLD
Sbjct: 491 QEIAVKRLSMSSGQGSKEFKNEVILINKLQHRNLVKLLGCSIQREERLLVYEYMPNKSLD 550
Query: 531 YFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKIS 590
F+FD+ +SKLL W KRF+II GIARGLLYLHQDS+L++IHRDLK+SN+LLD ++NPKIS
Sbjct: 551 SFLFDQTKSKLLDWSKRFNIICGIARGLLYLHQDSRLRIIHRDLKSSNVLLDKDMNPKIS 610
Query: 591 DFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNR 650
DFGLAR FGGD E T RV GT+GYM+PEYA DG S+KSDVFS G++L+EIV+GK +R
Sbjct: 611 DFGLARTFGGDQTEGNTSRVVGTYGYMAPEYATDGLFSVKSDVFSFGIMLLEIVTGKKSR 670
Query: 651 GFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRP 710
GF HP + +LIG+AW LW +G+ L L+D E+S+ S+V++CI + LLCVQ+ PEDRP
Sbjct: 671 GFYHPDNSLSLIGYAWRLWKEGKPLELVDGLAEESWNLSEVMKCIHISLLCVQQYPEDRP 730
Query: 711 DMSSVVFLLANDGVTLPQPRQPGFFTERG 739
M+SVV +L + TLP+P++PGFF +RG
Sbjct: 731 SMASVVLMLGGE-RTLPKPKEPGFFKDRG 758
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113157|ref|XP_002332644.1| predicted protein [Populus trichocarpa] gi|222832839|gb|EEE71316.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 806 bits (2082), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/750 (53%), Positives = 536/750 (71%), Gaps = 22/750 (2%)
Query: 7 FIFFYLLILIFIIEFSFAADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWY 66
F + LIF ++FS A D+++ + + DG+TLVS SFELGFFSPG S NRYLGIWY
Sbjct: 15 LTLFNISFLIFQLKFSTALDTIAPSQSLIDGKTLVSREGSFELGFFSPGISKNRYLGIWY 74
Query: 67 KSSP-RTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVA-HL 124
K+ P RTV+WVANR +PI D +G LT N +LLL++ +WSSNS+ ++P+ L
Sbjct: 75 KNIPVRTVLWVANRRNPIEDSSGFLTIDNTANLLLVSNRNVVVWSSNSTIVAKSPIVLQL 134
Query: 125 LDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLKTGFERYLTPWRSADDPTP 184
LDSGNLVLRD S S Y+WQSFD+PSDTL+PGMKLGW+L+TG ER L+ WRS+DDP+P
Sbjct: 135 LDSGNLVLRDEKSDSGR-YLWQSFDHPSDTLIPGMKLGWDLRTGLERRLSSWRSSDDPSP 193
Query: 185 GEFSLRLDISALPELVIISGSRKEARSGPWNGQQFGGIPR-VKNSIFIPKLEHTEDELYF 243
G+ + + + PE +I GS++ RSGPW G F G P V+N +F +EDE+Y
Sbjct: 194 GDLTWGIKLQNNPETIIWRGSQQYFRSGPWTGIAFTGAPELVQNPVFKLNFVSSEDEVYL 253
Query: 244 TFRPFNDKVITRLLVNESGTLQR-LVWNETSTEWRMLYSWPFDTCDSYAQCGANDNCRIS 302
++ N +R++VN++ + WNE + W + S P D+CD+YA CGAN NC I+
Sbjct: 254 SYNLKNISAFSRIVVNQTTNYREAYTWNEATQTWVLYASVPRDSCDNYASCGANGNCIIN 313
Query: 303 KTPICECLTGFISKSQDDWDSPE-TRRCVR-KPSDCPSGEGFLKLPRMKLPE--NYWSNK 358
PIC CL F KS + W+ + + CVR KP +C G+GF+K +K P+ + W NK
Sbjct: 314 DLPICRCLKKFKPKSPEKWNLMDWSDGCVRNKPLNCQKGDGFVKYLGLKWPDATHSWLNK 373
Query: 359 SMNLKECEAECTKNCSCRAYANSDVTGGGSGCLMWFGDLVDLRECSEGYIWGQDFFIRV- 417
SMNL EC A+C +NCSC AY+NSDV GGGSGC++W+GDL+D+R+ G GQ+ +IR+
Sbjct: 374 SMNLNECRAKCLQNCSCMAYSNSDVRGGGSGCIIWYGDLIDIRQFPAG---GQELYIRMN 430
Query: 418 --PSSELGLENWKV------DIEVPLYDLATITTATNHFSEANMIGKGGFGPVYMGKLST 469
S+E+ +N ++ D+E+P ++ A I ATN+FS N +G+GGFGPVY G L
Sbjct: 431 PSESAEMDQQNDQITDGENEDLELPQFEFAKIVNATNNFSIKNKLGQGGFGPVYKGTLED 490
Query: 470 GQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSL 529
GQEIA KRLS +S QG +EF NEV+LI KLQHRNLV LLG I+ +ER+L+YEYMP+KSL
Sbjct: 491 GQEIAVKRLSMSSRQGSKEFKNEVILINKLQHRNLVKLLGCSIQREERLLVYEYMPNKSL 550
Query: 530 DYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKI 589
D F+FD+ +SKLL W KRF+II GIARGLLYLHQDS+L++IHRDLK+SN+LLD ++NPKI
Sbjct: 551 DSFLFDQTKSKLLDWSKRFNIICGIARGLLYLHQDSRLRIIHRDLKSSNVLLDKDMNPKI 610
Query: 590 SDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMN 649
SDFGLAR FGGD E T RV GT+GYM+PEYA DG S+KSDVFS G++L+EIV+GK +
Sbjct: 611 SDFGLARTFGGDQTEGNTSRVVGTYGYMAPEYATDGLFSVKSDVFSFGIMLLEIVTGKKS 670
Query: 650 RGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDR 709
RGF HP + +LIG+AW LW +G+ L L+D E+S+ S+V++CI + LLCVQ+ PEDR
Sbjct: 671 RGFYHPDNSLSLIGYAWRLWKEGKPLELVDGLAEESWNLSEVMKCIHISLLCVQQYPEDR 730
Query: 710 PDMSSVVFLLANDGVTLPQPRQPGFFTERG 739
P M+SVV +L + TLP+P++PGFF +RG
Sbjct: 731 PSMASVVLMLGGER-TLPKPKEPGFFKDRG 759
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 802 bits (2071), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/814 (50%), Positives = 537/814 (65%), Gaps = 57/814 (7%)
Query: 5 AVFIFFYLLILIFIIEFSFAADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGI 64
V + F + I++ S A D++++ + + DGETLVS+ SFELGFF+P ST+RYLG+
Sbjct: 3 VVDVIFVYSLFFSILKISSALDAMNTTQSLRDGETLVSTGGSFELGFFTPAGSTSRYLGL 62
Query: 65 WYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHL 124
WYK SP+TVVWVANR PI++K G L ++ G L+LLN + +WSSN+S T++NPVA L
Sbjct: 63 WYKKSPQTVVWVANRGIPISNKFGTLNVTSQGILVLLNGTNNIVWSSNTSTTVQNPVAQL 122
Query: 125 LDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLKTGFERYLTPWRSADDPTP 184
LDSGNLV+RD ++ ++WQSFDYP DTLLPGMKLG NL TG +L+ W+ ++P P
Sbjct: 123 LDSGNLVVRDGNDNKADNFLWQSFDYPCDTLLPGMKLGSNLVTGLNSFLSSWKGKENPAP 182
Query: 185 GEFSLRLDISALPELVIISGSRKEARSGPWNGQQFGGIPRVK-NSIFIPKLEHTEDELYF 243
G+F+L +D+ P+L++ +R R G WNGQ F G P +K + I+ + +E+YF
Sbjct: 183 GQFTLGIDVQGYPQLILRKETRIMYRVGSWNGQYFTGFPELKPDPIYTFEFVFNRNEVYF 242
Query: 244 TFRPFNDKVITRLLVNESGTLQRLVWNETSTEWRMLYSWPFDTCDSYAQCGANDNCRISK 303
F N V +RL V SG +Q W+ + +W + + D C++YA CGAN C +
Sbjct: 243 KFELQNSSVFSRLTVTPSGLVQLFTWSHQTNDWYVFATAVVDRCENYALCGANARCDSNS 302
Query: 304 TPICECLTGFISKSQDDWDSPE-TRRCVRK-PSDCPSGEGFLKLPRMKLPE--NYWSNKS 359
+P+C+CL GFI KS +W+S T C+R+ P DC +GF +KLP+ + W + S
Sbjct: 303 SPVCDCLDGFIHKSPTEWNSQNWTGGCIRRTPLDCTDKDGFQSYTGVKLPDTSSSWYDDS 362
Query: 360 MNLKECEAECTKNCSCRAYANSDVTGGGSGCLMWFGDLVDLRECSEGYIWGQDFFIRVPS 419
+L ECE C +NCSC AYAN D G GSGCL WFGDL+D R +EG GQD +IR+ +
Sbjct: 363 FSLVECEGLCIQNCSCFAYANLDFRGRGSGCLRWFGDLIDTRRLAEG---GQDIYIRLAA 419
Query: 420 SELGLENWKV----------------------------------------------DIEV 433
S+ G+ K ++E+
Sbjct: 420 SQSGVTGEKKRKKKTHAGVIGGAVILGSSILILGIVFCIRRRKHRKNGNFEDRKEEEMEL 479
Query: 434 PLYDLATITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEV 493
P+ DL TI AT++FS + +G+GGFG VY G+L GQEIA KRLSK+SGQGL EF NEV
Sbjct: 480 PMLDLTTIEHATDNFSSSKKLGEGGFGAVYKGELIEGQEIAVKRLSKSSGQGLNEFKNEV 539
Query: 494 VLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITG 553
+LI KLQHRNLV LLG CI EDE+MLIYEYMP++SLD FIFD R K L W KR II G
Sbjct: 540 LLIAKLQHRNLVKLLGCCIHEDEKMLIYEYMPNRSLDSFIFDPTRRKFLDWSKRTHIIDG 599
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGT 613
IARGLLYLHQDS+L++IHRD+KASNILLD LNPKISDFGLAR+FGGD EA T+RV GT
Sbjct: 600 IARGLLYLHQDSRLRIIHRDIKASNILLDNELNPKISDFGLARMFGGDQTEANTKRVVGT 659
Query: 614 HGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGH-RHNLIGHAWLLWNDG 672
+GYMSPEYA DG S+KSDVFS GVL++EIVSGK NRGF HP + + NL+GHAW+LW +G
Sbjct: 660 YGYMSPEYALDGHFSVKSDVFSFGVLVLEIVSGKKNRGFCHPDYNQKNLLGHAWMLWFNG 719
Query: 673 RALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGVTLPQPRQP 732
L L+D C DS S+ LRCI V LLCVQ+ PEDRP+MSSVV +L ++ LPQP+QP
Sbjct: 720 IPLELIDECFADSCTPSEALRCIHVALLCVQQRPEDRPNMSSVVLMLGSEN-PLPQPKQP 778
Query: 733 GFFTERGFTVGALSSHE-KCHSENALSITIQEGR 765
GFF SS++ + HS N +++T+ + R
Sbjct: 779 GFFMGSNPPEKDTSSNKHQSHSANEVTVTLLQAR 812
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356546914|ref|XP_003541865.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 799 bits (2064), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/782 (51%), Positives = 543/782 (69%), Gaps = 27/782 (3%)
Query: 7 FIFFYLLILIFIIEFSFAADSLSSGKFITD---GETLVSSFQSFELGFFSPGNSTNRYLG 63
IF IL+++ S A DS+S ++D TLVS +FELGFF+PGNS RYLG
Sbjct: 11 IIFLCYHILVYLSGISLALDSISQDLSLSDDGKNTTLVSKDGTFELGFFTPGNSQKRYLG 70
Query: 64 IWYKSSP-RTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVA 122
IWY+ P +TVVWVANR +PI D +G+L + + L+L + IWS+ S R E+PVA
Sbjct: 71 IWYRKIPIQTVVWVANRLNPINDSSGILRMNPSTGTLVLTHNGTVIWSTASIRRPESPVA 130
Query: 123 HLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLKTGFERYLTPWRSADDP 182
LL+SGNLV+RD +SE+Y+W+SF+YP+DT LP MK GW+L+TG R L W+S DDP
Sbjct: 131 LLLNSGNLVIRDEKDANSEDYLWESFNYPTDTFLPEMKFGWDLRTGLNRKLIAWKSPDDP 190
Query: 183 TPGEFSLRLDISALPELVIISGSRKEARSGPWNGQQFGGIPRVK-NSIFIPKLEHTEDEL 241
+P +FS + ++ PE ++ G +K RSGPWNG G P+VK N I+ K +DEL
Sbjct: 191 SPSDFSFGMVLNNYPEAYMMKGDQKFYRSGPWNGLHSSGSPQVKANPIYDFKFVSNKDEL 250
Query: 242 YFTFRPFNDKVITRLLVNESGTL-QRLVWNETSTEWRMLYSWPFDTCDSYAQCGANDNCR 300
Y+T+ N +I+RL++N + + +R VW E+ W + S P D CDSY+ CGAN NC
Sbjct: 251 YYTYSLKNSSMISRLVLNATSYVRKRYVWIESKQRWEVYTSVPLDLCDSYSLCGANANCV 310
Query: 301 ISKTPICECLTGFISKSQDDWDSPE-TRRCVR-KPSDC--PSGEGFLKLPRMKLPE--NY 354
IS +P+C+CL GF K + W S + + C+R K C + +GF KL +K P+ +
Sbjct: 311 ISDSPVCQCLQGFKPKLPEAWSSMDWSHGCIRNKELSCENKNKDGFNKLTLLKTPDTTHS 370
Query: 355 WSNKSMNLKECEAECTKNCSCRAYANSDVTGGGSGCLMWFGDLVDLRECSEGYIWGQDFF 414
W ++++ L+EC+A+C NCSC AYANSD++G GSGC MWFGDL+D+R+ + G GQD +
Sbjct: 371 WLDQTIGLEECKAKCLDNCSCMAYANSDISGQGSGCAMWFGDLIDIRQFAAG---GQDVY 427
Query: 415 IRVPSSELGLENWKV-----------DIEVPLYDLATITTATNHFSEANMIGKGGFGPVY 463
+R+ +SEL ++ + D+++P++DL+TI AT++F+ N IG+GGFGPVY
Sbjct: 428 VRIDASELERSDFSIKSNQNSGMQVDDMDLPVFDLSTIAKATSNFTVKNKIGEGGFGPVY 487
Query: 464 MGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523
G L+ GQEIA KRLS +SGQGL EF NEV LI KLQHRNLV LLG C+E +E+ML+YEY
Sbjct: 488 RGSLTDGQEIAVKRLSASSGQGLTEFKNEVKLIAKLQHRNLVKLLGCCLEGEEKMLVYEY 547
Query: 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI 583
M + SLD FIFD +RS L W KRF+II GIA+GLLYLHQDS+L++IHRDLKASN+LLD
Sbjct: 548 MLNGSLDSFIFDEQRSGSLDWSKRFNIICGIAKGLLYLHQDSRLRIIHRDLKASNVLLDS 607
Query: 584 NLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEI 643
LNPKISDFG+ARIFG D +E T+R+ GT+GYM+PEYA DG S+KSDVFS GVLL+EI
Sbjct: 608 ELNPKISDFGMARIFGVDQQEGNTKRIVGTYGYMAPEYATDGLFSVKSDVFSFGVLLLEI 667
Query: 644 VSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQ 703
+SGK +RG+ + H NLIGHAW LW +GR L L+D +EDS SQ+L CI V LLCVQ
Sbjct: 668 ISGKRSRGYYNQNHSQNLIGHAWKLWKEGRPLELIDKSIEDSSSLSQMLHCIHVSLLCVQ 727
Query: 704 KLPEDRPDMSSVVFLLANDGVTLPQPRQPGFFTERGFTVGALSSHEKCHSENALSITIQE 763
+ PEDRP MSSV+ +L ++ + LP+P+QPGFF + + +S ++ S N ++IT+ E
Sbjct: 728 QNPEDRPGMSSVLLMLVSE-LELPEPKQPGFFGKYSGEADSSTSKQQLSSTNEITITLLE 786
Query: 764 GR 765
R
Sbjct: 787 AR 788
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115102|ref|XP_002316940.1| predicted protein [Populus trichocarpa] gi|222860005|gb|EEE97552.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 797 bits (2058), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/751 (54%), Positives = 524/751 (69%), Gaps = 25/751 (3%)
Query: 5 AVFIFFYLLILIFIIEFSFAADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGI 64
+F++ +LL I + S A D +S G+FI DG+T+VS+ Q+FELGFFSPG+ST RYLGI
Sbjct: 14 GLFVYSFLLSTIRV---SNAPDIISPGQFIGDGDTIVSAGQNFELGFFSPGSSTRRYLGI 70
Query: 65 WYKS-SPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAH 123
WYK S TVVWVANR +PI D +GVL F+N G+LLLLN K +WSSN + NPVA
Sbjct: 71 WYKKFSTGTVVWVANRENPIFDHSGVLYFTNQGTLLLLNGTKDVVWSSNRTTPKNNPVAQ 130
Query: 124 LLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLKTGFERYLTPWRSADDPT 183
LL+SGNLV++D + E ++WQSFDYP DT LP MKLG NL TG + ++ W+S DDP
Sbjct: 131 LLESGNLVVKDGNDSNPESFLWQSFDYPGDTNLPDMKLGRNLVTGLDWSISSWKSLDDPA 190
Query: 184 PGEFSLRLDISALPELVIISGSRKEARSGPWNGQQFGGIPRVK-NSIFIPKLEHTEDELY 242
GE+SL +D +LV G + R+G WNG +F G R++ N ++ + + E+Y
Sbjct: 191 RGEYSLGIDPRGYQQLVYKKGRAIQFRAGSWNGIRFTGATRLRPNPVYRYEFVLNDKEVY 250
Query: 243 FTFRPFNDKVITRLLVNESGTLQRLVWNETSTEWRMLYSWPFDTCDSYAQCGANDNCRIS 302
F F N V +R +VN SG ++RL W W ++ D CD+Y+ CG+N C I
Sbjct: 251 FNFELLNSSVASRFVVNASGVVERLTWISQMHRWTRYFAVGEDQCDAYSFCGSNAKCNID 310
Query: 303 KTPICECLTGFISKSQDDWDSPE-TRRCVRKPS-DCPSGEGFLKLPRMKLPE--NYWSNK 358
K+P+C CL GF KS DW + + CVR+ + C GEGF+K MKLP+ + W N
Sbjct: 311 KSPVCACLDGFEPKSARDWSFQDWSGGCVRRTTLTCNRGEGFVKHTGMKLPDTSSSWYNT 370
Query: 359 SMNLKECEAECTKNCSCRAYANSDVTGGGSGCLMWFGDLVDLRECSEGYIWGQDFFIRVP 418
S++LKEC+ C K CSC AYAN+DV GGGSGCL+WFGDL+D+RE GQD +IR+
Sbjct: 371 SISLKECQELCLKKCSCMAYANTDVRGGGSGCLLWFGDLIDMREFVNT---GQDLYIRMA 427
Query: 419 SSELG-----LE------NWKVDIEVPLYDLATITTATNHFSEANMIGKGGFGPVYMGKL 467
+S LG LE + K ++E+P+ DL+TI AT +FS +G+GGFG VY G L
Sbjct: 428 ASYLGKMKNILEMDYDSHSRKEELELPIIDLSTIAKATGNFSSNKKLGEGGFGLVYKGTL 487
Query: 468 STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHK 527
GQ+IA KRLS SGQG+EEF NEV+LI KLQHRNLV LLG CIE DERMLIYEYMP+K
Sbjct: 488 -YGQDIAVKRLSMYSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCIEGDERMLIYEYMPNK 546
Query: 528 SLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNP 587
SLDYFIFD+ RSKLL W R SII GIARGLLYLHQDS+L++IHRDLKASN+LLD ++NP
Sbjct: 547 SLDYFIFDQSRSKLLDWPTRISIIDGIARGLLYLHQDSRLRIIHRDLKASNVLLDTDMNP 606
Query: 588 KISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
KISDFG+ARIFGG+ EA T+RV GT+GYM+PEYA +G S+KSD+FS GVL++EIVSG+
Sbjct: 607 KISDFGMARIFGGNQTEANTKRVVGTYGYMAPEYAVEGLFSVKSDIFSFGVLVLEIVSGR 666
Query: 648 MNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPE 707
NRGF H NL+GHAW LW + R+L L D L S S+++R I VGLLCVQ+ P+
Sbjct: 667 KNRGFFSHNHHLNLVGHAWKLWMEERSLELTDNTLGASHALSEIIRYIHVGLLCVQQQPD 726
Query: 708 DRPDMSSVVFLLANDGVTLPQPRQPGFFTER 738
DRP+MS+ V +L + +LPQP+QPGFF ER
Sbjct: 727 DRPNMSTAVLMLGGES-SLPQPKQPGFFLER 756
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 765 | ||||||
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.441 | 0.414 | 0.604 | 7.2e-191 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.445 | 0.401 | 0.537 | 9.5e-187 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.437 | 0.397 | 0.555 | 2.9e-183 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.456 | 0.412 | 0.536 | 2.3e-181 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.877 | 0.856 | 0.477 | 5.1e-177 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.452 | 0.407 | 0.545 | 1.8e-170 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.436 | 0.402 | 0.549 | 1.7e-165 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.410 | 0.390 | 0.548 | 9.1e-154 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.439 | 0.399 | 0.524 | 2.8e-152 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.407 | 0.386 | 0.529 | 1.2e-151 |
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1071 (382.1 bits), Expect = 7.2e-191, Sum P(2) = 7.2e-191
Identities = 208/344 (60%), Positives = 260/344 (75%)
Query: 423 GLENWKVDIEVPLYDLATITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNS 482
G+E + D+++P++D TI+ AT+ FS N +G+GGFGPVY GKL GQEIA KRLS NS
Sbjct: 477 GIE--EEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANS 534
Query: 483 GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLL 542
GQG+EEF NEV LI KLQHRNLV LLG CI+ +E MLIYEYMP+KSLD+FIFD RS L
Sbjct: 535 GQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTEL 594
Query: 543 PWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602
WKKR +II G+ARG+LYLHQDS+L++IHRDLKA N+LLD ++NPKISDFGLA+ FGGD
Sbjct: 595 DWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQ 654
Query: 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLI 662
E+ T RV GT+GYM PEYA DG S+KSDVFS GVL++EI++GK NRGFRH H NL+
Sbjct: 655 SESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLL 714
Query: 663 GHAWLLWNDGRALGLMDT-CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721
GH W +W + R + + + LE++ V +VLRCI V LLCVQ+ PEDRP M+SVV + +
Sbjct: 715 GHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGS 774
Query: 722 DGVTLPQPRQPGFFTERGFTVGALSSHEKCHSENALSITIQEGR 765
D +LP P QPGFFT R V +SS S+N +SIT+ +GR
Sbjct: 775 DS-SLPHPTQPGFFTNRN--VPDISSSLSLRSQNEVSITMLQGR 815
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 951 (339.8 bits), Expect = 9.5e-187, Sum P(2) = 9.5e-187
Identities = 187/348 (53%), Positives = 244/348 (70%)
Query: 425 ENWKVDIEVPLYDLATITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQ 484
EN D+E+PL + + ATN+FS AN +G+GGFG VY GKL GQE+A KRLSK S Q
Sbjct: 503 ENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQ 562
Query: 485 GLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPW 544
G +EF NEV LI +LQH NLV LL C++ E+MLIYEY+ + SLD +FD+ R+ L W
Sbjct: 563 GTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNW 622
Query: 545 KKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604
+ RF II GIARGLLYLHQDS+ ++IHRDLKASNILLD + PKISDFG+ARIFG D+ E
Sbjct: 623 QMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETE 682
Query: 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGH 664
A T +V GT+GYMSPEYA DG SMKSDVFS GVLL+EI+S K N+GF + NL+G
Sbjct: 683 ANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGC 742
Query: 665 AWLLWNDGRALGLMDTCLEDS---FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721
W W +G+ L ++D + DS F + ++LRCIQ+GLLCVQ+ EDRP MS V+ +L +
Sbjct: 743 VWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGS 802
Query: 722 DGVTLPQPRQPGFFTERGFTVGALSSHEKCHSE----NALSITIQEGR 765
+ T+PQP+ PG+ ER SS ++ E N +++++ + R
Sbjct: 803 ESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 954 (340.9 bits), Expect = 2.9e-183, Sum P(2) = 2.9e-183
Identities = 190/342 (55%), Positives = 244/342 (71%)
Query: 431 IEVPLYDLATITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFM 490
+E+PL +L + TATN+FS N +G+GGFG VY G+L G+EIA KRLSK S QG +EFM
Sbjct: 502 LELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFM 561
Query: 491 NEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSI 550
NEV LI KLQH NLV LLG C+++ E+MLIYEY+ + SLD +FD+ RS L W+KRF I
Sbjct: 562 NEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDI 621
Query: 551 ITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERV 610
I GIARGLLYLHQDS+ ++IHRDLKASN+LLD N+ PKISDFG+ARIFG ++ EA T RV
Sbjct: 622 INGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRV 681
Query: 611 AGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWN 670
GT+GYMSPEYA DG SMKSDVFS GVLL+EI+SGK N+GF + NL+G W W
Sbjct: 682 VGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWK 741
Query: 671 DGRALGLMDTCLEDS----FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGVTL 726
+G L ++D DS F ++LRCIQ+GLLCVQ+ EDRP MSSV+ +L ++ +
Sbjct: 742 EGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAI 801
Query: 727 PQPRQPGFFTERGFTVGALSSHEKCHSE---NALSITIQEGR 765
PQP++PGF R SS + E N +++++ + R
Sbjct: 802 PQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 951 (339.8 bits), Expect = 2.3e-181, Sum P(2) = 2.3e-181
Identities = 193/360 (53%), Positives = 252/360 (70%)
Query: 415 IRVPSSELGLENWKVD-IEVPLYDLATITTATNHFSEANMIGKGGFGPVYMGKLSTGQEI 473
++ S EN K D +E+PL + + ATN+FS N +G+GGFG VY G L G+EI
Sbjct: 490 VKASRSYTSKEN-KTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEI 548
Query: 474 AAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFI 533
A KRLSK S QG +EFMNEV LI KLQH NLV LLG C+++ E+MLIYEY+ + SLD +
Sbjct: 549 AVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHL 608
Query: 534 FDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFG 593
FD+ RS L W+KRF II GIARGLLYLHQDS+ ++IHRDLKASN+LLD N+ PKISDFG
Sbjct: 609 FDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFG 668
Query: 594 LARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFR 653
+ARIFG ++ EA T RV GT+GYMSPEYA DG SMKSDVFS GVLL+EI+SGK N+GF
Sbjct: 669 MARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFY 728
Query: 654 HPGHRHNLIGHAWLLWNDGRALGLMDT----CLEDSFVESQVLRCIQVGLLCVQKLPEDR 709
+ NL+G W W +G+ L ++D L F ++LRCIQ+GLLCVQ+ EDR
Sbjct: 729 NSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDR 788
Query: 710 PDMSSVVFLLANDGVTLPQPRQPGFFTERG-FTVGALSSHEK---CHSENALSITIQEGR 765
P MSSV+ +L ++ +PQP++PGF R V + SS ++ C + N +++++ + R
Sbjct: 789 PVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDEC-TVNQVTLSVIDAR 847
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1719 (610.2 bits), Expect = 5.1e-177, P = 5.1e-177
Identities = 334/699 (47%), Positives = 474/699 (67%)
Query: 86 KNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMW 145
+NG L N+ + ++ + S S+ +L NP+ +LD+GNLV+R+ S ++Y+W
Sbjct: 94 ENGSLCLFNDRNHIIWSSSSSP---SSQKASLRNPIVQILDTGNLVVRN--SGDDQDYIW 148
Query: 146 QSFDYPSDTLLPGMKLGWNLKTGFERYLTPWRSADDPTPGEFSLRLDISALPELVIISGS 205
QS DYP D LPGMK G N TG R+LT WR+ DDP+ G ++ ++D + +P+ + S
Sbjct: 149 QSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNS 208
Query: 206 RKEARSGPWNGQQFGGIPRVK-NSIFIPKLEHTEDELYFTFRPFNDKVITRLLVNESGTL 264
R+GPWNG +F G+P +K N I+ + TE+E+Y+T++ N V+TR+ +N +G L
Sbjct: 209 VVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVYYTYKLENPSVLTRMQLNPNGAL 268
Query: 265 QRLVWNETSTEWRMLYSWPFDTCDSYAQCGANDNCRISKTPICECLTGFISKSQDDWDSP 324
QR W + W S D+CD Y CG+ +C I+++P C CL GF++K+ W +
Sbjct: 269 QRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINESPACRCLKGFVAKTPQAWVAG 328
Query: 325 E-TRRCVRKPS-DCPSGE-GFLKLPRMKLPENY--WSNKSMNLKECEAECTKNCSCRAYA 379
+ + CVR+ DC GE GFLK+ ++KLP+ W +K+M+L EC+ C +NC+C AY+
Sbjct: 329 DWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKVCLRNCTCSAYS 388
Query: 380 NSDVTGGGSGCLMWFGDLVDLRECSEGYIWGQDFFIRVPSSE---LGLENWKV------- 429
D+ GG GC++WFGDL+D+RE +E GQD ++R+ SSE L E+ +V
Sbjct: 389 PFDIRDGGKGCILWFGDLIDIREYNEN---GQDLYVRLASSEIETLQRESSRVSSRKQEE 445
Query: 430 -DIEVPLYDLATITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEE 488
D+E+P DL T++ AT+ FS N +G+GGFGPVY G L+ GQE+A KRLS+ S QG+EE
Sbjct: 446 EDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEE 505
Query: 489 FMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRF 548
F NE+ LI KLQHRNLV +LG C++E+ERMLIYEY P+KSLD FIFD+ER + L W KR
Sbjct: 506 FKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRV 565
Query: 549 SIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTE 608
II GIARG+LYLH+DS+L++IHRDLKASN+LLD ++N KISDFGLAR GGD+ EA T
Sbjct: 566 EIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTT 625
Query: 609 RVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLL 668
RV GT+GYMSPEY DG S+KSDVFS GVL++EIVSG+ NRGFR+ H+ NL+GHAW
Sbjct: 626 RVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQ 685
Query: 669 WNDGRALGLMDTCLEDSFVE-SQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGVTLP 727
+ + +A ++D + +S + S+VLR I +GLLCVQ+ P+DRP+MS VV +L+++ + L
Sbjct: 686 FLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLL- 744
Query: 728 QPRQPGFFTERGFTVG-ALSSHEKCHSENALSITIQEGR 765
PRQPGFF ER +S + + S N ++++ + R
Sbjct: 745 DPRQPGFFNERNLLFSDTVSINLEIPSNNFQTMSVIDPR 783
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 957 (341.9 bits), Expect = 1.8e-170, Sum P(2) = 1.8e-170
Identities = 192/352 (54%), Positives = 251/352 (71%)
Query: 419 SSELGLENWKVDI-EVPLYDLATITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKR 477
S ++ +E V+ E+P++ L I ATN F + N +G+GGFGPVY G L G+EIA KR
Sbjct: 499 SVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKR 558
Query: 478 LSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRE 537
LS SGQG++EF NE++LI KLQHRNLV LLG C E +E+ML+YEYMP+KSLD+F+FD
Sbjct: 559 LSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDET 618
Query: 538 RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597
+ L+ WK RFSII GIARGLLYLH+DS+L++IHRDLK SN+LLD +NPKISDFG+ARI
Sbjct: 619 KQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARI 678
Query: 598 FGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGH 657
FGG+ EA T RV GT+GYMSPEYA +G S+KSDV+S GVLL+EIVSGK N R H
Sbjct: 679 FGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEH 738
Query: 658 RHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717
+LIG+AW L+ GR+ L+D + + + + LRCI V +LCVQ +RP+M+SV+
Sbjct: 739 G-SLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLL 797
Query: 718 LLANDGVTLPQPRQPGFFTERGFTVG---AL-SSHEKCHSENALSITIQEGR 765
+L +D TL PRQP F + R ++ AL SS + S N ++ T+ GR
Sbjct: 798 MLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 968 (345.8 bits), Expect = 1.7e-165, Sum P(2) = 1.7e-165
Identities = 184/335 (54%), Positives = 244/335 (72%)
Query: 432 EVPLYDLATITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMN 491
E+PL++ + ATN+FS N +G+GGFG VY G+L G +IA KRLS+ SGQG+EEF+N
Sbjct: 496 ELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVN 555
Query: 492 EVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSII 551
EVV+I KLQHRNLV LLG CIE +ERML+YE+MP LD ++FD + +LL WK RF+II
Sbjct: 556 EVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNII 615
Query: 552 TGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVA 611
GI RGL+YLH+DS+L++IHRDLKASNILLD NLNPKISDFGLARIF G+++E T RV
Sbjct: 616 DGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVSTVRVV 675
Query: 612 GTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWND 671
GT+GYM+PEYA G S KSDVFSLGV+L+EIVSG+ N F + G NL +AW LWN
Sbjct: 676 GTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSAYAWKLWNT 735
Query: 672 GRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGVTLPQPRQ 731
G + L+D + + E+++ RC+ VGLLCVQ DRP +++V+++L+++ LP+P+Q
Sbjct: 736 GEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSENSNLPEPKQ 795
Query: 732 PGFFTERGFT-VGALSSHEKCHSENALSITIQEGR 765
P F RG + V + + S N +S+T GR
Sbjct: 796 PAFIPRRGTSEVESSGQSDPRASINNVSLTKITGR 830
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 874 (312.7 bits), Expect = 9.1e-154, Sum P(2) = 9.1e-154
Identities = 176/321 (54%), Positives = 225/321 (70%)
Query: 420 SELGLENWKVDI---EVP---LYDLATITTATNHFSEANMIGKGGFGPVYMGKLSTGQEI 473
+ + + WK D+ +VP +D+ TI ATN+FS +N +G+GGFG VY GKL G+EI
Sbjct: 457 AHISKDAWKNDLKPQDVPGLDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEI 516
Query: 474 AAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFI 533
A KRLS +SGQG EEFMNE+VLI KLQHRNLV +LG CIEE+E++LIYE+M +KSLD F+
Sbjct: 517 AVKRLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFL 576
Query: 534 FDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFG 593
FD + + W KRF II GIARGLLYLH DS+L+VIHRDLK SNILLD +NPKISDFG
Sbjct: 577 FDSRKRLEIDWPKRFDIIQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFG 636
Query: 594 LARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFR 653
LAR++ G + + T RV GT GYMSPEYA G S KSD++S GVL++EI+SG+ F
Sbjct: 637 LARMYQGTEYQDNTRRVVGTLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFS 696
Query: 654 HPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMS 713
+ LI +AW W++ R + L+D L DS +V RCIQ+GLLCVQ P DRP+
Sbjct: 697 YGVEGKTLIAYAWESWSEYRGIDLLDQDLADSCHPLEVGRCIQIGLLCVQHQPADRPNTL 756
Query: 714 SVVFLLANDGVTLPQPRQPGF 734
++ +L LP P+QP F
Sbjct: 757 ELLAMLTTTS-DLPSPKQPTF 776
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 897 (320.8 bits), Expect = 2.8e-152, Sum P(2) = 2.8e-152
Identities = 179/341 (52%), Positives = 237/341 (69%)
Query: 428 KVDI-EVPLYDLATITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGL 486
+VD ++P++ ++ +AT F+E N +G+GGFG VY G S G+EIA KRLS S QGL
Sbjct: 504 QVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGL 563
Query: 487 EEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKK 546
EEF NE++LI KLQHRNLV LLG CIE++E+ML+YEYMP+KSLD F+FD + L W+K
Sbjct: 564 EEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRK 623
Query: 547 RFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606
R+ +I GIARGLLYLH+DS+L++IHRDLKASNILLD +NPKISDFG+ARIF + A
Sbjct: 624 RWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHAN 683
Query: 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAW 666
T RV GT+GYM+PEYA +G S KSDV+S GVL++EIVSG+ N FR H +LIG+AW
Sbjct: 684 TIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHG-SLIGYAW 742
Query: 667 LLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGVTL 726
LW+ G+ ++D ++D+ ++ +RCI VG+LC Q RP+M SV+ +L + L
Sbjct: 743 HLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQL 802
Query: 727 PQPRQPGF--FTERGFTVGALSSHEKCHSENALSITIQEGR 765
P PRQP F F G H+ S N ++ T GR
Sbjct: 803 PPPRQPTFHSFLNSGDIELNFDGHDVA-SVNDVTFTTIVGR 842
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 844 (302.2 bits), Expect = 1.2e-151, Sum P(2) = 1.2e-151
Identities = 169/319 (52%), Positives = 219/319 (68%)
Query: 426 NWKVDI---EVP---LYDLATITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLS 479
+W+ D+ +VP +D+ TI TATN+FS +N +G+GGFGPVY GKL G+EIA KRLS
Sbjct: 466 SWRNDLKPQDVPGLDFFDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQDGKEIAVKRLS 525
Query: 480 KNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERS 539
+SGQG EEFMNE+VLI KLQH+NLV +LG CIE +E++LIYE+M + SLD F+FD +
Sbjct: 526 SSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLDTFLFDSRKR 585
Query: 540 KLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599
+ W KR II GIARG+ YLH+DS L+VIHRDLK SNILLD +NPKISDFGLAR++
Sbjct: 586 LEIDWPKRLDIIQGIARGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKISDFGLARMYQ 645
Query: 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRH 659
G + + T RV GT GYM+PEYA G S KSD++S GVL++EI+SG+ F +
Sbjct: 646 GTEYQDNTRRVVGTLGYMAPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGKEEK 705
Query: 660 NLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719
LI +AW W D + L+D + DS +V RC+Q+GLLCVQ P DRP+ ++ +L
Sbjct: 706 TLIAYAWESWCDTGGIDLLDKDVADSCRPLEVERCVQIGLLCVQHQPADRPNTLELLSML 765
Query: 720 ANDGVTLPQPRQPGFFTER 738
LP P QP F R
Sbjct: 766 TTTS-DLPPPEQPTFVVHR 783
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81832 | Y4729_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4993 | 0.9542 | 0.9323 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_LG_XI001046 | hypothetical protein (802 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 765 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-48 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-45 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 2e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-39 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 5e-39 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 7e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-33 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 2e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-31 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-31 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-29 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-29 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-28 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-28 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 2e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-27 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-26 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-25 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-25 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-24 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-23 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 3e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-23 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-21 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-21 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-19 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-16 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-14 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-09 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 4e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-05 | |
| cd00129 | 80 | cd00129, PAN_APPLE, PAN/APPLE-like domain; present | 7e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.001 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 0.002 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 3e-50
Identities = 75/194 (38%), Positives = 108/194 (55%), Gaps = 11/194 (5%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSK-NSGQGLEEFMNEVVLIGKLQHRNLVGLLGSC 511
+G+GGFG VY+ + TG+++A K + K +S LEE + E+ ++ KL H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 512 IEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIH 571
+E+ L+ EY SL + +E L + I+ I GL YLH +IH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 572 RDLKASNILLD-INLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE-YANDGTISM 629
RDLK NILLD N K++DFGL+++ D +T GT YM+PE G S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGYYSE 173
Query: 630 KSDVFSLGVLLVEI 643
KSD++SLGV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 1e-48
Identities = 92/281 (32%), Positives = 134/281 (47%), Gaps = 31/281 (11%)
Query: 452 NMIGKGGFGPVYMGKLSTGQ----EIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVG 506
+G+G FG VY GKL E+A K L ++ S + ++F+ E ++ KL H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFI------FDRERSKLLPWKKRFSIITGIARGLLY 560
LLG C EE+ L+ EYM L ++ F L K S IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 561 LHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR-IFGGDDEEAQTERVAGTHGYMSP 619
L + +HRDL A N L+ +L KISDFGL+R ++ D +T +M+P
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 620 EYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679
E DG + KSDV+S GVLL EI + +PG + + +L G L +
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT---LGATPYPGLSNEEV-LEYL--RKGYRLPKPE 230
Query: 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720
C ++ + ++ L C Q PEDRP S +V L
Sbjct: 231 YCPDELY---------ELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 2e-48
Identities = 96/276 (34%), Positives = 130/276 (47%), Gaps = 33/276 (11%)
Query: 453 MIGKGGFGPVYMGKL-----STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVG 506
+G+G FG VY GKL E+A K L ++ S Q +EEF+ E ++ KL H N+V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSK 566
LLG C EE+ ++ EYM L ++ R+ L S IARG+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLES--- 120
Query: 567 LQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG---YMSPEYAN 623
IHRDL A N L+ NL KISDFGL+R DD+ R G +M+PE
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYY---RKRGGKLPIRWMAPESLK 176
Query: 624 DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683
+G + KSDV+S GVLL EI G + N +L +G L C
Sbjct: 177 EGKFTSKSDVWSFGVLLWEI----FTLGEQPYPGMSNEEVLEYLK--NGYRLPQPPNCPP 230
Query: 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719
+ + + L C + PEDRP S +V +L
Sbjct: 231 ELY---------DLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 5e-48
Identities = 97/276 (35%), Positives = 131/276 (47%), Gaps = 32/276 (11%)
Query: 453 MIGKGGFGPVYMGKLS-----TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVG 506
+G+G FG VY G L E+A K L ++ S Q +EEF+ E ++ KL H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSK 566
LLG C EE+ M++ EYMP L ++ R K L S IARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLES--- 121
Query: 567 LQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG---YMSPEYAN 623
IHRDL A N L+ NL KISDFGL+R D + +V G +M+PE
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 624 DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683
+G + KSDV+S GVLL EI + G N +L G L C
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFT----LGEEPYPGMSNAEVLEYLK--KGYRLPKPPNCPP 231
Query: 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719
+ + ++ L C + PEDRP S +V +L
Sbjct: 232 ELY---------KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 2e-46
Identities = 79/244 (32%), Positives = 109/244 (44%), Gaps = 22/244 (9%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSK--NSGQGLEEFMNEVVLIGKLQHRNLVGLLGS 510
+G G FG VY K TG+ +A K L K + + E+ ++ +L H N+V L+ +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 511 CIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVI 570
++D L+ EY L ++ R L + I I RGL YLH + +I
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHSNG---II 120
Query: 571 HRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGT-ISM 629
HRDLK NILLD N KI+DFGLA+ T GT YM+PE G
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGYGP 178
Query: 630 KSDVFSLGVLLVEIVSGKM---NRGFRHPGHRHNLIGHA-----WLLWNDG--RALGLMD 679
K DV+SLGV+L E+++GK I W+ G A L+
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIK 238
Query: 680 TCLE 683
CL
Sbjct: 239 KCLN 242
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 1e-45
Identities = 68/196 (34%), Positives = 105/196 (53%), Gaps = 11/196 (5%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEE-FMNEVVLIGKLQHRNLVGLLGSC 511
+G+G FG VY+ + TG+ +A K + K + E + E+ ++ KL+H N+V L
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 512 IEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIH 571
+ED+ L+ EY L + ++R +L + RF + I L YLH ++H
Sbjct: 67 EDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF-YLRQILSALEYLH---SKGIVH 120
Query: 572 RDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKS 631
RDLK NILLD + + K++DFGLAR E+ T GT YM+PE
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQL-DPGEKLTT--FVGTPEYMAPEVLLGKGYGKAV 177
Query: 632 DVFSLGVLLVEIVSGK 647
D++SLGV+L E+++GK
Sbjct: 178 DIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 4e-45
Identities = 77/204 (37%), Positives = 105/204 (51%), Gaps = 21/204 (10%)
Query: 454 IGKGGFGPVYMGKL-----STGQEIAAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVGL 507
+G+G FG VY G L T ++A K L + + + EEF+ E ++ KL H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
LG C + + ++ EYMP L F+ R+ + L K + IA+G+ YL SK
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE--SK- 121
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGY-----MSPEYA 622
+HRDL A N L+ NL KISDFGL+R DD G M+PE
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY-----RKRGGGKLPIKWMAPESL 176
Query: 623 NDGTISMKSDVFSLGVLLVEIVSG 646
DG + KSDV+S GVLL EI +
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 2e-39
Identities = 55/113 (48%), Positives = 72/113 (63%), Gaps = 5/113 (4%)
Query: 70 PRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGN 129
+TVVWVANR +P+TD + L ++G+L+L + +WSSN+S VA L D GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 130 LVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLKTGFERYLTPWRSADDP 182
LVL DN S + +WQSFD+P+DTLLPG K G N+ G R LT W+S DP
Sbjct: 61 LVLYDN----SGKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDP 108
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 66/203 (32%), Positives = 109/203 (53%), Gaps = 15/203 (7%)
Query: 452 NMIGKGGFGPVYMGK-LSTGQEIAAK--RLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLL 508
++G+G FG VY+ TG+ +A K LS +S + LE E+ ++ LQH N+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 509 GSCIEEDERML-IY-EYMPHKSLDYFIFDRERSKLLPWK--KRFSIITGIARGLLYLHQD 564
GS +E++ L I+ EY+ SL + ++ LP ++++ I GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKLPEPVIRKYT--RQILEGLAYLHS- 119
Query: 565 SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND 624
++HRD+K +NIL+D + K++DFG A+ G + T V GT +M+PE
Sbjct: 120 --NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 625 GTISMKSDVFSLGVLLVEIVSGK 647
+D++SLG ++E+ +GK
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 5e-39
Identities = 55/118 (46%), Positives = 75/118 (63%), Gaps = 5/118 (4%)
Query: 34 ITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFS 93
++ G+TLVSS FELGFF + Y I YK S RTVVWVANR++P + + LT
Sbjct: 4 LSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQ 62
Query: 94 NNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYP 151
++G+L++ + + +WSSN++R N V LLD GNLVL D S ++WQSFDYP
Sbjct: 63 SDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYD----SDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 7e-37
Identities = 55/117 (47%), Positives = 76/117 (64%), Gaps = 6/117 (5%)
Query: 34 ITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFS 93
++ G+TLVS FELGFF+ N Y I YKSS RTVVWVANR++P++D + LT
Sbjct: 4 LSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSSRTVVWVANRDNPVSD-SCTLTLQ 61
Query: 94 NNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDY 150
++G+L+L + + +WSSN++ N V LLD GNLV+ D S ++WQSFDY
Sbjct: 62 SDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYD----SDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 3e-36
Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 21/208 (10%)
Query: 447 HFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLV 505
F IGKGGFG VY + TG+E+A K + S + E+ +NE+ ++ K +H N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 506 GLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARGLL 559
GS +++DE ++ E+ SL + L + + + + +GL
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSL--------KDLLKSTNQTLTESQIAYVCKELLKGLE 112
Query: 560 YLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSP 619
YLH +IHRD+KA+NILL + K+ DFGL+ + + GT +M+P
Sbjct: 113 YLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAP 166
Query: 620 EYANDGTISMKSDVFSLGVLLVEIVSGK 647
E N K+D++SLG+ +E+ GK
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 68/204 (33%), Positives = 107/204 (52%), Gaps = 11/204 (5%)
Query: 447 HFSEANMIGKGGFGPVYMG-KLSTGQEIAAKRLS--KNSGQGLEEFMNEVVLIGKLQHRN 503
++ ++IG+G FG VY G L TG +A K++S K + L+ M E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
+V +GS D +I EY + SL I ++ P + + +GL YLH+
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLHE 117
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAN 623
VIHRD+KA+NIL + K++DFG+A +D V GT +M+PE
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMAPEVIE 172
Query: 624 DGTISMKSDVFSLGVLLVEIVSGK 647
S SD++SLG ++E+++G
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-31
Identities = 41/109 (37%), Positives = 66/109 (60%), Gaps = 1/109 (0%)
Query: 210 RSGPWNGQQFGGIPRV-KNSIFIPKLEHTEDELYFTFRPFNDKVITRLLVNESGTLQRLV 268
RSGPWNG +F GIP + K S ++ +E+Y+T+R N+ + +RL ++ G+L+R
Sbjct: 2 RSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLERFT 61
Query: 269 WNETSTEWRMLYSWPFDTCDSYAQCGANDNCRISKTPICECLTGFISKS 317
W S +W + +S P D CD Y +CG C ++ +P C C+ GF+ K+
Sbjct: 62 WIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 82/273 (30%), Positives = 127/273 (46%), Gaps = 35/273 (12%)
Query: 452 NMIGKGGFGPVYMGK-LSTGQEIAAKR--LSKNSGQGLEEFMNEVVLIGKLQHRNLVGLL 508
IGKG FG VY+ + S G+ K LS S + E+ +NEV ++ KL H N++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 509 GSCIEEDERMLIYEYMPHKSLDYFIFDR-ERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
S E+ + ++ EY L I + + K P ++ + L YLH
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR--- 122
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTI 627
+++HRD+K NI L N K+ DFG++++ + A+T V GT Y+SPE +
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPELCQNKPY 180
Query: 628 SMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFV 687
+ KSD++SLG +L E+ + K HP NL L L L+ +
Sbjct: 181 NYKSDIWSLGCVLYELCTLK------HPFEGENL-------------LELALKILKGQYP 221
Query: 688 E-----SQVLRCIQVGLLCVQKLPEDRPDMSSV 715
S LR + LL QK PE+RP ++ +
Sbjct: 222 PIPSQYSSELRNLVSSLL--QKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 5e-31
Identities = 82/221 (37%), Positives = 113/221 (51%), Gaps = 29/221 (13%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513
+G G FG V+MG + ++A K L K E F+ E ++ KL+H LV L C E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 514 EDERMLIYEYMPHKSLDYFIFDRERSKL-LPWKKRFSIITGIARGLLYLHQDSKLQVIHR 572
E+ ++ EYM SL F+ E KL LP + + IA G+ YL IHR
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP--QLVDMAAQIAEGMAYLES---RNYIHR 127
Query: 573 DLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTH---GYMSPEYANDGTISM 629
DL A NIL+ NL KI+DFGLAR+ D+ A+ G + +PE AN G ++
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAANYGRFTI 183
Query: 630 KSDVFSLGVLLVEIVS-GKM--------------NRGFRHP 655
KSDV+S G+LL EIV+ G++ RG+R P
Sbjct: 184 KSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP 224
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 6e-29
Identities = 86/259 (33%), Positives = 133/259 (51%), Gaps = 26/259 (10%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513
+G G FG V+MG + ++A K L K E F+ E L+ +LQH LV L + +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLY-AVVT 71
Query: 514 EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRD 573
++ +I EYM + SL F+ E KL K + IA G+ ++ + + IHRD
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKL-TINKLIDMAAQIAEGMAFIERKN---YIHRD 127
Query: 574 LKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDV 633
L+A+NIL+ L KI+DFGLAR+ ++ A+ E + +PE N GT ++KSDV
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 634 FSLGVLLVEIVS-GKMNR-GFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQV 691
+S G+LL EIV+ G++ G +P NL G + D C E+ +
Sbjct: 187 WSFGILLTEIVTYGRIPYPGMTNPEVIQNL--------ERGYRMPRPDNCPEELY----- 233
Query: 692 LRCIQVGLLCVQKLPEDRP 710
++ LC ++ PE+RP
Sbjct: 234 ----ELMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 68/223 (30%), Positives = 110/223 (49%), Gaps = 21/223 (9%)
Query: 448 FSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGL 507
F+ +G G FG V+ G +A K L + ++F EV + +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
C + +I E M SL F+ E ++LP + +A G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTI 627
IHRDL A NIL+ +L K++DFGLAR+ D + +++ + + +PE A+ GT
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEAASHGTF 181
Query: 628 SMKSDVFSLGVLLVEIVS-GKM--------------NRGFRHP 655
S KSDV+S G+LL E+ + G++ G+R P
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP 224
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 75/226 (33%), Positives = 106/226 (46%), Gaps = 27/226 (11%)
Query: 441 ITTATNHFSEANMIGKGGFGPVYMGKL------STGQEIAAKRLSKN-SGQGLEEFMNEV 493
I + F E +G+G FG VY G+L + +A K L +N + +EF E
Sbjct: 2 IPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEA 59
Query: 494 VLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIF-------------DRERSK 540
L+ LQH N+V LLG C +E +++EY+ H L F+ D
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 541 LLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR-IFG 599
L I IA G+ YL S +HRDL A N L+ L KISDFGL+R I+
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176
Query: 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
D Q++ + +M PE G + +SD++S GV+L EI S
Sbjct: 177 ADYYRVQSKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 69/203 (33%), Positives = 101/203 (49%), Gaps = 12/203 (5%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFM--NEVVLIGKLQHRNLVGLLGS 510
IGKG FG V + S G+ + K + + E+ +EV ++ +L+H N+V
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 511 CI-EEDERMLIY-EYMPHKSLDYFI--FDRERSKLLPWKKRFSIITGIARGLLYLH--QD 564
I ++ + I EY L I +ER + + + I+T + L H D
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYI-EEEFIWRILTQLLLALYECHNRSD 126
Query: 565 SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND 624
V+HRDLK +NI LD N N K+ DFGLA+I G D A+T GT YMSPE N
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPEQLNH 184
Query: 625 GTISMKSDVFSLGVLLVEIVSGK 647
+ KSD++SLG L+ E+ +
Sbjct: 185 MSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 3e-28
Identities = 74/277 (26%), Positives = 118/277 (42%), Gaps = 25/277 (9%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSK---NSGQGLEEFMNEVVLIGKLQH-RNLVGLLG 509
+G+G FG VY+ + + +A K L+K + + +E F+ E+ ++ L H N+V L
Sbjct: 8 LGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 510 SCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQV 569
+E L+ EY+ SL+ + R L + I+ I L YLH +
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGI 122
Query: 570 IHRDLKASNILLDINLN-PKISDFGLARIFGGDDEEAQTER----VAGTHGYMSPEYA-- 622
IHRD+K NILLD + K+ DFGLA++ + GT GYM+PE
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 623 -NDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681
+ S SD++SLG+ L E+++G P L
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTG------LPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 682 LEDSFVESQVLRCIQVGLL--CVQKLPEDRPDMSSVV 716
S +++ LL + K P++R SS +
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 85/259 (32%), Positives = 132/259 (50%), Gaps = 25/259 (9%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513
+G G FG V+MG + ++A K L K ++ F+ E L+ LQH LV L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 514 EDERMLIYEYMPHKSLDYFIFDRERSKL-LPWKKRFSIITGIARGLLYLHQDSKLQVIHR 572
E+ +I EYM SL F+ E K+ LP FS IA G+ Y+ + IHR
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFS--AQIAEGMAYIE---RKNYIHR 127
Query: 573 DLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSD 632
DL+A+N+L+ +L KI+DFGLAR+ D+E E + +PE N G+ ++KSD
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186
Query: 633 VFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQV 691
V+S G+LL EIV+ GK+ +PG ++ + A G + M+ C ++ +
Sbjct: 187 VWSFGILLYEIVTYGKIP----YPGMSNSDVMSA---LQRGYRMPRMENCPDELY----- 234
Query: 692 LRCIQVGLLCVQKLPEDRP 710
+ C ++ E+RP
Sbjct: 235 ----DIMKTCWKEKAEERP 249
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 69/195 (35%), Positives = 106/195 (54%), Gaps = 17/195 (8%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513
IGKG FG V +G GQ++A K L K+ + F+ E ++ L+H NLV LLG ++
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 514 EDERMLIYEYMPHKSLDYFIFDRERSKL-LPWKKRFSIITGIARGLLYLHQDSKLQVIHR 572
+ ++ EYM SL ++ R R+ + L + F++ + G+ YL + K +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL--DVCEGMEYL--EEK-NFVHR 126
Query: 573 DLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTH--GYMSPEYANDGTISMK 630
DL A N+L+ +L K+SDFGLA+ EA + +G + +PE + S K
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTK 179
Query: 631 SDVFSLGVLLVEIVS 645
SDV+S G+LL EI S
Sbjct: 180 SDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-27
Identities = 37/67 (55%), Positives = 48/67 (71%), Gaps = 3/67 (4%)
Query: 336 CPSGEGFLKLPRMKLPEN--YWSNKSMNLKECEAECTKNCSCRAYANSDVTGGGSGCLMW 393
C G+GFL+LP MKLP+ ++S+ LKECE C NCSC AYA +D+ GGSGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIR-GGSGCLIW 59
Query: 394 FGDLVDL 400
G+LVD+
Sbjct: 60 TGELVDM 66
|
Length = 66 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 67/200 (33%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513
+G G FG V+ G + +A K L + ++F+ E ++ KL+H L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 514 EDERMLIYEYMPHKSL-DYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHR 572
E+ ++ E M + SL +Y R+ LP + + +A G+ YL + IHR
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLP--QLIDMAAQVASGMAYLEAQN---YIHR 127
Query: 573 DLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTH---GYMSPEYANDGTISM 629
DL A N+L+ N K++DFGLAR+ D EA+ G + +PE A S+
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSI 183
Query: 630 KSDVFSLGVLLVEIVS-GKM 648
KSDV+S G+LL EIV+ G+M
Sbjct: 184 KSDVWSFGILLTEIVTYGRM 203
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 68/208 (32%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 452 NMIGKGGFGPVYMGKL-----STGQEIAAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLV 505
+G+G FG V + + +TG+++A K L+ + Q +F E+ ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 506 GLLGSCIEEDER--MLIYEYMPHKSL-DYFIFDRER---SKLLPWKKRFSIITGIARGLL 559
G C + R LI EY+P SL DY R++ +LL FS I +G+
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLL----LFSS--QICKGMD 123
Query: 560 YLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE--EAQTERVAGTHGYM 617
YL + IHRDL A NIL++ KISDFGLA++ D + + + Y
Sbjct: 124 YLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179
Query: 618 SPEYANDGTISMKSDVFSLGVLLVEIVS 645
+PE S SDV+S GV L E+ +
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 13/220 (5%)
Query: 430 DIEVPLYDLATITTATNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEE 488
+++ L D+ + + IG+G G VY +TG+E+A K++ Q E
Sbjct: 3 ELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKEL 61
Query: 489 FMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRF 548
+NE++++ +H N+V S + DE ++ EYM SL I + + +
Sbjct: 62 IINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII--TQNFVRMNEPQIA 119
Query: 549 SIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTE 608
+ + +GL YLH VIHRD+K+ NILL + + K++DFG A + +++
Sbjct: 120 YVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT----KEKSK 172
Query: 609 R--VAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSG 646
R V GT +M+PE K D++SLG++ +E+ G
Sbjct: 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN--EVVLIGKLQHRNLVGLLGS 510
IG+G +G VY + TG+ +A K++ E+ L+ +L H N++ LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 511 CIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVI 570
+ + L++E+M D + ++R + LP S + + +GL + H ++
Sbjct: 67 FRHKGDLYLVFEFMDT---DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---IL 120
Query: 571 HRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE-YANDGTISM 629
HRDLK N+L++ K++DFGLAR FG T V T Y +PE D S
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGS-PVRPYTHYVV-TRWYRAPELLLGDKGYST 178
Query: 630 KSDVFSLGVLLVEIVSGK 647
D++S+G + E++S +
Sbjct: 179 PVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 454 IGKGGFGPVYM-GKLSTGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLG 509
+GKG FG V + K TG+ A K L K + +E + E ++ ++ H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 510 SCIEEDERM-LIYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
+ +E++ L+ EY P L + F ER++ I L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF--------YAAEIVLALEYLHS 111
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAN 623
L +I+RDLK NILLD + + K++DFGLA+ + T GT Y++PE
Sbjct: 112 ---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLL 166
Query: 624 DGTISMKSDVFSLGVLLVEIVSGK 647
D +SLGVLL E+++GK
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 454 IGKGGFGPVYMGKLSTGQE------IAAKRLSKNSGQGLEE-FMNEVVLIGKLQHRNLVG 506
+G+G FG V++G+ + +A K L + + + F E L+ QH N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYF---------IFDRERSKLLPWKKR--FSIITGIA 555
G C E D ++++EYM H L+ F S + I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 556 RGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR-IFGGDDEEAQTERVAGTH 614
G++YL + +HRDL N L+ +L KI DFG++R ++ D RV G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD-----YYRVGGHT 184
Query: 615 ----GYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GK 647
+M PE + +SDV+S GV+L EI + GK
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 69/267 (25%), Positives = 114/267 (42%), Gaps = 35/267 (13%)
Query: 454 IGKGGFGPVYMGKLS-TGQEIAAKRL-SKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSC 511
+G+G G VY + TG+ A K++ + ++ + E+ + + +V G+
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 512 IEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRF-SIIT-GIARGLLYLHQDSKLQV 569
+E E ++ EYM SL + K+ + + I I +GL YLH +
Sbjct: 69 YKEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGLDYLHTKRH--I 121
Query: 570 IHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISM 629
IHRD+K SN+L++ KI+DFG++++ ++ T GT YMSPE + S
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMSPERIQGESYSY 179
Query: 630 KSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLW--NDGRALGLMDTCLED--- 684
+D++SLG+ L+E GK P L+ DG L
Sbjct: 180 AADIWSLGLTLLECALGK------FPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFR 233
Query: 685 SFVESQVLRCIQVGLLCVQKLPEDRPD 711
F+ C+QK P+ RP
Sbjct: 234 DFIS-----------ACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 83/292 (28%), Positives = 119/292 (40%), Gaps = 62/292 (21%)
Query: 454 IGKGGFGPVYMGKLST--GQEI--AAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLL 508
+G G FG V G G+E+ A K L + G +EF+ E ++ +L H +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRER---SKLLPWKKRFSIITGIARGLLYLHQDS 565
G C + + ML+ E P L ++ R S L +A G+ YL +S
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYL--ES 113
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG-----YMSPE 620
K +HRDL A N+LL KISDFG++R G + + A T G + +PE
Sbjct: 114 K-HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR----ATTAGRWPLKWYAPE 168
Query: 621 YANDGTISMKSDVFSLGVLLVEIVS--GKMNRGFRHP--------GHRHNLIGHAWLLWN 670
N G S KSDV+S GV L E S K + G R
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER------------ 216
Query: 671 DGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722
L + C ++ + + L C + PEDRP S + D
Sbjct: 217 ----LPRPEECPQEIY---------SIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 67/199 (33%), Positives = 105/199 (52%), Gaps = 10/199 (5%)
Query: 452 NMIGKGGFGPVYMG--KLSTGQEI--AAKRL-SKNSGQGLEEFMNEVVLIGKLQHRNLVG 506
+IG G FG V G KL +EI A K L + +S + +F+ E ++G+ H N++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSK 566
L G + M+I EYM + SLD F+ RE + ++ GIA G+ YL S+
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---SE 124
Query: 567 LQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGT 626
+ +HRDL A NIL++ NL K+SDFGL+R + T+ + +PE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 627 ISMKSDVFSLGVLLVEIVS 645
+ SDV+S G+++ E++S
Sbjct: 185 FTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 74/212 (34%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 452 NMIGKGGFGPVYMGKL------STG-QEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRN 503
N +G G FG VY G +G +A K L K + Q +EF+ E L+ H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFD----RERSKLLPWKKRFSIITGIARGLL 559
+V LLG C+ + + +I E M L ++ D R LL K+ I +A+G +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 560 YLHQDSKLQVIHRDLKASNILL-----DINLNPKISDFGLAR-IFGGDDEEAQTERVAGT 613
YL Q + IHRDL A N L+ D + KI DFGLAR I+ D + E +
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 614 HGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+M+PE DG + +SDV+S GVL+ EI++
Sbjct: 178 R-WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 69/241 (28%), Positives = 113/241 (46%), Gaps = 28/241 (11%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513
+G G FG V++GK ++A K + + + ++F+ E ++ KL H NLV L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 514 EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRD 573
+ ++ EYM + L ++ RER L + + + + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRD 125
Query: 574 LKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDV 633
L A N L+ + K+SDFGLAR + DD+ ++ + PE + S KSDV
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 634 FSLGVLLVEIVS-GKM--------------NRGFR------HPGHRHNLIGHAWLLWNDG 672
+S GVL+ E+ S GKM + G+R P + ++ W +
Sbjct: 185 WSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPED 244
Query: 673 R 673
R
Sbjct: 245 R 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 81/258 (31%), Positives = 131/258 (50%), Gaps = 24/258 (9%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513
+G G FG V+M + ++A K + K +E F+ E ++ LQH LV L + +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV-KLHAVVT 71
Query: 514 EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRD 573
++ +I E+M SL F+ E SK P K IA G+ ++ Q + IHRD
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRN---YIHRD 127
Query: 574 LKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDV 633
L+A+NIL+ +L KI+DFGLAR+ D+E E + +PE N G+ ++KSDV
Sbjct: 128 LRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186
Query: 634 FSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVL 692
+S G+LL+EIV+ G++ +PG + + A G + + C E+ +
Sbjct: 187 WSFGILLMEIVTYGRIP----YPGMSNPEVIRA---LERGYRMPRPENCPEELY------ 233
Query: 693 RCIQVGLLCVQKLPEDRP 710
+ + C + PE+RP
Sbjct: 234 ---NIMMRCWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 452 NMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSC 511
+ +G G +G VY G A + K +EEF+ E ++ +++H NLV LLG C
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 512 IEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIH 571
E +I E+M + +L ++ + R + + T I+ + YL + + IH
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---FIH 127
Query: 572 RDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTH---GYMSPEYANDGTIS 628
RDL A N L+ N K++DFGL+R+ GD A AG + +PE S
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH----AGAKFPIKWTAPESLAYNKFS 183
Query: 629 MKSDVFSLGVLLVEI---------------VSGKMNRGFR 653
+KSDV++ GVLL EI V + +G+R
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR 223
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 65/194 (33%), Positives = 94/194 (48%), Gaps = 6/194 (3%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGL-EEFMNEVVLIGKLQHRNLVGLLGSCI 512
IGKG FG VY G L E+A K L +F+ E ++ + H N+V L+G C+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 513 EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHR 572
++ ++ E +P SL F+ R++ L KK + A G+ YL + IHR
Sbjct: 63 QKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHR 117
Query: 573 DLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSD 632
DL A N L+ N KISDFG++R G + +PE N G + +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 633 VFSLGVLLVEIVSG 646
V+S G+LL E S
Sbjct: 178 VWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 31/210 (14%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEF----MNEVVLIGKLQHRNLVGLL 508
IG+G +G VY + TG+ +A K++ + + E F + E+ L+ KL+H N+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 509 GSCIEEDER--MLIYEYMPHKSLDYFIFDRERSKL-LPWKKRFSIITGIARGLLYLHQDS 565
+ + +++EYM H L + D K K + + GL YLH +
Sbjct: 65 EIVTSKGKGSIYMVFEYMDH-DLTGLL-DSPEVKFTESQIK--CYMKQLLEGLQYLHSN- 119
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE----- 620
++HRD+K SNIL++ + K++DFGLAR + + T RV T Y PE
Sbjct: 120 --GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGA 176
Query: 621 --YANDGTISMKSDVFSLGVLLVEIVSGKM 648
Y G + D++S+G +L E+ GK
Sbjct: 177 TRY---GP---EVDMWSVGCILAELFLGKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 19/212 (8%)
Query: 448 FSEANMIGKGGFGPVYMGKLSTGQ------EIAAKRLSKNSGQGLEEFMNEVVLIGKLQH 501
+ + ++G+G FG V++ + Q +I ++++K+ + NE ++ L H
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSH 58
Query: 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
N++ + +E+ M++ EY P +L +I R S LL I L ++
Sbjct: 59 PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNS-LLDEDTILHFFVQILLALHHV 117
Query: 562 HQDSKLQVIHRDLKASNILLDINLNP-KISDFGLARIFGGDDEEAQTERVAGTHGYMSPE 620
H ++HRDLK NILLD + KI DFG+++I +++ V GT Y+SPE
Sbjct: 118 HTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPE 171
Query: 621 YANDGTISMKSDVFSLGVLLVEIVSGKMNRGF 652
+ KSD+++LG +L E+ S + R F
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELAS--LKRAF 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 20/203 (9%)
Query: 453 MIGKGGFGPVYMG-----KLSTGQEIAAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVG 506
++G G FG VY G +A K L + + + +E ++E ++ + H ++V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIF---DRERSK-LLPWKKRFSIITGIARGLLYLH 562
LLG C+ + LI + MP L ++ D S+ LL W + IA+G+ YL
Sbjct: 74 LLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126
Query: 563 QDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA 622
+ +++HRDL A N+L+ + KI+DFGLA++ D++E E +M+ E
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 623 NDGTISMKSDVFSLGVLLVEIVS 645
+ KSDV+S GV + E+++
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 71/211 (33%), Positives = 104/211 (49%), Gaps = 20/211 (9%)
Query: 448 FSEAN---MIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRN 503
+ E ++GKG +G VY + LST IA K + + + ++ E+ L L+HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIIT----GIARGLL 559
+V LGS E + E +P SL + RSK P K I I GL
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIIFYTKQILEGLK 122
Query: 560 YLHQDSKLQVIHRDLKASNILLDINLNP-KISDFGLARIFGGDDEEAQTERVAGTHGYMS 618
YLH Q++HRD+K N+L++ KISDFG ++ G + TE GT YM+
Sbjct: 123 YLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN--PCTETFTGTLQYMA 177
Query: 619 PEYANDGT--ISMKSDVFSLGVLLVEIVSGK 647
PE + G +D++SLG +VE+ +GK
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 72/234 (30%), Positives = 106/234 (45%), Gaps = 28/234 (11%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513
IG G FG V++G +++A K + + E+F+ E ++ KL H LV L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 514 EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRD 573
L++E+M H L ++ R + + + + G+ YL + VIHRD
Sbjct: 71 RSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125
Query: 574 LKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDV 633
L A N L+ N K+SDFG+ R F DD+ + + SPE + S KSDV
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 634 FSLGVLLVEIVS-GKM--------------NRGFR------HPGHRHNLIGHAW 666
+S GVL+ E+ S GK N GFR + L+ H W
Sbjct: 185 WSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCW 238
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 59/196 (30%), Positives = 101/196 (51%), Gaps = 10/196 (5%)
Query: 454 IGKGGFGPVY-MGKLSTGQEIAAKRLSKNSGQGLE-EFMNEVVLIGKLQHRNLVGLLGSC 511
+G G G V + TG+ +A K + + ++ + + E+ ++ K +VG G+
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 512 IEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIH 571
+ + EYM SLD + +E +P + I + +GL YLH K ++IH
Sbjct: 69 YNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLH--EKHKIIH 124
Query: 572 RDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKS 631
RD+K SNIL++ K+ DFG++ + A+T GT YM+PE S+KS
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTF--VGTSSYMAPERIQGNDYSVKS 180
Query: 632 DVFSLGVLLVEIVSGK 647
D++SLG+ L+E+ +G+
Sbjct: 181 DIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 9/203 (4%)
Query: 448 FSEANMIGKGGFGPVYMG-KLSTGQEIAAKR--LSKNSGQGLEEFMNEVVLIGKLQHRNL 504
F N IGKG FG V+ + + + A K+ LSK + + EE ++E ++ KL +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 505 VGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD 564
+ S +++ + ++ EY + L + +R + LP + + I GL +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLH-- 118
Query: 565 SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND 624
+++HRD+K+ N+ LD N KI D G+A++ + A T + GT Y+SPE D
Sbjct: 119 -SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCED 175
Query: 625 GTISMKSDVFSLGVLLVEIVSGK 647
+ KSDV++LGV+L E +GK
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 69/212 (32%), Positives = 106/212 (50%), Gaps = 23/212 (10%)
Query: 447 HFSEANMIGKGGFGPVYMGKL-----STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQH 501
H +GKG FG V + + +TG+ +A K+L ++ + L +F E+ ++ LQH
Sbjct: 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQH 64
Query: 502 RNLVGLLGSCIEEDER--MLIYEYMPHKSL-DYFIFDRER---SKLLPWKKRFSIITGIA 555
N+V G C R L+ EY+P+ SL DY RER KLL + + I
Sbjct: 65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ------IC 118
Query: 556 RGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG 615
+G+ YL + +HRDL NIL++ KI DFGL ++ D+E R G
Sbjct: 119 KGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVL-PQDKEYYKVREPGESP 174
Query: 616 --YMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+ +PE + S+ SDV+S GV+L E+ +
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 41/276 (14%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLS---KNSGQGLEEFMNEVVLIGKLQHRNLVGLLG 509
IGKG F VY L G+ +A K++ + ++ + E+ L+ +L H N++ L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 510 SCIEEDERMLIYEYMPHKSLDYFI-FDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQ 568
S IE +E ++ E L I +++ +L+P + + + L ++H +
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---R 126
Query: 569 VIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTIS 628
++HRD+K +N+ + K+ D GL R F A + + GT YMSPE ++ +
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYN 184
Query: 629 MKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVE 688
KSD++SLG LL E+ + + P + G + L C + +
Sbjct: 185 FKSDIWSLGCLLYEMAA------LQSPFY--------------GDKMNLYSLCKKIEKCD 224
Query: 689 ---------SQVLRCIQVGLLCVQKLPEDRPDMSSV 715
S+ LR + C+ PE RPD+S V
Sbjct: 225 YPPLPADHYSEELR--DLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 65/198 (32%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKR--LSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGS 510
+GKG +G VY K LS Q A K L S + E+ +NE+ ++ + H N++ +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 511 CIEEDERMLIYEYMPHKSLDYFIFDRERS-KLLPWKKRFSIITGIARGLLYLHQDSKLQV 569
++ ++ ++ EY P L I R++ KL+P ++ + I + RGL LH+ ++
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKI 124
Query: 570 IHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISM 629
+HRDLK++NILL N KI D G++++ + + Q GT YM+PE S
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPHYMAPEVWKGRPYSY 180
Query: 630 KSDVFSLGVLLVEIVSGK 647
KSD++SLG LL E+ +
Sbjct: 181 KSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 75/235 (31%), Positives = 117/235 (49%), Gaps = 30/235 (12%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513
+G G FG V+MG + ++A K L K E F+ E ++ KL+H LV L + +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLY-AVVS 71
Query: 514 EDERMLIYEYMPHKSLDYFIFDRE-RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHR 572
E+ ++ EYM SL F+ D E R+ LP + +A G+ Y+ ++ IHR
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLP--NLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 573 DLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSD 632
DL+++NIL+ L KI+DFGLAR+ D+E + + +PE A G ++KSD
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 633 VFSLGVLLVEIVSG---------------KMNRGFRH------PGHRHNLIGHAW 666
V+S G+LL E+V+ ++ RG+R P H L+ W
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCW 240
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 3e-23
Identities = 64/210 (30%), Positives = 109/210 (51%), Gaps = 16/210 (7%)
Query: 448 FSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGL------EEFMNEVVLIGKLQH 501
+++ ++GKG +G VY G + GQ IA K++ ++ L E+ EV L+ L+H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
N+V LG+C++++ + E++P S+ + R LP I G+ YL
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYL 118
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR---IFGGDDEEAQTER-VAGTHGYM 617
H + V+HRD+K +N++L N K+ DFG AR G + + + GT +M
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 618 SPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
+PE N+ KSD++S+G + E+ +GK
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-23
Identities = 74/234 (31%), Positives = 116/234 (49%), Gaps = 28/234 (11%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513
+G+G FG V+MG + +A K L K E F+ E ++ KL+H LV L + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY-AVVS 71
Query: 514 EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRD 573
E+ ++ EYM SL F+ E K L + + IA G+ Y+ ++ +HRD
Sbjct: 72 EEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127
Query: 574 LKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDV 633
L+A+NIL+ NL K++DFGLAR+ D+E + + +PE A G ++KSDV
Sbjct: 128 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 634 FSLGVLLVEI---------------VSGKMNRGFRH------PGHRHNLIGHAW 666
+S G+LL E+ V ++ RG+R P H+L+ W
Sbjct: 187 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 240
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-23
Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 453 MIGKGGFGPVYMG-KLSTGQEIAAKRL--------SKNSGQGLEEFMNEVVLIGKLQHRN 503
++G+G FG VY+ + TG+E+A K++ +K LE E+ L+ LQH
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALE---CEIQLLKNLQHER 65
Query: 504 LVGLLGSCIEEDERMLIY-EYMPHKSL-DYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
+V G C+ +DE + I+ EYMP S+ D ++ + K I+ G+ YL
Sbjct: 66 IVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYL 120
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLA-RIFGGDDEEAQTERVAGTHGYMSPE 620
H + ++HRD+K +NIL D N K+ DFG + R+ + V GT +MSPE
Sbjct: 121 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 621 YANDGTISMKSDVFSLGVLLVEIVSGK 647
+ K+DV+S+G +VE+++ K
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-23
Identities = 34/89 (38%), Positives = 49/89 (55%), Gaps = 9/89 (10%)
Query: 333 PSDCPSGE---GFLKLPRMKLPENYWSNKSMNLKECEAECTKNCSCRAYANSDVTGGGSG 389
P +C GFLKLP +KLP+N + +++L+EC C NCSC AYA ++ G G
Sbjct: 2 PLNCGGDGSTDGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNN---GSGG 58
Query: 390 CLMWFGDLVDLRECSEGYIWGQDFFIRVP 418
CL+W G L +LR G ++R+
Sbjct: 59 CLLWNGLLNNLR---SLSSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 4e-23
Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 39/222 (17%)
Query: 454 IGKGGFGPVYMGKL-STGQEIAAKRLSK---NSGQGLEEFMNEVVLIGKL-QHRNLVGLL 508
IG+G F V + K T +E A K L K + ++ E ++ +L H ++ L
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 509 GSCIEEDERMLIYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
+ +E+ + EY P+ L +I D + ++ I L YLH
Sbjct: 69 YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF--------YAAEILLALEYLHS 120
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVA------------ 611
+IHRDLK NILLD +++ KI+DFG A++ + + A
Sbjct: 121 ---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 612 ------GTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
GT Y+SPE N+ SD+++LG ++ ++++GK
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 58/195 (29%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 454 IGKGGFGPVYMG-KLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512
+G+G +G VY TGQ +A K + L+E + E+ ++ + +V GS
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 513 EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHR 572
+ + ++ EY S+ + + +K L ++ +I+ +GL YLH + K IHR
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHSNKK---IHR 123
Query: 573 DLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSD 632
D+KA NILL+ K++DFG++ D A+ V GT +M+PE + + K+D
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVSGQLT--DTMAKRNTVIGTPFWMAPEVIQEIGYNNKAD 181
Query: 633 VFSLGVLLVEIVSGK 647
++SLG+ +E+ GK
Sbjct: 182 IWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 6e-23
Identities = 73/279 (26%), Positives = 129/279 (46%), Gaps = 38/279 (13%)
Query: 447 HFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLS---KNSGQG---LEEFMNEVVLIGKL 499
+ + +G G F Y + + TG +A K+++ S + +E E+ L+ +L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 500 QHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSI--ITGIARG 557
H +++ +LG+ E+ L E+M S+ + + SK +K+ I + RG
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLL-----SKYGAFKEAVIINYTEQLLRG 115
Query: 558 LLYLHQDSKLQVIHRDLKASNILLD-INLNPKISDFGLA-----RIFGGDDEEAQTERVA 611
L YLH++ Q+IHRD+K +N+L+D +I+DFG A + G + + Q +
Sbjct: 116 LSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ---LL 169
Query: 612 GTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWND 671
GT +M+PE DV+S+G +++E+ + K P + H L++
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKP------PWNAEKHSNHLALIFKI 223
Query: 672 GRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRP 710
A + + S LR V L C++ PEDRP
Sbjct: 224 ASATTAPS--IPEHL--SPGLR--DVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 63/200 (31%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 454 IGKGGFGPVY------MGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGL 507
+GKGGFG V GK+ +++ KRL K G+ + +NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKVSSRFIVSL 58
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
+ +D+ L+ M L Y I++ + F I GL +LHQ
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIF-YAAQIICGLEHLHQ---R 114
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTI 627
++++RDLK N+LLD + N +ISD GLA + + AGT GYM+PE
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVEL---KGGKKIKGRAGTPGYMAPEVLQGEVY 171
Query: 628 SMKSDVFSLGVLLVEIVSGK 647
D F+LG L E+++G+
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 8e-23
Identities = 86/277 (31%), Positives = 128/277 (46%), Gaps = 36/277 (12%)
Query: 452 NMIGKGGFGPVYMGKL--STGQEI--AAKRLSK-NSGQGLEEFMNEVVLIGKLQHRNLVG 506
+IGKG FG VY G L S GQ+I A K L++ + +E+F+ E +++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 507 LLGSCI-EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
LLG C+ E +++ YM H L FI + + K +A+G+ YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV--KDLIGFGLQVAKGMEYLASK- 117
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG------YMSP 619
+ +HRDL A N +LD + K++DFGLAR D + + V G +M+
Sbjct: 118 --KFVHRDLAARNCMLDESFTVKVADFGLAR----DIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 620 EYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679
E + KSDV+S GVLL E+ M RG + +LL GR L +
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWEL----MTRGAPPYPDVDSFDITVYLL--QGRRLLQPE 225
Query: 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVV 716
C + + +V L C PE RP S +V
Sbjct: 226 YCPDPLY---------EVMLSCWHPKPEMRPTFSELV 253
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 9e-23
Identities = 67/197 (34%), Positives = 100/197 (50%), Gaps = 10/197 (5%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEE-FMNEVVLIGKLQHRNLVGLLGSCI 512
+G G FG V++GK ++A K + N G EE F+ E ++ KL H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAI--NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 513 EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHR 572
++ ++ E+M + L ++ R+R L S+ + G+ YL ++S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 573 DLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSD 632
DL A N L+ K+SDFG+ R + DDE + + PE N S KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183
Query: 633 VFSLGVLLVEIVS-GKM 648
V+S GVL+ E+ + GKM
Sbjct: 184 VWSFGVLMWEVFTEGKM 200
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 69/210 (32%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 447 HFSEANMIGKGGFGPVY-MGKLSTGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHR 502
HF +IGKG FG V + K T + A K ++K + +NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 503 NLVGLLGSCIEEDERMLIYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITGIARG 557
LV L S +E+ L+ + + L Y + F E+ K I I
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF--------WICEIVLA 112
Query: 558 LLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYM 617
L YLH SK +IHRD+K NILLD + I+DF +A D T +GT GYM
Sbjct: 113 LEYLH--SKG-IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTTSTSGTPGYM 166
Query: 618 SPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
+PE S+ D +SLGV E + GK
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 76/290 (26%), Positives = 129/290 (44%), Gaps = 35/290 (12%)
Query: 448 FSEANMIGKGGFGPVYMGKLS----TGQEIAAK--RLSKNSGQGLEEFMNEVVLIGKLQH 501
++G+G FG V G+LS + ++A K +L ++ +EEF++E + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 502 RNLVGLLGSCIEEDER------MLIYEYMPHKSLDYFIFDR---ERSKLLPWKKRFSIIT 552
N++ L+G C E M+I +M H L F+ + LP + +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 553 GIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAG 612
IA G+ YL S IHRDL A N +L ++ ++DFGL++ D Q
Sbjct: 121 DIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 613 THGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFR-HPGHRHNLIGHAWLLWND 671
+++ E D + KSDV++ GV + EI RG +PG ++ I + +L
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEI----ATRGQTPYPGVENHEI-YDYLR--H 230
Query: 672 GRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721
G L + CL++ + + C + P+DRP + + +L N
Sbjct: 231 GNRLKQPEDCLDE--LYDLMYSCWRAD-------PKDRPTFTKLREVLEN 271
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 69/212 (32%), Positives = 106/212 (50%), Gaps = 16/212 (7%)
Query: 454 IGKGGFGPVYMGKLSTGQE---IAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGS 510
IG+G FG +Y+ K + E I L+K + E EV+L+ K++H N+V S
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 511 CIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVI 570
E ++ EY L I +R+R L + S I+ GL ++H D K ++
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIH-DRK--IL 123
Query: 571 HRDLKASNILLDIN-LNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISM 629
HRD+K+ NI L N + K+ DFG+AR E A T GT Y+SPE + +
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYYLSPEICQNRPYNN 181
Query: 630 KSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNL 661
K+D++SLG +L E+ + +HP +NL
Sbjct: 182 KTDIWSLGCVLYELCT------LKHPFEGNNL 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 70/236 (29%), Positives = 117/236 (49%), Gaps = 36/236 (15%)
Query: 446 NHFSEANMIGKGGFGPVYMG--KLSTGQEIAAKRLSKNSG---QGLEEFMNEVVLIGKLQ 500
+H ++ +IG G FG V+ G K+ +E+A + G + ++F++E ++G+
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 501 HRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLY 560
H N++ L G + M+I EYM + +LD ++ R+ + ++ GIA G+ Y
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYL--RDHDGEFSSYQLVGMLRGIAAGMKY 122
Query: 561 LHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG----- 615
L S + +HRDL A NIL++ NL K+SDFGL+R+ D E T T G
Sbjct: 123 L---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT-----TSGGKIPI 174
Query: 616 -YMSPEYANDGTISMKSDVFSLGVLLVEIVS---------------GKMNRGFRHP 655
+ +PE + SDV+S G+++ E++S +N GFR P
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 4e-22
Identities = 74/234 (31%), Positives = 119/234 (50%), Gaps = 28/234 (11%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513
+G+G FG V+MG + ++A K L K E F+ E ++ KL+H LV L + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLY-AVVS 71
Query: 514 EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRD 573
E+ ++ E+M SL F+ + + K L + + IA G+ Y+ ++ IHRD
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127
Query: 574 LKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDV 633
L+A+NIL+ NL KI+DFGLAR+ D+E + + +PE A G ++KSDV
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 634 FSLGVLLVEIVSG---------------KMNRGFRHPGHR------HNLIGHAW 666
+S G+LL E+V+ ++ RG+R P + H L+ W
Sbjct: 187 WSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCW 240
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 15/207 (7%)
Query: 447 HFSEANMIGKGGFGPVYM------GKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ 500
H+ ++GKG FG + L +E+ RLS+ + + +NE+V++ LQ
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE---KERRDALNEIVILSLLQ 57
Query: 501 HRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLY 560
H N++ ++++ ++ EY +L Y R++ +L + + I + Y
Sbjct: 58 HPNIIAYYNHFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 561 LHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE 620
+H+ ++HRD+K NI L K+ DFG+++I G + A+T V GT YMSPE
Sbjct: 117 IHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPE 171
Query: 621 YANDGTISMKSDVFSLGVLLVEIVSGK 647
+ KSD+++LG +L E+++ K
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYELLTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 9e-22
Identities = 75/276 (27%), Positives = 124/276 (44%), Gaps = 53/276 (19%)
Query: 453 MIGKGGFGPVYMG-KLSTGQEIAAKRLS-----KNSGQGLEEFMNEVVLIGKLQHRNLVG 506
++G G FG VY G L G A K +S + + +++ E+ L+ KLQH N+V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIIT---------GIARG 557
LG+ EED + E +P SL +KLL K++ I G
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSL---------AKLL---KKYGSFPEPVIRLYTRQILLG 114
Query: 558 LLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYM 617
L YLH +HRD+K +NIL+D N K++DFG+A+ E + + G+ +M
Sbjct: 115 LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWM 168
Query: 618 SPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676
+PE G + +D++SLG ++E+ +GK P + + + +
Sbjct: 169 APEVIAQQGGYGLAADIWSLGCTVLEMATGKP------PWSQLEGVAAVFKIGRSKELPP 222
Query: 677 LMDTCLEDS--FVESQVLRCIQVGLLCVQKLPEDRP 710
+ D +++ F+ L C+Q+ P RP
Sbjct: 223 IPDHLSDEAKDFI-----------LKCLQRDPSLRP 247
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 83/281 (29%), Positives = 120/281 (42%), Gaps = 36/281 (12%)
Query: 452 NMIGKGGFGPVYMGKLS------TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNL 504
+G G FG VY G ++A K L ++ S Q +F+ E +++ K H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 505 VGLLGSCIEEDERMLIYEYMPHKSLDYFIFD----RERSKLLPWKKRFSIITGIARGLLY 560
V L+G E R ++ E M L F+ + ER L K +A+G Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 561 LHQDSKLQVIHRDLKASNILLDINLNP----KISDFGLARIFGGDDEEAQTERVAGTHGY 616
L ++ IHRD+ A N LL P KI+DFG+AR + R +
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 617 MSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRAL 675
M PE DG + K+DV+S GVLL EI S G M +PG R N G L
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP----YPG-RTN--QEVMEFVTGGGRL 240
Query: 676 GLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVV 716
C ++ C Q PEDRP+ ++++
Sbjct: 241 DPPKGCPG---------PVYRIMTDCWQHTPEDRPNFATIL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 1e-21
Identities = 70/202 (34%), Positives = 110/202 (54%), Gaps = 19/202 (9%)
Query: 447 HFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVG 506
+ +IG+G FG V G+ TGQ++A K + + + F+ E ++ KL H+NLV
Sbjct: 7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVR 63
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKL-LPWKKRFSIITGIARGLLYLHQDS 565
LLG I + ++ E M +L F+ R R+ + + +FS+ +A G+ YL +S
Sbjct: 64 LLG-VILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL--DVAEGMEYL--ES 118
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARI--FGGDDEEAQTERVAGTHGYMSPEYAN 623
K +++HRDL A NIL+ + K+SDFGLAR+ G D+ + + + +PE
Sbjct: 119 K-KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-------WTAPEALK 170
Query: 624 DGTISMKSDVFSLGVLLVEIVS 645
S KSDV+S GVLL E+ S
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 65/199 (32%), Positives = 105/199 (52%), Gaps = 11/199 (5%)
Query: 453 MIGKGGFGPVYMGKLSTGQE----IAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGL 507
+IG G FG V G+L + +A K L + + +F++E ++G+ H N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
G + M++ EYM + SLD F+ R+ + ++ GIA G+ YL S +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQLVGMLRGIASGMKYL---SDM 125
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTH-GYMSPEYANDGT 626
+HRDL A NIL++ NL K+SDFGL+R+ D E A T R + +PE
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 627 ISMKSDVFSLGVLLVEIVS 645
+ SDV+S G+++ E++S
Sbjct: 186 FTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 33/208 (15%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKR--LSKNSGQGLEEFMNEVVLIGKLQHRNLVGLL-- 508
IG+G G V+ K TG+ +A K+ L + G + + E+ + QH +V LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 509 ---GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
GS +L+ EYMP L + D ER K + + + +G+ Y+H
Sbjct: 68 FPHGSGF-----VLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRM--LLKGVAYMH--- 116
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE----- 620
++HRDLK +N+L+ + KI+DFGLAR+F ++ + +VA T Y +PE
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPELLYGA 175
Query: 621 --YANDGTISMKSDVFSLGVLLVEIVSG 646
Y D + D++++G + E+++G
Sbjct: 176 RKY--DPGV----DLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 68/222 (30%), Positives = 112/222 (50%), Gaps = 36/222 (16%)
Query: 453 MIGKGGFGPVYMG-KLSTGQEIAAKRLSKNSGQG---------LEEFMNEVVLIGKLQHR 502
+IG G FG VY+G S+G+ +A K++ S L+ E+ L+ +LQH
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 503 NLVGLLGSCIEEDERMLIYEYMPHKSL-----DYFIFDRERSKLLPWKKRFSIITGIARG 557
N+V LGS ++ D + EY+P S+ +Y F+ + + + I +G
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR--------NFVRQILKG 118
Query: 558 LLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD----DEEAQTERVAGT 613
L YLH +IHRD+K +NIL+D KISDFG+++ + + G+
Sbjct: 119 LNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 614 HGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHP 655
+M+PE + + K+D++SLG L+VE+++GK HP
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK------HP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-21
Identities = 76/227 (33%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 441 ITTATNHFSEANMIGKGGFGPVYMGKL------STGQEIAAKRLS-KNSGQGLEEFMNEV 493
I +T F E +G+ FG VY G L Q +A K L K G EEF +E
Sbjct: 2 INLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59
Query: 494 VLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRE--------------RS 539
++ +LQH N+V LLG +E +I+ Y H L F+ R +S
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 540 KLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR-IF 598
L P I+T IA G+ +L S V+H+DL N+L+ LN KISD GL R ++
Sbjct: 120 TLEP-ADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 599 GGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
D + + +MSPE G S+ SD++S GV+L E+ S
Sbjct: 176 AADYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 6e-21
Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 36/210 (17%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN--EVVLIGKLQ-HRNLVGLLG 509
+G G FG VY+ + TG+ +A K++ K EE MN EV + KL H N+V L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 510 SCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQV 569
E DE ++EYM +L + DR+ K SII I +GL ++H K
Sbjct: 66 VFRENDELYFVFEYM-EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIH---KHGF 120
Query: 570 IHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ-----TERVAGTHGYMSPEYAND 624
HRDLK N+L+ KI+DFGLAR E + T+ V T Y +PE
Sbjct: 121 FHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYV-STRWYRAPE---- 168
Query: 625 GTISMKS-------DVFSLGVLLVEIVSGK 647
I ++S D+++LG ++ E+ + +
Sbjct: 169 --ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 7e-21
Identities = 67/201 (33%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 454 IGKGGFGPVY------MGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGL 507
+GKGGFG V GKL +++ KRL K +G E M E ++ K+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFD-RERSKLLPWKKRFSIITGIARGLLYLHQDSK 566
+ + + L+ M L Y I++ E + P + I GL +LHQ
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-- 116
Query: 567 LQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGT 626
++I+RDLK N+LLD + N +ISD GLA D +++T+ AGT G+M+PE
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGFMAPELLQGEE 173
Query: 627 ISMKSDVFSLGVLLVEIVSGK 647
D F+LGV L E+++ +
Sbjct: 174 YDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 8e-21
Identities = 68/227 (29%), Positives = 119/227 (52%), Gaps = 24/227 (10%)
Query: 430 DIEVPLYDLATITTATN---HFSEANMIGKGGFGPVYMG-KLSTGQEIAAKRLSKNSGQG 485
D E+ L L TI + + ++ IG+G G VY ++TGQE+A K+++
Sbjct: 1 DEEI-LEKLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK 59
Query: 486 LEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWK 545
E +NE++++ + +H N+V L S + DE ++ EY+ SL + + +
Sbjct: 60 KELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE----- 114
Query: 546 KRFSIITGIARGLL----YLHQDSKLQVIHRDLKASNILLDINLNPKISDFGL-ARIFGG 600
I + R L +LH + QVIHRD+K+ NILL ++ + K++DFG A+I
Sbjct: 115 ---GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--- 165
Query: 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
E+++ + GT +M+PE K D++SLG++ +E+V G+
Sbjct: 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 9e-21
Identities = 65/208 (31%), Positives = 107/208 (51%), Gaps = 22/208 (10%)
Query: 452 NMIGKGGFGPVYMG-KLSTGQEIAAK--RLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLL 508
N IG G FG VY L TG+ +A K R+ N + ++E +E+ ++ L+H NLV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 509 GSCIE-EDERMLIY-EYMPHKSLDYFIFDRERSKLLPWK--KRFSIITGIARGLLYLHQD 564
G +E E++ I+ EY +L+ + E ++L + +++ + GL YLH
Sbjct: 66 G--VEVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTL--QLLEGLAYLHSH 118
Query: 565 SKLQVIHRDLKASNILLDINLNPKISDFGLARIF--GGDDEEAQTERVAGTHGYMSPEYA 622
++HRD+K +NI LD N K+ DFG A + + +AGT YM+PE
Sbjct: 119 G---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 623 NDGTISMK---SDVFSLGVLLVEIVSGK 647
G +D++SLG +++E+ +GK
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 17/212 (8%)
Query: 447 HFSEANMIGKGGFGPVYMGKLSTGQE------IAAKRLSKNSGQGLE-EFMNEVVLIGKL 499
+ E +G+G FG V++ K +E + K L K + L+ EF E+ + KL
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 500 QHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFI------FDRERSKLLPWKKRFSIITG 553
H+N+V LLG C E + +I EY L F+ ++ + L K++ ++ T
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGT 613
IA G+ +L S + +HRDL A N L+ K+S L++ + +
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 614 HGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+++PE + S KSDV+S GVL+ E+ +
Sbjct: 183 R-WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 63/200 (31%), Positives = 103/200 (51%), Gaps = 21/200 (10%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512
+G G FG VY + TG AAK + S + LE+FM E+ ++ + +H N+VGL +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 513 EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIAR----GLLYLHQDSKLQ 568
E++ ++ E+ +LD + + ER P I + R L +LH +
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQ------IRYVCRQMLEALNFLHSH---K 123
Query: 569 VIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAN----- 623
VIHRDLKA NILL ++ + K++DFG++ + + GT +M+PE
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAK--NKSTLQKRDTFIGTPYWMAPEVVACETFK 181
Query: 624 DGTISMKSDVFSLGVLLVEI 643
D K+D++SLG+ L+E+
Sbjct: 182 DNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 61/212 (28%), Positives = 108/212 (50%), Gaps = 27/212 (12%)
Query: 453 MIGKGGFGPVYMG-KLSTGQEIAAKRLS---------KNSGQGLEEFMN-EVVLIGKLQH 501
+IGKG +G VY+ ++TG+ +A K++ + + + + + E+ + L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
N+V LG E+ + EY+P S+ + R + RF + GL YL
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL--RTYGRFEEQLVRF-FTEQVLEGLAYL 124
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR----IFGGDDEEAQTERVAGTHGYM 617
H ++HRDLKA N+L+D + KISDFG+++ I+ D Q + G+ +M
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDND----QNMSMQGSVFWM 177
Query: 618 SPE--YANDGTISMKSDVFSLGVLLVEIVSGK 647
+PE ++ S K D++SLG +++E+ +G+
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 4e-20
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKR--LSKNSGQGLEEFMNEVVLIGKLQHRN 503
E + +G+G G V +L I A + + + ++ + E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 504 LVGLLGSCIEEDERML--IYEYMPHKSLDYFIFDRERSKLLPWKKRF--SIITGIARGLL 559
+V G+ ++E + EY SLD I+ + + + ++ I + +GL
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 560 YLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSP 619
YLH ++IHRD+K SNILL K+ DFG++ G+ + GT YM+P
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSFYMAP 172
Query: 620 EYANDGTISMKSDVFSLGVLLVEIVSGK 647
E S+ SDV+SLG+ L+E+ +
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 83/289 (28%), Positives = 125/289 (43%), Gaps = 46/289 (15%)
Query: 454 IGKGGFGPVYMGK---LSTGQE---IAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVG 506
IG+G FG V+ + L + +A K L + S +F E L+ + H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDR-------------------ERSKLLPWKKR 547
LLG C L++EYM + L+ F+ R L ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 548 FSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQT 607
I +A G+ YL S+ + +HRDL N L+ N+ KI+DFGL+R D +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 608 ERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRH-NLIGHAW 666
E A +M PE + +SDV++ GV+L EI S M + G H +I +
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY---GMAHEEVIYYV- 245
Query: 667 LLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSV 715
DG L D C + + ++R LC KLP DRP +S+
Sbjct: 246 ---RDGNVLSCPDNCPLELY---NLMR------LCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 69/196 (35%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513
+G G FG V GK GQ A ++ K +EF+ E ++ KL H LV L G C +
Sbjct: 12 LGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 514 EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRD 573
+ ++ EYM + L ++ RE K + + + G+ YL +SK Q IHRD
Sbjct: 71 QRPIYIVTEYMSNGCLLNYL--REHGKRFQPSQLLEMCKDVCEGMAYL--ESK-QFIHRD 125
Query: 574 LKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDV 633
L A N L+D K+SDFGL+R + DDE + + PE S KSDV
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184
Query: 634 FSLGVLLVEIVS-GKM 648
++ GVL+ E+ S GKM
Sbjct: 185 WAFGVLMWEVYSLGKM 200
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 26/208 (12%)
Query: 454 IGKGGFGPVYMG-KLSTGQEIAAKRLSKNSGQG---LEEFMNEVVLIGKLQHRNLVGLLG 509
I KG +G V++ K STG A K + K +++ + E ++ + Q +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 510 SCIEEDERMLIYEYMPH---KSL--DYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD 564
S + L+ EY+P SL + D + +++ I I L YLH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI--------YIAEIVLALEYLHS- 111
Query: 565 SKLQVIHRDLKASNILLDINLNPKISDFGLA------RIFGGDDEEAQTERVAGTHGYMS 618
+IHRDLK NIL+D N + K++DFGL+ R +D+E + +R+ GT Y++
Sbjct: 112 --NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 619 PEYANDGTISMKSDVFSLGVLLVEIVSG 646
PE S D +SLG +L E + G
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 63/199 (31%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 454 IGKGGFGPVYMG--KLSTGQEI--AAKRLSKNSGQG-LEEFMNEVVLIGKLQHRNLVGLL 508
+G G FG V G S G+ I A K L + +++F+ E ++ L H NL+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 509 GSCIEEDERMLIYEYMPHKSL-DYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
G + M++ E P SL D D L+ +++ IA G+ YL
Sbjct: 63 G-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAV--QIANGMRYLESK--- 116
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFG-GDDEEAQTERVAGTHGYMSPEYANDGT 626
+ IHRDL A NILL + KI DFGL R +D E + + +PE T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 627 ISMKSDVFSLGVLLVEIVS 645
S SDV+ GV L E+ +
Sbjct: 177 FSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 2e-19
Identities = 62/220 (28%), Positives = 117/220 (53%), Gaps = 12/220 (5%)
Query: 430 DIEVPLYDLATITTATNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEE 488
+I L + +I ++ IG+G G V+ ++TGQE+A K+++ E
Sbjct: 3 EIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL 62
Query: 489 FMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRF 548
+NE++++ +L++ N+V L S + DE ++ EY+ SL D + +
Sbjct: 63 IINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIA 118
Query: 549 SIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGL-ARIFGGDDEEAQT 607
++ + L +LH + QVIHRD+K+ N+LL ++ + K++DFG A+I E+++
Sbjct: 119 AVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI---TPEQSKR 172
Query: 608 ERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
+ GT +M+PE K D++SLG++ +E+V G+
Sbjct: 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 78/268 (29%), Positives = 122/268 (45%), Gaps = 30/268 (11%)
Query: 453 MIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLE-EFMNEVVLIGKLQHRNLVGLLGSC 511
++GKG FG V+ G L +A K ++ Q L+ +F++E ++ + H N+V L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 512 IEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIH 571
+ ++ E +P D+ F R++ L K+ A G+ YL +SK IH
Sbjct: 62 TQRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYL--ESK-NCIH 116
Query: 572 RDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTH----GYMSPEYANDGTI 627
RDL A N L+ N KISDFG++R E+ +G + +PE N G
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171
Query: 628 SMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFV 687
S +SDV+S G+LL E S + +PG + A G + C +D +
Sbjct: 172 SSESDVWSYGILLWETFSLGV---CPYPGMTNQ---QAREQVEKGYRMSCPQKCPDDVY- 224
Query: 688 ESQVLRCIQVGLLCVQKLPEDRPDMSSV 715
+V C PE+RP S +
Sbjct: 225 --------KVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 454 IGKGGFGPVYMG------KLSTGQEIAAKRLSKNSGQG-LEEFMNEVVLIGKLQHRNLVG 506
+G+G FG VY G K +A K +++N+ EF+NE ++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 507 LLGSCIEEDERMLIYEYMPHKSL-DYFIFDRERSKLLPWKKRFSIITG---------IAR 556
LLG +++ E M L Y R ++ P T IA
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNP---GLGPPTLQKFIQMAAEIAD 130
Query: 557 GLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTH-- 614
G+ YL + +HRDL A N ++ +L KI DFG+ R D E R G
Sbjct: 131 GMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGKGLL 183
Query: 615 --GYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+M+PE DG + KSDV+S GV+L E+ +
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 61/215 (28%), Positives = 114/215 (53%), Gaps = 12/215 (5%)
Query: 435 LYDLATITTATNHFSEANMIGKGGFGPVYMG-KLSTGQEIAAKRLSKNSGQGLEEFMNEV 493
L + ++ ++ IG+G G VY ++TGQE+A K+++ E +NE+
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 494 VLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITG 553
+++ + ++ N+V L S + DE ++ EY+ SL D + + ++
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGL-ARIFGGDDEEAQTERVAG 612
+ L +LH + QVIHRD+K+ NILL ++ + K++DFG A+I E+++ + G
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVG 177
Query: 613 THGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
T +M+PE K D++SLG++ +E+V G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 66/194 (34%), Positives = 98/194 (50%), Gaps = 15/194 (7%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513
IGKG FG V +G G ++A K + KN + F+ E ++ +L+H NLV LLG +E
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCI-KNDATA-QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 514 EDERMLIY-EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHR 572
E + I EYM SL ++ R RS +L + + YL ++ +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 573 DLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTH-GYMSPEYANDGTISMKS 631
DL A N+L+ + K+SDFGL + E + T+ + +PE + S KS
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 632 DVFSLGVLLVEIVS 645
DV+S G+LL EI S
Sbjct: 181 DVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 62/201 (30%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 453 MIGKGGFGPVYMGKLSTG----QEIAAKRL-SKNSGQGLEEFMNEVVLIGKLQHRNLVGL 507
+IG G FG V G+L +A K L S + + +F++E ++G+ H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
G + M+I E+M + +LD F+ R+ + ++ GIA G+ YL S++
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYL---SEM 125
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTH---GYMSPEYAND 624
+HRDL A NIL++ NL K+SDFGL+R D + G + +PE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 625 GTISMKSDVFSLGVLLVEIVS 645
+ SDV+S G+++ E++S
Sbjct: 186 RKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 4e-19
Identities = 63/203 (31%), Positives = 109/203 (53%), Gaps = 20/203 (9%)
Query: 453 MIGKGGFGPVYMGKLSTGQE-----IAAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVG 506
++G G FG VY G E +A K L++ +G + EFM+E +++ + H +LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDRE----RSKLLPWKKRFSIITGIARGLLYLH 562
LLG C+ + L+ + MPH L ++ + + LL W IA+G++YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 126
Query: 563 QDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA 622
+ +++HRDL A N+L+ + KI+DFGLAR+ GD++E + +M+ E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 623 NDGTISMKSDVFSLGVLLVEIVS 645
+ + +SDV+S GV + E+++
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 454 IGKGGFGPVYMGK---LSTGQE---IAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGL 507
+G+G FG V++ + L Q+ +A K L S ++F E L+ LQH ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKL----------LPWKKRFSIITGIARG 557
G C+E D ++++EYM H L+ F+ + L + I IA G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 558 LLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTH--- 614
++YL + +HRDL N L+ NL KI DFG++R D RV G
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRVGGHTMLP 185
Query: 615 -GYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+M PE + +SDV+SLGV+L EI +
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 59/215 (27%), Positives = 114/215 (53%), Gaps = 12/215 (5%)
Query: 435 LYDLATITTATNHFSEANMIGKGGFGPVYMG-KLSTGQEIAAKRLSKNSGQGLEEFMNEV 493
L + ++ ++ IG+G G VY ++TGQE+A ++++ E +NE+
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 494 VLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITG 553
+++ + ++ N+V L S + DE ++ EY+ SL D + + ++
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGL-ARIFGGDDEEAQTERVAG 612
+ L +LH + QVIHRD+K+ NILL ++ + K++DFG A+I E+++ + G
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVG 178
Query: 613 THGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
T +M+PE K D++SLG++ +E++ G+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 16/207 (7%)
Query: 448 FSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLS-KNSGQGL-EEFMNEVVLIGKLQHRNL 504
+++ IG+G +G VY G+ TGQ +A K++ ++ +G+ + E+ L+ +LQH N+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 505 VGLLGSCIEEDERMLIYEYMP---HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
V L ++E LI+E++ K LD + L + I+ GI L+
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI----LFC 117
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
H +V+HRDLK N+L+D K++DFGLAR FG E V T Y +PE
Sbjct: 118 HSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEV 172
Query: 622 ANDGT-ISMKSDVFSLGVLLVEIVSGK 647
S D++S+G + E+ + K
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 19/207 (9%)
Query: 448 FSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQG-LEEFMNEVVLIGKLQH---R 502
+ +IG+G +G VY GK + TG+ +A K ++ ++ + + EV L+ +L+
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 503 NLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS--IITGIARGLLY 560
N+ GS ++ +I EY S+ R K P +++ II + L Y
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSV------RTLMKAGPIAEKYISVIIREVLVALKY 116
Query: 561 LHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE 620
+H+ VIHRD+KA+NIL+ N K+ DFG+A + + + T GT +M+PE
Sbjct: 117 IHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPE 171
Query: 621 YANDG-TISMKSDVFSLGVLLVEIVSG 646
+G K+D++SLG+ + E+ +G
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 64/208 (30%), Positives = 111/208 (53%), Gaps = 21/208 (10%)
Query: 454 IGKGGFGPVYMGKLSTGQEI---AAK--RLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLL 508
+G+G FG V G+L+ I A K +++ + +E+F++E V + + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 509 GSCIEEDER------MLIYEYMPHKSL-DYFIFDR--ERSKLLPWKKRFSIITGIARGLL 559
G C++ E ++I +M H L + ++ R + + LP + +T IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 560 YLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA-RIFGGDDEEAQTERVAGTH-GYM 617
YL S IHRDL A N +L+ N+N ++DFGL+ +I+ GD + R+A ++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD--YYRQGRIAKMPVKWI 181
Query: 618 SPEYANDGTISMKSDVFSLGVLLVEIVS 645
+ E D + KSDV+S GV + EI +
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 7e-19
Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 35/222 (15%)
Query: 454 IGKGGFGPVYMGK------LSTGQEIAAKRLSKNSGQG-LEEFMNEVVLIGKLQHRNLVG 506
+G+G FG V + +A K L +N+ L + ++E L+ ++ H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLP----------------------- 543
L G+C ++ +LI EY + SL F+ RE K+ P
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFL--RESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 544 WKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603
S I+RG+ YL ++++++HRDL A N+L+ KISDFGL+R +D
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+ + +M+ E D + +SDV+S GVLL EIV+
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 454 IGKGGFGPVYMGK---LSTGQE---IAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGL 507
+G+G FG V++ + L Q+ +A K L + S ++F E L+ LQH+++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDR-------ERSKLLP-----WKKRFSIITGIA 555
G C E ++++EYM H L+ F+ + + + +I + IA
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 556 RGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG 615
G++YL + L +HRDL N L+ L KI DFG++R D R
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 616 YMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+M PE + +SD++S GV+L EI +
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 28/216 (12%)
Query: 453 MIGKGGFGPVYMG------KLSTGQEIAAKRLSKN-SGQGLEEFMNEVV---LIGKLQHR 502
+G+G FG V + +A K L + + + L + ++E+ +IGK H+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HK 76
Query: 503 NLVGLLGSCIEEDERMLIYEYMPHKSL-DY------------FIFDRERSKLLPWKKRFS 549
N++ LLG C +E ++ EY H +L D+ R + L K S
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 550 IITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTER 609
+ARG+ +L SK + IHRDL A N+L+ + KI+DFGLAR D +T
Sbjct: 137 FAYQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 610 VAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+M+PE D + +SDV+S GVLL EI +
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 60/197 (30%), Positives = 104/197 (52%), Gaps = 15/197 (7%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512
+G G FG VY K TG AAK + S + LE++M E+ ++ H +V LLG+
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 513 EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHR 572
+ + ++ E+ P ++D + + +R P + I + L YLH +++IHR
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ--VICRQMLEALQYLHS---MKIIHR 134
Query: 573 DLKASNILLDINLNPKISDFGLARIFGGDDEEAQT-ERVAGTHGYMSPEYA-----NDGT 626
DLKA N+LL ++ + K++DFG++ + + Q + GT +M+PE D
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVS---AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191
Query: 627 ISMKSDVFSLGVLLVEI 643
K+D++SLG+ L+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 73/220 (33%), Positives = 105/220 (47%), Gaps = 40/220 (18%)
Query: 452 NMIGKGGFGPVYMGKLSTG---QEIAAKRLSKNSGQG-LEEFMNEVVLIGKL-QHRNLVG 506
++IG+G FG V ++ + A KR+ + + + +F E+ ++ KL H N++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSII--------------- 551
LLG+C L EY PH +L F+ +S++L F+I
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 552 -TGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERV 610
+ARG+ YL Q Q IHRDL A NIL+ N KI+DFGL+R Q V
Sbjct: 130 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYV 178
Query: 611 AGTHG-----YMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
T G +M+ E N + SDV+S GVLL EIVS
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 454 IGKGGFGPVYMGK---LSTGQE---IAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGL 507
+G+G FG V++ + LS ++ +A K L + ++F E L+ LQH ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIF-------------DRERSKLLPWKKRFSIITGI 554
G C + D ++++EYM H L+ F+ R+ L + I + I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 555 ARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTH 614
A G++YL + +HRDL N L+ NL KI DFG++R D RV G
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGHT 185
Query: 615 ----GYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+M PE + +SDV+S GV+L EI +
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 10/200 (5%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKR--LSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGS 510
IG G VY L +++A KR L K ++E EV + + H N+V S
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 511 CIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVI 570
+ DE L+ Y+ SL + L +++ + +GL YLH + I
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQI 124
Query: 571 HRDLKASNILLDINLNPKISDFGL-ARIF-GGDDEEAQTERVAGTHGYMSPEYANDGT-I 627
HRD+KA NILL + + KI+DFG+ A + GGD + GT +M+PE
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184
Query: 628 SMKSDVFSLGVLLVEIVSGK 647
K+D++S G+ +E+ +G
Sbjct: 185 DFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 68/200 (34%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 454 IGKGGFGPVYMGK---------LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNL 504
+GKG FG VY+ K L +EI L+ N + E L+ KL H +
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLSKLDHPAI 64
Query: 505 VGLLGSCIEEDERMLIYEYMPHKSLDYFIFD-RERSKLLPWKKRFSIITGIARGLLYLHQ 563
V S +E D +I EY + LD + + + K L + + G+ Y+HQ
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAN 623
+++HRDLKA NI L NL KI DFG++R+ G + A T GT YMSPE
Sbjct: 125 R---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEALK 178
Query: 624 DGTISMKSDVFSLGVLLVEI 643
KSD++SLG +L E+
Sbjct: 179 HQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 45/218 (20%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN---------EVVLIGKLQHRN 503
IG G +G V TG+++A K++S F + E+ L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 504 LVGLL-----GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGL 558
++GLL S + ++ ++ E M L I + L ++ + I RGL
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVI--KSPQPLTDDHIQY-FLYQILRGL 116
Query: 559 LYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ--TERVAGTHGY 616
YLH VIHRDLK SNIL++ N + KI DFGLAR D++E TE V T Y
Sbjct: 117 KYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRWY 172
Query: 617 MSPE-------YANDGTISMKSDVFSLGVLLVEIVSGK 647
+PE Y I D++S+G + E+++ K
Sbjct: 173 RAPELLLSSSRY--TKAI----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (213), Expect = 3e-18
Identities = 47/154 (30%), Positives = 81/154 (52%), Gaps = 19/154 (12%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEF----MNEVVLIGKLQHRNLVGLL 508
+G+G +G VY + TG+ +A K++ ++ + E + E+ L+ +L+H N+V LL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEE--EGIPSTALREISLLKELKHPNIVKLL 64
Query: 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKL-LPWKKRFS--IITGIARGLLYLHQDS 565
E + L++EY L ++ D+ L K ++ G+A Y H
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPLSPNLIKSIMYQLLRGLA----YCHSH- 117
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599
+++HRDLK NIL++ + K++DFGLAR FG
Sbjct: 118 --RILHRDLKPQNILINRDGVLKLADFGLARAFG 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 3e-18
Identities = 86/297 (28%), Positives = 131/297 (44%), Gaps = 53/297 (17%)
Query: 448 FSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEF---MNEVVLIGKLQHRN 503
F++ IG G FG VY + T + +A K++S + Q E++ + EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
+ G + E L+ EY + D I + + K L + +I G +GL YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHK-KPLQEVEIAAICHGALQGLAYLHS 133
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY-- 621
+ IHRD+KA NILL K++DFG A + A + GT +M+PE
Sbjct: 134 ---HERIHRDIKAGNILLTEPGTVKLADFGSASLV----SPANS--FVGTPYWMAPEVIL 184
Query: 622 -ANDGTISMKSDVFSLGVLLVEIVSGK-----MN--RGFRHPGHRHNLIGHAWLLWNDGR 673
++G K DV+SLG+ +E+ K MN H + ND
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------------IAQNDSP 232
Query: 674 ALGLMDTCLE-DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGVTLPQP 729
L D +FV+S C+QK+P+DRP LL + V +P
Sbjct: 233 TLSSNDWSDYFRNFVDS-----------CLQKIPQDRPSSEE---LLKHRFVLRERP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 74/275 (26%), Positives = 127/275 (46%), Gaps = 25/275 (9%)
Query: 447 HFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLS---KNSGQGLEEFMNEVVLIGKLQHR 502
+F IG+G F VY L G +A K++ + + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 503 NLVGLLGSCIEEDERMLIYEYMPHKSLDYFI--FDRERSKLLPWKKRFSIITGIARGLLY 560
N++ S IE++E ++ E L I F +++ +L+P K + + L +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK-RLIPEKTVWKYFVQLCSALEH 121
Query: 561 LHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE 620
+H +V+HRD+K +N+ + K+ D GL R F A + + GT YMSPE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 176
Query: 621 YANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680
++ + KSD++SLG LL E+ + + P G L++ + + D
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAA------LQSP-----FYGDKMNLYSLCKKIEQCDY 225
Query: 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSV 715
S S+ LR Q+ +C+ PE RPD++ V
Sbjct: 226 PPLPSDHYSEELR--QLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 448 FSEANMIGKGGFGPVYMG-KLSTGQEIAAKRLS-KNSGQGLEEFMNEVVLIGKLQHRNLV 505
F+ IGKG FG VY T Q +A K + + + +E+ E+ + + + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 506 GLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
GS ++ + +I EY S D + L I+ + GL YLH++
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTER--VAGTHGYMSPEYAN 623
K IHRD+KA+NILL + K++DFG++ G ++R GT +M+PE
Sbjct: 119 K---IHRDIKAANILLSEEGDVKLADFGVS----GQLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 624 DGTISMKSDVFSLGVLLVEIVSGK 647
K+D++SLG+ +E+ G+
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 63/215 (29%), Positives = 109/215 (50%), Gaps = 21/215 (9%)
Query: 448 FSEANMIGKGGFGPVYMGKLSTGQEIAAKRLS--KNSGQGLEEFMNEVVLIGKLQHRNLV 505
F++ IGKG FG VY G + +E+ A ++ + + +E+ E+ ++ + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 506 GLLGSCIEEDERMLIYEYMPHKS-LDYFIFDRERSKLLPWKKRF--SIITGIARGLLYLH 562
GS ++ + +I EY+ S LD K P ++ + +I+ I +GL YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL-------KPGPLEETYIATILREILKGLDYLH 118
Query: 563 QDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTER--VAGTHGYMSPE 620
+ K IHRD+KA+N+LL + K++DFG+A G + Q +R GT +M+PE
Sbjct: 119 SERK---IHRDIKAANVLLSEQGDVKLADFGVA----GQLTDTQIKRNTFVGTPFWMAPE 171
Query: 621 YANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHP 655
K+D++SLG+ +E+ G+ HP
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP 206
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 72/214 (33%), Positives = 107/214 (50%), Gaps = 28/214 (13%)
Query: 452 NMIGKGGFGPVY--MGKLSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKL-QHRNLVG 506
++IG+G FG V M K + AA ++ K S +F E+ ++ KL H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFI-----------FDRER--SKLLPWKKRFSIITG 553
LLG+C + EY P+ +L F+ F +E + L ++ +
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGT 613
+A G+ YL S+ Q IHRDL A N+L+ NL KI+DFGL+R EE ++ G
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTMGR 179
Query: 614 HG--YMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+M+ E N + KSDV+S GVLL EIVS
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 28/222 (12%)
Query: 444 ATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHR 502
T F +IG+G +G VY + ++ A ++ EE E ++ K H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHP 63
Query: 503 NLVGLLG------SCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------I 550
N+ G +D+ L+ E S+ + L KR I
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIAYI 118
Query: 551 ITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERV 610
+ RGL YLH++ +VIHRD+K NILL N K+ DFG++ D +
Sbjct: 119 LRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNTF 173
Query: 611 AGTHGYMSPE-----YANDGTISMKSDVFSLGVLLVEIVSGK 647
GT +M+PE D + +SDV+SLG+ +E+ GK
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 9e-18
Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 30/218 (13%)
Query: 454 IGKGGFGPVYMGKLSTGQE---------------IAAKRLSKN-SGQGLEEFMNEVVLIG 497
+G+G FG V++ + E +A K L + + +F+ E+ ++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 498 KLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRE-RSKL-----LPWKKRFSII 551
+L++ N++ LLG C+ +D +I EYM + L+ F+ RE S +P +++
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 552 ---TGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR-IFGGDDEEAQT 607
IA G+ YL + L +HRDL N L+ + KI+DFG++R ++ GD Q
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 608 ERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
V +M+ E G + SDV++ GV L E+ +
Sbjct: 190 RAVLPIR-WMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 58/184 (31%), Positives = 96/184 (52%), Gaps = 19/184 (10%)
Query: 448 FSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLS-KNSGQGLEEFM-NEVVLIGKLQ---H 501
+ E IG+G +G VY + L+TG+ +A K++ S +G+ E+ L+ +L+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 502 RNLVGLLGSC-IEEDER----MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIAR 556
N+V LL C +R L++E++ + L ++ + L P + ++ + R
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKD-LMRQLLR 118
Query: 557 GLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGY 616
G+ +LH ++HRDLK NIL+ + KI+DFGLARI+ E A T V T Y
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVV-TLWY 172
Query: 617 MSPE 620
+PE
Sbjct: 173 RAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 58/197 (29%), Positives = 104/197 (52%), Gaps = 14/197 (7%)
Query: 454 IGKGGFGPVYMG-KLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512
IG+G G V + STG+++A K++ Q E NEVV++ QH N+V + S +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 513 EEDERMLIYEYMPHKSL-DYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIH 571
DE ++ E++ +L D R + + ++ + + L +LH VIH
Sbjct: 87 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLAVLKALSFLHAQG---VIH 138
Query: 572 RDLKASNILLDINLNPKISDFGL-ARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMK 630
RD+K+ +ILL + K+SDFG A++ E + + + GT +M+PE + +
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPEVISRLPYGTE 195
Query: 631 SDVFSLGVLLVEIVSGK 647
D++SLG++++E+V G+
Sbjct: 196 VDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN----EVVLIGKLQHRNLVGL 507
++G+G +G V + +TG+ +A K+ ++ E+ EV ++ +L+H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNL 65
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
+ + L++EY+ L+ + L P R S I + + + Y H
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELL--EASPGGLPPDAVR-SYIWQLLQAIAYCH---SH 119
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE-YANDGT 626
+IHRD+K NIL+ + K+ DFG AR T+ VA T Y +PE D
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGDTN 178
Query: 627 ISMKSDVFSLGVLLVEIVSG 646
DV+++G ++ E++ G
Sbjct: 179 YGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 57/203 (28%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN-----EVVLIGKLQHRNLVGL 507
+G+G + VY + TG+ +A K++ + ++ +N E+ L+ +L+H N++GL
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
L + L++E+M L+ I D+ K S + RGL YLH
Sbjct: 68 LDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIK--SYMLMTLRGLEYLH---SN 121
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY---AND 624
++HRDLK +N+L+ + K++DFGLAR FG + + + V T Y +PE A
Sbjct: 122 WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYRAPELLFGARH 179
Query: 625 GTISMKSDVFSLGVLLVEIVSGK 647
+ + D++S+G + E++
Sbjct: 180 YGVGV--DMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 2e-17
Identities = 77/273 (28%), Positives = 124/273 (45%), Gaps = 40/273 (14%)
Query: 448 FSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLS---KNSGQGLEEFMNEVVLIGKLQHRN 503
F++ IG G FG VY + + T + +A K++S K S + ++ + EV + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
+ G + E L+ EY + D K L + +I G +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY-- 621
+ +IHRD+KA NILL K++DFG A I + GT +M+PE
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASIA------SPANSFVGTPYWMAPEVIL 194
Query: 622 -ANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680
++G K DV+SLG+ +E+ K P N + + + + + L
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERK------PPLFNMNAMSALYHIAQN-ESPTLQSN 247
Query: 681 CLED---SFVESQVLRCIQVGLLCVQKLPEDRP 710
D +FV+S C+QK+P+DRP
Sbjct: 248 EWSDYFRNFVDS-----------CLQKIPQDRP 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 69/214 (32%), Positives = 109/214 (50%), Gaps = 22/214 (10%)
Query: 446 NHFSEANMIGKGGFGPVY-MGKLSTGQEIAAKRL-SKNSGQGLEEFMNEVVLIGKLQH-R 502
+ IG+G FG V M +G +A KR+ S + + + ++ ++ +
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63
Query: 503 NLVGLLGSCIEEDERMLIYEYMPHKSLDYF---IFDRERSKLLPWKKRFSIITGIARGLL 559
+V G+ E + + E M SLD F +++ +S + P + I + L
Sbjct: 64 YIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVI-PEEILGKIAVATVKALN 121
Query: 560 YLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD--DEEAQTERVAGTHGYM 617
YL ++ L++IHRD+K SNILLD N N K+ DFG++ G D A+T R AG YM
Sbjct: 122 YLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGIS----GQLVDSIAKT-RDAGCRPYM 174
Query: 618 SPE----YANDGTISMKSDVFSLGVLLVEIVSGK 647
+PE A DG ++SDV+SLG+ L E+ +GK
Sbjct: 175 APERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 68/217 (31%), Positives = 102/217 (47%), Gaps = 34/217 (15%)
Query: 452 NMIGKGGFGPVYMG-------KLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRN 503
++IG+G FG V ++ + + SK+ + +F E+ ++ KL H N
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR---DFAGELEVLCKLGHHPN 57
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFI-----------FDRER--SKLLPWKKRFSI 550
++ LLG+C L EY PH +L F+ F + L ++
Sbjct: 58 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 551 ITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERV 610
+ARG+ YL S+ Q IHRDL A NIL+ N KI+DFGL+R +E ++
Sbjct: 118 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKT 169
Query: 611 AGTHG--YMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
G +M+ E N + SDV+S GVLL EIVS
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 60/212 (28%), Positives = 106/212 (50%), Gaps = 15/212 (7%)
Query: 448 FSEANMIGKGGFGPVYMGKLSTGQEIAAKRLS--KNSGQGLEEFMNEVVLIGKLQHRNLV 505
F++ IGKG FG V+ G + Q++ A ++ + + +E+ E+ ++ + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 506 GLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
GS +++ + +I EY+ S D L + +I+ I +GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTER--VAGTHGYMSPEYAN 623
K IHRD+KA+N+LL + K++DFG+A G + Q +R GT +M+PE
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNTFVGTPFWMAPEVIK 174
Query: 624 DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHP 655
K+D++SLG+ +E+ G+ HP
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPHSELHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 11/210 (5%)
Query: 448 FSEANMIGKGGFGPVYMGKLSTGQEIAAKRLS--KNSGQGLEEFMNEVVLIGKLQHRNLV 505
F++ IGKG FG V+ G + Q++ A ++ + + +E+ E+ ++ + +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 506 GLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
GS ++ + +I EY+ S D R+ + +++ I +GL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG 625
K IHRD+KA+N+LL + K++DFG+A D + + GT +M+PE
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIQQS 176
Query: 626 TISMKSDVFSLGVLLVEIVSGKMNRGFRHP 655
K+D++SLG+ +E+ G+ HP
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDMHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 59/196 (30%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512
+G G FG VY + TG AAK + S + LE++M E+ ++ H N+V LL +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 513 EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHR 572
E+ ++ E+ ++D + + ER P + + L YLH++ ++IHR
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIR--VVCKQTLEALNYLHEN---KIIHR 127
Query: 573 DLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY-----ANDGTI 627
DLKA NIL ++ + K++DFG++ + + GT +M+PE + D
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 628 SMKSDVFSLGVLLVEI 643
K+DV+SLG+ L+E+
Sbjct: 186 DYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLS---KNSGQGLEEFMNEVVLIGKLQHRNLVGLLG 509
IG+G F VY L + +A K++ + ++ + E+ L+ +L H N++ L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 510 SCIEEDERMLIYEYMPHKSLDYFI-FDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQ 568
S IE++E ++ E L I + +++ +L+P + + + + ++H +
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---R 126
Query: 569 VIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTIS 628
V+HRD+K +N+ + K+ D GL R F A + + GT YMSPE ++ +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYN 184
Query: 629 MKSDVFSLGVLLVEIV-------SGKMN 649
KSD++SLG LL E+ KMN
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKMN 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 64/276 (23%), Positives = 125/276 (45%), Gaps = 34/276 (12%)
Query: 454 IGKGGFGPVY-MGKLSTGQEIAA-----------KRLSKNSGQGLEEFMNEVVLIGK-LQ 500
+G G FG VY + K + GQ + A + + + + + ++EV +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 501 HRNLVGLLGSCIEEDERMLIYEYMPHKSL-DYFIFDRERSKLLPWKKRFSIITGIARGLL 559
H N+V + +E D ++ + + L ++F +E+ + ++ ++I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 560 YLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSP 619
YLH++ +++HRDL +NI+L + I+DFGLA+ E++ V GT Y P
Sbjct: 128 YLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSCP 182
Query: 620 EYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679
E + K+DV++ G +L ++ + + P + N++ A + + +
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLATKIVE-----AVYE 231
Query: 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSV 715
L + V I C+ E RPD+ V
Sbjct: 232 P-LPEGMYSEDVTDVITS---CLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-17
Identities = 78/273 (28%), Positives = 120/273 (43%), Gaps = 40/273 (14%)
Query: 448 FSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLS---KNSGQGLEEFMNEVVLIGKLQHRN 503
FS+ IG G FG VY + + + +A K++S K S + ++ + EV + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
+ G + E L+ EY + D K L + ++ G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY-- 621
+ +IHRD+KA NILL K+ DFG A I A GT +M+PE
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 622 -ANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680
++G K DV+SLG+ +E+ K P N + + + + L
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK------PPLFNMNAMSALYHIAQNESPA-LQSG 237
Query: 681 CLEDS---FVESQVLRCIQVGLLCVQKLPEDRP 710
+ FV+S C+QK+P+DRP
Sbjct: 238 HWSEYFRNFVDS-----------CLQKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 19/208 (9%)
Query: 448 FSEANMIGKGGFGPV------YMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQH 501
F + ++GKGGFG V GK+ +++ KR+ K G+ + +NE ++ K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
R +V L + +D L+ M L + I+ + + I GL L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF-EEGRAVFYAAEICCGLEDL 118
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQT--ERVAGTHGYMSP 619
HQ+ ++++RDLK NILLD + + +ISD GLA E QT RV GT GYM+P
Sbjct: 119 HQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV----PEGQTIKGRV-GTVGYMAP 170
Query: 620 EYANDGTISMKSDVFSLGVLLVEIVSGK 647
E + + D ++LG LL E+++G+
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 69/213 (32%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 454 IGKGGFGPVYMGKL-----STGQEIAAKRLSK-NSGQGLEEFMNEVVLIGKLQHRNLVGL 507
+G+ FG +Y G L Q +A K L N+ Q EF E L+ +L H N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRER--------------SKLLPWKKRFSIITG 553
LG +E +++EY+ L F+ R L I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR-IFGGDDEEAQTERVAG 612
IA G+ YL S +H+DL A NIL+ L+ KISD GL+R I+ D Q + +
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 613 THGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+M PE G S SD++S GV+L EI S
Sbjct: 190 IR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 6e-17
Identities = 69/223 (30%), Positives = 109/223 (48%), Gaps = 24/223 (10%)
Query: 448 FSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRNLV 505
F ++G G +G VY G+ + TGQ +AA ++ +G EE E+ ++ K HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQ-LAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIA 66
Query: 506 GLLGSCIE------EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRF--SIITGIARG 557
G+ I+ +D+ L+ E+ S+ I + + + L K+ + I I RG
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL---KEEWIAYICREILRG 123
Query: 558 LLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYM 617
L +LHQ +VIHRD+K N+LL N K+ DFG++ D + GT +M
Sbjct: 124 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWM 178
Query: 618 SPEYAN-----DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHP 655
+PE D T KSD++SLG+ +E+ G HP
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 6e-17
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 448 FSEANMIGKGGFGPVYMGKL----STGQEIAAKRLSK--NSGQGLEEFMNEVVLIGKLQH 501
F+ M+GKG FG V +L + Q++A K L S +EEF+ E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 502 RNLVGLLGSCIEEDER------MLIYEYMPHKSLDYFIFDR---ERSKLLPWKKRFSIIT 552
N++ L+G + + M+I +M H L F+ E LP + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 553 GIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAG 612
IA G+ YL S IHRDL A N +L+ N+ ++DFGL++ D Q
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 613 THGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+++ E D + SDV++ GV + EI++
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 54/195 (27%), Positives = 103/195 (52%), Gaps = 10/195 (5%)
Query: 454 IGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512
IG+G G V + + +G+++A K + Q E NEVV++ QH+N+V + S +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 513 EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHR 572
+E ++ E++ +L + L ++ ++ + + L YLH VIHR
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTR----LNEEQIATVCESVLQALCYLHSQG---VIHR 141
Query: 573 DLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSD 632
D+K+ +ILL ++ K+SDFG D + ++ + GT +M+PE + + D
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEVD 199
Query: 633 VFSLGVLLVEIVSGK 647
++SLG++++E+V G+
Sbjct: 200 IWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 448 FSEANMIGKGGFGPVYMGKLSTGQE-----IAAKRLSK-NSGQGLEEFMNEVVLIGKLQH 501
F + ++G G FG VY G E +A K L + S + +E ++E ++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 502 RNLVGLLGSCIEEDERMLIYEYMPHKSL-DYFIFDRER---SKLLPWKKRFSIITGIARG 557
++ LLG C+ + LI + MP L DY ++ LL W IA+G
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121
Query: 558 LLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYM 617
+ YL + +++HRDL A N+L+ + KI+DFGLA++ G D++E E +M
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 618 SPEYANDGTISMKSDVFSLGVLLVEIVS 645
+ E + +SDV+S GV + E+++
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 448 FSEANMIGKGGFGPV------YMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQH 501
F + ++GKGGFG V GK+ + + KR+ K G+ + +NE ++ K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
+ +V L + +D L+ M L + I++ + F I GL L
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF-YAAEILCGLEDL 118
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLA-RIFGGDDEEAQTERVAGTHGYMSPE 620
H+++ ++RDLK NILLD + +ISD GLA +I G+ + GT GYM+PE
Sbjct: 119 HREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV----GTVGYMAPE 171
Query: 621 YANDGTISMKSDVFSLGVLLVEIVSGK 647
N+ ++ D + LG L+ E++ G+
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 61/219 (27%), Positives = 108/219 (49%), Gaps = 34/219 (15%)
Query: 452 NMIGKGGFGPVYMGKL-----STGQEIAAKRLSKNSGQ-GLEEFMNEVVLIGKLQHRNLV 505
+++ +G FG ++ G L +E+ K + ++ + + + E L+ L H+N++
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 506 GLLGSCIEEDER-MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIIT--------GIAR 556
+L CIE+ E ++Y YM +L F+ ++ +L ++ T IA
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFL---QQCRLGEANNPQALSTQQLVHMAIQIAC 128
Query: 557 GLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR-IFGGD-----DEEAQTERV 610
G+ YLH K VIH+D+ A N ++D L KI+D L+R +F D D E + +
Sbjct: 129 GMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK- 184
Query: 611 AGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKM 648
+M+ E + S SDV+S GVLL E+++ G+
Sbjct: 185 -----WMALESLVNKEYSSASDVWSFGVLLWELMTLGQT 218
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 65/200 (32%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 454 IGKGGFGPVY------MGKLSTGQEIAAKRL-SKNSGQGLEEFMNEVVLIGKL-QHRNLV 505
+G G FG V + K ++A K L E M+E+ ++ L H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 506 GLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
LLG+C ++I EY + L F+ R+R L + S +A+G+ +L S
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKGMAFL--AS 159
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG 625
K IHRDL A N+LL KI DFGLAR D +M+PE +
Sbjct: 160 K-NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC 218
Query: 626 TISMKSDVFSLGVLLVEIVS 645
+ +SDV+S G+LL EI S
Sbjct: 219 VYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 69/242 (28%), Positives = 112/242 (46%), Gaps = 51/242 (21%)
Query: 447 HFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGL-EEFMNEVVLIGKLQHRNL 504
+ + IG+G +G V TG ++A K++S Q + + E+ ++ + +H N+
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65
Query: 505 VGLL-----GSCIEEDERMLIYEYMP---HKSL----------DYFIFDRERSKLLPWKK 546
+G+L S ++ ++ E M +K + YF++
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQ----------- 114
Query: 547 RFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606
I RGL Y+H + V+HRDLK SN+LL+ N + KI DFGLARI D E
Sbjct: 115 -------ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI---ADPEHD 161
Query: 607 -----TERVAGTHGYMSPEYA-NDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHN 660
TE VA T Y +PE N + D++S+G +L E++S + + H+ N
Sbjct: 162 HTGFLTEYVA-TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN 220
Query: 661 LI 662
LI
Sbjct: 221 LI 222
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 57/197 (28%), Positives = 103/197 (52%), Gaps = 14/197 (7%)
Query: 454 IGKGGFGPVYMG-KLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512
IG+G G V + + TG+++A K++ Q E NEVV++ H N+V + S +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 513 EEDERMLIYEYMPHKSL-DYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIH 571
DE ++ E++ +L D R + + ++ + R L YLH VIH
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHNQG---VIH 141
Query: 572 RDLKASNILLDINLNPKISDFGL-ARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMK 630
RD+K+ +ILL + K+SDFG A++ E + + + GT +M+PE + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 631 SDVFSLGVLLVEIVSGK 647
D++SLG++++E++ G+
Sbjct: 199 VDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 453 MIGKGGFG-PVYMGKLSTGQEIAAK--RLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLG 509
++G+G FG + + +++ Q+ A K RL K+S +E+ E VL+ K++H N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 510 SCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQV 569
S + ++ EY L I +R KL P + G+ ++H + +V
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIH---EKRV 121
Query: 570 IHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISM 629
+HRD+K+ NI L N K+ DFG AR+ A T GT Y+ PE + +
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPYNN 179
Query: 630 KSDVFSLGVLLVEIVSGKMNRGFRHP 655
KSD++SLG +L E+ + +HP
Sbjct: 180 KSDIWSLGCILYELCT------LKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 22/206 (10%)
Query: 454 IGKGGFGPVY-MGKLSTGQEIAAKRL--SKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGS 510
+G+G +G V M + TG +A KR+ + NS + M+ + + + V G+
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 511 CIEEDERMLIYEYMPHKSLDYF---IFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
E + + E M SLD F ++D+ + +P I I + L YLH SKL
Sbjct: 69 LFREGDVWICMEVM-DTSLDKFYKKVYDKGLT--IPEDILGKIAVSIVKALEYLH--SKL 123
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGD--DEEAQTERVAGTHGYMSPEYANDG 625
VIHRD+K SN+L++ N K+ DFG++ G D A+T AG YM+PE N
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTID-AGCKPYMAPERINPE 178
Query: 626 T----ISMKSDVFSLGVLLVEIVSGK 647
+KSDV+SLG+ ++E+ +G+
Sbjct: 179 LNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 447 HFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLV 505
+ IG G +G VY + ++TG+ +A K + G E E+ ++ + +H N+V
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV 63
Query: 506 GLLGSCIEEDERMLIYEYMPHKSLD--YFIFDRERSKLLPWKKRFSIITGIAR----GLL 559
GS + D+ ++ EY SL Y + S+L I + R GL
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQ--------IAYVCRETLKGLA 115
Query: 560 YLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ-TERVA------G 612
YLH+ K IHRD+K +NILL + + K++DFG++ AQ T +A G
Sbjct: 116 YLHETGK---IHRDIKGANILLTEDGDVKLADFGVS---------AQLTATIAKRKSFIG 163
Query: 613 THGYMSPEYAN---DGTISMKSDVFSLGVLLVEIVSGK 647
T +M+PE A G K D+++LG+ +E+ +
Sbjct: 164 TPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 26/215 (12%)
Query: 454 IGKGGFGPVYMG--------KLSTGQEIAAKRLSKNSGQ-GLEEFMNEVVLIGKL-QHRN 503
+G+G FG V M K +A K L ++ + L + ++E+ ++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFI-----------FDRER--SKLLPWKKRFSI 550
++ LLG+C ++ +I EY +L ++ +D R + + +K S
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 551 ITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERV 610
+ARG+ YL + + IHRDL A N+L+ N KI+DFGLAR D +T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 611 AGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+M+PE D + +SDV+S GVL+ EI +
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 27/206 (13%)
Query: 454 IGKGGFGPV------YMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGL 507
+GKGGFG V GK+ +++ KRL K SG+ + E+ + K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFD-----RERSKLLPWKKRFSIITGIARGLLYLH 562
+ + L+ M L Y I++ E +++ + + I G+L+LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ------ITCGILHLH 112
Query: 563 QDSKLQVIHRDLKASNILLDINLNPKISDFGLA-RIFGGDDEEAQTERVAGTHGYMSPEY 621
+ +++RD+K N+LLD N ++SD GLA + G + T+R AGT+GYM+PE
Sbjct: 113 S---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR-AGTNGYMAPEI 165
Query: 622 ANDGTISMKSDVFSLGVLLVEIVSGK 647
+ S D F++G + E+V+G+
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 4e-16
Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 25/209 (11%)
Query: 453 MIGKGGFGPVYMG-KLSTGQEIAAKRL-----SKNSGQGLEEFMNEVVLIGKLQHRNLVG 506
++G+G FG VY+ + TG+E+AAK++ S + + + E+ L+ LQH +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 507 LLGSCIEEDERML--IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIIT-----GIARGLL 559
G + E+ L EYMP S+ + +L + +T I G+
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSV--------KDQLKAYGALTESVTRKYTRQILEGMS 120
Query: 560 YLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTER-VAGTHGYMS 618
YLH + ++HRD+K +NIL D N K+ DFG ++ R V GT +MS
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 619 PEYANDGTISMKSDVFSLGVLLVEIVSGK 647
PE + K+DV+SLG +VE+++ K
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 4e-16
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 31/219 (14%)
Query: 454 IGKGGFGPVYMGKLSTGQE-----------------IAAKRLSKNSGQGLE-EFMNEVVL 495
+G+G FG V++ + ++ +A K L +++ + +F+ E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 496 IGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFI--------FDRERSKLLPWKKR 547
+ +L+ N++ LL CI D +I EYM + L+ F+ ++ + +
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 548 FSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR-IFGGDDEEAQ 606
+ T IA G+ YL S L +HRDL N L+ N KI+DFG++R ++ GD Q
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
V +MS E G + SDV++ GV L EI++
Sbjct: 190 GRAVLPIR-WMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 4e-16
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 440 TITTATNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGK 498
TI + E N+I +G G Y GK + G + K ++ + E + +GK
Sbjct: 684 TINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGK 739
Query: 499 LQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGL 558
LQH N+V L+G C E LI+EY+ K+L E + L W++R I GIA+ L
Sbjct: 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLS------EVLRNLSWERRRKIAIGIAKAL 793
Query: 559 LYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMS 618
+LH V+ +L I++D P + L + D + + Y++
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVA 846
Query: 619 PEYANDGTISMKSDVFSLGVLLVEIVSGK 647
PE I+ KSD++ G++L+E+++GK
Sbjct: 847 PETRETKDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 5e-16
Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 31/214 (14%)
Query: 448 FSEANMIGKGGFGPV------YMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQH 501
F ++GKGGFG V GK+ +++ KR+ K G+ + +NE ++ K+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNS 59
Query: 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFI-------FDRERSKLLPWKKRFSIITGI 554
R +V L + +D L+ M L + I FD ER+ + I
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE--------I 111
Query: 555 ARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA-RIFGGDDEEAQTERVAGT 613
GL LH++ ++++RDLK NILLD + +ISD GLA I G+ RV GT
Sbjct: 112 TCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG---RV-GT 164
Query: 614 HGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
GYM+PE + + D + LG L+ E++ GK
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 57/183 (31%), Positives = 87/183 (47%), Gaps = 14/183 (7%)
Query: 473 IAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDY 531
+A K L + S E+F+ EV ++ +L N+ LLG C + +I EYM + L+
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 532 FI--------FDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI 583
F+ SK L + + T IA G+ YL L +HRDL N L+
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGK 165
Query: 584 NLNPKISDFGLAR-IFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVE 642
N KI+DFG++R ++ D Q +M+ E G + KSDV++ GV L E
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR-WMAWESVLLGKFTTKSDVWAFGVTLWE 224
Query: 643 IVS 645
I++
Sbjct: 225 ILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-16
Identities = 83/292 (28%), Positives = 127/292 (43%), Gaps = 43/292 (14%)
Query: 448 FSEANMIGKGGFGPVYMGKLSTGQEIAA-KRLS---KNSGQGLEEFMNEVVLIGKLQHRN 503
F + IG G FG VY S E+ A K++S K + + ++ + EV + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
+ G ++E L+ EY + D K L + +I G +GL YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY-- 621
+ IHRD+KA NILL K++DFG A + GT +M+PE
Sbjct: 140 HNM---IHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSFVGTPYWMAPEVIL 190
Query: 622 -ANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAW-LLWNDGRALGLMD 679
++G K DV+SLG+ +E+ K P N + + + ND L
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERK------PPLFNMNAMSALYHIAQNDSPT--LQS 242
Query: 680 TCLEDSFVESQVLRCIQVGLL--CVQKLPEDRPDMSSVVFLLANDGVTLPQP 729
DSF G + C+QK+P++RP + LL +D V +P
Sbjct: 243 NEWTDSF----------RGFVDYCLQKIPQERP---ASAELLRHDFVRRDRP 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 65/203 (32%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 454 IGKGGFGPVYMGKLS-----TGQEIAAKRLSKNSGQGLEE-FMNEVVLIGKLQHRNLVGL 507
+G+G FG V + TG+ +A K L + GQ + E+ ++ L H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 508 LGSCIEEDER--MLIYEYMPHKSL-DYFIFDR-ERSKLLPWKKRFSIITGIARGLLYLHQ 563
G C E+ + LI EY+P SL DY + ++LL + ++ I G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ------ICEGMAYLHS 125
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLAR-IFGGDDEEAQTERVAGTHGYMSPEYA 622
IHRDL A N+LLD + KI DFGLA+ + G + E + + E
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182
Query: 623 NDGTISMKSDVFSLGVLLVEIVS 645
+ S SDV+S GV L E+++
Sbjct: 183 KENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAKRL--SKNSGQGLEEFMNEVVLIGKLQHRNLVGLLG 509
++G+G +G V K TGQ +A K+ S++ + M E+ ++ +L+H NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 510 SCIEEDERMLIYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITGIARGLLYLHQD 564
+ L++E++ H LD D R + ++ I RG+ + H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQ--------ILRGIEFCHSH 119
Query: 565 SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY-AN 623
+ +IHRD+K NIL+ + K+ DFG AR E T+ VA T Y +PE
Sbjct: 120 N---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVA-TRWYRAPELLVG 174
Query: 624 DGTISMKSDVFSLGVLLVEIVSG 646
D D++++G L+ E+++G
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 7e-16
Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 8/197 (4%)
Query: 454 IGKGGFGPVYMGKLST-GQEIAAKRLSKNSGQGLEEFM--NEVVLIGKLQHRNLVGLLGS 510
+GKG +G V + + T G++ K+L+ + E E L+ +L+H N+V S
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 511 CIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVI 570
ED + I Y ++ KLLP + IA L YLH+ ++
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HIL 124
Query: 571 HRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMK 630
HRDLK N+ L K+ D G+AR+ + A T + GT YMSPE ++ + K
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYNYK 182
Query: 631 SDVFSLGVLLVEIVSGK 647
SDV++LG + E+ + K
Sbjct: 183 SDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 50/158 (31%), Positives = 79/158 (50%), Gaps = 16/158 (10%)
Query: 454 IGKGGFGPVYMGKL---STGQEIAAKRL--SKNSGQGLEE-FMNEVVLIGKLQHRNLVGL 507
IG+G +G VY K G+E A K+ K G+ + E+ L+ +L+H N+V L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 508 LGSCIEEDERM--LIYEYMPHKSLDYFIFDRE-RSKLLPWKKRFSIITGIARGLLYLHQD 564
+ +E ++ L+++Y H F R+ + +P S++ I G+ YLH +
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN 127
Query: 565 SKLQVIHRDLKASNILLDINLNP----KISDFGLARIF 598
V+HRDLK +NIL+ KI D GLAR+F
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 67/222 (30%), Positives = 102/222 (45%), Gaps = 32/222 (14%)
Query: 438 LATITTATNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKN-SGQGLEEFM-NEVV 494
T+ TN + + +G G FG V + TGQ +A K++ K S L + E+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 495 LIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS--IIT 552
L+ L+H N++ L I E + + L + R P +K+F +
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSR------PLEKQFIQYFLY 115
Query: 553 GIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAG 612
I RGL Y+H V+HRDLK SNIL++ N + KI DFGLARI ++ Q
Sbjct: 116 QILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVS 167
Query: 613 THGYMSPE-------YANDGTISMKSDVFSLGVLLVEIVSGK 647
T Y +PE Y ++ D++S G + E++ GK
Sbjct: 168 TRYYRAPEIMLTWQKY------DVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 25/221 (11%)
Query: 443 TATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLS-KNSGQGLE-EFMNEVVLIGKL 499
+ F IG+G +G VY + TG+ +A K++ N +G + E+ ++ +L
Sbjct: 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL 63
Query: 500 QHRNLVGLLGSCIEEDERM----------LIYEYMPHKSLDYFIFDRERSKLLPWKKRF- 548
HRN+V L ++ + + L++EYM H + S L+ + +
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL-----ESGLVHFSEDHI 118
Query: 549 -SIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQT 607
S + + GL Y H K +HRD+K SNILL+ K++DFGLAR++ ++ T
Sbjct: 119 KSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 608 ERVAGTHGYMSPE-YANDGTISMKSDVFSLGVLLVEIVSGK 647
+V T Y PE + DV+S G +L E+ + K
Sbjct: 176 NKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 57/197 (28%), Positives = 103/197 (52%), Gaps = 14/197 (7%)
Query: 454 IGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512
IG+G G V + + S+G+ +A K++ Q E NEVV++ QH N+V + S +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 513 EEDERMLIYEYMPHKSL-DYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIH 571
DE ++ E++ +L D R + + ++ + + L LH VIH
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQG---VIH 139
Query: 572 RDLKASNILLDINLNPKISDFGL-ARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMK 630
RD+K+ +ILL + K+SDFG A++ E + + + GT +M+PE + +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 631 SDVFSLGVLLVEIVSGK 647
D++SLG++++E+V G+
Sbjct: 197 VDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 31/214 (14%)
Query: 448 FSEANMIGKGGFGPV------YMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQH 501
F ++GKGGFG V GK+ +++ KR+ K G+ + +NE ++ K+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNS 59
Query: 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFI-------FDRERSKLLPWKKRFSIITGI 554
R +V L + +D L+ M L + I FD +R+ + +
Sbjct: 60 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE--------L 111
Query: 555 ARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTER-VAGT 613
GL L ++ ++++RDLK NILLD + +ISD GLA E +T R GT
Sbjct: 112 CCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAV----QIPEGETVRGRVGT 164
Query: 614 HGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
GYM+PE N+ + D + LG L+ E++ G+
Sbjct: 165 VGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 454 IGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLE-EFMNEVVLIGKLQHRNLVGLLGSC 511
IG+G FG V+ G+L + +A K + L+ +F+ E ++ + H N+V L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 512 IEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIH 571
++ ++ E + + D+ F R L K+ ++ A G+ YL +SK IH
Sbjct: 63 TQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL--ESK-HCIH 117
Query: 572 RDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTH----GYMSPEYANDGTI 627
RDL A N L+ KISDFG++R ++E+ G + +PE N G
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 628 SMKSDVFSLGVLLVEIVS 645
S +SDV+S G+LL E S
Sbjct: 174 SSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 61/197 (30%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 454 IGKGGFGPVYMGKLST-GQEIAAKRL--SKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGS 510
IG+G FG + K G++ K + SK S + EE EV ++ ++H N+V S
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 511 CIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVI 570
E ++ +Y L Y + +R L P + I L ++H D K ++
Sbjct: 68 FEENGNLYIVMDYCEGGDL-YKKINAQRGVLFPEDQILDWFVQICLALKHVH-DRK--IL 123
Query: 571 HRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMK 630
HRD+K+ NI L + K+ DFG+AR+ E A+T GT Y+SPE + + K
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEICENRPYNNK 181
Query: 631 SDVFSLGVLLVEIVSGK 647
SD+++LG +L E+ + K
Sbjct: 182 SDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 21/202 (10%)
Query: 454 IGKGGFGPVYMG--KLSTGQEIAAKRLSKNSGQGL---EEFMNEVVLIGKLQHRNLVGLL 508
+G G FG V G K+ ++ A ++ KN +E + E ++ +L + +V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQ 568
G C E + ML+ E L+ F+ +++K + K ++ ++ G+ YL + +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN--- 115
Query: 569 VIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG-----YMSPEYAN 623
+HRDL A N+LL KISDFGL++ G D+ + A THG + +PE N
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK----AKTHGKWPVKWYAPECMN 171
Query: 624 DGTISMKSDVFSLGVLLVEIVS 645
S KSDV+S GVL+ E S
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 454 IGKGGFGPVYMGKL-STGQEIAAKRLSKNS--GQGLEE-FMNEVVLIGKLQHRNLVGLLG 509
+G GGFG V + K+ S + A K + K G +E +E ++ + H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 510 SCIEEDERMLIYEYMPHKSLDYFIFD--RERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
+ ++ ++ EY L + R+R + RF I + YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGEL----WTILRDRGLFDEYTARF-YIACVVLAFEYLHN---R 112
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTI 627
+I+RDLK N+LLD N K+ DFG A+ +T GT Y++PE I
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS---GQKTWTFCGTPEYVAPE-----II 164
Query: 628 SMK-----SDVFSLGVLLVEIVSGK 647
K D +SLG+LL E+++G+
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 30/217 (13%)
Query: 454 IGKGGFGPVYMG--------KLSTGQEIAAKRL-SKNSGQGLEEFMNEV---VLIGKLQH 501
+G+G FG V M K + ++A K L S + + L + ++E+ +IGK H
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--H 83
Query: 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRER-------------SKLLPWKKRF 548
+N++ LLG+C ++ +I EY +L ++ R + L +K
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 549 SIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTE 608
S +ARG+ YL + + IHRDL A N+L+ + KI+DFGLAR D +T
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 609 RVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+M+PE D + +SDV+S GVLL EI +
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAK--RLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGS 510
IG+G +G VY + TG+ +A K RL + E+ L+ +L H N+V LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 511 CIEEDERMLIYEYMPH---KSLD---YFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD 564
E++ L++E++ K +D D K S + + +G+ Y H
Sbjct: 67 VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIK--------SYLYQLLQGIAYCHSH 118
Query: 565 SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND 624
+V+HRDLK N+L+D K++DFGLAR FG E V T Y +PE
Sbjct: 119 ---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 173
Query: 625 G-TISMKSDVFSLGVLLVEIVSGK 647
S D++S+G + E+V+ +
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 25/209 (11%)
Query: 453 MIGKGGFGPVYMG-KLSTGQEIAAKRL-----SKNSGQGLEEFMNEVVLIGKLQHRNLVG 506
++G+G FG VY+ TG+E+A K++ S+ + + + E+ L+ L+H +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 507 LLGSCIEEDERML--IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIIT-----GIARGLL 559
G + +E+ L EYMP S+ + +L + +T I +G+
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSI--------KDQLKAYGALTENVTRRYTRQILQGVS 120
Query: 560 YLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA-RIFGGDDEEAQTERVAGTHGYMS 618
YLH + ++HRD+K +NIL D N K+ DFG + RI + V GT +MS
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177
Query: 619 PEYANDGTISMKSDVFSLGVLLVEIVSGK 647
PE + K+DV+S+ +VE+++ K
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 448 FSEANMIGKGGFGPVYMGK-LSTGQEIAAK--RLSKNSGQGLEEFMNEVVLIGKLQHRNL 504
F + IG+G +G VY + TG+ +A K RL + + E+ L+ +L H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 505 VGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKL-LPWKKRFSIITGIARGLLYLHQ 563
V LL E++ L++E++ H+ L F+ S + LP K S + + +GL + H
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIK--SYLFQLLQGLAFCHS 118
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE-YA 622
+V+HRDLK N+L++ K++DFGLAR FG E V T Y +PE
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 173
Query: 623 NDGTISMKSDVFSLGVLLVEIVSGK 647
S D++SLG + E+V+ +
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 69/198 (34%), Positives = 96/198 (48%), Gaps = 13/198 (6%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEE---FMNE-VVLIGKLQHRNLVGLL 508
IGKG FG V + K + G+ A K L K + +E M E VL+ ++H LVGL
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQ 568
S D+ + +Y+ L +F RERS P + RF IA L YLH L
Sbjct: 63 YSFQTADKLYFVLDYVNGGEL-FFHLQRERSFPEP-RARF-YAAEIASALGYLHS---LN 116
Query: 569 VIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTIS 628
+I+RDLK NILLD + ++DFGL + G + T GT Y++PE
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174
Query: 629 MKSDVFSLGVLLVEIVSG 646
D + LG +L E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 60/203 (29%), Positives = 107/203 (52%), Gaps = 9/203 (4%)
Query: 448 FSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGL-EEFMNEVVLIGKLQHRNLV 505
F + +G+G + VY G+ +TG+ +A K + ++ +G + E+ L+ +L+H N+V
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 506 GLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
L E++ ML++EYM Y R L P + S + +G+ + H++
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVK-SFTYQLLKGIAFCHEN- 119
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE-YAND 624
+V+HRDLK N+L++ K++DFGLAR FG E V T Y +P+
Sbjct: 120 --RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGS 175
Query: 625 GTISMKSDVFSLGVLLVEIVSGK 647
T S D++S+G ++ E+++G+
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 5e-15
Identities = 60/188 (31%), Positives = 98/188 (52%), Gaps = 18/188 (9%)
Query: 473 IAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLIYEYMPHKSLD 530
+A K L N + + L + ++E+ L+ + +H+N++ LLG C +E +I EY +L
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106
Query: 531 YFI-----------FDRERS--KLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKAS 577
F+ FD + + L +K S +ARG+ YL +S+ + IHRDL A
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAAR 163
Query: 578 NILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLG 637
N+L+ + KI+DFGLAR D +T +M+PE D + +SDV+S G
Sbjct: 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 638 VLLVEIVS 645
+L+ EI +
Sbjct: 224 ILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 21/189 (11%)
Query: 443 TATNHFSEANMIGKGGFGPVYMG-KLSTGQEIAAKR-LSKNSGQGLE-EFMNEVVLIGKL 499
+ + +G+G FG VY ++ TG+ +A K+ L N G + E+ ++ KL
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL 64
Query: 500 QHRNLVGLLGSCIEE-----DERMLIYEYMPHKSLDYF-IFDRERSKLLPWKKRFSIITG 553
+H N+V L+ +E +R +Y P+ D + + KL S I
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTE-----SQIKC 119
Query: 554 IAR----GLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTER 609
G+ YLH++ ++HRD+KA+NIL+D KI+DFGLAR + G +
Sbjct: 120 YMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 610 VAGTHGYMS 618
GT Y +
Sbjct: 177 GGGTRKYTN 185
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 23/204 (11%)
Query: 453 MIGKGGFGPVYMG--KLSTGQE--IAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGL 507
++G G FG + G KL + +E +A L S + F+ E + +G+ H N+V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
G + M++ EYM + +LD F+ R+ L + ++ G+A G+ YL S++
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYL---SEM 126
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG------YMSPEY 621
+H+ L A +L++ +L KIS F +E ++E + T + +PE
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRL-------QEDKSEAIYTTMSGKSPVLWAAPEA 179
Query: 622 ANDGTISMKSDVFSLGVLLVEIVS 645
S SDV+S G+++ E++S
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 454 IGKGGFGPVYMGKLSTGQEIA---AKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVGLLG 509
IG G FG V +G+ G A K L ++ F+ EV +L H N++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 510 SCIEEDERMLIYEYMPHKSL-DYFIFDRERSKLLPWKK-RFSIITGIARGLLYLHQDSKL 567
CIE +L+ E+ P L +Y +R + K + +A GLL+LHQ
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---A 119
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND--- 624
IH DL N L +L+ KI D+GLA +D + A +++PE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 625 ----GTISMKSDVFSLGVLLVEI 643
+ KS+++SLGV + E+
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-15
Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 30/217 (13%)
Query: 454 IGKGGFGPVYMG--------KLSTGQEIAAKRLSKN-SGQGLEEFMNEV---VLIGKLQH 501
+G+G FG V M K + +A K L + + + L + ++E+ +IGK H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK--H 77
Query: 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFI-----------FDRER--SKLLPWKKRF 548
+N++ LLG+C ++ ++ EY +L ++ FD + + L +K
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 549 SIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTE 608
S +ARG+ YL + + IHRDL A N+L+ + KI+DFGLAR D +T
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 609 RVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+M+PE D + +SDV+S GVLL EI +
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 6e-15
Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 54/222 (24%)
Query: 454 IGKGGFGPVYMG-KLSTGQEIAAKRLSKNSGQGLEEFMN---------EVVLIGKL-QHR 502
+GKG +G V+ T + +A K++ + F N E++ + +L H
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMFLQELGDHP 67
Query: 503 NLVGLLGSCIEEDER--MLIYEYMP---HKSLDYFIFDRERSKLL-PWKKRFSIITGIAR 556
N+V LL E+++ L++EYM H + R+ +L KR+ I+ + +
Sbjct: 68 NIVKLLNVIKAENDKDIYLVFEYMETDLHAVI--------RANILEDVHKRY-IMYQLLK 118
Query: 557 GLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ----TERVAG 612
L Y+H VIHRDLK SNILL+ + K++DFGLAR +E + T+ VA
Sbjct: 119 ALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA- 174
Query: 613 THGYMSPEYANDGTISMKS-------DVFSLGVLLVEIVSGK 647
T Y +PE I + S D++S+G +L E++ GK
Sbjct: 175 TRWYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 8e-15
Identities = 64/227 (28%), Positives = 106/227 (46%), Gaps = 39/227 (17%)
Query: 454 IGKGGFGPVYMGKLSTGQE-----------------IAAKRLSKNSGQGLE-EFMNEVVL 495
+G+G FG V++ ++ Q+ +A K L ++ + +F+ EV +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 496 IGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRE-------------RSKLL 542
+ +L+ N++ LLG C++ED +I EYM + L+ F+ + L
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 543 P---WKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR-IF 598
P + + IA G+ YL S L +HRDL N L+ NL KI+DFG++R ++
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 599 GGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
GD Q V +M+ E G + SDV++ GV L EI+
Sbjct: 190 AGDYYRIQGRAVLPIR-WMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 8e-15
Identities = 47/146 (32%), Positives = 75/146 (51%), Gaps = 13/146 (8%)
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRF--SIITGIARGLLYL 561
+V G+ + E+ + E+M SLD R K P I + GL YL
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSLD-----RIYKKGGPIPVEILGKIAVAVVEGLTYL 119
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
+ + +++HRD+K SNIL++ K+ DFG++ G+ + + GT YMSPE
Sbjct: 120 Y--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPER 173
Query: 622 ANDGTISMKSDVFSLGVLLVEIVSGK 647
G ++KSDV+SLG+ ++E+ GK
Sbjct: 174 IQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEI----AAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVG 506
++G G FG V+ G + G I A K + SG Q +E + ++ +G L H +V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSK 566
LLG C L+ + P SL + R+ L ++ + IA+G+ YL +
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEH-- 128
Query: 567 LQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGT 626
+++HR+L A NILL + +I+DFG+A + DD++ +M+ E G
Sbjct: 129 -RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187
Query: 627 ISMKSDVFSLGVLLVEIVS 645
+ +SDV+S GV + E++S
Sbjct: 188 YTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 66/208 (31%), Positives = 100/208 (48%), Gaps = 29/208 (13%)
Query: 453 MIGKGGFGPVYMGKLSTGQEI-AAKRLSK---NSGQGLEEFMNEV-VLIGKLQHRNLVGL 507
++GKG FG V + +L E+ A K L K +E M E VL +H L L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 508 LGSCIEEDERM-LIYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITGIARGLLYL 561
SC + +R+ + EY+ L + I FD R++ + I GL +L
Sbjct: 62 H-SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAE--------IVLGLQFL 112
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR--IFGGDDEEAQTERVAGTHGYMSP 619
H+ +I+RDLK N+LLD + KI+DFG+ + I GG T GT Y++P
Sbjct: 113 HERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFCGTPDYIAP 165
Query: 620 EYANDGTISMKSDVFSLGVLLVEIVSGK 647
E + D ++LGVLL E+++G+
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 20/223 (8%)
Query: 437 DLATITTATNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVL 495
DL+ + F ++G G +G VY G+ + TGQ +AA ++ + EE E+ +
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQ-LAAIKVMDVTEDEEEEIKLEINM 65
Query: 496 IGKL-QHRNLVGLLGSCIE------EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRF 548
+ K HRN+ G+ I+ +D+ L+ E+ S+ + + L
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV-KNTKGNALKEDWIA 124
Query: 549 SIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTE 608
I I RGL +LH +VIHRD+K N+LL N K+ DFG++ D +
Sbjct: 125 YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRN 179
Query: 609 RVAGTHGYMSPEYAN-----DGTISMKSDVFSLGVLLVEIVSG 646
GT +M+PE D T +SD++SLG+ +E+ G
Sbjct: 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 21/200 (10%)
Query: 454 IGKGGFGPVYMG-KLSTGQEIAAKRLSKNSGQGLEEFMN----EVVLIGKLQHRNLVGLL 508
I KG FG VY+ K STG A K L K+ + N +++ + + + L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLP--WKKRFSIITGIARGLLYLHQDSK 566
S +D L+ EY+ I + LP W K++ I + G+ LHQ
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG- 117
Query: 567 LQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGT 626
+IHRD+K N+L+D + K++DFGL+R + ++ GT Y++PE
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFVGTPDYLAPETILGVG 169
Query: 627 ISMKSDVFSLGVLLVEIVSG 646
SD +SLG ++ E + G
Sbjct: 170 DDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 31/212 (14%)
Query: 453 MIGKGGFGPVYMG-KLSTGQEIAAKRL-----SKNSGQGLEEFMNEVVLIGKLQHRNLVG 506
++G+G FG VY+ TG+E+A K++ S + + + E+ L+ L H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 507 LLGSCIEEDERML--IYEYMPHKSLDYFIFDRERS-KLLPWKKRFSIITGIARGLLYLHQ 563
G + ER L E+MP S I D+ +S L I G+ YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQILEGVSYLHS 124
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQT--------ERVAGTHG 615
+ ++HRD+K +NIL D N K+ DFG ++ QT + V GT
Sbjct: 125 N---MIVHRDIKGANILRDSVGNVKLGDFGASK-------RLQTICLSGTGMKSVTGTPY 174
Query: 616 YMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
+MSPE + K+D++S+G +VE+++ K
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 42/99 (42%), Positives = 63/99 (63%), Gaps = 11/99 (11%)
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA-RIFGGDDEEAQTERVAG 612
I + L YL + K VIHRD+K SNILLD + N K+ DFG++ R+ D +A+T R AG
Sbjct: 123 IVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-RSAG 176
Query: 613 THGYMSPEYAN----DGTISMKSDVFSLGVLLVEIVSGK 647
YM+PE + + +++DV+SLG+ LVE+ +G+
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 453 MIGKGGFGPVYMG--KLSTGQEIA-AKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGL 507
IG+G FG VY G ++IA A + KN S E+F+ E ++ + H ++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
+G E+ ++ E P L ++ + L ++ L YL SK
Sbjct: 73 IGVI-TENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLE--SK- 126
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTI 627
+ +HRD+ A N+L+ K+ DFGL+R D+ + + +M+PE N
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL-EDESYYKASKGKLPIKWMAPESINFRRF 185
Query: 628 SMKSDVFSLGVLLVEIVS 645
+ SDV+ GV + EI+
Sbjct: 186 TSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 68/199 (34%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 453 MIGKGGFGPVYMGKLST-GQEIAAKRLSKNSGQGLEE---FMNEV-VLIGKLQHRNLVGL 507
+IGKG FG V + K + G A K L K + +E M E VL+ L+H LVGL
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
S ++ + +Y+ L +F RER L P + RF +A + YLH L
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGEL-FFHLQRERCFLEP-RARF-YAAEVASAIGYLHS---L 115
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTI 627
+I+RDLK NILLD + ++DFGL + G + E T GT Y++PE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 628 SMKSDVFSLGVLLVEIVSG 646
D + LG +L E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 454 IGKGGFGPVYMG--KLSTGQ-EIAAKRLSKNSGQGL-EEFMNEVVLIGKLQHRNLVGLLG 509
+G G FG V G K+ Q ++A K L + + + +E M E ++ +L + +V ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 510 SCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQV 569
C E + ML+ E L+ F+ ++ + ++ ++ G+ YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDE--ITVSNVVELMHQVSMGMKYLEGKN---F 116
Query: 570 IHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTH--GYMSPEYANDGTI 627
+HRDL A N+LL KISDFGL++ G DD R AG + +PE N
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECINFRKF 175
Query: 628 SMKSDVFSLGVLLVEIVS 645
S +SDV+S G+ + E S
Sbjct: 176 SSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 66/202 (32%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 453 MIGKGGFGPVY-MGKLSTGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRN---LV 505
+IG+GGFG VY K TG+ A K L K QG +NE +++ + + +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 506 GLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
+ + D+ I + M L Y + + + K+ T I GL ++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILGLEHMHNRF 117
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG 625
V++RDLK +NILLD + + +ISD GLA F A GTHGYM+PE G
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKG 170
Query: 626 TI-SMKSDVFSLGVLLVEIVSG 646
T +D FSLG +L +++ G
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 16/202 (7%)
Query: 454 IGKGGFGPVYMGKL-----STGQEIAAKRLS-KNSGQGLEEFMNEVVLIGKLQHRNLVGL 507
+G+G FG V + + +TG+++A K L ++ G + + E+ ++ L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 508 LGSCIEEDER--MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
G C E+ LI E++P SL ++ R ++K+ K++ I +G+ YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKI-NLKQQLKYAVQICKGMDYL---G 126
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE--EAQTERVAGTHGYMSPEYAN 623
Q +HRDL A N+L++ KI DFGL + D E + + + Y +PE
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLI 185
Query: 624 DGTISMKSDVFSLGVLLVEIVS 645
+ SDV+S GV L E+++
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 23/209 (11%)
Query: 446 NHFSEANMIGKGGFGPVYMG-KLSTGQEIAAKRLSKNSGQGLEE---FMNEVVLIGKLQH 501
F +G+GG+G V++ K TG+ +A KR+ K+ L E + E ++ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFD----RERSKLLPWKKRFSIITGIARG 557
LV LL + +++ L EY+P + + E RF +
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHA------RFYMAEMFE-A 113
Query: 558 LLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYM 617
+ LH+ L IHRDLK N L+D + + K++DFGL++ G A + V G+ YM
Sbjct: 114 VDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANS--VVGSPDYM 165
Query: 618 SPEYANDGTISMKSDVFSLGVLLVEIVSG 646
+PE D +SLG +L E + G
Sbjct: 166 APEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 57/197 (28%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLS-KNSGQGLEEF-MNEVVLIGKLQHRNLVGLLGS 510
IG+G +G V+ K T + +A KR+ + +G+ + E+ L+ +L+H+N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 511 CIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVI 570
+ + L++EY YF D + P + S + + +GL + H V+
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYF--DSCNGDIDPEIVK-SFMFQLLKGLAFCHSH---NVL 121
Query: 571 HRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMK 630
HRDLK N+L++ N K++DFGLAR FG E V T Y P+ +
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYST 179
Query: 631 S-DVFSLGVLLVEIVSG 646
S D++S G + E+ +
Sbjct: 180 SIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 448 FSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVG 506
F IG G +G VY + ++TG+ A K + G+ E++++ +H N+V
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 507 LLGSCIEEDERMLIYEYMPHKSLD--YFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD 564
GS + D+ + E+ SL Y + + + R ++ +GL YLH
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSK 125
Query: 565 SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA-- 622
K +HRD+K +NILL N + K++DFG++ A+ + GT +M+PE A
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAV 180
Query: 623 -NDGTISMKSDVFSLGVLLVEI 643
G + D++++G+ +E+
Sbjct: 181 ERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 34/207 (16%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN--EVVLIGKLQ-HRNLVGLLG 509
IG+G F V + TG+ A K + K + LE+ N E+ + +L H N++ L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 510 ----------SCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLL 559
+ + E M +YE + + R + LP K+ S + + + L
Sbjct: 66 VLFDRKTGRLALVFELMDMNLYELI-----------KGRKRPLPEKRVKSYMYQLLKSLD 114
Query: 560 YLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSP 619
++H++ + HRD+K NIL+ ++ K++DFG R G + TE ++ T Y +P
Sbjct: 115 HMHRNG---IFHRDIKPENILIKDDI-LKLADFGSCR--GIYSKPPYTEYIS-TRWYRAP 167
Query: 620 E-YANDGTISMKSDVFSLGVLLVEIVS 645
E DG K D++++G + EI+S
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 454 IGKGGFGPVYMG------KLSTGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVG 506
+G+G FG VY G K +A K +++ S + EF+NE ++ + ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIF----DRERSKLL---PWKKRFSIITGIARGLL 559
LLG + ++I E M L ++ + E + + KK + IA G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 560 YLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTH----G 615
YL+ + + +HRDL A N ++ + KI DFG+ R D E R G
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 186
Query: 616 YMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+MSPE DG + SDV+S GV+L EI +
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 5e-14
Identities = 69/228 (30%), Positives = 100/228 (43%), Gaps = 50/228 (21%)
Query: 444 ATNHFSE---ANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLE-EFMNEVVLIGK 498
A SE N IG G G VY TG+ A K + N + + E+ ++
Sbjct: 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRD 128
Query: 499 LQHRNLVGLLGSCIEEDERMLIYEYMPHKSLD-------YFIFDRERSKLLPWKKRFSII 551
+ H N+V E ++ E+M SL+ F+ D R I+
Sbjct: 129 VNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ----------IL 178
Query: 552 TGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQT---- 607
+GIA YLH + ++HRD+K SN+L++ N KI+DFG++RI AQT
Sbjct: 179 SGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL------AQTMDPC 225
Query: 608 ERVAGTHGYMSPEYAN--------DGTISMKSDVFSLGVLLVEIVSGK 647
GT YMSPE N DG D++SLGV ++E G+
Sbjct: 226 NSSVGTIAYMSPERINTDLNHGAYDG---YAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 47/144 (32%), Positives = 78/144 (54%), Gaps = 9/144 (6%)
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
+VG G+ + E + E+M SLD + + +K +P + + + RGL YL +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLAYLRE 121
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAN 623
K Q++HRD+K SNIL++ K+ DFG++ G ++ GT YMSPE
Sbjct: 122 --KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 175
Query: 624 DGTISMKSDVFSLGVLLVEIVSGK 647
S++SD++S+G+ LVE+ G+
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 16/203 (7%)
Query: 454 IGKGGFGPVYMGKLSTG---QEIAAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVGLLG 509
IG G FG V +G++++G ++ K L ++ Q +F+ E LQH NL+ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 510 SCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRF--SIITGIARGLLYLHQDSKL 567
C E +L+ E+ P L ++ +++L+ + IA GLL+LH+++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND--G 625
IH DL N LL +L KI D+GL+ +D +++ +++PE ++ G
Sbjct: 121 -FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 626 TI-----SMKSDVFSLGVLLVEI 643
+ + +S+V+SLGV + E+
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 6e-14
Identities = 64/209 (30%), Positives = 97/209 (46%), Gaps = 39/209 (18%)
Query: 454 IGKGGFGPVYMGKL-STGQEIAAKRLSKN----SGQGLEEFMNEVVLIGKLQHRNLVGLL 508
+G G FG V + + +G+ A K LSK Q +E +NE ++ ++H LV L
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNLY 67
Query: 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITG------IARGLLYLH 562
GS ++ L+ EY+P L F R RF + L YLH
Sbjct: 68 GSFQDDSNLYLVMEYVPGGEL----FSHLRKS-----GRFPEPVARFYAAQVVLALEYLH 118
Query: 563 QDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA 622
L +++RDLK N+LLD + KI+DFG A+ G T + GT Y++PE
Sbjct: 119 S---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPE-- 168
Query: 623 NDGTISMK-----SDVFSLGVLLVEIVSG 646
I K D ++LG+L+ E+++G
Sbjct: 169 ---IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 14/198 (7%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRL--SKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGS 510
IG+G +G V+ + TGQ +A K+ S++ + + E+ ++ +L+H NLV L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI-E 67
Query: 511 CIEEDERM-LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQV 569
++ L++EY H L+ ++ + +P II + + + H K
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNEL--EK-NPRGVPEHLIKKIIWQTLQAVNFCH---KHNC 121
Query: 570 IHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY-ANDGTIS 628
IHRD+K NIL+ K+ DFG ARI G ++ T+ VA T Y +PE D
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-YTDYVA-TRWYRAPELLVGDTQYG 179
Query: 629 MKSDVFSLGVLLVEIVSG 646
DV+++G + E+++G
Sbjct: 180 PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 46/144 (31%), Positives = 77/144 (53%), Gaps = 9/144 (6%)
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
+VG G+ + E + E+M SLD + +++ +P I + RGL YL +
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIAVLRGLTYLRE 117
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAN 623
K +++HRD+K SNIL++ K+ DFG++ G ++ GT YMSPE
Sbjct: 118 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 171
Query: 624 DGTISMKSDVFSLGVLLVEIVSGK 647
+++SD++SLG+ LVE+ G+
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 74/296 (25%), Positives = 129/296 (43%), Gaps = 64/296 (21%)
Query: 452 NMIGKGGFGPVYMG-KLSTGQEIAAKRLSKNSGQGLE-EFMNEVVLIGKLQHRNLVGLLG 509
++G G G VY L T + +A K + + L+ + M+E+ ++ K ++G G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 510 SCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQV 569
+ E+ + E+M SLD + + +P I + +GL YL L++
Sbjct: 67 AFFVENRISICTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS---LKI 116
Query: 570 IHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISM 629
+HRD+K SN+L++ K+ DFG++ + A+T GT+ YM+PE + +
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKT--YVGTNAYMAPERISGEQYGI 172
Query: 630 KSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVES 689
SDV+SLG+ +E+ G+ F +P + N + S +
Sbjct: 173 HSDVWSLGISFMELALGR----FPYPQIQKN----------------------QGSLMPL 206
Query: 690 QVLRCI--------QVGLL----------CVQKLPEDRPD----MSSVVFLLANDG 723
Q+L+CI VG C++K P++RP M + NDG
Sbjct: 207 QLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDG 262
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQ-GLE-EFMNEVVLIGKLQ---HRNLVGL 507
IG G +G VY + +G +A K + + + GL + EV L+ +L+ H N+V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 508 LGSCI-----EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLH 562
+ C E + L++E++ Y D+ LP + ++ RGL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYL--DKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 563 QDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA 622
+ ++HRDLK NIL+ K++DFGLARI+ + V T Y +PE
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALTPVVVTLWYRAPEVL 179
Query: 623 NDGTISMKSDVFSLGVLLVEIVSGK 647
T + D++S+G + E+ K
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 454 IGKGGFGPVYM----GKLSTGQEIAAKRLSK----NSGQGLEEFMNEVVLIGKLQHRNLV 505
+G G +G V++ G G+ A K L K + E E ++ ++ +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 506 GLLGSCIEEDERM-LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD 564
L + D ++ LI +Y+ L ++ RE + R I I L +LHQ
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES--EVRV-YIAEIVLALDHLHQ- 123
Query: 565 SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND 624
L +I+RD+K NILLD + ++DFGL++ F ++EE + GT YM+PE
Sbjct: 124 --LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRG 180
Query: 625 GTISMKS--DVFSLGVLLVEIVSG 646
G+ D +SLGVL E+++G
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 24/205 (11%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAK--RLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGS 510
IG+G +G VY + T + IA K RL + + E+ L+ ++QH N+V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 511 CIEEDERMLIYEYMP---HKSLDY---FIFDRERSKLLPWKKRFSIITGIARGLLYLHQD 564
E L++EY+ K +D F + K ++ I RG+ Y H
Sbjct: 70 VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ--------ILRGIAYCHSH 121
Query: 565 SKLQVIHRDLKASNILLDINLNP-KISDFGLARIFGGDDEEAQTERVAGTHGYMSPE-YA 622
+V+HRDLK N+L+D N K++DFGLAR FG E V T Y +PE
Sbjct: 122 ---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEILL 176
Query: 623 NDGTISMKSDVFSLGVLLVEIVSGK 647
S D++S+G + E+V+ K
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 454 IGKGGFGPVYMG-KLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512
+G G +G VY L TG+ A K + G E+ ++ + +H N+V GS +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 513 EEDERMLIYEYMPHKSL-DYFIFDRERSKL-LPWKKRFSIITGIARGLLYLHQDSKLQVI 570
++ + EY SL D + S+L + + R ++ +GL YLH K+
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGKM--- 128
Query: 571 HRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA---NDGTI 627
HRD+K +NILL N + K++DFG+A A+ + GT +M+PE A +G
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITA--TIAKRKSFIGTPYWMAPEVAAVEKNGGY 186
Query: 628 SMKSDVFSLGVLLVEI 643
+ D++++G+ +E+
Sbjct: 187 NQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 20/203 (9%)
Query: 453 MIGKGGFGPVYMGKLSTGQE-----IAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVG 506
++G G FG VY G E +A K L +N S + +E ++E ++ + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 507 LLGSCIEEDERMLIYEYMPHKSL-DYFIFDRER---SKLLPWKKRFSIITGIARGLLYLH 562
LLG C+ + L+ + MP+ L DY +++R LL W IA+G+ YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLE 126
Query: 563 QDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA 622
+ ++++HRDL A N+L+ + KI+DFGLAR+ D+ E + +M+ E
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 623 NDGTISMKSDVFSLGVLLVEIVS 645
+ +SDV+S GV + E+++
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 66/202 (32%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 453 MIGKGGFGPVY-MGKLSTGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRN---LV 505
+IG+GGFG VY K TG+ A K L K QG +NE +++ + + +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 506 GLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
+ + D+ I + M L Y + + + RF I GL ++H
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEAEMRF-YAAEIILGLEHMHNRF 117
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG 625
V++RDLK +NILLD + + +ISD GLA F A GTHGYM+PE G
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKG 170
Query: 626 TISMKS-DVFSLGVLLVEIVSG 646
S D FSLG +L +++ G
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 56/183 (30%), Positives = 92/183 (50%), Gaps = 25/183 (13%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKR-LSKNSGQGLE-EFMNEVVLIGKLQHRNLVGLLGS 510
IG+G FG V+ + T Q +A K+ L +N +G + E+ ++ L+H N+V L+
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 511 CIEEDERMLIYEYMPHKSLDYFIFD---RERSKLLPWKK-RFS------IITGIARGLLY 560
C R Y +K Y +F+ + + LL K +F+ ++ + GL Y
Sbjct: 80 C-----RTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134
Query: 561 LHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG---GDDEEAQTERVAGTHGYM 617
+H++ +++HRD+KA+NIL+ + K++DFGLAR F T RV T Y
Sbjct: 135 IHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWYR 190
Query: 618 SPE 620
PE
Sbjct: 191 PPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 68/269 (25%), Positives = 119/269 (44%), Gaps = 33/269 (12%)
Query: 454 IGKGGFGPVYMGKLS-TGQEIAAK--RLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGS 510
+GKG +G VY TG +A K RL + + + + E+ ++ K +V G+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFYGA 67
Query: 511 CIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVI 570
E + EYM SLD ++ +P I + +GL +L ++ +I
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNII 125
Query: 571 HRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY------AND 624
HRD+K +N+L++ N K+ DFG++ G+ + + G YM+PE +
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKSGGPNQN 181
Query: 625 GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684
T +++SDV+SLG+ ++E+ G+ + +P + I DG L +D
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGR----YPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237
Query: 685 S--FVESQVLRCIQVGLLCVQKLPEDRPD 711
+ FV C+ K+P RP
Sbjct: 238 AQDFVAK-----------CLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 66/227 (29%)
Query: 454 IGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMN---------EVVLIGKLQHRN 503
IG+G +G V K S T +++A K+++ F N E+ L+ L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIAN-------AFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 504 LVGLLGSCIEEDERM------LIYEYMP---HKSL-----------DYFIFDRERSKLLP 543
++ + + R ++YE M H+ + YF++ +LL
Sbjct: 66 VIAI-KDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLY-----QLL- 118
Query: 544 WKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603
RGL Y+H + V+HRDLK SN+LL+ N + KI DFGLAR +
Sbjct: 119 ------------RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKG 162
Query: 604 EAQTERVAGTHGYMSPEY---ANDGTISMKSDVFSLGVLLVEIVSGK 647
+ TE V T Y +PE ++ T ++ DV+S+G + E++ K
Sbjct: 163 DFMTEYVV-TRWYRAPELLLNCSEYTTAI--DVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 6e-13
Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 30/210 (14%)
Query: 452 NMIGKGGFGPVYMGK-LSTGQEIAAKRL---SKNSG---QGLEEFMNEVVLIGKLQHRNL 504
N I +G +G VY + TG+ +A K+L + G L E +L+ KLQH N+
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREIN---ILL-KLQHPNI 66
Query: 505 VGL----LGSCIEEDERMLIYEYMPH--KSLDYFIFDRERSKLLPWKKRFSIITGIARGL 558
V + +GS + D+ ++ EY+ H KSL + + L + ++ + G+
Sbjct: 67 VTVKEVVVGSNL--DKIYMVMEYVEHDLKSL----METMKQPFLQ-SEVKCLMLQLLSGV 119
Query: 559 LYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMS 618
+LH + ++HRDLK SN+LL+ KI DFGLAR + G + T+ V T Y +
Sbjct: 120 AHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVV-TLWYRA 174
Query: 619 PEYANDGTI-SMKSDVFSLGVLLVEIVSGK 647
PE S D++S+G + E+++ K
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 65/199 (32%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 453 MIGKGGFGPVYMGKLSTGQEI-AAKRLSKNSGQGLEE---FMNEV-VLIGKLQHRNLVGL 507
+IGKG FG V + + ++ A K L K + +E M+E VL+ ++H LVGL
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
S D+ + +Y+ L Y + RER L P + RF IA L YLH L
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHL-QRERCFLEP-RARF-YAAEIASALGYLHS---L 115
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTI 627
+++RDLK NILLD + ++DFGL + + T GT Y++PE +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 628 SMKSDVFSLGVLLVEIVSG 646
D + LG +L E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 453 MIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEV-VLIGKLQHRNLVGL 507
M+GKG FG V++ +L T Q A K L K+ +E M E VL +H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITGIARGLLYLH 562
+ ++ + EY+ L + I FD R+ + I GL +LH
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAE--------IICGLQFLH 113
Query: 563 QDSKLQVIHRDLKASNILLDINLNPKISDFGLAR--IFGGDDEEAQTERVAGTHGYMSPE 620
+++RDLK NILLD + + KI+DFG+ + + G +A+T GT Y++PE
Sbjct: 114 SKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPE 166
Query: 621 YANDGTISMKSDVFSLGVLLVEIVSGK 647
+ D +S GVLL E++ G+
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 9e-13
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 454 IGKGGFGPVYMG------KLSTGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVG 506
+G+G FG VY G K +A K ++++ S + EF+NE ++ ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIF----DRERSKLLP---WKKRFSIITGIARGLL 559
LLG + +++ E M H L ++ + E + P ++ + IA G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 560 YLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTH----G 615
YL+ + +HRDL A N ++ + KI DFG+ R D E R G
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 186
Query: 616 YMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+M+PE DG + SD++S GV+L EI S
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 63/200 (31%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEF---MNEVVLIGKLQHRNLVGLL 508
++GKG FG V + K +TG+ A K L K +E + E ++ +H L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQ 568
S D + EY L +F RER + RF I L YLH S+
Sbjct: 62 YSFQTHDRLCFVMEYANGGEL-FFHLSRERV-FSEDRARF-YGAEIVSALDYLH--SEKN 116
Query: 569 VIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTIS 628
V++RDLK N++LD + + KI+DFGL + G + A + GT Y++PE D
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYG 174
Query: 629 MKSDVFSLGVLLVEIVSGKM 648
D + LGV++ E++ G++
Sbjct: 175 RAVDWWGLGVVMYEMMCGRL 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 448 FSEANMIGKGGFGPVYMGKLSTGQEIAA-KRLS-KNSGQGLE-EFMNEVVLIGKLQHRNL 504
F + N IG+G +G VY + +T EI A K++ N G+ + E+ L+ L+H N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 505 VGLL----GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLY 560
V L G + D L+ EY L + + K ++ + RGL Y
Sbjct: 69 VELKEVVVGKHL--DSIFLVMEYCEQ-DLASLLDNMPTPFSESQVK--CLMLQLLRGLQY 123
Query: 561 LHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE 620
LH++ +IHRDLK SN+LL KI+DFGLAR + G + T +V T Y +PE
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLWYRAPE 178
Query: 621 YANDGTISMKS-DVFSLGVLLVEIVSGK 647
T + D++++G +L E+++ K
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 44/144 (30%), Positives = 78/144 (54%), Gaps = 9/144 (6%)
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
+VG G+ + E + E+M SLD + +++ +P + + + +GL YL +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAN 623
K +++HRD+K SNIL++ K+ DFG++ G ++ GT YMSPE
Sbjct: 122 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 175
Query: 624 DGTISMKSDVFSLGVLLVEIVSGK 647
S++SD++S+G+ LVE+ G+
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 453 MIGKGGFGPVYMGKLSTGQEI-AAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLL 508
++GKG FG V + +L E+ A K L K+ ++ M E ++ + L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 509 GSCIEEDERML-IYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITGIARGLLYLH 562
C + +R+ + EY+ L + I FD RS+ + + L++LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAE--------VTLALMFLH 113
Query: 563 QDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA 622
+ VI+RDLK NILLD + K++DFG+ + G T GT Y++PE
Sbjct: 114 RHG---VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEIL 168
Query: 623 NDGTISMKSDVFSLGVLLVEIVSGK 647
+ D ++LGVL+ E+++G+
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 63/199 (31%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 453 MIGKGGFGPVYMGKLS-TGQEIAAKRLSK----NSGQGLEEFMNEVVLIGKLQHRNLVGL 507
+IGKG FG V + K G+ A K L K N + VL+ ++H LVGL
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
S ++ + +++ L +F RERS P + RF IA L YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGEL-FFHLQRERSFPEP-RARF-YAAEIASALGYLHS---I 115
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTI 627
+++RDLK NILLD + ++DFGL + G + T GT Y++PE
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 628 SMKSDVFSLGVLLVEIVSG 646
D + LG +L E++ G
Sbjct: 174 DNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 5e-12
Identities = 65/233 (27%), Positives = 107/233 (45%), Gaps = 65/233 (27%)
Query: 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMN---------EVVL 495
+ + + +G G +G V + TG+++A K+LS F + E+ L
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRL 67
Query: 496 IGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYF--------IFDRERSKLLPWKK- 546
+ + H N++GLL + P SL+ F + + + ++ +K
Sbjct: 68 LKHMDHENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKL 115
Query: 547 -----RFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601
+F ++ I RGL Y+H +IHRDLK SNI ++ + KI DFGLAR D
Sbjct: 116 SDDHIQF-LVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARH--TD 169
Query: 602 DEEAQTERVAGTHGYMSPE-------YANDGTISMKSDVFSLGVLLVEIVSGK 647
DE T VA T Y +PE Y T+ D++S+G ++ E+++GK
Sbjct: 170 DE--MTGYVA-TRWYRAPEIMLNWMHYNQ--TV----DIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-12
Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 24/194 (12%)
Query: 469 TGQEIAAKRLSKNSGQGLEE---FMNEVVLIGKLQHRNLVGLLGSCIEEDERML-IYEYM 524
TG E+A K L ++ + + F E L +L H N+V LL S + ++EY+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 525 PHKSLDYFIFDRER---SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL 581
P ++L RE LP + ++ + L H ++HRDLK NI++
Sbjct: 62 PGRTL------REVLAADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMV 112
Query: 582 ---DINLNPKISDFGLARIFGG--DDEEAQTER---VAGTHGYMSPEYANDGTISMKSDV 633
+ + K+ DFG+ + G D + A R V GT Y +PE ++ SD+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 634 FSLGVLLVEIVSGK 647
++ G++ +E ++G+
Sbjct: 173 YAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 448 FSEANMIGKGGFGPVYMGKLSTGQEI-AAKRLSKN---SGQGLEEFMNEVVLIGKLQHRN 503
F+ ++GKG FG V + + E+ A K L K+ +E M E ++
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 504 LVGLLGSCIEEDERM-LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITG--IARGLLY 560
+ L SC + +R+ + EY+ L Y I ++ +K+ ++ IA GL +
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPHAVFYAAEIAIGLFF 116
Query: 561 LHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR--IFGGDDEEAQTERVAGTHGYMS 618
LH +I+RDLK N++LD + KI+DFG+ + IFGG T GT Y++
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFCGTPDYIA 169
Query: 619 PEYANDGTISMKSDVFSLGVLLVEIVSGK 647
PE D ++ GVLL E+++G+
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 454 IGKGGFGPVYMGK--LSTGQEIAAKRLS-KNSGQGLE-EFMNEVVLIGKLQ---HRNLVG 506
IG+G +G V+ + + G+ +A KR+ + +G+ + EV ++ L+ H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 507 LLGSCI-----EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
L C E + L++E++ Y D+ +P + ++ + RGL +L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
H +V+HRDLK NIL+ + K++DFGLARI+ + V T Y +PE
Sbjct: 127 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEV 180
Query: 622 ANDGTISMKSDVFSLGVLLVEI 643
+ + D++S+G + E+
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 27/207 (13%)
Query: 453 MIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEV-VLIGKLQHRNLVGL 507
++GKG FG V + +L T + A K L K+ +E M E VL +H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITGIARGLLYLH 562
+ ++ + EY+ L + I FD R++ + I GL +LH
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAE--------IICGLQFLH 113
Query: 563 QDSKLQVIHRDLKASNILLDINLNPKISDFGLAR--IFGGDDEEAQTERVAGTHGYMSPE 620
+ +I+RDLK N+LLD + + KI+DFG+ + + G E + GT Y++PE
Sbjct: 114 KKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFCGTPDYIAPE 166
Query: 621 YANDGTISMKSDVFSLGVLLVEIVSGK 647
+ D +S GVLL E++ G+
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 5/95 (5%)
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGT 613
+A L +LH L +I+RDLK NILLD + K++DFGL++ D E + GT
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGT 161
Query: 614 HGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKM 648
YM+PE N + +D +S GVL+ E+++G +
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSL 196
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 453 MIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLL 508
++GKG FG V + +L +G+ A K L K+ +E M E ++ ++ + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 509 GSCIEEDERML-IYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITGIARGLLYLH 562
C + +R+ + E++ L + I FD R++ + I L++LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE--------ITSALMFLH 113
Query: 563 QDSKLQVIHRDLKASNILLDINLNPKISDFGLAR--IFGGDDEEAQTERVAGTHGYMSPE 620
+I+RDLK N+LLD + K++DFG+ + IF G T GT Y++PE
Sbjct: 114 DKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFCGTPDYIAPE 166
Query: 621 YANDGTISMKSDVFSLGVLLVEIVSG 646
+ D +++GVLL E++ G
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 20/212 (9%)
Query: 447 HFSEANMIGKGGFGPVYM-GKLS---TGQEIAAKRLSKNS----GQGLEEFMNEVVLIGK 498
+F ++G G +G V++ K+S +G+ A K L K + + E E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 499 LQHRNLVGLLGSCIEEDERM-LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITG-IAR 556
++ + L + D ++ LI +Y+ L + RER K ++ I +G I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQEVQIYSGEIVL 116
Query: 557 GLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGY 616
L +LH KL +I+RD+K NILLD N + ++DFGL++ F D+ E + GT Y
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEY 172
Query: 617 MSPEY--ANDGTISMKSDVFSLGVLLVEIVSG 646
M+P+ DG D +S+GVL+ E+++G
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 19/203 (9%)
Query: 453 MIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEV-----VLIGKLQHRNLVGL 507
+IG+G + V + +L + I A ++ K +E ++ V V H LVGL
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 508 LGSCIEEDERML-IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSK 566
SC + + R+ + EY+ L +F +R + LP + I+ L YLH+
Sbjct: 62 -HSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG- 116
Query: 567 LQVIHRDLKASNILLDINLNPKISDFGLAR--IFGGDDEEAQTERVAGTHGYMSPEYAND 624
+I+RDLK N+LLD + K++D+G+ + + GD T GT Y++PE
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSTFCGTPNYIAPEILRG 170
Query: 625 GTISMKSDVFSLGVLLVEIVSGK 647
D ++LGVL+ E+++G+
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 21/160 (13%)
Query: 492 EVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSII 551
E +L+ + H +++ + + + ++ +PH S D + + +RS+ LP + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 552 TGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI------FGGDDEEA 605
I GL YLH ++IHRD+K NI ++ I D G A+ F G
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG----- 215
Query: 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+AGT +PE + K+D++S G++L E+++
Sbjct: 216 ----LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEF----MNEVVLIGKLQH 501
N F ++G+G +G V + +EI A + K+S + EE + E+ ++ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS-EENEEVKETTLRELKMLRTLKQ 59
Query: 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
N+V L + + L++EY+ L+ + + + + P K R S I + + + +
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVR-SYIYQLIKAIHWC 116
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
H++ ++HRD+K N+L+ N K+ DFG AR TE VA T Y SPE
Sbjct: 117 HKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA-TRWYRSPEL 172
Query: 622 ANDGTISMKSDVFSLGVLLVEIVSGK 647
D++S+G +L E+ G+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-11
Identities = 67/225 (29%), Positives = 105/225 (46%), Gaps = 39/225 (17%)
Query: 453 MIGKGGFGPVYMG-KLSTGQEIAAKRLSKN-SGQGL--EEFMNEVVLIGKLQHRNLVGLL 508
+IGKGG G VY+ + +A K++ ++ S L + F+ E + L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 509 GSCIEEDERMLIYEYMPH------KSLDYFIFDRER-SKLLPWKKR----FSIITGIARG 557
C + D +Y MP+ KSL ++ +E SK L K SI I
Sbjct: 69 SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 558 LLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTE--------- 608
+ Y+H SK V+HRDLK NILL + I D+G A IF +EE +
Sbjct: 126 IEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAA-IFKKLEEEDLLDIDVDERNIC 181
Query: 609 --------RVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
++ GT YM+PE S +D+++LGV+L ++++
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 450 EANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLE-EFMNEVVLIGKLQHRNLVGLL 508
E +G+G +G VY K G++ L + G G+ E+ L+ +L+H N++ L
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQ 64
Query: 509 GSCIEEDERM--LIYEYMPHKSLDYFIFDR-----ERSKLLPWKKRFSIITGIARGLLYL 561
+ +R L+++Y H F R ++ LP S++ I G+ YL
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 562 HQDSKLQVIHRDLKASNILLDINLNP-----KISDFGLARIFGGDDEE-AQTERVAGTHG 615
H + V+HRDLK +NIL+ + P KI+D G AR+F + A + V T
Sbjct: 125 HAN---WVLHRDLKPANILV-MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 616 YMSPEYANDGTISMKS-DVFSLGVLLVEIVSGK 647
Y +PE K+ D++++G + E+++ +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEF---MNEVVLIGKLQHRNLVGLL 508
++GKG FG V + + ++G+ A K L K +E + E ++ +H L L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQ 568
S +D + EY+ L +F RER + RF I L YLH +
Sbjct: 62 YSFQTKDRLCFVMEYVNGGEL-FFHLSRERV-FSEDRTRF-YGAEIVSALDYLHSG---K 115
Query: 569 VIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTIS 628
+++RDLK N++LD + + KI+DFGL + G + A + GT Y++PE D
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 629 MKSDVFSLGVLLVEIVSGKM 648
D + LGV++ E++ G++
Sbjct: 174 RAVDWWGLGVVMYEMMCGRL 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 19/203 (9%)
Query: 453 MIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEV-----VLIGKLQHRNLVGL 507
+IG+G + V + +L + I A ++ K +E ++ V V H LVGL
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 508 LGSCIEEDERM-LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSK 566
SC + + R+ + E++ L +F +R + LP + I+ L +LH+
Sbjct: 62 -HSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNFLHERG- 116
Query: 567 LQVIHRDLKASNILLDINLNPKISDFGLAR--IFGGDDEEAQTERVAGTHGYMSPEYAND 624
+I+RDLK N+LLD + K++D+G+ + I GD T GT Y++PE
Sbjct: 117 --IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFCGTPNYIAPEILRG 170
Query: 625 GTISMKSDVFSLGVLLVEIVSGK 647
D ++LGVL+ E+++G+
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 71/261 (27%), Positives = 106/261 (40%), Gaps = 71/261 (27%)
Query: 453 MIGKGGFGPVY------MGKLSTGQEIAAKRLSKNSGQGLEE-FMNEV-VLIGKLQHRNL 504
++G G FG V + K S+ +A K L + + + M+E+ +LI H N+
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73
Query: 505 VGLLGSCIEED-ERMLIYEYMPHKSL--------DYFIFDRERSKLLPWK---------- 545
V LLG+C + + M+I E+ + +L ++F RE+S +
Sbjct: 74 VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133
Query: 546 -------------KRFSIITG----------------------------IARGLLYLHQD 564
RF T +ARG+ +L
Sbjct: 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL--- 190
Query: 565 SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND 624
+ + IHRDL A NILL N KI DFGLAR D + + +M+PE D
Sbjct: 191 ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD 250
Query: 625 GTISMKSDVFSLGVLLVEIVS 645
+ +SDV+S GVLL EI S
Sbjct: 251 KVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 454 IGKGGFGPVY-MGKLSTGQEIAAKRLSKNSGQGLEEFMNEV----VLIGKLQHRN--LVG 506
IGKG FG VY + K T + A K LSK +E + + +L+ L + +VG
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITGIARGLLYL 561
L S + + L+ +YM L + + F +R+K IA +L L
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFY-----------IAELVLAL 109
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE- 620
K +++RDLK NILLD + + DFGL++ D+ T GT Y++PE
Sbjct: 110 EHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNTFCGTTEYLAPEV 167
Query: 621 YANDGTISMKSDVFSLGVLLVEIVSG 646
++ + D +SLGVL+ E+ G
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 440 TITTATNHFSEANMIGKGGFGPVYMG-KLSTGQEIAAKRLSK--NSGQGLEEFMNEVVLI 496
TI + + +G G +G V TG +A K+LS+ S + E+ L+
Sbjct: 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 497 GKLQHRNLVGLL-----GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSII 551
++H N++GLL +EE + + ++ L+ + + KL +F +I
Sbjct: 71 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LI 126
Query: 552 TGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVA 611
I RGL Y+H +IHRDLK SN+ ++ + KI DFGLAR DDE T VA
Sbjct: 127 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE--MTGYVA 179
Query: 612 GTHGYMSPEYA-NDGTISMKSDVFSLGVLLVEIVSGK 647
T Y +PE N + D++S+G ++ E+++G+
Sbjct: 180 -TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 31/206 (15%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLG 509
+G G FG V++ + + A K ++ + + NE ++ ++ H ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67
Query: 510 SCIEEDERML--IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITG------IARGLLYL 561
E D+R L + EY+P L F + R RFS TG I L YL
Sbjct: 68 -WTEHDQRFLYMLMEYVPGGEL--FSYLRNS-------GRFSNSTGLFYASEIVCALEYL 117
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
H ++++RDLK NILLD + K++DFG A+ +T + GT Y++PE
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPEV 169
Query: 622 ANDGTISMKSDVFSLGVLLVEIVSGK 647
+ D ++LG+L+ E++ G
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEF---MNEVVLIGKLQHRNLVGLL 508
++GKG FG V + + +TG+ A K L K +E + E ++ +H L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQ 568
+ D + EY L +F RER + RF I L YLH
Sbjct: 62 YAFQTHDRLCFVMEYANGGEL-FFHLSRERV-FTEERARF-YGAEIVSALEYLHSRD--- 115
Query: 569 VIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTIS 628
V++RD+K N++LD + + KI+DFGL + G + A + GT Y++PE D
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 629 MKSDVFSLGVLLVEIVSGKM 648
D + LGV++ E++ G++
Sbjct: 174 RAVDWWGLGVVMYEMMCGRL 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 450 EANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLE-EFMNEVVLIGKLQHRNLVGLL 508
E +G+G +G VY K G++ L + G G+ E+ L+ +L+H N++ L
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQ 64
Query: 509 GSCIEEDERM--LIYEYMPHKSLDYFIFDR-----ERSKLLPWKKRFSIITGIARGLLYL 561
+ +R L+++Y H F R ++ LP S++ I G+ YL
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 562 HQDSKLQVIHRDLKASNILLDINLNP-----KISDFGLARIFGGDDEE-AQTERVAGTHG 615
H + V+HRDLK +NIL+ + P KI+D G AR+F + A + V T
Sbjct: 125 HAN---WVLHRDLKPANILV-MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 616 YMSPEYANDGTISMKS-DVFSLGVLLVEIVSGK 647
Y +PE K+ D++++G + E+++ +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 27/208 (12%)
Query: 454 IGKGGFGPVYMGKLSTGQEIA---AKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVGLLG 509
IG G FG V + ++ T +A K L N+ + EF+ + LQH N++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 510 SCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS-------IITGIARGLLYLH 562
C+E +L++EY L ++ + W +R S + IA G+ ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQ------WHRRNSQLLLLQRMACEIAAGVTHMH 116
Query: 563 QDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA 622
K +H DL N L +L K+ D+G+ +D + +++PE
Sbjct: 117 ---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV 173
Query: 623 ---NDGTISMK----SDVFSLGVLLVEI 643
+ G I+ + S+V++LGV L E+
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 453 MIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEV-VLIGKLQHRNLVGL 507
++GKG FG V + +L G+ A K L K+ +E M E VL ++ L L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
+ ++ + E++ L + I D+ R L ++ F I GL +LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATF-YAAEIVCGLQFLHSKG-- 116
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLAR--IFGGDDEEAQTERVAGTHGYMSPEYANDG 625
+I+RDLK N++LD + + KI+DFG+ + +FG D A T GT Y++PE
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRAST--FCGTPDYIAPEILQGL 171
Query: 626 TISMKSDVFSLGVLLVEIVSGK 647
+ D +S GVLL E++ G+
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 19/203 (9%)
Query: 453 MIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEV-----VLIGKLQHRNLVGL 507
+IG+G + V + +L +I A ++ K +E ++ V V + LVGL
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 508 LGSCIEEDERM-LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSK 566
SC + R+ L+ EY+ L +F +R + LP + I L +LH+
Sbjct: 62 -HSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHERG- 116
Query: 567 LQVIHRDLKASNILLDINLNPKISDFGLAR--IFGGDDEEAQTERVAGTHGYMSPEYAND 624
+I+RDLK N+LLD + + K++D+G+ + + GD T GT Y++PE
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD----TTSTFCGTPNYIAPEILRG 170
Query: 625 GTISMKSDVFSLGVLLVEIVSGK 647
D ++LGVL+ E+++G+
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 454 IGKGGFGPVYMG-KLSTGQEIAAKRLSK--NSGQGLEEFMNEVVLIGKLQHRNLVGLLG- 509
+G G +G V TG+++A K+LS+ S + E+ L+ +QH N++GLL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 510 --SCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
S + DE Y MP+ D + L K ++ + GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSEDKVQYLVYQMLCGLKYIH---SA 136
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA-NDGT 626
+IHRDLK N+ ++ + KI DFGLAR +A+ T Y +PE N
Sbjct: 137 GIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILNWMH 191
Query: 627 ISMKSDVFSLGVLLVEIVSGK 647
+ D++S+G ++ E+++GK
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 39/92 (42%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGT 613
+ARG+ +L + + IHRDL A NILL N KI DFGLAR D + +
Sbjct: 182 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 614 HGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+M+PE D + +SDV+S GVLL EI S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 53/233 (22%)
Query: 452 NMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEE--------------FMNEVVLI 496
+G+G +G V TG+ +A K++ + E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 497 GKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------I 550
+++H N++GL+ +E D L+ + M + K++ K R + I
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM----------ASDLKKVVDRKIRLTESQVKCI 124
Query: 551 ITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG--------GDD 602
+ I GL LH K +HRDL +NI ++ KI+DFGLAR +G D
Sbjct: 125 LLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 603 EEAQ-----TERVAGTHGYMSPEY---ANDGTISMKSDVFSLGVLLVEIVSGK 647
E Q T +V T Y +PE A ++ D++S+G + E+++GK
Sbjct: 182 ETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 454 IGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNE---VVLIGKLQHRNLVG 506
+G+G FG V + + TG+ A K L K + +E M E +H LV
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 507 LLGSCIEEDERM-LIYEYMPHKSLDYFI----FDRERSKLLPWKKRFSIITGIARGLLYL 561
L +C + ++ + + EY L I F R+ + GL YL
Sbjct: 67 LF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY--------AACVVLGLQYL 117
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR--IFGGDDEEAQTERVAGTHGYMSP 619
H++ ++++RDLK N+LLD KI+DFGL + + GD +T GT +++P
Sbjct: 118 HEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD----RTSTFCGTPEFLAP 170
Query: 620 EYANDGTISMKSDVFSLGVLLVEIVSG 646
E + + + D + LGVL+ E++ G
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 37/202 (18%)
Query: 470 GQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLV------GLLGSCIEEDERML---- 519
+ +A K++ Q ++ + E+ +I +L H N+V G GS + ED L
Sbjct: 30 DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89
Query: 520 -IY---EYMP---HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHR 572
+Y EYM L+ E ++L ++ + RGL Y+H + V+HR
Sbjct: 90 SVYIVQEYMETDLANVLEQGPLSEEHARLFMYQ--------LLRGLKYIHSAN---VLHR 138
Query: 573 DLKASNILLDI-NLNPKISDFGLARIFGGDDEEAQ--TERVAGTHGYMSPE---YANDGT 626
DLK +N+ ++ +L KI DFGLARI +E + T Y SP N+ T
Sbjct: 139 DLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-TKWYRSPRLLLSPNNYT 197
Query: 627 ISMKSDVFSLGVLLVEIVSGKM 648
++ D+++ G + E+++GK
Sbjct: 198 KAI--DMWAAGCIFAEMLTGKP 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 454 IGKGGFGPVYMG-KLSTGQEIAAKRLSKNSGQGLE-EFMNEVVLIGKLQHRNLVGLLGSC 511
+G+G + VY G GQ +A K +S + +G+ + E L+ L+H N+V LL
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV-LLHDI 71
Query: 512 IEEDERM-LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVI 570
I E + ++EYM Y I + L P+ R + + RGL Y+H ++
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMI--QHPGGLHPYNVRLFMFQ-LLRGLAYIHGQ---HIL 125
Query: 571 HRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGT-ISM 629
HRDLK N+L+ K++DFGLAR + +E V T Y P+ T S
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYSS 183
Query: 630 KSDVFSLGVLLVEIVSGK 647
D++ G + +E++ G+
Sbjct: 184 ALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAK--RLSKNSGQGLEEFMNEVVLIGKLQHR 502
+ + + +G+G + VY GK G+ +A K RL + G + E L+ L+H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA-IREASLLKGLKHA 63
Query: 503 NLVGLLGSCIEEDERM-LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
N+V LL I E + L++EY+ H L ++ D+ L P + + + RGL Y+
Sbjct: 64 NIV-LLHDIIHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVKLFLFQ-LLRGLSYI 119
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
HQ ++HRDLK N+L+ K++DFGLAR E V T Y P+
Sbjct: 120 HQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDV 174
Query: 622 ANDGT-ISMKSDVFSLGVLLVEIVSG 646
T S D++ +G + VE++ G
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 40/103 (38%), Positives = 57/103 (55%), Gaps = 8/103 (7%)
Query: 549 SIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ-- 606
S I I GL Y+H + V+HRDLK N+L++ + KI DFGLAR F + E
Sbjct: 109 SFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165
Query: 607 -TERVAGTHGYMSPEYA-NDGTISMKSDVFSLGVLLVEIVSGK 647
TE VA T Y +PE + + + DV+S+G +L E++ K
Sbjct: 166 MTEYVA-TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 448 FSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRN 503
F +G G FG V + K TG+ A K L K + ++ E ++ +L H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
+V ++ S +E+ + E++ L F R+ + +F + YLH
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGEL--FTHLRKAGRFPNDVAKF-YHAELVLAFEYLHS 136
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTER---VAGTHGYMSPE 620
+I+RDLK N+LLD + K++DFG A+ +R + GT Y++PE
Sbjct: 137 ---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK--------KVPDRTFTLCGTPEYLAPE 185
Query: 621 YANDGTISMKSDVFSLGVLLVEIVSG 646
D +++GVLL E ++G
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 36/102 (35%), Positives = 55/102 (53%), Gaps = 17/102 (16%)
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGT 613
I RGL YLH ++HRD+K N+L++ N KI DFGLAR+ D+ + T+ V T
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-T 167
Query: 614 HGYMSPEYANDGTISMKS-------DVFSLGVLLVEIVSGKM 648
Y +PE I M S D++S+G + E++ ++
Sbjct: 168 QYYRAPE------ILMGSRHYTSAVDIWSVGCIFAELLGRRI 203
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 68/214 (31%), Positives = 96/214 (44%), Gaps = 43/214 (20%)
Query: 454 IGKGGFGPVYMG-KLSTGQEIAAKRLSKNSGQGLEEFMN---------EVVLIGKLQHRN 503
IG G G V TGQ +A K+LS+ F N E+VL+ + H+N
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSR-------PFQNVTHAKRAYRELVLMKLVNHKN 76
Query: 504 LVGLLG------SCIEEDERMLIYEYMPHKSLDYFI---FDRER-SKLLPWKKRFSIITG 553
++GLL S E + L+ E M +L I D ER S LL + ++ G
Sbjct: 77 IIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSYLL-----YQMLCG 130
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGT 613
I +LH +IHRDLK SNI++ + KI DFGLAR G T V T
Sbjct: 131 IK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVV-T 180
Query: 614 HGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
Y +PE D++S+G ++ E++ G
Sbjct: 181 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 453 MIGKGGFGPVYMGKLSTGQEI-AAKRLSKNSGQGLEEF---MNEVVLIGKLQHRNLVGLL 508
++GKG FG V + + + A K L K +E + E ++ +H L L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQ 568
S D + EY L +F RER + RF I L YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSED-RARF-YGAEIVSALGYLHSC---D 115
Query: 569 VIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTIS 628
V++RDLK N++LD + + KI+DFGL + G + A + GT Y++PE D
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 629 MKSDVFSLGVLLVEIVSGKM 648
D + LGV++ E++ G++
Sbjct: 174 RAVDWWGLGVVMYEMMCGRL 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 454 IGKGGFGPVYMG-KLSTGQEIAAKRLSK--NSGQGLEEFMNEVVLIGKLQHRNLVGLL-- 508
+G G +G V Q++A K+LS+ S E+ L+ ++H N++GLL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 509 ---GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
+ IE + + + L+ + + KL +F +I + RGL Y+H
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIV---KCQKLSDEHVQF-LIYQLLRGLKYIHSAG 138
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA-ND 624
+IHRDLK SN+ ++ + +I DFGLAR DDE T VA T Y +PE N
Sbjct: 139 ---IIHRDLKPSNVAVNEDCELRILDFGLAR--QADDE--MTGYVA-TRWYRAPEIMLNW 190
Query: 625 GTISMKSDVFSLGVLLVEIVSGK 647
+ D++S+G ++ E++ GK
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 448 FSEANMIGKGGFGPVYMGKLSTGQ--EIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHR 502
F+ +G G FG V + +A KR K+ + ++ +E ++ + H
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91
Query: 503 NLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGI---ARGLL 559
V L GS +E L+ E++ ++F F R KRF G A+ +L
Sbjct: 92 FCVNLYGSFKDESYLYLVLEFVIGG--EFFTFLRR-------NKRFPNDVGCFYAAQIVL 142
Query: 560 YLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSP 619
L +++RDLK N+LLD + K++DFG A++ + +T + GT Y++P
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAP 197
Query: 620 EYANDGTISMKSDVFSLGVLLVEIVSG 646
E + +D ++LG+ + EI+ G
Sbjct: 198 EILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 5e-10
Identities = 62/230 (26%), Positives = 92/230 (40%), Gaps = 49/230 (21%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSK----NSGQGLEEFMNEVVLIGKLQHRNLVGLL 508
IG+G FG V++ + TGQ A K L K Q E ++ +V L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADADSPWIVKLY 67
Query: 509 GSCIEEDERMLIYEYMPHKSL-----DYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
S +E+ L+ EYMP L +F E ++ IA +L L
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFY-----------IAELVLALDS 116
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLA-RIFGGDDEEAQTER------------- 609
KL IHRD+K NIL+D + + K++DFGL ++ D E
Sbjct: 117 VHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 610 -------------VAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSG 646
GT Y++PE ++ D +SLGV+L E++ G
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 5e-10
Identities = 34/90 (37%), Positives = 52/90 (57%)
Query: 558 LLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYM 617
LL +H +IHRD+K++NILL N K+ DFG ++++ + GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 618 SPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
+PE S K+D+FSLGVLL E+++ K
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLK 242
|
Length = 496 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 448 FSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRN 503
F+ ++GKG FG V + + T + A K L K+ +E M E ++
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 504 LVGLLGSCIEEDERM-LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITG--IARGLLY 560
+ L SC + +R+ + EY+ L Y I ++ +K+ ++ I+ GL +
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPQAVFYAAEISVGLFF 116
Query: 561 LHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE 620
LH+ +I+RDLK N++LD + KI+DFG+ + D T GT Y++PE
Sbjct: 117 LHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPE 171
Query: 621 YANDGTISMKSDVFSLGVLLVEIVSGK 647
D ++ GVLL E+++G+
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEE---FMNEVVLIGKLQHRNLVGLL 508
+IGKG +G V TG+++A K++ + + + + + E+ L+ L+H ++V +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 509 GSCIEEDER-----MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
+ R +++E M L I + L P +F + + R L Y+H
Sbjct: 66 HIMLPPSRREFKDIYVVFELM-ESDLHQVI--KANDDLTPEHHQF-FLYQLLRALKYIHT 121
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA--QTERVAGTHGYMSPEY 621
+ V HRDLK NIL + + KI DFGLAR+ D A T+ VA T Y +PE
Sbjct: 122 AN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA-TRWYRAPEL 177
Query: 622 AND--GTISMKSDVFSLGVLLVEIVSGK 647
+ D++S+G + E+++GK
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 48/149 (32%), Positives = 74/149 (49%), Gaps = 16/149 (10%)
Query: 454 IGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLE-EFMNEVVLIGKLQHRNLVGLLGSC 511
+G+G + VY G+ TGQ +A K + +G + E L+ L+H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV-TLHDI 71
Query: 512 IEEDERM-LIYEYMPHKSLDYFIFDRERSKLLPWKKR---FSIITGIARGLLYLHQDSKL 567
I + + L++EY+ L ++ D L R F ++ RGL Y HQ
Sbjct: 72 IHTKKTLTLVFEYL-DTDLKQYM-DDCGGGLSMHNVRLFLFQLL----RGLAYCHQR--- 122
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLAR 596
+V+HRDLK N+L+ K++DFGLAR
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 8e-10
Identities = 39/120 (32%), Positives = 56/120 (46%), Gaps = 4/120 (3%)
Query: 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI 583
MP D F + +RS LP ++ +I + L YLH +IHRD+K NI LD
Sbjct: 165 MPKYKCDLFTY-VDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDE 220
Query: 584 NLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEI 643
N + DFG A + Q +GT SPE K+D++S G++L E+
Sbjct: 221 PENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 454 IGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLE-EFMNEVVLIGKLQHRNLVGLLGSC 511
+G+G + VY G+ T +A K + +G + EV L+ L+H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 512 IEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIH 571
E L++EY+ K L ++ D S + K F + + RGL Y H + +V+H
Sbjct: 74 HTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH---RRKVLH 127
Query: 572 RDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGT-ISMK 630
RDLK N+L++ K++DFGLAR + E V T Y P+ T S +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYSTQ 185
Query: 631 SDVFSLGVLLVEIVSGK 647
D++ +G + E+ +G+
Sbjct: 186 IDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 38/92 (41%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGT 613
+A+G+ +L + + IHRDL A NILL N KI DFGLAR D + +
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 614 HGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+M+PE D +++SDV+S GVLL EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 1e-09
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 33/200 (16%)
Query: 475 AKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIF 534
AKR+ K + + NE++ +G+L H N++ IEE R YM + D+ ++
Sbjct: 197 AKRV-KAGSRAAIQLENEILALGRLNHENILK-----IEEILRSEANTYMITQKYDFDLY 250
Query: 535 DRERSKLLPWKKR------FSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPK 588
+ WK R +I+ + + Y+H D KL IHRD+K NI L+ +
Sbjct: 251 SFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH-DKKL--IHRDIKLENIFLNCDGKIV 307
Query: 589 ISDFGLARIFGGDDEEAQTERVAGTHGYM------SPE-YANDGTISMKSDVFSLGVLLV 641
+ DFG A F + ER A +G++ SPE A DG + +D++S G++L+
Sbjct: 308 LGDFGTAMPF-------EKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILL 359
Query: 642 EIVSGK---MNRGFRHPGHR 658
+++S + G PG +
Sbjct: 360 DMLSHDFCPIGDGGGKPGKQ 379
|
Length = 501 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 453 MIGKGGFGPVYMGKLSTGQE----IAAKRLSK----NSGQGLEEFMNEVVLIGKLQHRNL 504
++GKGG+G V+ + TG + A K L K + + E ++ ++H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 505 VGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD 564
V L+ + + LI EY+ L ER + ++ I+ L +LHQ
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGEL---FMHLEREGIFMEDTACFYLSEISLALEHLHQ- 118
Query: 565 SKLQVIHRDLKASNILLDINLNPKISDFGLAR--IFGGDDEEAQTERVAGTHGYMSPEYA 622
+I+RDLK NILLD + K++DFGL + I G T GT YM+PE
Sbjct: 119 --QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTIEYMAPE-- 170
Query: 623 NDGTISMKS------DVFSLGVLLVEIVSG 646
I M+S D +SLG L+ ++++G
Sbjct: 171 ----ILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 57/202 (28%), Positives = 91/202 (45%), Gaps = 22/202 (10%)
Query: 454 IGKGGFGPVY-MGKLSTGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLG 509
IGKG FG V + K T + A K + K S + + E ++ ++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 510 SCIEEDERMLIYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITGIARGLLYLHQD 564
S ++ L+ ++ L + + FD R++ A L L
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFY-----------TAELLCALENL 109
Query: 565 SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND 624
K VI+RDLK NILLD + + DFGL ++ DD+ +T GT Y++PE
Sbjct: 110 HKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGTPEYLAPELLLG 167
Query: 625 GTISMKSDVFSLGVLLVEIVSG 646
+ D ++LGVLL E+++G
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 35/94 (37%), Positives = 57/94 (60%), Gaps = 5/94 (5%)
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGT 613
I L +LH KL +++RD+K NILLD + ++DFGL++ F +++E +T GT
Sbjct: 114 IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGT 169
Query: 614 HGYMSPEYANDGTISMKS-DVFSLGVLLVEIVSG 646
YM+PE K+ D +SLG+L+ E+++G
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 21/209 (10%)
Query: 448 FSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKN----SGQGLEEFMNEVVLIGKLQHRN 503
F+ ++GKG FG V + + E+ A ++ K +E M E ++
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 504 LVGLLGSCIEEDERM-LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITG--IARGLLY 560
+ L SC + +R+ + EY+ L Y I R +K+ ++ IA GL +
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR-----FKEPHAVFYAAEIAIGLFF 116
Query: 561 LHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR--IFGGDDEEAQTERVAGTHGYMS 618
LH +I+RDLK N++LD + KI+DFG+ + ++ G T+ GT Y++
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFCGTPDYIA 169
Query: 619 PEYANDGTISMKSDVFSLGVLLVEIVSGK 647
PE D ++ GVLL E+++G+
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAK---RLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGS 510
+G+G + V+ G+ + + A RL G + EV L+ L+H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA-IREVSLLKDLKHANIVTLHDI 72
Query: 511 CIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVI 570
+ L++EY+ K L ++ D + K F + I RGL Y H + +V+
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RRKVL 126
Query: 571 HRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE-YANDGTISM 629
HRDLK N+L++ K++DFGLAR + E V T Y P+ S
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYST 184
Query: 630 KSDVFSLGVLLVEIVSGK 647
+ D++ +G + E+ SG+
Sbjct: 185 QIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-09
Identities = 27/84 (32%), Positives = 42/84 (50%), Gaps = 9/84 (10%)
Query: 337 PSGEGFLKLPRMKLPENYWSNKS-MNLKECEAECTK-NCSCRAYANSDVTGGGSGCLMW- 393
S + F++LP KLP S +L+EC ++C NCSCR++ ++ G GCL+W
Sbjct: 1 KSDDCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWS 57
Query: 394 FGDLVDLRECSEGYIWGQDFFIRV 417
L D R G D + ++
Sbjct: 58 ESSLGDAR---LFPSGGVDLYEKI 78
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 19/216 (8%)
Query: 440 TITTATNHFSEANMIGKGGFGPV-YMGKLSTGQEIAAKRLSKNSGQGL--EEFMNEVVLI 496
TI + + + +G G +G V TG ++A K+L + L + E+ L+
Sbjct: 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 68
Query: 497 GKLQHRNLVGLLGSCIEE---DERMLIYEYMPHKSLDY-FIFDRERSKLLPWKKRFSIIT 552
++H N++GLL + D Y MP D + E+ L + ++
Sbjct: 69 KHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK---LSEDRIQFLVY 125
Query: 553 GIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAG 612
+ +GL Y+H +IHRDLK N+ ++ + KI DFGLAR D E V
Sbjct: 126 QMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVV-- 177
Query: 613 THGYMSPEYA-NDGTISMKSDVFSLGVLLVEIVSGK 647
T Y +PE N + D++S+G ++ E+++GK
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 35/101 (34%), Positives = 52/101 (51%), Gaps = 20/101 (19%)
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ---TERV 610
+ RGL Y+H VIHRDLK SN+L++ + +I DFG+AR E + TE V
Sbjct: 116 LLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 611 AGTHGYMSPE-------YANDGTISMKSDVFSLGVLLVEIV 644
A T Y +PE Y + D++S+G + E++
Sbjct: 173 A-TRWYRAPELLLSLPEY------TTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKR-LSKNSGQGL-EEFMNEVVLIGKLQHRN-LVGLLG 509
IG+G +G VY + +TG+ +A K+ + +G+ + E+ L+ L +V LL
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL- 67
Query: 510 SCIEEDER-------MLIYEYMPHKSLDYFI-FDRERSKLLPWKKRFSIITGIARGLLYL 561
+E E L++EY+ + R + LP K S + + +G+ +
Sbjct: 68 -DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 562 HQDSKLQVIHRDLKASNILLDINLNP-KISDFGLARIFGGDDEEAQTERVAGTHGYMSPE 620
H K V+HRDLK N+L+D KI+D GL R F + E V T Y +PE
Sbjct: 127 H---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLWYRAPE 181
Query: 621 YANDGT-ISMKSDVFSLGVLLVEIVSG 646
T S D++S+G + E+
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-09
Identities = 57/211 (27%), Positives = 107/211 (50%), Gaps = 31/211 (14%)
Query: 452 NMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN-EVVLIGKLQHRNLVGL-- 507
N+IG G FG VY + T +++A K++ ++ ++ N E++++ L H N++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKD 126
Query: 508 --LGSCIEEDERML----IYEYMP---HKSLDYFIFDRERSKLLPWKKRFSIITGIARGL 558
C +++E+ + + E++P HK + ++ + L K +S + R L
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF-LVKLYSY--QLCRAL 183
Query: 559 LYLHQDSKLQVIHRDLKASNILLDINLNP-KISDFGLAR-IFGGDDEEAQTERVAGTHGY 616
Y+H SK + HRDLK N+L+D N + K+ DFG A+ + G ++ + Y
Sbjct: 184 AYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ----RSVSYICSRFY 236
Query: 617 MSPEYANDGT-ISMKSDVFSLGVLLVEIVSG 646
+PE T + D++SLG ++ E++ G
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 31/212 (14%)
Query: 454 IGKGGFGPVYMGKL---------STGQEIAAKR-LSKNSGQGLEEFMNEVVLIGKLQHRN 503
+G+G F +Y G L GQE++ + + + F L+ +L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
LV L G C+ DE +++ EY+ LD F+ + + L WK + +A L YL +
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYL-E 118
Query: 564 DSKLQVIHRDLKASNILL---DINLNP----KISDFGLARIFGGDDEEAQTERVAGTHGY 616
D KL +H ++ NIL+ +N K+SD G+ +E + ER+ +
Sbjct: 119 DKKL--VHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE--RVERIP----W 170
Query: 617 MSPEYANDGTISMKS--DVFSLGVLLVEIVSG 646
++PE +G S+ D +S G L+EI S
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 50/194 (25%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 471 QEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLD 530
+++ AK + N + +E+ + H +V +D+ +LI EY L+
Sbjct: 94 EKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLN 153
Query: 531 YFIFDRERSKLLPWKKRFSIITGIARGLLY------LHQDSKLQVIHRDLKASNILLDIN 584
I R + L P+++ GLL+ L + +++HRDLK++NI L
Sbjct: 154 KQIKQRLKEHL-PFQEY-------EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT 205
Query: 585 LNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIV 644
K+ DFG ++ + GT Y++PE S K+D++SLGV+L E++
Sbjct: 206 GIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265
Query: 645 SGKMNRGFRHPGHR 658
+ ++R F+ P R
Sbjct: 266 T--LHRPFKGPSQR 277
|
Length = 478 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 28/210 (13%)
Query: 454 IGKGGFGPVYMGK----LSTGQ----EIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLV 505
+G+G F ++ G G+ E+ K L K+ E F ++ +L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 506 GLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
G C+ DE +++ EY+ SLD ++ + + WK + +A L +L +D
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFL-EDK 119
Query: 566 KLQVIHRDLKASNILL-----DINLNP---KISDFGLARIFGGDDEEAQTERVAGTHGYM 617
L H ++ A N+LL NP K+SD G++ +E ER+ ++
Sbjct: 120 GL--THGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV--LPKEILLERIP----WV 171
Query: 618 SPEYANDG-TISMKSDVFSLGVLLVEIVSG 646
PE + +S+ +D +S G L EI SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 52/189 (27%), Positives = 86/189 (45%), Gaps = 26/189 (13%)
Query: 471 QEIAAKRLSK---NSGQGLEEFMNEVVLIGKLQHRNLVGLLG-----SCIEEDERMLIYE 522
+ +A K+LS+ N + E+VL+ + H+N++GLL +EE + + I
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 108
Query: 523 YMPHKSLDYFI---FDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNI 579
+ +L I D ER L ++ + G+ +LH +IHRDLK SNI
Sbjct: 109 ELMDANLCQVIQMELDHERMSYLLYQ--------MLCGIKHLHSAG---IIHRDLKPSNI 157
Query: 580 LLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVL 639
++ + KI DFGLAR G T Y +PE D++S+G +
Sbjct: 158 VVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 214
Query: 640 LVEIVSGKM 648
+ E++ G +
Sbjct: 215 MGEMIKGGV 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 448 FSEANMIGKGGFGPVY-MGKLSTGQEIAAKRLSKNSGQGLEE---FMNEVVLIGKLQHRN 503
F +IG+G FG V + S+ Q A K LSK + F E ++
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104
Query: 504 LVGLLGSCIEEDERML--IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
+V L +D++ L + EYMP L + + + + W + + A +L L
Sbjct: 105 IVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE--KWARFY-----TAEVVLAL 155
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
+ IHRD+K N+LLD + + K++DFG + + + + GT Y+SPE
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRCDTAVGTPDYISPEV 214
Query: 622 ----ANDGTISMKSDVFSLGVLLVEIVSG 646
DG + D +S+GV L E++ G
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 453 MIGKGGFGPVYMGKLSTGQEIAAKRL------SKNSGQGLEEFMNEVVLIGKLQHRNLVG 506
+IG+G FG V + + + Q++ A +L K S F E ++ +V
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQ 107
Query: 507 LLGSCIEEDERML--IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD 564
L C +D++ L + EYMP L + + + + W K ++ A +L L
Sbjct: 108 LF--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--KWAKFYT-----AEVVLALDAI 158
Query: 565 SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA--QTERVAGTHGYMSPEY- 621
+ +IHRD+K N+LLD + + K++DFG DE + + GT Y+SPE
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM---DETGMVRCDTAVGTPDYISPEVL 215
Query: 622 ---ANDGTISMKSDVFSLGVLLVEIVSG 646
DG + D +S+GV L E++ G
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 5e-08
Identities = 73/249 (29%), Positives = 105/249 (42%), Gaps = 48/249 (19%)
Query: 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEE-----FMNEVVLIGKLQ 500
N + IG G FG V++ K QE + S +GL+E + EV ++ +L+
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAI--SYRGLKEREKSQLVIEVNVMRELK 70
Query: 501 HRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPW--KKRFSIITGIARGL 558
H+N+V + + + + L Y+ + D R K K I I R L
Sbjct: 71 HKNIVRYIDRFLNKANQKL---YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL 127
Query: 559 L----YLHQ----DSKLQVIHRDLKASNILLDI-------------NLN----PKISDFG 593
L Y H + +V+HRDLK NI L NLN KI DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187
Query: 594 LARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISM--KSDVFSLGVLLVEIVSGKMNRG 651
L++ G E+ GT Y SPE T S KSD+++LG ++ E+ SGK
Sbjct: 188 LSKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT--- 241
Query: 652 FRHPGHRHN 660
P H+ N
Sbjct: 242 ---PFHKAN 247
|
Length = 1021 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 56/198 (28%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 454 IGKGGFGPVYMGKLS-TGQEIAAK--RLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGS 510
+G+G + V+ G+ T +A K RL G + EV L+ L+H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA-IREVSLLKNLKHANIVTLHDI 71
Query: 511 CIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVI 570
E L++EY+ Y L+ + + RGL Y H K +++
Sbjct: 72 IHTERCLTLVFEYLDSDLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKIL 125
Query: 571 HRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGT-ISM 629
HRDLK N+L++ K++DFGLAR + E V T Y P+ T S
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYST 183
Query: 630 KSDVFSLGVLLVEIVSGK 647
D++ +G +L E+ +G+
Sbjct: 184 PIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGT 613
IA +L +H +L +HRD+K N+LLD+N + +++DFG + + D Q+ GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGT 166
Query: 614 HGYMSPEYAND-----GTISMKSDVFSLGVLLVEIVSGK 647
Y+SPE G + D +SLGV + E++ G+
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 37/92 (40%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGT 613
+A+G+ +L SK IHRDL A NILL KI DFGLAR D
Sbjct: 223 VAKGMSFL--ASK-NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 614 HGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+M+PE + + +SDV+S G+LL EI S
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 37/99 (37%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 547 RFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606
RFS + +A+G+ +L + IHRD+ A N+LL KI DFGLAR D
Sbjct: 216 RFS--SQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270
Query: 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+M+PE D +++SDV+S G+LL EI S
Sbjct: 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 22/208 (10%)
Query: 454 IGKG--GFGPVYMGK-LSTGQEIAAKR--LSKNSGQGLEEFMNEVVLIGKLQHRNLVGLL 508
IGK V++ K T +A K+ L S + L+ E++ +LQH N++ +
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65
Query: 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQ 568
S I + E ++ M + S + + + LP I+ + L Y+H
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLL-KTHFPEGLPELAIAFILKDVLNALDYIH---SKG 121
Query: 569 VIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG--------YMSPE 620
IHR +KAS+ILL + +S + + + +RV ++SPE
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSM---IKHGKRQRVVHDFPKSSVKNLPWLSPE 178
Query: 621 --YANDGTISMKSDVFSLGVLLVEIVSG 646
N + KSD++S+G+ E+ +G
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 43/164 (26%), Positives = 81/164 (49%), Gaps = 21/164 (12%)
Query: 489 FMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKL-LPWKKR 547
F L+ ++ H +L + G C+ E +++ E++ H LD + +E+ ++ + WK
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL-RKEKGRVPVAWK-- 119
Query: 548 FSIITGIARGLLYLHQDSKLQVIHRDLKASNIL-----LDINLNP--KISDFGLARIFGG 600
++ +A L YL + ++H ++ A NIL L +P K+SD G++ F
Sbjct: 120 ITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTA 174
Query: 601 DDEEAQTERVAGTHGYMSPEYANDGT-ISMKSDVFSLGVLLVEI 643
E + ER+ +++PE G +S +D +S G L+EI
Sbjct: 175 LSREERVERIP----WIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 65/256 (25%), Positives = 99/256 (38%), Gaps = 76/256 (29%)
Query: 446 NHFSEANMIGKGGFGPVYM-GKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQH--- 501
+ F +IG+G FG V + K TG A K+L K+ E++ ++ H
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKS----------EMLEKEQVAHVRA 50
Query: 502 -RNL---------VGLLGSCIEEDERMLIYEYMPHKSL-----DYFIFDRERSKLLPWKK 546
R++ V L S +E+ LI EY+P + F E +
Sbjct: 51 ERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET------- 103
Query: 547 RFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGL------------ 594
RF I A +L + KL IHRD+K N+LLD + K+SDFGL
Sbjct: 104 RFYI----AETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159
Query: 595 ARIFGGD------DEEAQTE------------------RVAGTHGYMSPEYANDGTISMK 630
RI D ++ GT Y++PE + +
Sbjct: 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE 219
Query: 631 SDVFSLGVLLVEIVSG 646
D +SLGV++ E++ G
Sbjct: 220 CDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 443 TATNHFSEANMIGKGGFGPVYMGKLST--GQEIAAKRLSK---NSGQGLEEFMNEVVLIG 497
T + + IG G G V T G +A K+LS+ N + E+VL+
Sbjct: 18 TVLKRYQQLKPIGSGAQGIV-CAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLK 75
Query: 498 KLQHRNLVGLLG-----SCIEEDERM-LIYEYMPHK--SLDYFIFDRERSKLLPWKKRFS 549
+ H+N++ LL +EE + + L+ E M + + D ER L ++
Sbjct: 76 CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQ---- 131
Query: 550 IITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTER 609
+ G+ +LH +IHRDLK SNI++ + KI DFGLAR T
Sbjct: 132 ----MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTPY 182
Query: 610 VAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKM 648
V T Y +PE D++S+G ++ E+V G +
Sbjct: 183 VV-TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 35/92 (38%), Positives = 46/92 (50%), Gaps = 3/92 (3%)
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGT 613
+ARG+ +L + +HRDL A N+LL KI DFGLAR D
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 614 HGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+M+PE D + SDV+S G+LL EI S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-07
Identities = 62/235 (26%), Positives = 103/235 (43%), Gaps = 22/235 (9%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLG 509
+IG+G FG V + + ST + A K LSK + F E I + V L
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 510 SCIEEDERM-LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQ 568
++D + ++ EYMP L + + + + W + ++ A +L L +
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE--KWARFYT-----AEVVLALDAIHSMG 162
Query: 569 VIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY----AND 624
IHRD+K N+LLD + + K++DFG + + + GT Y+SPE D
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 625 GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679
G + D +S+GV L E++ G P + +L+G + N +L D
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDT------PFYADSLVGTYSKIMNHKNSLTFPD 270
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 64/236 (27%), Positives = 98/236 (41%), Gaps = 29/236 (12%)
Query: 438 LATITTATNHFSEANMIGKGGFGPVY-MGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLI 496
L ++ T+ + IGKG +G VY + G A K L S EE E ++
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72
Query: 497 GKL-QHRNLVGLLGSCIEEDERM-----LIYEYMPHKSLDYFIFDRERSKLLPWKKRFS- 549
L H N+V G + D+ + L+ E S+ + LL +R
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDE 127
Query: 550 -----IITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604
I+ G GL +LH + ++IHRD+K +NILL K+ DFG++
Sbjct: 128 AMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184
Query: 605 AQTERVAGTHGYMSPEYAN-----DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHP 655
T GT +M+PE D + + DV+SLG+ +E+ G HP
Sbjct: 185 RNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 50/173 (28%), Positives = 74/173 (42%), Gaps = 20/173 (11%)
Query: 446 NHFSEANMIGKGGFGPVYM-GKLSTGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQH 501
F +IGKG FG V + K TG+ A K L K+ L E ++ +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 502 RNLVGLLGSCIEEDERMLIYEYMPHKSL-----DYFIFDRERSKLLPWKKRFSIITGIAR 556
+V L S + LI E++P L Y F + + RF + A
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVT-------RFYM----AE 109
Query: 557 GLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTER 609
+L + KL IHRD+K NIL+D + K+SDFGL+ F + A ++
Sbjct: 110 CVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQK 162
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 61/220 (27%), Positives = 96/220 (43%), Gaps = 31/220 (14%)
Query: 443 TATNHFSEANMIGKGGFGPV---YMGKLSTGQEIAAKRLSK---NSGQGLEEFMNEVVLI 496
T + IG G G V Y L + +A K+LS+ N + E+VL+
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAY-RELVLM 70
Query: 497 GKLQHRNLVGLLG-----SCIEEDERMLIYEYMPHKSLDYFI---FDRERSKLLPWKKRF 548
+ H+N++ LL +EE + + + + +L I D ER L ++
Sbjct: 71 KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ--- 127
Query: 549 SIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTE 608
+ G+ +LH +IHRDLK SNI++ + KI DFGLAR G T
Sbjct: 128 -----MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTP 177
Query: 609 RVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKM 648
V T Y +PE D++S+G ++ E+V K+
Sbjct: 178 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 454 IGKGGFGPVYMGKL---------STGQEIAAKRLSKNSGQGLEE----FMNEVVLIGKLQ 500
+G+G +Y G L E K + K + F ++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 501 HRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLL--PWKKRFSIITGIARGL 558
H+++V L G C+ + E +++ E++ LD F+ +S +L PWK F + +A L
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFM--HRKSDVLTTPWK--FKVAKQLASAL 118
Query: 559 LYLHQDSKLQVIHRDLKASNILL-----DINLNP--KISDFGLARIFGGDDEEAQTERVA 611
YL +D L +H ++ NILL D P K+SD G+ E ER+
Sbjct: 119 SYL-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQE--CVERIP 173
Query: 612 GTHGYMSPEYANDG-TISMKSDVFSLGVLLVEI 643
+++PE D +S+ +D +S G L EI
Sbjct: 174 ----WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 52/210 (24%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 448 FSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEE-----FMNEVVLIGKLQHR 502
F +IG+G FG V + KL ++ A ++ N + L+ F E ++ ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKIL-NKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 503 NLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLH 562
+ L + +E+ L+ +Y L + + +L RF + A ++ +
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYL----AEMVIAID 116
Query: 563 QDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA 622
+L +HRD+K NIL+D+N + +++DFG +D Q+ GT Y+SPE
Sbjct: 117 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAVGTPDYISPEIL 175
Query: 623 N-----DGTISMKSDVFSLGVLLVEIVSGK 647
G + D +SLGV + E++ G+
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 49/179 (27%), Positives = 70/179 (39%), Gaps = 39/179 (21%)
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGT 613
+A G+ +L + +HRDL A N+L+ KI DFGLAR D
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 614 HGYMSPEYANDGTISMKSDVFSLGVLLVEIVS--------GKMNRGFRHP---GHRHNLI 662
+M+PE + + SDV+S G+LL EI + MN F + G+R
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKP 364
Query: 663 GHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721
HA +M C E+ F E RPD S +V L+ +
Sbjct: 365 AHA-----SDEIYEIMQKCWEEKF--------------------EIRPDFSQLVHLVGD 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 37/156 (23%), Positives = 68/156 (43%), Gaps = 8/156 (5%)
Query: 492 EVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSII 551
E ++ + H +++ L G+ LI +P D + + + + +I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNI-AICDILAIE 188
Query: 552 TGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVA 611
+ R + YLH++ +IHRD+KA NI ++ + + DFG A F D + A
Sbjct: 189 RSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244
Query: 612 GTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
GT +PE D++S G++L E+ +
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 16/212 (7%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEE---FMNEVVLIGKLQH 501
F +++G+G FG V + + +TG A K + K+ E F E ++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
+ L + ++D L+ EY P L + +R + +F + A +L +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDL-LSLLNRYEDQFDEDMAQFYL----AELVLAI 115
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
H ++ +HRD+K N+L+D + K++DFG A + V GT Y++PE
Sbjct: 116 HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEV 174
Query: 622 ------ANDGTISMKSDVFSLGVLLVEIVSGK 647
GT ++ D +SLGV+ E++ G+
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 43/179 (24%), Positives = 82/179 (45%), Gaps = 16/179 (8%)
Query: 476 KRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERM----LIYEYMPHKSLDY 531
K+ K ++ NE+ + ++ N++ + G I+ + + LI EY L
Sbjct: 52 KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111
Query: 532 FIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISD 591
+ D+E+ L +K + + +GL L++ + +++L + + L+ N KI
Sbjct: 112 VL-DKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIIC 166
Query: 592 FGLARIFGGDDEEAQTERVAGTHGYMSPEYAND--GTISMKSDVFSLGVLLVEIVSGKM 648
GL +I + V Y S + ND ++K D++SLGV+L EI +GK+
Sbjct: 167 HGLEKIL----SSPPFKNV-NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKI 220
|
Length = 283 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 17/210 (8%)
Query: 448 FSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEE---FMNEVVLIGKLQHRN 503
F +IG+G FG V + K+ +TGQ A K L+K E F E ++ R
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
+ L + +E+ L+ +Y L + + +L RF + A +L +
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYL----AEMVLAIDS 117
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFG-LARIFGGDDEEAQTERVAGTHGYMSPEY- 621
+L +HRD+K N+LLD N + +++DFG R+ D Q+ GT Y+SPE
Sbjct: 118 VHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL--ADGTVQSNVAVGTPDYISPEIL 175
Query: 622 --ANDGTISM--KSDVFSLGVLLVEIVSGK 647
DG + D +SLGV + E++ G+
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 34/104 (32%), Positives = 49/104 (47%), Gaps = 10/104 (9%)
Query: 557 GLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGY 616
GL +LH + + IHRD+K +NILL K+ DFG++ T GT +
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFW 190
Query: 617 MSPEYAN-----DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHP 655
M+PE D T + DV+SLG+ +E+ G HP
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 3e-05
Identities = 36/112 (32%), Positives = 52/112 (46%), Gaps = 26/112 (23%)
Query: 550 IITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNP-KISDFGLARIFGGDDEEAQTE 608
II + L LH K +IH D+K N+L D + + D+GL +I G T
Sbjct: 114 IIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG-------TP 163
Query: 609 RVA-GTHGYMSPE----YANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHP 655
GT Y SPE + D +S D +++GVL E+++GK HP
Sbjct: 164 SCYDGTLDYFSPEKIKGHNYD--VSF--DWWAVGVLTYELLTGK------HP 205
|
Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 7e-05
Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 30/158 (18%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRN---------L 504
I +G FG VY+G+ ++ A ++ K + + +N+ ++ R+ +
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKA-----DMINKNMVHQVQAERDALALSKSPFI 66
Query: 505 VGLLGSCIEEDERMLIYEYM---PHKSL--DYFIFDRERSKLLPWKKRFSIITGIARGLL 559
V L S + L+ EY+ KSL Y FD E + I+ +A L
Sbjct: 67 VHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAV--------KYISEVALALD 118
Query: 560 YLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597
YLH+ +IHRDLK N+L+ + K++DFGL+++
Sbjct: 119 YLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|238074 cd00129, PAN_APPLE, PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-05
Identities = 17/70 (24%), Positives = 26/70 (37%), Gaps = 11/70 (15%)
Query: 336 CPSGEGFLKLPRMKLPENYWSNKSMNLKECEAECTKN---CSCRAYANSDVTGGGSGCLM 392
C S L +K+ K+ EC C KN SC+A+ + CL
Sbjct: 5 CKSAGTTLIKIALKIKTT----KANTADECANRCEKNGLPFSCKAFVFAKARK---QCLW 57
Query: 393 W-FGDLVDLR 401
+ F + +R
Sbjct: 58 FPFNSMSGVR 67
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 80 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 57/239 (23%), Positives = 91/239 (38%), Gaps = 51/239 (21%)
Query: 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQG---LEEFMNEVVLIGKLQHR 502
HF + ++GKG G V++ +L TG+ A K L K ++ + E ++ L H
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 503 NLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIAR------ 556
L L S E L+ +Y P + F + + K S +AR
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGG--ELFRLLQRQPG-----KCLSE--EVARFYAAEV 112
Query: 557 --GLLYLHQDSKLQVIHRDLKASNILL---------DINLNPKISDFGLARIF------- 598
L YLH L +++RDLK NILL D +L+ +
Sbjct: 113 LLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169
Query: 599 GGDDEEAQTERVA-----------GTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSG 646
+E + GT Y++PE + D ++LG+LL E++ G
Sbjct: 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 38/218 (17%)
Query: 454 IGKG--GFGPVYMGKLS-TGQEIAAK--RLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLL 508
IG+G VY+ + + TG + + L + + L+ NEVVL +H N++
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65
Query: 509 GSCIEEDERMLIYEYMPHKSLDYFI---FDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
+I +M + S + + F S+ L +I+ G RGL YLHQ+
Sbjct: 66 TVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG----NILFGALRGLNYLHQNG 121
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD-----EEAQTERVA--------G 612
IHR++KAS+IL IS GL + G Q +V
Sbjct: 122 ---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTS 170
Query: 613 THGYMSPEYANDGT--ISMKSDVFSLGVLLVEIVSGKM 648
++SPE ++KSD++S+G+ E+ +G++
Sbjct: 171 VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRV 208
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 31/102 (30%), Positives = 51/102 (50%), Gaps = 16/102 (15%)
Query: 558 LLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI---------FGG----DDEE 604
L YLH ++HRDLK N+L+ + K++DFGL++I + G D E
Sbjct: 114 LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSG 646
++V GT Y++PE D +++G++L E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 14/157 (8%)
Query: 448 FSEANMIGKGGFGPVYMG-KLSTGQEIAAKRLSK----NSGQGLEEFMNEVVLIGKLQHR 502
F + +G G FG V + K+ T A K L K N Q + E ++ + +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQ-VAHVKAERDILAEADNE 61
Query: 503 NLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWK-KRFSIITGIARGLLYL 561
+V L S ++D + +Y+P + + R ++ P RF I A L +
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RMEVFPEVLARFYI----AELTLAI 114
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598
K+ IHRD+K NIL+D++ + K++DFGL F
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 44/151 (29%), Positives = 68/151 (45%), Gaps = 10/151 (6%)
Query: 448 FSEANMIGKGGFGPVYM-GKLSTGQEIAAKRLSKNSGQGLEEFMN---EVVLIGKLQHRN 503
F +IG+G FG V + K TG A K L K E+ + E ++ +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
+V + S ++ LI E++P D ++ L +F I A +L +
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGG--DMMTLLMKKDTLSEEATQFYI----AETVLAIDA 116
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGL 594
+L IHRD+K N+LLD + K+SDFGL
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 44/151 (29%), Positives = 69/151 (45%), Gaps = 10/151 (6%)
Query: 448 FSEANMIGKGGFGPVYM-GKLSTGQEIAAKRLSKNSGQGLEEFMN---EVVLIGKLQHRN 503
F +IG+G FG V + K TG A K L K E+ + E ++ +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
+V + S ++ LI E++P D ++ L + +F I A +L +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGG--DMMTLLMKKDTLTEEETQFYI----AETVLAIDS 116
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGL 594
+L IHRD+K N+LLD + K+SDFGL
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 36.1 bits (84), Expect = 0.002
Identities = 12/48 (25%), Positives = 23/48 (47%), Gaps = 3/48 (6%)
Query: 721 NDGVTLPQPRQPGFFTERGFTVGALSSHEKCHSE---NALSITIQEGR 765
++ +PQP+QPGF R SS + N +++++ + R
Sbjct: 1 SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 33/113 (29%), Positives = 52/113 (46%), Gaps = 25/113 (22%)
Query: 552 TGIARGLLYLHQDSKLQVIHRDLKASNILL---DINLNP-------------KISDFGLA 595
TG+A L Y H ++L ++H DLK NIL+ D ++P +I D G
Sbjct: 240 TGVA--LDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-- 293
Query: 596 RIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKM 648
G DE + T Y SPE +D++S+G ++ E+ +GK+
Sbjct: 294 ---GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL 343
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 765 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.55 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.51 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.38 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.32 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.27 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.26 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.23 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.12 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.09 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.04 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.02 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.0 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.91 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.83 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.8 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.77 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.73 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.67 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.62 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.53 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.52 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.49 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.4 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.37 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.34 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.32 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.26 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.21 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 98.19 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.17 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.12 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.06 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.03 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.02 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.89 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.85 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.84 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.78 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.73 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.7 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.66 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.65 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.59 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.46 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.37 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.3 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.25 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.19 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.03 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.0 | |
| PLN02236 | 344 | choline kinase | 96.93 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.89 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.86 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.55 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.51 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.32 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.26 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.24 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.14 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.95 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-52 Score=446.55 Aligned_cols=288 Identities=42% Similarity=0.738 Sum_probs=257.8
Q ss_pred cccccchHhHHHHhcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeee
Q 004264 432 EVPLYDLATITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSC 511 (765)
Q Consensus 432 ~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~ 511 (765)
....|++.++..+|++|...+.||+|+||.||+|.+++++.||||++.....+..++|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999998765443156699999999999999999999999
Q ss_pred eecC-ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeec
Q 004264 512 IEED-ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKIS 590 (765)
Q Consensus 512 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~ 590 (765)
.+.+ +++||||||++|+|.++++..... +++|..|++|+.++|+||+|||+....+||||||||.|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999875544 78999999999999999999999998899999999999999999999999
Q ss_pred ccccceeeCCCCcccccccc-cccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhh
Q 004264 591 DFGLARIFGGDDEEAQTERV-AGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLW 669 (765)
Q Consensus 591 DFGla~~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 669 (765)
|||+|+..... ....... .||.+|+|||++..+..+.|+||||||++|+||++|+.+.+...+.....+..|++..+
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999664321 1111122 89999999999999999999999999999999999999988776666677899999999
Q ss_pred ccCCcccccccccc-CccCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 670 NDGRALGLMDTCLE-DSFVE-SQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 670 ~~~~~~~l~d~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
.++++.+++|+.+. ..+.. .++.++.+++.+|++.+|.+||+|.+|+++|+..
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 99999999999987 56664 6889999999999999999999999999999553
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=381.53 Aligned_cols=257 Identities=32% Similarity=0.475 Sum_probs=212.3
Q ss_pred cccccccccCCceeEEEEEeCCCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecC-ceEEEEEec
Q 004264 448 FSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED-ERMLIYEYM 524 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~-~~~lV~E~~ 524 (765)
..+.+.||+|+||+||+|.+.....||+|++.... ....++|.+|+.+|.+++|||||+++|+|.+.. ...+||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 34455699999999999999655559999997643 222679999999999999999999999999988 799999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC-CCeecccccceeeCCCCc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL-NPKISDFGLARIFGGDDE 603 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~vkL~DFGla~~~~~~~~ 603 (765)
++|+|..+++.. ....+++..+++++.|||+||.|||+.+. ||||||||+|||++.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999764 45679999999999999999999999874 99999999999999997 99999999998764322
Q ss_pred ccccccccccccccCccccc--CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYAN--DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~--~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
...+...||+.|||||++. ...|+.|+||||||++||||+||+.||....+.. -+......+....+..
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~------~~~~v~~~~~Rp~~p~-- 269 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ------VASAVVVGGLRPPIPK-- 269 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcCCCCCCCc--
Confidence 2333478999999999999 5699999999999999999999999997655421 1222222333332222
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCC
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGV 724 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 724 (765)
.....+..++.+||+.||+.||++.+++.+|+....
T Consensus 270 -------~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 270 -------ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred -------cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 245568899999999999999999999999986443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=359.50 Aligned_cols=250 Identities=28% Similarity=0.398 Sum_probs=207.1
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecC-ceEEEEEe
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED-ERMLIYEY 523 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~-~~~lV~E~ 523 (765)
+.+..+.||+|..|+|||++++ +++.+|+|++... .....+++.+|++++++.+||+||+++++|.... ...++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4556788999999999999975 6788999998543 4556789999999999999999999999999988 49999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhh-cCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ-DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|.+|+|++++... +.+++...-+|+.+|++||.|||+ .+ ||||||||+|||++..|.|||+|||.++.+.+.
T Consensus 160 MDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999998433 569999999999999999999996 55 999999999999999999999999999987433
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCC--CCcccHHHHHHHhhccCCccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHP--GHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
....++||..|||||.+++..|+.++||||||+.++|+.+|+.|+....+ .....+... .-.+....+++
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~----Iv~~ppP~lP~- 304 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA----IVDEPPPRLPE- 304 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH----HhcCCCCCCCc-
Confidence 44578999999999999999999999999999999999999999876521 111111111 11111111111
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.....++..++..||+.||.+||++.|++++
T Consensus 305 -------~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 305 -------GEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -------ccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1356778999999999999999999999853
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=379.66 Aligned_cols=247 Identities=27% Similarity=0.413 Sum_probs=211.2
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
.+|+..+.||+|||+.+|+++. ..|..||+|++.+. .....+.+.+||+|.+.|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999997 88999999999874 3344677899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
|+|++++|..++ ++++++.+.+++.+++||+.||.|||+.+ |+|||||..|+||+++.+|||+|||+|..+...
T Consensus 98 ELC~~~sL~el~---Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELL---KRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHH---HhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999988 35678999999999999999999999999 999999999999999999999999999998654
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
.++. ...+||+.|+|||++....++..+||||+|||||-|+.|++||....-.+. .......+
T Consensus 172 ~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket-------y~~Ik~~~-------- 234 (592)
T KOG0575|consen 172 GERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET-------YNKIKLNE-------- 234 (592)
T ss_pred cccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH-------HHHHHhcC--------
Confidence 4433 358999999999999999999999999999999999999999964332211 11111111
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
-..+.....+..+||.++|+.+|.+|||+++|+.
T Consensus 235 --Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 235 --YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred --cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1122233455678999999999999999999993
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=362.22 Aligned_cols=254 Identities=25% Similarity=0.325 Sum_probs=205.9
Q ss_pred HhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChh-------hHHHHHHHHHHHhccccCceEeeeeeeeecC
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQ-------GLEEFMNEVVLIGKLQHRNLVGLLGSCIEED 515 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-------~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~ 515 (765)
..+.|.+.+.||+|+||.|-+|.. ++++.||||++++.... .....++|+++|++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 446788999999999999999974 57999999999875211 1233579999999999999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC---CCCeeccc
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN---LNPKISDF 592 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~vkL~DF 592 (765)
..|+||||++||.|.+.+.. .+.+.+.....+++||+.|+.|||+.| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999888854 345778888999999999999999999 9999999999999765 77999999
Q ss_pred ccceeeCCCCcccccccccccccccCcccccCCC---CCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhh
Q 004264 593 GLARIFGGDDEEAQTERVAGTHGYMSPEYANDGT---ISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLW 669 (765)
Q Consensus 593 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 669 (765)
|+|+..+ ........+||+.|.|||++.+.. +..|+|+||+|||||-+++|.+||........ + .+..
T Consensus 324 GlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l----~eQI 394 (475)
T KOG0615|consen 324 GLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--L----KEQI 394 (475)
T ss_pred chhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--H----HHHH
Confidence 9999874 333455789999999999998764 34488999999999999999999976544321 1 1112
Q ss_pred ccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 670 NDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 670 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..|+... .+..-.+..++.+++|.+||..||++|||+.|+++.
T Consensus 395 ~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 395 LKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 2232211 112223456678899999999999999999999853
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=358.66 Aligned_cols=203 Identities=32% Similarity=0.519 Sum_probs=182.6
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
..+|.+.+.||+|+|++||+|+++ ++..||||.+.+. .....+.+..|+.||+.++|||||++++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357888899999999999999964 6789999999766 5666778899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC------CCCeecccccc
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN------LNPKISDFGLA 595 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~------~~vkL~DFGla 595 (765)
|||.+|+|.++++.. +.+++..+..++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999999543 36999999999999999999999999 9999999999999764 45899999999
Q ss_pred eeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCC
Q 004264 596 RIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPG 656 (765)
Q Consensus 596 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~ 656 (765)
+.+. ........+|++-|||||+++.++|+.|+|+||+|+|||+|++|+.||....+.
T Consensus 163 R~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 163 RFLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred hhCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 9975 344455789999999999999999999999999999999999999999865544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=343.92 Aligned_cols=259 Identities=28% Similarity=0.424 Sum_probs=212.7
Q ss_pred cCcccccccccCCceeEEEEE-eCCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeee-eeeecCc-eEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLG-SCIEEDE-RMLI 520 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~-~~~~~~~-~~lV 520 (765)
.+|.|.++||.|.||.||++. +.+|..+|.|.++-. +.+..+....|+.+|++|+|||||++++ .+.++.. .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 468899999999999999997 568999999998743 4566778899999999999999999998 5666655 8899
Q ss_pred EEecCCCChhHHhhc-cccCCCCChHHHHHHHHHHHHHHHHhhhcC-CCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 521 YEYMPHKSLDYFIFD-RERSKLLPWKKRFSIITGIARGLLYLHQDS-KLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
|||+..|+|..++.. ++..+.+++..+|+++.|+++||.++|.+- +..|+||||||.||+|+.+|.|||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999865 345567999999999999999999999942 234999999999999999999999999999998
Q ss_pred CCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
..... .....+||+.||+||.+.+.+|+.|+||||+||++|||+.-+.||.... +. ....+..+++...++
T Consensus 179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~-~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LL-SLCKKIEQGDYPPLP 249 (375)
T ss_pred cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HH-HHHHHHHcCCCCCCc
Confidence 54433 3346899999999999999999999999999999999999999997541 11 122333444332222
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+ ...+..+.+|+..|+..||+.||+...+++.+..
T Consensus 250 ~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 250 D--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred H--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1 3346678899999999999999996555555543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=350.16 Aligned_cols=242 Identities=27% Similarity=0.332 Sum_probs=202.0
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
.++|++.++||+|+||+|+.++. ++++.+|+|++++. ...+.+...+|..||.+++||+||+++..|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 47899999999999999999985 46888999999875 234567889999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
+||+.||.|..+|. +.+.+++..+.-++..|+.||.|||+++ ||||||||+|||||++|+++|+|||+++..-.
T Consensus 104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999994 4456999999999999999999999999 99999999999999999999999999996432
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
. ...+..++||+.|||||++.+..|+..+|.||||+++|||++|.+||...+...... ....++.
T Consensus 178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~-------~I~~~k~------ 242 (357)
T KOG0598|consen 178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYD-------KILKGKL------ 242 (357)
T ss_pred C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHH-------HHhcCcC------
Confidence 2 223445899999999999999999999999999999999999999997544322111 1111221
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCC
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRP 710 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 710 (765)
...+.-...+..+++...|+.+|++|.
T Consensus 243 ---~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 ---PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 011111234567888999999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=335.12 Aligned_cols=263 Identities=21% Similarity=0.317 Sum_probs=210.5
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
++|+...++|+|+||.|||++.+ +|+.||||++.... +...+-.++|+++|++|+|+|+|.++++|......+||||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999975 58999999997643 3345667899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++.-|+++-. ....++...+.+++.|+++|+.|+|+++ +|||||||+||||+.++.+||||||+|+.+..
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-- 153 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-- 153 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence 999988877753 3345899999999999999999999999 99999999999999999999999999998854
Q ss_pred cccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHhhccCC
Q 004264 603 EEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHA--------WLLWNDGR 673 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 673 (765)
....-+..+.|+.|+|||.+.+ -+|...+|||++||++.||++|.+.|...++-+....+... ...+..+.
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 2233446789999999999987 68999999999999999999999998877765554433221 12222222
Q ss_pred cc-ccccccccCcc-----CHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 004264 674 AL-GLMDTCLEDSF-----VESQVLRCIQVGLLCVQKLPEDRPDMSSVV 716 (765)
Q Consensus 674 ~~-~l~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl 716 (765)
.. .+.=+.+.... -+....-+++++..||+.||++|++-++++
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 21 11111111100 112233578999999999999999999987
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=358.98 Aligned_cols=252 Identities=33% Similarity=0.501 Sum_probs=209.8
Q ss_pred cccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCC
Q 004264 448 FSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHK 527 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~g 527 (765)
++..+.||+|-||.|+.|.+.....||+|.+... ....+.|.+|+.+|++|+|+|||+++++|..++..+||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 4556889999999999999988889999998654 344578999999999999999999999999999999999999999
Q ss_pred ChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccccc
Q 004264 528 SLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQT 607 (765)
Q Consensus 528 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~ 607 (765)
+|.+++.. ..+..+.....+.++.|||+||+||++++ +|||||..+||||+++..+||+|||+|+......... .
T Consensus 287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~-~ 361 (468)
T KOG0197|consen 287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA-S 361 (468)
T ss_pred cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee-c
Confidence 99999976 33456899999999999999999999999 9999999999999999999999999999543332222 2
Q ss_pred ccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCcc
Q 004264 608 ERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSF 686 (765)
Q Consensus 608 ~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 686 (765)
....-...|.|||.+..+.|+.|+|||||||+||||+| |+.|+......+ +......|....-++.
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-------v~~~le~GyRlp~P~~------ 428 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-------VLELLERGYRLPRPEG------ 428 (468)
T ss_pred CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-------HHHHHhccCcCCCCCC------
Confidence 23444567999999999999999999999999999999 777765444332 2333344444333333
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 687 VESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 687 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+..++.+||..||+.+|++|||++.+...|+.
T Consensus 429 ---CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~ 460 (468)
T KOG0197|consen 429 ---CPDEVYELMKSCWHEDPEDRPTFETLREVLED 460 (468)
T ss_pred ---CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence 34567799999999999999999999998876
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=319.54 Aligned_cols=284 Identities=23% Similarity=0.306 Sum_probs=220.8
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEccccCh--hhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSG--QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
++|...++||+|.||.||+|+. ..|+.||||++..... .......+|++.|+.++|+||+.++++|-..+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999985 5799999999975422 224568899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
||+ .+|+..+.+ ....+....+..++.++++||+|||++. |+||||||.|+|++++|.+||+|||+|+.+....
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 995 478888854 3456889999999999999999999999 9999999999999999999999999999987554
Q ss_pred cccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc---cc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG---LM 678 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---l~ 678 (765)
..... .+-|..|+|||.+.+. .|+..+||||.|||+.||+.|.+-|...++-+....+-.+...-.+..+.+ +.
T Consensus 156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 43332 3789999999998874 699999999999999999999988876665544444333322222222221 22
Q ss_pred c---------ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCCCCCCCCCCCccccccc
Q 004264 679 D---------TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGVTLPQPRQPGFFTERGF 740 (765)
Q Consensus 679 d---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~p~~~~~~~~ 740 (765)
| +... ..-.......++++..++.+||.+|++++|++++= --..+|.|..|.....++.
T Consensus 234 dY~~~~~~P~~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~--yf~~~P~pt~~~~lp~p~~ 301 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKHP--YFKSLPLPTPPSKLPIPST 301 (318)
T ss_pred cHHHHhcCCCCccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcch--hhhcCCCCCChhhCcCCcc
Confidence 2 1111 12223445668999999999999999999999873 2222566666665554433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=349.66 Aligned_cols=255 Identities=27% Similarity=0.354 Sum_probs=212.0
Q ss_pred HHHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCc
Q 004264 442 TTATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDE 516 (765)
Q Consensus 442 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~ 516 (765)
.....+|...+.||+|+|++|++|+. ..+++||||++.+. .....+-...|-.+|.+| .||.|++++..|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34457899999999999999999985 57899999999875 233345567899999999 79999999999999999
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
+|+|+||+++|.|.++|. +.+.+++.....++.+|+.||+|||+.| ||||||||+|||||.++++||+|||.|+
T Consensus 149 LYFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999994 3456999999999999999999999999 9999999999999999999999999999
Q ss_pred eeCCCCcc---------ccc--ccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 004264 597 IFGGDDEE---------AQT--ERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHA 665 (765)
Q Consensus 597 ~~~~~~~~---------~~~--~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~ 665 (765)
.+...... ... ..++||..|.+||++.....++.+|+|+||||||+|+.|++||....+......+...
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l 302 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL 302 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence 98643222 111 4589999999999999999999999999999999999999999876654332222111
Q ss_pred HHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004264 666 WLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719 (765)
Q Consensus 666 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 719 (765)
+- .++........+|+.+.|..||.+|++.++|.+..
T Consensus 303 -------------~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 303 -------------DY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred -------------cc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 11 12222235567889999999999999999998654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=335.50 Aligned_cols=262 Identities=24% Similarity=0.331 Sum_probs=215.9
Q ss_pred hcCcccccccccCCceeEEEEE-eCCCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
.++|++.+.||.|..++||+|+ .+.+..||||++.-. .....+.+++|+..++.++||||++++..|..+...++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4679999999999999999998 467899999999743 23347889999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
||.+||+.++++..-.. .+++..+..|++++++||.|||++| .||||||+.||||+++|.|||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999765443 4999999999999999999999999 9999999999999999999999999987664433
Q ss_pred cccc--cccccccccccCcccccC--CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 603 EEAQ--TERVAGTHGYMSPEYAND--GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 603 ~~~~--~~~~~gt~~Y~aPE~~~~--~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
.+.. ....+||+.|||||++.+ ..|+.|+|||||||...||.+|+.||....|....- ..-++....+.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl-------~tLqn~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL-------LTLQNDPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH-------HHhcCCCCCcc
Confidence 2222 146789999999999654 469999999999999999999999998777654311 11133333233
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
...+..+........+.+++..||+.||.+|||++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 333333344445567889999999999999999999984
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=340.92 Aligned_cols=267 Identities=24% Similarity=0.293 Sum_probs=208.8
Q ss_pred HhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeec--CceE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE--DERM 518 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~--~~~~ 518 (765)
..+.|+..++||+|.||.||+|+. .+|+.||+|++.... ........+||.||++|.||||+++.+...+. ...|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 346788899999999999999984 679999999987554 44566788999999999999999999998876 6899
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
||||||++. |.-++. ...-.+++.++..+++||+.||+|||..+ |+|||||..|||||.+|.+||+|||+|+++
T Consensus 195 lVFeYMdhD-L~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDHD-LSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccch-hhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 999999874 444442 22346899999999999999999999999 999999999999999999999999999988
Q ss_pred CCCCcccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcc--
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRAL-- 675 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 675 (765)
........ +..+-|..|+|||.+.+. .|+.++|+||.||||.||+.|++.+....+.+....+-..-.-..+..+.
T Consensus 269 ~~~~~~~~-T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSGSAPY-TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCCCccc-ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 66554443 356779999999999875 69999999999999999999999998777655544433221111111111
Q ss_pred ccccc---cccCccCH-------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 676 GLMDT---CLEDSFVE-------SQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 676 ~l~d~---~l~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
+++.. .....+.. ......++|+..+|..||.+|.|+.++++
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 12210 01111111 11234678999999999999999999884
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.65 Aligned_cols=266 Identities=24% Similarity=0.286 Sum_probs=211.4
Q ss_pred HHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccCh-hhHHHHHHHHHHHhccc-cCceEeeeeeeeecC-ceE
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSG-QGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEED-ERM 518 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~-~~~ 518 (765)
...++|.+.++||.|.||.||+|+. ..+..||||++++.-. .+...-++|+..|++|. ||||+++.+.+.+.+ ..+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 3457899999999999999999984 5788999999976532 22334468999999998 999999999999988 999
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
+|||||+. +|.+++.++ +..+++..+..|+.||++||+|+|++| +.|||+||+|||+.....+||+|||+|+..
T Consensus 87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 99999965 677888554 678999999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCcccccccccccccccCcccc-cCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc-
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYA-NDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG- 676 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 676 (765)
..... -+..+.|+.|+|||++ +.+.|+.+.|||++|||++|+.+-++.|.+..+.+....+-.+...-.+..+.+
T Consensus 161 ~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 161 RSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred ccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 44332 3357899999999976 467899999999999999999999999877666555444322211111111111
Q ss_pred -------------cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 677 -------------LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 677 -------------l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.....+..-. .....++++++.+|+++||.+|||+.+.+++
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111111111 2256678899999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=335.15 Aligned_cols=255 Identities=28% Similarity=0.437 Sum_probs=204.0
Q ss_pred cCcccccccccCCceeEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecC--ceEEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLST-GQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED--ERMLIYE 522 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~--~~~lV~E 522 (765)
.+|...+.||+|+||.||++...+ |...|||..........+.+.+|+.+|.+++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 457778899999999999998754 8899999987654333677899999999999999999999855555 5899999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec-CCCCeecccccceeeCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI-NLNPKISDFGLARIFGGD 601 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~vkL~DFGla~~~~~~ 601 (765)
|+++|+|.+++..... .+++..+..+++||++||+|||+++ ||||||||+|||++. ++.+||+|||+++.....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999954332 6999999999999999999999999 999999999999999 799999999999987541
Q ss_pred C-cccccccccccccccCcccccCCC-CCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 602 D-EEAQTERVAGTHGYMSPEYANDGT-ISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 602 ~-~~~~~~~~~gt~~Y~aPE~~~~~~-~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
. .........||+.|||||++.++. ...++|||||||++.||+||+.||... ................
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~----- 241 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSL----- 241 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCC-----
Confidence 1 112233588999999999999643 345999999999999999999998653 1111111111111211
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 719 (765)
+.++........+++..|++.+|++||||+++++..
T Consensus 242 ----P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 242 ----PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ----CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 133333455677999999999999999999999765
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=349.45 Aligned_cols=259 Identities=29% Similarity=0.419 Sum_probs=203.8
Q ss_pred hcCcccccccccCCceeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecC-
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL------STGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEED- 515 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~- 515 (765)
.++|++.++||+|+||.||+|.. ..++.||+|++.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46899999999999999999973 235679999987543 33456789999999999 8999999999887644
Q ss_pred ceEEEEEecCCCChhHHhhcccc---------------------------------------------------------
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRER--------------------------------------------------------- 538 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 538 (765)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999998864211
Q ss_pred --CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccccccccccccc
Q 004264 539 --SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGY 616 (765)
Q Consensus 539 --~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y 616 (765)
...+.+..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 134778889999999999999999998 999999999999999999999999999865432222222234566789
Q ss_pred cCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHH
Q 004264 617 MSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCI 695 (765)
Q Consensus 617 ~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~ 695 (765)
+|||++.+..++.++||||||++||||++ |+.||....... . .......+..... +......+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~----~~~~~~~~~~~~~---------~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--E----FCQRLKDGTRMRA---------PENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--H----HHHHHhcCCCCCC---------CCCCCHHHH
Confidence 99999999999999999999999999997 999986543221 1 1111112221111 112234578
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 696 QVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 696 ~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+|+.+||+.+|++|||+.+|+++|+.
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHH
Confidence 99999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=345.20 Aligned_cols=263 Identities=27% Similarity=0.416 Sum_probs=215.4
Q ss_pred hHHHHhcCcccccccccCCceeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCce
Q 004264 440 TITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDER 517 (765)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~ 517 (765)
+.....+...+.+.||+|.||+||+|.+. ..||||++... .....+.|++||..+++-+|.||+-++|+|.....
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 33444566778899999999999999985 47999999754 45567899999999999999999999999998877
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
.||+.+|+|.+|..+++... ..++..+.++|++||++|+.|||.++ |||||||..|||+.++++|||+|||++..
T Consensus 463 AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence 99999999999999996543 56899999999999999999999999 99999999999999999999999999987
Q ss_pred eCCCCcccccccccccccccCcccccCC---CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCc
Q 004264 598 FGGDDEEAQTERVAGTHGYMSPEYANDG---TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRA 674 (765)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (765)
..............|...|||||+++.. +|++.+||||||+++|||++|..|+.....+... |..|+-
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi---------fmVGrG 608 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII---------FMVGRG 608 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE---------EEeccc
Confidence 6655444445567788899999999753 6999999999999999999999998833333222 222322
Q ss_pred cccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 675 LGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 675 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
.-.+|... ......+++.+|+..||..++++||.+.+|+.+|+..
T Consensus 609 ~l~pd~s~---~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 609 YLMPDLSK---IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred ccCccchh---hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 11222211 1123455788899999999999999999999988764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=341.53 Aligned_cols=244 Identities=28% Similarity=0.402 Sum_probs=208.1
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+. ..++.+.+.+|++|++.|+||||+.+++.|....+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57889999999999999999865 6788999998764 45667889999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+.+ +|..++.. .+.++++.+..++.+++.||.|||+.+ |+|||+||+|||++.++.+|++|||+|+....
T Consensus 82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-- 152 (808)
T ss_pred hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc--
Confidence 9987 99988843 456999999999999999999999999 99999999999999999999999999998643
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
.....+...||+-|||||...+++|+..+|+||+|||+|||+.|++||..... . +++...+
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si------~-------------~Lv~~I~ 213 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI------T-------------QLVKSIL 213 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH------H-------------HHHHHHh
Confidence 22334468999999999999999999999999999999999999999853221 1 1111111
Q ss_pred cC--ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 683 ED--SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 683 ~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.+ .++......+..++...|+.||.+|.+-.+++.
T Consensus 214 ~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 214 KDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 11 123355667889999999999999999999974
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=360.06 Aligned_cols=258 Identities=31% Similarity=0.413 Sum_probs=215.3
Q ss_pred CcccccccccCCceeEEEEEe------CCCcEEEEEEccccChh-hHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKL------STGQEIAAKRLSKNSGQ-GLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~~-~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
+-...+.||+|.||+||+|+. ++...||||.+++.... ...+|++|++++..|+|||||+++|.|.+++..++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 344557899999999999974 23567999999876544 78899999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhcccc-----------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCe
Q 004264 520 IYEYMPHKSLDYFIFDRER-----------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPK 588 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vk 588 (765)
|+|||.+|+|.++|..... ..+++..+.+.|+.|||.||+||-++. +|||||..+|+||.++..||
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEE
Confidence 9999999999999965321 223888999999999999999999998 99999999999999999999
Q ss_pred ecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHH
Q 004264 589 ISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWL 667 (765)
Q Consensus 589 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 667 (765)
|+|||+++.....+.......-.-.++|||||.|..++|++++|||||||+|||+++ |+-|+......+ +..
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------VIe 716 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------VIE 716 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------HHH
Confidence 999999998755544433333344678999999999999999999999999999999 777876555443 334
Q ss_pred hhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 004264 668 LWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDG 723 (765)
Q Consensus 668 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 723 (765)
...+|++...++. +..++..||..||+.+|.+||+++||-..|+...
T Consensus 717 ~i~~g~lL~~Pe~---------CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 717 CIRAGQLLSCPEN---------CPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred HHHcCCcccCCCC---------CCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 4455665444443 4556889999999999999999999999997643
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=341.45 Aligned_cols=250 Identities=27% Similarity=0.416 Sum_probs=211.6
Q ss_pred cCcccccccccCCceeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
..|...++||+|+.|.||.|+ ...++.||||++........+-+.+|+.+|+..+|+|||++++.|..++..++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 457778899999999999997 4678899999998776666778899999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++|+|.+.+-. ..+++..+..|.++++.||+|||.++ |+|||||.+|||++.++.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 353 EGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 99999999833 34899999999999999999999999 99999999999999999999999999988754433
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
.....+||+.|||||+.....|.+|+||||||++++||+-|++||-...|-....+ ....|.. .-
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL------Ia~ng~P--------~l 489 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNGTP--------KL 489 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH------HhhcCCC--------Cc
Confidence 33468999999999999999999999999999999999999999865444332222 2222221 11
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.........+.+++.+||+.|+++||++.|+|+.
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1223345568899999999999999999999864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=311.56 Aligned_cols=236 Identities=27% Similarity=0.337 Sum_probs=199.9
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccCh---hhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSG---QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|+..+.||.|+||.|.+++.+ .|..+|+|++.+... ...+...+|..+|+.+.||+++++++.+.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 57889999999999999999865 578899999987643 23456778999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||++||.|..+++. .+.+++..+..++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+...
T Consensus 124 eyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS-- 195 (355)
T ss_pred eccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec--
Confidence 99999999999843 446999999999999999999999999 9999999999999999999999999999863
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
..+...+||+.|+|||+++...|+.++|.|+||+++|||+.|..||....+... ..+.-++++
T Consensus 196 ---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i-------Y~KI~~~~v------- 258 (355)
T KOG0616|consen 196 ---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI-------YEKILEGKV------- 258 (355)
T ss_pred ---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH-------HHHHHhCcc-------
Confidence 235578999999999999999999999999999999999999999987666321 122212221
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCC
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDR 709 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~R 709 (765)
.++.-....+.+|+...|+.|-.+|
T Consensus 259 ---~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 ---KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ---cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1233334456678888888888888
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=332.38 Aligned_cols=264 Identities=26% Similarity=0.372 Sum_probs=203.5
Q ss_pred cCcccccccccCCceeEEEEEeCC-----------------CcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEee
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLST-----------------GQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGL 507 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~ 507 (765)
++|.+.++||+|+||.||++.+.+ +..||+|++... ......++.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578899999999999999997532 236999998754 33345679999999999999999999
Q ss_pred eeeeeecCceEEEEEecCCCChhHHhhccc----------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEe
Q 004264 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRE----------------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIH 571 (765)
Q Consensus 508 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH 571 (765)
++++.+.+..++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999885421 1124678889999999999999999998 999
Q ss_pred cccCCCcEEEecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhC--CCC
Q 004264 572 RDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSG--KMN 649 (765)
Q Consensus 572 ~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG--~~p 649 (765)
|||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999876433322223344567889999999999999999999999999999974 455
Q ss_pred CCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 650 RGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+...... ................... ..+......+.+++.+||+.+|++|||+.+|.+.|+.
T Consensus 242 ~~~~~~~---~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDE---QVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHH---HHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 5433222 1222221111111110000 0111223567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=340.31 Aligned_cols=248 Identities=24% Similarity=0.355 Sum_probs=205.1
Q ss_pred HhcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc----Ch-hhHHHHHHHHHHHhccc-cCceEeeeeeeeecCc
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN----SG-QGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDE 516 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~-~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~ 516 (765)
..++|.+.+.||+|+||+|+.|.. .++..||+|++.+. .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 457899999999999999999975 46899999977653 22 34556778999999998 9999999999999999
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC-CCCeecccccc
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN-LNPKISDFGLA 595 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~vkL~DFGla 595 (765)
.++||||+.+|.|.+++.. .+.+.+.++..+++||+.|++|||+.+ |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999954 455888999999999999999999999 9999999999999999 99999999999
Q ss_pred eeeCCCCcccccccccccccccCcccccCCC-CC-ccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC
Q 004264 596 RIFGGDDEEAQTERVAGTHGYMSPEYANDGT-IS-MKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR 673 (765)
Q Consensus 596 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 673 (765)
.... .........+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||....... .......+.
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-------l~~ki~~~~ 239 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-------LYRKIRKGE 239 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-------HHHHHhcCC
Confidence 9864 2333445689999999999999977 85 78999999999999999999998622211 111111111
Q ss_pred ccccccccccCccCHHH-HHHHHHHHHHccccCCCCCCCHHHHH
Q 004264 674 ALGLMDTCLEDSFVESQ-VLRCIQVGLLCVQKLPEDRPDMSSVV 716 (765)
Q Consensus 674 ~~~l~d~~l~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl 716 (765)
. . ++... ..++..++.+|++.+|.+|+++.+|+
T Consensus 240 ~-~---------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 240 F-K---------IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred c-c---------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1 0 11111 45678999999999999999999999
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=333.30 Aligned_cols=254 Identities=24% Similarity=0.275 Sum_probs=206.2
Q ss_pred HhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
..++|+++++||+|+||.||+++. .+|+.+|+|++++.. ....+..+.|-.+|....+++||+++..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 557899999999999999999985 468999999998863 3446678889999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||++||++..+|. +...+++..+..++.+++.|++.||+.| +|||||||+|+|||..|++||+|||++.-+.
T Consensus 219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999984 4567999999999999999999999999 9999999999999999999999999985431
Q ss_pred CC----------------------Ccc-----------------------cccccccccccccCcccccCCCCCccccch
Q 004264 600 GD----------------------DEE-----------------------AQTERVAGTHGYMSPEYANDGTISMKSDVF 634 (765)
Q Consensus 600 ~~----------------------~~~-----------------------~~~~~~~gt~~Y~aPE~~~~~~~s~k~Dvw 634 (765)
.. ... ......+|||.|+|||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 000 001236799999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCC---
Q 004264 635 SLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPD--- 711 (765)
Q Consensus 635 SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs--- 711 (765)
|||||+||||.|.+||....+.+.-..+..-...+. .++ ......+..+||.+|+. ||++|.-
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~------fP~-------~~~~s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK------FPE-------EVDLSDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc------CCC-------cCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence 999999999999999998887665333321111110 010 11112556788899999 9999975
Q ss_pred HHHHHH
Q 004264 712 MSSVVF 717 (765)
Q Consensus 712 ~~evl~ 717 (765)
++||.+
T Consensus 439 ~~EIK~ 444 (550)
T KOG0605|consen 439 AEEIKK 444 (550)
T ss_pred HHHHhc
Confidence 566653
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=343.09 Aligned_cols=258 Identities=28% Similarity=0.371 Sum_probs=203.7
Q ss_pred cCcccccccccCCceeEEEEEe------CCCcEEEEEEcccc-ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCce
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL------STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDER 517 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~ 517 (765)
++|++.+.||+|+||.||+|+. ..+..||+|++... .....+.+.+|+.+++.+ +||||+++++++.+.+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4688899999999999999963 24568999998643 234456788999999999 899999999999999999
Q ss_pred EEEEEecCCCChhHHhhcccc-----------------------------------------------------------
Q 004264 518 MLIYEYMPHKSLDYFIFDRER----------------------------------------------------------- 538 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 538 (765)
++||||+++|+|.+++.....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999988854221
Q ss_pred -------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 539 -------------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 539 -------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 124788899999999999999999998 9999999999999999999999999998764332222
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
......++..|+|||.+.+..++.++||||||+++|||++ |..||....... ........+.....
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~~------- 338 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEGYRMLS------- 338 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhCccCCC-------
Confidence 2223445677999999999999999999999999999998 888875432211 11111222211100
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+.....++.+|+.+||+.+|++||++.+|+++|++
T Consensus 339 --~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 339 --PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred --CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 01113467899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.81 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=212.3
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
..|+..+.||+|.||.||+|.. ..++.||+|++.-. ...+.+.+++|+.+|.+++++||.++++.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4577778999999999999986 46888999999754 455678899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+.+|++.+.+ +....+++..+.-|+++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+-.+.....
T Consensus 93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999998 33445588888899999999999999999 99999999999999999999999999988754443
Q ss_pred ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
.. ..++||+.|||||++++..|+.|+||||||++.+||.+|.+|+...+|.....++. ....
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp----------------k~~P 228 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP----------------KSAP 228 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc----------------CCCC
Confidence 33 46899999999999998899999999999999999999999999888865544331 1111
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
+.........+.+++..||..+|+.||++.++++
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 2222234556889999999999999999999984
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=342.48 Aligned_cols=259 Identities=27% Similarity=0.386 Sum_probs=203.6
Q ss_pred hcCcccccccccCCceeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCc
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL------STGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDE 516 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~ 516 (765)
.++|.+.+.||+|+||.||+++. .+++.||+|++.... ......+.+|+.+++.+ +|+||+++++++.+...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 35788999999999999999874 234579999997543 33456788999999999 89999999999999999
Q ss_pred eEEEEEecCCCChhHHhhccc-----------------------------------------------------------
Q 004264 517 RMLIYEYMPHKSLDYFIFDRE----------------------------------------------------------- 537 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 537 (765)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999998885421
Q ss_pred --------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccccccc
Q 004264 538 --------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTER 609 (765)
Q Consensus 538 --------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~ 609 (765)
....+++..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1124788889999999999999999998 99999999999999999999999999987543322222223
Q ss_pred ccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCH
Q 004264 610 VAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVE 688 (765)
Q Consensus 610 ~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~ 688 (765)
..++..|+|||++.+..++.++||||||+++|||++ |+.||........ .......+... ..+.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~~~~~---------~~~~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKRGYQM---------SRPD 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHcccCc---------cCCC
Confidence 345678999999999999999999999999999997 9999865432211 11111111100 0011
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 689 SQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 689 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.....+.+++.+||+.+|++||++.+|+++|++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 123467889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=336.78 Aligned_cols=281 Identities=24% Similarity=0.329 Sum_probs=225.5
Q ss_pred HHHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccc-cCceEeeeeeeeecCc
Q 004264 442 TTATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDE 516 (765)
Q Consensus 442 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~ 516 (765)
....++|...++||+|+||+|+++..+ +++.+|||.+++. ...+.+..+.|..|+.... ||.+++++.+|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 445678999999999999999999865 6788999999886 3556778888999888875 9999999999999999
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
.++||||+.||++..+ .+.+.+++..+.-++..|+.||.|||+++ |||||||.+|||||.+|++||+|||+++
T Consensus 444 l~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999984322 34456999999999999999999999999 9999999999999999999999999999
Q ss_pred eeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 597 IFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
.-... ...+.+++||+.|+|||++.+..|+.++|.|||||+||||+.|+.||...++++
T Consensus 517 e~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------------------- 575 (694)
T KOG0694|consen 517 EGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------------------- 575 (694)
T ss_pred ccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-------------------
Confidence 75322 335567999999999999999999999999999999999999999997665543
Q ss_pred ccccccc--CccCHHHHHHHHHHHHHccccCCCCCCCH-----HHHH----------HHHhcCCCCCCCCCCCCccccc-
Q 004264 677 LMDTCLE--DSFVESQVLRCIQVGLLCVQKLPEDRPDM-----SSVV----------FLLANDGVTLPQPRQPGFFTER- 738 (765)
Q Consensus 677 l~d~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl----------~~L~~~~~~l~~p~~p~~~~~~- 738 (765)
++|..+. ..++.-...+.+.|+.++|..+|++|.-+ .+|. ..|++.. ++.|=.|..-..+
T Consensus 576 ~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~--i~PPf~P~i~~~~D 653 (694)
T KOG0694|consen 576 VFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRR--IKPPFVPTIKGPED 653 (694)
T ss_pred HHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhcc--CCCCCCcccCChhh
Confidence 2333332 23566667788899999999999999866 3333 3344432 4555555553332
Q ss_pred --ccccccCCCCcccc
Q 004264 739 --GFTVGALSSHEKCH 752 (765)
Q Consensus 739 --~~~~~~~~~~~~~~ 752 (765)
.++.++++-.+.++
T Consensus 654 ~snFd~eFt~e~p~Lt 669 (694)
T KOG0694|consen 654 VSNFDEEFTSEKPALT 669 (694)
T ss_pred hcccchhhhcCCCccC
Confidence 24555555444444
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=326.96 Aligned_cols=243 Identities=21% Similarity=0.303 Sum_probs=196.8
Q ss_pred cccccCCceeEEEEEeCCCcEEEEEEccccChhh---HHHHHHHHHHHhccccCceEeeeeeeee----cCceEEEEEec
Q 004264 452 NMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQG---LEEFMNEVVLIGKLQHRNLVGLLGSCIE----EDERMLIYEYM 524 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~---~~~~~~Ev~~l~~l~h~niv~~~~~~~~----~~~~~lV~E~~ 524 (765)
..|++|+++.||+|.. +++.||+|++....... .+.+.+|+.+|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 68899999997643322 5678899999999999999999999877 34678999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhc-CCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD-SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
++|+|.+++.. .+.+++..+..++.|++.||.|||+. + ++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999854 34588999999999999999999985 6 8899999999999999999999999998653221
Q ss_pred ccccccccccccccCcccccC--CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYAND--GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~--~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
....++..|+|||++.+ ..++.++||||||+++|||++|+.||......+ .... ....+...
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~~---i~~~~~~~------ 241 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYDL---IINKNNSL------ 241 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHHH---HHhcCCCC------
Confidence 13467889999999976 689999999999999999999999997543221 1111 11111111
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..+......+.+++.+||+.||++|||+++|++.|+.
T Consensus 242 ---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 242 ---KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred ---CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 1111234568899999999999999999999999975
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=323.53 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=200.9
Q ss_pred cccccccccCCceeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 448 FSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
|++.+.||+|+||.||++.. .+++.||+|++.+.. ......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999986 578999999986532 22345678999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++++|..++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 99999988875432 235889999999999999999999999 9999999999999999999999999998753221
Q ss_pred ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
......|+..|+|||++.+..++.++||||||+++|||++|+.||............ ........
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~~~~~~---------- 221 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV---DRRVKEDQ---------- 221 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH---HHHhhccc----------
Confidence 122457899999999999999999999999999999999999999754432211111 11110000
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPD-----MSSVVFL 718 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 718 (765)
..++......+.+|+.+||+.||++||+ ++++++.
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1122223456778999999999999997 7888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=299.16 Aligned_cols=262 Identities=26% Similarity=0.282 Sum_probs=212.8
Q ss_pred hcCcccccccccCCceeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecC-----ceE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED-----ERM 518 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~-----~~~ 518 (765)
.++|.+.++||+|||+.||.++ ..+++.||+|++.-...++.+..++|++..++++|||+++++++...+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4689999999999999999998 5788999999998777788899999999999999999999999887554 489
Q ss_pred EEEEecCCCChhHHhhccccCC-CCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSK-LLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~-~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
|+++|...|+|.+.+...+..+ .+++.+++.|+.+|++||++||+.. .++.||||||.|||+.+.+.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence 9999999999999987655444 7999999999999999999999986 4799999999999999999999999999876
Q ss_pred eCCCCcc-------cccccccccccccCccccc---CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 004264 598 FGGDDEE-------AQTERVAGTHGYMSPEYAN---DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWL 667 (765)
Q Consensus 598 ~~~~~~~-------~~~~~~~gt~~Y~aPE~~~---~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~ 667 (765)
..-.-.. ..-.....|..|.|||.+. +...++++|||||||+||+|+.|..||+....
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~------------ 246 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ------------ 246 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh------------
Confidence 5311110 0011345788999999885 45689999999999999999999999863221
Q ss_pred hhccCC-cc-ccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 668 LWNDGR-AL-GLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 668 ~~~~~~-~~-~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
+|. +. .+....+.-.......+.+.+++.+|++.||.+||++.+++..+...
T Consensus 247 ---~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 ---QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ---cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 121 11 12222222222223677899999999999999999999999998653
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=316.27 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=208.9
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
-+|++.+.||+|.||.|-+|+. ..|+.||||.+.+. +.++.-.+.+|++||..|+||||+.++++|...+..+|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4789999999999999999985 68999999999875 4566677899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||..+|.|.+++.. .+.+++.++.++++||..|+.|+|+++ ++|||||.+|||+|.++++||+|||++.++.
T Consensus 133 EYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~-- 204 (668)
T KOG0611|consen 133 EYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA-- 204 (668)
T ss_pred EecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc--
Confidence 99999999999954 445999999999999999999999999 9999999999999999999999999998873
Q ss_pred CcccccccccccccccCcccccCCCC-CccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTI-SMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
.......++|++-|.+||+..+.+| .+.+|-||||++||-|+.|..||+..+... ++. ....|...+-
T Consensus 205 -~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---lvr----QIs~GaYrEP--- 273 (668)
T KOG0611|consen 205 -DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---LVR----QISRGAYREP--- 273 (668)
T ss_pred -cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---HHH----HhhcccccCC---
Confidence 2334457899999999999999998 578999999999999999999997644321 111 1122222111
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 719 (765)
.......-||.|||..+|++|-|+.+|....
T Consensus 274 --------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 --------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred --------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1122344688999999999999999998765
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=323.81 Aligned_cols=257 Identities=30% Similarity=0.433 Sum_probs=207.2
Q ss_pred cCcccccccccCCceeEEEEEeCC------CcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLST------GQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~ 518 (765)
++|++.+.||+|+||.||+|.... .+.+++|.+.... .....++.+|+.++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998532 2579999886543 334567899999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhcccc-------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC
Q 004264 519 LIYEYMPHKSLDYFIFDRER-------------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL 585 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 585 (765)
++|||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999998854321 145788999999999999999999998 99999999999999999
Q ss_pred CCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHH
Q 004264 586 NPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGH 664 (765)
Q Consensus 586 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~ 664 (765)
.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....+.+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999987543332222334556788999999999999999999999999999998 999986543321
Q ss_pred HHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 665 AWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 665 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.......+.... .+.....++.+|+.+||+.+|++||++++|+++|++
T Consensus 235 ~~~~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEMIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111111222111 122334678899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=331.35 Aligned_cols=266 Identities=24% Similarity=0.338 Sum_probs=204.1
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
.++|++.+.||+|+||.||+++.. ++..+|+|.+... ......++.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999875 5778899988654 33445679999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999999853 235889999999999999999999853 3999999999999999999999999999865321
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCc--------
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRA-------- 674 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 674 (765)
......|+..|+|||++.+..++.++||||||+++|||++|+.||......+..............+..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 223457899999999999999999999999999999999999998643321110000000000000000
Q ss_pred -------------------cccccccc----cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004264 675 -------------------LGLMDTCL----EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719 (765)
Q Consensus 675 -------------------~~l~d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 719 (765)
.++.+... ...........+.+++.+||+.||++|||+.+|++.-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000000 0001112345688999999999999999999998653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=323.16 Aligned_cols=257 Identities=27% Similarity=0.416 Sum_probs=207.1
Q ss_pred cCcccccccccCCceeEEEEEeCC------CcEEEEEEccccChh-hHHHHHHHHHHHhccccCceEeeeeeeeecCceE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLST------GQEIAAKRLSKNSGQ-GLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~ 518 (765)
++|.+.+.||+|+||.||+|...+ ++.+|+|++...... ..+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 568889999999999999998633 478999998765443 4678999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhccc-----------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCC
Q 004264 519 LIYEYMPHKSLDYFIFDRE-----------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNP 587 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~v 587 (765)
+||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999986432 1245788999999999999999999998 9999999999999999999
Q ss_pred eecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 004264 588 KISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAW 666 (765)
Q Consensus 588 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~ 666 (765)
||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||....... ..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~---- 234 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VI---- 234 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH----
Confidence 9999999986533222222223445778999999999999999999999999999998 999975433221 11
Q ss_pred HhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 667 LLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 667 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.....+..... +......+.+++.+||+.+|++||++.||+++|++
T Consensus 235 ~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 235 ECITQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11112221111 11223567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=334.68 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=204.2
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999975 58899999987542 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999843 345889999999999999999999999 99999999999999999999999999986532
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+ ..+. ..+...
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i----~~~~-----~~~~~~ 220 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL----KYWK-----ETLQRP 220 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH----Hhcc-----ccccCC
Confidence 223467899999999999999999999999999999999999998754432211110 0000 000000
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
............+.+++.+||+.+|++||+++++++.
T Consensus 221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000011234567789999999999999999999965
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=328.13 Aligned_cols=245 Identities=22% Similarity=0.258 Sum_probs=200.7
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999875 68899999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999998853 345889999999999999999999999 999999999999999999999999999865321
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||....... .......+..
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~------- 215 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-------IYEKILAGKL------- 215 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCc-------
Confidence 224568999999999999999999999999999999999999986543211 1111111111
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPD-----MSSVVFL 718 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 718 (765)
..+......+.+++.+||+.||.+||+ ++++++.
T Consensus 216 ---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 ---EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111112345778999999999999995 8888755
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=320.06 Aligned_cols=254 Identities=24% Similarity=0.328 Sum_probs=202.3
Q ss_pred cCcccccccccCCceeEEEEEeC----CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS----TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
++|++.+.||+|+||.||+|.++ .+..+|+|.+.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56888999999999999999753 35689999987643 33456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||+++++|++++... ...+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 9999999999988532 246889999999999999999999998 99999999999999999999999998765421
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ . .....++....
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~----~~~~~~~~~~~--- 228 (266)
T cd05064 160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---V----IKAVEDGFRLP--- 228 (266)
T ss_pred cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---H----HHHHHCCCCCC---
Confidence 111 11112345678999999999999999999999999999775 999986443221 1 11111221111
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.+......+.+++..||+.+|++||++++|++.|++
T Consensus 229 ------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 229 ------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred ------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 111234467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=323.31 Aligned_cols=265 Identities=21% Similarity=0.293 Sum_probs=202.3
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
++|++.+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999975 57889999986532 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|++++++..+.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999988765542 2345889999999999999999999998 9999999999999999999999999998763322
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HH-hhccCC
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHA--------WL-LWNDGR 673 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~--------~~-~~~~~~ 673 (765)
. .......++..|+|||++.+..++.++||||||+++|||++|+.||......+....+... .. ......
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 1 1222457899999999999999999999999999999999999998754322111111000 00 000111
Q ss_pred ccccccccccC------ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 674 ALGLMDTCLED------SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 674 ~~~l~d~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
......+.... .........+.+++.+||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 10100010000 011112346889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=317.54 Aligned_cols=255 Identities=29% Similarity=0.447 Sum_probs=206.4
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
.++|++.++||+|+||.||+|...+++.|++|++.... ...+.+.+|+.++++++|+||+++++.+...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 36789999999999999999998888899999886533 34578899999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999988543 2345888999999999999999999998 999999999999999999999999999876432221
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
......++..|+|||++.+..++.++||||||+++|+|++ |+.||....... .. .....+....
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~----~~~~~~~~~~------- 224 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VM----SALQRGYRMP------- 224 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HH----HHHHcCCCCC-------
Confidence 1123345678999999999999999999999999999998 999985432211 11 1111111110
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
........+.+++.+|++.+|++||++++++++|++
T Consensus 225 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 --RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011123457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.92 Aligned_cols=255 Identities=28% Similarity=0.416 Sum_probs=206.2
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
.++|++.+.||+|++|.||+|....++.||+|.+.... ...+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688999999999999999998778899999986543 34567899999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999985433 345899999999999999999999998 999999999999999999999999999877522111
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
.......+..|+|||++.+..++.++||||||++++||++ |+.||....... ...........
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~-------- 223 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VLQQVDQGYRM-------- 223 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC--------
Confidence 1111223457999999999999999999999999999999 998886432211 11111111100
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..+......+.+++.+|++.+|++||++.+|++.|+.
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 -PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1111234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.75 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=202.5
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecC
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
++|++.+.||+|+||.||++..+++..+|+|.+... ......+.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 458888999999999999999888889999988643 2334678899999999999999999999999999999999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||.++.........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999999885432 35889999999999999999999999 9999999999999999999999999998653222111
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||......+ .. ....++... ..+
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~----~~i~~~~~~--~~~---- 223 (256)
T cd05114 158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VV----EMISRGFRL--YRP---- 223 (256)
T ss_pred -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHCCCCC--CCC----
Confidence 112345568999999998899999999999999999999 888885433211 11 111111111 011
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
......+.+++.+||+.+|++||++.+++++|.
T Consensus 224 ---~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 ---KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ---CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112346789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.34 Aligned_cols=260 Identities=27% Similarity=0.387 Sum_probs=210.7
Q ss_pred cCcccccccccCCceeEEEEEeC------CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS------TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
.+|.+.+.||+|+||.||+++.. ++..+++|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999742 355689999876666666789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccc-------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCC
Q 004264 520 IYEYMPHKSLDYFIFDRE-------------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLN 586 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 586 (765)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985432 1235889999999999999999999999 999999999999999999
Q ss_pred CeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHH
Q 004264 587 PKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHA 665 (765)
Q Consensus 587 vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~ 665 (765)
+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||....+.+ .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~ 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 99999999986543332222234456788999999999999999999999999999999 999876543321 1
Q ss_pred HHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCC
Q 004264 666 WLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGV 724 (765)
Q Consensus 666 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 724 (765)
......+...... ......+.+++.+||+.+|++||++++|+++|+....
T Consensus 235 ~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 235 IECITQGRVLERP---------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHhCCCCCCCC---------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1122222222111 1123467899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=323.66 Aligned_cols=264 Identities=20% Similarity=0.265 Sum_probs=198.6
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
++|++.++||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57899999999999999999864 67899999986432 23345778999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++ +|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 985 787777432 345788999999999999999999999 9999999999999999999999999998653221
Q ss_pred ccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHhhcc-CC
Q 004264 604 EAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHA--------WLLWND-GR 673 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~-~~ 673 (765)
.......+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||......+....+... +..... ..
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 11223567899999998875 56899999999999999999999998654432211111100 000000 00
Q ss_pred ccccccccccCc----cCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 674 ALGLMDTCLEDS----FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 674 ~~~l~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
......+..... .......++++++.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000000 00112345779999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.96 Aligned_cols=259 Identities=25% Similarity=0.359 Sum_probs=203.9
Q ss_pred HhcCcccccccccCCceeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCc
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS------TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE 516 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~ 516 (765)
..++|++.+.||+|+||.||+|... .+..+|+|++.... .....++.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999998743 34679999886432 3345678899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHhhcccc-------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCee
Q 004264 517 RMLIYEYMPHKSLDYFIFDRER-------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKI 589 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL 589 (765)
.++||||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999854221 124577889999999999999999998 999999999999999999999
Q ss_pred cccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHh
Q 004264 590 SDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLL 668 (765)
Q Consensus 590 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 668 (765)
+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||....... ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-------~~~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VLRF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH
Confidence 99999986533222222222345778999999999999999999999999999999 678875432211 1111
Q ss_pred hccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 669 WNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 669 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..++...... ......+.+++.+|++.+|++||++.+++++|++
T Consensus 234 ~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1122211111 1123467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.26 Aligned_cols=245 Identities=24% Similarity=0.293 Sum_probs=200.6
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||.||+|+.. +++.+|+|++.+.. ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57899999999999999999875 57899999986532 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999988853 345889999999999999999999999 999999999999999999999999999875322
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....+.. ......++.. .
T Consensus 172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~i~~~~~-~----- 233 (329)
T PTZ00263 172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-------IYEKILAGRL-K----- 233 (329)
T ss_pred -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-------HHHHHhcCCc-C-----
Confidence 123578999999999999999999999999999999999999986433211 1111112211 0
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPD-----MSSVVFL 718 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 718 (765)
.+.....++.+++.+||+.||++||+ +++++..
T Consensus 234 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 ----FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11112345778999999999999997 6777643
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=328.38 Aligned_cols=251 Identities=27% Similarity=0.381 Sum_probs=212.7
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCc-eEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE-RMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~-~~lV~ 521 (765)
++|...+++|+|+||.++..+.+ +++.+|+|++.-. .....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57889999999999999998754 6778999988643 45556688999999999999999999999999998 99999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
+|++||+|.+.+...+ +..++++.+..++.||+.|+.|||++. |+|||||+.|||++.+..|||+|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999996654 567999999999999999999999888 999999999999999999999999999998654
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
. .......||+.|+.||.+.+.+|+.|+|||||||++|||++-+++|...+... ++. ....+.
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~----ki~~~~-------- 222 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LIL----KINRGL-------- 222 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHH----HHhhcc--------
Confidence 3 23446899999999999999999999999999999999999999987544321 111 011111
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
-...+.....++..++..|++.+|+.||++.+++.+
T Consensus 223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 123344556778899999999999999999999865
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=321.79 Aligned_cols=258 Identities=29% Similarity=0.416 Sum_probs=207.9
Q ss_pred cCcccccccccCCceeEEEEEe------CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL------STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
.+|.+.+.||+|+||.||++.. .++..+++|.+..........+.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 5688899999999999999974 2345689999877666667789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccc----------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCee
Q 004264 520 IYEYMPHKSLDYFIFDRE----------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKI 589 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL 589 (765)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999885432 1235899999999999999999999999 999999999999999999999
Q ss_pred cccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHh
Q 004264 590 SDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLL 668 (765)
Q Consensus 590 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 668 (765)
+|||+++...............++..|+|||++.+..++.++||||||++++||++ |+.||......+ ....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIEC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence 99999986543322222223445778999999999999999999999999999998 888875443221 1111
Q ss_pred hccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 669 WNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 669 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
...+...... ......+.+++.+||+.+|.+|||+++|+..|++.
T Consensus 235 i~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 235 ITQGRVLQRP---------RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred HHcCCcCCCC---------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1222211111 11234588999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=320.33 Aligned_cols=257 Identities=29% Similarity=0.375 Sum_probs=204.0
Q ss_pred cCcccccccccCCceeEEEEEe-----CCCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-----STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
.+|++.+.||+|+||.||+|.. ..++.+++|.+... .......+.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999974 34678999998743 34445788999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhcccc--------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC
Q 004264 520 IYEYMPHKSLDYFIFDRER--------------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL 585 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 585 (765)
||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999998853221 234788899999999999999999998 99999999999999999
Q ss_pred CCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHH
Q 004264 586 NPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGH 664 (765)
Q Consensus 586 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~ 664 (765)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||....+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999987643322222233445678999999998899999999999999999998 888875432211
Q ss_pred HHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 665 AWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 665 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
............ .+......+.+++.+|++.+|++||++.+|+++|..
T Consensus 235 ~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111111111 111123457789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=332.00 Aligned_cols=247 Identities=26% Similarity=0.355 Sum_probs=206.5
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
.-|+..+.||+|+.|.|-+|++ .+|+..|||++.+.. ......+.+|+.||+.+.|||++++++.+.+..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4577889999999999999985 579999999998652 222456779999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++|.|.+++. ..+++++.++.++++||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|..-
T Consensus 92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe--- 162 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLE--- 162 (786)
T ss_pred EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecc---
Confidence 9999999998884 3456999999999999999999999999 999999999999999999999999999873
Q ss_pred CcccccccccccccccCcccccCCCC-CccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTI-SMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
.........+|.++|.|||++.|.+| ..++||||-|||||.|++|+.||+... +.....+...|.. +++.
T Consensus 163 ~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-------ir~LLlKV~~G~f-~MPs- 233 (786)
T KOG0588|consen 163 VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-------IRVLLLKVQRGVF-EMPS- 233 (786)
T ss_pred cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-------HHHHHHHHHcCcc-cCCC-
Confidence 33445567899999999999999998 568999999999999999999997221 1122223333332 2222
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
....++.+|+.+|+..||++|.|++||++.
T Consensus 234 --------~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 234 --------NISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred --------cCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 223456688999999999999999999975
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=340.50 Aligned_cols=266 Identities=25% Similarity=0.310 Sum_probs=214.0
Q ss_pred cCcccccccccCCceeEEEEEeCCC-cEEEEEEccccChhhHHHHHHHHHHHhccc-cCceEeeeeee-ee------cCc
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTG-QEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-HRNLVGLLGSC-IE------EDE 516 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~-~~------~~~ 516 (765)
-+.+|.+.|.+|||+.||.|....+ .++|+|++...++...+.+.+||++|++|+ |+|||.+++.. .. .-+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4677889999999999999997665 999999998888889999999999999997 99999999943 22 135
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
.+|.||||.+|.|-+++..+.... +.+.++++|+.++++|+++||... .+|||||||-+||||..+++.||||||.|.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 789999999999999997655444 999999999999999999999875 789999999999999999999999999997
Q ss_pred eeCCCCcccc-------cccccccccccCcccc---cCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 004264 597 IFGGDDEEAQ-------TERVAGTHGYMSPEYA---NDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAW 666 (765)
Q Consensus 597 ~~~~~~~~~~-------~~~~~gt~~Y~aPE~~---~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~ 666 (765)
.......... .-...-|+.|+|||++ .+.++++|+|||+|||+||-|+....||+.....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---------- 264 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---------- 264 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----------
Confidence 6533221111 0023468899999976 5788999999999999999999999999743321
Q ss_pred HhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc-CCCCCCCCCCC
Q 004264 667 LLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN-DGVTLPQPRQP 732 (765)
Q Consensus 667 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~-~~~~l~~p~~p 732 (765)
.+++..-.-........++.+||..||+.+|++||++-+|+..+-. ...+++.|..+
T Consensus 265 ---------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 265 ---------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred ---------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 2222222222224678889999999999999999999999987754 33334444433
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.80 Aligned_cols=259 Identities=29% Similarity=0.414 Sum_probs=203.8
Q ss_pred hcCcccccccccCCceeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHhcc-ccCceEeeeeeeee-cC
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS------TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIE-ED 515 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~-~~ 515 (765)
.++|++.+.||+|+||.||+|... .++.||+|++.... ....+.+.+|+.++.++ +|+||+++++++.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357999999999999999999632 34789999987543 33456788899999999 79999999998865 45
Q ss_pred ceEEEEEecCCCChhHHhhcccc---------------------------------------------------------
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRER--------------------------------------------------------- 538 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 538 (765)
..++++||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999988854221
Q ss_pred -CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccccccccccccccc
Q 004264 539 -SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYM 617 (765)
Q Consensus 539 -~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~ 617 (765)
...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 125789999999999999999999998 9999999999999999999999999998764333222333455677899
Q ss_pred CcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHH
Q 004264 618 SPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQ 696 (765)
Q Consensus 618 aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~ 696 (765)
|||++.+..++.++|||||||++|||++ |+.||......+. .......+.... .+.....++.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTRMR---------APEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCCCC---------CCccCCHHHHH
Confidence 9999999999999999999999999998 9999864332211 111111111111 11122356789
Q ss_pred HHHHccccCCCCCCCHHHHHHHHhc
Q 004264 697 VGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 697 li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
++.+||+.+|++||++.+|+++|++
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHH
Confidence 9999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=334.54 Aligned_cols=260 Identities=26% Similarity=0.350 Sum_probs=204.8
Q ss_pred hcCcccccccccCCceeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHhccc-cCceEeeeeeeeecCc
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS------TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDE 516 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~ 516 (765)
.++|.+.++||+|+||.||+|+.. .+..||+|++.... ....+.+.+|+.+++++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 367889999999999999999742 23469999997543 334567899999999996 9999999999999999
Q ss_pred eEEEEEecCCCChhHHhhcccc----------------------------------------------------------
Q 004264 517 RMLIYEYMPHKSLDYFIFDRER---------------------------------------------------------- 538 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 538 (765)
.+|||||+++|+|.+++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999988754210
Q ss_pred -----------------------------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec
Q 004264 539 -----------------------------------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI 583 (765)
Q Consensus 539 -----------------------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 583 (765)
...+++..+..++.||++||+|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124778888999999999999999998 999999999999999
Q ss_pred CCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHH
Q 004264 584 NLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLI 662 (765)
Q Consensus 584 ~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~ 662 (765)
++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~---- 348 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST---- 348 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH----
Confidence 99999999999987643332222233456778999999999999999999999999999997 8888754322111
Q ss_pred HHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 663 GHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 663 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
.......+... ..+......+.+++.+||+.+|++||++.+|+++|++.
T Consensus 349 --~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 349 --FYNKIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred --HHHHHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 11111111110 11112345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=342.96 Aligned_cols=252 Identities=20% Similarity=0.206 Sum_probs=204.2
Q ss_pred CcccccccccCCceeEEEEEeC-C-CcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-T-GQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~-~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
.|.+.+.||+|+||.||+|... + ++.||+|++..........+.+|+.+++.++||||+++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999754 3 5678888776555555667888999999999999999999999999999999999
Q ss_pred CCCChhHHhhcc-ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 525 PHKSLDYFIFDR-ERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 525 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
++++|.+++... ....++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999887543 33456889999999999999999999998 99999999999999999999999999997654332
Q ss_pred ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .......+....
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-------~~~~~~~~~~~~------- 290 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-------IMQQVLYGKYDP------- 290 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCC-------
Confidence 223345679999999999999999999999999999999999999986432211 111111111111
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.+......+.+++..||+.+|++||++.+++.
T Consensus 291 --~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 --FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11122346789999999999999999999864
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=317.05 Aligned_cols=256 Identities=29% Similarity=0.433 Sum_probs=210.5
Q ss_pred HhcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
...+|++.++||+|+||.||+|...+++.+++|.+.........++..|+.+++.++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34678999999999999999999888999999999877665677899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.+||+|||.+........
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999996532 346899999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
. .....++..|+|||.+.+..++.++||||||+++++|++ |+.||......+ ... ....+...
T Consensus 160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~----~~~~~~~~------- 223 (261)
T cd05148 160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYD----QITAGYRM------- 223 (261)
T ss_pred c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHH----HHHhCCcC-------
Confidence 1 113345678999999999999999999999999999998 888885433211 111 11111111
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..+......+.+++.+|++.+|++|||+.++++.|++
T Consensus 224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 --PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1112234567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=304.56 Aligned_cols=266 Identities=24% Similarity=0.251 Sum_probs=204.2
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHhccccCceEeeeeeeee--cCceEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSG--QGLEEFMNEVVLIGKLQHRNLVGLLGSCIE--EDERML 519 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~--~~~~~l 519 (765)
.++|+.++.|++|.||.||+|+++ ++..||+|+++-... .-.-...+||.+|.+++|||||.+-.+..- -+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 357899999999999999999864 678899999974321 112346799999999999999999887664 346899
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+++ +|..++.. -.+++...++.-++.|+++|++|||.+. |+||||||+|+|+...|.+||+|||+|+.++
T Consensus 155 VMe~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999986 56666633 2357899999999999999999999998 9999999999999999999999999999886
Q ss_pred CCCcccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
.. ....+..+-|..|+|||.+.+. .|++.+|+||+|||+.||+++++.|....+.+....+-.......+..+..+-
T Consensus 229 sp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 229 SP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred CC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 43 2334467789999999999875 59999999999999999999999998877666554443322222222221111
Q ss_pred cc--------------cccCccCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 679 DT--------------CLEDSFVES-QVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 679 d~--------------~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
+. .+...+... ..+.-.+++...+.+||.+|-|+++.++.
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 10 011111111 22445678889999999999999998865
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=329.69 Aligned_cols=241 Identities=25% Similarity=0.325 Sum_probs=195.4
Q ss_pred cccccCCceeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCC
Q 004264 452 NMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHK 527 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~g 527 (765)
+.||+|+||.||+++. .+++.+|+|++.+. .......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999986 46889999998753 2334567788999999999999999999999999999999999999
Q ss_pred ChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccccc
Q 004264 528 SLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQT 607 (765)
Q Consensus 528 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~ 607 (765)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~ 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence 99888843 346889999999999999999999999 999999999999999999999999998753221 1122
Q ss_pred ccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccC
Q 004264 608 ERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFV 687 (765)
Q Consensus 608 ~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~ 687 (765)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. .....+.. .++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~----~~~~~~~~----------~~p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LF----ELILMEEI----------RFP 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HH----HHHHcCCC----------CCC
Confidence 34679999999999999999999999999999999999999986432211 11 11111110 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 004264 688 ESQVLRCIQVGLLCVQKLPEDRP-----DMSSVVF 717 (765)
Q Consensus 688 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 717 (765)
......+.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 22345678899999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=325.05 Aligned_cols=242 Identities=26% Similarity=0.429 Sum_probs=199.6
Q ss_pred cccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCCCh
Q 004264 450 EANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSL 529 (765)
Q Consensus 450 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gsL 529 (765)
.++-||+|+.|-||+|+++ ++.||||+++.. -..+|+-|++|+|+||+.+.|+|.....++||||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 3567999999999999984 688999988532 22578889999999999999999999999999999999999
Q ss_pred hHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccccccc
Q 004264 530 DYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTER 609 (765)
Q Consensus 530 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~ 609 (765)
...+. .+.++.......|.++||.||.|||.+. |||||||.-||||..+..|||+|||-++..... . ..-.
T Consensus 200 ~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--S-TkMS 270 (904)
T KOG4721|consen 200 YEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK--S-TKMS 270 (904)
T ss_pred HHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh--h-hhhh
Confidence 99994 4556888899999999999999999998 999999999999999999999999999876433 1 1125
Q ss_pred ccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHH
Q 004264 610 VAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVES 689 (765)
Q Consensus 610 ~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 689 (765)
+.||..|||||+++..+.++|+||||||+|||||+||..|+...+..-. .|..|. ..+.-..+..
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---------IwGVGs------NsL~LpvPst 335 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---------IWGVGS------NSLHLPVPST 335 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---------EEeccC------CcccccCccc
Confidence 8999999999999999999999999999999999999999764332211 111111 1122223334
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 004264 690 QVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDG 723 (765)
Q Consensus 690 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 723 (765)
+..-+.-|+.+||+..|..||++.+|+..|+=..
T Consensus 336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred CchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 4555778899999999999999999999996433
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=315.18 Aligned_cols=256 Identities=29% Similarity=0.409 Sum_probs=205.1
Q ss_pred hcCcccccccccCCceeEEEEEeCC----CcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLST----GQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
.++|++.+.||+|+||.||+|.+.. ...+++|++... ......++.+|+.++++++|+||+++++.+.+.+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578999999999999999998642 457999988754 33445678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||+++.+.
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999998542 236899999999999999999999998 9999999999999999999999999999875
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
............++..|+|||.+.+..++.++||||||+++|||++ |..|+......+ . ......+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~----~~~~~~~~~~~-- 228 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---V----IKAVEDGYRLP-- 228 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---H----HHHHHcCCCCC--
Confidence 2222222223345678999999999999999999999999999998 988875332111 1 11111111100
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.+......+.+++.+|++.+|++||++++|+++|++
T Consensus 229 -------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 229 -------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred -------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 111224567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=320.01 Aligned_cols=250 Identities=34% Similarity=0.528 Sum_probs=194.8
Q ss_pred cccccccCCceeEEEEEeC-----CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 450 EANMIGKGGFGPVYMGKLS-----TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 450 ~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
+.+.||.|.||.||+|.+. .+..|+||.+... .....+.+.+|++++++++||||+++++++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999876 3567999999653 344578999999999999999999999999988889999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++|+|.+++... ....+++..++.|+.||++||.|||+.+ ++|++|+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999654 2345899999999999999999999998 99999999999999999999999999988633323
Q ss_pred ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
............|+|||.+....++.++||||||+++|||++ |+.|+..... ..+ .....++.....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~----~~~~~~~~~~~~----- 226 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEI----IEKLKQGQRLPI----- 226 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHH----HHHHHTTEETTS-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccc----ccccccccccee-----
Confidence 233334556778999999999999999999999999999999 6777643321 111 112222222111
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 719 (765)
+......+.+++..||+.+|++||++++|++.|
T Consensus 227 ----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 ----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112244577999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=326.07 Aligned_cols=254 Identities=24% Similarity=0.410 Sum_probs=201.4
Q ss_pred cCcccccccccCCceeEEEEEeC-CCc----EEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQ----EIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
.+|++.+.||+|+||.||+|++. ++. .||+|++... .....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56999999999999999999853 333 3899998654 344567899999999999999999999998764 5779
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999988543 235889999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
.............+..|+|||++.+..++.++||||||+++|||++ |+.|+......+ .......+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~- 232 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQ- 232 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHhCCCCCCC-
Confidence 4333222223344678999999999999999999999999999998 999886432211 1111111111110
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+......+.+++.+||+.+|++||++.+|+..|..
T Consensus 233 --------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~ 267 (316)
T cd05108 233 --------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 267 (316)
T ss_pred --------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11123457789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=350.86 Aligned_cols=257 Identities=33% Similarity=0.492 Sum_probs=207.6
Q ss_pred cCcccccccccCCceeEEEEEeC--CCc----EEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS--TGQ----EIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~--~~~----~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~ 518 (765)
..-+..+.||+|.||.||+|... ++. .||+|.+.+. +.+...+|.+|..+|+++.|||||+++|.|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 34556778999999999999853 233 4899999865 5677889999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhccc----cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccc
Q 004264 519 LIYEYMPHKSLDYFIFDRE----RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGL 594 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGl 594 (765)
|++|||++|+|..+|++.. ....+.....+.++.|||+|+.|||++. +|||||..+|+||++...|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999997642 1346889999999999999999999999 99999999999999999999999999
Q ss_pred ceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCC
Q 004264 595 ARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGR 673 (765)
Q Consensus 595 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 673 (765)
|+.+...+.-.......-...|||||.++.+.|+.|+||||||++|||++| |..|+......+.. ....+.|+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~------~~~~~ggR 922 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL------LDVLEGGR 922 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH------HHHHhCCc
Confidence 995433322222222233467999999999999999999999999999999 77776544433221 11222331
Q ss_pred ccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 674 ALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 674 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
. ..+..+...+.+||.+||+.+|++||++..|++.+..
T Consensus 923 -L---------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~ 960 (1025)
T KOG1095|consen 923 -L---------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPA 960 (1025)
T ss_pred -c---------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhh
Confidence 1 2233345667899999999999999999999998866
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=295.13 Aligned_cols=250 Identities=27% Similarity=0.340 Sum_probs=208.7
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
+-++|++.+.||+|.||.||.|+.+ ++..||+|++.+.. .+..+++.+|++|-..|+||||++++++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3478999999999999999999864 56789999997652 3446789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
++||...|++...+... ....+++.....++.|+|.||.|+|..+ +|||||||+|+|++..+.+||+|||.+....
T Consensus 100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999888643 3456899999999999999999999999 9999999999999999999999999998642
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
.......+||..|.|||...+..++.++|+|++|++.||++.|.+||......+....+.. .++.
T Consensus 176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k----------~~~~- 240 (281)
T KOG0580|consen 176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK----------VDLK- 240 (281)
T ss_pred ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH----------cccc-
Confidence 2333468999999999999999999999999999999999999999975543221111110 1111
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
++........+++..|+..+|.+|.+..|++..
T Consensus 241 ------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 241 ------FPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ------CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 112234457799999999999999999999864
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=317.07 Aligned_cols=254 Identities=26% Similarity=0.354 Sum_probs=202.0
Q ss_pred HhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC--------------hhhHHHHHHHHHHHhccccCceEeee
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS--------------GQGLEEFMNEVVLIGKLQHRNLVGLL 508 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--------------~~~~~~~~~Ev~~l~~l~h~niv~~~ 508 (765)
.-++|++.+.||+|.||.|-+|+. .+++.||||++.+.. ....+...+|+.||++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 347899999999999999999985 478999999997631 11245788999999999999999999
Q ss_pred eeeee--cCceEEEEEecCCCChhHHhhccccCCC-CChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC
Q 004264 509 GSCIE--EDERMLIYEYMPHKSLDYFIFDRERSKL-LPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL 585 (765)
Q Consensus 509 ~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 585 (765)
++..+ .+..|||+|||..|.+... ...++ +.+.++++++++++.||+|||.++ ||||||||.|+||+++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 99875 4689999999999887433 23334 899999999999999999999999 99999999999999999
Q ss_pred CCeecccccceeeCCC---CcccccccccccccccCcccccCCC----CCccccchHHHHHHHHHHhCCCCCCCCCCCCc
Q 004264 586 NPKISDFGLARIFGGD---DEEAQTERVAGTHGYMSPEYANDGT----ISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHR 658 (765)
Q Consensus 586 ~vkL~DFGla~~~~~~---~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~ 658 (765)
+|||+|||.+..+... .........+||+.|+|||...++. .+.+.||||+|+.||.|+.|+.||-.....+.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 9999999999877322 2222334578999999999987743 35689999999999999999999864333221
Q ss_pred ccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004264 659 HNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719 (765)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 719 (765)
. .+++...+.-....+.-+.+.+|+.++|+.||+.|.+..+|....
T Consensus 328 ~---------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 328 F---------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred H---------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1 112222222112223456788999999999999999999998776
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=324.80 Aligned_cols=241 Identities=25% Similarity=0.331 Sum_probs=194.5
Q ss_pred cccccCCceeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCC
Q 004264 452 NMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHK 527 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~g 527 (765)
+.||+|+||.||+++. .+++.||+|++.+. .......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999986 46889999998754 2334566788999999999999999999999999999999999999
Q ss_pred ChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccccc
Q 004264 528 SLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQT 607 (765)
Q Consensus 528 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~ 607 (765)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 99888743 345899999999999999999999998 9999999999999999999999999987532211 122
Q ss_pred ccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccC
Q 004264 608 ERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFV 687 (765)
Q Consensus 608 ~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~ 687 (765)
....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ... ....... ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~----~~~~~~~----------~~p 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFE----LILMEEI----------RFP 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---HHH----HHhcCCC----------CCC
Confidence 24678999999999999999999999999999999999999986433221 111 1101110 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 004264 688 ESQVLRCIQVGLLCVQKLPEDRP-----DMSSVVF 717 (765)
Q Consensus 688 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 717 (765)
......+.+++.+||+.+|++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 12234577899999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=313.59 Aligned_cols=252 Identities=27% Similarity=0.374 Sum_probs=202.9
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecC
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
++|++.+.||+|+||.||++...++..+|+|.+.... ....++.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4688889999999999999998777789999886543 334678999999999999999999999999999999999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+++|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 999999885432 35899999999999999999999998 999999999999999999999999999865332211
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+....
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~-------- 221 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-------TVEKVSQGLRLY-------- 221 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHhcCCCCC--------
Confidence 1112345677999999998889999999999999999998 998875433211 111111111110
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
.+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 222 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 -RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 01112456789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=319.79 Aligned_cols=263 Identities=21% Similarity=0.274 Sum_probs=196.8
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccCh-hhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
.++|++.+.||+|+||.||+|+.. +++.+|+|++..... .....+.+|+.++++++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999975 688999999875432 233567889999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+. ++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 566666532 2345888999999999999999999999 9999999999999999999999999997643221
Q ss_pred cccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC---cc---
Q 004264 603 EEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR---AL--- 675 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~--- 675 (765)
.......+++.|+|||++.+ ..++.++|||||||++|||++|+.||....+. ............... +.
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchh
Confidence 12224567899999999865 45889999999999999999999999753321 111111111110000 00
Q ss_pred ---cccccccc--CccC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 676 ---GLMDTCLE--DSFV-------ESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 676 ---~l~d~~l~--~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
........ .... ......+.+++..||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000000 0000 001235678999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=318.71 Aligned_cols=257 Identities=28% Similarity=0.395 Sum_probs=203.4
Q ss_pred CcccccccccCCceeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS------TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
+|.+.+.||+|+||.||+|... ....+++|.+.... ....+++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999742 23568888886543 3345678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccc---------------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCc
Q 004264 520 IYEYMPHKSLDYFIFDRE---------------------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASN 578 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~N 578 (765)
|+||+.+++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875321 1235789999999999999999999998 9999999999
Q ss_pred EEEecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCC
Q 004264 579 ILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGH 657 (765)
Q Consensus 579 Ill~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~ 657 (765)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||....+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999986543322222223445678999999999999999999999999999998 99888543221
Q ss_pred cccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 658 RHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
..+.....+... ..+......+.+++.+|++.+|++||++.+|+++|++.
T Consensus 237 ------~~~~~~~~~~~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 237 ------RLFNLLKTGYRM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred ------HHHHHHhCCCCC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 111222111111 11112235688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=330.92 Aligned_cols=272 Identities=21% Similarity=0.238 Sum_probs=208.7
Q ss_pred cchHhHHHHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccc-c-----CceEeee
Q 004264 436 YDLATITTATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-H-----RNLVGLL 508 (765)
Q Consensus 436 ~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h-----~niv~~~ 508 (765)
|.+..-.+...+|++.+.||+|.||.|.+|.+ ++++.||||++++ ...-.++.+.|+.+|..|+ | -|+|+++
T Consensus 176 Y~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~ 254 (586)
T KOG0667|consen 176 YQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRML 254 (586)
T ss_pred eeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence 33334445556899999999999999999986 4688999999964 4555678889999999996 4 3899999
Q ss_pred eeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC--CC
Q 004264 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN--LN 586 (765)
Q Consensus 509 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~--~~ 586 (765)
++|...++.+||+|.+ ..+|.+++...+. ..++...+..++.||+.||.+||+.+ |||+||||+||||.+. ..
T Consensus 255 d~F~fr~HlciVfELL-~~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~ 329 (586)
T KOG0667|consen 255 DYFYFRNHLCIVFELL-STNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSR 329 (586)
T ss_pred eccccccceeeeehhh-hhhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCc
Confidence 9999999999999998 4578888865443 45999999999999999999999999 9999999999999654 36
Q ss_pred CeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 004264 587 PKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAW 666 (765)
Q Consensus 587 vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~ 666 (765)
|||+|||.++.... .......++.|+|||++.+.+|+.+.||||||||++||++|.+.|....+.+....+....
T Consensus 330 vKVIDFGSSc~~~q-----~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l 404 (586)
T KOG0667|consen 330 IKVIDFGSSCFESQ-----RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL 404 (586)
T ss_pred eeEEecccccccCC-----cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh
Confidence 99999999997532 2225677889999999999999999999999999999999988887766654433322111
Q ss_pred H-----hhccC-Cccccccc---------------------------------ccc-------CccCHHHHHHHHHHHHH
Q 004264 667 L-----LWNDG-RALGLMDT---------------------------------CLE-------DSFVESQVLRCIQVGLL 700 (765)
Q Consensus 667 ~-----~~~~~-~~~~l~d~---------------------------------~l~-------~~~~~~~~~~l~~li~~ 700 (765)
. .+..+ +....++. ... .......-..+++++.+
T Consensus 405 G~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~ 484 (586)
T KOG0667|consen 405 GLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR 484 (586)
T ss_pred CCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence 0 00000 00000000 000 00111334568999999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 004264 701 CVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 701 cl~~dP~~RPs~~evl~~ 718 (765)
||+.||.+|+|+.+.++.
T Consensus 485 ~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 485 CLEWDPAERITPAQALNH 502 (586)
T ss_pred HhccCchhcCCHHHHhcC
Confidence 999999999999999854
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=325.50 Aligned_cols=242 Identities=24% Similarity=0.320 Sum_probs=195.7
Q ss_pred cccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCC
Q 004264 452 NMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHK 527 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~g 527 (765)
+.||+|+||.||+++.. +++.+|+|++.+. .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999864 6889999999754 2334567889999999999999999999999999999999999999
Q ss_pred ChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccccc
Q 004264 528 SLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQT 607 (765)
Q Consensus 528 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~ 607 (765)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~ 152 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATM 152 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccc
Confidence 99888743 345889999999999999999999999 999999999999999999999999998753221 1222
Q ss_pred ccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccC
Q 004264 608 ERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFV 687 (765)
Q Consensus 608 ~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~ 687 (765)
....||+.|+|||++.+..++.++||||||+++|||++|+.||....... .. ........ ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~----~~~~~~~~----------~~p 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LF----ELILMEDI----------KFP 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HH----HHhccCCc----------cCC
Confidence 34678999999999999999999999999999999999999986433211 10 11100100 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004264 688 ESQVLRCIQVGLLCVQKLPEDRP-----DMSSVVFL 718 (765)
Q Consensus 688 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 718 (765)
.....++.+++.+||+.+|++|| ++.++++.
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 12234577899999999999997 89998854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=311.76 Aligned_cols=248 Identities=26% Similarity=0.343 Sum_probs=196.1
Q ss_pred cccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCCCh
Q 004264 452 NMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSL 529 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gsL 529 (765)
+.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999864 68889999876543 34456799999999999999999999999999999999999999999
Q ss_pred hHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccccccc
Q 004264 530 DYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTER 609 (765)
Q Consensus 530 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~ 609 (765)
.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9988432 345889999999999999999999998 99999999999999999999999999876432111111111
Q ss_pred ccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCH
Q 004264 610 VAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVE 688 (765)
Q Consensus 610 ~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~ 688 (765)
...+..|+|||.+.+..++.++||||||+++|||++ |..|+....+.. .......... ...+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~~~---------~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQGVR---------LPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCC---------CCCcc
Confidence 223456999999999999999999999999999998 888875332211 1111111110 11112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 689 SQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 689 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
.....+.+++.+|++.+|++||++.+|+++|.
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 22456788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=325.45 Aligned_cols=199 Identities=26% Similarity=0.397 Sum_probs=173.9
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
.++|++.++||+|+||.||++... ++..+|+|++... .......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999875 5778888887654 33345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhc-CCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD-SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
|+++++|.+++.. .+.+++..+..++.|++.||.|||+. + |+|+||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999853 34588999999999999999999975 5 999999999999999999999999999765221
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCC
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFR 653 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~ 653 (765)
......++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 122456899999999999999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=342.26 Aligned_cols=259 Identities=22% Similarity=0.261 Sum_probs=207.4
Q ss_pred HHHHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecC--
Q 004264 441 ITTATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED-- 515 (765)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~-- 515 (765)
+....++|.+.+.||+|+||.||+++. .+++.||+|++... .......+.+|+.++..++|+|++++...+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 344557999999999999999999985 47899999998653 3445667889999999999999999988776433
Q ss_pred ------ceEEEEEecCCCChhHHhhcc-ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCe
Q 004264 516 ------ERMLIYEYMPHKSLDYFIFDR-ERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPK 588 (765)
Q Consensus 516 ------~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vk 588 (765)
..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 367999999999999988653 23456899999999999999999999998 99999999999999999999
Q ss_pred ecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHh
Q 004264 589 ISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLL 668 (765)
Q Consensus 589 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~ 668 (765)
|+|||+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.||...... . ....
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~-~~~~ 256 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------E-VMHK 256 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------H-HHHH
Confidence 99999998765433333334567999999999999999999999999999999999999998643221 1 1111
Q ss_pred hccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 669 WNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 669 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...+.... .+......+.+++..||+.+|++||++.+++++
T Consensus 257 ~~~~~~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAGRYDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11121111 111234567899999999999999999999864
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=328.76 Aligned_cols=264 Identities=22% Similarity=0.285 Sum_probs=209.0
Q ss_pred hcCcccccccccCCceeEEEEEeCC--CcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLST--GQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
.++|++.+.||+|+||.||+|.... +..+|+|++.+. .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3579999999999999999998543 368999998643 23345678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999853 345889999999999999999999999 9999999999999999999999999998753
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. .......+..
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------~~~~i~~~~~----- 245 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-------IYQKILEGII----- 245 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCC-----
Confidence 21 224678999999999999999999999999999999999999986543211 1111111111
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH--Hhc------CCCCCCCCCCCCccc
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRP-----DMSSVVFL--LAN------DGVTLPQPRQPGFFT 736 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~--L~~------~~~~l~~p~~p~~~~ 736 (765)
.++......+.+++.+|++.+|++|+ +++++++. +.+ ....++.|..|.+..
T Consensus 246 -----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~ 310 (340)
T PTZ00426 246 -----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKN 310 (340)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 01111234567899999999999995 89998765 221 122456666776533
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=308.04 Aligned_cols=267 Identities=25% Similarity=0.320 Sum_probs=206.7
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEccc--cChhhHHHHHHHHHHHhccccCceEeeeeeeee-----cCc
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSK--NSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE-----EDE 516 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~--~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~-----~~~ 516 (765)
...|...+.||+|+||.|..+.. .+|+.||+|++.+ ......++..+|+++|+.++|+||+.+.+.+.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 35566678999999999999985 4789999999973 455667889999999999999999999998876 346
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
.|+|+|+| ..+|...+. .++.+....+..++.||++||+|+|+.+ |+||||||.|+|++.+..+||+|||+|+
T Consensus 101 vYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 89999999 667888883 3445899999999999999999999999 9999999999999999999999999999
Q ss_pred eeCCCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH--------
Q 004264 597 IFGGDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWL-------- 667 (765)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~-------- 667 (765)
...........+..+.|..|.|||++.. ..|+.++||||.|||+.||++|+..|.+.+.-+...++-....
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 8865433344456889999999998754 6799999999999999999999999987665544433321111
Q ss_pred hhccCCcccccccccc-CccCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 668 LWNDGRALGLMDTCLE-DSFVE-----SQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 668 ~~~~~~~~~l~d~~l~-~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.....+....+.+... +..+. ......++|+.+||..||.+|+|++|.++.
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1110111111111110 01111 122346789999999999999999999854
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=315.95 Aligned_cols=254 Identities=26% Similarity=0.351 Sum_probs=200.4
Q ss_pred cCcccccccccCCceeEEEEEeC-CCc----EEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQ----EIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
++|++.+.||+|+||.||+|.+. +++ .+++|.+.... .....++..|+.+++++.||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 57888899999999999999863 344 47778775433 334567888999999999999999999875 456789
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
++||+++++|.+++... ...+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999998542 345899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
............++..|+|||++.+..++.++||||||+++|||++ |+.|+....+.. .......+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~- 232 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEKGERLAQ- 232 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcCCC-
Confidence 3333223334567788999999999999999999999999999998 998886543221 1111122221111
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+. .....+.+++.+|++.+|++||++.+++++|..
T Consensus 233 -~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 233 -PQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred -CC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 10 122356788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=318.28 Aligned_cols=257 Identities=29% Similarity=0.379 Sum_probs=203.6
Q ss_pred cCcccccccccCCceeEEEEEeC------CCcEEEEEEccccCh-hhHHHHHHHHHHHhccccCceEeeeeeeeecCceE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS------TGQEIAAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~ 518 (765)
.+|.+.+.||+|+||.||+|... .++.+|+|++..... ...+.+.+|+.++.+++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 35778899999999999999853 357899999975433 23467889999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhccc-------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC
Q 004264 519 LIYEYMPHKSLDYFIFDRE-------------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL 585 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 585 (765)
+++||+.+++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999998884321 1235788899999999999999999998 99999999999999999
Q ss_pred CCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHH
Q 004264 586 NPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGH 664 (765)
Q Consensus 586 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~ 664 (765)
.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+......+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------- 234 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999887643332222233456778999999998899999999999999999998 777775432211
Q ss_pred HHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 665 AWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 665 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.......+.... .+......+.+++..|++.+|++||++.+|++.|+.
T Consensus 235 ~~~~i~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIRNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111121222111 112234557799999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=311.72 Aligned_cols=252 Identities=27% Similarity=0.396 Sum_probs=201.9
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecC
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
.+|++.+.||+|+||.||++..+.++.+|+|++.+... ....+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35788899999999999999987778899999865432 34578899999999999999999999999999999999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 83 NGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence 999999885432 35899999999999999999999999 999999999999999999999999999865322111
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||....+.+ .. .....+.. .
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~----~~~~~~~~---------~ 220 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VV----ESVSAGYR---------L 220 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HH----HHHHcCCc---------C
Confidence 1112233457999999999999999999999999999999 788886433221 11 11111110 0
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
..+......+.+++.+||+.+|++||++.+|+++|.
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 111123456889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=307.65 Aligned_cols=268 Identities=22% Similarity=0.262 Sum_probs=204.4
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccCh--hhHHHHHHHHHHHhccccCc-eEeeeeeeeecC-----
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSG--QGLEEFMNEVVLIGKLQHRN-LVGLLGSCIEED----- 515 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~Ev~~l~~l~h~n-iv~~~~~~~~~~----- 515 (765)
...|...++||+|.||+||+|+. .+|+.||+|++.-... .......+|+.+|++|+|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34577788999999999999985 4788999999875433 23456789999999999999 999999999877
Q ss_pred -ceEEEEEecCCCChhHHhhccccC-CCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccc
Q 004264 516 -ERMLIYEYMPHKSLDYFIFDRERS-KLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFG 593 (765)
Q Consensus 516 -~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFG 593 (765)
..++||||+. .+|..++...... +.++...+..++.||++||+|||+++ |+||||||+||||++.|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 7889999995 4777777543322 45777899999999999999999999 9999999999999999999999999
Q ss_pred cceeeCCCCcccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccC
Q 004264 594 LARIFGGDDEEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDG 672 (765)
Q Consensus 594 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 672 (765)
+|+.+.-... ..+..+.|..|+|||++.+. .|+...||||+|||++||++++..|....+.+....+-.......+.
T Consensus 166 lAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 166 LARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred hHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 9997643222 23457789999999999887 79999999999999999999999887666533222222221111222
Q ss_pred Cccccc---cccc--cCcc-C-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 673 RALGLM---DTCL--EDSF-V-------ESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 673 ~~~~l~---d~~l--~~~~-~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.+..+. +-.. .... + ........+++.+||+++|.+|.|++.++++
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 222211 1110 0000 0 0111357789999999999999999999987
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=324.43 Aligned_cols=239 Identities=23% Similarity=0.250 Sum_probs=192.3
Q ss_pred cccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCCCh
Q 004264 454 IGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSL 529 (765)
Q Consensus 454 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gsL 529 (765)
||+|+||.||+++.. +++.||+|++.+. .......+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999865 5788999998653 234456788999999999999999999999999999999999999999
Q ss_pred hHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccccccc
Q 004264 530 DYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTER 609 (765)
Q Consensus 530 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~ 609 (765)
.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 988853 345899999999999999999999999 9999999999999999999999999998643222 12234
Q ss_pred ccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHH
Q 004264 610 VAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVES 689 (765)
Q Consensus 610 ~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 689 (765)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...... . .......+.. ..+..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~-~~~~~~~~~~----------~~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------E-MYRKILQEPL----------RFPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------H-HHHHHHcCCC----------CCCCc
Confidence 67899999999999999999999999999999999999998643221 1 1111111110 11112
Q ss_pred HHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 004264 690 QVLRCIQVGLLCVQKLPEDRPD---MSSVVF 717 (765)
Q Consensus 690 ~~~~l~~li~~cl~~dP~~RPs---~~evl~ 717 (765)
....+.+++.+||+.||++||+ +.+++.
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 2345778999999999999986 455543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=327.13 Aligned_cols=248 Identities=25% Similarity=0.346 Sum_probs=194.8
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
++|+..++||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45667789999999999999864 68999999986543 33456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++++|.... ...+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999985432 3567788899999999999999999 99999999999999999999999999987642211
Q ss_pred ccccccccccccccCcccccC-----CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 604 EAQTERVAGTHGYMSPEYAND-----GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~-----~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
......||..|+|||++.. ...+.++|||||||++|||++|+.||......+...+... .....
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~----~~~~~----- 292 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA----ICMSQ----- 292 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH----HhccC-----
Confidence 1224578999999998753 2345689999999999999999999974332221111110 00000
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..........++.+++.+||+.+|++||++.||++.
T Consensus 293 ----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 ----PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011112234568899999999999999999999875
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=317.89 Aligned_cols=264 Identities=24% Similarity=0.310 Sum_probs=194.3
Q ss_pred cCcccccccccCCceeEEEEEeC--CCcEEEEEEccccC--hhhHHHHHHHHHHHhcc---ccCceEeeeeeeee-----
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS--TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKL---QHRNLVGLLGSCIE----- 513 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l---~h~niv~~~~~~~~----- 513 (765)
++|++.+.||+|+||.||+|+.. .++.+|+|++.... ......+.+|+.+++++ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999863 46789999886432 22234566777777765 69999999998853
Q ss_pred cCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccc
Q 004264 514 EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFG 593 (765)
Q Consensus 514 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFG 593 (765)
....++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456899999997 57877775332 345889999999999999999999999 9999999999999999999999999
Q ss_pred cceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC
Q 004264 594 LARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR 673 (765)
Q Consensus 594 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 673 (765)
+++..... .......++..|+|||.+.+..++.++||||||+++|||++|+.||......+....+...........
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 99875432 223346789999999999999999999999999999999999999876543221111110000000000
Q ss_pred cc---cccccccc--C-----ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 674 AL---GLMDTCLE--D-----SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 674 ~~---~l~d~~l~--~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.. .+...... . .........+.+++.+||+.+|++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 00000000 0 001112345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=316.04 Aligned_cols=257 Identities=26% Similarity=0.375 Sum_probs=205.0
Q ss_pred cCcccccccccCCceeEEEEEeC------CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS------TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
++|...++||+|+||.||++... ++..+++|.+..........+.+|+++++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 56778899999999999999642 356789999887666677889999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhcccc------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCC
Q 004264 520 IYEYMPHKSLDYFIFDRER------------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNP 587 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~v 587 (765)
||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864321 134789999999999999999999998 9999999999999999999
Q ss_pred eecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 004264 588 KISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAW 666 (765)
Q Consensus 588 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~ 666 (765)
||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------~ 234 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-------I 234 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-------H
Confidence 9999999986543222122223345678999999999999999999999999999998 8888754322111 1
Q ss_pred HhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 667 LLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 667 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.....+..... +......+.+++.+||+.+|++||++.+|++.|++
T Consensus 235 ~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ECITQGRELER---------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHcCccCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11111111111 11223457799999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=314.67 Aligned_cols=258 Identities=29% Similarity=0.417 Sum_probs=202.4
Q ss_pred HhcCcccccccccCCceeEEEEEeCC------CcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCc
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLST------GQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE 516 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~ 516 (765)
..++|.+.+.||+|++|.||+|.+.. +..+++|.+.... ......+.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678999999999999999998643 5678889886443 3345678999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHhhcccc----CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC---CCee
Q 004264 517 RMLIYEYMPHKSLDYFIFDRER----SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL---NPKI 589 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~vkL 589 (765)
.++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999998854321 235889999999999999999999998 99999999999998754 5899
Q ss_pred cccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHh
Q 004264 590 SDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLL 668 (765)
Q Consensus 590 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 668 (765)
+|||+++................+..|+|||++.+..++.++||||||+++|||++ |+.||....... .. ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~----~~ 233 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VM----EF 233 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HH
Confidence 99999987633222111212333567999999999999999999999999999997 988886433221 11 11
Q ss_pred hccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 669 WNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 669 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
...... ...+......+.+++.+|++.+|++||++.+|++.|+
T Consensus 234 ~~~~~~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGGGR---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111111 1111222356789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.56 Aligned_cols=258 Identities=26% Similarity=0.379 Sum_probs=206.5
Q ss_pred hcCcccccccccCCceeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCce
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS------TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDER 517 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~ 517 (765)
.++|++.+.||+|+||.||+|... .++.+++|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 357889999999999999999854 24689999987543 34456788999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhcccc-------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeec
Q 004264 518 MLIYEYMPHKSLDYFIFDRER-------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKIS 590 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~ 590 (765)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999864321 234788899999999999999999998 9999999999999999999999
Q ss_pred ccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhh
Q 004264 591 DFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLW 669 (765)
Q Consensus 591 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 669 (765)
|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....+.. .....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLKFV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-------HHHHH
Confidence 9999986543322222233456788999999998899999999999999999998 888875433221 11111
Q ss_pred ccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 670 NDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 670 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..+....... .....+.+++.+||+.+|++|||+.+|++.|++
T Consensus 235 ~~~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGHLDLPE---------NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCCCCCCC---------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1222211111 124567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=312.44 Aligned_cols=254 Identities=28% Similarity=0.402 Sum_probs=204.1
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
.+|++.+.||+|+||.||+|... .++.+++|++... .....++.+|+.++++++|+||+++++++..+...++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45888899999999999999864 5788999988654 334578899999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999885432 345899999999999999999999998 999999999999999999999999999876432211
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
. ......+..|+|||.+.+..++.++||||||+++|||++ |..|+...... ..+.....+..
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~--------- 223 (263)
T cd05052 161 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELLEKGYR--------- 223 (263)
T ss_pred c-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCC---------
Confidence 1 112234567999999999999999999999999999998 88887543221 11111111111
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
...+......+.+++.+||+.+|++||++.+++++|++
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 11111223567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.76 Aligned_cols=265 Identities=26% Similarity=0.380 Sum_probs=206.6
Q ss_pred hcCcccccccccCCceeEEEEEeCC-----------------CcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEe
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLST-----------------GQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVG 506 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~ 506 (765)
..+|++.+.||+|+||.||++.... +..+|+|++.... ....+++.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3678999999999999999987542 2458999987543 345678899999999999999999
Q ss_pred eeeeeeecCceEEEEEecCCCChhHHhhccc--------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCc
Q 004264 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDRE--------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASN 578 (765)
Q Consensus 507 ~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~N 578 (765)
+++++..+...++|+||+++++|..++.... ....+++..++.++.|++.||+|||+.+ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986432 1225899999999999999999999998 9999999999
Q ss_pred EEEecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh--CCCCCCCCCCC
Q 004264 579 ILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS--GKMNRGFRHPG 656 (765)
Q Consensus 579 Ill~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt--G~~p~~~~~~~ 656 (765)
|+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999987643333233334556788999999998899999999999999999998 5566643221
Q ss_pred CcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 657 HRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..........+.......... .+.....++.+++.+|++.+|++||++.+|++.|++
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 112222222211111111111 111223568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=327.12 Aligned_cols=260 Identities=17% Similarity=0.149 Sum_probs=195.3
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
..+|++.+.||+|+||.||++.. ..++.||+|+... ..+.+|+.++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 35799999999999999999986 4678899997532 3567899999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+. ++|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 85 577777633 235889999999999999999999998 99999999999999999999999999975432211
Q ss_pred ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCc----ccHHHHHHHhhccC-------
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHR----HNLIGHAWLLWNDG------- 672 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~----~~~~~~~~~~~~~~------- 672 (765)
.......||+.|+|||++.+..++.++||||||+++|||++|+.|+-....... ...+..........
T Consensus 238 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 -NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred -cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 122246799999999999999999999999999999999999987643221110 00010000000000
Q ss_pred ---Ccccc---------ccccccCc--cCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 673 ---RALGL---------MDTCLEDS--FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 673 ---~~~~l---------~d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
....+ ..+..... ........+.+++.+||+.||++|||++|+++.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 00000000 001234468899999999999999999999853
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=316.82 Aligned_cols=262 Identities=26% Similarity=0.409 Sum_probs=201.3
Q ss_pred cCcccccccccCCceeEEEEEe-----CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeee--cCceE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-----STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE--EDERM 518 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~--~~~~~ 518 (765)
.+|++.+.||+|+||.||++.. .+++.|++|++........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5788899999999999999974 3578899999987766667889999999999999999999998754 34678
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
+|+||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998432 245899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcccc-cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCc---------ccHHHHHHHh
Q 004264 599 GGDDEEAQ-TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHR---------HNLIGHAWLL 668 (765)
Q Consensus 599 ~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~---------~~~~~~~~~~ 668 (765)
........ .....++..|+|||++.+..++.++||||||++++||++|..++........ ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 43222111 1122234569999999999999999999999999999998776432211000 0000000000
Q ss_pred hccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 669 WNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 669 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
...+ ............+.+++.+||+.+|++|||+.+|+++|+.
T Consensus 239 ~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 239 LKNN---------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred HhcC---------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 1011 0001111223568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=316.55 Aligned_cols=261 Identities=26% Similarity=0.380 Sum_probs=207.6
Q ss_pred HhcCcccccccccCCceeEEEEEeCC-----CcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeee-cCc
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLST-----GQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE-EDE 516 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~-~~~ 516 (765)
..++|++.+.||+|+||.||+|.... +..+++|++... .....+.+.+|+.++++++|+||+++++++.+ ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45789999999999999999998765 678999988754 33446778899999999999999999998776 567
Q ss_pred eEEEEEecCCCChhHHhhccccC-----CCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecc
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERS-----KLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISD 591 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~D 591 (765)
.++++||+++++|.+++...... ..+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998654322 46899999999999999999999998 99999999999999999999999
Q ss_pred cccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhc
Q 004264 592 FGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWN 670 (765)
Q Consensus 592 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 670 (765)
||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||....+.+ .. ....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~ 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MA----AYLK 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HH----HHHH
Confidence 999986643332222223445678999999998899999999999999999999 999986433211 11 1111
Q ss_pred cCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 004264 671 DGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDG 723 (765)
Q Consensus 671 ~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 723 (765)
.+... .........+.+++.+||+.+|++|||+.+|+++|+...
T Consensus 234 ~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 234 DGYRL---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred cCCCC---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11100 001112346789999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.42 Aligned_cols=263 Identities=23% Similarity=0.357 Sum_probs=201.2
Q ss_pred cCcccccccccCCceeEEEEEeCC---------------CcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeee
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLST---------------GQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLG 509 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~---------------~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~ 509 (765)
++|++.+.||+|+||.||+++... ...||+|++... .......+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578999999999999999987532 234899998754 3344567899999999999999999999
Q ss_pred eeeecCceEEEEEecCCCChhHHhhcccc---------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEE
Q 004264 510 SCIEEDERMLIYEYMPHKSLDYFIFDRER---------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNIL 580 (765)
Q Consensus 510 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIl 580 (765)
++...+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999998854221 124688899999999999999999998 999999999999
Q ss_pred EecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh--CCCCCCCCCCCCc
Q 004264 581 LDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS--GKMNRGFRHPGHR 658 (765)
Q Consensus 581 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt--G~~p~~~~~~~~~ 658 (765)
++.++.+||+|||++................++..|+|||++.+..++.++||||||+++++|++ |..||.......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 99999999999999986533222222223445678999999999999999999999999999998 445554332221
Q ss_pred ccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 659 HNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
.+......+......... ..+......+.+|+.+|++.+|++||++.+|+++|+
T Consensus 241 --~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 --VIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111111111100000 001112346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.64 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=201.1
Q ss_pred cccccccccCCceeEEEEEeCC----CcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCc-----
Q 004264 448 FSEANMIGKGGFGPVYMGKLST----GQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE----- 516 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~----- 516 (765)
|.+.+.||+|+||.||+|.... +..+|+|++... ......++.+|+.+++.++|+||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998642 367999998743 23445688999999999999999999998876554
Q ss_pred -eEEEEEecCCCChhHHhhccc---cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccc
Q 004264 517 -RMLIYEYMPHKSLDYFIFDRE---RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDF 592 (765)
Q Consensus 517 -~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DF 592 (765)
.++|+||+++++|..++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999998885432 2246899999999999999999999998 999999999999999999999999
Q ss_pred ccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhcc
Q 004264 593 GLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWND 671 (765)
Q Consensus 593 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 671 (765)
|+++................+..|+|||.+.+..++.++||||||+++|||++ |..||...... ... .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~----~~~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIY----DYLRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHc
Confidence 99987643322222222345678999999998999999999999999999999 88887543221 111 11111
Q ss_pred CCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 672 GRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 672 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+..... +......+.+++.+|++.+|++||++.+|++.|++
T Consensus 231 ~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 231 GNRLKQ---------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred CCCCCC---------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 211111 11234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=315.06 Aligned_cols=269 Identities=26% Similarity=0.364 Sum_probs=202.6
Q ss_pred cCc-ccccccccCCceeEEEEEe-----CCCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeec--Cc
Q 004264 446 NHF-SEANMIGKGGFGPVYMGKL-----STGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE--DE 516 (765)
Q Consensus 446 ~~y-~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~--~~ 516 (765)
++| ++.+.||+|+||+||++.. .+++.+|+|.+.... ......+.+|+.++++++||||+++++++.+. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 344 8889999999999988642 357789999987543 33456788999999999999999999988764 35
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
.++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence 7899999999999998843 24899999999999999999999998 9999999999999999999999999998
Q ss_pred eeCCCCcccc-cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcc
Q 004264 597 IFGGDDEEAQ-TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRAL 675 (765)
Q Consensus 597 ~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (765)
.......... .....++..|+|||.+.+..++.++||||||++++||++|..|+....... .................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLI 234 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhh
Confidence 7643222111 112345667999999998899999999999999999999999975433211 00010000000011111
Q ss_pred ccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 676 GLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 676 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
++++.......+......+.+++.+||+.+|++||++++|+++|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11222111122223346788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=317.97 Aligned_cols=260 Identities=27% Similarity=0.400 Sum_probs=206.1
Q ss_pred HhcCcccccccccCCceeEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecC
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS------TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEED 515 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~ 515 (765)
..++|++.+.||+|+||.||++... ....+|+|.+... ......++.+|+.+++++ +|+||+++++++....
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3467888999999999999999853 2357899988754 334456788999999999 7999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhcc-------------ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEe
Q 004264 516 ERMLIYEYMPHKSLDYFIFDR-------------ERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD 582 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 582 (765)
..+++|||+++++|..++... .....+++..++.++.||+.||.|||+.+ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998542 22346889999999999999999999998 99999999999999
Q ss_pred cCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccH
Q 004264 583 INLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNL 661 (765)
Q Consensus 583 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~ 661 (765)
.++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+......+
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 242 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 242 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH----
Confidence 999999999999987643322222223345678999999999999999999999999999998 888875322111
Q ss_pred HHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 662 IGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 662 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
.......+... ..+......+.+++.+|++.+|++|||+.++++.|++.
T Consensus 243 ---~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 ---LFKLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ---HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11111111111 11122345678999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.04 Aligned_cols=241 Identities=25% Similarity=0.339 Sum_probs=190.2
Q ss_pred cccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhc-cccCceEeeeeeeeecCceEEEEEecCC
Q 004264 452 NMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGK-LQHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~-l~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999864 57889999987532 2334556667777765 4799999999999999999999999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 606 (765)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 999888843 345889999999999999999999998 9999999999999999999999999998653222 22
Q ss_pred cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCcc
Q 004264 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSF 686 (765)
Q Consensus 607 ~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 686 (765)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ... ...... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~~----~i~~~~----------~~~ 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LFD----SILNDR----------PHF 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHcCC----------CCC
Confidence 334678999999999999999999999999999999999999986543211 111 110100 111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 004264 687 VESQVLRCIQVGLLCVQKLPEDRPDMS-SVVF 717 (765)
Q Consensus 687 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 717 (765)
+......+.+++.+||+.+|++||++. ++++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 122234567899999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=311.79 Aligned_cols=260 Identities=23% Similarity=0.292 Sum_probs=195.9
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecC-----ceEEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED-----ERMLI 520 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~-----~~~lV 520 (765)
.|+..+++|.|+||.||+|... .++.||||+.-.+.+ .-.+|+.+|+++.|||||+++.+|.... ...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4667789999999999999864 468999998864432 2347999999999999999999887533 34589
Q ss_pred EEecCCCChhHHhhc-cccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC-CCCeecccccceee
Q 004264 521 YEYMPHKSLDYFIFD-RERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN-LNPKISDFGLARIF 598 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~vkL~DFGla~~~ 598 (765)
||||+. +|...+.. ...+..++...+.-+..||++||+|||+.+ |+||||||+|||+|.+ +.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999986 56666643 233456888889999999999999999998 9999999999999976 89999999999998
Q ss_pred CCCCcccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCc---
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRA--- 674 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 674 (765)
...... ....-|+-|+|||.+.+. .|+.+.||||.|||+.||+-|++.|.+.+..+....+-.........++
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 554433 245678899999999875 6999999999999999999999999875554433332211111100000
Q ss_pred ----cccccccccC-----ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 675 ----LGLMDTCLED-----SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 675 ----~~l~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.+...+.+.. -.......+.++++.++++++|.+|.++.|++.
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0111111111 122334456889999999999999999999884
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=326.32 Aligned_cols=253 Identities=25% Similarity=0.334 Sum_probs=203.5
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||.||+|+.. +++.||+|++.+.. ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999865 68899999987532 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998543 56899999999999999999999998 999999999999999999999999999876433
Q ss_pred C---------------------------cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCC
Q 004264 602 D---------------------------EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRH 654 (765)
Q Consensus 602 ~---------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~ 654 (765)
. .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0112234578999999999999999999999999999999999999987544
Q ss_pred CCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 004264 655 PGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPD-MSSVVFL 718 (765)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 718 (765)
.... ............+.. .......+.+++..|++ +|++||+ ++++++.
T Consensus 235 ~~~~------~~~i~~~~~~~~~p~-------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQET------YNKIINWKESLRFPP-------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHH------HHHHhccCCcccCCC-------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 2111 111110000000000 00124557788899998 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.89 Aligned_cols=255 Identities=31% Similarity=0.405 Sum_probs=203.0
Q ss_pred CcccccccccCCceeEEEEEeCC--C--cE-EEEEEccc---cChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLST--G--QE-IAAKRLSK---NSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~~--~--~~-vavK~l~~---~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~ 518 (765)
+-...++||+|+||.||+|++.. + .. ||+|.... .......+|.+|++++++++|||||+++|++......+
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 33445899999999999998643 2 23 89998874 34667889999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
||||+|.||+|.+++.... +.++..++..++.+.|+||+|||+++ +|||||..+|+|++.++.+||+|||+++.-
T Consensus 238 ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence 9999999999999995433 36999999999999999999999999 999999999999999999999999998764
Q ss_pred CCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhh-ccCCccc
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLW-NDGRALG 676 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 676 (765)
.. .........-...|+|||.+....|++++|||||||++||+++ |..|+......+. .... ..+....
T Consensus 313 ~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v-------~~kI~~~~~r~~ 383 (474)
T KOG0194|consen 313 SQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV-------KAKIVKNGYRMP 383 (474)
T ss_pred cc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH-------HHHHHhcCccCC
Confidence 21 1111111234568999999999999999999999999999999 7777654433211 1111 1222111
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCC
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGV 724 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 724 (765)
. +......+..++.+|+..+|++||+|.++.+.|+....
T Consensus 384 ~---------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 384 I---------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred C---------CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 1 11334557788889999999999999999999987443
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=322.86 Aligned_cols=252 Identities=23% Similarity=0.286 Sum_probs=198.2
Q ss_pred CcccccccccCCceeEEEEEe----CCCcEEEEEEcccc----ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCce
Q 004264 447 HFSEANMIGKGGFGPVYMGKL----STGQEIAAKRLSKN----SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDER 517 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~----~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~ 517 (765)
+|++.+.||+|+||.||+++. ..++.+|+|++.+. .....+.+..|+.+++++ +|+||+++++++.+.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999875 35789999998653 223345678899999999 599999999999999999
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999988853 345889999999999999999999999 99999999999999999999999999986
Q ss_pred eCCCCcccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 598 FGGDDEEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
+...... ......||..|+|||++.+. .++.++||||||+++|||++|+.||............ .......
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~---~~~~~~~---- 226 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV---SRRILKC---- 226 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH---HHHHhcC----
Confidence 5332221 22246799999999999875 4789999999999999999999999654332221111 1111000
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRP-----DMSSVVFL 718 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 718 (765)
++ ..+......+.+++.+||+.||++|| +++++++.
T Consensus 227 --~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 --DP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --CC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 01 11112234567899999999999999 67777753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=309.08 Aligned_cols=254 Identities=29% Similarity=0.458 Sum_probs=202.7
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
.++|++.++||+|+||.||++..+++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 357889999999999999999988888999999875433 3467899999999999999999999875 45688999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++..+......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999885432 345789999999999999999999998 999999999999999999999999999876432211
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ... ....+..
T Consensus 159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~----~~~~~~~--------- 221 (260)
T cd05070 159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLE----QVERGYR--------- 221 (260)
T ss_pred c-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHHcCCC---------
Confidence 1 112334567999999998899999999999999999999 888885432211 111 1111110
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
...+......+.+++.+|++.+|++|||+.+++++|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112234568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=325.85 Aligned_cols=265 Identities=23% Similarity=0.324 Sum_probs=195.4
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecC-----ceE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED-----ERM 518 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~-----~~~ 518 (765)
+|++.+.||+|+||.||+|+.. +++.||+|++... ......++.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999864 6889999998643 2234467889999999999999999999886432 479
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
+||||+. ++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 578777743 345899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCc-ccccccccccccccCcccccC--CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHH--------HHH
Q 004264 599 GGDDE-EAQTERVAGTHGYMSPEYAND--GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGH--------AWL 667 (765)
Q Consensus 599 ~~~~~-~~~~~~~~gt~~Y~aPE~~~~--~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~--------~~~ 667 (765)
..... ........+|..|+|||++.+ ..++.++||||||+++|||++|+.||...........+.. ...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32221 112234578999999999876 6789999999999999999999999865432111000000 000
Q ss_pred hhccCCccccccccccCc-cC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 668 LWNDGRALGLMDTCLEDS-FV-----ESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 668 ~~~~~~~~~l~d~~l~~~-~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..........+....... .. ......+.+++.+||+.+|++||+++++++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000000000000 00 0112456789999999999999999999854
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=329.00 Aligned_cols=253 Identities=21% Similarity=0.290 Sum_probs=195.9
Q ss_pred CcccccccccCCceeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
.|++.+.||+|+||.||+|+. .+++.+|+|++.+.. ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999986 467899999997532 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999998853 345889999999999999999999998 9999999999999999999999999986432100
Q ss_pred c---------------------------------------------ccccccccccccccCcccccCCCCCccccchHHH
Q 004264 603 E---------------------------------------------EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLG 637 (765)
Q Consensus 603 ~---------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG 637 (765)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHH--ccccCCCCCCCHHHH
Q 004264 638 VLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLL--CVQKLPEDRPDMSSV 715 (765)
Q Consensus 638 ~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~ev 715 (765)
|++|||++|+.||....+.+.. ...........+.. ......++.+++.+ |+..+|..||++.+|
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~------~~i~~~~~~~~~~~-------~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQ------LKVINWENTLHIPP-------QVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHH------HHHHccccccCCCC-------CCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 9999999999999754432110 00110000001110 00112345566665 556677779999999
Q ss_pred HHH
Q 004264 716 VFL 718 (765)
Q Consensus 716 l~~ 718 (765)
++.
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=309.20 Aligned_cols=253 Identities=28% Similarity=0.414 Sum_probs=202.0
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecC
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
++|++.++||+|+||.||+|+..+...+++|++.... ...+++.+|+.++++++|+||+++++.+. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 5699999999999999999998777789999987533 23467899999999999999999998874 456899999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+++|.+++... ....+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||.+..+......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 99999998543 2345789999999999999999999998 999999999999999999999999999876432221
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
......++..|+|||+..+..++.++||||||+++|||++ |+.||....+.. . ......+.. .
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~----~~~~~~~~~---------~ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---V----LDQVERGYR---------M 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---H----HHHHhcCCC---------C
Confidence 1112345678999999998999999999999999999999 787875433211 1 111111110 0
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.........+.+++.+|++.+|++||++.+++++|+.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1122334567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=312.46 Aligned_cols=263 Identities=24% Similarity=0.346 Sum_probs=201.9
Q ss_pred cCcccccccccCCceeEEEEEeC-----------------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEee
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-----------------TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGL 507 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-----------------~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~ 507 (765)
++|++.++||+|+||.||++... +...+|+|++... .......+.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56899999999999999998532 2346899998754 33445789999999999999999999
Q ss_pred eeeeeecCceEEEEEecCCCChhHHhhcccc--------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcE
Q 004264 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRER--------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNI 579 (765)
Q Consensus 508 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NI 579 (765)
++++...+..++||||+++++|.+++..... ...+++..+..++.||+.||+|||+.+ |+|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999998865321 124678889999999999999999999 99999999999
Q ss_pred EEecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh--CCCCCCCCCCCC
Q 004264 580 LLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS--GKMNRGFRHPGH 657 (765)
Q Consensus 580 ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt--G~~p~~~~~~~~ 657 (765)
+++.++.++|+|||+++.+..............+..|+|||...++.++.++||||||+++|||++ |..|+....+.+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986533222222223344678999999888899999999999999999998 667765433221
Q ss_pred cccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 658 RHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
. ................. + .+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 242 ~---~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 V---IENTGEFFRDQGRQVYL-P-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred H---HHHHHHHHhhccccccC-C-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 11111111111100000 0 01112356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=308.73 Aligned_cols=255 Identities=27% Similarity=0.429 Sum_probs=198.0
Q ss_pred cccccccccCCceeEEEEEeCCCc---EEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeec------Cc
Q 004264 448 FSEANMIGKGGFGPVYMGKLSTGQ---EIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE------DE 516 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~~~~~---~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~------~~ 516 (765)
|.+.++||+|+||.||+|...... .+|+|.+... .....+.+.+|+.++++++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 346788999999999999875432 5899988653 344567889999999999999999999987532 25
Q ss_pred eEEEEEecCCCChhHHhhcc---ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccc
Q 004264 517 RMLIYEYMPHKSLDYFIFDR---ERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFG 593 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFG 593 (765)
.++|+||+++++|..++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999998887432 12345889999999999999999999998 9999999999999999999999999
Q ss_pred cceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccC
Q 004264 594 LARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDG 672 (765)
Q Consensus 594 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 672 (765)
+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ........+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-------EIYDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHcC
Confidence 9987643222111223345678999999999999999999999999999999 78887543221 111222222
Q ss_pred CccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 673 RALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 673 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..... .......+.+++.+||+.+|++|||+.+|++.|++
T Consensus 231 ~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRLKQ---------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 21111 11123457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=322.49 Aligned_cols=241 Identities=24% Similarity=0.306 Sum_probs=193.8
Q ss_pred cccccCCceeEEEEEe----CCCcEEEEEEcccc----ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 452 NMIGKGGFGPVYMGKL----STGQEIAAKRLSKN----SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~----~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
+.||+|+||.||+++. ..++.||+|++.+. .......+.+|+.+++.++||||+++++.+.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 35788999998753 223345678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++++|.+++.. .+.+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 999999888843 345788889999999999999999999 9999999999999999999999999997543221
Q ss_pred ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .......+.. .
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-------~~~~~~~~~~-~------- 218 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-------TIDKILKGKL-N------- 218 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC-C-------
Confidence 12234678999999999999999999999999999999999999986533211 1111111111 1
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRP-----DMSSVVF 717 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 717 (765)
.+......+.+++.+||+.+|++|| +++++++
T Consensus 219 --~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 219 --LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1111234577999999999999999 7888875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=308.91 Aligned_cols=259 Identities=24% Similarity=0.360 Sum_probs=207.3
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||.||+|+.. +++.+|+|++... .......+.+|+.++++++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999864 6889999987542 2344567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccc-cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 522 EYMPHKSLDYFIFDRE-RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998875422 2345889999999999999999999998 99999999999999999999999999987643
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
... ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+...... ..... .........
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~-~~~~~~~~~----- 226 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLC-QKIEQCDYP----- 226 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHH-HHHhcCCCC-----
Confidence 221 122356788999999999888999999999999999999999997543221 11111 111111111
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
..........+.+++.+||+.+|++||++.+|++.|++.
T Consensus 227 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 ---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 011122345688999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=310.84 Aligned_cols=247 Identities=28% Similarity=0.380 Sum_probs=196.3
Q ss_pred cccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCCCh
Q 004264 454 IGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSL 529 (765)
Q Consensus 454 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gsL 529 (765)
||+|+||+||++... +++.+|+|++.+.. ....+.+..|+.++++++|+||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999864 68899999987542 22345678899999999999999999999999999999999999999
Q ss_pred hHHhhcc-ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccccc
Q 004264 530 DYFIFDR-ERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTE 608 (765)
Q Consensus 530 ~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~ 608 (765)
..++... .....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 8887542 23456899999999999999999999998 99999999999999999999999999987643222 222
Q ss_pred cccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCH
Q 004264 609 RVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVE 688 (765)
Q Consensus 609 ~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~ 688 (765)
...||+.|+|||++.+..++.++||||||+++|||++|+.||........... ..... ..... ..+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~---~~~~~--------~~~~~--~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE---LKQRI--------LNDSV--TYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH---HHHhh--------cccCC--CCcc
Confidence 45789999999999999999999999999999999999999865433211100 00000 00000 1122
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004264 689 SQVLRCIQVGLLCVQKLPEDRP-----DMSSVVFL 718 (765)
Q Consensus 689 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 718 (765)
.....+.+++.+||+.+|++|| +++++++.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 2345678999999999999999 77777753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=317.41 Aligned_cols=260 Identities=27% Similarity=0.406 Sum_probs=206.2
Q ss_pred HhcCcccccccccCCceeEEEEEe--------CCCcEEEEEEcccc-ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeee
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL--------STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIE 513 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~--------~~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~ 513 (765)
..++|.+.+.||+|+||.||+++. .++..+|+|.+... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 356788999999999999999973 13457899988654 244567899999999999 79999999999999
Q ss_pred cCceEEEEEecCCCChhHHhhcccc-------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEE
Q 004264 514 EDERMLIYEYMPHKSLDYFIFDRER-------------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNIL 580 (765)
Q Consensus 514 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIl 580 (765)
....++||||+++++|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 9999999999999999999865321 235788899999999999999999998 999999999999
Q ss_pred EecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 004264 581 LDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRH 659 (765)
Q Consensus 581 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~ 659 (765)
++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+......
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--- 246 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--- 246 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---
Confidence 99999999999999987654333322333455678999999999999999999999999999998 77776433211
Q ss_pred cHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 660 NLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
........+.... .+......+.+++.+||+.+|++||++.+|++.|++.
T Consensus 247 ----~~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 247 ----ELFKLLKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred ----HHHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 1111111221111 1112345678899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=310.76 Aligned_cols=252 Identities=26% Similarity=0.351 Sum_probs=201.0
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
.|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.++++++|+||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999864 68899999986532 2233557789999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999988875432 345899999999999999999999999 9999999999999999999999999998753221
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
......|+..|+|||++.+..++.++||||+|+++|||++|+.||......... ..........
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~---------- 220 (285)
T cd05605 157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKED---------- 220 (285)
T ss_pred ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhc----------
Confidence 112356889999999999999999999999999999999999999754322111 1111111000
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRP-----DMSSVVFL 718 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 718 (765)
...++......+.+++..||+.||++|| ++.++++.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0112223345678999999999999999 88888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=308.88 Aligned_cols=255 Identities=24% Similarity=0.341 Sum_probs=202.7
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
.++|++.+.||+|+||.||+|+. .+++.+|+|++..........+.+|+.++++++|+||+++++.+...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999986 56788999998765555566788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999988843 345889999999999999999999998 99999999999999999999999999987632211
Q ss_pred ccccccccccccccCccccc---CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYAN---DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~---~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
......++..|+|||.+. ...++.++||||||+++|||++|+.|+....+.+... ....... ..+
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~---~~~ 229 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSNF---QPP 229 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCCC---CCC
Confidence 122356788999999884 3457889999999999999999999985433221110 0000100 001
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 719 (765)
.+.. .......+.+++.+||+.+|++||++++|++.|
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1110 112245688999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=318.95 Aligned_cols=246 Identities=25% Similarity=0.303 Sum_probs=195.7
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhcccc-CceEeeeeeeeecCceEEEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQH-RNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h-~niv~~~~~~~~~~~~~lV~ 521 (765)
+|++.+.||+|+||.||+|+.. .++.||+|++.+. .....+.+..|+.++..+.| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999865 5678999998753 23345678889999999975 56888999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999888843 335889999999999999999999998 999999999999999999999999998753211
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .. ........
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~----~~i~~~~~------- 218 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LF----QSIMEHNV------- 218 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HH----HHHHcCCC-------
Confidence 1 12234678999999999999999999999999999999999999986443211 11 11111110
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDM-----SSVVF 717 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 717 (765)
..+......+.+++.+||+.+|.+||+. +++++
T Consensus 219 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 219 ---SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1111223457789999999999999976 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=308.04 Aligned_cols=254 Identities=31% Similarity=0.459 Sum_probs=204.2
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
.++|++.++||+|+||.||+|..++++.+|+|.+..... ....+.+|+.++++++|+|++++++++ ..+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence 367889999999999999999988899999999875433 346789999999999999999999886 456789999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999885433 346889999999999999999999998 999999999999999999999999999876422211
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
......++..|+|||++....++.++||||||+++|||++ |+.||......+ .. .....+....
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~~~~~------- 223 (260)
T cd05067 159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VI----QNLERGYRMP------- 223 (260)
T ss_pred -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HH----HHHHcCCCCC-------
Confidence 1112345678999999999999999999999999999999 999986433211 11 1111111111
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.......++.+++.+|++.+|++||++++++++|+.
T Consensus 224 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 --RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111123468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=308.05 Aligned_cols=246 Identities=26% Similarity=0.396 Sum_probs=195.5
Q ss_pred ccccCCceeEEEEEe---CCCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCC
Q 004264 453 MIGKGGFGPVYMGKL---STGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHK 527 (765)
Q Consensus 453 ~LG~G~fg~Vy~~~~---~~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~g 527 (765)
+||+|+||.||+|.+ .+++.+|+|++.... ....+++.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 357889999986442 344678899999999999999999999875 55778999999999
Q ss_pred ChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc-
Q 004264 528 SLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ- 606 (765)
Q Consensus 528 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~- 606 (765)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||.||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99998843 235889999999999999999999998 99999999999999999999999999987643322111
Q ss_pred cccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCc
Q 004264 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDS 685 (765)
Q Consensus 607 ~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 685 (765)
.....++..|+|||.+....++.++||||||+++|||++ |+.||......+ . ......+....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~----~~~i~~~~~~~--------- 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---V----TQMIESGERME--------- 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHCCCCCC---------
Confidence 112334578999999988889999999999999999998 999986433221 1 11111221111
Q ss_pred cCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 686 FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 686 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.+......+.+++.+||+.+|++||++.+|+++|++
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 111234567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=308.54 Aligned_cols=258 Identities=24% Similarity=0.361 Sum_probs=206.9
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||.||+++. .+++.+++|.+... ......++.+|+.+++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999985 57899999987643 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhcc-ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 522 EYMPHKSLDYFIFDR-ERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 522 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
||+++++|.+++... .....+++..++.++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999888542 23456899999999999999999999998 99999999999999999999999999887643
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
... ......++..|+|||++.+..++.++||||||+++|+|++|..||....... .. .......... +
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~-~~~~~~~~~~-----~ 226 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YS-LCKKIEQCDY-----P 226 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HH-HhhhhhcCCC-----C
Confidence 221 1123568889999999999999999999999999999999999985432211 00 0001111110 0
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..........+.+++.+|++.+|++||||.+|++++++
T Consensus 227 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 227 ---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred ---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 01111234568899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.46 Aligned_cols=260 Identities=25% Similarity=0.386 Sum_probs=203.4
Q ss_pred HhcCcccccccccCCceeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCc
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS------TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE 516 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~ 516 (765)
..++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999743 24579999886543 2334568889999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHhhcccc-------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCee
Q 004264 517 RMLIYEYMPHKSLDYFIFDRER-------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKI 589 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL 589 (765)
.++||||+++++|.+++..... .....+..+..++.||+.||.|||+.+ |+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999864221 234567788899999999999999998 999999999999999999999
Q ss_pred cccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHh
Q 004264 590 SDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLL 668 (765)
Q Consensus 590 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 668 (765)
+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .. ..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~----~~ 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VL----KF 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HH
Confidence 99999986533222222223345678999999999999999999999999999998 777875432211 11 11
Q ss_pred hccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 669 WNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 669 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
...+..... +......+.+++.+|++.+|++||++.++++.|.+.
T Consensus 234 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 234 VMDGGYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHcCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111111111 111235688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.61 Aligned_cols=258 Identities=28% Similarity=0.402 Sum_probs=203.3
Q ss_pred hcCcccccccccCCceeEEEEEeC--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeec
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS--------TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEE 514 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~ 514 (765)
.++|.+.+.||+|+||.||+++.. ....+|+|.+... ......++.+|+.+++++ +|+||+++++++.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 367999999999999999999742 2356999998754 234456788999999999 799999999999999
Q ss_pred CceEEEEEecCCCChhHHhhcccc-------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE
Q 004264 515 DERMLIYEYMPHKSLDYFIFDRER-------------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL 581 (765)
Q Consensus 515 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll 581 (765)
+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999865321 235889999999999999999999998 9999999999999
Q ss_pred ecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 004264 582 DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHN 660 (765)
Q Consensus 582 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~ 660 (765)
+.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.|+......
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---- 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence 9999999999999986532221111222334568999999999999999999999999999998 88887533211
Q ss_pred HHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 661 LIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
........+.... .+......+.+++.+|++.+|++||++.+|++.|+.
T Consensus 250 ---~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 250 ---ELFKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred ---HHHHHHHcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 1111111221111 111223567789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=328.69 Aligned_cols=253 Identities=23% Similarity=0.281 Sum_probs=198.9
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||.||+++.. +++.||+|++.+.. ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999864 68899999997532 334466888999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999998853 345899999999999999999999999 999999999999999999999999999765321
Q ss_pred Cccc------------------------------------ccccccccccccCcccccCCCCCccccchHHHHHHHHHHh
Q 004264 602 DEEA------------------------------------QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645 (765)
Q Consensus 602 ~~~~------------------------------------~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt 645 (765)
.... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1100 0112468999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 004264 646 GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPD---MSSVVFL 718 (765)
Q Consensus 646 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 718 (765)
|+.||....+... ............+... ......+.+++.+|+. +|.+|++ +.++++.
T Consensus 235 G~~Pf~~~~~~~~------~~~i~~~~~~~~~~~~-------~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQET------YRKIINWKETLQFPDE-------VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHHHH------HHHHHcCCCccCCCCC-------CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999865432211 1111100000011111 0113356678888886 9999998 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=315.35 Aligned_cols=256 Identities=28% Similarity=0.369 Sum_probs=200.1
Q ss_pred cCcccccccccCCceeEEEEEeCC-C--cEEEEEEcccc-ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLST-G--QEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~-~--~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV 520 (765)
++|++.+.||+|+||.||+|...+ + ..+++|.+... .....+.+.+|+.++.++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999998653 3 34788887642 344556789999999999 799999999999999999999
Q ss_pred EEecCCCChhHHhhccc-------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCC
Q 004264 521 YEYMPHKSLDYFIFDRE-------------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNP 587 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~v 587 (765)
+||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985432 1135889999999999999999999998 9999999999999999999
Q ss_pred eecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 004264 588 KISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAW 666 (765)
Q Consensus 588 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~ 666 (765)
||+|||++...... ........+..|+|||++.+..++.++||||||+++|||++ |+.||......+ ..
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------LY 228 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HH
Confidence 99999998643211 11111233457999999999999999999999999999997 999985433221 11
Q ss_pred HhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 004264 667 LLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDG 723 (765)
Q Consensus 667 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 723 (765)
.....+... ..+......+.+++.+||+.+|.+||++.+|+++|++..
T Consensus 229 ~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 229 EKLPQGYRM---------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred HHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111100 111122345789999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=317.85 Aligned_cols=241 Identities=25% Similarity=0.318 Sum_probs=193.3
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV~ 521 (765)
+|.+.+.||+|+||.||+|+.. +++.+|+|++.+.. ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999865 57789999987542 23345567788888777 5899999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+.+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999888743 245889999999999999999999998 999999999999999999999999999754321
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.. .......
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~----~i~~~~~------- 218 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQ----SIMEHNV------- 218 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHH----HHHhCCC-------
Confidence 1 12234678999999999999999999999999999999999999986543221 111 1111111
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCCH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDM 712 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 712 (765)
.++.....++.+++.+|++.+|++|++.
T Consensus 219 ---~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 ---AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1111234567889999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=307.47 Aligned_cols=251 Identities=23% Similarity=0.346 Sum_probs=199.5
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
++|++.+.||+|+||.||+|.. .+++.+|+|++... .....+++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3677889999999999999985 56888999998654 334456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999996542 3678889999999999999999999 999999999999999999999999999865322
Q ss_pred ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
......++..|+|||++.+..++.++||||||+++|+|++|+.||..........................+
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 220 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL------ 220 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC------
Confidence 222457889999999999999999999999999999999999998654332211111111111111111110
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.......++.+++.+|++.+|++||+++++++.
T Consensus 221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011123457899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=315.22 Aligned_cols=259 Identities=28% Similarity=0.397 Sum_probs=205.3
Q ss_pred HhcCcccccccccCCceeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecC
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL------STGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEED 515 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~ 515 (765)
..++|.+.+.||+|+||.||++.. ..+..+|+|++.... ....+.+.+|+.+++++ +|+||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 346799999999999999999974 134579999887543 34456789999999999 7999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccc
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA 595 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla 595 (765)
..++||||+++++|.+++.... ...+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 9999999999999999985422 234899999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCc
Q 004264 596 RIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRA 674 (765)
Q Consensus 596 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (765)
+...............++..|+|||.+.+..++.++||||||+++|||++ |+.||........ .......+..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~~~~~~~~~~ 262 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKLIKEGYR 262 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------HHHHHHcCCc
Confidence 87643322222223455778999999999999999999999999999998 9988754332111 1111111111
Q ss_pred cccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 675 LGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 675 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
. ..+.....++.+++.+|++.+|++||++.+|++.|++
T Consensus 263 ~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 263 M---------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0 0111123468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=329.24 Aligned_cols=253 Identities=23% Similarity=0.254 Sum_probs=196.9
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||.||++.. .+++.||+|++.+. .....+++.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688999999999999999985 46889999998653 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999998843 345889999999999999999999999 999999999999999999999999999643211
Q ss_pred Ccc---------------------------------------------cccccccccccccCcccccCCCCCccccchHH
Q 004264 602 DEE---------------------------------------------AQTERVAGTHGYMSPEYANDGTISMKSDVFSL 636 (765)
Q Consensus 602 ~~~---------------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSl 636 (765)
... .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 00012468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCC---CCHH
Q 004264 637 GVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDR---PDMS 713 (765)
Q Consensus 637 G~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~ 713 (765)
||++|||++|+.||....+.+. . ...........+.+. ......+.+++.+|++ +|.+| +++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~---~---~~i~~~~~~~~~p~~-------~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHET---Y---RKIINWRETLYFPDD-------IHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHH---H---HHHHccCCccCCCCC-------CCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 9999999999999965433211 0 111100011111110 0123456788889997 66665 5999
Q ss_pred HHHHH
Q 004264 714 SVVFL 718 (765)
Q Consensus 714 evl~~ 718 (765)
++++.
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.32 Aligned_cols=245 Identities=26% Similarity=0.355 Sum_probs=193.8
Q ss_pred cccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHH---hccccCceEeeeeeeeecCceEEE
Q 004264 448 FSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLI---GKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l---~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
|++.+.||+|+||.||++... +++.||+|++.+.. ....+.+..|+.++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 667889999999999999864 68899999987532 23345666776655 566899999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||+++++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999887732 35899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
. ........|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ .. .....+..
T Consensus 154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~---~~----~~i~~~~~------ 218 (324)
T cd05589 154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE---VF----DSIVNDEV------ 218 (324)
T ss_pred C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH---HH----HHHHhCCC------
Confidence 1 122234678999999999999999999999999999999999999986443221 11 11111111
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRP-----DMSSVVFL 718 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 718 (765)
..+......+.+++.+||+.||.+|| ++.++++.
T Consensus 219 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 219 ----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 01112234577899999999999999 56666653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=325.24 Aligned_cols=203 Identities=25% Similarity=0.329 Sum_probs=175.2
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||.||+++.. +++.+|+|++.+.. ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999864 68899999997532 233457888999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999853 346899999999999999999999999 999999999999999999999999999764321
Q ss_pred Cc---------------------------------ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCC
Q 004264 602 DE---------------------------------EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKM 648 (765)
Q Consensus 602 ~~---------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~ 648 (765)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 000123579999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 004264 649 NRGFRH 654 (765)
Q Consensus 649 p~~~~~ 654 (765)
||....
T Consensus 235 Pf~~~~ 240 (363)
T cd05628 235 PFCSET 240 (363)
T ss_pred CCCCCC
Confidence 996543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=304.71 Aligned_cols=259 Identities=25% Similarity=0.375 Sum_probs=208.5
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||.||+|... +++.+++|.++.. .....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999876 7899999988632 2334568899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhcc-ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 522 EYMPHKSLDYFIFDR-ERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 522 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
||+++++|..++... .....+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999888543 23456899999999999999999999998 99999999999999999999999999886543
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
.... .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+...... ... .......+......
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~~~~~~~~-- 229 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS-LCKKIEKCDYPPLP-- 229 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHH-HHhhhhcCCCCCCC--
Confidence 2211 22356788899999999989999999999999999999999997543211 111 11111111111111
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
.......+.+++.+|++.+|++||++.+|+++|++.
T Consensus 230 ------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 230 ------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 112345678999999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=325.79 Aligned_cols=259 Identities=25% Similarity=0.353 Sum_probs=203.1
Q ss_pred hcCcccccccccCCceeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHhccc-cCceEeeeeeeeecCc
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS------TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDE 516 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~ 516 (765)
.++|.+.++||+|+||.||+|++. .++.||+|++.... ....+.+.+|+.+|.++. ||||+++++++.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 356888899999999999999853 34679999997643 333457889999999997 9999999999999999
Q ss_pred eEEEEEecCCCChhHHhhcccc----------------------------------------------------------
Q 004264 517 RMLIYEYMPHKSLDYFIFDRER---------------------------------------------------------- 538 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 538 (765)
.++|+||+++|+|.+++.....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999998864311
Q ss_pred -------------------------------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE
Q 004264 539 -------------------------------------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL 581 (765)
Q Consensus 539 -------------------------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll 581 (765)
...+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 123667788899999999999999998 9999999999999
Q ss_pred ecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 004264 582 DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHN 660 (765)
Q Consensus 582 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~ 660 (765)
++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~--- 349 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE--- 349 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH---
Confidence 9999999999999987543222222223456788999999999999999999999999999998 888875432211
Q ss_pred HHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 661 LIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
........+... ..+......+.+++.+||+.+|++||++++|++.|++
T Consensus 350 ---~~~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 350 ---QFYNAIKRGYRM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred ---HHHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111111111110 1111223567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=325.01 Aligned_cols=253 Identities=21% Similarity=0.256 Sum_probs=200.8
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||.||+++.. +++.+|+|++.+.. ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999864 68899999987542 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998543 246899999999999999999999999 999999999999999999999999999876433
Q ss_pred CcccccccccccccccCccccc------CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcc
Q 004264 602 DEEAQTERVAGTHGYMSPEYAN------DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRAL 675 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (765)
... ......||+.|+|||++. ...++.++||||||+++|||++|+.||....... ............
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~ 228 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRFL 228 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCcc
Confidence 221 222457899999999986 4568899999999999999999999986433211 111111111111
Q ss_pred ccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 676 GLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 676 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...+ .......+.+++..|++ +|.+||++.++++.
T Consensus 229 ~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 229 KFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 1111 11123456788889998 99999999999853
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=329.14 Aligned_cols=251 Identities=22% Similarity=0.302 Sum_probs=193.3
Q ss_pred CcccccccccCCceeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
+|++.++||+|+||.||+|+. .+++.+|+|++.+.. ......+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999986 467889999987542 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++|+|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999988843 245889999999999999999999999 9999999999999999999999999975431100
Q ss_pred c---------------------------------------------ccccccccccccccCcccccCCCCCccccchHHH
Q 004264 603 E---------------------------------------------EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLG 637 (765)
Q Consensus 603 ~---------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG 637 (765)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 0011235689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCC---HHH
Q 004264 638 VLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPD---MSS 714 (765)
Q Consensus 638 ~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~e 714 (765)
|++|||++|+.||....+.+. ............... .......+.+++.+++ .+|++|++ +.+
T Consensus 236 vil~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~p~-------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLET------QMKVINWQTSLHIPP-------QAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHH------HHHHHccCCCcCCCC-------cccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 999999999999975433211 111111000001110 0111233456666655 49999997 777
Q ss_pred HHH
Q 004264 715 VVF 717 (765)
Q Consensus 715 vl~ 717 (765)
+++
T Consensus 302 i~~ 304 (382)
T cd05625 302 IKA 304 (382)
T ss_pred Hhc
Confidence 764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=310.32 Aligned_cols=256 Identities=25% Similarity=0.362 Sum_probs=201.2
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCc----EEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQ----EIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~----~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~ 518 (765)
.++|++.++||+|+||.||+|++ .+++ .||+|++... .....+++.+|+.+++.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 35788899999999999999985 3444 4799988654 34446778899999999999999999999875 4578
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
+++||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999988542 345899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
.............++..|+|||.+.+..++.++||||||+++|||++ |..||....... + ......+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~~~~- 231 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---I----PDLLEKGERLP- 231 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHCCCcCC-
Confidence 43222222222344677999999999999999999999999999998 888875432211 1 11111111111
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
.+......+.+++.+||+.+|++||++.++++.|+..
T Consensus 232 --------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 232 --------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred --------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1112234577899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=312.43 Aligned_cols=258 Identities=30% Similarity=0.435 Sum_probs=204.5
Q ss_pred hcCcccccccccCCceeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCce
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS------TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDER 517 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~ 517 (765)
.++|++.+.||+|+||.||++..+ ++..+|+|++.... ....+++.+|+.+++++.||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999853 46789999987543 34457799999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhccc-------------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCc
Q 004264 518 MLIYEYMPHKSLDYFIFDRE-------------------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASN 578 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~N 578 (765)
++||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986421 1124788899999999999999999998 9999999999
Q ss_pred EEEecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCC
Q 004264 579 ILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGH 657 (765)
Q Consensus 579 Ill~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~ 657 (765)
|+++.++.++|+|||++.................+..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999986543322111222344667999999998999999999999999999997 777764322211
Q ss_pred cccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 658 RHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.......+..... +.....++.+++.+|++.+|++||++.||++.|++
T Consensus 241 -------~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 -------VIYYVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -------HHHHHhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1112222222111 11223568889999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=318.22 Aligned_cols=248 Identities=22% Similarity=0.319 Sum_probs=195.2
Q ss_pred cccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEEEEecCC
Q 004264 452 NMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
++||+|+||.||+++.. +++.||+|++.+. .....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999864 6789999999753 233456688999999998 699999999999999999999999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 606 (765)
++|..++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~ 152 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence 999888743 345899999999999999999999999 999999999999999999999999998753211 122
Q ss_pred cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCC--cccHHHHHHHhhccCCccccccccccC
Q 004264 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGH--RHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 607 ~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
.....||..|+|||++.+..++.++||||||+++|||++|+.||......+ ......+.......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~-------- 223 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-R-------- 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-C--------
Confidence 234678999999999999999999999999999999999999996433221 11111111111111111 1
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPD------MSSVVF 717 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~ 717 (765)
.+......+.+++.+||+.||.+||+ ++++++
T Consensus 224 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 -IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 11122345778999999999999997 667764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=303.94 Aligned_cols=250 Identities=27% Similarity=0.392 Sum_probs=204.4
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
+|++.+.||+|++|.||++... +++.+++|.+... .......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999864 6889999988643 344567889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998653 2356889999999999999999999998 99999999999999999999999999987643322
Q ss_pred ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
......++..|+|||++.+..++.++||||||+++++|++|+.||....+.. .......+...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~-------- 219 (256)
T cd08529 157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-------LILKIIRGVFP-------- 219 (256)
T ss_pred --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCC--------
Confidence 1223567889999999999999999999999999999999999986443211 11111111111
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.........+.+++.+||+.+|++||++.++++.
T Consensus 220 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 -PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1111234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=303.66 Aligned_cols=247 Identities=28% Similarity=0.370 Sum_probs=197.8
Q ss_pred cccccCCceeEEEEEeCCCcEEEEEEccccCh-hhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCCChh
Q 004264 452 NMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLD 530 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gsL~ 530 (765)
++||+|+||.||+|...+++.+|+|++..... .....+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999988889999999876543 33457889999999999999999999999999999999999999999
Q ss_pred HHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccccccc
Q 004264 531 YFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERV 610 (765)
Q Consensus 531 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 610 (765)
+++... ...+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++......... .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 888432 235789999999999999999999998 999999999999999999999999999764322111 11123
Q ss_pred cccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHH
Q 004264 611 AGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVES 689 (765)
Q Consensus 611 ~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 689 (765)
.++..|+|||++.+..++.++||||||+++|+|++ |..||....... .......+... ..+..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKGYRM---------SCPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCCCC---------CCCCC
Confidence 34567999999999999999999999999999998 888885432211 11111111111 11112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 690 QVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 690 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
....+.+++.+|++.+|++||++.+++++|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2456889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=317.76 Aligned_cols=243 Identities=23% Similarity=0.342 Sum_probs=191.5
Q ss_pred cccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEEEEecCC
Q 004264 452 NMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
+.||+|+||.||+++.. +++.+|+|++.+. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999864 5788999998753 233456678899888876 799999999999999999999999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 606 (765)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 999888743 345899999999999999999999999 9999999999999999999999999997532211 12
Q ss_pred cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCc--ccHHHHHHHhhccCCccccccccccC
Q 004264 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHR--HNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 607 ~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
.....||..|+|||++.+..++.++||||||+++|||++|+.||........ .....+..........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------- 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------
Confidence 2346789999999999999999999999999999999999999964322111 1111122221111111
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCH
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDM 712 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~ 712 (765)
..+......+.+++.+||+.||++||++
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1112234457789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=305.03 Aligned_cols=253 Identities=29% Similarity=0.436 Sum_probs=201.6
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecC
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
++|.+.+.||+|++|.||++....+..+|+|++.... ...+.+.+|+.++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688889999999999999998777789999886533 23467889999999999999999998875 566889999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 99999988543 2345789999999999999999999998 999999999999999999999999999876332211
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||....+.+ .. .....+...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~~--------- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VL----EQVERGYRM--------- 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCCC---------
Confidence 1112345678999999998999999999999999999999 888886433211 11 111111100
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..+......+.+++.+||+.+|++||++++|+++|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111234568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=303.64 Aligned_cols=254 Identities=27% Similarity=0.373 Sum_probs=193.0
Q ss_pred cccccCCceeEEEEEeCC---CcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCC
Q 004264 452 NMIGKGGFGPVYMGKLST---GQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHK 527 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~---~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~g 527 (765)
+.||+|+||.||+|...+ +..+++|++.... ......+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998543 4579999887543 334467889999999999999999999999999999999999999
Q ss_pred ChhHHhhcccc--CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 528 SLDYFIFDRER--SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 528 sL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+|.+++..... ....++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999864322 234567788899999999999999998 9999999999999999999999999997643322222
Q ss_pred ccccccccccccCcccccCC-------CCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 606 QTERVAGTHGYMSPEYANDG-------TISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~-------~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||....+.+. ... .. .+....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~---~~-~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTY---TV-REQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHH---Hh-hcccCCC
Confidence 22234567889999998642 35789999999999999996 9999864332211 111 11 1111222
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
.++.+.. .....+.+++..|+ .+|++|||+++|++.|+
T Consensus 231 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222221 12334667888998 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=324.80 Aligned_cols=262 Identities=21% Similarity=0.300 Sum_probs=197.7
Q ss_pred CcccccccccCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecC-----ceE
Q 004264 447 HFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED-----ERM 518 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~-----~~~ 518 (765)
+|++.+.||+|+||.||++.. .+++.||+|++... .....+++.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999986 47899999998653 2334567889999999999999999999998776 789
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
+|+||+. ++|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 467666632 345899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCcccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHH-------------
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGH------------- 664 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~------------- 664 (765)
..... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||....+.+....+..
T Consensus 154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 33221 122235678899999998874 579999999999999999999999975543321111100
Q ss_pred ---HHHhh-ccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 665 ---AWLLW-NDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 665 ---~~~~~-~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..... ............ .........++.+++.+||+.||++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVL--YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHh--cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000 000000000000 00111124567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=315.30 Aligned_cols=260 Identities=28% Similarity=0.393 Sum_probs=204.2
Q ss_pred hcCcccccccccCCceeEEEEEeC--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeec
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS--------TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEE 514 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~ 514 (765)
.++|.+.+.||+|+||.||+++.. ....+|+|.+... ......++.+|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 367889999999999999999742 2456899988754 334466788999999999 599999999999999
Q ss_pred CceEEEEEecCCCChhHHhhccc-------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE
Q 004264 515 DERMLIYEYMPHKSLDYFIFDRE-------------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL 581 (765)
Q Consensus 515 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll 581 (765)
...++||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999986532 1245889999999999999999999998 9999999999999
Q ss_pred ecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 004264 582 DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHN 660 (765)
Q Consensus 582 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~ 660 (765)
+.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--- 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--- 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 9999999999999987643222222222334567999999999999999999999999999999 888875332211
Q ss_pred HHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 004264 661 LIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDG 723 (765)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 723 (765)
.......+..... +......+.+++.+|++.+|++||++.++++.|.+..
T Consensus 245 ----~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 245 ----LFKLLREGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ----HHHHHHcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111112211111 1122346778999999999999999999999997743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=322.43 Aligned_cols=242 Identities=26% Similarity=0.325 Sum_probs=194.1
Q ss_pred cccccCCceeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCC
Q 004264 452 NMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHK 527 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~g 527 (765)
+.||+|+||.||+++. .+++.+|+|++.+. ......++.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999986 46889999998753 2334566788999999999999999999999999999999999999
Q ss_pred ChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhh-cCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc
Q 004264 528 SLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ-DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 528 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 606 (765)
+|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 99888743 3458999999999999999999997 67 9999999999999999999999999987542221 12
Q ss_pred cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCcc
Q 004264 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSF 686 (765)
Q Consensus 607 ~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 686 (765)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... .. ........ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---~~----~~i~~~~~----------~~ 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LF----ELILMEEI----------RF 215 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---HH----HHHhcCCC----------CC
Confidence 224579999999999999999999999999999999999999986433211 11 11101110 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004264 687 VESQVLRCIQVGLLCVQKLPEDRP-----DMSSVVFL 718 (765)
Q Consensus 687 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 718 (765)
+......+.+++.+||+.||++|+ ++.++++.
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 111234577899999999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=306.79 Aligned_cols=256 Identities=30% Similarity=0.455 Sum_probs=203.0
Q ss_pred hcCcccccccccCCceeEEEEEeCC-C---cEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLST-G---QEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
.++|+..+.||+|+||.||+|..+. + ..+++|++... .....+.+.+|+.++++++|+|++++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3578888999999999999998642 3 36899988654 34446778999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999988532 245889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCccccc-ccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 600 GDDEEAQT-ERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 600 ~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
........ .....+..|+|||++.+..++.++||||||+++|||++ |+.||......+ .......+.. .
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-------~~~~i~~~~~--~ 229 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAINDGFR--L 229 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhcCCC--C
Confidence 32221111 11223457999999998899999999999999999997 999985433211 1111111110 0
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.........+.+++.+|++.+|++||++.+|+++|++
T Consensus 230 -------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 230 -------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0111223567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=308.21 Aligned_cols=255 Identities=28% Similarity=0.412 Sum_probs=200.9
Q ss_pred cCcccccccccCCceeEEEEEeCC-C---cEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLST-G---QEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
.+|++.+.||+|+||.||+|.... + ..|++|.+... ......+|..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357888999999999999998643 3 36999998754 344567899999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||+++++|.+++... .+.+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999988543 345889999999999999999999998 99999999999999999999999999886543
Q ss_pred CCccccccc-c--cccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 601 DDEEAQTER-V--AGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 601 ~~~~~~~~~-~--~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
......... . ..+..|+|||++.+..++.++||||||+++|||++ |+.||......+ ... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~----~i~~~~~-- 229 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VIN----AIEQDYR-- 229 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHH----HHHcCCc--
Confidence 222111111 1 12457999999999999999999999999999886 998885433211 111 1111100
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
. ..+......+.+++.+||+.+|++||++.+|+.+|++
T Consensus 230 ~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 230 L-------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred C-------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0 0011223457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=314.29 Aligned_cols=240 Identities=23% Similarity=0.325 Sum_probs=190.7
Q ss_pred cccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEEEEecCC
Q 004264 452 NMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
+.||+|+||.||+++.. +++.||+|++.+.. ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999875 67899999987532 23345667788888764 899999999999999999999999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 606 (765)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 999888843 345889999999999999999999999 9999999999999999999999999987532111 12
Q ss_pred cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCcc
Q 004264 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSF 686 (765)
Q Consensus 607 ~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 686 (765)
.....||..|+|||++.+..++.++||||||+++|||++|+.||...... .+. .....+. + ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~----~~~~~~~------~----~~ 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELF----ESIRVDT------P----HY 215 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCC------C----CC
Confidence 23467899999999999999999999999999999999999998643321 111 1111111 0 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 004264 687 VESQVLRCIQVGLLCVQKLPEDRPDMS-SVV 716 (765)
Q Consensus 687 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 716 (765)
+.....++.+++.+||+.||++||++. +++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 111234577899999999999999984 565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=300.83 Aligned_cols=250 Identities=35% Similarity=0.473 Sum_probs=203.9
Q ss_pred cccccCCceeEEEEEeCC----CcEEEEEEccccChh-hHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCC
Q 004264 452 NMIGKGGFGPVYMGKLST----GQEIAAKRLSKNSGQ-GLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~-~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
+.||+|+||.||++.... +..+++|.+...... ..+.+.+|+.+++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998754 788999999765433 367899999999999999999999999999999999999999
Q ss_pred CChhHHhhcccc------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 527 KSLDYFIFDRER------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 527 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865421 366899999999999999999999998 99999999999999999999999999988754
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
...........++..|+|||.+....++.++||||+|+++|||++ |+.||......+ .......+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~--- 227 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGYRLP--- 227 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCCC---
Confidence 332222334567889999999998899999999999999999999 588886542211 111111111111
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
.+......+.+++.+|++.+|++||++.+++++|+
T Consensus 228 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 ------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11122456889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.83 Aligned_cols=264 Identities=27% Similarity=0.385 Sum_probs=215.8
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccCh-hhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
....++++||+|-||.|.+++...+..||||+++.... ...+.|.+|+++|.+|+||||++++++|..++..++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 34667899999999999999998889999999987643 44589999999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++|+|..++....... +.-....+|+.||+.||+||.+.+ +|||||.++|+|+|.++++||+|||+++.+...+..
T Consensus 618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999997654333 456667789999999999999998 999999999999999999999999999977655555
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHh--CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS--GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
....+.+-.++|||||.+.-++++.++|||+||+.+||+++ ...|+...+.+. .++.....+..+.....
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~~~----- 765 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQVV----- 765 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCccee-----
Confidence 55556677889999999999999999999999999999765 667766544332 22322222222221111
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
...+..+...+.++++.||..+.++||++++|...|...
T Consensus 766 -l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 -LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 122334556788999999999999999999999998653
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.01 Aligned_cols=242 Identities=24% Similarity=0.317 Sum_probs=193.7
Q ss_pred cccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEEEEecCC
Q 004264 452 NMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
++||+|+||.||+|+.. .++.+|+|++.+. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999865 5789999998753 233445677899998876 799999999999999999999999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 606 (765)
++|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 999888743 345889999999999999999999999 9999999999999999999999999998643221 22
Q ss_pred cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCcc
Q 004264 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSF 686 (765)
Q Consensus 607 ~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 686 (765)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....+.. .. .....+.. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~----~~i~~~~~----------~~ 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LF----ESILHDDV----------LY 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HH----HHHHcCCC----------CC
Confidence 234678999999999999999999999999999999999999986543221 11 11111110 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 004264 687 VESQVLRCIQVGLLCVQKLPEDRP-------DMSSVVFL 718 (765)
Q Consensus 687 ~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~ 718 (765)
+......+.+++..||+.+|++|| +++++++.
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 111234577899999999999999 78888744
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=302.21 Aligned_cols=248 Identities=29% Similarity=0.379 Sum_probs=198.6
Q ss_pred cccccCCceeEEEEEeCCCcEEEEEEccccChh-hHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCCChh
Q 004264 452 NMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQ-GLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLD 530 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gsL~ 530 (765)
++||+|+||.||++...+++.+++|++...... ....+.+|+.++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 369999999999999877999999998765433 5678999999999999999999999999999999999999999999
Q ss_pred HHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccccccc
Q 004264 531 YFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERV 610 (765)
Q Consensus 531 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 610 (765)
+++... ...+++..+..++.+++.+|+|||+++ ++||||||+||+++.++.+||+|||+++..............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 988542 235789999999999999999999998 999999999999999999999999999865322211111123
Q ss_pred cccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHH
Q 004264 611 AGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVES 689 (765)
Q Consensus 611 ~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 689 (765)
..+..|+|||.+.+..++.++||||||+++|||++ |..||....+... ......+. ....+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~-------~~~~~~~~---------~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT-------RERIESGY---------RMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH-------HHHHhcCC---------CCCCCcc
Confidence 34567999999998999999999999999999999 7877754332110 11111110 0011122
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 690 QVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 690 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
....+.+++.+|++.+|++||++.+|++.|.
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 3456889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=315.50 Aligned_cols=243 Identities=23% Similarity=0.319 Sum_probs=192.6
Q ss_pred cccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEEEEecCC
Q 004264 452 NMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
+.||+|+||.||++... +++.+|+|++.+.. ....+.+.+|+.++.++ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999864 57889999997542 33456688999999888 699999999999999999999999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 606 (765)
++|..++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 999888743 345899999999999999999999999 9999999999999999999999999997532211 12
Q ss_pred cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCcc
Q 004264 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSF 686 (765)
Q Consensus 607 ~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 686 (765)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........................ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~ 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RI 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CC
Confidence 23467899999999999999999999999999999999999999654433222222222222211110 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH
Q 004264 687 VESQVLRCIQVGLLCVQKLPEDRPDM 712 (765)
Q Consensus 687 ~~~~~~~l~~li~~cl~~dP~~RPs~ 712 (765)
+......+.+++.+||+.||++||++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 11123456789999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=328.55 Aligned_cols=253 Identities=22% Similarity=0.268 Sum_probs=195.6
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
.+|++.+.||+|+||.||+++.. +++.+|+|++.+.. ......+.+|+.++++++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999864 58899999986532 223466889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999843 345888999999999999999999999 999999999999999999999999998533110
Q ss_pred Cc-----------------------------------------ccccccccccccccCcccccCCCCCccccchHHHHHH
Q 004264 602 DE-----------------------------------------EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLL 640 (765)
Q Consensus 602 ~~-----------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll 640 (765)
.. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00 0001135799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCC---CHHHHHH
Q 004264 641 VEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRP---DMSSVVF 717 (765)
Q Consensus 641 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~ 717 (765)
|||++|+.||....+.+... ..........+.. .......+.+++.+|+ .+|++|+ ++.++++
T Consensus 235 yell~G~~Pf~~~~~~~~~~------~i~~~~~~~~~~~-------~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQL------KVINWETTLHIPS-------QAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHHHHHH------HHhccCccccCCC-------CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 99999999997544322110 0000000000000 0111234556666665 4999999 8888885
Q ss_pred H
Q 004264 718 L 718 (765)
Q Consensus 718 ~ 718 (765)
.
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=331.37 Aligned_cols=263 Identities=21% Similarity=0.272 Sum_probs=191.8
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeec--------
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE-------- 514 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~-------- 514 (765)
..++|++.+.||+|+||.||+|... .++.||||++.... ....+|+.++++++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999864 67899999885432 2345799999999999999999876532
Q ss_pred CceEEEEEecCCCChhHHhhc-cccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC-CCeeccc
Q 004264 515 DERMLIYEYMPHKSLDYFIFD-RERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL-NPKISDF 592 (765)
Q Consensus 515 ~~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~vkL~DF 592 (765)
...++||||+++ +|.+++.. ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999986 56555532 233456899999999999999999999999 99999999999998665 6999999
Q ss_pred ccceeeCCCCcccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH-----
Q 004264 593 GLARIFGGDDEEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAW----- 666 (765)
Q Consensus 593 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~----- 666 (765)
|+++.+.... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+....
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 9998764322 12245689999999998764 68999999999999999999999987544322111110000
Q ss_pred ---Hhh----ccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 667 ---LLW----NDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 667 ---~~~----~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
... .+-.........+...++.....++++++.+||+.+|.+|||+.|+++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000 000000000000111111123356889999999999999999999984
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=305.35 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=201.6
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC-----hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS-----GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
++|.+.+.||+|++|.||++.. .+++.+++|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5688999999999999999986 468899999886432 2234578899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999988843 345889999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCcccc-cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 600 GDDEEAQ-TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 600 ~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
....... .....++..|+|||++.+..++.++||||||+++|||++|+.||...... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~---- 225 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPTN---- 225 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhccCCC----
Confidence 3222111 12356778899999999999999999999999999999999998543221 111111111111
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...+......+.+++.+||+.+|++||++.++++.
T Consensus 226 -----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 -----PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11122234457789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=304.02 Aligned_cols=250 Identities=29% Similarity=0.430 Sum_probs=204.2
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
.++|++.+.||+|+||.||++... ++.+++|++..... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357888999999999999999864 78999999976544 5678999999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999885432 235899999999999999999999999 99999999999999999999999999987632111
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
....+..|+|||++.+..++.++||||||++++||++ |+.||......+ .......+.....
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~------ 220 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKGYRMEA------ 220 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCCCCC------
Confidence 2334567999999998899999999999999999997 998875432211 1111111111111
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+......+.+++.+|++.+|++||++.+|+++|++
T Consensus 221 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 ---PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ---ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11224567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=321.58 Aligned_cols=255 Identities=22% Similarity=0.244 Sum_probs=200.8
Q ss_pred HHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceE
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~ 518 (765)
...++|++.+.||+|+||.||+++.. +++.+|+|++.+. .......+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34578999999999999999999864 6889999998643 2233456788999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
+||||+++++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999998843 24788889999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCcccccCC----CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCc
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYANDG----TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRA 674 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (765)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ...........
T Consensus 193 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~~ 265 (370)
T cd05596 193 DANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMDHKNS 265 (370)
T ss_pred cCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------HHHHHHcCCCc
Confidence 43221 112246799999999998653 47899999999999999999999986543211 11111111010
Q ss_pred cccccccccCccCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 004264 675 LGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPED--RPDMSSVVFL 718 (765)
Q Consensus 675 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 718 (765)
....+ .......+.+++..||+.+|.+ ||++.++++.
T Consensus 266 ~~~~~-------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 LTFPD-------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCC-------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11111 0112456778999999999988 9999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=313.60 Aligned_cols=254 Identities=30% Similarity=0.407 Sum_probs=199.1
Q ss_pred cCcccccccccCCceeEEEEEeC-CCc--EEEEEEcccc-ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQ--EIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~--~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV 520 (765)
++|++.+.||+|+||.||+|.+. ++. .+++|.+... .....+++.+|+.++.++ +|+||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57888999999999999999864 343 4577777543 344567889999999999 899999999999999999999
Q ss_pred EEecCCCChhHHhhccc-------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCC
Q 004264 521 YEYMPHKSLDYFIFDRE-------------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNP 587 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~v 587 (765)
|||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986432 1235789999999999999999999998 9999999999999999999
Q ss_pred eecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 004264 588 KISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAW 666 (765)
Q Consensus 588 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~ 666 (765)
||+|||+++..... ........+..|+|||++.+..++.++||||||+++|||++ |..||......+ ..
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~---- 233 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY---- 233 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HH----
Confidence 99999998643111 11112234567999999988889999999999999999998 999985433211 11
Q ss_pred HhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 667 LLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 667 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.....+... ..+......+.+++.+|++.+|++||++++++++|++
T Consensus 234 ~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 234 EKLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred HHHhcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111111000 0111123457899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=321.38 Aligned_cols=244 Identities=27% Similarity=0.420 Sum_probs=208.0
Q ss_pred ccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCCChhH
Q 004264 453 MIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDY 531 (765)
Q Consensus 453 ~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gsL~~ 531 (765)
+||+|.||+||.|++. +...+|||.+.....+..+.+.+|+.+.++|+|+|||+++|.+.++...-+.||.++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999965 466799999998888888899999999999999999999999999999999999999999999
Q ss_pred HhhccccCCCC--ChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEe-cCCCCeecccccceeeCCCCcccccc
Q 004264 532 FIFDRERSKLL--PWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD-INLNPKISDFGLARIFGGDDEEAQTE 608 (765)
Q Consensus 532 ~l~~~~~~~~l--~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~vkL~DFGla~~~~~~~~~~~~~ 608 (765)
++...- +++ .+.++-.+.+||++||.|||++. |||||||-+||||+ -.|.+||+|||-++.+.+.... +.
T Consensus 662 LLrskW--GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~--TE 734 (1226)
T KOG4279|consen 662 LLRSKW--GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC--TE 734 (1226)
T ss_pred HHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCcc--cc
Confidence 996543 344 78888899999999999999998 99999999999996 5688999999999988654443 44
Q ss_pred cccccccccCcccccCCC--CCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCcc
Q 004264 609 RVAGTHGYMSPEYANDGT--ISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSF 686 (765)
Q Consensus 609 ~~~gt~~Y~aPE~~~~~~--~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 686 (765)
.+.||..|||||++-.++ |..++|||||||.+.||.||++||........ ..++.|- -...+.+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGm------yKvHP~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGM------YKVHPPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhcc------eecCCCC
Confidence 689999999999997764 89999999999999999999999975443321 1111111 1234667
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 687 VESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 687 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
+.+...+...++++|+.++|.+||+++++++
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 7778889999999999999999999999984
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=304.52 Aligned_cols=255 Identities=33% Similarity=0.485 Sum_probs=205.5
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
.++|++.++||+|+||.||++..++++.+++|.+.... ...+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46799999999999999999998888899999987543 34567899999999999999999999999989999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++++|.+++.... ...+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++..+.....
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY- 158 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh-
Confidence 9999999985432 345899999999999999999999998 99999999999999999999999999987643211
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
........+..|+|||.+.+..++.++||||||+++++|++ |+.||....... ... ....+...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~----~~~~~~~~-------- 223 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLE----QVERGYRM-------- 223 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCCCC--------
Confidence 11112334567999999999999999999999999999998 999985432211 111 11111000
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..+.....++.+++.+|++.+|++||+++++++.|+.
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 -PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011123467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=321.96 Aligned_cols=238 Identities=23% Similarity=0.289 Sum_probs=191.4
Q ss_pred cccccCCceeEEEEEe----CCCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecC
Q 004264 452 NMIGKGGFGPVYMGKL----STGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
+.||+|+||.||+++. ..++.+|+|++.+.. ......+.+|+.++++++||||+++++++.+....++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 357899999997542 2234567789999999999999999999999999999999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 9999888843 345899999999999999999999999 9999999999999999999999999998653221 1
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCc
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDS 685 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 685 (765)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ... ....... .
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~----~i~~~~~----------~ 216 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---TMT----MILKAKL----------G 216 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH---HHH----HHHcCCC----------C
Confidence 2234678999999999999899999999999999999999999986433211 111 1111111 0
Q ss_pred cCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 004264 686 FVESQVLRCIQVGLLCVQKLPEDRPDMSS 714 (765)
Q Consensus 686 ~~~~~~~~l~~li~~cl~~dP~~RPs~~e 714 (765)
.+......+.+++.+||+.||++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11112345778999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=303.41 Aligned_cols=247 Identities=25% Similarity=0.358 Sum_probs=194.7
Q ss_pred ccccCCceeEEEEEeC---CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCCC
Q 004264 453 MIGKGGFGPVYMGKLS---TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKS 528 (765)
Q Consensus 453 ~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gs 528 (765)
.||+|+||.||+|.+. .+..+|+|++.... ....+++.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 35579999987543 334567999999999999999999999875 457899999999999
Q ss_pred hhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc-c
Q 004264 529 LDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ-T 607 (765)
Q Consensus 529 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~-~ 607 (765)
|.+++... ...+++..+++++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++........... .
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99988532 346899999999999999999999998 99999999999999999999999999986543322111 1
Q ss_pred ccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCcc
Q 004264 608 ERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSF 686 (765)
Q Consensus 608 ~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 686 (765)
....++..|+|||.+....++.++||||||+++|||++ |+.||......+ .......+... ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGKRL---------DC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCC---------CC
Confidence 11233568999999998889999999999999999996 999986433211 11122222211 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 687 VESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 687 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 22234567789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=316.08 Aligned_cols=259 Identities=27% Similarity=0.398 Sum_probs=204.0
Q ss_pred cCcccccccccCCceeEEEEEeC--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecC
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS--------TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEED 515 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~ 515 (765)
.+|++.+.||+|+||.||+++.. ....+|+|.+... .....+++.+|+.+++++ +|+||+++++++....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46899999999999999999742 1236899988754 334567899999999999 7999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhccc-------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEe
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRE-------------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD 582 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 582 (765)
..++++||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986432 2235788899999999999999999998 99999999999999
Q ss_pred cCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccH
Q 004264 583 INLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNL 661 (765)
Q Consensus 583 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~ 661 (765)
.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 244 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----
Confidence 999999999999987643322222223344567999999999999999999999999999998 788875432111
Q ss_pred HHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 004264 662 IGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDG 723 (765)
Q Consensus 662 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 723 (765)
.......+..... +......+.+++.+|++.+|++||++.+|++.|++..
T Consensus 245 ---~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 245 ---LFKLLKEGHRMDK---------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred ---HHHHHHcCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 1111111111111 1122346789999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=323.40 Aligned_cols=258 Identities=20% Similarity=0.239 Sum_probs=200.3
Q ss_pred hHHHHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecC
Q 004264 440 TITTATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED 515 (765)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~ 515 (765)
.+....++|++.+.||+|+||.||+++.. +++.+|+|++.+. .....+.+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34445678999999999999999999875 5788999998642 2233456889999999999999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccc
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA 595 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla 595 (765)
..++||||+++++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccc
Confidence 99999999999999998843 24788999999999999999999999 999999999999999999999999999
Q ss_pred eeeCCCCcccccccccccccccCcccccCC----CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhcc
Q 004264 596 RIFGGDDEEAQTERVAGTHGYMSPEYANDG----TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWND 671 (765)
Q Consensus 596 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 671 (765)
........ .......||+.|+|||++.+. .++.++||||+|+++|||++|+.||....... ........
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------~~~~i~~~ 262 (370)
T cd05621 190 MKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------TYSKIMDH 262 (370)
T ss_pred eecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH------HHHHHHhC
Confidence 87642221 122356799999999998754 37899999999999999999999996443211 11111111
Q ss_pred CCccccccccccCccCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 004264 672 GRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPED--RPDMSSVVFL 718 (765)
Q Consensus 672 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 718 (765)
.......+ .......+.+++..|++.++.+ ||++.++++.
T Consensus 263 ~~~~~~p~-------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 263 KNSLNFPE-------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CcccCCCC-------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11111111 1112345667888888855543 8899999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=318.02 Aligned_cols=236 Identities=24% Similarity=0.334 Sum_probs=189.9
Q ss_pred cccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEEEEecCC
Q 004264 452 NMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
+.||+|+||.||+++.. +++.||+|++.+. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999865 5789999998753 223456677888888876 699999999999999999999999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 606 (765)
++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 999888843 345889999999999999999999999 9999999999999999999999999987642211 12
Q ss_pred cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCcc
Q 004264 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSF 686 (765)
Q Consensus 607 ~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 686 (765)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... .......+.. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~----------~~ 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEV----------VY 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCC----------CC
Confidence 234678999999999999999999999999999999999999986543221 1111111111 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH
Q 004264 687 VESQVLRCIQVGLLCVQKLPEDRPDM 712 (765)
Q Consensus 687 ~~~~~~~l~~li~~cl~~dP~~RPs~ 712 (765)
+......+.+++.+||+.||++||++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 11123457789999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=314.94 Aligned_cols=264 Identities=21% Similarity=0.292 Sum_probs=197.7
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
++|.+.+.||+|+||.||+|+.+ +++.+|+|++.... ......+.+|+.++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57899999999999999999865 57789999986442 22345678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++ +|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 986 676666432 345788999999999999999999998 99999999999999999999999999986532221
Q ss_pred ccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHhhccCCc
Q 004264 604 EAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHA--------WLLWNDGRA 674 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~ 674 (765)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+... +........
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1223467889999998865 56899999999999999999999999755433221111110 000000000
Q ss_pred ---cccccccccC--ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 675 ---LGLMDTCLED--SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 675 ---~~l~d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.......... .........+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000 000112345678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.52 Aligned_cols=263 Identities=23% Similarity=0.323 Sum_probs=200.4
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
++|++.+.||+|+||.||++... ++..+++|.+... ......++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36889999999999999999864 5778888887654 333456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhh-cCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ-DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
+++++|.+++... ..+++..+..++.||++||.|||+ .+ ++|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 9999999998532 458899999999999999999997 46 999999999999999999999999998754221
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC---------
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR--------- 673 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 673 (765)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||.......................
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 12245788999999999888899999999999999999999999854332211110000000000000
Q ss_pred --------cccccccccc---Ccc-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 674 --------ALGLMDTCLE---DSF-VESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 674 --------~~~l~d~~l~---~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..++.+.... ... .......+.+++.+||+.+|++||++.+|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000 000 00123458899999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=319.15 Aligned_cols=259 Identities=29% Similarity=0.402 Sum_probs=200.8
Q ss_pred hcCcccccccccCCceeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHhcc-ccCceEeeeeeeeec-C
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL------STGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEE-D 515 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~-~ 515 (765)
.++|++.+.||+|+||.||+|.. ..++.||||++.... ......+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 36799999999999999999973 356789999997543 33456788999999999 689999999988654 4
Q ss_pred ceEEEEEecCCCChhHHhhcccc---------------------------------------------------------
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRER--------------------------------------------------------- 538 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 538 (765)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999998854210
Q ss_pred -------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccccccccc
Q 004264 539 -------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVA 611 (765)
Q Consensus 539 -------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 611 (765)
...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 123678888999999999999999998 9999999999999999999999999998753322222222344
Q ss_pred ccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHH
Q 004264 612 GTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQ 690 (765)
Q Consensus 612 gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~ 690 (765)
++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ........+....... ..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~---------~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRAPD---------YT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccCCCCCCC---------CC
Confidence 5678999999999999999999999999999997 888875432211 1111111221111110 11
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 691 VLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 691 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
...+.+++..||+.+|++||++.+|++.|+.
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 2357899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=323.03 Aligned_cols=262 Identities=19% Similarity=0.244 Sum_probs=200.1
Q ss_pred hcCcccccccccCCceeEEEEEeC---CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS---TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
..+|++.+.||+|+||.||++... .++.|++|.+... +...+|+.++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357999999999999999999743 3567999987543 24568999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
|++. ++|.+++ .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9986 5676776 23356899999999999999999999999 999999999999999999999999999876544
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcc------
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRAL------ 675 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 675 (765)
..........||..|+|||++.+..++.++|||||||++|||++|+.||...........+.............
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 33333335679999999999999999999999999999999999999986554332221111111111100000
Q ss_pred -cc------ccccccCccC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 676 -GL------MDTCLEDSFV-------ESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 676 -~l------~d~~l~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.+ ........+. ......+.+++.+||+.+|++||++.+++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0000000000 0113457788999999999999999999876
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=309.64 Aligned_cols=252 Identities=24% Similarity=0.382 Sum_probs=204.5
Q ss_pred HhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
...+|++.+.||+|++|.||+|.. .+++.+++|.+........+.+.+|+.+++.+.|+|++++++.+......++|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 346899999999999999999985 4688999999876655556788999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred ccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999998842 34788999999999999999999999 9999999999999999999999999988653222
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
. ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||....+... .......+. ..+
T Consensus 171 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~------~~~~~~~~~-~~~----- 236 (296)
T cd06654 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGT-PEL----- 236 (296)
T ss_pred c--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh------HHHHhcCCC-CCC-----
Confidence 1 12234688899999999988899999999999999999999999865433211 111111110 000
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..+......+.+++.+||+.+|++||++.+|++.
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1111233457789999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=314.27 Aligned_cols=241 Identities=25% Similarity=0.328 Sum_probs=192.3
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccc-cCceEeeeeeeeecCceEEEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~~~lV~ 521 (765)
+|+..+.||+|+||.||+++.. +++.||+|++.+.. ....+.+..|+.+++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999864 68899999987532 234456788999988885 578888999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999888843 345899999999999999999999998 999999999999999999999999998754222
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||....+.. .... ......
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~----i~~~~~------- 218 (323)
T cd05615 155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQS----IMEHNV------- 218 (323)
T ss_pred C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHH----HHhCCC-------
Confidence 1 12234568999999999999999999999999999999999999986543211 1111 111111
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCCH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDM 712 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 712 (765)
..+......+.+++.+|++.+|.+|++.
T Consensus 219 ---~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 ---SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1111223457789999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=306.11 Aligned_cols=253 Identities=28% Similarity=0.448 Sum_probs=200.5
Q ss_pred cccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHH--HHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 448 FSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLE--EFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~--~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
|++.+.||+|+||.||+++.. +++.+|+|++......... ...+|+.++++++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 677899999999999999975 4568999999876443322 3456999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
.+++|.+++. ....+++..+..++.||++||++||+.+ |+|+||||+||++++++.++|+|||.+... ....
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SENN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TSTT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--cccc
Confidence 9999999985 3456899999999999999999999998 999999999999999999999999999865 1222
Q ss_pred cccccccccccccCccccc-CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 605 AQTERVAGTHGYMSPEYAN-DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~-~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
.......++..|+|||++. +..++.++||||+|+++++|++|..|+......+.......... .........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~ 225 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK-------RPLPSSSQQ 225 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH-------THHHHHTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc-------ccccccccc
Confidence 3344567899999999998 88899999999999999999999999875411111111110000 000000000
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.......+.+++..||+.+|++||++.++++.
T Consensus 226 ---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 226 ---SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp ---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ---cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00012678899999999999999999999853
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.87 Aligned_cols=247 Identities=26% Similarity=0.322 Sum_probs=193.0
Q ss_pred cccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCCCh
Q 004264 454 IGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSL 529 (765)
Q Consensus 454 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gsL 529 (765)
||+|+||.||+++.+ +++.+|+|++.+.. ......+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 68999999986432 12234566799999999999999999999999999999999999999
Q ss_pred hHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccccccc
Q 004264 530 DYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTER 609 (765)
Q Consensus 530 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~ 609 (765)
.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 88875432 334889999999999999999999998 9999999999999999999999999998764321 1224
Q ss_pred ccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHH
Q 004264 610 VAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVES 689 (765)
Q Consensus 610 ~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 689 (765)
..++..|+|||++.+..++.++||||||+++|||++|+.||........ ......... .... .. . ...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~-~~~~----~~-~----~~~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTL-EDEV----KF-E----HQN 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhh-cccc----cc-c----ccc
Confidence 5688999999999998999999999999999999999999864332111 011001100 1110 00 0 011
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004264 690 QVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719 (765)
Q Consensus 690 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L 719 (765)
...++.+++..||+.+|++||++.|+++.+
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 234578999999999999999997766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=305.08 Aligned_cols=255 Identities=29% Similarity=0.431 Sum_probs=202.4
Q ss_pred cCcccccccccCCceeEEEEEeC----CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS----TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
.+|++.+.||+|+||.||+|+.. .+..+++|.+.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57888999999999999999863 23479999886543 33456889999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998532 245889999999999999999999998 99999999999999999999999999987643
Q ss_pred CCcccc-cccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 601 DDEEAQ-TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 601 ~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
...... .....++..|+|||++.+..++.++||||||+++||+++ |+.||......+ ... ...++.. .
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~----~~~~~~~--~- 228 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIK----AIEEGYR--L- 228 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHH----HHhCCCc--C-
Confidence 322111 112233567999999999899999999999999999886 999986433221 111 1111110 0
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.........+.+++.+|++.+|++||++.++++.|++
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 229 ------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0011123457799999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=314.78 Aligned_cols=241 Identities=26% Similarity=0.349 Sum_probs=191.1
Q ss_pred cccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhc-cccCceEeeeeeeeecCceEEEEEecCC
Q 004264 452 NMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGK-LQHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~-l~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
+.||+|+||.||+|+.. +++.||+|++.+.. ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999865 57889999987542 2334556778888876 4899999999999999999999999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 606 (765)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 999988843 245889999999999999999999998 9999999999999999999999999997542211 12
Q ss_pred cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCcc
Q 004264 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSF 686 (765)
Q Consensus 607 ~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 686 (765)
.....||..|+|||++.+..++.++||||||+++|||++|+.||......+ +.. ...... + ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~----~i~~~~------~----~~ 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQ----SIRMDN------P----CY 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHhCC------C----CC
Confidence 234578999999999999999999999999999999999999986433211 111 111111 0 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 004264 687 VESQVLRCIQVGLLCVQKLPEDRPDMS-SVVF 717 (765)
Q Consensus 687 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 717 (765)
+......+.+++.+||+.+|++||++. ++++
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 111234577899999999999999997 6643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.30 Aligned_cols=249 Identities=27% Similarity=0.384 Sum_probs=203.3
Q ss_pred cCcccccccccCCceeEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLST-GQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
++|++.+.||+|+||.||++.... ++.+++|.+..... .+++.+|+.++++++|+||+++++.+.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 678999999999999999999764 78999999865433 678999999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999998843 2356899999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
......++..|+|||++.+..++.++||||||+++++|++|+.|+....+..... ...... ....
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~-----~~~~-- 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-------MIPNKP-----PPTL-- 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-------hhccCC-----CCCC--
Confidence 2223557889999999999999999999999999999999999986543321100 000000 0000
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
..+......+.+++.+|++.+|++||++++|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 111223356788999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=304.05 Aligned_cols=262 Identities=24% Similarity=0.393 Sum_probs=202.2
Q ss_pred cCcccccccccCCceeEEEEEe-----CCCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeec--Cce
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-----STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE--DER 517 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~--~~~ 517 (765)
+.|++.+.||+|+||.||+++. ..++.+|+|.+... .......+.+|+.++++++|+|++++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3478889999999999999973 35788999998754 344456899999999999999999999998875 568
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999988432 235899999999999999999999999 99999999999999999999999999987
Q ss_pred eCCCCcc-cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCC--------CCcccHHHHHHHh
Q 004264 598 FGGDDEE-AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHP--------GHRHNLIGHAWLL 668 (765)
Q Consensus 598 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~--------~~~~~~~~~~~~~ 668 (765)
+...... .......++..|+|||++.+..++.++||||||+++|||++++.|...... .............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6432221 112234567789999999988999999999999999999998766422110 0000001111111
Q ss_pred hccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 669 WNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 669 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
...+.... ........+.+++.+|++.+|++||++.++++.|+.
T Consensus 239 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 239 LEEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HHcCccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 11111111 111234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.43 Aligned_cols=254 Identities=29% Similarity=0.456 Sum_probs=203.6
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
.++|++.+.||+|+||.||++...++..+++|.+... ......+.+|+.++++++|+||+++.+.+.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 3678899999999999999999877888999988653 3345678899999999999999999999887 7789999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++++|.+++.... ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||.+..+.....
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 157 (260)
T cd05073 83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY- 157 (260)
T ss_pred CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence 9999999985432 345788999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
.......++..|+|||++....++.++|+||||+++|+|++ |+.||....... +. .....+....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~----~~~~~~~~~~------- 223 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VI----RALERGYRMP------- 223 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HH----HHHhCCCCCC-------
Confidence 11122345677999999998899999999999999999999 888886432211 11 1111111111
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
........+.+++.+|++.+|++||++.+|+++|++
T Consensus 224 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 --RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111233567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=302.77 Aligned_cols=240 Identities=21% Similarity=0.374 Sum_probs=189.0
Q ss_pred cccccCCceeEEEEEeCC-------------CcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceE
Q 004264 452 NMIGKGGFGPVYMGKLST-------------GQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~ 518 (765)
+.||+|+||.||+|+... ...+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2258888887655555667889999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCC-------Ceecc
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLN-------PKISD 591 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------vkL~D 591 (765)
+||||+++++|+.++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999888743 2345899999999999999999999998 999999999999987664 89999
Q ss_pred cccceeeCCCCcccccccccccccccCccccc-CCCCCccccchHHHHHHHHHH-hCCCCCCCCCCCCcccHHHHHHHhh
Q 004264 592 FGLARIFGGDDEEAQTERVAGTHGYMSPEYAN-DGTISMKSDVFSLGVLLVEIV-SGKMNRGFRHPGHRHNLIGHAWLLW 669 (765)
Q Consensus 592 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~k~DvwSlG~ll~ell-tG~~p~~~~~~~~~~~~~~~~~~~~ 669 (765)
||++...... ....++..|+|||.+. +..++.++||||||+++|||+ .|+.|+......+. ....
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~~ 222 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERFY 222 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHHH
Confidence 9998754211 1345778899999887 467899999999999999998 57777653322111 0000
Q ss_pred ccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 670 NDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 670 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
.+.. ... ......+.+|+.+||+.+|++||++.+|++.|+
T Consensus 223 -~~~~-~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 -EGQC-MLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -hcCc-cCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1110 011 111345789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=292.00 Aligned_cols=253 Identities=25% Similarity=0.312 Sum_probs=202.0
Q ss_pred HHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
..++.|++.+.||+|.|+.|++... +.|+.+|+|++... ...+.+++.+|+.|-+.|+||||+++.+.+.+....++
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 3457899999999999999999864 57889999887532 34467889999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec---CCCCeecccccce
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI---NLNPKISDFGLAR 596 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~vkL~DFGla~ 596 (765)
|+|+|.|+.|-.-+-.+ ..+++..+-..++||++||.|+|.++ |||||+||+|+++.+ ..-+||+|||+|.
T Consensus 88 vFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEE
Confidence 99999999985554332 34778888899999999999999999 999999999999954 3458999999999
Q ss_pred eeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 597 IFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
.++. ...-...+||++|||||+++..+|+..+|||+-|+|||-|+.|.+||...+..+ + .+....+...
T Consensus 162 ~l~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r---l----ye~I~~g~yd- 230 (355)
T KOG0033|consen 162 EVND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---L----YEQIKAGAYD- 230 (355)
T ss_pred EeCC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH---H----HHHHhccccC-
Confidence 8862 222235789999999999999999999999999999999999999997533221 1 1122222211
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
+ + +.+-....++..+|+.+||..||.+|.|+.|.++
T Consensus 231 ~-~----~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 231 Y-P----SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred C-C----CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1 1 1111122345678999999999999999998763
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=299.54 Aligned_cols=253 Identities=23% Similarity=0.246 Sum_probs=207.3
Q ss_pred cCcccccccccCCceeEEEEEeCC-CcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLST-GQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|+..+.||+|.-|+||++++.. +..+|+|++.+.. .....+.+.|-+||+.+.||.++.++..|..++..+|||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 567888999999999999999764 5889999998753 445667888999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC-
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG- 600 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~- 600 (765)
|||+||+|..+.+. +..+.+++..+..++..++.||+|||-.| ||+|||||+||||.++|++-|+||.++.....
T Consensus 157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999887754 45567999999999999999999999999 99999999999999999999999999754311
Q ss_pred --------------------------------CCc---------------------ccccccccccccccCcccccCCCC
Q 004264 601 --------------------------------DDE---------------------EAQTERVAGTHGYMSPEYANDGTI 627 (765)
Q Consensus 601 --------------------------------~~~---------------------~~~~~~~~gt~~Y~aPE~~~~~~~ 627 (765)
... ......++||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 011234789999999999999999
Q ss_pred CccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCC
Q 004264 628 SMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPE 707 (765)
Q Consensus 628 s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~ 707 (765)
+.++|.|+|||+||||+.|+.||......+...-+ +...+.=.........+.+||...|..||.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI---------------v~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI---------------VGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH---------------hcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 99999999999999999999999876655432111 111111111113456688999999999999
Q ss_pred CCCC----HHHHHH
Q 004264 708 DRPD----MSSVVF 717 (765)
Q Consensus 708 ~RPs----~~evl~ 717 (765)
+|.. +.||.+
T Consensus 378 kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKR 391 (459)
T ss_pred hhhccccchHHhhc
Confidence 9998 777764
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=315.64 Aligned_cols=242 Identities=25% Similarity=0.309 Sum_probs=194.1
Q ss_pred cccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEEEEecCC
Q 004264 452 NMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
+.||+|+||.||+++.. +++.+|+|++.+.. ......+..|..+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 57889999987542 33456677899999887 699999999999999999999999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 606 (765)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 999888743 335899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCcc
Q 004264 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSF 686 (765)
Q Consensus 607 ~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 686 (765)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||....... .......... ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-------~~~~i~~~~~----------~~ 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-------LFQSILEDEV----------RY 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCC----------CC
Confidence 224568999999999999999999999999999999999999986433211 1111111110 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 004264 687 VESQVLRCIQVGLLCVQKLPEDRPDM-----SSVVFL 718 (765)
Q Consensus 687 ~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 718 (765)
+......+.+++.+||+.||.+||++ .++++.
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 11223467899999999999999999 888653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.63 Aligned_cols=249 Identities=29% Similarity=0.404 Sum_probs=199.4
Q ss_pred cccccCCceeEEEEEeCC--C--cEEEEEEccccCh-hhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCC
Q 004264 452 NMIGKGGFGPVYMGKLST--G--QEIAAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
++||+|++|.||+|.+.. + ..+|+|.+..... ...+.+.+|+.++++++|+||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 2 3689999987655 567789999999999999999999999988 889999999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc-c
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE-A 605 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~-~ 605 (765)
++|.+.+..... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999865432 46899999999999999999999998 999999999999999999999999999876432221 1
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
......++..|+|||++.+..++.++||||||+++|||++ |+.|+......+ ..... .......
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~---~~~~~~~--------- 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKI---DKEGERL--------- 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---HhcCCcC---------
Confidence 1123456788999999999999999999999999999998 999985432221 11111 1011100
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
..+......+.+++.+|++.+|++||++.+|++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011122356788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=304.11 Aligned_cols=262 Identities=27% Similarity=0.410 Sum_probs=204.0
Q ss_pred cCcccccccccCCceeEEEEEeC-----CCcEEEEEEccccChh-hHHHHHHHHHHHhccccCceEeeeeeeee--cCce
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-----TGQEIAAKRLSKNSGQ-GLEEFMNEVVLIGKLQHRNLVGLLGSCIE--EDER 517 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~Ev~~l~~l~h~niv~~~~~~~~--~~~~ 517 (765)
++|++.+.||+|+||.||++... .++.+|+|++...... ..+.+.+|+.+++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46778899999999999999853 3678999999765443 56789999999999999999999999887 5678
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
++||||+++++|.+++.... ..+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999985432 25899999999999999999999998 99999999999999999999999999987
Q ss_pred eCCCCcc-cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcc--------cHHHHHHHh
Q 004264 598 FGGDDEE-AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRH--------NLIGHAWLL 668 (765)
Q Consensus 598 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~--------~~~~~~~~~ 668 (765)
....... .......++..|+|||.+.+..++.++||||||++++||++|+.|+......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6422221 1111234456699999999889999999999999999999999887543221100 001111111
Q ss_pred hccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 669 WNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 669 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
...+.. ...+.....++.+++.+|++.+|++||++.+|+++|++
T Consensus 239 ~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05038 239 LKEGER---------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282 (284)
T ss_pred HHcCCc---------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence 111111 01111223568899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=338.25 Aligned_cols=259 Identities=21% Similarity=0.289 Sum_probs=201.8
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.++||+|+||.||+|... .++.||+|++.... ....+++.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999865 58899999987532 334567899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccc--------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccc
Q 004264 522 EYMPHKSLDYFIFDRE--------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFG 593 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFG 593 (765)
||+++++|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885421 1234567788999999999999999998 9999999999999999999999999
Q ss_pred cceeeCCCCc----------------ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCC
Q 004264 594 LARIFGGDDE----------------EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGH 657 (765)
Q Consensus 594 la~~~~~~~~----------------~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~ 657 (765)
+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 001123569999999999999999999999999999999999999986532211
Q ss_pred cccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhc
Q 004264 658 RHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRP-DMSSVVFLLAN 721 (765)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~ 721 (765)
. .. . .. +.++... .........+.+++.+|++.+|++|| +++++++.|+.
T Consensus 239 i---~~-~------~~---i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 I---SY-R------DV---ILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred h---hh-h------hh---ccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 00 0 00 0000000 00012234577899999999999996 67777777765
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=313.89 Aligned_cols=237 Identities=27% Similarity=0.308 Sum_probs=187.5
Q ss_pred cccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHH-HHhccccCceEeeeeeeeecCceEEEEEecCC
Q 004264 452 NMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVV-LIGKLQHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~-~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
+.||+|+||.||+|+.. +++.||+|++.+.. ....+++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999874 68899999987532 223344555554 56789999999999999999999999999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 606 (765)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence 999888843 345889999999999999999999999 999999999999999999999999998754221 122
Q ss_pred cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCcc
Q 004264 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSF 686 (765)
Q Consensus 607 ~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 686 (765)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .......+.. .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~------~~---- 215 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-------MYDNILNKPL------RL---- 215 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-------HHHHHHcCCC------CC----
Confidence 334678999999999999999999999999999999999999986432211 1111111110 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHH
Q 004264 687 VESQVLRCIQVGLLCVQKLPEDRPDMS 713 (765)
Q Consensus 687 ~~~~~~~l~~li~~cl~~dP~~RPs~~ 713 (765)
.......+.+++.+||+.+|++||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 111244577899999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.93 Aligned_cols=252 Identities=30% Similarity=0.448 Sum_probs=201.8
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecC
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
.+|++.+.||+|+||.||++.+.+++.+++|++..... ....+.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46788899999999999999987788999998865432 34678899999999999999999999999999999999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+++|.+++... ...+++..++.++.|++.+|+|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999888532 235789999999999999999999998 9999999999999999999999999998653322111
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .. ....++. ....+.
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~~--~~~~~~--- 224 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VV----ETINAGF--RLYKPR--- 224 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HH----HHHhCCC--CCCCCC---
Confidence 112334578999999998899999999999999999998 888875433211 11 1111111 111111
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
.....+.+|+.+||+.+|++||++.+++++|.
T Consensus 225 ----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 ----LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ----CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 12356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=307.34 Aligned_cols=266 Identities=24% Similarity=0.281 Sum_probs=198.3
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
+|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.+++++.||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999864 68899999986432 22346788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
++ ++|.+++........+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 578777755444467899999999999999999999998 9999999999999999999999999998653221
Q ss_pred ccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC---------
Q 004264 604 EAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR--------- 673 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 673 (765)
.......++..|+|||.+.+. .++.++||||||+++++|++|+.||....+.+.............+..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 111234568889999988754 578999999999999999999999865432111000000000000000
Q ss_pred ccccccccccC---ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 674 ALGLMDTCLED---SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 674 ~~~l~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
........... ........++.+++.+||+.||++|||+.+|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000000 0001123466799999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=301.88 Aligned_cols=253 Identities=26% Similarity=0.348 Sum_probs=189.5
Q ss_pred ccccCCceeEEEEEeCC---CcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCCC
Q 004264 453 MIGKGGFGPVYMGKLST---GQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKS 528 (765)
Q Consensus 453 ~LG~G~fg~Vy~~~~~~---~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gs 528 (765)
.||+|+||.||+|.... ...+++|.+.... ......+.+|+.+++.++|+||+++++.+.+....++||||+++++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 59999999999997543 3468888776443 3345678899999999999999999999999999999999999999
Q ss_pred hhHHhhcccc--CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc
Q 004264 529 LDYFIFDRER--SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 529 L~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 606 (765)
|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999865332 233567888999999999999999998 99999999999999999999999999875432221111
Q ss_pred cccccccccccCcccccC-------CCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 607 TERVAGTHGYMSPEYAND-------GTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 607 ~~~~~gt~~Y~aPE~~~~-------~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
.....++..|+|||++.. ..++.++||||||+++|||++ |+.|+....+.+ . ..... ......+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~---~~~~~-~~~~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---V---LKQVV-REQDIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---H---HHHHh-hccCccCC
Confidence 223445677999998743 457889999999999999999 777775432211 1 11111 11122222
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
++.+.. .....+.+++..|+ .+|++||++++|+++|.
T Consensus 232 ~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222222 22344566778888 59999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=305.90 Aligned_cols=252 Identities=27% Similarity=0.382 Sum_probs=202.2
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
+.|++.++||+|+||.||+|+.. +++.+++|.+........+.+.+|+.++++++|+||+++++.+..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56889999999999999999875 57899999998777777788999999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++++|..++... ...+++..+..++.||+.+|.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 999998877432 245899999999999999999999998 9999999999999999999999999987643221
Q ss_pred cccccccccccccCccccc-----CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 605 AQTERVAGTHGYMSPEYAN-----DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~-----~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
.......++..|+|||++. ...++.++||||||+++|||++|+.|+....+.. .............
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~~-- 235 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-------VLLKIAKSEPPTL-- 235 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-------HHHHHhcCCCccC--
Confidence 1122456788999999985 3457889999999999999999999986433211 0111111111110
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..+......+.+++.+||+.+|++||++.++++.
T Consensus 236 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 236 -----SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0111223457789999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=301.59 Aligned_cols=256 Identities=27% Similarity=0.365 Sum_probs=199.6
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
+++.+.....||+|+||.||+|... ++..+++|.+........+.+.+|+.++++++|+||+++++++..++..++|+|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 3445555668999999999999854 577899999887766677889999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec-CCCCeecccccceeeCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI-NLNPKISDFGLARIFGGD 601 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~vkL~DFGla~~~~~~ 601 (765)
|+++++|.+++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.++|+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 9999999999864322112278888999999999999999998 999999999999976 678999999999865332
Q ss_pred CcccccccccccccccCcccccCCC--CCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGT--ISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
.. ......++..|+|||++.+.. ++.++||||||+++|+|++|+.|+........ .. +. ... .
T Consensus 163 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~--~~---~~~-~---- 227 (268)
T cd06624 163 NP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AM--FK---VGM-F---- 227 (268)
T ss_pred CC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hH--hh---hhh-h----
Confidence 21 122345788999999987643 78999999999999999999999864322110 00 00 000 0
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
......+.....++.+++.+||+.+|++||++.+|++.
T Consensus 228 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 -KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00111222334567789999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=321.59 Aligned_cols=262 Identities=17% Similarity=0.192 Sum_probs=195.5
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
..+|.+.+.||+|+||.||++... .++.||+|.... ..+.+|+.+|++++|+||+++++++..+...++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999875 477899996432 3456899999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+. ++|..++... ...+++..++.|+.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 5777766432 236899999999999999999999999 99999999999999999999999999987643322
Q ss_pred ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCC-CCCCCCCcccHHHHHHHhhccCCc--cccc--
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNR-GFRHPGHRHNLIGHAWLLWNDGRA--LGLM-- 678 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~-~~~~~~~~~~~~~~~~~~~~~~~~--~~l~-- 678 (765)
........||..|+|||++.+..++.++|||||||+||||++|..++ ........................ ....
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 22223467999999999999999999999999999999999988654 222111111111111111111110 0000
Q ss_pred -cccc------------c-----CccC--HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 679 -DTCL------------E-----DSFV--ESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 679 -d~~l------------~-----~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...+ . .... ......+.+|+.+||+.||++|||+.||++.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 0 0000 0112357789999999999999999999875
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=300.99 Aligned_cols=248 Identities=26% Similarity=0.381 Sum_probs=198.0
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeee-ecCceEEEEEec
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI-EEDERMLIYEYM 524 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~-~~~~~~lV~E~~ 524 (765)
++|++.+.||+|+||.||++... ++.+++|.+.... ..+.+.+|+.++++++|+|++++++++. +.+..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 47888999999999999999864 7789999886433 3467889999999999999999999765 456789999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999885432 235889999999999999999999998 9999999999999999999999999988643221
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
.....+..|+|||++.+..++.++||||||+++|||++ |+.|+...... . .......+...
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~------~-~~~~~~~~~~~-------- 218 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------D-VVPRVEKGYKM-------- 218 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHhcCCCC--------
Confidence 12334567999999999999999999999999999998 88887532211 1 11111111111
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.........+.+++.+|++.+|++|||+.++++.|+.
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 -DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1111224567789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=300.13 Aligned_cols=248 Identities=31% Similarity=0.463 Sum_probs=196.0
Q ss_pred cccccCCceeEEEEEeCC----CcEEEEEEccccCh-hhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCC
Q 004264 452 NMIGKGGFGPVYMGKLST----GQEIAAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
++||+|+||.||+|.... +..+|+|.+..... ...+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997432 36899999876543 34567899999999999999999999775 5678999999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 606 (765)
++|.+++... ..+++..+..++.|++.||+|||..+ ++|+||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999998543 25899999999999999999999998 99999999999999999999999999987643322111
Q ss_pred -cccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 607 -TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 607 -~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ... .....+....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~----~~~~~~~~~~-------- 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVI----AMLESGERLP-------- 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHH----HHHHcCCcCC--------
Confidence 112233467999999999999999999999999999998 99998644321 111 1111221111
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
.+......+.+++.+|++.+|++||++.+|+++|++.
T Consensus 219 -~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 -RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1112234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=317.64 Aligned_cols=261 Identities=22% Similarity=0.257 Sum_probs=202.0
Q ss_pred hHhHHHHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeee
Q 004264 438 LATITTATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513 (765)
Q Consensus 438 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~ 513 (765)
+..+....++|++.+.||+|+||.||+++.. +++.+|+|++.+. .....+.+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4445556689999999999999999999875 5788999998642 22334567889999999999999999999999
Q ss_pred cCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccc
Q 004264 514 EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFG 593 (765)
Q Consensus 514 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFG 593 (765)
+...++||||+++++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999988843 24788889999999999999999999 9999999999999999999999999
Q ss_pred cceeeCCCCcccccccccccccccCcccccCC----CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhh
Q 004264 594 LARIFGGDDEEAQTERVAGTHGYMSPEYANDG----TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLW 669 (765)
Q Consensus 594 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 669 (765)
+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .......
T Consensus 188 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~ 260 (371)
T cd05622 188 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIM 260 (371)
T ss_pred ceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHH
Confidence 9987643221 122346799999999998754 3789999999999999999999999643321 1111111
Q ss_pred ccCCccccccccccCccCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 004264 670 NDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPED--RPDMSSVVFLL 719 (765)
Q Consensus 670 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L 719 (765)
.........+ .......+.+++..|++.++.+ ||++.++++..
T Consensus 261 ~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 261 NHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1111111111 1122445678888999844433 78999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=315.98 Aligned_cols=238 Identities=25% Similarity=0.314 Sum_probs=188.0
Q ss_pred cccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHH-HHhccccCceEeeeeeeeecCceEEEEEecCC
Q 004264 452 NMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVV-LIGKLQHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~-~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
+.||+|+||.||+++.. +++.+|+|++.+. ......++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999864 6889999998653 2233445566654 56778999999999999999999999999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 606 (765)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 152 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT 152 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence 999888743 346899999999999999999999999 999999999999999999999999998753221 122
Q ss_pred cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCcc
Q 004264 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSF 686 (765)
Q Consensus 607 ~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 686 (765)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .......... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~~~~~~~------~~~~-- 217 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-------MYDNILHKPL------VLRP-- 217 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-------HHHHHHcCCc------cCCC--
Confidence 234678999999999999999999999999999999999999986433211 1111111111 0011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHH
Q 004264 687 VESQVLRCIQVGLLCVQKLPEDRPDMSS 714 (765)
Q Consensus 687 ~~~~~~~l~~li~~cl~~dP~~RPs~~e 714 (765)
.....+.+++..|++.+|++||++.+
T Consensus 218 --~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 218 --GASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred --CCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 12345678999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=306.80 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=205.0
Q ss_pred HhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
...+|++.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 347899999999999999999986 5789999999976655556778899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999998843 34788999999999999999999998 9999999999999999999999999998653322
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....+...... ....+ ..
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~--------~~ 233 (297)
T cd06656 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG--------TP 233 (297)
T ss_pred c--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC--------CC
Confidence 1 12235678899999999999999999999999999999999999865443221100 00000 00
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
....+......+.+++.+||+.+|++||++.+|++.
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111223456789999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=313.16 Aligned_cols=252 Identities=24% Similarity=0.298 Sum_probs=210.6
Q ss_pred HhcCcccccccccCCceeEEEEEeCC-CcEEEEEEccccCh---hhHHHHHHHHHHHhccc-cCceEeeeeeeeecCceE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLST-GQEIAAKRLSKNSG---QGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~~~ 518 (765)
....|++.+.||+|.||.||+++.+. |+.+|+|.+.+... .....+.+|+.+|+++. |||||.+.+.+.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34678888999999999999999765 99999999987543 24568999999999998 999999999999999999
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC----CCCeeccccc
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN----LNPKISDFGL 594 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~vkL~DFGl 594 (765)
+|||++.+|.|.+.+... .+++..+..++.||+.+++|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999998655 2899999999999999999999999 9999999999999543 4799999999
Q ss_pred ceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCc
Q 004264 595 ARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRA 674 (765)
Q Consensus 595 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (765)
+..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.......... ....++.
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~ 255 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF 255 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC
Confidence 998754 334557899999999999999999999999999999999999999997655443211 1112222
Q ss_pred cccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 675 LGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 675 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
......-........+++..++..||.+|+|+.++++.
T Consensus 256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11111112235567789999999999999999999985
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=304.42 Aligned_cols=251 Identities=27% Similarity=0.377 Sum_probs=198.7
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
.|++.+.||+|+||.||++... +++.+|+|++.... ......+.+|+.++++++|++++++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677789999999999999864 68899999986542 2234567889999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999998885432 235889999999999999999999998 9999999999999999999999999987653221
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||............. .......
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~~~~~~--------- 221 (285)
T cd05630 157 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKEVQ--------- 221 (285)
T ss_pred ---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hhhhhhh---------
Confidence 1123568999999999999999999999999999999999999997543221111110 0000000
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPD-----MSSVVF 717 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 717 (765)
..........+.+++..||+.+|++||| ++++++
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 -EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0111122345778999999999999999 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.51 Aligned_cols=251 Identities=32% Similarity=0.456 Sum_probs=197.2
Q ss_pred cccccCCceeEEEEEeCC-------CcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 452 NMIGKGGFGPVYMGKLST-------GQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
+.||+|+||.||+|+..+ ++.+++|.+.+.. .....++.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998643 2578999886543 23466889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccc----cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC-----CCeeccccc
Q 004264 524 MPHKSLDYFIFDRE----RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL-----NPKISDFGL 594 (765)
Q Consensus 524 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~vkL~DFGl 594 (765)
+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986432 2235788999999999999999999998 99999999999999877 899999999
Q ss_pred ceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCC
Q 004264 595 ARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGR 673 (765)
Q Consensus 595 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 673 (765)
++...............++..|+|||++.+..++.++||||||+++|||++ |+.||......+ .. .....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~----~~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VL----QHVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HH----HHHhcCC
Confidence 986543322222223345678999999999999999999999999999998 998875332211 11 1111111
Q ss_pred ccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 674 ALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 674 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.. ..+......+.+++.+||+.+|.+||++.+|+++|++
T Consensus 231 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 10 1111234567899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=302.51 Aligned_cols=248 Identities=31% Similarity=0.421 Sum_probs=193.5
Q ss_pred cccccCCceeEEEEEeCC-Cc--EEEEEEcccc-ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEEEEecCC
Q 004264 452 NMIGKGGFGPVYMGKLST-GQ--EIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
+.||+|+||.||+|.+.+ +. .+++|.+... .....+.+.+|+.+++++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998754 33 4688888643 344556889999999999 799999999999999999999999999
Q ss_pred CChhHHhhccc-------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccc
Q 004264 527 KSLDYFIFDRE-------------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFG 593 (765)
Q Consensus 527 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFG 593 (765)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999985432 1234789999999999999999999998 9999999999999999999999999
Q ss_pred cceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccC
Q 004264 594 LARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDG 672 (765)
Q Consensus 594 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 672 (765)
++..... .........+..|+|||++....++.++||||||++++||++ |+.||......+ . ......+
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~----~~~~~~~ 227 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L----YEKLPQG 227 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---H----HHHHhCC
Confidence 9863211 111112233567999999998899999999999999999997 999985432211 1 1111111
Q ss_pred CccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 673 RALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 673 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
...+ .+......+.+++.+|++.+|.+||++.+++..|++
T Consensus 228 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 228 YRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred CCCC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 1111 111123457799999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=304.12 Aligned_cols=239 Identities=22% Similarity=0.357 Sum_probs=187.6
Q ss_pred ccccCCceeEEEEEeCC-------------------------CcEEEEEEccccChhhHHHHHHHHHHHhccccCceEee
Q 004264 453 MIGKGGFGPVYMGKLST-------------------------GQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGL 507 (765)
Q Consensus 453 ~LG~G~fg~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~ 507 (765)
.||+|+||.||+|.+.. ...|++|++.........++.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 13588898876555556778899999999999999999
Q ss_pred eeeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC--
Q 004264 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL-- 585 (765)
Q Consensus 508 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 585 (765)
++++.+....++||||+++++|+.++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999888532 345889999999999999999999998 99999999999997643
Q ss_pred -----CCeecccccceeeCCCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHH-hCCCCCCCCCCCCc
Q 004264 586 -----NPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIV-SGKMNRGFRHPGHR 658 (765)
Q Consensus 586 -----~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~ell-tG~~p~~~~~~~~~ 658 (765)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+....+.+.
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3799999988653211 12346778999998876 56899999999999999985 68888865433221
Q ss_pred ccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 659 HNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
.. ..... ..+. . .....+.+++.+||+.+|++||++.+|++.|+
T Consensus 231 ~~-------~~~~~--~~~~-----~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ER-------FYEKK--HRLP-----E----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HH-------HHHhc--cCCC-----C----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11 00000 0000 0 11235788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=303.02 Aligned_cols=256 Identities=27% Similarity=0.380 Sum_probs=202.9
Q ss_pred cCcccccccccCCceeEEEEEeC------CCcEEEEEEccccChh-hHHHHHHHHHHHhccccCceEeeeeeeeecCceE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS------TGQEIAAKRLSKNSGQ-GLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~ 518 (765)
++|++.+.||+|+||.||+|+.+ ..+.+++|.+...... ..+++.+|+.++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999853 3467999988764433 4678999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhccccC------CCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccc
Q 004264 519 LIYEYMPHKSLDYFIFDRERS------KLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDF 592 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DF 592 (765)
+||||+++++|.+++...... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998654321 25899999999999999999999998 999999999999999999999999
Q ss_pred ccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhcc
Q 004264 593 GLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWND 671 (765)
Q Consensus 593 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 671 (765)
|++........ .......++..|+|||.+.+..++.++||||||+++++|++ |..||....... .. .....
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~----~~~~~ 233 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VL----NRLQA 233 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HH----HHHHc
Confidence 99875432211 11223456778999999998889999999999999999999 777875332211 11 11111
Q ss_pred CCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 672 GRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 672 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
+.... .........+.+++.+||+.+|++||++.+++.+|.
T Consensus 234 ~~~~~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLEL--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11110 011122346889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=301.63 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=200.3
Q ss_pred CcccccccccCCceeEEEEEeCCCcEEEEEEccccC------hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNS------GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~------~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
+|++.+.||+|+||.||+|...+++.+|+|++.... ......+.+|+.++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998889999999886431 22345688999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999998432 35789999999999999999999998 99999999999999999999999999886532
Q ss_pred CCc----ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 601 DDE----EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 601 ~~~----~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
... ........++..|+|||++.+..++.++||||||+++++|++|+.||........ . .......+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~--~~~~~~~~~~~- 228 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA---M--FYIGAHRGLMP- 228 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH---H--HHhhhccCCCC-
Confidence 111 1112235688899999999999999999999999999999999999864321110 0 00000001111
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
..+......+.+++.+||+.+|++||++.++++
T Consensus 229 --------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 --------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111123455788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=326.94 Aligned_cols=255 Identities=29% Similarity=0.393 Sum_probs=211.3
Q ss_pred CcccccccccCCceeEEEEEeCC----CcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLST----GQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
..+|.++||.|.||.|++|+++. ...||||.|+.. .+...+.|+.|+.||.++.||||+++.|+.......++|+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 45678899999999999998742 346999999865 4566789999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
|||++|+|+.+|+.+ .+.+.+.+...++++||.||+||-+.+ +|||||..+|||++.+...|++|||+++.+..+
T Consensus 710 EyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence 999999999999654 355899999999999999999999999 999999999999999999999999999987554
Q ss_pred Ccccccc-cccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 602 DEEAQTE-RVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 602 ~~~~~~~-~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
.+...++ ...-..+|.|||.+...+++.++|||||||+|||.++ |.+|+=.....++.+-++
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe---------------- 848 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE---------------- 848 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH----------------
Confidence 4332221 1223467999999999999999999999999999877 888864444333222221
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
....-..+..+...|.+||+.|||+|-.+||.+.+|+.+|.+.
T Consensus 849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 1122234455677899999999999999999999999999773
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.96 Aligned_cols=263 Identities=24% Similarity=0.296 Sum_probs=192.4
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhcc---ccCceEeeeeeeee-----cC
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKL---QHRNLVGLLGSCIE-----ED 515 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l---~h~niv~~~~~~~~-----~~ 515 (765)
+|++.+.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|+.+++++ .||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999865 68899999886532 22234566777777765 69999999998864 34
Q ss_pred ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccc
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA 595 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla 595 (765)
..++||||+.+ +|..++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999985 7777764322 345899999999999999999999999 999999999999999999999999999
Q ss_pred eeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcc
Q 004264 596 RIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRAL 675 (765)
Q Consensus 596 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (765)
+...... ......++..|+|||++.+..++.++||||||+++|||++|+.||......+....+...........+.
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 8763221 1224567899999999999999999999999999999999999986543221111110000000000000
Q ss_pred c-------ccccccc---CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 676 G-------LMDTCLE---DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 676 ~-------l~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
. ...+... ..........+.+++.+||+.||++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 0000000 0011122345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=303.61 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=200.2
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecC
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
.|++.+.||+|+||.||++... .+..+++|.+........+.+.+|+.+++.++|+|++++++++...+..++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3678889999999999999875 467888998876666667789999999999999999999999999999999999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+++|..++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~ 158 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 158 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence 9999887743 2346899999999999999999999998 9999999999999999999999999987653221 1
Q ss_pred ccccccccccccCccccc-----CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 606 QTERVAGTHGYMSPEYAN-----DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~-----~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
......++..|+|||++. +..++.++||||||+++|||++|+.||....+.. . ... ........+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~---~~~-~~~~~~~~~~-- 229 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR---V---LLK-IAKSEPPTLA-- 229 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH---H---HHH-HhhcCCCCCC--
Confidence 222456889999999984 4567889999999999999999999986433211 0 000 1111111111
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.+......+.+++.+||+.+|++||++.++++.
T Consensus 230 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 -----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111223567899999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=303.10 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=201.8
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
.++|++.+.||+|+||.||+|+. .+++.+|+|.+..........+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 35788999999999999999986 46889999998766555566788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++++|.+++.. .+.+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 999999998843 345899999999999999999999998 9999999999999999999999999998664221
Q ss_pred ccccccccccccccCccccc---CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYAN---DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~---~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
.......|+..|+|||++. ...++.++||||||+++|+|++|+.|+....+.... ... ...... .+
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~~~-~~~~~~---~~ 229 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLM-TKSNFQ---PP 229 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------Hhh-hccCCC---CC
Confidence 1223457889999999874 456889999999999999999999997543322110 000 011100 00
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.... .......+.+++.+|++.+|++||++++|+++
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 230 KLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0000 00123457789999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=302.76 Aligned_cols=249 Identities=26% Similarity=0.371 Sum_probs=203.4
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
++|++.+.||.|++|.||+|... +++.+++|.+.... ......+.+|+.+++.++|+|++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999865 68899999986543 44456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 9999999988532 6899999999999999999999998 9999999999999999999999999998875432
Q ss_pred ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
.......++..|+|||++.+..++.++||||||+++|+|++|+.||....+... . .....+....+.
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~----~~~~~~~~~~~~----- 219 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---L----FLIPKNNPPSLE----- 219 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---H----HHhhhcCCCCCc-----
Confidence 122345678899999999998899999999999999999999999865432211 1 111111111111
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.. .....+.+++.+||+.+|++||+++++++.
T Consensus 220 ~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 220 GN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred cc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11 033457789999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=300.04 Aligned_cols=250 Identities=25% Similarity=0.345 Sum_probs=202.3
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
+|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++++++|+||+++++.+..+...++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999864 6889999988543 3345677889999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+||++++++.++|+|||.+........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999998887532 3345789999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
......++..|+|||++.+..++.++|+||||+++|+|++|+.||....... . . .....+....+
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~---~-~~~~~~~~~~~------- 220 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN---L---I-LKVCQGSYKPL------- 220 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH---H---H-HHHhcCCCCCC-------
Confidence 1223568889999999999899999999999999999999999986432211 1 1 11112222111
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
+......+.+++.+||+.+|++||++.+|+..
T Consensus 221 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 --PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11223457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=299.22 Aligned_cols=254 Identities=25% Similarity=0.348 Sum_probs=205.4
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
++|++.+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57899999999999999999864 57889999988766556788999999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 999999988542 245889999999999999999999998 99999999999999999999999999986543211
Q ss_pred cccccccccccccCcccccCC---CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 605 AQTERVAGTHGYMSPEYANDG---TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~---~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....+... ... ..... +....
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~------~~~-~~~~~---~~~~~ 225 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA------LFL-ISKSN---FPPPK 225 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHhcc---CCCcc
Confidence 12235678889999999776 889999999999999999999999864332211 000 00110 00011
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
+ .........+.+++.+||+.+|++||++++|+.+
T Consensus 226 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 226 L--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred c--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1 1122345678899999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=303.67 Aligned_cols=255 Identities=25% Similarity=0.384 Sum_probs=202.1
Q ss_pred cCcccccccccCCceeEEEEEeCC-Cc----EEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLST-GQ----EIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
.+|.+.+.||+|+||.||+|..+. ++ .+++|.+.... .....++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 578889999999999999998643 32 58999887654 3445788999999999999999999999887 78899
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
|+||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998543 234899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
............++..|+|||.+....++.++||||||++++||++ |+.||......+ .......+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~--- 230 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPDLLEKGERL--- 230 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhCCCCC---
Confidence 3322222212234567999999998899999999999999999998 999986433221 11111111111
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
..+......+.+++.+||..+|.+||++.++++.|+..
T Consensus 231 ------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 231 ------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 01111234577889999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=297.64 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=204.8
Q ss_pred CcccccccccCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 447 HFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
+|+..+.||+|+||.||.++. .+++.+++|++... .....+++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999875 46888999987643 345567789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999885432 346899999999999999999999998 99999999999999999999999999987643332
Q ss_pred ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
......++..|+|||.+.+..++.++||||||++++||++|+.||....+.+ ... ....+.....
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~-~~~~~~~~~~------ 221 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVV-KIVQGNYTPV------ 221 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHH-HHHcCCCCCC------
Confidence 2234568899999999998889999999999999999999999986433211 111 1112221111
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 719 (765)
.......+.+++.+|++.+|++||+++++++.+
T Consensus 222 ---~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 ---VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 122345678999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=304.29 Aligned_cols=253 Identities=24% Similarity=0.385 Sum_probs=201.2
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
++|++.+.||+|+||.||++... .++.+|+|.+... .......+.+|+.++++++|+||+++++.+......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999875 7889999988653 334456889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhc-CCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD-SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
+++++|..++........+++..+..++.||+.||.|||+. + |+|+||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999998885543344689999999999999999999974 6 999999999999999999999999999765321
Q ss_pred cccccccccccccccCcccccCC------CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDG------TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~------~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||........ ... ......+..
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~-~~~~~~~~~-- 227 (286)
T cd06622 157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FAQ-LSAIVDGDP-- 227 (286)
T ss_pred ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HHH-HHHHhhcCC--
Confidence 12234678899999998554 358899999999999999999999864322111 110 011111111
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...+......+.+++.+||+.+|++||++.+++..
T Consensus 228 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 228 -------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11222345567899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=299.32 Aligned_cols=238 Identities=23% Similarity=0.408 Sum_probs=189.1
Q ss_pred cccccCCceeEEEEEeCCCc-----------EEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 452 NMIGKGGFGPVYMGKLSTGQ-----------EIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
+.||+|+||.||+|.+.... .+++|.+...... ...+.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36899999999999875433 4777877554333 6788999999999999999999999988 788999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC-------CCeecccc
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL-------NPKISDFG 593 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~vkL~DFG 593 (765)
|||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999985432 25889999999999999999999998 99999999999999887 79999999
Q ss_pred cceeeCCCCcccccccccccccccCcccccCC--CCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhc
Q 004264 594 LARIFGGDDEEAQTERVAGTHGYMSPEYANDG--TISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWN 670 (765)
Q Consensus 594 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 670 (765)
++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..|+......... ..+.
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~-------~~~~ 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-------RFYQ 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH-------HHHh
Confidence 9987532 1234566789999999876 78999999999999999999 46666543322110 0111
Q ss_pred cCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 671 DGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 671 ~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
.... ... .....+.+++.+||+.+|++||++.+|++.|+
T Consensus 221 ~~~~--~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQHR--LPM---------PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCCC--CCC---------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1110 000 01156789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.65 Aligned_cols=263 Identities=22% Similarity=0.250 Sum_probs=196.2
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecC-----
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED----- 515 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~----- 515 (765)
..++|++.+.||+|+||.||++... .++.+|+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999864 6889999998653 3344567889999999999999999999886543
Q ss_pred -ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccc
Q 004264 516 -ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGL 594 (765)
Q Consensus 516 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGl 594 (765)
..++||||+.++ |...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 478999999764 444442 23788889999999999999999999 99999999999999999999999999
Q ss_pred ceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccH------------H
Q 004264 595 ARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNL------------I 662 (765)
Q Consensus 595 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~------------~ 662 (765)
++..... .......+|..|+|||.+.+..++.++||||||+++|+|++|+.||......+.... .
T Consensus 170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 9764221 122345789999999999999999999999999999999999999975432111000 0
Q ss_pred H----HHHHhhcc-CCc-----ccccccccc---CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 663 G----HAWLLWND-GRA-----LGLMDTCLE---DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 663 ~----~~~~~~~~-~~~-----~~l~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
. ........ ... .++...... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 00000000 000 000000000 00111123457899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=314.88 Aligned_cols=241 Identities=25% Similarity=0.309 Sum_probs=188.0
Q ss_pred cccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHH-HHHhccccCceEeeeeeeeecCceEEEEEecCC
Q 004264 452 NMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEV-VLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev-~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
+.||+|+||.||+++.. +++.+|+|++.+.. ......+..|. .+++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999865 56789999987532 22233444454 456788999999999999999999999999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 606 (765)
++|.+++.. ...+.+..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCC
Confidence 999988853 345778888999999999999999999 999999999999999999999999999754221 122
Q ss_pred cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCcc
Q 004264 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSF 686 (765)
Q Consensus 607 ~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 686 (765)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .... .. .... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~---i~-~~~~----------~~ 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDN---IL-NKPL----------QL 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHHH---HH-hCCc----------CC
Confidence 334679999999999999999999999999999999999999986433211 1111 00 1100 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 687 VESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 687 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.......+.+++.+|++.+|.+||++.+.+.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 1122345778999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=311.04 Aligned_cols=237 Identities=25% Similarity=0.314 Sum_probs=186.7
Q ss_pred cccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHH-HHhccccCceEeeeeeeeecCceEEEEEecCC
Q 004264 452 NMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVV-LIGKLQHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~-~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
++||+|+||.||+|+.. +++.+|+|++.+.. .....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999874 67889999986532 223344555554 67889999999999999999999999999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 606 (765)
++|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET 152 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence 999887743 345788999999999999999999998 999999999999999999999999998753221 122
Q ss_pred cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCcc
Q 004264 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSF 686 (765)
Q Consensus 607 ~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 686 (765)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .... ...... . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~----~i~~~~-~---------~~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYD----NILHKP-L---------QL 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHH----HHhcCC-C---------CC
Confidence 33467899999999999999999999999999999999999998643211 1111 111111 0 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHH
Q 004264 687 VESQVLRCIQVGLLCVQKLPEDRPDMS 713 (765)
Q Consensus 687 ~~~~~~~l~~li~~cl~~dP~~RPs~~ 713 (765)
+......+.+++.+||+.+|.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 112234577899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=320.15 Aligned_cols=253 Identities=23% Similarity=0.269 Sum_probs=195.5
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||.||++... +++.||+|++.+. .......+.+|+.++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999864 6889999998643 2334567888999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999998853 345889999999999999999999999 999999999999999999999999998754321
Q ss_pred Cc---------------------------------ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCC
Q 004264 602 DE---------------------------------EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKM 648 (765)
Q Consensus 602 ~~---------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~ 648 (765)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 001123579999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 004264 649 NRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPD---MSSVVFL 718 (765)
Q Consensus 649 p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 718 (765)
||....+.... ...........+... . ....++.+++.+++. +|++|++ +.++++.
T Consensus 235 Pf~~~~~~~~~------~~i~~~~~~~~~p~~-----~--~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSETPQETY------RKVMNWKETLVFPPE-----V--PISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCHHHHH------HHHHcCCCceecCCC-----C--CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 99754432211 011100000011110 0 112345667777664 9999996 5666543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=312.42 Aligned_cols=193 Identities=22% Similarity=0.322 Sum_probs=164.1
Q ss_pred HHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
....+|++.+.||+|+||.||+|+.. .++.||+|+..+. ....|+.++++++|+||+++++++.+....++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 44568999999999999999999875 4678888875432 2356999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
|++. ++|..++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9995 567666643 3346899999999999999999999998 999999999999999999999999999753211
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCC
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNR 650 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~ 650 (765)
.......||..|+|||++.+..++.++||||||+++|||+++..++
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1222456899999999999999999999999999999999866554
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=309.53 Aligned_cols=255 Identities=22% Similarity=0.237 Sum_probs=194.8
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999864 5889999998652 2234556889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999998843 2345889999999999999999999999 999999999999999999999999999765432
Q ss_pred CcccccccccccccccCcccccC-----CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYAND-----GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+ .............
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~ 228 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKEHFQ 228 (331)
T ss_pred CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCccc
Confidence 221 1123568999999999863 457889999999999999999999986432211 1111111111111
Q ss_pred cccccccCccCHHHHHHHHHHHHHcccc--CCCCCCCHHHHHHH
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQK--LPEDRPDMSSVVFL 718 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~ 718 (765)
+.... ......+.+++.+|+.. ++..||+++++++.
T Consensus 229 ~~~~~------~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 FPPDV------TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCcc------CCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 11110 11233456677776654 33448899998866
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=303.84 Aligned_cols=256 Identities=24% Similarity=0.347 Sum_probs=203.5
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
.++|++.+.||+|+||.||++... +++.+|+|++.... ....+++.+|+++++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 357888999999999999999864 58889999876542 3446788999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhh-cCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ-DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
|+++++|.+++.. .+.+++..+..++.+++.+|.|||+ .+ ++|+||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999988743 3458999999999999999999997 46 999999999999999999999999998754211
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCc-----ccHHHHHHHhhccCCccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHR-----HNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 676 (765)
......++..|+|||++.+..++.++||||||+++|+|++|+.||....+... ........... ....
T Consensus 158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-- 230 (284)
T cd06620 158 ----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-QEPP-- 230 (284)
T ss_pred ----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-hccC--
Confidence 12245789999999999888999999999999999999999999975443211 11111111111 0000
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 719 (765)
+.+ ........+.+++.+|++.+|++||++.||+++.
T Consensus 231 ---~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 ---PRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---CCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 000 0111345678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.35 Aligned_cols=264 Identities=21% Similarity=0.261 Sum_probs=197.0
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
++|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++|+||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57999999999999999999865 57889999986432 33345678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
++ ++|..++... ...+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 5787777432 345889999999999999999999998 99999999999999999999999999976432211
Q ss_pred ccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc---
Q 004264 604 EAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD--- 679 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d--- 679 (765)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||......+....+...........+..+++
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 12234568899999988654 578899999999999999999999865433211100000000000000000000
Q ss_pred ------ccccC----ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 680 ------TCLED----SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 680 ------~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
+.... .........+.+++.+|++.||.+|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 001112345778999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=302.96 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=201.1
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
+.|++.+.||+|+||.||+|... .++.+|+|.+.... ....+.+.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34777889999999999999864 57789999886443 34456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++++|.+++.. ..+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 84 LGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred cCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 999999988742 45889999999999999999999998 9999999999999999999999999998654322
Q ss_pred ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
.......++..|+|||++.+..++.++||||||++++||++|+.|+....+.... .....+. .
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~---------~ 218 (277)
T cd06642 156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL-------FLIPKNS---------P 218 (277)
T ss_pred -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH-------hhhhcCC---------C
Confidence 1122346788999999999999999999999999999999999997643332110 0011111 1
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..........+.+++.+|++.+|++||++.+|+++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11122234567899999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=297.47 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=189.8
Q ss_pred ccccCCceeEEEEEeCCC---cEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCCC
Q 004264 453 MIGKGGFGPVYMGKLSTG---QEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKS 528 (765)
Q Consensus 453 ~LG~G~fg~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gs 528 (765)
.||+|+||.||++...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975433 346677665433 3456789999999999999999999999999999999999999999
Q ss_pred hhHHhhcccc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccccc
Q 004264 529 LDYFIFDRER-SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQT 607 (765)
Q Consensus 529 L~~~l~~~~~-~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~ 607 (765)
|.+++..... ....++..+..++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999865322 234677788899999999999999998 999999999999999999999999998643221111222
Q ss_pred ccccccccccCcccccC-------CCCCccccchHHHHHHHHHHhC-CCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 608 ERVAGTHGYMSPEYAND-------GTISMKSDVFSLGVLLVEIVSG-KMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 608 ~~~~gt~~Y~aPE~~~~-------~~~s~k~DvwSlG~ll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
....++..|+|||++.. ..++.++||||||+++|||+++ ..|+....+. .... ... .+....+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~---~~~-~~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLN---HVI-KDQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---HHH-hhcccccCC
Confidence 24567889999998853 2457899999999999999975 5566432221 1111 111 222233333
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
+.+... ....+.+++..|+ .+|++||++++|+++|.
T Consensus 232 ~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 333322 2345667888899 57999999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=303.72 Aligned_cols=253 Identities=27% Similarity=0.400 Sum_probs=203.3
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
.++|++.+.||+|+||.||++... +++.+|+|.+........+.+.+|+.++++++|+||+++++.+.+....++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 357999999999999999999864 6889999998766666677899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999999988532 345899999999999999999999999 99999999999999999999999999876532211
Q ss_pred ccccccccccccccCccccc-----CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 604 EAQTERVAGTHGYMSPEYAN-----DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~-----~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
......++..|+|||.+. ...++.++||||||+++|||++|+.||....+.. .. .....+....+
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~~~~~~~- 228 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR---VL----LKILKSEPPTL- 228 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH---HH----HHHhcCCCCCc-
Confidence 122356888999999875 3457889999999999999999999986543221 11 11111111100
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..+......+.+++..||+.+|.+||++.+|++.
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 ------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0111223457789999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=299.88 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=199.4
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccCh---------hhHHHHHHHHHHHhccccCceEeeeeeeeecCc
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSG---------QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE 516 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~ 516 (765)
+|.+.+.||+|++|.||+|... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4777889999999999999864 578999998865322 123568899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
.++|+||+++++|..++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999843 245889999999999999999999998 9999999999999999999999999998
Q ss_pred eeCCCCcc----cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccC
Q 004264 597 IFGGDDEE----AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDG 672 (765)
Q Consensus 597 ~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 672 (765)
........ .......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ...... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~-~~~ 227 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIFKI-GEN 227 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHHHH-hcc
Confidence 76422111 1112345788999999999989999999999999999999999998643211 111110 011
Q ss_pred CccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 673 RALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 673 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
. ....+......+.+++.+||+.+|++||++.+|++.
T Consensus 228 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 228 A---------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred C---------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 1 111122234567789999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=303.74 Aligned_cols=265 Identities=23% Similarity=0.329 Sum_probs=201.2
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
++|++.+.||+|++|.||+|+.. +++.+|+|++.... ....+.+.+|+.++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999875 58899999886432 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++++|..++.. ...+++..+..++.||+.+|+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999998877632 335899999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH--------HhhccCC
Q 004264 603 EEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAW--------LLWNDGR 673 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 673 (765)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+.... ..+....
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1223457788999999876 568899999999999999999999987544322211111000 0000000
Q ss_pred cc-ccccccccCccC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 674 AL-GLMDTCLEDSFV-----ESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 674 ~~-~l~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.. .+..+......+ ......+.+++.+||+.+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00 000000000000 1124567899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=302.43 Aligned_cols=251 Identities=26% Similarity=0.351 Sum_probs=198.1
Q ss_pred cccccccccCCceeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 448 FSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
|+..+.||+|+||+||++.. .+++.+|+|++.... ......+.+|+.++++++|+|++++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66778899999999999986 468899999986542 22345578899999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 99999988875432 235899999999999999999999999 9999999999999999999999999997653221
Q ss_pred ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
......|+..|+|||.+.+..++.++|+||||+++|||++|+.||....+...... .........
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~~~~~~~~---------- 221 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VDRRVLETE---------- 221 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhhhccc----------
Confidence 12235689999999999999999999999999999999999999865432211111 111111110
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPD-----MSSVVFL 718 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 718 (765)
..+.......+.+|+..|++.+|++||+ +.+++..
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0111122345678999999999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=308.18 Aligned_cols=198 Identities=27% Similarity=0.421 Sum_probs=160.2
Q ss_pred ccccccCCceeEEEEEeC---CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeee--cCceEEEEEecC
Q 004264 451 ANMIGKGGFGPVYMGKLS---TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE--EDERMLIYEYMP 525 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~--~~~~~lV~E~~~ 525 (765)
.++||+|+||.||+|+.. .++.+|+|++.... ....+.+|+.++++++||||+++++.+.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999854 46789999986542 23457789999999999999999998864 456789999986
Q ss_pred CCChhHHhhcc------ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE----ecCCCCeecccccc
Q 004264 526 HKSLDYFIFDR------ERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL----DINLNPKISDFGLA 595 (765)
Q Consensus 526 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~vkL~DFGla 595 (765)
+ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 666665321 12235889999999999999999999999 9999999999999 45678999999999
Q ss_pred eeeCCCCcc-cccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCC
Q 004264 596 RIFGGDDEE-AQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRH 654 (765)
Q Consensus 596 ~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~ 654 (765)
+........ .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 876432211 22234678999999999877 458999999999999999999999996544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=305.68 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=202.8
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
.+|++.+.||.|++|.||++.. .+++.|++|.+........+.+.+|+.+++.++|+|++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4699999999999999999985 578899999987655555678899999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++++|..++.. ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 99999988842 34889999999999999999999999 99999999999999999999999999886543221
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||....+... ..... ......+
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~~~~-~~~~~~~------- 235 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIA-TNGTPEL------- 235 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH-hcCCccc-------
Confidence 12235688899999999999999999999999999999999999865443211 10111 0110000
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
..+......+.+++.+||+.+|++||++.+|+.
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 011112345778999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=299.92 Aligned_cols=254 Identities=22% Similarity=0.306 Sum_probs=201.1
Q ss_pred cCcccccccccCCceeEEEEEeCC----CcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLST----GQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
++|.+.+.||+|+||.||+|...+ ...+++|+..... ....+.+.+|+.++++++|+||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 568888999999999999998643 3468999887654 4556789999999999999999999998865 567899
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||+++++|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999998543 235899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
..... .....++..|+|||.+....++.++||||||++++||++ |+.||......+. . .....+.....
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~----~~~~~~~~~~~-- 229 (270)
T cd05056 160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---I----GRIENGERLPM-- 229 (270)
T ss_pred cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---H----HHHHcCCcCCC--
Confidence 32211 112334567999999988889999999999999999986 9999864432211 1 11112211111
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
+......+.+++.+|+..+|++|||+.++++.|++.
T Consensus 230 -------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 230 -------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred -------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 112234678899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=315.35 Aligned_cols=263 Identities=22% Similarity=0.261 Sum_probs=196.5
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeec------
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE------ 514 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~------ 514 (765)
..++|++.+.||+|+||.||++... .++.+|||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3478999999999999999999864 6788999998753 233456788999999999999999999987643
Q ss_pred CceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccc
Q 004264 515 DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGL 594 (765)
Q Consensus 515 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGl 594 (765)
...++||||+++ +|...+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999976 5555552 23788899999999999999999998 99999999999999999999999999
Q ss_pred ceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHH--------HH
Q 004264 595 ARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGH--------AW 666 (765)
Q Consensus 595 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~--------~~ 666 (765)
++..... .......+|..|+|||++.+..++.++||||||+++|||++|+.||......+....+.. ..
T Consensus 173 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 173 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred ccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9865322 122345789999999999999999999999999999999999999965432211100000 00
Q ss_pred -------HhhccCC--c-----cccccccc---cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 667 -------LLWNDGR--A-----LGLMDTCL---EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 667 -------~~~~~~~--~-----~~l~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
......+ . ..+..... ...........+.+++.+|++.||.+|||+.++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 0 00000000 001111123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=308.20 Aligned_cols=256 Identities=26% Similarity=0.427 Sum_probs=199.7
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCc----EEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQ----EIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~ 518 (765)
.++|++.+.||+|+||.||+|.+. ++. .+|+|.+.... .....++.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356888899999999999999863 343 47888886543 33345788999999999999999999988754 567
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
+++||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 999999999999988543 335789999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... .......+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~ 232 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLLEKGERLPQ 232 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCCCCC
Confidence 43332222223445678999999999999999999999999999997 888875432111 1111111111100
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
+......+.+++..|+..+|++||++.+|+++|+..
T Consensus 233 ---------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 233 ---------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111234577899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.07 Aligned_cols=240 Identities=23% Similarity=0.362 Sum_probs=189.3
Q ss_pred cccccCCceeEEEEEeCC--------CcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 452 NMIGKGGFGPVYMGKLST--------GQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
+.||+|+||.||+|.... ...+++|.+........+.+.+|+.+++.++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999997532 234888888665555667889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCC--------Ceecccccc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLN--------PKISDFGLA 595 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------vkL~DFGla 595 (765)
+++++|..++.... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999985432 35889999999999999999999999 999999999999987765 589999988
Q ss_pred eeeCCCCcccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCC-CCCCCCCCCCcccHHHHHHHhhccCC
Q 004264 596 RIFGGDDEEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGK-MNRGFRHPGHRHNLIGHAWLLWNDGR 673 (765)
Q Consensus 596 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 673 (765)
..... .....++..|+|||++.+. .++.++||||||+++|||++|. .|+....+.. .. ... ...
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~~-~~~-~~~ 221 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------KL-QFY-EDR 221 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------HH-HHH-Hcc
Confidence 75422 1235678889999999874 5899999999999999999995 4543222111 00 000 000
Q ss_pred ccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 674 ALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 674 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
.. .+......+.+++.+||+.+|++|||+++|++.|+
T Consensus 222 -~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 -HQ---------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -cc---------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01 11112345789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=299.37 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=201.0
Q ss_pred CcccccccccCCceeEEEEEeCC--CcEEEEEEcccc----------ChhhHHHHHHHHHHHhc-cccCceEeeeeeeee
Q 004264 447 HFSEANMIGKGGFGPVYMGKLST--GQEIAAKRLSKN----------SGQGLEEFMNEVVLIGK-LQHRNLVGLLGSCIE 513 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~----------~~~~~~~~~~Ev~~l~~-l~h~niv~~~~~~~~ 513 (765)
+|++.+.||+|+||.||++.... ++.+|+|.+... ......++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999754 678999987532 22334567788888875 789999999999999
Q ss_pred cCceEEEEEecCCCChhHHhhcc-ccCCCCChHHHHHHHHHHHHHHHHhhh-cCCCcEEecccCCCcEEEecCCCCeecc
Q 004264 514 EDERMLIYEYMPHKSLDYFIFDR-ERSKLLPWKKRFSIITGIARGLLYLHQ-DSKLQVIHRDLKASNILLDINLNPKISD 591 (765)
Q Consensus 514 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~vkL~D 591 (765)
.+..++||||+++++|.+++... .....+++..++.++.|++.+|.|||+ .+ ++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999998887542 234568999999999999999999996 56 99999999999999999999999
Q ss_pred cccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhcc
Q 004264 592 FGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWND 671 (765)
Q Consensus 592 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 671 (765)
||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... .. ....+
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~~----~~~~~ 227 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---LA----TKIVE 227 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---HH----HHHhh
Confidence 99998764332 2334668889999999999889999999999999999999999985432211 11 11111
Q ss_pred CCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 672 GRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 672 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
+...... .......+.+++.+|++.+|++||++.||..+|+
T Consensus 228 ~~~~~~~--------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 AVYEPLP--------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccCCcCC--------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111111 1112346788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=303.74 Aligned_cols=264 Identities=22% Similarity=0.312 Sum_probs=200.6
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccChh-----hHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQ-----GLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
+|++.+.||+|++|.||+|... +++.|++|++...... ....+..|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999864 6889999999754322 345677899999999999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||+ +++|..++.... ..+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999885432 36899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccC-------
Q 004264 601 DDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDG------- 672 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~------- 672 (765)
... ......++..|+|||.+.+ ..++.++||||||++++||++|..+|....+.+. ...........
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ---LGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH---HHHHHHHcCCCchhhhhh
Confidence 321 1223456788999998865 4678999999999999999999877754433211 11110000000
Q ss_pred --CccccccccccCc-----cCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhc
Q 004264 673 --RALGLMDTCLEDS-----FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL--LAN 721 (765)
Q Consensus 673 --~~~~l~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~ 721 (765)
............. ........+.+++.+||+.+|++|||+.+|+++ +++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 0000000000001 112234578899999999999999999999986 554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.40 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=203.7
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
..|+..+.||+|+||.||+|... .++.+|+|.+... .......+.+|+.+++++.|+||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45778889999999999999865 5788999988754 345567889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999998842 34788899999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
......++..|+|||++.+..++.++|+||||+++|||++|+.|+....+...... ...+ ..
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-------~~~~---------~~ 218 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-------IPKN---------NP 218 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-------hhcC---------CC
Confidence 12234678889999999988999999999999999999999999865433211100 0001 11
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..........+.+++..||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 12233445678899999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=301.90 Aligned_cols=253 Identities=29% Similarity=0.408 Sum_probs=198.6
Q ss_pred HHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeec------
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEE------ 514 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~------ 514 (765)
.+++.|++.+.||+|+||.||+|... .++.+|+|++.... ....++.+|+.+++++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35678999999999999999999864 57889999886543 3456788999999998 699999999998753
Q ss_pred CceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccc
Q 004264 515 DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGL 594 (765)
Q Consensus 515 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGl 594 (765)
...++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4578999999999999988542 2345889999999999999999999998 99999999999999999999999999
Q ss_pred ceeeCCCCcccccccccccccccCccccc-----CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhh
Q 004264 595 ARIFGGDDEEAQTERVAGTHGYMSPEYAN-----DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLW 669 (765)
Q Consensus 595 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 669 (765)
+....... .......|+..|+|||++. +..++.++||||||+++|||++|+.||....+... .....
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~------~~~~~ 229 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA------LFLIP 229 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH------HHHHh
Confidence 98653221 1223467889999999986 34688899999999999999999999854332111 01111
Q ss_pred ccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 670 NDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 670 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
........ .......+.+++.+||+.+|.+|||+.+|++
T Consensus 230 -~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 -RNPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -cCCCCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11111111 1112345789999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=287.10 Aligned_cols=253 Identities=23% Similarity=0.309 Sum_probs=200.5
Q ss_pred HHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC--------hhhHHHHHHHHHHHhcc-ccCceEeeeeeee
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS--------GQGLEEFMNEVVLIGKL-QHRNLVGLLGSCI 512 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--------~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~ 512 (765)
..-..|...+.||.|..+.|-++.. +.++++|+|++.... ..-.+.-.+|+.||+++ .||+|+++.+++.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3446788889999999999988875 568899999986431 11234456799999998 5999999999999
Q ss_pred ecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccc
Q 004264 513 EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDF 592 (765)
Q Consensus 513 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DF 592 (765)
.....++|+|.|+.|.|.+++.. .-.+++.+..+|++|+.+|++|||..+ ||||||||+|||+|++.++||+||
T Consensus 94 s~sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence 99999999999999999999943 346899999999999999999999999 999999999999999999999999
Q ss_pred ccceeeCCCCcccccccccccccccCccccc------CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 004264 593 GLARIFGGDDEEAQTERVAGTHGYMSPEYAN------DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAW 666 (765)
Q Consensus 593 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~ 666 (765)
|+++.+.. .......+||++|+|||.+. +..|+..+|+|+.|+|+|.|+.|-+||--. ..--..
T Consensus 168 GFa~~l~~---GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-------kQmlML 237 (411)
T KOG0599|consen 168 GFACQLEP---GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-------KQMLML 237 (411)
T ss_pred ceeeccCC---chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-------HHHHHH
Confidence 99998743 33344689999999999885 346889999999999999999999997311 111112
Q ss_pred HhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 667 LLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 667 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
....+|+.. +-.+ +. ........+|+.+||+.||.+|.|++|++.
T Consensus 238 R~ImeGkyq-F~sp----eW-adis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 238 RMIMEGKYQ-FRSP----EW-ADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHhcccc-cCCc----ch-hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 222333321 1111 11 122344668999999999999999999874
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=298.06 Aligned_cols=247 Identities=29% Similarity=0.415 Sum_probs=198.1
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecC
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
++|++.+.||+|+||.||++.. .++.+|+|++.... ....+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5688999999999999999974 67889999986533 346788999999999999999999998654 5799999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 999999986432 335789999999999999999999998 999999999999999999999999999764221
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
......+..|+|||.+.+..++.++|+||||+++|||++ |+.||......+ .......+....
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~-------- 217 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKGYRME-------- 217 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhCCCCCC--------
Confidence 112234567999999998999999999999999999998 888876433211 111111111111
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.+......+.+++.+||+.+|++||++.+|++.|++
T Consensus 218 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 -PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111224567799999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.89 Aligned_cols=258 Identities=25% Similarity=0.370 Sum_probs=206.3
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
++|++.+.||.|+||.||+|... ++..+++|++.... ....+.+.+|+.+++.++|+|++++++.+..++..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999854 67889999987542 33567899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++++|.+++........+++..+..++.||+.||+|||+.+ |+|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865443356899999999999999999999998 99999999999999999999999999987654332
Q ss_pred cc--ccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 604 EA--QTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 604 ~~--~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
.. ......++..|+|||++... .++.++|+||||++++||++|+.||....+... . .... .... +
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~----~~~~-~~~~-----~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--L----MLTL-QNDP-----P 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--H----HHHh-cCCC-----C
Confidence 21 22345688999999999877 789999999999999999999999865433211 0 0111 1110 0
Q ss_pred cccCcc-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 681 CLEDSF-VESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 681 ~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...... .......+.+++..|++.+|++||++.+|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111100 11234567899999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=316.03 Aligned_cols=263 Identities=23% Similarity=0.275 Sum_probs=196.7
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeec------
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE------ 514 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~------ 514 (765)
..++|.+.+.||+|+||.||++... .++.+|+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999864 6889999998753 233456788899999999999999999988643
Q ss_pred CceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccc
Q 004264 515 DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGL 594 (765)
Q Consensus 515 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGl 594 (765)
...++||||+++ +|...+. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 357899999976 4545542 23788899999999999999999999 99999999999999999999999999
Q ss_pred ceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHH-H----------
Q 004264 595 ARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLI-G---------- 663 (765)
Q Consensus 595 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~-~---------- 663 (765)
++..... .......+|..|+|||++.+..++.++||||||+++|+|++|+.||......+..... .
T Consensus 166 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 166 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9865322 1223457899999999999999999999999999999999999998654321110000 0
Q ss_pred -----HHHHhh-ccCCccccc------cccc--cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 664 -----HAWLLW-NDGRALGLM------DTCL--EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 664 -----~~~~~~-~~~~~~~l~------d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...... .......+. +... ...........+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000 000000000 0000 001111223567899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=295.56 Aligned_cols=250 Identities=25% Similarity=0.362 Sum_probs=200.3
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeec-CceEEEEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE-DERMLIYE 522 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~-~~~~lV~E 522 (765)
+|++.+.||+|++|.||++... +++.+++|++... .....+.+.+|+.++++++|+|++++++.+... ...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999864 5788999998643 234456788999999999999999999887643 45789999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++++|.+++... ....+++..++.++.|++.||++||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999888643 2345899999999999999999999999 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
.......+++.|+|||++.+..++.++||||||+++++|++|+.||...... ..... ...+...
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~-~~~~~~~------- 220 (257)
T cd08223 157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYR-IIEGKLP------- 220 (257)
T ss_pred --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHH-HHhcCCC-------
Confidence 1223456888999999999999999999999999999999999998633211 11111 1111111
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..+......+.+++.+|++.+|++||++.++++.
T Consensus 221 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 --PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1122334568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=297.40 Aligned_cols=249 Identities=30% Similarity=0.414 Sum_probs=190.2
Q ss_pred cccccCCceeEEEEEeC----CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeee-cCceEEEEEecC
Q 004264 452 NMIGKGGFGPVYMGKLS----TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE-EDERMLIYEYMP 525 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~-~~~~~lV~E~~~ 525 (765)
+.||+|+||.||+|... ....+|+|++... .....+.+.+|+.+++.++||||+++++++.. +...++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999853 2457999988643 34456788899999999999999999997764 556789999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc-
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE- 604 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~- 604 (765)
+++|.+++... ....++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998543 234677788899999999999999998 999999999999999999999999999865322111
Q ss_pred -cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCC-CCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 605 -AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK-MNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 605 -~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
.......++..|+|||.+.+..++.++||||||+++|||++|. .|+..... ..+.. ....+....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~----~~~~~~~~~------ 222 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITV----YLLQGRRLL------ 222 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH----HHhcCCCCC------
Confidence 1112344567899999999889999999999999999999964 45432211 11111 111111100
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.+......+.+++..||+.+|++||++.+|++.|++
T Consensus 223 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 223 ---QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred ---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 011123467899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=297.16 Aligned_cols=250 Identities=25% Similarity=0.354 Sum_probs=193.5
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-----hhhHHHHHHHHHHHhccccCceEeeeeeeee--cCce
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-----GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE--EDER 517 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~--~~~~ 517 (765)
.+|++.+.||+|+||.||++... .++.+++|++.... ......+.+|+.++++++|+||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999864 58899999886431 2344678899999999999999999998875 3567
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
++++||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999998843 234789999999999999999999998 99999999999999999999999999986
Q ss_pred eCCCCc-ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 598 FGGDDE-EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 598 ~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||...... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~~--- 226 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQPT--- 226 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCCC---
Confidence 532211 11122355788999999999989999999999999999999999998643211 11111111111
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
....+......+..++ .|+..+|++||++++|++
T Consensus 227 ------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 ------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1111222223344455 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=311.09 Aligned_cols=255 Identities=21% Similarity=0.235 Sum_probs=195.1
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.++||+|+||.||+++.+ .++.+|+|++.+. .......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999865 4678999998643 2223445788999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999998532 245889999999999999999999999 999999999999999999999999999765322
Q ss_pred CcccccccccccccccCccccc-----CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYAN-----DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
.. .......||+.|+|||++. ...++.++||||||+++|||++|+.||......+ .............
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~ 228 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKERFQ 228 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCCcccc
Confidence 21 1222457999999999986 3468899999999999999999999986433211 1111111111111
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPE--DRPDMSSVVFL 718 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~ 718 (765)
.... .......+.+++.+|+..++. .||+++++++.
T Consensus 229 ~p~~------~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 FPAQ------VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCCc------cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 1110 111234566777787765444 36899999866
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=347.27 Aligned_cols=263 Identities=25% Similarity=0.445 Sum_probs=212.0
Q ss_pred HHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
.....|...+.||+|+||.||+|+. .+++.||+|++...... ...|++++++++||||++++++|.+.+..++||
T Consensus 687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 3345678888999999999999986 57899999998654322 235688999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++. .++|..+.+++.||++||+|||.....+|+||||||+||+++.++.+++. |+.......
T Consensus 763 Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~- 834 (968)
T PLN00113 763 EYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT- 834 (968)
T ss_pred eCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-
Confidence 9999999999983 27899999999999999999996544459999999999999999888875 665543211
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
.....++..|+|||++.+..++.|+||||||+++|||++|+.|+..... .......+.............+|+.
T Consensus 835 -----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 835 -----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred -----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCcc
Confidence 1123678999999999999999999999999999999999999854332 2334555555544444555566665
Q ss_pred ccC--ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 004264 682 LED--SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDG 723 (765)
Q Consensus 682 l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 723 (765)
+.. ..+..+..++.+++.+||+.+|++||+|+||+++|++..
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 543 344566778899999999999999999999999998743
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.97 Aligned_cols=257 Identities=19% Similarity=0.287 Sum_probs=193.8
Q ss_pred cccccccC--CceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 450 EANMIGKG--GFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 450 ~~~~LG~G--~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
+.++||+| +|++||++.. ++++.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7889999986 57889999998754 2334567788999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999985432 234889999999999999999999999 999999999999999999999999876543211111
Q ss_pred c-----ccccccccccccCcccccC--CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 605 A-----QTERVAGTHGYMSPEYAND--GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 605 ~-----~~~~~~gt~~Y~aPE~~~~--~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ... . ..+....+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~----~-~~~~~~~~ 230 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLE----K-LNGTVPCL 230 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHH----H-hcCCcccc
Confidence 0 1122356778999999976 4689999999999999999999999864322110 000 0 00000000
Q ss_pred cc-------------------c-----------------cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 678 MD-------------------T-----------------CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 678 ~d-------------------~-----------------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
++ . .............+.+++.+||+.||++|||+++|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 0 0000111223456889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=299.03 Aligned_cols=255 Identities=26% Similarity=0.399 Sum_probs=197.9
Q ss_pred cccccccccCCceeEEEEEeC----CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecC------
Q 004264 448 FSEANMIGKGGFGPVYMGKLS----TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED------ 515 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~------ 515 (765)
|++.+.||+|+||.||+|.+. .++.+|+|++... .....+++.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999753 3678999998754 3345677899999999999999999999886543
Q ss_pred ceEEEEEecCCCChhHHhhccc---cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccc
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRE---RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDF 592 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DF 592 (765)
..++++||+.+++|..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988875322 1234788999999999999999999998 999999999999999999999999
Q ss_pred ccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhcc
Q 004264 593 GLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWND 671 (765)
Q Consensus 593 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 671 (765)
|+++...............++..|++||.+.+..++.++||||||+++|||++ |+.|+...... .+ ......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~----~~~~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EI----YNYLIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HH----HHHHHc
Confidence 99987643222112223345677999999999999999999999999999999 88887533221 11 111111
Q ss_pred CCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 672 GRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 672 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+.... .+......+.+++.+|++.+|++||++.+|++.|++
T Consensus 231 ~~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 231 GNRLK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred CCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 11110 011223568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.53 Aligned_cols=255 Identities=21% Similarity=0.233 Sum_probs=196.3
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||.||+++.. .++.+|+|++.+. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999865 5788999998653 2233456788999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998542 245889999999999999999999999 999999999999999999999999999876432
Q ss_pred CcccccccccccccccCcccccC-----CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYAND-----GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
... ......||+.|+|||++.+ +.++.++||||||+++|||++|+.||......+ .............
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~ 228 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHEERFQ 228 (331)
T ss_pred Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCCCccc
Confidence 221 1223568999999999876 568899999999999999999999986433211 1111111111111
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPED--RPDMSSVVFL 718 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 718 (765)
+.. . ......++.+++.+|++.++++ |++++++++.
T Consensus 229 ~p~-~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 FPS-H-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCC-c-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 110 0 0112345778888888865544 4678888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=295.14 Aligned_cols=251 Identities=36% Similarity=0.522 Sum_probs=200.0
Q ss_pred cccccccccCCceeEEEEEeCC-----CcEEEEEEccccChh-hHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 448 FSEANMIGKGGFGPVYMGKLST-----GQEIAAKRLSKNSGQ-GLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~-~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
+++.+.||.|+||.||++.... +..+|+|++...... ..+.+.+|+.++++++|+||+++++.+.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999998653 478999999765433 5678999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++..... ..+++..+..++.||+.||++||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999854322 22899999999999999999999998 999999999999999999999999999876443
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
...... ...++..|+|||.+.+..++.++||||+|+++++|++ |+.|+...... ... .....+.....
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~----~~~~~~~~~~~--- 225 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVL----EYLKKGYRLPK--- 225 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHhcCCCCCC---
Confidence 221111 2336788999999988889999999999999999998 77776542211 111 11111111111
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 719 (765)
+.....++.+++.+|++.+|++|||+.+++++|
T Consensus 226 ------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 ------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111345688899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=295.41 Aligned_cols=248 Identities=27% Similarity=0.392 Sum_probs=200.7
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-----hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-----GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|+.++++++|+||+++++++......++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999876 78899999886533 33557889999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
+||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999843 235889999999999999999999998 99999999999999999999999999987643
Q ss_pred CCcccccccccccccccCcccccCCC-CCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGT-ISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
.. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||....+.. ............
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~---- 221 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFKIGRSKELP---- 221 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHHHHhcccCC----
Confidence 22 223456888999999988776 8999999999999999999999986543111 111111001111
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..+......+.+++.+||+.+|++||++.++++.
T Consensus 222 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 222 -----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -----CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1112234567789999999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=298.70 Aligned_cols=248 Identities=23% Similarity=0.303 Sum_probs=210.3
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
.-|...+.||+|.|..|-+|++ -.|..||||++.+.. .....++.+|+.-|+.++|||||+++++.......|||.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4466778999999999999985 479999999998763 4445678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE-ecCCCCeecccccceeeCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL-DINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll-~~~~~vkL~DFGla~~~~~~ 601 (765)
.-.+|+|.++|... ...+.+..+.+++.||+.|+.|+|+.. +|||||||+||.+ ..-|-|||.|||++..+.
T Consensus 98 LGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-- 170 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-- 170 (864)
T ss_pred ecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC--
Confidence 99999999999643 445899999999999999999999998 9999999999876 667899999999998763
Q ss_pred CcccccccccccccccCcccccCCCCC-ccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTIS-MKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
.....+..+|...|-|||++.+..|. +++||||||+|||-|++|+.||....+.+... .++|.
T Consensus 171 -PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---------------mImDC 234 (864)
T KOG4717|consen 171 -PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---------------MIMDC 234 (864)
T ss_pred -CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---------------hhhcc
Confidence 33445578999999999999999885 67999999999999999999997655544322 22332
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
. -..+.....+|.+||..||+.||.+|-+.++|+..
T Consensus 235 K--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 K--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred c--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 2 24455667889999999999999999999999854
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=313.10 Aligned_cols=263 Identities=22% Similarity=0.266 Sum_probs=194.8
Q ss_pred HHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeec-----
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE----- 514 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~----- 514 (765)
...++|.+.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999986 467889999987532 23446678899999999999999999987643
Q ss_pred -CceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccc
Q 004264 515 -DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFG 593 (765)
Q Consensus 515 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFG 593 (765)
...++++|++ +++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3568999987 778877763 235899999999999999999999999 9999999999999999999999999
Q ss_pred cceeeCCCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHH--------
Q 004264 594 LARIFGGDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGH-------- 664 (765)
Q Consensus 594 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~-------- 664 (765)
+++..... .....+|..|+|||++.+ ..++.++||||||+++|+|++|+.||......+....+..
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99875321 224578999999999877 5789999999999999999999999864332111000000
Q ss_pred HHHhhccCCcccccccccc-CccC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 665 AWLLWNDGRALGLMDTCLE-DSFV-----ESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 665 ~~~~~~~~~~~~l~d~~l~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.............+..... .... ......+.+++.+|++.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000000000 0000 0012246789999999999999999999954
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=302.31 Aligned_cols=265 Identities=22% Similarity=0.333 Sum_probs=199.3
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSG--QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
++|++.++||+|+||.||+|..+ .++.+|+|++.+... ...+.+.+|+++++.++|+||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999975 588999999865422 235678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++++|..+... ...+++..+..++.||+.||+|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999877632 234899999999999999999999998 9999999999999999999999999998754322
Q ss_pred cccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHhhccCC
Q 004264 603 EEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHA--------WLLWNDGR 673 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 673 (765)
.......++..|+|||++.+ ..++.++||||||++++||++|+.||......+....+... ........
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 11223567889999999875 45788999999999999999999888643321100000000 00000000
Q ss_pred c-cccccccccC-----ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 674 A-LGLMDTCLED-----SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 674 ~-~~l~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
. .....+.... .........+.+++.+||+.+|++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0 0000000000 0011224568899999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=304.71 Aligned_cols=268 Identities=24% Similarity=0.308 Sum_probs=197.6
Q ss_pred CcccccccccCCceeEEEEEeC---CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeec--CceE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS---TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE--DERM 518 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~--~~~~ 518 (765)
+|.+.+.||+|+||.||+|... .++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999864 47899999997632 33446778899999999999999999999988 7899
Q ss_pred EEEEecCCCChhHHhhcc-c-cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec----CCCCeeccc
Q 004264 519 LIYEYMPHKSLDYFIFDR-E-RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI----NLNPKISDF 592 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~-~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~----~~~vkL~DF 592 (765)
+||||+++ +|.+++... . ....+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 455554322 2 2236889999999999999999999999 999999999999999 899999999
Q ss_pred ccceeeCCCCc-ccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccH------HHH
Q 004264 593 GLARIFGGDDE-EAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNL------IGH 664 (765)
Q Consensus 593 Gla~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~------~~~ 664 (765)
|++........ ........++..|+|||.+.+ ..++.++||||||+++++|++|+.||........... ...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643222 112224567889999998876 4589999999999999999999999976544321000 000
Q ss_pred HHHhhcc------------CCcccccc---------ccccCccCH--HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 665 AWLLWND------------GRALGLMD---------TCLEDSFVE--SQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 665 ~~~~~~~------------~~~~~l~d---------~~l~~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
....+.. .......+ ..+...... ....++.+++.+|++.+|++|||+.++++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000 00000000 000000000 233468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=298.28 Aligned_cols=259 Identities=25% Similarity=0.292 Sum_probs=200.8
Q ss_pred hHHHHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhcc-ccCceEeeeeeee-----
Q 004264 440 TITTATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCI----- 512 (765)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~----- 512 (765)
.+..+.++|++.+.||+|+||.||++... .++.+++|++.... ....++.+|+.+++++ +|+||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 34456789999999999999999999864 57889999876432 2235688899999999 6999999999885
Q ss_pred ecCceEEEEEecCCCChhHHhhcc-ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecc
Q 004264 513 EEDERMLIYEYMPHKSLDYFIFDR-ERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISD 591 (765)
Q Consensus 513 ~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~D 591 (765)
.+...++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEcc
Confidence 345689999999999999887532 23456889999999999999999999998 99999999999999999999999
Q ss_pred cccceeeCCCCcccccccccccccccCcccccC-----CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 004264 592 FGLARIFGGDDEEAQTERVAGTHGYMSPEYAND-----GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAW 666 (765)
Q Consensus 592 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~ 666 (765)
||+++....... ......|+..|+|||++.. ..++.++||||||+++|||++|+.|+....+... .
T Consensus 168 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~------~- 238 (286)
T cd06638 168 FGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA------L- 238 (286)
T ss_pred CCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH------H-
Confidence 999987643221 1223568899999999853 4578999999999999999999999864432211 0
Q ss_pred HhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 667 LLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 667 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..........+.++ ......+.+++.+||+.+|++||++.+|++.
T Consensus 239 ~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 239 FKIPRNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred hhccccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00101111111111 1123457899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.43 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=201.9
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
+|++.+.||+|+||.||++... +++.+++|++... .....+++.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999864 6889999998643 334456889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+.+++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999998888542 2235789999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
......++..|+|||++.+..++.++|+||||+++++|++|+.|+...... ...... ..+...
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~-~~~~~~-------- 219 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKI-IRGSYP-------- 219 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHH-hcCCCC--------
Confidence 122345788899999999999999999999999999999999997532211 111111 111111
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..+......+.+++.+|++.+|++||++.+|++.
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 -PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1122234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=293.39 Aligned_cols=252 Identities=26% Similarity=0.381 Sum_probs=206.8
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccCh-hhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
++|++.+.||+|++|.||++... +++.+++|++..... ...+.+.+|+.++.+++|+|++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999876 589999999876543 4567899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhh-cCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ-DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
+++++|.+++... ..+++..++.++.||++||.|||+ .+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998543 568999999999999999999999 88 9999999999999999999999999998764332
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.|+............... ......
T Consensus 155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~----~~~~~~------- 221 (264)
T cd06623 155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI----CDGPPP------- 221 (264)
T ss_pred Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH----hcCCCC-------
Confidence 221 2456788999999999999999999999999999999999998655432211111111 111111
Q ss_pred cCccCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 683 EDSFVES-QVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 683 ~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..+.. ....+.+++.+|++.+|++||++.++++.
T Consensus 222 --~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 --SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11111 34578899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=295.01 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=201.1
Q ss_pred CcccccccccCCceeEEEEEe-CCCcEEEEEEccccC------hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS------GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~------~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
+|+..+.||+|++|.||++.. .+++.+|+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477888999999999999985 568899999986432 2235678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC-CCeecccccceee
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL-NPKISDFGLARIF 598 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~vkL~DFGla~~~ 598 (765)
|+||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++ .+||+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999998843 345889999999999999999999998 99999999999998776 5999999999876
Q ss_pred CCCCcc--cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 599 GGDDEE--AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 599 ~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
...... .......++..|+|||.+.+..++.++||||+|+++++|++|+.||...........+ .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~------ 225 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FKIAS------ 225 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH---HHHhc------
Confidence 433111 1112356788999999998888999999999999999999999998643322111111 11000
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.......+......+.+++.+|++.+|++||++.++++
T Consensus 226 ---~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 ---ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 01112223334566888999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=301.32 Aligned_cols=266 Identities=22% Similarity=0.339 Sum_probs=202.3
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
++|++.+.||+|+||.||+|... +++.|++|++... .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999875 5788999988653 23345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|++++.+..+... ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9998777666532 344889999999999999999999998 9999999999999999999999999998764433
Q ss_pred cccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH--------Hhhc-cC
Q 004264 603 EEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAW--------LLWN-DG 672 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~-~~ 672 (765)
.. ......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+......... ..+. ..
T Consensus 155 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 AS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred cc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 21 22245678889999999888 88999999999999999999999886433221110000000 0000 00
Q ss_pred Ccc--cccccc----ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 673 RAL--GLMDTC----LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 673 ~~~--~l~d~~----l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
... ...+.. ....++......+.+++.+||+.+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 000000 0001112235678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=292.13 Aligned_cols=247 Identities=26% Similarity=0.376 Sum_probs=211.5
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecC
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
-|.++++||+|+||.||++.++ .|+.+|+|++... ...+++.+|+.|+++...|++|+++|.+.....+++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3778899999999999999864 6999999998654 356899999999999999999999999999999999999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
-|+..++++ .+++++.+.++..+++..++||+|||... -||||||..|||+..+|.+||+|||.|-.+.. ...
T Consensus 112 AGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMA 184 (502)
T KOG0574|consen 112 AGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMA 184 (502)
T ss_pred CCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh--hHH
Confidence 999999995 45678999999999999999999999988 89999999999999999999999999976632 223
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC-
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED- 684 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~- 684 (765)
....+.||+.|||||+++.-.|+.++||||||+...||..|++|+..-+|......+ + ..+.+
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI---------------P-T~PPPT 248 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI---------------P-TKPPPT 248 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec---------------c-CCCCCC
Confidence 334688999999999999999999999999999999999999999877776543222 1 11111
Q ss_pred -ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 685 -SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 685 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.-+.....++.+++..||-..|++|-|+.++++.
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1234456778899999999999999999988754
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=302.83 Aligned_cols=197 Identities=27% Similarity=0.425 Sum_probs=159.2
Q ss_pred cccccCCceeEEEEEeC---CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeee--cCceEEEEEecCC
Q 004264 452 NMIGKGGFGPVYMGKLS---TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE--EDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~--~~~~~lV~E~~~~ 526 (765)
.+||+|+||.||+|+.. +++.+|+|++.... ....+.+|+.++++++||||+++++++.. ....++|+||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999864 45789999886543 23467889999999999999999998854 4567899999876
Q ss_pred CChhHHhhcc------ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE----ecCCCCeecccccce
Q 004264 527 KSLDYFIFDR------ERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL----DINLNPKISDFGLAR 596 (765)
Q Consensus 527 gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~vkL~DFGla~ 596 (765)
+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 555554321 12235888999999999999999999998 9999999999999 456789999999998
Q ss_pred eeCCCCcc-cccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCC
Q 004264 597 IFGGDDEE-AQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRH 654 (765)
Q Consensus 597 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~ 654 (765)
........ .......+|..|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 76433221 12234578999999999876 458999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=294.23 Aligned_cols=255 Identities=25% Similarity=0.363 Sum_probs=199.2
Q ss_pred CcccccccccCCceeEEEEEe-CCCcEEEEEEccccC----------hhhHHHHHHHHHHHhccccCceEeeeeeeeecC
Q 004264 447 HFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS----------GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED 515 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----------~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~ 515 (765)
+|.+.+.||+|+||.||+|.. .+++.+|+|++.... ....+.+.+|+.++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477788999999999999985 468899999875321 112346788999999999999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccc
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA 595 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla 595 (765)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999988543 46889999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCcccccccccccccccCcccccCCC--CCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC
Q 004264 596 RIFGGDDEEAQTERVAGTHGYMSPEYANDGT--ISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR 673 (765)
Q Consensus 596 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 673 (765)
+...............++..|+|||.+.... ++.++|+||||++++||++|+.|+...... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~ 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGNKRS 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhcccc
Confidence 8754322222233456888999999987654 889999999999999999999998532211 11111111111
Q ss_pred ccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 674 ALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 674 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...+.+ .........+.+++.+|++.+|++||++.+|++.
T Consensus 230 ~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPIPP-----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcCCc-----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111 1111234567889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.38 Aligned_cols=254 Identities=24% Similarity=0.352 Sum_probs=202.9
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
++|++.+.||+|++|.||++... +++.+++|++.... ....+++.+|++++++++||||+++++.+......++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999875 68889999987653 34567789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhh-cCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ-DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
+++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999985432 568899999999999999999999 88 9999999999999999999999999987653211
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
.....++..|+|||.+.+..++.++||||||+++++|++|+.|+....... ......... ........+.
T Consensus 156 ----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~-~~~~~~~~~~---- 225 (265)
T cd06605 156 ----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQY-IVNEPPPRLP---- 225 (265)
T ss_pred ----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHH-HhcCCCCCCC----
Confidence 112667889999999999999999999999999999999999986543211 111111111 1111110010
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.......+.+++.+|+..+|++||++.+++..
T Consensus 226 ----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 226 ----SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ----hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 00134567899999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.67 Aligned_cols=256 Identities=20% Similarity=0.251 Sum_probs=200.8
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||.||++... .++.|++|.+.+.. ......+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999864 57889999987543 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999998432 45889999999999999999999998 999999999999999999999999998742110
Q ss_pred C-------------cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHh
Q 004264 602 D-------------EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLL 668 (765)
Q Consensus 602 ~-------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~ 668 (765)
. .........++..|+|||.+.+..++.++||||||+++|||++|+.||....+.+ + ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~----~~~ 227 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---L----FGQ 227 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H----HHH
Confidence 0 0001112457888999999999899999999999999999999999986432211 1 111
Q ss_pred hccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 669 WNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 669 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
...+.. ..+.. .......+.+++.+||+.+|++||++.++.+.|+.
T Consensus 228 ~~~~~~---~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VISDDI---EWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHhccc---CCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111110 00110 01223457799999999999999998777777755
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=294.42 Aligned_cols=251 Identities=23% Similarity=0.310 Sum_probs=196.0
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc-----ChhhHHHHHHHHHHHhccccCceEeeeeeeeec--Cce
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN-----SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE--DER 517 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~--~~~ 517 (765)
.+|++.+.||+|+||.||++... +++.|++|++... .....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47889999999999999999864 5889999987532 123456788999999999999999999988764 467
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999988432 34788899999999999999999999 99999999999999999999999999986
Q ss_pred eCCCCcc-cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 598 FGGDDEE-AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 598 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~---- 225 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQP---- 225 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------HHHHHHhcCC----
Confidence 5322111 1122356888999999999888999999999999999999999998632111 1111111010
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.....+......+..++.+|+. +|++||++++|++.
T Consensus 226 -----~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 -----TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -----CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0112233344556778888885 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=330.32 Aligned_cols=255 Identities=23% Similarity=0.308 Sum_probs=197.0
Q ss_pred HHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeec--Cce
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE--DER 517 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~--~~~ 517 (765)
...++|++.+.||+|+||.||++... .++.+|+|++... .......+..|+.++++|+||||+++++++... ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34478999999999999999999865 5667888887643 334456789999999999999999999988653 468
Q ss_pred EEEEEecCCCChhHHhhcc-ccCCCCChHHHHHHHHHHHHHHHHhhhcCC----CcEEecccCCCcEEEecC--------
Q 004264 518 MLIYEYMPHKSLDYFIFDR-ERSKLLPWKKRFSIITGIARGLLYLHQDSK----LQVIHRDLKASNILLDIN-------- 584 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~----~~ivH~Dlkp~NIll~~~-------- 584 (765)
+|||||+++++|.+++... .....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 8999999999999988643 223569999999999999999999998541 249999999999999643
Q ss_pred ---------CCCeecccccceeeCCCCcccccccccccccccCcccccC--CCCCccccchHHHHHHHHHHhCCCCCCCC
Q 004264 585 ---------LNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND--GTISMKSDVFSLGVLLVEIVSGKMNRGFR 653 (765)
Q Consensus 585 ---------~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~k~DvwSlG~ll~elltG~~p~~~~ 653 (765)
..+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||||++|+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 348999999998753221 2234578999999999864 45899999999999999999999998643
Q ss_pred CCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 004264 654 HPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVV 716 (765)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 716 (765)
... . ........+.. +. + ......+.+|+..||+.+|++||++.+++
T Consensus 247 ~~~--~----qli~~lk~~p~--lp---i-----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL 293 (1021)
T PTZ00266 247 NNF--S----QLISELKRGPD--LP---I-----KGKSKELNILIKNLLNLSAKERPSALQCL 293 (1021)
T ss_pred CcH--H----HHHHHHhcCCC--CC---c-----CCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence 211 1 11111111110 00 0 11234678999999999999999999998
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=322.31 Aligned_cols=263 Identities=18% Similarity=0.193 Sum_probs=190.9
Q ss_pred HHHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhcccc------CceEeeeeeeeec
Q 004264 442 TTATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQH------RNLVGLLGSCIEE 514 (765)
Q Consensus 442 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h------~niv~~~~~~~~~ 514 (765)
....++|++.++||+|+||.||+|... .++.||||++... ....+.+..|+.++++++| .+++++++++...
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 345688999999999999999999864 5778999998643 2234456677777777654 4588999888764
Q ss_pred -CceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhc-CCCcEEecccCCCcEEEecCC-------
Q 004264 515 -DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD-SKLQVIHRDLKASNILLDINL------- 585 (765)
Q Consensus 515 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivH~Dlkp~NIll~~~~------- 585 (765)
.+.++|||++ +++|.+++.. ...+++..+..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence 4788999987 6677777643 24589999999999999999999984 7 99999999999998765
Q ss_pred ---------CCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCC
Q 004264 586 ---------NPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPG 656 (765)
Q Consensus 586 ---------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~ 656 (765)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 49999999886421 1223567999999999999999999999999999999999999999754432
Q ss_pred CcccHHHHHH-----------------Hhhc-cCCcccccccc-----ccC--ccCHHHHHHHHHHHHHccccCCCCCCC
Q 004264 657 HRHNLIGHAW-----------------LLWN-DGRALGLMDTC-----LED--SFVESQVLRCIQVGLLCVQKLPEDRPD 711 (765)
Q Consensus 657 ~~~~~~~~~~-----------------~~~~-~~~~~~l~d~~-----l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs 711 (765)
+....+.... ..+. .+......++. ... .........+++|+..||+.||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 2111111100 0000 00000000000 000 000011345779999999999999999
Q ss_pred HHHHHH
Q 004264 712 MSSVVF 717 (765)
Q Consensus 712 ~~evl~ 717 (765)
++|+++
T Consensus 432 a~e~L~ 437 (467)
T PTZ00284 432 ARQMTT 437 (467)
T ss_pred HHHHhc
Confidence 999996
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=299.91 Aligned_cols=262 Identities=21% Similarity=0.305 Sum_probs=200.9
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
+|++.+.||+|++|.||+|... +++.+++|++.... ......+.+|+.++++++|+||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5788999999999999999864 68899999987543 33456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+ +++|.+++.... ..+++..++.++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999998885432 56899999999999999999999998 99999999999999999999999999987643322
Q ss_pred ccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC---------
Q 004264 604 EAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR--------- 673 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 673 (765)
.......++..|+|||.+.+. .++.++||||+|++++||++|+.+|....+... ............
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccC
Confidence 112245688899999998654 568999999999999999999877754332111 111111000000
Q ss_pred ---cccccccccc----CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 674 ---ALGLMDTCLE----DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 674 ---~~~l~d~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...+..+... ..........+.+++.+|++.+|++||+++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 00011223678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=294.00 Aligned_cols=260 Identities=25% Similarity=0.278 Sum_probs=202.0
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeec--CceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE--DERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~--~~~~lV~ 521 (765)
++|++.+.||.|++|.||++... .++.+|+|.+.... .....++.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36888899999999999999974 57889999887543 34567789999999999999999999988654 4689999
Q ss_pred EecCCCChhHHhhcc-ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 522 EYMPHKSLDYFIFDR-ERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 522 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
||+++++|.+++... .....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999998887532 23456889999999999999999999998 99999999999999999999999999876532
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+........ ...... ..........+.+.
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~ 231 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIELL-SYIVNMPNPELKDE 231 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHHH-HHHhcCCchhhccC
Confidence 21 1234577889999999999999999999999999999999999875533111 111111 11111111111111
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
. .........+.+++.+||+.+|++|||+.||++
T Consensus 232 -~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 -P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1 111123466889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=287.86 Aligned_cols=252 Identities=27% Similarity=0.432 Sum_probs=206.0
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeec--CceEEEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE--DERMLIY 521 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~--~~~~lV~ 521 (765)
+|.+.+.||+|++|.||+|... +++.+++|++.... ....+.+.+|+.++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777889999999999999976 68899999987654 25567899999999999999999999999988 8899999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++.... .+++..++.++.|++++|+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999985432 6899999999999999999999998 999999999999999999999999999887544
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
..........++..|+|||.+.+..++.++||||||+++++|++|+.||.... ......+........
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~------- 222 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEP------- 222 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCC-------
Confidence 33212334668889999999998889999999999999999999999986544 111111111110111
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...+......+.+++.+|++.+|++||++.++++.
T Consensus 223 --~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 223 --PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred --cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 11222225678899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=310.81 Aligned_cols=240 Identities=25% Similarity=0.294 Sum_probs=186.3
Q ss_pred cccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhcc---ccCceEeeeeeeeecCceEEEEEecCC
Q 004264 454 IGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKL---QHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 454 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l---~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
||+|+||.||+|+.. +++.||+|++.+.. ......+..|..++.++ +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999864 58899999986532 22334455677777665 699999999999999999999999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 606 (765)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 999888743 345899999999999999999999999 9999999999999999999999999997642221 22
Q ss_pred cccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCc
Q 004264 607 TERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDS 685 (765)
Q Consensus 607 ~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 685 (765)
.....||..|+|||++.+. .++.++||||||+++|||++|+.||....... .......+.. .+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~-~~~~~----- 219 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------MYRNIAFGKV-RFPKN----- 219 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-------HHHHHHcCCC-CCCCc-----
Confidence 2346799999999998765 48999999999999999999999986432211 1111111111 11111
Q ss_pred cCHHHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 004264 686 FVESQVLRCIQVGLLCVQKLPEDRP----DMSSVVF 717 (765)
Q Consensus 686 ~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~ 717 (765)
.....+.+++.+||+.+|++|| ++.++++
T Consensus 220 ---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 ---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1234567899999999999998 4666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=297.81 Aligned_cols=251 Identities=26% Similarity=0.379 Sum_probs=203.8
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
.++|++.+.||+|+||.||++.. .+++.+++|.+........+.+.+|+.++++++|||++++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36899999999999999999985 46789999998755555567789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998843 24788999999999999999999999 99999999999999999999999999876543222
Q ss_pred ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
......+++.|+|||.+.+..++.++||||||+++|+|++|+.||....+....... ...+. ..
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~~~~--------~~ 234 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGT--------PE 234 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hcCCC--------CC
Confidence 122356888999999999888999999999999999999999998654432211100 00000 00
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..........+.+++.+||+.+|++||++.+++.+
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111223457789999999999999999999966
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.73 Aligned_cols=248 Identities=24% Similarity=0.359 Sum_probs=198.6
Q ss_pred cccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCC
Q 004264 448 FSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
|.....||+|+||.||++... +++.+|+|.+........+.+.+|+.+++.++|||++++++++..++..++|+||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 344557999999999999864 6889999998765555567788999999999999999999999999999999999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 606 (765)
++|..++.. ..+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++........ .
T Consensus 103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~ 173 (297)
T cd06659 103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K 173 (297)
T ss_pred CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence 999887732 34789999999999999999999998 99999999999999999999999999876532221 1
Q ss_pred cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCcc
Q 004264 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSF 686 (765)
Q Consensus 607 ~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 686 (765)
.....++..|+|||++.+..++.++||||||++++||++|+.||....+... . . ........ . . ..
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~---~-~~~~~~~~-~----~--~~ 239 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---M---K-RLRDSPPP-K----L--KN 239 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H---H-HHhccCCC-C----c--cc
Confidence 2235688999999999998999999999999999999999999864332111 1 1 11111000 0 0 00
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 687 VESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 687 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.......+.+++.+|++.+|++||++++|++.
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11123457789999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=301.29 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=199.5
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecC
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
.|.....||+|+||.||++... +++.+|+|++........+.+.+|+.++++++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444567999999999999864 688999999876655666789999999999999999999999999999999999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+++|.+++.. +.+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 103 ~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 103 GGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--
Confidence 9999988732 34789999999999999999999998 99999999999999999999999999876533221
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCc
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDS 685 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 685 (765)
......++..|+|||.+.+..++.++||||||+++|||++|+.||....+... .. ..... ....+..
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~----~~~~~-----~~~~~~~- 240 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---MR----RIRDN-----LPPRVKD- 240 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH----HHHhc-----CCCcccc-
Confidence 12235688999999999988999999999999999999999999864332110 10 00000 1111111
Q ss_pred cCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 686 FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 686 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.......+..++.+|++.+|.+|||++++++.
T Consensus 241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11123356788999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=303.55 Aligned_cols=256 Identities=26% Similarity=0.328 Sum_probs=204.5
Q ss_pred HHHhcCcccccccccCCceeEEEEEeCCCcEEEEEEccc--cChhhHHHHHHHHHHHhccc-cCceEeeeeeeeecCceE
Q 004264 442 TTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSK--NSGQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 442 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~~~ 518 (765)
......|++.++||+||.+.||++...+.+.+|+|++.. .+.+...-|.+|+.+|.+|+ |.+|+++++|-..++..|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 345567999999999999999999988889999998753 35667788999999999996 999999999999999999
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
+||||- ..+|..+|..... .++.-.+..+..||+.|+.++|+++ |||.||||.|+|+- .|.+||+|||+|..+
T Consensus 437 mvmE~G-d~DL~kiL~k~~~--~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKS--IDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred EEeecc-cccHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 999985 4578888854332 2332377788999999999999999 99999999999997 468999999999998
Q ss_pred CCCCcccccccccccccccCcccccCC-----------CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYANDG-----------TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWL 667 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~ 667 (765)
............+||+.||+||.+..- +.++++||||+|||||+|+.|+.||+.. .+. +
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n~--~--- 579 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----INQ--I--- 579 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HHH--H---
Confidence 777777777778999999999988532 2568899999999999999999998521 111 1
Q ss_pred hhccCCccccccccccCccCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 668 LWNDGRALGLMDTCLEDSFVES-QVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 668 ~~~~~~~~~l~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.++..+.|+...-+++.. .-.++++++..||+.||.+||+..+|++.
T Consensus 580 ----aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 ----AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 122334444332222211 11228899999999999999999999865
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=297.77 Aligned_cols=260 Identities=25% Similarity=0.289 Sum_probs=201.5
Q ss_pred HhHHHHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeec--
Q 004264 439 ATITTATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEE-- 514 (765)
Q Consensus 439 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~-- 514 (765)
..+..++++|++.+.||+|+||.||++.. .+++.+|+|.+.... ....++.+|+.+++++ +|||++++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 34445678999999999999999999986 467889999886532 2345678899999998 799999999998754
Q ss_pred ---CceEEEEEecCCCChhHHhhcc-ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeec
Q 004264 515 ---DERMLIYEYMPHKSLDYFIFDR-ERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKIS 590 (765)
Q Consensus 515 ---~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~ 590 (765)
...++|+||+++++|.+++... .....+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.+||+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEe
Confidence 3589999999999999887532 23456899999999999999999999998 9999999999999999999999
Q ss_pred ccccceeeCCCCcccccccccccccccCcccccCC-----CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 004264 591 DFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG-----TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHA 665 (765)
Q Consensus 591 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~ 665 (765)
|||++......... .....++..|+|||.+... .++.++||||||+++|||++|+.|+....+... .
T Consensus 171 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~------~ 242 (291)
T cd06639 171 DFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT------L 242 (291)
T ss_pred ecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH------H
Confidence 99998865432211 1234678899999998643 368999999999999999999999864332111 1
Q ss_pred HHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 666 WLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 666 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.. ...+....+.+ +......+.+++.+|++.+|++||++.++++.
T Consensus 243 ~~-~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 FK-IPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HH-HhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11 11111111111 11223468899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.39 Aligned_cols=253 Identities=23% Similarity=0.276 Sum_probs=201.6
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccCh---hhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSG---QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|++|.||++... +++.+|+|.+..... ...+.+.+|++++++++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999875 488999999976432 24567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+.+++|.+++... ....+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999988532 3456899999999999999999999998 999999999999999999999999998765321
Q ss_pred Ccc---------------------------cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCC
Q 004264 602 DEE---------------------------AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRH 654 (765)
Q Consensus 602 ~~~---------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~ 654 (765)
... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 11123467889999999999899999999999999999999999986443
Q ss_pred CCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 004264 655 PGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPD----MSSVVF 717 (765)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 717 (765)
.... ..... ... ..-.........+.+++.+|++.+|++||+ +.+++.
T Consensus 237 ~~~~------~~~~~-~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDET------FSNIL-KKE--------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHHH------HHHHh-cCC--------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 2211 00000 111 000001113456889999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=297.35 Aligned_cols=262 Identities=22% Similarity=0.264 Sum_probs=194.7
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
+|++.+.||+|+||.||+|+.. +|+.+++|++.... ......+.+|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999864 68899999986432 22235677899999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++ +|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 975 666665332 345899999999999999999999998 99999999999999999999999999986533221
Q ss_pred ccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC------ccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR------ALG 676 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 676 (765)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....... .............. ...
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhh
Confidence 11234568899999998764 47999999999999999999998864322111 11110000000000 000
Q ss_pred ccccc----cc-----CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 677 LMDTC----LE-----DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 677 l~d~~----l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
+.+.. .. .+........+.+++.+||+.||.+|||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000 00 01111234567899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=299.11 Aligned_cols=262 Identities=22% Similarity=0.301 Sum_probs=195.4
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccCh-hhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
++|++.+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67899999999999999999865 678999999865422 2234577899999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+.+ +|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 888877433 236889999999999999999999998 99999999999999999999999999875422111
Q ss_pred ccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC---ccc---
Q 004264 604 EAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR---ALG--- 676 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~--- 676 (765)
......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||...... .......+....... ...
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhh
Confidence 1112346788999999875 56899999999999999999999998643311 111111111100000 000
Q ss_pred ----------cc-cccccCc-cCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 677 ----------LM-DTCLEDS-FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 677 ----------l~-d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.. ...+... ........+.+++.+|++.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 0000000 00111256778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=290.78 Aligned_cols=249 Identities=26% Similarity=0.385 Sum_probs=200.6
Q ss_pred CcccccccccCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 447 HFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
+|++.+.||+|++|.||++.. ..++.+++|.+... .....+.+.+|+.++++++|+|++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 578889999999999999986 46788999998653 234467889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC-CCeecccccceeeCCCC
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL-NPKISDFGLARIFGGDD 602 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~vkL~DFGla~~~~~~~ 602 (765)
+++++|.+++.... ...+++..+..++.|++++|+|||+.+ ++|+||||+||++++++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999985432 345899999999999999999999998 99999999999998654 57999999998764322
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
......++..|+|||.+.+..++.++||||||+++++|++|+.||....... .... ...+....+
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~----~~~~~~~~~----- 221 (256)
T cd08220 157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLK----IMSGTFAPI----- 221 (256)
T ss_pred ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHH----HHhcCCCCC-----
Confidence 1223567889999999999889999999999999999999999986433211 1111 111111111
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
+......+.+++.+||+.+|++|||+.++++.
T Consensus 222 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 ----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ----CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11234457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=292.82 Aligned_cols=251 Identities=28% Similarity=0.393 Sum_probs=201.4
Q ss_pred CcccccccccCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeee--cCceEEEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE--EDERMLIY 521 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~--~~~~~lV~ 521 (765)
+|++.+.||+|+||.||++.. .+++.+++|.+... .....+++.+|+.++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999985 46788999988643 33445678899999999999999999998764 44678999
Q ss_pred EecCCCChhHHhhcc-ccCCCCChHHHHHHHHHHHHHHHHhh-----hcCCCcEEecccCCCcEEEecCCCCeecccccc
Q 004264 522 EYMPHKSLDYFIFDR-ERSKLLPWKKRFSIITGIARGLLYLH-----QDSKLQVIHRDLKASNILLDINLNPKISDFGLA 595 (765)
Q Consensus 522 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla 595 (765)
||+++++|.+++... .....+++..++.++.||+.||.||| +.+ ++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999988543 22456899999999999999999999 666 999999999999999999999999999
Q ss_pred eeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcc
Q 004264 596 RIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRAL 675 (765)
Q Consensus 596 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (765)
......... .....++..|+|||.+.+..++.++|+||||+++++|++|+.|+...... ... .....+..
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~~~~- 227 (265)
T cd08217 158 KILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLA----SKIKEGKF- 227 (265)
T ss_pred ccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHH----HHHhcCCC-
Confidence 876433221 22356889999999999989999999999999999999999998654311 111 11111111
Q ss_pred ccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 676 GLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 676 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...+......+.+++.+|++.+|++||++.+|+++
T Consensus 228 --------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 --------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11222334568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=296.84 Aligned_cols=259 Identities=28% Similarity=0.387 Sum_probs=201.2
Q ss_pred chHhHHHHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhcc-ccCceEeeeeeeee-
Q 004264 437 DLATITTATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIE- 513 (765)
Q Consensus 437 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~- 513 (765)
++.++....+.|++.+.||+|+||.||+|.. ..++.+|+|++.... ....++..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3444556678899999999999999999986 467889999886543 3446788999999998 69999999999863
Q ss_pred -----cCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCe
Q 004264 514 -----EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPK 588 (765)
Q Consensus 514 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vk 588 (765)
....+++|||+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 457899999999999999885432 345788889999999999999999998 99999999999999999999
Q ss_pred ecccccceeeCCCCcccccccccccccccCccccc-----CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHH
Q 004264 589 ISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAN-----DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIG 663 (765)
Q Consensus 589 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~ 663 (765)
|+|||++........ ......++..|+|||.+. ...++.++||||||+++|||++|+.||....+......
T Consensus 162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-- 237 (282)
T cd06636 162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-- 237 (282)
T ss_pred EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh--
Confidence 999999876532211 122456888999999886 35688899999999999999999999864432211110
Q ss_pred HHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 664 HAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 664 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.. ... .... ........+.+++.+||+.+|.+||++.+|++
T Consensus 238 ----~~-~~~-----~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 ----IP-RNP-----PPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ----Hh-hCC-----CCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 000 0000 01122346889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=304.08 Aligned_cols=254 Identities=29% Similarity=0.448 Sum_probs=208.9
Q ss_pred cCcccccccccCCceeEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLST-GQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
.+.++.++||-|-||.||.|.|+. .-.||||.++. +....++|++|+.+|+.++|||+|+++|+|..+...|||+|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 456778899999999999999865 45799999965 4556899999999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
..|+|.++++...+ ..++....+.++.||..||+||..+. +|||||..+|.|+.++..|||+|||+++++..+...
T Consensus 346 ~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred cCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 99999999977654 34677778899999999999999998 999999999999999999999999999998655443
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
... ...-.+.|.|||-+....++.|+|||+||++||||.| |-.|+.. ..+ .++..+++.+-..+-++.|
T Consensus 422 AHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG------idl-SqVY~LLEkgyRM~~PeGC-- 491 (1157)
T KOG4278|consen 422 AHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG------IDL-SQVYGLLEKGYRMDGPEGC-- 491 (1157)
T ss_pred ccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC------ccH-HHHHHHHhccccccCCCCC--
Confidence 332 2344567999999999999999999999999999998 4445322 222 2344455555444444333
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
...+.+||+.||+++|.+||++.|+-+.++.
T Consensus 492 -------PpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 492 -------PPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred -------CHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 4457799999999999999999998777653
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=291.86 Aligned_cols=252 Identities=26% Similarity=0.405 Sum_probs=201.1
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSG--QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
+|.+.+.||+|+||.||++... +++.+++|.+..... ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999864 688999999876544 3677899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999853 234789999999999999999999999 99999999999999999999999999987643322
Q ss_pred ccc--cccccccccccCcccccCCC---CCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 604 EAQ--TERVAGTHGYMSPEYANDGT---ISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 604 ~~~--~~~~~gt~~Y~aPE~~~~~~---~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
... .....++..|+|||++.+.. ++.++||||||+++++|++|+.||...... ... ..... .+....+.
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---~~~--~~~~~-~~~~~~~~ 228 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---FQI--MFHVG-AGHKPPIP 228 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---HHH--HHHHh-cCCCCCCC
Confidence 111 12356788999999998766 899999999999999999999998643211 011 11000 11111111
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
. .......+.+++.+|++.+|++||++.+++.
T Consensus 229 ~-------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 229 D-------SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred c-------ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1 0112445678999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=293.13 Aligned_cols=248 Identities=26% Similarity=0.414 Sum_probs=199.2
Q ss_pred CcccccccccCCceeEEEEEe-CCCcEEEEEEcccc-ChhhHHHHHHHHHHHhccc---cCceEeeeeeeeecCceEEEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQ---HRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~---h~niv~~~~~~~~~~~~~lV~ 521 (765)
.|++.+.||+|+||.||+|.. .+++.+++|.+... ......++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477888999999999999986 56889999998654 3445567889999999996 999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988743 25889999999999999999999999 999999999999999999999999999876543
Q ss_pred CcccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
.. ......|+..|+|||.+.++ .++.++||||||+++|+|++|+.||.......... ...... .+
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------~~~~~~-----~~ 220 (277)
T cd06917 155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------LIPKSK-----PP 220 (277)
T ss_pred cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------ccccCC-----CC
Confidence 32 12235688899999998754 57899999999999999999999986443221100 000000 01
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.+... .....+.+++.+||+.+|++||++.+++++
T Consensus 221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 11111 134567889999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=284.92 Aligned_cols=250 Identities=30% Similarity=0.463 Sum_probs=204.7
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecC
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
+|++.+.||+|++|.||++... +++.+++|++..........+.+|+.++++++|+|++++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778889999999999999975 688999999987655567889999999999999999999999999999999999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+++|.+++.... ..+++..+..++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999885432 46899999999999999999999988 99999999999999999999999999987643322
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCc
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDS 685 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 685 (765)
.....++..|+|||.+.+..++.++||||||+++++|++|+.|+....+.... ..........+...
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~~~~~----- 220 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL-------FKIATNGPPGLRNP----- 220 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH-------HHHHhcCCCCcCcc-----
Confidence 23466888999999999888999999999999999999999998643321110 01111111111111
Q ss_pred cCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 686 FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 686 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
......+.+++.+|++.+|++|||+.++++.
T Consensus 221 --~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 --EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred --cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1113568899999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=294.07 Aligned_cols=256 Identities=28% Similarity=0.363 Sum_probs=201.3
Q ss_pred HHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecC-----
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEED----- 515 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~----- 515 (765)
..+++|++.+.||+|++|.||+|... +++.+++|++..... ..+++.+|+.+++++ +|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35688999999999999999999974 577899998865443 346789999999999 6999999999997654
Q ss_pred -ceEEEEEecCCCChhHHhhccc-cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccc
Q 004264 516 -ERMLIYEYMPHKSLDYFIFDRE-RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFG 593 (765)
Q Consensus 516 -~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFG 593 (765)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999998885422 2456899999999999999999999998 9999999999999999999999999
Q ss_pred cceeeCCCCcccccccccccccccCcccccC-----CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHh
Q 004264 594 LARIFGGDDEEAQTERVAGTHGYMSPEYAND-----GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLL 668 (765)
Q Consensus 594 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~ 668 (765)
++....... .......++..|+|||++.. ..++.++||||||+++++|++|+.||....+.. ... .
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~----~ 229 (275)
T cd06608 159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR---ALF----K 229 (275)
T ss_pred cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH---HHH----H
Confidence 998653222 12224568889999998753 347889999999999999999999986432211 110 1
Q ss_pred hccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 669 WNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 669 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...+....+ ..+......+.+++.+||+.||++|||+.+|++.
T Consensus 230 ~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 230 IPRNPPPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hhccCCCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111111111 1112234568899999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=295.51 Aligned_cols=255 Identities=27% Similarity=0.381 Sum_probs=205.6
Q ss_pred HHHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 442 TTATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 442 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
....+.|++.+.||+|++|.||++..+ +++.+++|++..... ..+.+.+|++++++++|+|++++++++......++|
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 345677899999999999999999876 688999999876544 567788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
+||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 94 MEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 99999999999986533 36899999999999999999999998 99999999999999999999999999876533
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
... ......++..|+|||++.+..++.++||||||+++|+|++|+.|+....+... ..... ........
T Consensus 169 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~~~~~-~~~~~~~~-- 237 (286)
T cd06614 169 EKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------LFLIT-TKGIPPLK-- 237 (286)
T ss_pred chh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH-hcCCCCCc--
Confidence 221 11234578899999999988999999999999999999999999864332211 00000 11111111
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
........+.+++.+|++.+|.+||++.+|++.
T Consensus 238 -----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 238 -----NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -----chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 011123567889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=295.01 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=193.0
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHH-HhccccCceEeeeeeeeecCceEEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVVL-IGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~~-l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
++|++.+.||+|+||.||+++.. +++.||+|++.... .....++..|+.+ ++.++|+||+++++++......++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46889999999999999999875 68999999987542 2334556667665 566789999999999999999999999
Q ss_pred ecCCCChhHHhhcc-ccCCCCChHHHHHHHHHHHHHHHHhhhc-CCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 523 YMPHKSLDYFIFDR-ERSKLLPWKKRFSIITGIARGLLYLHQD-SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 523 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|++ ++|..++... .....+++..++.++.||+.||+|||++ + ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 6777776442 2335689999999999999999999987 7 99999999999999999999999999986532
Q ss_pred CCcccccccccccccccCcccccC----CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYAND----GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~----~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... ........ .+....
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~~~~ 227 (283)
T cd06617 157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVV-EEPSPQ 227 (283)
T ss_pred c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHH-hcCCCC
Confidence 1 11223467889999998865 45789999999999999999999998532211 01111111 111111
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
+.. ......+.+++.+||+.+|++||++.+|++
T Consensus 228 ~~~--------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 LPA--------EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCc--------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 112356789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=296.67 Aligned_cols=265 Identities=23% Similarity=0.279 Sum_probs=198.7
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeec--CceEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE--DERMLI 520 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~--~~~~lV 520 (765)
++|++.+.||+|+||.||+|... +++.+++|++.... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57889999999999999999975 57889999986432 22234567899999999999999999998877 899999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
+||+.+ +|.+++.... ..+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999975 8887774322 35899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCcccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHH--------HHHhh--
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGH--------AWLLW-- 669 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~--------~~~~~-- 669 (765)
.. .......++..|+|||.+.+. .++.++||||||+++++|++|+.||...........+.. .|..+
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 32 112234568889999998764 468999999999999999999999875433211111000 00000
Q ss_pred ----ccCCccccccccccCccCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 670 ----NDGRALGLMDTCLEDSFVES-QVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 670 ----~~~~~~~l~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
............+...++.. ....+.+++.+||+.+|++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000011111111112211 24567789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=292.52 Aligned_cols=247 Identities=25% Similarity=0.395 Sum_probs=199.9
Q ss_pred CcccccccccCCceeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 447 HFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
-|++.+.||+|+||.||+|.. .+++.+|+|.+.... ......+.+|+.++++++|+||+++++++.++...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 467788999999999999986 467899999876432 344567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++++|.+++.. ..+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 99999988742 35889999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
......++..|+|||.+.+..++.++|+||||+++++|++|..|+....+.. .. .....+.. .
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~----~~~~~~~~---------~ 219 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VL----FLIPKNNP---------P 219 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HH----HHHhcCCC---------C
Confidence 1223467888999999998889999999999999999999999986433211 01 01111111 1
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.........+.+++.+|++.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1112234557789999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=296.77 Aligned_cols=244 Identities=26% Similarity=0.331 Sum_probs=199.6
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||.||++... +++.+|+|++.+.. ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999865 58899999986532 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999988543 46899999999999999999999998 999999999999999999999999999876432
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...... ........+..
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~------- 215 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-------QIYEKILEGKV------- 215 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCc-------
Confidence 22456889999999998888999999999999999999999998643311 11111111111
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRP-----DMSSVVF 717 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 717 (765)
..+......+.+++.+||+.+|.+|| +++++++
T Consensus 216 ---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 ---RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ---cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11111245677899999999999999 6777763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=295.03 Aligned_cols=282 Identities=26% Similarity=0.350 Sum_probs=221.6
Q ss_pred HHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceE
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~ 518 (765)
...+.|+.-++||+||||.||-++. .+|+-+|.|++.+. ..++....++|-.||.+++.+.||.+-.+|...+.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 3446688889999999999999875 47899999998764 3455667889999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
||+..|.||+|..+|.+... ..+++..+..++.+|+.||++||+.. ||+|||||+|||+|+.|+++|+|+|+|..+
T Consensus 262 lVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999999999976544 46999999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
..... ....+||.+|||||+++++.|+...|.|||||+||||+.|+.||........... +
T Consensus 338 ~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE----------------v 398 (591)
T KOG0986|consen 338 PEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE----------------V 398 (591)
T ss_pred CCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH----------------H
Confidence 54433 2345899999999999999999999999999999999999999865433321111 1
Q ss_pred cccc---cCccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHH----------HHHhcCCCCCCC-CCCCCcccccc
Q 004264 679 DTCL---EDSFVESQVLRCIQVGLLCVQKLPEDRPD-----MSSVV----------FLLANDGVTLPQ-PRQPGFFTERG 739 (765)
Q Consensus 679 d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl----------~~L~~~~~~l~~-p~~p~~~~~~~ 739 (765)
|.+. ...++....+++..|....|+.||++|.- +++|. ++|+....+-|. |++-+-|....
T Consensus 399 drr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv 478 (591)
T KOG0986|consen 399 DRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDV 478 (591)
T ss_pred HHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchhhh
Confidence 1111 12355566677888888999999999963 44554 345443322222 33334455555
Q ss_pred cccccCCC
Q 004264 740 FTVGALSS 747 (765)
Q Consensus 740 ~~~~~~~~ 747 (765)
++-++.++
T Consensus 479 ~DIeqFs~ 486 (591)
T KOG0986|consen 479 LDIEQFST 486 (591)
T ss_pred hhhhhccc
Confidence 55554443
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=298.20 Aligned_cols=266 Identities=24% Similarity=0.324 Sum_probs=195.2
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeec--CceEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE--DERML 519 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~--~~~~l 519 (765)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999864 68899999986432 22234567899999999999999999998765 46899
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+.+ +|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 677776432 256899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHhhc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHA--------WLLWN 670 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~ 670 (765)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....+.+....+... +....
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 3221 1122345778999999865 56899999999999999999999998654432211111100 00000
Q ss_pred cCCc---cccccccccC--ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 671 DGRA---LGLMDTCLED--SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 671 ~~~~---~~l~d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.... ..+....... .........+.+++.+|++.||++|||++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 0000000000 0000123456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=322.44 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=193.0
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeec-------
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE------- 514 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~------- 514 (765)
-..+|++.+.||+||||.||+++.+ ||+.||||++.-. .......+.+|+..|.+|+|||||+++....+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 4468999999999999999999965 8999999999754 344566788999999999999999997653320
Q ss_pred --------------------------------------------------------------------------------
Q 004264 515 -------------------------------------------------------------------------------- 514 (765)
Q Consensus 515 -------------------------------------------------------------------------------- 514 (765)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhh
Q 004264 515 --------------------------------DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLH 562 (765)
Q Consensus 515 --------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH 562 (765)
...||=||||+..+|.+++....... .....++++++|++||+|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence 01356689998888888885443221 47788999999999999999
Q ss_pred hcCCCcEEecccCCCcEEEecCCCCeecccccceeeC----------------CCCcccccccccccccccCcccccCC-
Q 004264 563 QDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG----------------GDDEEAQTERVAGTHGYMSPEYANDG- 625 (765)
Q Consensus 563 ~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~----------------~~~~~~~~~~~~gt~~Y~aPE~~~~~- 625 (765)
+.+ ||||||||.|||+|++..|||+|||+|+... ........+..+||.-|+|||++.+.
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 999 9999999999999999999999999998721 01111234568899999999999765
Q ss_pred --CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccc
Q 004264 626 --TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQ 703 (765)
Q Consensus 626 --~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~ 703 (765)
.|+.|+|+|||||||+||+. ||. ...++... ...++.+.+..- ..+.......-..++.++++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~--TsMERa~i----L~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFG--TSMERASI----LTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCC--chHHHHHH----HHhcccCCCCCC------cccccccchHHHHHHHHHhc
Confidence 49999999999999999985 332 22222222 222333333221 12222333444589999999
Q ss_pred cCCCCCCCHHHHHHH
Q 004264 704 KLPEDRPDMSSVVFL 718 (765)
Q Consensus 704 ~dP~~RPs~~evl~~ 718 (765)
.||.+|||+.|++..
T Consensus 857 hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 857 HDPSKRPTATELLNS 871 (1351)
T ss_pred CCCccCCCHHHHhhc
Confidence 999999999999853
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=293.90 Aligned_cols=263 Identities=24% Similarity=0.324 Sum_probs=198.9
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccCh-hhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
+|++.+.||+|++|.||+|+.. +++.+|+|++..... .....+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999975 688899999875432 23466788999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++ +|.+++........+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 78777755444456899999999999999999999998 99999999999999999999999999976532211
Q ss_pred cccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHhhccCCcc
Q 004264 605 AQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHA--------WLLWNDGRAL 675 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 675 (765)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+... +..+. ...
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 232 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS--QLP 232 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh--cCc
Confidence 11234568889999988664 5789999999999999999999998654432111110000 00000 000
Q ss_pred ccccccc------cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 676 GLMDTCL------EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 676 ~l~d~~l------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
....... ...........+.+++.+|++.+|++||++.+|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 00111122456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=293.58 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=199.5
Q ss_pred cccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCC
Q 004264 448 FSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++|+||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457899999999999985 46889999998765555567789999999999999999999999999999999999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 606 (765)
++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||++........ .
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~ 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence 999998854 34889999999999999999999999 99999999999999999999999998876533221 1
Q ss_pred cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCcc
Q 004264 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSF 686 (765)
Q Consensus 607 ~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 686 (765)
.....++..|+|||.+.+..++.++||||||++++||++|+.||....+... .. ........ .+. .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~---~~----~~~~~~~~-----~~~--~ 237 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA---MK----RIRDNLPP-----KLK--N 237 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH---HH----HHHhcCCC-----CCc--c
Confidence 1235688899999999988999999999999999999999999864332111 11 11111100 000 0
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 687 VESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 687 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.......+.+++.+||+.+|++||++.++++.
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 11123468899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=293.67 Aligned_cols=264 Identities=21% Similarity=0.294 Sum_probs=195.3
Q ss_pred HhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++++|.+.+.||+|+||.||+|.. .+++.+++|++.... ......+.+|+.+++.++|+||+++++++..+...++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 457899999999999999999986 468899999986543 223346788999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+. ++|...+... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 5665555322 234778888999999999999999998 999999999999999999999999999764322
Q ss_pred CcccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccC--------
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDG-------- 672 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 672 (765)
.. ......++..|+|||++.+. .++.++||||||+++|||++|+.||....+. ...+...+......
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhh
Confidence 11 11234568899999998764 5888999999999999999999998643321 11111111111000
Q ss_pred -----CccccccccccCc-----cCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 673 -----RALGLMDTCLEDS-----FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 673 -----~~~~l~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
............. ........+.+++.+|++.+|.+|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000 00011345778999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=305.98 Aligned_cols=252 Identities=26% Similarity=0.361 Sum_probs=205.5
Q ss_pred CcccccccccCCceeEEEEEeC--CCc--EEEEEEccccCh-hhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS--TGQ--EIAAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~--~~~--~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
+.+..++||+|.||.|++|.|. .|+ .||||.+..... .....|++|+.+|.+|+|+|+++++|...+ ....+||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3455678999999999999874 343 589999976543 367899999999999999999999999887 7788999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
|.++.|+|.+.+.. .....+.......++.|||.||.||.+++ +|||||..+|+||-....|||+|||+.+.++..
T Consensus 190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999976 45567889999999999999999999999 999999999999999999999999999988654
Q ss_pred Ccccc-cccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 602 DEEAQ-TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 602 ~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
..... .....-.+.|+|||.++...++.++|||+||+.||||++ |..||....... +.+.+|
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------IL~~iD 329 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------ILKNID 329 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------HHHhcc
Confidence 44332 223334567999999999999999999999999999999 667775433321 112222
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 719 (765)
....-.-+..+.+++.+++..||..+|++|||+..|++.+
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 2222223345677899999999999999999999998554
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=293.84 Aligned_cols=264 Identities=23% Similarity=0.281 Sum_probs=198.1
Q ss_pred cccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeec--CceEEEEE
Q 004264 448 FSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE--DERMLIYE 522 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~--~~~~lV~E 522 (765)
|++.+.||+|++|.||+|... +++.+++|++.... ......+.+|+.++++++|+|++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667889999999999999875 57899999997653 33446788999999999999999999999988 89999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++ +|..++... ...+++..++.++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 787777433 246899999999999999999999998 9999999999999999999999999998775433
Q ss_pred cccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc-----
Q 004264 603 EEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG----- 676 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 676 (765)
.. ......++..|+|||.+.+ ..++.++||||||++++||++|+.||...........+..............
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 21 1223456788999998765 4689999999999999999999999865443211111100000000000000
Q ss_pred ---------cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 677 ---------LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 677 ---------l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.....+...........+.+++.+||+.+|++||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000011111124568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=318.86 Aligned_cols=269 Identities=21% Similarity=0.263 Sum_probs=187.0
Q ss_pred HHHhcCcccccccccCCceeEEEEEeCC--CcEEEE------------------EEccccChhhHHHHHHHHHHHhcccc
Q 004264 442 TTATNHFSEANMIGKGGFGPVYMGKLST--GQEIAA------------------KRLSKNSGQGLEEFMNEVVLIGKLQH 501 (765)
Q Consensus 442 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~--~~~vav------------------K~l~~~~~~~~~~~~~Ev~~l~~l~h 501 (765)
....++|++.+.||+|+||.||++..+. +...++ |++. .......++.+|+.+|++++|
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCC
Confidence 3456789999999999999999986432 111111 1111 122345678899999999999
Q ss_pred CceEeeeeeeeecCceEEEEEecCCCChhHHhhccc--cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcE
Q 004264 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRE--RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNI 579 (765)
Q Consensus 502 ~niv~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NI 579 (765)
+||+++++++...+..++|+|++.+ +|..++.... .........+..++.||+.||+|||+.+ |+||||||+||
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NI 298 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENI 298 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 9999999999999999999999865 5555553321 1122345667789999999999999998 99999999999
Q ss_pred EEecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCC-CCCCCCCCc
Q 004264 580 LLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMN-RGFRHPGHR 658 (765)
Q Consensus 580 ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p-~~~~~~~~~ 658 (765)
|++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..+ +........
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred EECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 999999999999999987643222 122246789999999999999999999999999999999998864 332221111
Q ss_pred ccHHHHHHHhhccCCccccccc----------c-c--cCccCH------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 659 HNLIGHAWLLWNDGRALGLMDT----------C-L--EDSFVE------SQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~d~----------~-l--~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..+.. ....... ...++.+. . . ...... .....+.+++.+||+.||++|||+.|++++
T Consensus 378 ~~~~~-~~~~~~~-~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 378 KQLLK-IIDSLSV-CDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHH-HHHhccc-ChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111 0000000 00000000 0 0 000000 012245677889999999999999999864
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=295.54 Aligned_cols=264 Identities=23% Similarity=0.284 Sum_probs=194.7
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhccc-cCceEeeeeeeeecCc-----
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDE----- 516 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~----- 516 (765)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++++. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999864 68899999876532 223457888999999995 6999999999987666
Q ss_pred eEEEEEecCCCChhHHhhcccc--CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec-CCCCeecccc
Q 004264 517 RMLIYEYMPHKSLDYFIFDRER--SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI-NLNPKISDFG 593 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~vkL~DFG 593 (765)
.++||||+++ +|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 78777654322 346899999999999999999999998 999999999999998 8899999999
Q ss_pred cceeeCCCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccC
Q 004264 594 LARIFGGDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDG 672 (765)
Q Consensus 594 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 672 (765)
+++.+..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||....+.... ..........
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL---LHIFKLLGTP 231 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHhCCC
Confidence 9986532211 1112356788999998865 45799999999999999999999998653322110 0000000000
Q ss_pred Ccc---c---ccc----cccc----CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 673 RAL---G---LMD----TCLE----DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 673 ~~~---~---l~d----~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
... . ..+ +... .........++.+++.+||+.+|.+||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 0 000 0000 00011234567899999999999999999998753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=290.54 Aligned_cols=247 Identities=27% Similarity=0.330 Sum_probs=201.5
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
+|++.+.||+|+||.||++... .++.+++|.+.+.. ....+.+.+|+.++++++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788999999999999999875 58899999987542 2456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+.+++|.+++... ..+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999988433 46889999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+....... .......... .
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~-~--------- 217 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET-A--------- 217 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc-c---------
Confidence 2224567888999999998889999999999999999999999987554321 1111111110 0
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDM--SSVV 716 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl 716 (765)
....+......+.+++.+||+.+|.+||++ +|++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 011112233668899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=300.71 Aligned_cols=263 Identities=25% Similarity=0.286 Sum_probs=197.4
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeec------
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE------ 514 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~------ 514 (765)
..++|++.+.||+|+||.||++... +++.+|+|++.+. ......++.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999864 7889999998653 233456778899999999999999999988643
Q ss_pred CceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccc
Q 004264 515 DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGL 594 (765)
Q Consensus 515 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGl 594 (765)
...++||||+.+ +|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 357999999965 67666632 2788899999999999999999998 99999999999999999999999999
Q ss_pred ceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHH------------
Q 004264 595 ARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLI------------ 662 (765)
Q Consensus 595 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~------------ 662 (765)
++...... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+
T Consensus 165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 98753321 122346788999999999999999999999999999999999998644321100000
Q ss_pred ---HHHHHhhccCC-------cccccccccc----CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 663 ---GHAWLLWNDGR-------ALGLMDTCLE----DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 663 ---~~~~~~~~~~~-------~~~l~d~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
......+...+ ..++....+. ..........+.+++.+||+.||++|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000000 0011111110 01112335567899999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=301.64 Aligned_cols=246 Identities=29% Similarity=0.396 Sum_probs=200.1
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
..|+-++.||.|+||-||.|++. +...||||++... .......+.+||..|++++|||++.+-|+|..+...+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 34666788999999999999864 6678999999754 3445678999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
|||- |+-.+++. -..+++.+.++..|..+.+.||+|||+.+ .||||||..|||+.+.|.|||+|||.|.....
T Consensus 106 EYCl-GSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 106 EYCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred HHHh-ccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 9994 56667763 33467899999999999999999999999 99999999999999999999999999987532
Q ss_pred CcccccccccccccccCccccc---CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYAN---DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
...++||+.|||||++. .+.|+-|+|||||||...||...++|.=...... +.....++..
T Consensus 179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-------ALYHIAQNes---- 242 (948)
T KOG0577|consen 179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNES---- 242 (948)
T ss_pred -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-------HHHHHHhcCC----
Confidence 33689999999999885 5789999999999999999999998842211111 1111111111
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
+.+ ........+.+++..||+.-|.+|||.+++++.
T Consensus 243 -PtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 -PTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred -CCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 111 134567788999999999999999999988753
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=302.84 Aligned_cols=267 Identities=22% Similarity=0.315 Sum_probs=197.8
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecC-----ce
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED-----ER 517 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~-----~~ 517 (765)
.++|++.+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 47899999999999999999985 46889999998643 2334567888999999999999999998876543 57
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
++|+||+.+ +|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 6666653 245899999999999999999999999 99999999999999999999999999987
Q ss_pred eCCCCccc-ccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC--
Q 004264 598 FGGDDEEA-QTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR-- 673 (765)
Q Consensus 598 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 673 (765)
........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... .............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHH
Confidence 64322211 1223568899999998754 568999999999999999999999985432211 0100000000000
Q ss_pred -cccccccc--------c-cCc-----cCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcC
Q 004264 674 -ALGLMDTC--------L-EDS-----FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL--LAND 722 (765)
Q Consensus 674 -~~~l~d~~--------l-~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 722 (765)
...+.+.. . ... .......++.+++.+||+.+|++||++.++++. ++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 00000000 0 000 001124568899999999999999999999986 5543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=293.98 Aligned_cols=261 Identities=23% Similarity=0.312 Sum_probs=195.6
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
+|++.+.||+|++|.||+|+.. +++.+++|++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999864 68899999886432 22345788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+. ++|..++.... ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 57877775432 345899999999999999999999998 99999999999999999999999999876532211
Q ss_pred ccccccccccccccCcccccCCC-CCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccC----------
Q 004264 604 EAQTERVAGTHGYMSPEYANDGT-ISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDG---------- 672 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~-~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 672 (765)
......++..|+|||.+.+.. ++.++||||||+++|||++|+.||....+.+. ... ........
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFR-IFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHH-HHHHhCCCChhhhhhhhH
Confidence 112335678899999887644 68899999999999999999999865432111 000 00000000
Q ss_pred ------CccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 673 ------RALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 673 ------~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.........+. .........+.+++.+|++.||.+||+++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 231 LPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000 0001123456789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=301.69 Aligned_cols=267 Identities=24% Similarity=0.311 Sum_probs=198.2
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeec--Cce
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEE--DER 517 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~--~~~ 517 (765)
..++|++.+.||+|+||.||+|... +++.+|+|++.+. .......+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999865 5788999988642 233445677899999999 999999999988654 367
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 488777743 25789999999999999999999998 99999999999999999999999999987
Q ss_pred eCCCCcc---cccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH-------
Q 004264 598 FGGDDEE---AQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAW------- 666 (765)
Q Consensus 598 ~~~~~~~---~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~------- 666 (765)
....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....+.+.........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 6433221 12234568899999998765 567899999999999999999999986443321111000000
Q ss_pred -HhhccCCcccccccccc------CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 667 -LLWNDGRALGLMDTCLE------DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 667 -~~~~~~~~~~l~d~~l~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..+.......+++.... ..........+.+++.+|++.+|++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000001110000 00011134568899999999999999999999965
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=293.96 Aligned_cols=248 Identities=28% Similarity=0.379 Sum_probs=195.6
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
...|.+.+.||+|+||.||+|... +++.||+|++... .....+++.+|+.+++.++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888999999999999999864 6889999988643 233446788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
+||+.+ ++.+++.. ....+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~g-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCLG-SASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhCC-CHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 999974 56555532 2245899999999999999999999998 99999999999999999999999999976432
Q ss_pred CCcccccccccccccccCccccc---CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYAN---DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
. ....++..|+|||.+. ...++.++||||||+++|||++|+.|+....... ...... .....
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~~~-~~~~~-- 232 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIA-QNDSP-- 232 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHHHh-cCCCC--
Confidence 1 2346788899999874 4568899999999999999999999975432211 011110 01000
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 719 (765)
. .........+.+++.+||+.+|++||++.+|+.+.
T Consensus 233 ---~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 233 ---T---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred ---C---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0 01112345688999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=291.32 Aligned_cols=255 Identities=26% Similarity=0.366 Sum_probs=195.1
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHhccc-cCceEeeeeeeeecCceEEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~~~lV~E 522 (765)
++|+..+.||+|+||.||++... +++.+|+|++.... ......+.+|+.++.++. |+||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35667789999999999999864 57899999987542 345567889999999996 9999999999999999999999
Q ss_pred ecCCCChhHHhhc--cccCCCCChHHHHHHHHHHHHHHHHhhhc-CCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 523 YMPHKSLDYFIFD--RERSKLLPWKKRFSIITGIARGLLYLHQD-SKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 523 ~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
|+.. ++.++... ......+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++..+.
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9864 54443321 12235689999999999999999999975 6 9999999999999999999999999997653
Q ss_pred CCCcccccccccccccccCcccccCC---CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDG---TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
.... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||.... ......... ..+..
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~-~~~~~-- 228 (288)
T cd06616 160 DSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQV-VKGDP-- 228 (288)
T ss_pred cCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhh-cCCCC--
Confidence 2211 1234678899999999876 68999999999999999999999986432 111111111 11111
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
+.+...........+.+++.+||+.+|++|||+.+|++.
T Consensus 229 ---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 ---PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ---CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111112345568899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=291.85 Aligned_cols=260 Identities=23% Similarity=0.307 Sum_probs=199.1
Q ss_pred cccccccccCCceeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 448 FSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSG--QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
|++.+.||+|++|.||++... +++.+++|++..... .....+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999864 688899999875432 24567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++ +|..++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 76 777776432 246899999999999999999999999 9999999999999999999999999998775433
Q ss_pred cccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccC---Cccccc--
Q 004264 605 AQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDG---RALGLM-- 678 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~l~-- 678 (765)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+..... ....... ....+.
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI---FRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHcCCCchHhcccchhh
Confidence 112234577889999998876 7899999999999999999999998654432111111 0000000 000000
Q ss_pred ---------cccc--cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 679 ---------DTCL--EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 679 ---------d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
+... ...........+.+++.+||+.+|.+||++++++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 011112335678899999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=299.35 Aligned_cols=246 Identities=26% Similarity=0.363 Sum_probs=206.2
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
...|.+.+.||+|.|++|.+|++ ..+..||+|.+.+.. ....+.+.+|+++|..|.|||||+++.+.......|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 35688899999999999999986 468999999998763 333456889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||..+|.+.+++.... .+.+..+..++.|+..|++|||+++ |+|||||++||||+.+.++||+|||++..+.
T Consensus 135 eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-- 206 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD-- 206 (596)
T ss_pred EeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec--
Confidence 9999999999995443 3556888999999999999999999 9999999999999999999999999999874
Q ss_pred CcccccccccccccccCcccccCCCC-CccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTI-SMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
........+|++.|.|||++.+..| .+++|+||+|++||-|+.|..||+...-.+ +-+.
T Consensus 207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-------------------Lr~r 266 (596)
T KOG0586|consen 207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-------------------LRPR 266 (596)
T ss_pred -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-------------------ccch
Confidence 3334456899999999999999876 678999999999999999999997543221 1111
Q ss_pred cccC--ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 681 CLED--SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 681 ~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.+.+ .++.....++-+++.++|-.+|.+|++++++.+.
T Consensus 267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred heeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1211 1222334567789999999999999999999753
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=300.88 Aligned_cols=268 Identities=24% Similarity=0.329 Sum_probs=198.5
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeec-----Cc
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE-----DE 516 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~-----~~ 516 (765)
.++|.+.+.||+|+||.||+++. .+++.||+|++... ......++.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46799999999999999999986 46889999998653 233455678899999999999999999988654 34
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
.++|+||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 677777742 345899999999999999999999998 9999999999999999999999999998
Q ss_pred eeCCCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH--------H
Q 004264 597 IFGGDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAW--------L 667 (765)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~--------~ 667 (765)
...... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+.... .
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 764322 12223567889999998865 568999999999999999999999986432211100000000 0
Q ss_pred hhccCCccccccc---cccC---ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhc
Q 004264 668 LWNDGRALGLMDT---CLED---SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL--LAN 721 (765)
Q Consensus 668 ~~~~~~~~~l~d~---~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~ 721 (765)
..........+.. .... .........+.+++.+||+.+|++|||++++++. ++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 0000000000000 0000 0011234567899999999999999999999977 544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=293.02 Aligned_cols=261 Identities=23% Similarity=0.283 Sum_probs=195.6
Q ss_pred cccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 448 FSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
|++.+.||.|++|.||+|... +++.|++|++.... ......+.+|+.++++++|+|++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999864 78999999986542 223457889999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
+ ++|.+++.... ...+++..++.++.||++||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 68888875432 235899999999999999999999998 99999999999999999999999999976532211
Q ss_pred cccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhc-cC-----Ccccc
Q 004264 605 AQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWN-DG-----RALGL 677 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~-~~-----~~~~l 677 (765)
......++..|+|||++.+. .++.++||||||+++|+|++|+.||....+.... .. ...... .. ....+
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL--FR-IFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-HHHHhCCCChHHhhhhhhc
Confidence 11223567889999988664 5789999999999999999999998654321110 00 000000 00 00000
Q ss_pred -------cccc--ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 678 -------MDTC--LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 678 -------~d~~--l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.... ............+.+++.+|++.+|++||+++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 0001111223567899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=287.62 Aligned_cols=242 Identities=28% Similarity=0.341 Sum_probs=187.1
Q ss_pred ccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhc---cccCceEeeeeeeeecCceEEEEEecC
Q 004264 453 MIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGK---LQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 453 ~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~---l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
.||+|+||.||++... +++.+|+|.+.+.. ......+.+|..+++. .+|+|++.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 58899999886532 1222334455544443 479999999999999999999999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+++|.+++.. .+.+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999988843 345899999999999999999999999 9999999999999999999999999997653221
Q ss_pred ccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 606 QTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
.....++..|+|||.+.+ ..++.++||||+|++++||++|+.||........... ... .. . ...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~--~~-~----------~~~ 216 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRM--TL-T----------VNV 216 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH-HHH--hh-c----------CCc
Confidence 123468999999999864 5689999999999999999999999875433221111 100 00 0 001
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRP-----DMSSVVFL 718 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 718 (765)
..+.....++.+++..||+.+|++|| ++++++++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11222345678999999999999999 69999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=294.82 Aligned_cols=268 Identities=21% Similarity=0.292 Sum_probs=194.2
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecC------
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED------ 515 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~------ 515 (765)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999864 68899999886432 222345678999999999999999999987654
Q ss_pred --ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccc
Q 004264 516 --ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFG 593 (765)
Q Consensus 516 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFG 593 (765)
..++||||+.+ +|.+.+.. ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 34999999975 67666632 2235899999999999999999999998 9999999999999999999999999
Q ss_pred cceeeCCCCcc--cccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhh-
Q 004264 594 LARIFGGDDEE--AQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLW- 669 (765)
Q Consensus 594 la~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~- 669 (765)
++......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....+......+.......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99876432221 112234577889999988664 47889999999999999999999986544322111111110000
Q ss_pred ----ccCCcccccc------cc---ccCc-cCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 670 ----NDGRALGLMD------TC---LEDS-FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 670 ----~~~~~~~l~d------~~---l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.........+ .. .... ........+.+++.+||+.+|++|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000000000 00 0000 000112356789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=291.73 Aligned_cols=263 Identities=23% Similarity=0.279 Sum_probs=194.5
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
++|++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999865 68899999986532 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec-CCCCeecccccceeeCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI-NLNPKISDFGLARIFGGD 601 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~vkL~DFGla~~~~~~ 601 (765)
|+++ +|.+++.... ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLDL-DLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cccc-cHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9964 6766664322 233678888899999999999999998 999999999999985 557999999999765322
Q ss_pred CcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC---cc--
Q 004264 602 DEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR---AL-- 675 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~-- 675 (765)
. .......++..|+|||++.+ ..++.++||||||+++|+|++|+.||....+.+. ............ +.
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE---LFKIFRILGTPNEETWPGV 231 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChhhcccc
Confidence 1 11123456889999998876 4678999999999999999999999865432211 111111000000 00
Q ss_pred -ccccc-----cccC----ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 676 -GLMDT-----CLED----SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 676 -~l~d~-----~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.+.+- .... ........++.+++.+|++.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0000 0011123457889999999999999999999863
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=290.32 Aligned_cols=259 Identities=18% Similarity=0.192 Sum_probs=183.4
Q ss_pred HhcCcccccccccCCceeEEEEEeCCC----cEEEEEEccccChhhH-----------HHHHHHHHHHhccccCceEeee
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLSTG----QEIAAKRLSKNSGQGL-----------EEFMNEVVLIGKLQHRNLVGLL 508 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~~~~-----------~~~~~Ev~~l~~l~h~niv~~~ 508 (765)
..++|++.++||+|+||.||+|...++ ..+++|+......... .....+...+..+.|+++++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346899999999999999999986543 4556665332211110 1122334455667899999999
Q ss_pred eeeeecC----ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC
Q 004264 509 GSCIEED----ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN 584 (765)
Q Consensus 509 ~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 584 (765)
+++.... ..++++|++.. ++.+.+.. ....++..+..++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 8776544 34677777643 45444422 123568888999999999999999998 9999999999999999
Q ss_pred CCCeecccccceeeCCCCcc-----cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcc
Q 004264 585 LNPKISDFGLARIFGGDDEE-----AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRH 659 (765)
Q Consensus 585 ~~vkL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~ 659 (765)
+.++|+|||+++.+...... .......||+.|+|||++.+..++.++||||||++++||++|+.||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 99999999999876432211 1122357999999999999999999999999999999999999999755322111
Q ss_pred -cHHH-HHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 660 -NLIG-HAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 660 -~~~~-~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
.... ........+.. .. ......+.+++..|++.+|++||++.+|++.|+
T Consensus 243 ~~~~~~~~~~~~~~~~~--------~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAAKCDFIKRLHEGKI--------KI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhHHHHHHHhhhhhh--------cc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0000 00111111111 00 011355789999999999999999999998873
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=285.93 Aligned_cols=242 Identities=25% Similarity=0.318 Sum_probs=194.4
Q ss_pred cccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCCCh
Q 004264 454 IGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSL 529 (765)
Q Consensus 454 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gsL 529 (765)
||+|++|.||+++.. .++.+++|++.+.. ....+.+.+|+.++++++|+||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 48899999987542 23456789999999999999999999999999999999999999999
Q ss_pred hHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccccccc
Q 004264 530 DYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTER 609 (765)
Q Consensus 530 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~ 609 (765)
.+++... ..+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 9998532 34889999999999999999999998 9999999999999999999999999998764322 2223
Q ss_pred ccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHH
Q 004264 610 VAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVES 689 (765)
Q Consensus 610 ~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 689 (765)
..++..|+|||.+.+..++.++|+||||+++|+|++|+.|+....... .... .....+. ....++..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~----~~~~~~~--------~~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIY----NDILKGN--------GKLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHH----HHHhccC--------CCCCCCcc
Confidence 567889999999988889999999999999999999999987554311 1111 1110000 01111222
Q ss_pred HHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 004264 690 QVLRCIQVGLLCVQKLPEDRPD-----MSSVVF 717 (765)
Q Consensus 690 ~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 717 (765)
....+.+++.+||+.+|++||+ +.|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 2456889999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=285.25 Aligned_cols=249 Identities=27% Similarity=0.389 Sum_probs=203.4
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
+|++.+.||+|++|.||+++.. +++.+++|++... ......++.+|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999754 6788999998753 234456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccc-cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 524 MPHKSLDYFIFDRE-RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 524 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
+++++|..++.... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999885522 2356889999999999999999999999 999999999999999999999999999876433
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
......++..|+|||.+.+..++.++|+||||++++||++|+.||....... .......+...
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~------- 219 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------LRYKVQRGKYP------- 219 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCCC-------
Confidence 2223457889999999999999999999999999999999999986443211 11111122211
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..+......+.+++.+|++.+|++||++.++++.
T Consensus 220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 --PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred --CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1122344568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=286.59 Aligned_cols=250 Identities=25% Similarity=0.358 Sum_probs=199.8
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
+|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788899999999999999865 5788999998653 223456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCC-CeecccccceeeCCCC
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLN-PKISDFGLARIFGGDD 602 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-vkL~DFGla~~~~~~~ 602 (765)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999885432 235789999999999999999999998 999999999999988754 6999999998764322
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
. ......+++.|+|||++.+..++.++|+||||++++||++|+.|+...... ....... .+....+
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~~----- 222 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKIC-QGYFAPI----- 222 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHh-cccCCCC-----
Confidence 2 122346888999999999889999999999999999999999998543221 1111111 1111111
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.......+.+++.+|++.+|++|||+.+|++.
T Consensus 223 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 ----SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11223467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=288.38 Aligned_cols=261 Identities=21% Similarity=0.251 Sum_probs=192.2
Q ss_pred cccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHhccc-cCceEeeeeeeeec--CceEEEEE
Q 004264 448 FSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEE--DERMLIYE 522 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~--~~~~lV~E 522 (765)
|++.+.||+|+||.||++... +++.+|+|++.+.. ........+|+.+++++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999864 68899999987542 222334557899999885 99999999999987 88999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++ +|.+.+... ...+++..+..++.||+.||+|||+.+ ++||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9975 666666432 246899999999999999999999998 999999999999999 999999999998764322
Q ss_pred cccccccccccccccCccccc-CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHH--------HHHhhccCC
Q 004264 603 EEAQTERVAGTHGYMSPEYAN-DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGH--------AWLLWNDGR 673 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~-~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~~~~ 673 (765)
. .....++..|+|||.+. +..++.++||||||+++|||++|+.||....+.+....... .........
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 1 12345788999999765 45678999999999999999999999865443211000000 000000000
Q ss_pred ccccccccccC----ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 674 ALGLMDTCLED----SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 674 ~~~l~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
......+.... .........+.+++.+||+.+|++||+++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000 0011235678899999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=282.41 Aligned_cols=247 Identities=30% Similarity=0.427 Sum_probs=202.0
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSG--QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
+|++.+.||+|++|.||++... .++.+++|.+..... .....+.+|++++++++|+|++++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999865 678899999976543 4567899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++++|.+++... ..+++..+..++.|++.+|.|||+.+ |+|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999988433 56899999999999999999999998 99999999999999999999999999987643322
Q ss_pred ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
. .....++..|+|||...+..++.++||||+|+++++|++|+.|+....+. ...+.. ......
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~~~~~-~~~~~~-------- 217 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM------AALFRI-VQDDHP-------- 217 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHH-hccCCC--------
Confidence 1 22356788999999998888999999999999999999999998643211 001111 111111
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
..+......+.+++.+||+.+|++||++.+++.
T Consensus 218 -~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 -PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111122456779999999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=301.50 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=207.8
Q ss_pred cCcccccccccCCceeEEEEEeCCCcE-EEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQE-IAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~-vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
+.|.|+..||.|+||.||+|..++... -|.|++........+.++-|++||....||+||++++.|..++.+++..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 457888899999999999998765544 4567776677888899999999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
.||-.+.++... +..+.+..+..+..|++.||.|||++. |||||||..|||++-+|.++|+|||.+-... ...
T Consensus 112 ~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STR 184 (1187)
T ss_pred CCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHH
Confidence 999999988654 456899999999999999999999999 9999999999999999999999999986542 222
Q ss_pred cccccccccccccCcccc-----cCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 605 AQTERVAGTHGYMSPEYA-----NDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~-----~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
.....+.||+.|||||+. ...+|+.++||||||+.|.||..+.+|.....+..+... ........++.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllK-------iaKSePPTLlq 257 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK-------IAKSEPPTLLQ 257 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHH-------HhhcCCCcccC
Confidence 334468999999999976 467899999999999999999999998765555432211 11222222222
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
+......+.+++..||..+|+.||++.++++.
T Consensus 258 -------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 258 -------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 23445668899999999999999999998753
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=299.81 Aligned_cols=267 Identities=20% Similarity=0.290 Sum_probs=199.0
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeee----cCce
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE----EDER 517 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~----~~~~ 517 (765)
.++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999864 68899999987542 2345677889999999999999999998763 3467
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 578777732 345899999999999999999999998 99999999999999999999999999987
Q ss_pred eCCCCccc--ccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHH--------HH
Q 004264 598 FGGDDEEA--QTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGH--------AW 666 (765)
Q Consensus 598 ~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~--------~~ 666 (765)
........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 64332211 1123578889999999866 5689999999999999999999999865432211100000 00
Q ss_pred HhhccCCcccccccccc-Cc-----cCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 667 LLWNDGRALGLMDTCLE-DS-----FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 667 ~~~~~~~~~~l~d~~l~-~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
............+.... .. ........+.+++.+||+.+|++||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000111111110000 00 111235668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=279.87 Aligned_cols=251 Identities=26% Similarity=0.384 Sum_probs=205.0
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
+|++.+.||+|+||.||++... +++.+++|++.... ....+.+.+|++++++++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999875 58899999987543 25567889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccc-cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 524 MPHKSLDYFIFDRE-RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 524 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999886532 2356899999999999999999999998 9999999999999999999999999998764433
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
.......+++.|+|||.+.+..++.++|+||+|+++++|++|+.|+...... . ............+
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~----~~~~~~~~~~~~~----- 223 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---E----LALKILKGQYPPI----- 223 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---H----HHHHHhcCCCCCC-----
Confidence 1223456888999999999999999999999999999999999997543311 1 1111111111111
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
+......+.+++.+||+.+|++||++.++++.
T Consensus 224 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 ----PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11223567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=286.72 Aligned_cols=244 Identities=29% Similarity=0.397 Sum_probs=192.2
Q ss_pred cccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCCCh
Q 004264 454 IGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSL 529 (765)
Q Consensus 454 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gsL 529 (765)
||+|+||+||++... +++.+++|.+.+.. ......+..|+.++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999854 68899999986532 22345667899999999999999999999999999999999999999
Q ss_pred hHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccccccc
Q 004264 530 DYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTER 609 (765)
Q Consensus 530 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~ 609 (765)
.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||.+..... ......
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCcccc
Confidence 988864432 45899999999999999999999999 99999999999999999999999999876532 111223
Q ss_pred ccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHH
Q 004264 610 VAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVES 689 (765)
Q Consensus 610 ~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 689 (765)
..++..|+|||.+.+..++.++||||||+++++|++|+.||...........+.. ... .. ....+..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------~~~-~~-----~~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR-------RTL-EM-----AVEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh-------ccc-cc-----cccCCcc
Confidence 4677889999999888899999999999999999999999865443211111100 000 00 0011112
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 004264 690 QVLRCIQVGLLCVQKLPEDRP-----DMSSVVF 717 (765)
Q Consensus 690 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 717 (765)
....+.+++.+||+.+|++|| ++.+++.
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 245677999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=292.71 Aligned_cols=251 Identities=25% Similarity=0.404 Sum_probs=205.3
Q ss_pred CcccccccccCCceeEEEEEeC---CCc--EEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS---TGQ--EIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~---~~~--~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
..+..+.||.|-||.||+|... .|. .||||..+.+ .....+.|++|..+|+++.||||++++|.|.+ ...++|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 3445678999999999999742 333 4889998874 55567889999999999999999999999976 467899
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
||.++.|.|..++..++ ..++......++.||+.||+|||+.. +|||||..+|||+.+..-|||+|||+++.+..
T Consensus 469 mEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 99999999999996543 45888999999999999999999999 99999999999999999999999999998754
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
...-... ...-.+.|||||-+.-..++.++|||.||+.+||++. |..||.+....++...++ .|...
T Consensus 544 ~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE-------nGeRl---- 611 (974)
T KOG4257|consen 544 DAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE-------NGERL---- 611 (974)
T ss_pred cchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec-------CCCCC----
Confidence 4332222 3344567999999999999999999999999999876 999998766665543322 23332
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
..++.+...|..|+.+||.++|.+||.+.++...|+
T Consensus 612 -----P~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 612 -----PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred -----CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence 233444556789999999999999999999987664
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=290.82 Aligned_cols=263 Identities=20% Similarity=0.215 Sum_probs=194.6
Q ss_pred ccccccccCCceeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCC
Q 004264 449 SEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 449 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
.+.+.+|.|+++.|+++.. +++.+|+|++... .....+.+.+|+.++++++|+||+++++++.+.+..+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3444556666666666654 6899999998754 345567899999999999999999999999999999999999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc---
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE--- 603 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~--- 603 (765)
++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 84 GSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999986432 235889999999999999999999998 99999999999999999999999999876532211
Q ss_pred --ccccccccccccccCcccccC--CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHh----h------
Q 004264 604 --EAQTERVAGTHGYMSPEYAND--GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLL----W------ 669 (765)
Q Consensus 604 --~~~~~~~~gt~~Y~aPE~~~~--~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~----~------ 669 (765)
........++..|+|||++.. ..++.++||||||++++||++|+.||....... ......... .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchh
Confidence 111223457778999999876 358899999999999999999999987533211 111100000 0
Q ss_pred -ccCCccc----ccccc----ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 670 -NDGRALG----LMDTC----LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 670 -~~~~~~~----l~d~~----l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
....... ..+.. ............+.+++.+||+.+|++|||++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000000 00000 0111222334578899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=283.42 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=197.2
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc-----ChhhHHHHHHHHHHHhccccCceEeeeeeeeec--Cce
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN-----SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE--DER 517 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~--~~~ 517 (765)
.+|.+.+.||+|+||.||+++.. +++.+++|++... .......+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999864 5889999987532 234456788999999999999999999998764 457
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
++|+||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999888432 34788999999999999999999999 99999999999999999999999999986
Q ss_pred eCCCCc-ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 598 FGGDDE-EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 598 ~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
...... ........++..|+|||.+.+..++.++|+||||+++++|++|+.||....... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~--- 226 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA------AIFKIATQPT--- 226 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH------HHHHHHcCCC---
Confidence 532111 111123568889999999998889999999999999999999999986432111 1111111111
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
....+......+.+++.+|++ +|..||++.+++..
T Consensus 227 ------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 227 ------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 112233344567889999999 57999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=291.56 Aligned_cols=248 Identities=28% Similarity=0.390 Sum_probs=195.2
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
.|+..+.||+|+||.||+++.. ++..+|+|++... .......+.+|+.++++++|+|++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3777889999999999999864 6789999998643 22344678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+.+ +|.+.+... ...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 106 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred CCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 9975 666665332 345899999999999999999999999 99999999999999999999999999875432
Q ss_pred cccccccccccccccCccccc---CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYAN---DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~---~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
.....++..|+|||++. .+.++.++||||||+++|||++|+.|+........ . . ....+...
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~---~-~~~~~~~~---- 242 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---L---Y-HIAQNESP---- 242 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---H---H-HHHhccCC----
Confidence 12346788999999974 45689999999999999999999999754321110 1 0 11111110
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..........+.+++.+||+.+|.+||++.+|++.+--
T Consensus 243 ----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 243 ----TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ----CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 01111223457899999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=301.90 Aligned_cols=258 Identities=24% Similarity=0.319 Sum_probs=198.2
Q ss_pred CcccccccccCCceeEEEEE-eCCCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeec------CceE
Q 004264 447 HFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE------DERM 518 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~------~~~~ 518 (765)
-|...+.||+|+||.||+|+ ...|+.||||.+.+. .....+...+|+++|++|+|+|||++++.=.+. ...+
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 45566789999999999999 457999999999764 344456778999999999999999999875543 3678
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEe--cCCC--Ceeccccc
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD--INLN--PKISDFGL 594 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~--vkL~DFGl 594 (765)
+|||||.+|+|...+....+...+++.+.+.++.++..||.|||+++ |+||||||.||++- ++|+ -||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999988877788999999999999999999999999 99999999999984 3343 59999999
Q ss_pred ceeeCCCCcccccccccccccccCccccc-CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC
Q 004264 595 ARIFGGDDEEAQTERVAGTHGYMSPEYAN-DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR 673 (765)
Q Consensus 595 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 673 (765)
|+.+.... .....+||..|++||.+. .+.|+..+|.||||+++|+++||..||..........-+.|.....+...
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 99875433 455789999999999998 58899999999999999999999999975543321111111111111111
Q ss_pred cccccccccc------------CccCHHHHHHHHHHHHHccccCCCCCC
Q 004264 674 ALGLMDTCLE------------DSFVESQVLRCIQVGLLCVQKLPEDRP 710 (765)
Q Consensus 674 ~~~l~d~~l~------------~~~~~~~~~~l~~li~~cl~~dP~~RP 710 (765)
+.....+..+ .+.......++-+....+|..+|++|-
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1111111111 122334455666777788888888888
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=290.46 Aligned_cols=268 Identities=24% Similarity=0.291 Sum_probs=196.2
Q ss_pred HHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecC----
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED---- 515 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~---- 515 (765)
...++|++.+.||+|+||.||+|..+ +++.+++|++.... ......+.+|+.++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 57899999986432 223456778999999999999999999987655
Q ss_pred ------ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCee
Q 004264 516 ------ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKI 589 (765)
Q Consensus 516 ------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL 589 (765)
..++|+||+++ ++...+... ...+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999987 555555322 345899999999999999999999998 999999999999999999999
Q ss_pred cccccceeeCCCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHh
Q 004264 590 SDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLL 668 (765)
Q Consensus 590 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~ 668 (765)
+|||++......... ......++..|+|||.+.+ ..++.++||||||++++||++|+.||...........+......
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 999999876433221 1112345778999998865 45789999999999999999999998643322111111110000
Q ss_pred hccCCcccc--------cc------ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 669 WNDGRALGL--------MD------TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 669 ~~~~~~~~l--------~d------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
........+ .+ ....... ......+.+++..||+.+|.+||++.+|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000000 00 0000000 0123467899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=288.73 Aligned_cols=245 Identities=24% Similarity=0.339 Sum_probs=196.5
Q ss_pred ccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCCCh
Q 004264 451 ANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSL 529 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gsL 529 (765)
..+||+|+||.||++.. .+++.+|+|++..........+.+|+.++++++|+|++++++.+...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35799999999999986 47889999998665555667799999999999999999999999999999999999999999
Q ss_pred hHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccccccc
Q 004264 530 DYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTER 609 (765)
Q Consensus 530 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~ 609 (765)
.+++.. ..+++..+..++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||++........ ....
T Consensus 105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~ 175 (292)
T cd06657 105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS 175 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence 987732 34789999999999999999999998 99999999999999999999999999876543221 1223
Q ss_pred ccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHH
Q 004264 610 VAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVES 689 (765)
Q Consensus 610 ~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 689 (765)
..++..|+|||++.+..++.++|+||+|+++|+|++|+.||........ .. ....... ..+. ....
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~----~~~~~~~-----~~~~--~~~~ 241 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MK----MIRDNLP-----PKLK--NLHK 241 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH----HHHhhCC-----cccC--Cccc
Confidence 5688899999999888899999999999999999999999864322111 11 0101100 0000 0011
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 690 QVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 690 ~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
....+.+++.+||+.+|.+||++.++++.
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 23356788999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=291.75 Aligned_cols=261 Identities=23% Similarity=0.281 Sum_probs=192.7
Q ss_pred cccccC--CceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCC
Q 004264 452 NMIGKG--GFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G--~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
..||+| +||+||++++ ..++.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457777 8999999986 47899999998643 233457788999999999999999999999999999999999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 606 (765)
++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++++||+.+...........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99998885432 235889999999999999999999998 99999999999999999999999986543321111100
Q ss_pred -----cccccccccccCcccccCC--CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH-------------
Q 004264 607 -----TERVAGTHGYMSPEYANDG--TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAW------------- 666 (765)
Q Consensus 607 -----~~~~~gt~~Y~aPE~~~~~--~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~------------- 666 (765)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||........ ......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccc
Confidence 1112345679999999764 478999999999999999999999864332110 000000
Q ss_pred ---Hhh----------------ccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 667 ---LLW----------------NDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 667 ---~~~----------------~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
... ..+....+.+..+...........+.+++.+||+.||++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 0000001111111222233455678999999999999999999999843
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=284.01 Aligned_cols=265 Identities=25% Similarity=0.360 Sum_probs=204.2
Q ss_pred CcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhc--cccCceEeeeeeeeecC----ceEEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGK--LQHRNLVGLLGSCIEED----ERMLI 520 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~--l~h~niv~~~~~~~~~~----~~~lV 520 (765)
.....++||+|.||.||||.+. ++.||||++.. +..+.|++|-+|... ++|+||++++++-.... .++||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 3445678999999999999985 49999999964 455678889888887 57999999999876555 88999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcC------CCcEEecccCCCcEEEecCCCCeeccccc
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS------KLQVIHRDLKASNILLDINLNPKISDFGL 594 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~------~~~ivH~Dlkp~NIll~~~~~vkL~DFGl 594 (765)
+||-+.|+|-+++.. ..++|....+|+..|++||+|||+.- +.+|+|||||.+||||.+|++..|+|||+
T Consensus 287 t~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999943 45899999999999999999999863 45699999999999999999999999999
Q ss_pred ceeeCCCCcccccccccccccccCcccccCCC-CC-----ccccchHHHHHHHHHHhCCCCCCC-CCCCCccc-------
Q 004264 595 ARIFGGDDEEAQTERVAGTHGYMSPEYANDGT-IS-----MKSDVFSLGVLLVEIVSGKMNRGF-RHPGHRHN------- 660 (765)
Q Consensus 595 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-----~k~DvwSlG~ll~elltG~~p~~~-~~~~~~~~------- 660 (765)
|..+.........-..+||.+|||||++.+.. +. .+.||||+|.|||||++.-.-... ..++-...
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 99998766666666689999999999997653 22 358999999999999996544421 11111111
Q ss_pred --HHHHHHHhh-ccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 004264 661 --LIGHAWLLW-NDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDG 723 (765)
Q Consensus 661 --~~~~~~~~~-~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 723 (765)
-.+..+... ++.....+.+...+. ..+.-+.+.+..||..||+-|.|+.=|-+.+.+..
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 112222222 222222333332221 23556778899999999999999999988887644
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=296.91 Aligned_cols=265 Identities=26% Similarity=0.321 Sum_probs=200.8
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecC-----ceE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED-----ERM 518 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~-----~~~ 518 (765)
+|.+.+.||+|++|.||+++.. .++.+++|++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788899999999999999975 48899999987643 445578899999999999999999999998775 789
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
+||||+++ +|.+++.. ...+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 77777743 236899999999999999999999999 999999999999999999999999999986
Q ss_pred CCCCcc-cccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHh--------
Q 004264 599 GGDDEE-AQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLL-------- 668 (765)
Q Consensus 599 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~-------- 668 (765)
...... .......++..|+|||++.+. .++.++||||||+++++|++|+.||......+....+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 543210 122345678899999999887 8899999999999999999999998655432111110000000
Q ss_pred hccCCccccccccc-c-----CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 669 WNDGRALGLMDTCL-E-----DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 669 ~~~~~~~~l~d~~l-~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.........+.... . ..........+.+++.+||+.+|++||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000000000 0 00111134567899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=285.57 Aligned_cols=246 Identities=27% Similarity=0.334 Sum_probs=196.7
Q ss_pred cccCCceeEEEEEeC-CCcEEEEEEccccCh---hhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCCCh
Q 004264 454 IGKGGFGPVYMGKLS-TGQEIAAKRLSKNSG---QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSL 529 (765)
Q Consensus 454 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gsL 529 (765)
||+|+||.||+++.. +++.+++|.+..... ...+.+.+|+.++++++|+||+++++.+..+...++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999875433 4566788999999999999999999999999999999999999999
Q ss_pred hHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc------
Q 004264 530 DYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE------ 603 (765)
Q Consensus 530 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~------ 603 (765)
.+++... ..+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9988542 25899999999999999999999998 99999999999999999999999999886533211
Q ss_pred ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
........++..|+|||.......+.++||||||+++++|++|+.||....+.. .......+... ...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~-~~~---- 222 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-------IFQNILNGKIE-WPE---- 222 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCcC-CCc----
Confidence 112234567888999999998889999999999999999999999986443221 11111111110 000
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
.......+.+++.+|++.+|.+||++.++.+.|+
T Consensus 223 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 223 ---DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ---cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0012456789999999999999999977777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=282.60 Aligned_cols=244 Identities=25% Similarity=0.258 Sum_probs=189.9
Q ss_pred cccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHH-hccccCceEeeeeeeeecCceEEEEEecCC
Q 004264 452 NMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLI-GKLQHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l-~~l~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
+.||+|+||.||+|... +++.+|+|.+.+.. ......+..|..++ ..++|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999864 58899999987542 22233445555444 445899999999999999999999999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 606 (765)
++|..++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999999843 345889999999999999999999998 99999999999999999999999999886432
Q ss_pred cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCcc
Q 004264 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSF 686 (765)
Q Consensus 607 ~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 686 (765)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||....... .......+... .....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~------~~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-------VFDNILSRRIN------WPEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcccC------CCCcc
Confidence 223567889999999998889999999999999999999999986433211 11111111110 00011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 687 VESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 687 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
.......+.+++.+||+.+|++||++.++.+.|+
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 1123456789999999999999998877766664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=291.74 Aligned_cols=264 Identities=25% Similarity=0.325 Sum_probs=197.1
Q ss_pred HHHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeee-cCce
Q 004264 442 TTATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE-EDER 517 (765)
Q Consensus 442 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~-~~~~ 517 (765)
..++++|++.+.||+|+||.||++... +++.+|+|++.+. .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346789999999999999999999854 7889999988643 22345678899999999999999999999876 5678
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
++|+||+ +++|..++. ...+++..+..++.||+.||.|||+.+ |+|+||+|+||++++++.+||+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 457877763 234788888999999999999999999 99999999999999999999999999875
Q ss_pred eCCCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHH--------HHHHHh
Q 004264 598 FGGDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLI--------GHAWLL 668 (765)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~--------~~~~~~ 668 (765)
... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+ ......
T Consensus 158 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 421 1123456788999998866 56899999999999999999999998644321100000 000000
Q ss_pred hccCCcccccccccc-CccCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 669 WNDGRALGLMDTCLE-DSFVE-----SQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 669 ~~~~~~~~l~d~~l~-~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...++..+++..... ...+. .....+.+++.+|++.+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 001111111111000 01111 123568899999999999999999999866
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=286.88 Aligned_cols=249 Identities=27% Similarity=0.351 Sum_probs=201.7
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccc-cCceEeeeeeeeecCceEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~~~lV 520 (765)
++|.+.+.||+|+||.||++... +++.+++|++.+. .....+.+.+|+.++++++ |+||+++++.+...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999865 6889999998753 2334567889999999998 99999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999988532 36899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCcc------------------cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHH
Q 004264 601 DDEE------------------AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLI 662 (765)
Q Consensus 601 ~~~~------------------~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~ 662 (765)
.... .......++..|+|||.+....++.++||||||++++++++|+.|+........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---- 230 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT---- 230 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH----
Confidence 3221 122245678899999999988899999999999999999999999864432110
Q ss_pred HHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 004264 663 GHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDM----SSVVF 717 (765)
Q Consensus 663 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~ 717 (765)
..... .. ....+......+.+++.+||+.+|++||++ +++++
T Consensus 231 --~~~~~-~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 --FQKIL-KL----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --HHHHH-hc----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00000 00 011112224567899999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=278.77 Aligned_cols=248 Identities=20% Similarity=0.232 Sum_probs=190.6
Q ss_pred hHHHHhcCccccccc--ccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecC
Q 004264 440 TITTATNHFSEANMI--GKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEED 515 (765)
Q Consensus 440 ~~~~~~~~y~~~~~L--G~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~ 515 (765)
+.....++|++.+.+ |+|+||.||++.. .+++.+|+|.+....... .|+.....+ +|+|++++++.+...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 344455678887777 9999999999986 467889999886532211 122222222 6999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC-CCeeccccc
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL-NPKISDFGL 594 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~vkL~DFGl 594 (765)
..++||||+++++|.+++... ..+++..+..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 999999999999999998533 36899999999999999999999999 99999999999999988 999999999
Q ss_pred ceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCc
Q 004264 595 ARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRA 674 (765)
Q Consensus 595 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (765)
++..... ....++..|+|||++.+..++.++||||||++++||++|+.||....... ........ .. ...
T Consensus 157 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~-~~--~~~ 226 (267)
T PHA03390 157 CKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLK-RQ--QKK 226 (267)
T ss_pred ceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHH-hh--ccc
Confidence 9865322 13467889999999999999999999999999999999999987433221 11111110 00 010
Q ss_pred cccccccccCccCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 004264 675 LGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPD-MSSVVF 717 (765)
Q Consensus 675 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 717 (765)
. .........+.+++.+||+.+|++||+ ++++++
T Consensus 227 ~---------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 L---------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred C---------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 111123456789999999999999996 588874
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-32 Score=284.24 Aligned_cols=263 Identities=25% Similarity=0.273 Sum_probs=195.5
Q ss_pred cccccccccCCceeEEEEEeC-CCcEEEEEEccccCh-hhHHHHHHHHHHHhccc-cCceEeeeeeeeecCceEEEEEec
Q 004264 448 FSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSG-QGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
|++.+.||+|++|.||+|... .++.+++|++..... .......+|+..+++++ |+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999975 578899999865422 22334567999999999 999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
+++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 778887775433 346899999999999999999999998 99999999999999999999999999986533211
Q ss_pred cccccccccccccCccccc-CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHH----------HHHHhhccCC
Q 004264 605 AQTERVAGTHGYMSPEYAN-DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIG----------HAWLLWNDGR 673 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~-~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~----------~~~~~~~~~~ 673 (765)
.....++..|+|||++. ...++.++|+||||++++||++|+.||......+...... +.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 22356788999999875 4568999999999999999999999886543321110000 0000000000
Q ss_pred cccccccccc---CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 674 ALGLMDTCLE---DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 674 ~~~l~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
....+..... ..........+.+++.+|++.+|++||+++|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 1000000000 00001113568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=283.40 Aligned_cols=259 Identities=23% Similarity=0.314 Sum_probs=193.8
Q ss_pred cccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhcc---ccCceEeeeeeeeecCc-----
Q 004264 448 FSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKL---QHRNLVGLLGSCIEEDE----- 516 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l---~h~niv~~~~~~~~~~~----- 516 (765)
|++.+.||+|+||.||+|+.+ +++.+|+|++.... ......+.+|+.+++++ .|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999976 48899999986432 22234566788777766 59999999999998776
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
.+++|||+.+ +|.+++.... ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 7877774322 235899999999999999999999998 9999999999999999999999999998
Q ss_pred eeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhcc-CC--
Q 004264 597 IFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWND-GR-- 673 (765)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-~~-- 673 (765)
.+..... .....++..|+|||++.+..++.++||||||+++|||++|+.||....+.+.. ......... ..
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 229 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL---DKIFDVIGLPSEEE 229 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH---HHHHHHcCCCChHh
Confidence 7643221 12345788899999999999999999999999999999999988654432211 111100000 00
Q ss_pred cc-------cccccccc---CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 674 AL-------GLMDTCLE---DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 674 ~~-------~l~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.. ........ ..........+.+++.+||+.+|.+||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 00000000 0111123456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=286.11 Aligned_cols=255 Identities=24% Similarity=0.310 Sum_probs=199.0
Q ss_pred CcccccccccCCceeEEEEEe----CCCcEEEEEEccccC----hhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCce
Q 004264 447 HFSEANMIGKGGFGPVYMGKL----STGQEIAAKRLSKNS----GQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDER 517 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~ 517 (765)
+|++.+.||+|++|.||++.. .+++.+|+|.+.+.. ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999874 356789999986432 23345688999999999 599999999999999999
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
++||||+++++|.+++.. ...+++..+..++.|++++|.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999988853 245889999999999999999999998 99999999999999999999999999887
Q ss_pred eCCCCcccccccccccccccCcccccCCC--CCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcc
Q 004264 598 FGGDDEEAQTERVAGTHGYMSPEYANDGT--ISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRAL 675 (765)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (765)
+...... ......++..|+|||.+.+.. .+.++||||||++++||++|+.||......... .......... .
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~~-~-- 228 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRRILKS-K-- 228 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHHHHcc-C--
Confidence 5433211 122356788999999987765 788999999999999999999998643222111 1111111100 0
Q ss_pred ccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 676 GLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 676 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
...+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 229 --------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 --------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 01111223457789999999999999999999888754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=285.45 Aligned_cols=252 Identities=23% Similarity=0.297 Sum_probs=195.6
Q ss_pred CcccccccccCCceeEEEEEe----CCCcEEEEEEccccC----hhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCce
Q 004264 447 HFSEANMIGKGGFGPVYMGKL----STGQEIAAKRLSKNS----GQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDER 517 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~ 517 (765)
+|++.+.||+|+||.||++.. .+++.||+|++.... ....+++.+|+.+++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999985 368899999986532 22346788899999999 599999999999999999
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
++||||+++++|.+++.. ...+++..+..++.||++||.|||+.+ ++||||+|+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999998853 245789999999999999999999998 99999999999999999999999999987
Q ss_pred eCCCCcccccccccccccccCcccccCC--CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcc
Q 004264 598 FGGDDEEAQTERVAGTHGYMSPEYANDG--TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRAL 675 (765)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (765)
....... ......++..|+|||.+.+. .++.++||||||+++|+|++|+.|+........ ............
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~--- 228 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE--- 228 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhccC---
Confidence 5332211 12235688899999998753 478899999999999999999999864322211 111111111100
Q ss_pred ccccccccCccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004264 676 GLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRP-----DMSSVVFL 718 (765)
Q Consensus 676 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 718 (765)
..++......+.+++.+|++.+|++|| ++.+++..
T Consensus 229 --------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 --------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred --------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 011122334577899999999999997 66666553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=293.17 Aligned_cols=265 Identities=21% Similarity=0.263 Sum_probs=195.9
Q ss_pred hcCccc-ccccccCCceeEEEEEeC-CCcEEEEEEccccChhh--------------HHHHHHHHHHHhccccCceEeee
Q 004264 445 TNHFSE-ANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQG--------------LEEFMNEVVLIGKLQHRNLVGLL 508 (765)
Q Consensus 445 ~~~y~~-~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~--------------~~~~~~Ev~~l~~l~h~niv~~~ 508 (765)
.++|.. .+.||+|+||.||+|... .++.||+|++....... ...+.+|+.++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 356654 567999999999999864 68899999986532211 12577899999999999999999
Q ss_pred eeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCe
Q 004264 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPK 588 (765)
Q Consensus 509 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vk 588 (765)
+++..++..++||||+. ++|.+++.. ...+++.....++.||+.||.|||+.+ |+|+||+|+||+++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999997 578777743 345889999999999999999999998 99999999999999999999
Q ss_pred ecccccceeeCCCC------------cccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCC
Q 004264 589 ISDFGLARIFGGDD------------EEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHP 655 (765)
Q Consensus 589 L~DFGla~~~~~~~------------~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~ 655 (765)
|+|||++....... .........++..|+|||.+.+. .++.++||||||+++|||++|+.||....+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999998764111 01111223467889999998764 478999999999999999999999875543
Q ss_pred CCcccHHHHHHHhhccCC---cccc--------cccccc---CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004264 656 GHRHNLIGHAWLLWNDGR---ALGL--------MDTCLE---DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719 (765)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~---~~~l--------~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 719 (765)
.+. ............ +... ...... ..........+.+++..||+.+|++||++++++..-
T Consensus 240 ~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 240 IDQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 221 111111111000 0000 000000 000111235678999999999999999999999643
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=296.70 Aligned_cols=243 Identities=24% Similarity=0.366 Sum_probs=193.1
Q ss_pred ccccccCCceeEEEEEeC-CCcEEEEEEcc--c--cChhhHHHHHHHHHHHhccccCceEeeeeeeeecCc--eEEEEEe
Q 004264 451 ANMIGKGGFGPVYMGKLS-TGQEIAAKRLS--K--NSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE--RMLIYEY 523 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~--~--~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~--~~lV~E~ 523 (765)
..+||+|+|-+||+|.+. +|.+||=-.++ + ..+...++|..|+.+|+.|+|+||++++.+..+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 457999999999999864 46566532222 1 245556899999999999999999999999987665 7789999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec-CCCCeecccccceeeCCCC
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI-NLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~vkL~DFGla~~~~~~~ 602 (765)
|..|+|..++.. .+.++...+..|++||++||.|||++. .+|||||||-+||||+. .|.|||+|+|+|.....
T Consensus 125 ~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~-- 198 (632)
T KOG0584|consen 125 FTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK-- 198 (632)
T ss_pred ccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc--
Confidence 999999999843 445888999999999999999999985 68999999999999975 58999999999998632
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
.......||+.|||||+.. ..|++.+||||||+.++||+|+..|+..-. + ..+...+...|.....+...-
T Consensus 199 --s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----n-~AQIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 199 --SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----N-PAQIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred --cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-----C-HHHHHHHHHcCCCHHHhhccC
Confidence 2333589999999999987 889999999999999999999999975321 1 122344444444333332221
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
..++.++|..||.. ..+|||+.|++.
T Consensus 270 --------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 270 --------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred --------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 22466889999999 999999999984
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=285.84 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=192.5
Q ss_pred cCcccccccccCCceeEEEEEeCC-CcEEEEEEccccC-hhhHHHHHHHHHHHhccc-cCceEeeeeeeeecCceEEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLST-GQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~~~lV~E 522 (765)
++|++.+.||+|+||.||+|.... ++.+|+|++.+.. .....++..|+.++.+++ |+||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 578889999999999999999764 8899999987543 334456777887777775 9999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhh-cCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ-DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
|+.+ ++..++... ...+++..+..++.||+.||+|||+ .+ |+||||+|+||++++++.+||+|||++..+...
T Consensus 95 ~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9854 666665332 2368999999999999999999997 46 999999999999999999999999999765332
Q ss_pred CcccccccccccccccCcccccCCC----CCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGT----ISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
... ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .+...... .......
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~-~~~~~~~ 239 (296)
T cd06618 169 KAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKIL-QEEPPSL 239 (296)
T ss_pred Ccc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHh-cCCCCCC
Confidence 211 2335778899999987553 889999999999999999999998542211 00011111 1111111
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.. ......++.+++.+||+.+|++||++.+++++
T Consensus 240 ~~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 PP-------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 10 00124567899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=296.34 Aligned_cols=265 Identities=22% Similarity=0.269 Sum_probs=193.8
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeec---------
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE--------- 514 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~--------- 514 (765)
..+|.+.+.||.|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999864 6889999998766556667889999999999999999999876653
Q ss_pred -----CceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec-CCCCe
Q 004264 515 -----DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI-NLNPK 588 (765)
Q Consensus 515 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~vk 588 (765)
...++||||++ ++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++. +..+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 47877763 235889999999999999999999998 999999999999974 56789
Q ss_pred ecccccceeeCCCCccc-ccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH-
Q 004264 589 ISDFGLARIFGGDDEEA-QTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHA- 665 (765)
Q Consensus 589 L~DFGla~~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~- 665 (765)
|+|||+++......... ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||....+..........
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999998754322111 1123457888999998754 56889999999999999999999999654321110000000
Q ss_pred -------HHhhccCCccccccccccCc-----cCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 666 -------WLLWNDGRALGLMDTCLEDS-----FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 666 -------~~~~~~~~~~~l~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
...........+........ .......++.+++.+||+.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000000000000000000 00112346779999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=269.99 Aligned_cols=272 Identities=22% Similarity=0.285 Sum_probs=198.0
Q ss_pred HhcCcccccccccCCceeEEEEEeC---C--CcEEEEEEccccCh--hhHHHHHHHHHHHhccccCceEeeeeeeee-cC
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS---T--GQEIAAKRLSKNSG--QGLEEFMNEVVLIGKLQHRNLVGLLGSCIE-ED 515 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~---~--~~~vavK~l~~~~~--~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~-~~ 515 (765)
--..|+..+.||+|.||.||+|... + .+.+|+|+++.... ..-...-+|+.+++.|+|||++.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3457899999999999999999532 2 34799999975421 123456789999999999999999999988 78
Q ss_pred ceEEEEEecCCCChhHHhhc--cccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC----CCCee
Q 004264 516 ERMLIYEYMPHKSLDYFIFD--RERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN----LNPKI 589 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~vkL 589 (765)
..+|++||.++..+ ..|.. ....+.++...+..|+.||+.|+.|||++- |+||||||.|||+..+ |.|||
T Consensus 102 ~v~l~fdYAEhDL~-~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEHDLW-HIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhhhHH-HHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 89999999988544 44432 233357899999999999999999999998 9999999999999877 89999
Q ss_pred cccccceeeCCCCc-ccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcc------cH
Q 004264 590 SDFGLARIFGGDDE-EAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRH------NL 661 (765)
Q Consensus 590 ~DFGla~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~------~~ 661 (765)
+|||+++.+...-. ......++-|..|+|||.+.+. .|+.+.|||+.|||+.||++-++.|......... ..
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 99999998854322 2244467889999999999875 6899999999999999999988887644322111 11
Q ss_pred HHHHHHhhc---cCCcccc---ccc------cccCccCHH-----------HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 662 IGHAWLLWN---DGRALGL---MDT------CLEDSFVES-----------QVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 662 ~~~~~~~~~---~~~~~~l---~d~------~l~~~~~~~-----------~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.......+. +.++..+ ++- .....++.. ......+|+..+|++||-+|.|+++.++.
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 111121111 1111111 110 000000000 01125578899999999999999998876
Q ss_pred H
Q 004264 719 L 719 (765)
Q Consensus 719 L 719 (765)
.
T Consensus 338 ~ 338 (438)
T KOG0666|consen 338 P 338 (438)
T ss_pred c
Confidence 4
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=281.61 Aligned_cols=242 Identities=28% Similarity=0.327 Sum_probs=187.0
Q ss_pred ccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHH---HHhccccCceEeeeeeeeecCceEEEEEecC
Q 004264 453 MIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVV---LIGKLQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 453 ~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~---~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
.||+|+||.||++... .++.||+|.+.+.. ......+..|.. +++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 58899999986542 122223444443 3444579999999999999999999999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 9999988743 346899999999999999999999998 9999999999999999999999999997653221
Q ss_pred ccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 606 QTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
.....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||............ ... ... ..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~-~~~---------~~ 216 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMT-LTM---------AV 216 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHh-hcc---------CC
Confidence 1235689999999999754 6899999999999999999999998754332211110 000 000 01
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRP-----DMSSVVFL 718 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 718 (765)
..+......+.+++.+|++.+|.+|| ++.++++.
T Consensus 217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 11112245688999999999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=290.89 Aligned_cols=266 Identities=23% Similarity=0.298 Sum_probs=193.1
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHhccccCceEeeeeeeeecC------
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSG--QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED------ 515 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~------ 515 (765)
.++|++.+.||+|+||.||+|... +++.+++|++..... .....+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999864 688999998864322 22346778999999999999999999876544
Q ss_pred --ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccc
Q 004264 516 --ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFG 593 (765)
Q Consensus 516 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFG 593 (765)
..++|+||+.+ +|...+.. ....+++..+..++.||++||.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 45899999976 45555432 2346899999999999999999999999 9999999999999999999999999
Q ss_pred cceeeCCCCccc---------ccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHH
Q 004264 594 LARIFGGDDEEA---------QTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIG 663 (765)
Q Consensus 594 la~~~~~~~~~~---------~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~ 663 (765)
++.......... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....+......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 998654322111 1123456888999998865 458999999999999999999999986543321111111
Q ss_pred HHHHhhccC------Cccccc--------cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 664 HAWLLWNDG------RALGLM--------DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 664 ~~~~~~~~~------~~~~l~--------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
......... ...... .+.+.. ........+.+++.+|++.+|++|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000000 000000 000000 00112256889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-33 Score=274.78 Aligned_cols=242 Identities=25% Similarity=0.331 Sum_probs=198.2
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
..++|..+++||+|.||+|.+++.+ .++.+|+|++++.. ..+...-+.|-.+|+..+||.+..+-..|...++.++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 4478888999999999999999854 78999999998763 3445556779999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||..||.|..++ .+...+++.....+...|+.||.|||+.+ ||+||||.+|+|+|.+|++||+|||+++.-.
T Consensus 246 VMeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999998887 34556888888899999999999999998 9999999999999999999999999998532
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
.....+..++||+.|+|||++....|..++|.|.+|+++|||++|+.||...+.+....++- ..+
T Consensus 320 --~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl-----~ed-------- 384 (516)
T KOG0690|consen 320 --KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL-----MED-------- 384 (516)
T ss_pred --cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH-----hhh--------
Confidence 22334557999999999999999999999999999999999999999997544332211110 000
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCC
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRP 710 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 710 (765)
-.++.....+...|+...|..||.+|.
T Consensus 385 ----~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 385 ----LKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ----ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 012223334455677788899999996
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=294.83 Aligned_cols=263 Identities=22% Similarity=0.309 Sum_probs=193.8
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecC------
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED------ 515 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~------ 515 (765)
.++|.+.+.||+|+||.||+|+. .+++.+|+|++.+. .......+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999986 46899999998653 2223456889999999999999999999987543
Q ss_pred ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccc
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA 595 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla 595 (765)
..++|+||+.. +|..++ ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999864 565544 235889999999999999999999998 999999999999999999999999998
Q ss_pred eeeCCCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHH--------HH
Q 004264 596 RIFGGDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGH--------AW 666 (765)
Q Consensus 596 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~--------~~ 666 (765)
+.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.. ..
T Consensus 165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 165 RHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred cCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 76422 1123467888999999876 4689999999999999999999999975432111000000 00
Q ss_pred HhhccCCcccccc---ccccCccC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhc
Q 004264 667 LLWNDGRALGLMD---TCLEDSFV---ESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL--LAN 721 (765)
Q Consensus 667 ~~~~~~~~~~l~d---~~l~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~ 721 (765)
............. ........ ......+.+++.+||+.+|++||++.+++.. ++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~ 302 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhh
Confidence 0000000000000 00000000 0123457799999999999999999999854 544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=280.31 Aligned_cols=250 Identities=28% Similarity=0.345 Sum_probs=194.8
Q ss_pred CcccccccccCCceeEEEEEeCC-CcEEEEEEcccc-----ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLST-GQEIAAKRLSKN-----SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
+|.+.+.||+|+||.||+++... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58888999999999999998643 344555554421 222345677899999999999999999999999999999
Q ss_pred EEecCCCChhHHhhcc-ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 521 YEYMPHKSLDYFIFDR-ERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
+||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++. +.+||+|||.++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888542 33456899999999999999999999998 999999999999975 569999999998764
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
.... ......++..|+|||.+.+..++.++|+||||+++++|++|+.|+..... ..... ....+..
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~-~~~~~~~----- 222 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVL-RIVEGPT----- 222 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHH-HHHcCCC-----
Confidence 3222 22245678899999999888899999999999999999999999853221 11111 1111111
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...+......+.+++.+|++.+|++||++.++++.
T Consensus 223 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 223 ----PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ----CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11222344568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-33 Score=321.15 Aligned_cols=255 Identities=25% Similarity=0.355 Sum_probs=204.3
Q ss_pred HHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
..+-+|.-...||.|.||.||.|.. .+|.-.|+|.+.-. .........+|+.++..|+|||+|+++|+=.+++..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 3445677778899999999999985 56777888876532 34456678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
.||||++|+|.+++. .++..++.....+..|++.|++|||+.| ||||||||.||+|+.+|.+|++|||.|..+.
T Consensus 1312 FMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence 999999999999984 3444677777788999999999999999 9999999999999999999999999999885
Q ss_pred CCCc--ccccccccccccccCcccccCCC---CCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCc
Q 004264 600 GDDE--EAQTERVAGTHGYMSPEYANDGT---ISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRA 674 (765)
Q Consensus 600 ~~~~--~~~~~~~~gt~~Y~aPE~~~~~~---~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (765)
.... ........||+.|||||++.+.. ...++||||+|||+.||+||++||...+.... + .....-|.
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a---I---My~V~~gh- 1458 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA---I---MYHVAAGH- 1458 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH---H---HhHHhccC-
Confidence 4421 22334578999999999997643 56789999999999999999999875443321 1 11111222
Q ss_pred cccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 675 LGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 675 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.++++.....+-.+++..||+.||.+|.++.|+++.
T Consensus 1459 --------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 --------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 233444445566789999999999999999988765
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=293.29 Aligned_cols=267 Identities=22% Similarity=0.280 Sum_probs=197.0
Q ss_pred HhHHHHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeec-
Q 004264 439 ATITTATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE- 514 (765)
Q Consensus 439 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~- 514 (765)
.++....++|++.+.||+|+||.||++.. .+++.||+|++.+.. ....+.+.+|+.++++++|+||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 45566789999999999999999999985 568899999987532 23356788899999999999999999987643
Q ss_pred -----CceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCee
Q 004264 515 -----DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKI 589 (765)
Q Consensus 515 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL 589 (765)
...+++++++ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 3467788876 7788777632 34889999999999999999999999 999999999999999999999
Q ss_pred cccccceeeCCCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHH----
Q 004264 590 SDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGH---- 664 (765)
Q Consensus 590 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~---- 664 (765)
+|||++..... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..
T Consensus 162 ~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 162 LDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred ecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999886422 1223567889999999876 5688999999999999999999999854332111000000
Q ss_pred ----HHHhhccCCccc---cccccccCccC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 665 ----AWLLWNDGRALG---LMDTCLEDSFV---ESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 665 ----~~~~~~~~~~~~---l~d~~l~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
............ .+......... ......+.+++.+|++.+|++||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000000000 00000000000 0123457899999999999999999999854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=285.55 Aligned_cols=247 Identities=28% Similarity=0.377 Sum_probs=194.5
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
+.|+..+.||+|+||.||+|+.. +++.+++|++... .....+++.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45777889999999999999864 5778999988642 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+. +++.+.+... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 5776665432 245889999999999999999999998 999999999999999999999999999865321
Q ss_pred CcccccccccccccccCccccc---CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYAN---DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
....++..|+|||.+. ...++.++||||||+++|+|++|+.|+........ . .....+....
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~-~~~~~~~~~~-- 233 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------L-YHIAQNESPA-- 233 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------H-HHHhhcCCCC--
Confidence 2356788999999974 35688899999999999999999999754321110 0 0111111100
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 719 (765)
.........+.+++.+||+.+|++||++.+|++.-
T Consensus 234 ------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 234 ------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred ------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 01112345578999999999999999999999774
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=285.01 Aligned_cols=244 Identities=28% Similarity=0.399 Sum_probs=191.3
Q ss_pred cccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 448 FSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
|...+.||+|+||.||+|+.. .++.+++|++... .....+.+.+|+.++++++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666778999999999999864 6888999998643 223446788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+.+ ++.+++.. ....+++..+..++.||+.+|.|||+.+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 103 ~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~---- 172 (313)
T cd06633 103 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS---- 172 (313)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence 964 66565532 2345899999999999999999999998 9999999999999999999999999986432
Q ss_pred ccccccccccccccCccccc---CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYAN---DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~---~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
......++..|+|||++. ...++.++||||||+++|+|++|+.|+........ ..... ........
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~~~-~~~~~~~~-- 241 (313)
T cd06633 173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIA-QNDSPTLQ-- 241 (313)
T ss_pred --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHH-hcCCCCCC--
Confidence 122456888999999984 46688999999999999999999999754332111 11111 11111111
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.......+.+++.+||+.+|++||++.++++.
T Consensus 242 ------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 ------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122357789999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=290.48 Aligned_cols=264 Identities=23% Similarity=0.280 Sum_probs=190.9
Q ss_pred CcccccccccCCceeEEEEEeC-C--CcEEEEEEcccc--ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeec----Cc
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-T--GQEIAAKRLSKN--SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEE----DE 516 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~--~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~----~~ 516 (765)
+|++.+.||+|+||.||++... . ++.+|+|++... .....+.+.+|+.+++++ +|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999864 3 678999998643 222356788899999999 599999999875432 45
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
.++++||+. ++|.+.+.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888886 578777742 345899999999999999999999999 9999999999999999999999999998
Q ss_pred eeCCCCcc--cccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHH--------H
Q 004264 597 IFGGDDEE--AQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGH--------A 665 (765)
Q Consensus 597 ~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~--------~ 665 (765)
.+...... .......++..|+|||++.+ ..++.++||||||+++|+|++|+.||...........+.. .
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 76432211 11224578999999998765 5689999999999999999999999865432111000000 0
Q ss_pred HHhhccCCcccc---cccccc---CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 666 WLLWNDGRALGL---MDTCLE---DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 666 ~~~~~~~~~~~l---~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
............ ...... ..........+.+++.+|++.+|++|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000 000000 0000111346789999999999999999999873
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=270.81 Aligned_cols=254 Identities=22% Similarity=0.284 Sum_probs=198.2
Q ss_pred cccccCCceeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHhccc-cCceEeeeeeeeecCceEEEEEecCCCCh
Q 004264 452 NMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDERMLIYEYMPHKSL 529 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~~~lV~E~~~~gsL 529 (765)
+.||+|+++.|-.+. +.++.+||||++.+.......+..+|++++.+.+ |+||++++++|.++...|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 579999999998886 6789999999999988888889999999999986 99999999999999999999999999999
Q ss_pred hHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCC---CeecccccceeeCCCC----
Q 004264 530 DYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLN---PKISDFGLARIFGGDD---- 602 (765)
Q Consensus 530 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---vkL~DFGla~~~~~~~---- 602 (765)
..+|..+ ..+++.++.++.++|+.||.+||.+| |.||||||+|||-....+ |||+||.+..-.....
T Consensus 164 LshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQKR---KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 9999654 35899999999999999999999999 999999999999976554 7999999875432111
Q ss_pred -cccccccccccccccCccccc-----CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccH--------HHHHHHh
Q 004264 603 -EEAQTERVAGTHGYMSPEYAN-----DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNL--------IGHAWLL 668 (765)
Q Consensus 603 -~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~--------~~~~~~~ 668 (765)
........+|+..|||||+.. ...|+.++|.||||+|||-|++|..||...-..+...- ......-
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 111223578899999999752 24689999999999999999999999987654333111 1111222
Q ss_pred hccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 669 WNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 669 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
..+|. .+++|.-.. ....+..+++...+..++.+|.++.+++.
T Consensus 318 IQEGk-YeFPdkdWa-----hIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 318 IQEGK-YEFPDKDWA-----HISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HhccC-CcCChhhhH-----HhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 22222 122222110 11334556777888899999999998876
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=291.43 Aligned_cols=262 Identities=21% Similarity=0.283 Sum_probs=194.9
Q ss_pred HHHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecC---
Q 004264 442 TTATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED--- 515 (765)
Q Consensus 442 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~--- 515 (765)
-...++|++.+.||+|+||.||++.. .+++.||+|++... .......+.+|+.++++++|+||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34567899999999999999999985 47889999998643 2334567889999999999999999999887654
Q ss_pred ---ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccc
Q 004264 516 ---ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDF 592 (765)
Q Consensus 516 ---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DF 592 (765)
..++||||+ +++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 358999998 6788877732 35899999999999999999999998 999999999999999999999999
Q ss_pred ccceeeCCCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHH--------H
Q 004264 593 GLARIFGGDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLI--------G 663 (765)
Q Consensus 593 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~--------~ 663 (765)
|++..... ......++..|+|||.+.+ ..++.++|+||||+++++|++|+.||...........+ .
T Consensus 163 g~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 163 GLARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99986532 1223467889999999876 45889999999999999999999998643321100000 0
Q ss_pred HHHHhhccCCccccccccc--cC----ccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 004264 664 HAWLLWNDGRALGLMDTCL--ED----SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVV 716 (765)
Q Consensus 664 ~~~~~~~~~~~~~l~d~~l--~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 716 (765)
................... .. .........+.+++.+|++.+|++|||+.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 0000000000000000000 00 00011233577999999999999999999998
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=281.45 Aligned_cols=262 Identities=25% Similarity=0.305 Sum_probs=197.4
Q ss_pred cccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 448 FSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
|+..+.||+|++|.||+|+.. +++.+++|++.... ....+.+..|+.++++++|+|++++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999875 58899999987653 333567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
+ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 58988885432 45899999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHH--------HHHHhhccCC-c
Q 004264 605 AQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIG--------HAWLLWNDGR-A 674 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~--------~~~~~~~~~~-~ 674 (765)
......++..|+|||.+.+. .++.++||||||++++||++|+.||...........+. ..+.....-. .
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 12234456789999998776 78999999999999999999999986543211100000 0000000000 0
Q ss_pred cccccccccC---ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 675 LGLMDTCLED---SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 675 ~~l~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.......... .........+.+++..||+.+|++||++++|+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000 000112456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=308.11 Aligned_cols=261 Identities=23% Similarity=0.255 Sum_probs=208.8
Q ss_pred chHhHHHHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeee
Q 004264 437 DLATITTATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512 (765)
Q Consensus 437 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~ 512 (765)
...+++...++|.|+++||+|+||.|..++.+ .++.||+|++++. .......|..|-.+|..-..+-|+.++.+|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 35566777899999999999999999999864 6888999999873 3445567899999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccc
Q 004264 513 EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDF 592 (765)
Q Consensus 513 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DF 592 (765)
+..++|+|||||+||+|-.++.. ...+++..+..++..|+.||.-||+.| +|||||||+|||||..|++||+||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred CccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 99999999999999999988832 236999999999999999999999999 999999999999999999999999
Q ss_pred ccceeeCCCCcccccccccccccccCccccc----C-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 004264 593 GLARIFGGDDEEAQTERVAGTHGYMSPEYAN----D-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWL 667 (765)
Q Consensus 593 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~ 667 (765)
|.+-.+.... .......+|||.|++||+++ + +.|++.+|.||+||++|||+.|..||.... +.+.-..
T Consensus 220 GsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~K 292 (1317)
T KOG0612|consen 220 GSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGK 292 (1317)
T ss_pred hhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHH
Confidence 9998775433 33444689999999999996 2 579999999999999999999999996432 2222222
Q ss_pred hhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 004264 668 LWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPD---MSSVVFL 718 (765)
Q Consensus 668 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 718 (765)
..+......+++.. ..+....+||...+. +|+.|.. ++++...
T Consensus 293 Im~hk~~l~FP~~~-------~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 293 IMNHKESLSFPDET-------DVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred HhchhhhcCCCccc-------ccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 22222222233111 134455566666665 7888888 8887654
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=286.06 Aligned_cols=243 Identities=26% Similarity=0.374 Sum_probs=195.1
Q ss_pred ccccccCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCC
Q 004264 451 ANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHK 527 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~g 527 (765)
.+.||+|-||+||-|+. +.|+.||||++.+- ......++++|+.||++++||.||.+...|...+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 47899999999999985 57999999999764 3445688999999999999999999999999999999999999776
Q ss_pred ChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC---CCCeecccccceeeCCCCcc
Q 004264 528 SLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN---LNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 528 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~vkL~DFGla~~~~~~~~~ 604 (765)
-|+-++... .+.+++.....++.||+.||.|||.++ |+|+||||+|||+.+. -++||+|||+|++++....
T Consensus 649 MLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 649 MLEMILSSE--KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred HHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 666555332 345888888999999999999999999 9999999999999654 4699999999999865443
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
...++||+.|+|||+++...|+..-|+||.|+|+|.-++|..||.... +....++.+...+....+
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW---------- 788 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPW---------- 788 (888)
T ss_pred --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCch----------
Confidence 335799999999999999999999999999999999999999986432 222223222221111111
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVV 716 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 716 (765)
.+.....+++|...||...++|-|..+-+
T Consensus 789 ---~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 789 ---SEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred ---hhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 11233566888888999999998877654
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=261.80 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=194.0
Q ss_pred cccccccccCCceeEEEEEe-CCCcEEEEEEcccc-ChhhHHHHHHHHHHHhccc-cCceEeeeeeeeecCceEEEEEec
Q 004264 448 FSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
.+.+..||.|..|.|++++. ..|+.+|||.+.+. +..+.++++..+.++.+-+ +|+||+.+|+|.......+.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 34466799999999999986 46899999999875 4556778888888887765 899999999999999999999988
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
.- -++.++.. -.+++++..+-++...++.||.||.++. .|+|||+||+|||+|+.|++||+|||++-++...
T Consensus 174 s~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--- 245 (391)
T KOG0983|consen 174 ST-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--- 245 (391)
T ss_pred HH-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc---
Confidence 43 34444432 2356899999999999999999998765 5999999999999999999999999999876432
Q ss_pred cccccccccccccCcccccC---CCCCccccchHHHHHHHHHHhCCCCCCCCCCC-CcccHHHHHHHhhccCCccccccc
Q 004264 605 AQTERVAGTHGYMSPEYAND---GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPG-HRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~---~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
...+...|-+.|||||.+.- ..|+.++||||||+.|+||.||+.|+.....+ +....+ . +.. + +
T Consensus 246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv------l-n~e----P-P 313 (391)
T KOG0983|consen 246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV------L-NEE----P-P 313 (391)
T ss_pred cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH------H-hcC----C-C
Confidence 23345678899999998853 46899999999999999999999998754322 111111 1 111 1 2
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
++.+.. .....+++++..||+.|+.+||...++++.
T Consensus 314 ~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 314 LLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 222221 145567899999999999999999998853
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=292.55 Aligned_cols=263 Identities=23% Similarity=0.313 Sum_probs=196.9
Q ss_pred HHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCc---
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE--- 516 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~--- 516 (765)
...++|++.+.||+|++|.||+|+.. +++.+|+|++... .....+.+.+|+.++++++|+|++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999875 5788999998653 23344667889999999999999999998876654
Q ss_pred ---eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccc
Q 004264 517 ---RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFG 593 (765)
Q Consensus 517 ---~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFG 593 (765)
.++|+||+ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 5688888743 45899999999999999999999998 9999999999999999999999999
Q ss_pred cceeeCCCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHH--------
Q 004264 594 LARIFGGDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGH-------- 664 (765)
Q Consensus 594 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~-------- 664 (765)
++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 99865322 223467888999999865 4678999999999999999999999864332111000000
Q ss_pred HHHhhccCCcccccccccc---Ccc---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 665 AWLLWNDGRALGLMDTCLE---DSF---VESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 665 ~~~~~~~~~~~~l~d~~l~---~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
....+........+..... ... .......+.+++.+|++.+|++|||+.+|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000000000000000000 000 01124568899999999999999999999763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=271.53 Aligned_cols=269 Identities=23% Similarity=0.343 Sum_probs=207.9
Q ss_pred HHHHhcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhc--cccCceEeeeeeeeecC---
Q 004264 441 ITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGK--LQHRNLVGLLGSCIEED--- 515 (765)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~--l~h~niv~~~~~~~~~~--- 515 (765)
.++..++..+.+.||+|.||.||+|.+ .|..||||++.... ++...+|.+|++. |+|+||+.+++.-..+.
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred HHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 345667888999999999999999998 48899999997543 3567788888877 69999999998876544
Q ss_pred -ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhc-----CCCcEEecccCCCcEEEecCCCCee
Q 004264 516 -ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD-----SKLQVIHRDLKASNILLDINLNPKI 589 (765)
Q Consensus 516 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~vkL 589 (765)
+++||++|-++|||.+++.. ..++....++++..+|.||++||-+ |+..|.|||||.+|||+..++..-|
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 68899999999999999943 4689999999999999999999974 6778999999999999999999999
Q ss_pred cccccceeeCCCCc--ccccccccccccccCcccccCCC----C-C-ccccchHHHHHHHHHHh----------CCCCCC
Q 004264 590 SDFGLARIFGGDDE--EAQTERVAGTHGYMSPEYANDGT----I-S-MKSDVFSLGVLLVEIVS----------GKMNRG 651 (765)
Q Consensus 590 ~DFGla~~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~~~----~-s-~k~DvwSlG~ll~ellt----------G~~p~~ 651 (765)
+|+|+|-....... ....+..+||.+|||||++...- + + ..+||||||.|+||+.. -+.||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 99999988754422 22334678999999999986432 2 2 35999999999999976 234555
Q ss_pred CCCCCCcccHHHHHHHhhccCCccccccccc-cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 004264 652 FRHPGHRHNLIGHAWLLWNDGRALGLMDTCL-EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDG 723 (765)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 723 (765)
...|.+... +......-..+ +.+.+ +...+.+.+..+.++|..||..+|.-|-|+-.|.+.|.+..
T Consensus 438 d~Vp~DPs~--eeMrkVVCv~~----~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 438 DVVPSDPSF--EEMRKVVCVQK----LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred cCCCCCCCH--HHHhcceeecc----cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 444433211 11111111111 11222 23345577888999999999999999999999999997754
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=262.94 Aligned_cols=254 Identities=22% Similarity=0.225 Sum_probs=197.0
Q ss_pred HhcCcccc-cccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhcc-ccCceEeeeeeeee----cCc
Q 004264 444 ATNHFSEA-NMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIE----EDE 516 (765)
Q Consensus 444 ~~~~y~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~----~~~ 516 (765)
.+++|++. ++||-|-.|.|..+..+ .++.+|+|++... ...++|+++.-+. .|||||.++++|.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45677765 57999999999998754 6888999998643 3566888887776 59999999998764 456
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec---CCCCeecccc
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI---NLNPKISDFG 593 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~vkL~DFG 593 (765)
+++|||.|+||.|...+.++. .+.+.+.++-.|++||+.|+.|||+.+ |.||||||+|+|... +..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 789999999999988886543 456999999999999999999999999 999999999999964 4568999999
Q ss_pred cceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC
Q 004264 594 LARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR 673 (765)
Q Consensus 594 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 673 (765)
+|+... ........+-|+.|.|||++...+|+..+|+||+|+++|-|++|.+||...+..-. .--.......|.
T Consensus 210 FAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---spgMk~rI~~gq 283 (400)
T KOG0604|consen 210 FAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKRRIRTGQ 283 (400)
T ss_pred cccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---ChhHHhHhhccC
Confidence 999753 23444567889999999999999999999999999999999999999976543110 000011111111
Q ss_pred ccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 674 ALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 674 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.+++++ ++ ...++...++|+.+|..+|.+|.|+++++..
T Consensus 284 -y~FP~p----EW-s~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 -YEFPEP----EW-SCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred -ccCCCh----hH-hHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 111111 11 1234567789999999999999999999854
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=273.17 Aligned_cols=271 Identities=19% Similarity=0.216 Sum_probs=206.5
Q ss_pred cchHhHHHHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccc--cC----ceEeee
Q 004264 436 YDLATITTATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ--HR----NLVGLL 508 (765)
Q Consensus 436 ~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~--h~----niv~~~ 508 (765)
+.+...+..+.+|++...+|+|.||.|-.+.+. .+..||+|+++ ......+..+-|+++|+++. .| -+|++.
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik-~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK-NVDKYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHH-HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 344444556889999999999999999999754 35778888874 44555677888999999994 23 389999
Q ss_pred eeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec-----
Q 004264 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI----- 583 (765)
Q Consensus 509 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~----- 583 (765)
++|...++.++|+|.+ |.|+.+++... ...+++...+..|+.|+++++++||+.+ ++|-||||+|||+.+
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEE
Confidence 9999999999999998 55888888543 3456899999999999999999999999 999999999999942
Q ss_pred ---------------CCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCC
Q 004264 584 ---------------NLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKM 648 (765)
Q Consensus 584 ---------------~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~ 648 (765)
+..++|+|||.|..- +......+.|..|.|||++.+-.++.++||||+||||.|+.+|..
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~-----~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~ 307 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFD-----HEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET 307 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCccee-----ccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence 234899999999874 233356889999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcccHHHH--------------HHHhhccCCcc-----------cccccccc----CccCHHHHHHHHHHHH
Q 004264 649 NRGFRHPGHRHNLIGH--------------AWLLWNDGRAL-----------GLMDTCLE----DSFVESQVLRCIQVGL 699 (765)
Q Consensus 649 p~~~~~~~~~~~~~~~--------------~~~~~~~~~~~-----------~l~d~~l~----~~~~~~~~~~l~~li~ 699 (765)
.|......+...+.+. +...+..+++. ...+++.. -.....+..+|.+|+.
T Consensus 308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 8875543221111110 11111122111 11111110 1123456677999999
Q ss_pred HccccCCCCCCCHHHHHH
Q 004264 700 LCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 700 ~cl~~dP~~RPs~~evl~ 717 (765)
.||..||.+|+|+.|++.
T Consensus 388 ~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALS 405 (415)
T ss_pred HHHccCccccccHHHHhc
Confidence 999999999999999885
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=306.22 Aligned_cols=145 Identities=26% Similarity=0.383 Sum_probs=130.6
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|.+.++||+|+||.||+|... .++.||+|++.... ......+.+|+.+++.++|+||+++++.+......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57899999999999999999875 68899999986532 334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
||+.+++|.+++.. .+.+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999998843 235788999999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=293.77 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=208.8
Q ss_pred cccccccccCCceeEEEEEe-CCCc----EEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 448 FSEANMIGKGGFGPVYMGKL-STGQ----EIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~-~~~~----~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
....++||+|+||+||+|.+ ++++ +||+|++... ..+...+++.|+.+|.+|.|||++|++++|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 44467899999999999985 4443 5899988764 4556789999999999999999999999998776 78999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
+||+.|+|.++++. .+..+..+..+.|..|||+||.|||++. ++||||..+|||+.+-.++||.|||+++.+..+
T Consensus 777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999965 4456889999999999999999999998 999999999999999999999999999998766
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
..+.......-.+.|||-|.+....|+.++||||||+.+||++| |..|.......+... .++.|..
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d-------lle~geR------ 918 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD-------LLEKGER------ 918 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH-------HHhcccc------
Confidence 66555555555677999999999999999999999999999998 877865444332221 2222221
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
-..++.....+..++.+||..|+..||+++++...+.+
T Consensus 919 ---LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 919 ---LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred ---CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 23344566678899999999999999999999887765
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=270.18 Aligned_cols=236 Identities=28% Similarity=0.343 Sum_probs=191.6
Q ss_pred cccCCceeEEEEEeC-CCcEEEEEEccccCh---hhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCCCh
Q 004264 454 IGKGGFGPVYMGKLS-TGQEIAAKRLSKNSG---QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSL 529 (765)
Q Consensus 454 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gsL 529 (765)
||+|+||.||++... +++.+++|.+.+... .....+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999865 588999999876432 2456889999999999999999999999999999999999999999
Q ss_pred hHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccccccc
Q 004264 530 DYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTER 609 (765)
Q Consensus 530 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~ 609 (765)
.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 9988433 35899999999999999999999988 9999999999999999999999999998764322 12334
Q ss_pred ccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHH
Q 004264 610 VAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVES 689 (765)
Q Consensus 610 ~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 689 (765)
..++..|+|||.+.+...+.++|+||||+++|+|++|+.||..... ...... ...+. ...+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~----~~~~~----------~~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEK----ILKDP----------LRFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHH----HhcCC----------CCCCCC
Confidence 6678899999999988899999999999999999999999854332 111111 11111 011111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHH
Q 004264 690 QVLRCIQVGLLCVQKLPEDRPDMSS 714 (765)
Q Consensus 690 ~~~~l~~li~~cl~~dP~~RPs~~e 714 (765)
....+.+++.+|++.+|++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 2456789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=272.60 Aligned_cols=241 Identities=25% Similarity=0.305 Sum_probs=197.2
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccc-cCceEeeeeeeeecCceEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~~~l 519 (765)
..+|..+.+||+|+||.|.+|..+ ....+|||+++++. ....+--+.|-++|.... -|.++++..+|..-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 457888899999999999999865 45679999998752 233445567777877764 6789999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+.+|+|-.++++ -+.+.+..+..++..||-||-+||+++ ||+||||.+|||+|.+|++||+|||+++.-.
T Consensus 428 VMEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999888843 345788899999999999999999999 9999999999999999999999999998632
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
.....+..++||+.|+|||++...+|+..+|.||||++||||+.|+.||+..++++... ...+.+
T Consensus 502 --~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~-------aI~ehn------ 566 (683)
T KOG0696|consen 502 --FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ-------AIMEHN------ 566 (683)
T ss_pred --cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-------HHHHcc------
Confidence 23344557999999999999999999999999999999999999999998766543211 111111
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCC
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRP 710 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 710 (765)
-.++...+.+...++...+...|.+|.
T Consensus 567 ----vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 ----VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ----CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 235555566777888888999999985
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=287.97 Aligned_cols=240 Identities=23% Similarity=0.240 Sum_probs=194.4
Q ss_pred HhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV~ 521 (765)
.++.|+....+|.|+|+.|-++.. .+++..++|++.+.. .+..+|+.++.+. +||||+++.+.+.+..+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 357788888999999999998875 578899999997652 2345677666665 6999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE-ecCCCCeecccccceeeCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL-DINLNPKISDFGLARIFGG 600 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll-~~~~~vkL~DFGla~~~~~ 600 (765)
|.+.++-+.+.+.... .....+..|+.+|+.|+.|||+++ +|||||||+|||+ ++.++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999998877775432 333778889999999999999999 9999999999999 5889999999999997644
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
. ....+-|..|.|||++....|++++|+||||++||+|++|+.||.....+ . ........
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~----ei~~~i~~--------- 528 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--I----EIHTRIQM--------- 528 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--H----HHHHhhcC---------
Confidence 3 22456788999999999999999999999999999999999998654333 1 11111111
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
+.+....+....+|+.+||+.||.+||+|.++..
T Consensus 529 ---~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 529 ---PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ---CccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 2222334556778999999999999999999974
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=239.41 Aligned_cols=264 Identities=22% Similarity=0.253 Sum_probs=197.3
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
+|...++||+|.||+|++|+.. .+..||+|++.-. .+.......+|+.+|+.++|+|||++++....++..-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4556689999999999999864 5677899987643 333356788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
|.. .|..+.- ..++.++.+.+..++.|+++||.++|+.. +.||||||+|.||..+|.+||+|||+++.++-.-.
T Consensus 83 cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 954 4555442 33456899999999999999999999999 99999999999999999999999999998754322
Q ss_pred ccccccccccccccCcccccCCC-CCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCc---cccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDGT-ISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRA---LGLM 678 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~-~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~l~ 678 (765)
.. ...+-|..|.+|.++.+.+ |+...|+||.|||+.|+.. |++.|...+-++....+-+......+..+ .++.
T Consensus 157 cy--saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 157 CY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred ee--eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 21 2345688999999998864 8999999999999999987 55555554444433333333323333333 3344
Q ss_pred cccccCccCHH---------HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 679 DTCLEDSFVES---------QVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 679 d~~l~~~~~~~---------~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
|-.+.+.++.. ....=.++....+.-+|..|.++++.++.
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 54443333221 11123456667777899999999887653
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=264.79 Aligned_cols=220 Identities=23% Similarity=0.194 Sum_probs=174.6
Q ss_pred CCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCCChhHHhhc
Q 004264 457 GGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFD 535 (765)
Q Consensus 457 G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 535 (765)
|.++.||++... +++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999864 67899999987543 233455555566799999999999999999999999999999988854
Q ss_pred cccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccccccccccccc
Q 004264 536 RERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG 615 (765)
Q Consensus 536 ~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~ 615 (765)
. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 3 34899999999999999999999998 999999999999999999999999988765322 112345677
Q ss_pred ccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHH
Q 004264 616 YMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCI 695 (765)
Q Consensus 616 Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~ 695 (765)
|+|||.+.+..++.++||||+|+++|||++|+.|+....... ...... ..+......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~~~~---------~~~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTHTTL---------NIPEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cccccc---------CCcccCCHHHH
Confidence 999999988889999999999999999999998764221100 000000 11112234577
Q ss_pred HHHHHccccCCCCCCCHH
Q 004264 696 QVGLLCVQKLPEDRPDMS 713 (765)
Q Consensus 696 ~li~~cl~~dP~~RPs~~ 713 (765)
+++.+|++.||++||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=295.45 Aligned_cols=257 Identities=30% Similarity=0.422 Sum_probs=205.2
Q ss_pred cCcccccccccCCceeEEEEEeC----C----CcEEEEEEcccc-ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecC
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS----T----GQEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEED 515 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~----~----~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~ 515 (765)
++..+.+.||+|.||.|++|... . ...||||.++.. .....+.+..|+++|+.+ +|+||+.++++|..+.
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 33455668999999999999732 1 457999999865 335677899999999998 5999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhccc------c-----C--CCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEe
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRE------R-----S--KLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD 582 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~------~-----~--~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 582 (765)
..++|.||+..|+|..+++... . . ..+.....+.++.|||.|++||++.. +|||||..+|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEec
Confidence 9999999999999999997654 0 0 23888899999999999999999998 99999999999999
Q ss_pred cCCCCeecccccceeeCCCCccccccccc--ccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 004264 583 INLNPKISDFGLARIFGGDDEEAQTERVA--GTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRH 659 (765)
Q Consensus 583 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~--gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~ 659 (765)
.+..+||+|||+|+.......-... ... -...|||||.+....|+.|+||||||++||||++ |..|+...
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~------ 525 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI------ 525 (609)
T ss_pred CCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC------
Confidence 9999999999999965332222111 111 2345999999999999999999999999999999 55665331
Q ss_pred cHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 660 NLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..........++|...+.++.+ ..++.++|..||+.+|++||++.++++.++.
T Consensus 526 ~~~~~l~~~l~~G~r~~~P~~c---------~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 526 PPTEELLEFLKEGNRMEQPEHC---------SDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred CcHHHHHHHHhcCCCCCCCCCC---------CHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 1111223455666665555444 3456799999999999999999999999987
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=270.11 Aligned_cols=261 Identities=27% Similarity=0.358 Sum_probs=199.8
Q ss_pred HHHHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccc--cC-----hhhHHHHHHHHHHHhccccCceEeeeeeee
Q 004264 441 ITTATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSK--NS-----GQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512 (765)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~--~~-----~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~ 512 (765)
.....++|-.+++||+|||+.||+|.+ ...+.||+|+-.. +- ....+...+|..|.+.|.||.||++++++.
T Consensus 458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS 537 (775)
T ss_pred CcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence 345667899999999999999999974 5677888887542 21 222456778999999999999999999986
Q ss_pred -ecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC---CCCe
Q 004264 513 -EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN---LNPK 588 (765)
Q Consensus 513 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~vk 588 (765)
+.+..+-|.||++|.+|+.++. ..+.+++.++..|+.||+.||.||.+.. .+|||-||||.|||+.++ |.+|
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eccccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeE
Confidence 4567889999999999999984 4556999999999999999999999875 789999999999999654 7799
Q ss_pred ecccccceeeCCCCcc-----cccccccccccccCcccccCC----CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcc
Q 004264 589 ISDFGLARIFGGDDEE-----AQTERVAGTHGYMSPEYANDG----TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRH 659 (765)
Q Consensus 589 L~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~----~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~ 659 (765)
|.|||+++++...... ..+....||..|++||.+.-+ .++.|+||||+|+|+|..+.|+.||+-.....
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-- 691 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-- 691 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--
Confidence 9999999998654433 234568899999999987533 47889999999999999999999997543211
Q ss_pred cHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 004264 660 NLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVV 716 (765)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 716 (765)
.+ +.++.+....+-... ..+....+...+|.+||++.-++|....++.
T Consensus 692 dI-------LqeNTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 692 DI-------LQENTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred HH-------HhhhchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 11 112222211111110 0111233466889999999999998766654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-31 Score=276.58 Aligned_cols=249 Identities=22% Similarity=0.266 Sum_probs=207.2
Q ss_pred cCcccccccccCCceeEEEEEeCCCc-EEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQ-EIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~-~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
.+++++..||-||||.|=++..+..+ .+|+|.+++. .....+....|-.||...+.|.||+++-.|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666778999999999988865443 4888888764 3344567888999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
|-|-||.|-..+.. ++.++..+...++..+++|++|||+++ ||+|||||+|.++|.+|-+||.|||+|+.+..
T Consensus 500 EaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~- 572 (732)
T KOG0614|consen 500 EACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS- 572 (732)
T ss_pred HhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc-
Confidence 99999999999854 445889999999999999999999999 99999999999999999999999999998743
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
...+..++||+.|.|||++.+...+.++|.||||+++|||++|.+||...+|....+++-.....+
T Consensus 573 --g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i------------ 638 (732)
T KOG0614|consen 573 --GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI------------ 638 (732)
T ss_pred --CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh------------
Confidence 344567999999999999999999999999999999999999999999888876555443222111
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPD-----MSSVVFL 718 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 718 (765)
+++........+++......+|.+|.- +.+|.+.
T Consensus 639 ---~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 639 ---EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred ---hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 233344455668888888899999986 5566544
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-31 Score=260.14 Aligned_cols=256 Identities=25% Similarity=0.330 Sum_probs=195.6
Q ss_pred CcccccccccCCceeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEEEEe
Q 004264 447 HFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
+.+....||.|+||+|+|-.+ +.|+.+|||++.... ..+.++++.|.+...+- +.||||+++|.+..+...++.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 334456899999999999875 579999999998653 46778888998766554 699999999999999999999999
Q ss_pred cCCCChhHHhhc--cccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 524 MPHKSLDYFIFD--RERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 524 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
|. .||+.+... ......+++...-.|....++||.||.+.- .|||||+||+|||++..|.+||+|||++-.+.
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv-- 219 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV-- 219 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH--
Confidence 84 567655422 123345889988899999999999998764 59999999999999999999999999987652
Q ss_pred CcccccccccccccccCcccccC--CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYAND--GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
.....+...|-..|||||.+.. ..|..++||||||+.|+|+.||+.|+..... +.++. .....|....+..
T Consensus 220 -~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql-~~Vv~gdpp~l~~ 292 (361)
T KOG1006|consen 220 -DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQL-CQVVIGDPPILLF 292 (361)
T ss_pred -HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHH-HHHHcCCCCeecC
Confidence 2222335678889999998853 3599999999999999999999999753322 11111 1222333322222
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
+ .........+.+++..|+..|-.+||...+++++
T Consensus 293 ~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 D----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred c----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1 1123346678899999999999999999999754
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=282.34 Aligned_cols=254 Identities=27% Similarity=0.362 Sum_probs=210.8
Q ss_pred HHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhcc-ccCceEeeeeeeee-----cC
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIE-----ED 515 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~-----~~ 515 (765)
.-++.|++.+.||.|.+|.||+++. ++++..|+|++... ....+++..|.+||+.+ +|||++.+++++.. ++
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 3456789999999999999999984 56788888888643 33456788899999988 59999999999875 56
Q ss_pred ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccc
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA 595 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla 595 (765)
+++||||||.+||..+++.... +..+.|..+..|++.+++||.+||... ++|||||-.|||++.++.|||.|||.+
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeee
Confidence 8999999999999999997766 677999999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCcccccccccccccccCcccccC-----CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhc
Q 004264 596 RIFGGDDEEAQTERVAGTHGYMSPEYAND-----GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWN 670 (765)
Q Consensus 596 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 670 (765)
..+.. .........||+.|||||++.- ..|+..+|+||||++..||--|.+|+...+|.....++
T Consensus 171 aQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I-------- 240 (953)
T KOG0587|consen 171 AQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-------- 240 (953)
T ss_pred eeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC--------
Confidence 87643 2333446889999999999863 34778899999999999999999999887776432221
Q ss_pred cCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 671 DGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 671 ~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.. .+.++-.-+....+++.++|..||..|.++||++.++++
T Consensus 241 ----pR--NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 241 ----PR--NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ----CC--CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11 122222234567888999999999999999999998875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=257.86 Aligned_cols=238 Identities=29% Similarity=0.338 Sum_probs=192.4
Q ss_pred CceeEEEEEeC-CCcEEEEEEccccChhh-HHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCCChhHHhhc
Q 004264 458 GFGPVYMGKLS-TGQEIAAKRLSKNSGQG-LEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFD 535 (765)
Q Consensus 458 ~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 535 (765)
+||.||++... +++.+++|++....... .+.+.+|+..+++++|+|++++++.+......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48899999997665444 68899999999999999999999999999999999999999999998854
Q ss_pred cccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccccccccccccc
Q 004264 536 RERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG 615 (765)
Q Consensus 536 ~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~ 615 (765)
.. .+++..++.++.++++++.+||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 32 2889999999999999999999998 9999999999999999999999999999864432 2334567889
Q ss_pred ccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHH
Q 004264 616 YMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCI 695 (765)
Q Consensus 616 Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~ 695 (765)
|++||.+.+..++.++||||||+++++|++|..|+...... ... ......+..... .........+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~----~~~~~~~~~~~~-------~~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LEL----FKKIGKPKPPFP-------PPEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHH----HHHHhccCCCCc-------cccccCCHHHH
Confidence 99999999888999999999999999999999987542111 111 111111111000 00000335688
Q ss_pred HHHHHccccCCCCCCCHHHHHH
Q 004264 696 QVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 696 ~li~~cl~~dP~~RPs~~evl~ 717 (765)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=260.47 Aligned_cols=266 Identities=26% Similarity=0.345 Sum_probs=221.3
Q ss_pred chHhHHHHhcCcccccccccCCceeEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeee
Q 004264 437 DLATITTATNHFSEANMIGKGGFGPVYMGKLS------TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLG 509 (765)
Q Consensus 437 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~ 509 (765)
..+++.....++.....+-+|.||.||+|.+. +.+.+.+|.++.. +......++.|..++..+.|||+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 34566677788888899999999999999653 3456777877654 3445677899999999999999999999
Q ss_pred eeeec-CceEEEEEecCCCChhHHhh-----ccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec
Q 004264 510 SCIEE-DERMLIYEYMPHKSLDYFIF-----DRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI 583 (765)
Q Consensus 510 ~~~~~-~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 583 (765)
.+.++ ...+++|.++.-|+|..++. +....+.+.......++.|++.|++|||+.+ +||.||..+|.+||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 98864 56788899999999999997 3344456778888899999999999999999 999999999999999
Q ss_pred CCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHH
Q 004264 584 NLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLI 662 (765)
Q Consensus 584 ~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~ 662 (765)
..+|||+|=.+++.+...+.+...........||+||.+++..|+.++||||||++||||+| |+.|+..-+|.+.
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm---- 507 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM---- 507 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH----
Confidence 99999999999999877777776666667788999999999999999999999999999998 8888876666542
Q ss_pred HHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 663 GHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 663 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..+..+|... ..+..+..++..+|..||...|++||+.++++..|..
T Consensus 508 ---~~ylkdGyRl---------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 508 ---EHYLKDGYRL---------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred ---HHHHhcccee---------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 3334444432 2334556778899999999999999999999999875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-31 Score=255.33 Aligned_cols=267 Identities=20% Similarity=0.319 Sum_probs=194.2
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccc-c-ChhhHHHHHHHHHHHhccccCceEeeeeeeee--------c
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSK-N-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE--------E 514 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~-~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~--------~ 514 (765)
..|+-..+||+|.||.||+|+.+ .++.||+|+.-- + .........+|+.+|+.|+|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45777789999999999999864 577788876532 2 12223456799999999999999999998864 2
Q ss_pred CceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccc
Q 004264 515 DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGL 594 (765)
Q Consensus 515 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGl 594 (765)
...++||.++++ +|.-++. .....++..++.++++++..||.|+|+.. |+|||+||.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLs--n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLS--NRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhc--CccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 347899999976 4445553 22345889999999999999999999998 99999999999999999999999999
Q ss_pred ceeeCCCCccc--ccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhcc
Q 004264 595 ARIFGGDDEEA--QTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWND 671 (765)
Q Consensus 595 a~~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 671 (765)
++.+....... .-+..+-|..|++||.+.+ ..|+++.|||..|||+.||+++.+.+..+.+.....++...-.....
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 98774332221 1224556999999998876 57999999999999999999999887766554443333322111111
Q ss_pred CCcccc--------c--cccccCccC--HHHH------HHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 672 GRALGL--------M--DTCLEDSFV--ESQV------LRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 672 ~~~~~l--------~--d~~l~~~~~--~~~~------~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.-+..+ + .+..++.+. .... .+.++|+..++..||.+|+.+.+++..
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 111110 0 111111110 0111 246688999999999999999998854
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=286.73 Aligned_cols=260 Identities=18% Similarity=0.201 Sum_probs=167.3
Q ss_pred HhcCcccccccccCCceeEEEEEeC-C----CcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeee------ee
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-T----GQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGS------CI 512 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~----~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~------~~ 512 (765)
..++|++.++||+|+||.||+|++. + +..||+|++...... +....| .+++..+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999875 4 688999988643221 111111 1112222222222211 24
Q ss_pred ecCceEEEEEecCCCChhHHhhccccC-----------------CCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccC
Q 004264 513 EEDERMLIYEYMPHKSLDYFIFDRERS-----------------KLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLK 575 (765)
Q Consensus 513 ~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlk 575 (765)
.+...++|+||+.+++|.+++...... .......+..++.||+.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566889999999999999888543210 01123345679999999999999998 9999999
Q ss_pred CCcEEEec-CCCCeecccccceeeCCCCcccccccccccccccCcccccCC----------------------CCCcccc
Q 004264 576 ASNILLDI-NLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG----------------------TISMKSD 632 (765)
Q Consensus 576 p~NIll~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~s~k~D 632 (765)
|+|||++. ++.+||+|||+++.+..... .......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 57899999999986533222 122346789999999966422 2445679
Q ss_pred chHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC----ccccccccccCc------cCHHHHHHHHHHHHHcc
Q 004264 633 VFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR----ALGLMDTCLEDS------FVESQVLRCIQVGLLCV 702 (765)
Q Consensus 633 vwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~d~~l~~~------~~~~~~~~l~~li~~cl 702 (765)
||||||+||||+++..+.... +..........+. +...+.+..... ..........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 999999999999977653211 0000000000000 000111110000 00001123457999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 004264 703 QKLPEDRPDMSSVVFL 718 (765)
Q Consensus 703 ~~dP~~RPs~~evl~~ 718 (765)
+.||++|||+.++++.
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999974
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=268.52 Aligned_cols=208 Identities=25% Similarity=0.370 Sum_probs=178.4
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
.-|..++.||-|+||+|.++.. +....||+|.|.+.+ .......+.|-.||.....+-||+++..|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 4588889999999999999974 456779999998754 333456778999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
+|++||++-.+|. +.+.+++..+..++..+..|+++.|..| +|||||||+|||||.+|++||.|||++.-+...
T Consensus 709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999988773 4556889999999999999999999999 999999999999999999999999998654210
Q ss_pred C--------c--------------------------------ccccccccccccccCcccccCCCCCccccchHHHHHHH
Q 004264 602 D--------E--------------------------------EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLV 641 (765)
Q Consensus 602 ~--------~--------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ 641 (765)
. . +......+||+.|+|||++....|+..+|.||.|+|||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 0 0 00112367999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCcc
Q 004264 642 EIVSGKMNRGFRHPGHRH 659 (765)
Q Consensus 642 elltG~~p~~~~~~~~~~ 659 (765)
||+.|+.||....+.+..
T Consensus 863 em~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQ 880 (1034)
T ss_pred HHhhCCCCccCCCCCcce
Confidence 999999999988887654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=251.99 Aligned_cols=292 Identities=23% Similarity=0.319 Sum_probs=219.2
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~l 519 (765)
.++|....+||+|+|.+|..++++ ..+.+|+|++++. ......-.+.|-.+..+. +||.+|-+..+|..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467888999999999999999865 5678999998763 344566677888777776 69999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
|.||+++|+|-.+++ +...++++.+..+...|..||.|||+.| ||+||||.+|+|+|..|++||.|+|+++.--
T Consensus 329 vieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999977763 4456999999999999999999999999 9999999999999999999999999998642
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCC-cccHHHHHHHhhccCCccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGH-RHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~ 678 (765)
. ....+..++||+.|+|||++++..|...+|.|+||++++||+.|+.||+...... ..+-..+..+.. +
T Consensus 403 ~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi--------l 472 (593)
T KOG0695|consen 403 G--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI--------L 472 (593)
T ss_pred C--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH--------h
Confidence 2 2334557999999999999999999999999999999999999999997543221 122222222221 1
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCC------HHHHH----------HHHhcCCCCCCCCCCCCccccccccc
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPD------MSSVV----------FLLANDGVTLPQPRQPGFFTERGFTV 742 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl----------~~L~~~~~~l~~p~~p~~~~~~~~~~ 742 (765)
+..+ .++.....+...++..-|..||.+|.- ..++. .+|++ .++..|=+|..-.+..++-
T Consensus 473 ekqi--riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leq--k~v~ppf~p~i~~d~~l~~ 548 (593)
T KOG0695|consen 473 EKQI--RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQ--KQVLPPFQPQITDDYGLDN 548 (593)
T ss_pred hhcc--cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhh--cccCCCCCCccccccCccc
Confidence 1111 122333444557777888999998852 23332 44543 2356677777766655443
Q ss_pred ccCCC---CcccccCCc
Q 004264 743 GALSS---HEKCHSENA 756 (765)
Q Consensus 743 ~~~~~---~~~~~~~~~ 756 (765)
-++|. ..++++.|.
T Consensus 549 fd~qft~e~~qltpdd~ 565 (593)
T KOG0695|consen 549 FDTQFTSEPVQLTPDDE 565 (593)
T ss_pred cccccccCCcccCCCCH
Confidence 33332 556666554
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=276.75 Aligned_cols=263 Identities=17% Similarity=0.217 Sum_probs=179.8
Q ss_pred HhcCcccccccccCCceeEEEEEe-----------------CCCcEEEEEEccccChhhHHH--------------HHHH
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL-----------------STGQEIAAKRLSKNSGQGLEE--------------FMNE 492 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~-----------------~~~~~vavK~l~~~~~~~~~~--------------~~~E 492 (765)
..++|++.++||+|+||.||+|.. ..++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 457899999999999999999963 245679999986543222223 3346
Q ss_pred HHHHhccccCce-----Eeeeeeeee--------cCceEEEEEecCCCChhHHhhcccc---------------------
Q 004264 493 VVLIGKLQHRNL-----VGLLGSCIE--------EDERMLIYEYMPHKSLDYFIFDRER--------------------- 538 (765)
Q Consensus 493 v~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------- 538 (765)
+.++.+++|.++ ++++++|.. ....+|||||+++++|.+++.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 667777653 3568999999999999998864211
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccccccccccccccC
Q 004264 539 SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMS 618 (765)
Q Consensus 539 ~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~a 618 (765)
...+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++........ .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123467788899999999999999998 99999999999999999999999999976532211 11112345789999
Q ss_pred cccccCCC--------------------C--CccccchHHHHHHHHHHhCCC-CCCCCCCCCcc----cHHHHHHHhhcc
Q 004264 619 PEYANDGT--------------------I--SMKSDVFSLGVLLVEIVSGKM-NRGFRHPGHRH----NLIGHAWLLWND 671 (765)
Q Consensus 619 PE~~~~~~--------------------~--s~k~DvwSlG~ll~elltG~~-p~~~~~~~~~~----~~~~~~~~~~~~ 671 (765)
||.+.... + ..+.||||+|||+++|++|.. |+......... ......|.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99886432 1 235799999999999999885 54321111100 000111111111
Q ss_pred CCccccccccccCccCHHHHHHHHHHHHHccccCC---CCCCCHHHHHHH
Q 004264 672 GRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLP---EDRPDMSSVVFL 718 (765)
Q Consensus 672 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~ 718 (765)
... + -...........+++.++|..+| .+|+|++|++++
T Consensus 459 ~~~----~----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QKY----D----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cCC----C----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 111 0 00111223456788888998765 689999999864
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-30 Score=228.01 Aligned_cols=110 Identities=54% Similarity=0.830 Sum_probs=82.4
Q ss_pred CCcEEEeecCCCCCCC--CCceEEEeeCCceEEEcCCCCeEEEe-ccCCCc-CccEEEEecCCCeeEeeccCCCccccee
Q 004264 70 PRTVVWVANRNHPITD--KNGVLTFSNNGSLLLLNQEKSAIWSS-NSSRTL-ENPVAHLLDSGNLVLRDNISRSSEEYMW 145 (765)
Q Consensus 70 ~~~~vW~an~~~p~~~--~~~~l~~~~~g~l~l~~~~~~~~w~s-~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~~~~~W 145 (765)
++||||+|||+.|+.+ ..++|.|+.||+|+|++..++++|++ ++.+.. ....|.|+|+|||||++ ..+.+||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d----~~~~~lW 76 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYD----SSGNVLW 76 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEE----TTSEEEE
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEe----ecceEEE
Confidence 4799999999999954 35899999999999999999999999 555433 57899999999999998 5788999
Q ss_pred eecCCCCCcccCcCeecceeecccceEEEeccCCCCCC
Q 004264 146 QSFDYPSDTLLPGMKLGWNLKTGFERYLTPWRSADDPT 183 (765)
Q Consensus 146 qSFd~PtDtlLpg~klg~~~~~~~~~~l~S~~s~~dps 183 (765)
|||||||||+||||+|+.+..++.+..++||++.+|||
T Consensus 77 ~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 77 QSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp ESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred eecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 99999999999999999988887777899999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-29 Score=274.02 Aligned_cols=246 Identities=27% Similarity=0.405 Sum_probs=186.5
Q ss_pred cccccccccCCcee-EEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEEEEecC
Q 004264 448 FSEANMIGKGGFGP-VYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 448 y~~~~~LG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
|.-.+++|.|..|+ ||+|.. +++.||||++-. ......++|+..|+.- .|||||++++.-.++...||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 45567899999875 699987 578999998853 2345678999999997 5999999999888889999999999
Q ss_pred CCChhHHhhccccC-CCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec---C--CCCeecccccceeeC
Q 004264 526 HKSLDYFIFDRERS-KLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI---N--LNPKISDFGLARIFG 599 (765)
Q Consensus 526 ~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~vkL~DFGla~~~~ 599 (765)
..+|.+++...... ........+.+..|++.||++||+.+ ||||||||+||||+. + .+++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 56899998653111 11112455778899999999999988 999999999999976 2 468999999999986
Q ss_pred CCCcc-cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhC-CCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 600 GDDEE-AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSG-KMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 600 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
..... .......||-+|+|||++....-+.++||||+|||+|+.++| ..||+..-..+.. ++ .+.. .+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N-Il--------~~~~-~L 732 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN-IL--------TGNY-TL 732 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh-hh--------cCcc-ce
Confidence 54433 234467899999999999999888899999999999999996 8898754332110 00 0000 00
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
. .+... ..+ +..+||.+|+.++|..||++.+|+.
T Consensus 733 ~--~L~~~--~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 733 V--HLEPL--PDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred e--eeccC--chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0 01111 111 5678999999999999999999973
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=229.97 Aligned_cols=200 Identities=28% Similarity=0.414 Sum_probs=167.4
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc-ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV~E 522 (765)
+...-...||+|++|.|-+-++ .+|+..|+|++... ..+..++.+.|+.+..+- .+|.+|+++|....+...++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 3344456799999999988875 57999999998754 456677888999887775 69999999999999999999999
Q ss_pred ecCCCChhHHhhc-cccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 523 YMPHKSLDYFIFD-RERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 523 ~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
.| ..||+.+..+ -..++.+++...-+|+..+.+||.|||++- .+||||+||+||||+.+|+||+||||.+-.+..
T Consensus 126 ~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d- 201 (282)
T KOG0984|consen 126 LM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD- 201 (282)
T ss_pred Hh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh-
Confidence 98 4577766544 355678999999999999999999999974 699999999999999999999999999987632
Q ss_pred CcccccccccccccccCcccccC----CCCCccccchHHHHHHHHHHhCCCCCC
Q 004264 602 DEEAQTERVAGTHGYMSPEYAND----GTISMKSDVFSLGVLLVEIVSGKMNRG 651 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~----~~~s~k~DvwSlG~ll~elltG~~p~~ 651 (765)
....+...|-..|+|||.+.. ..|+.|+||||||+.+.||.+++.|+.
T Consensus 202 --SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 202 --SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred --hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 122223567889999998853 469999999999999999999999975
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=231.83 Aligned_cols=211 Identities=37% Similarity=0.583 Sum_probs=183.5
Q ss_pred cccCCceeEEEEEeCC-CcEEEEEEccccChh-hHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCCChhH
Q 004264 454 IGKGGFGPVYMGKLST-GQEIAAKRLSKNSGQ-GLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDY 531 (765)
Q Consensus 454 LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gsL~~ 531 (765)
||+|.+|.||++.... ++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 889999999765432 35789999999999999999999999999999999999999999999
Q ss_pred HhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec-CCCCeecccccceeeCCCCcccccccc
Q 004264 532 FIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI-NLNPKISDFGLARIFGGDDEEAQTERV 610 (765)
Q Consensus 532 ~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~vkL~DFGla~~~~~~~~~~~~~~~ 610 (765)
++.... ..+++..+..++.++++++.+||+.+ ++|+||+|.||+++. +++++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 985432 35889999999999999999999998 999999999999999 89999999999987643321 12235
Q ss_pred cccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHH
Q 004264 611 AGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVES 689 (765)
Q Consensus 611 ~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 689 (765)
.+...|++||.+... .++.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 577889999999887 888999999999999999
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004264 690 QVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719 (765)
Q Consensus 690 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L 719 (765)
..+.+++..|++.+|++||++.++++.+
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3467899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=230.60 Aligned_cols=257 Identities=19% Similarity=0.269 Sum_probs=190.3
Q ss_pred HhcCcccccccccCCceeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHhccc-cCceEeeeeeeeec--CceEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEE--DERML 519 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~--~~~~l 519 (765)
..++|++.+++|+|.++.|+.|. ..++..++||+++. ...+.+.+|+.||+.|. ||||+++++...+. ....|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 34789999999999999999998 45778899999853 33467889999999997 99999999998764 46779
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC-CCCeecccccceee
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN-LNPKISDFGLARIF 598 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~vkL~DFGla~~~ 598 (765)
|+||+.+.+...+. +.+..-.+..++.+++.||.|||+.| |+|||+||.|++||.. -.++|+|+|+|.++
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998776554 34677788889999999999999999 9999999999999865 56999999999987
Q ss_pred CCCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCC-CCCcccHHH------HHHHhhc
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRH-PGHRHNLIG------HAWLLWN 670 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~-~~~~~~~~~------~~~~~~~ 670 (765)
-...+ -...+.+.-|-.||.+.. ..|+..-|+|||||+|..|+..+.||=-.+ ..+..-.+. .......
T Consensus 184 Hp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 184 HPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 33222 223455677899999976 458899999999999999999999974322 222211111 0111111
Q ss_pred cCCccccccccccC----------------ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 671 DGRALGLMDTCLED----------------SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 671 ~~~~~~l~d~~l~~----------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.-.+. +|+...+ +-..-...+.++++...|.+|-.+|||++|.+.
T Consensus 261 KY~i~--Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQID--LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccC--CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 11110 1111110 000011246778999999999999999999864
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=212.42 Aligned_cols=109 Identities=42% Similarity=0.950 Sum_probs=105.1
Q ss_pred eeeCCCCCccccCcccc-ccceeeeeeeecCceeEEEEeecCCceeEEEEEccCCcEEEEEEecCCCceEEEEecCCCCC
Q 004264 209 ARSGPWNGQQFGGIPRV-KNSIFIPKLEHTEDELYFTFRPFNDKVITRLLVNESGTLQRLVWNETSTEWRMLYSWPFDTC 287 (765)
Q Consensus 209 ~~sg~w~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~l~~~G~l~~~~w~~~~~~W~~~~~~p~~~C 287 (765)
||+|+|||..|+|+|.+ ...++.+.|+.+.++.+++|...++++++|++|+.+|++++|.|++.++.|.+.|.+|.|+|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C 80 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC 80 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence 89999999999999999 67889999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCceecCCCCccCC
Q 004264 288 DSYAQCGANDNCRISKTPICECLTGFISKS 317 (765)
Q Consensus 288 ~~~g~CG~~g~C~~~~~~~C~C~~Gf~~~~ 317 (765)
|+|+.||+||+|+.+..+.|.|++||+|++
T Consensus 81 d~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 81 DVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 999999999999988889999999999985
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-28 Score=239.93 Aligned_cols=264 Identities=22% Similarity=0.320 Sum_probs=194.5
Q ss_pred ccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecC-----ceEEE
Q 004264 449 SEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED-----ERMLI 520 (765)
Q Consensus 449 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~-----~~~lV 520 (765)
+..+.||.|+||.||.++++ +|+.+++|++..- .-...+.+.+|+++|.-++|.|++..++...-.. +.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 44578999999999999864 7999999998653 3334578889999999999999999888665432 46678
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
+|.|. .+|+.++- ..+.++...+.-++.||++||+|||+.+ |.||||||.|.|++++..+||+|||+++.-..
T Consensus 136 TELmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 88874 45666663 3456888888889999999999999999 99999999999999999999999999997543
Q ss_pred CCcccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHH--------HHHHhhcc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIG--------HAWLLWND 671 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~--------~~~~~~~~ 671 (765)
.+. ...+..+-|..|.|||++.+. .|+.++||||.|||+.||+..+..|....|-+...++- ++....-+
T Consensus 209 d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 209 RDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 333 233356678899999999875 69999999999999999999988887666544433321 11111122
Q ss_pred CCccccccccccC---------ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 672 GRALGLMDTCLED---------SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 672 ~~~~~l~d~~l~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
|....++....+. ..+...-.+...+..+++..||++|.+..+.+..+-
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 2222222211110 001112223446777889999999999998887663
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=240.72 Aligned_cols=132 Identities=23% Similarity=0.354 Sum_probs=108.3
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccc-----c---CceEeeeeeeee---
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-----H---RNLVGLLGSCIE--- 513 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-----h---~niv~~~~~~~~--- 513 (765)
.+|.+.++||-|.|++||++.+ ...+.||+|+.+ ......+..+.||++|++++ | .+||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK-SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK-SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEe-hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 6899999999999999999985 456678888774 44455677889999999983 3 369999999975
Q ss_pred -cCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEe
Q 004264 514 -EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD 582 (765)
Q Consensus 514 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 582 (765)
+.+.++|+|++.. +|..+|.... .+.++...+..|++||+.||.|||+++ .|||-||||+|||+.
T Consensus 157 NG~HVCMVfEvLGd-nLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVLGD-NLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhhhh-HHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 5689999999955 4445553332 345899999999999999999999987 699999999999994
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-28 Score=252.13 Aligned_cols=273 Identities=20% Similarity=0.175 Sum_probs=206.7
Q ss_pred cchHhHHHHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccc------cCceEeee
Q 004264 436 YDLATITTATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ------HRNLVGLL 508 (765)
Q Consensus 436 ~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~------h~niv~~~ 508 (765)
|.+........+|.+....|+|-|++|.+|... .++.||||++.++ ....+.=+.|++||++|+ .-|+++++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 444445566789999999999999999999864 5789999999764 334566678999999995 34899999
Q ss_pred eeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC-CCC
Q 004264 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN-LNP 587 (765)
Q Consensus 509 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~v 587 (765)
-.|...++++||||-+ ..+|.+.+..-...-.+....+..++.|+.-||..|-.-+ |+|.||||+|||+.+. ..+
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCccee
Confidence 9999999999999987 4578888866566667888999999999999999999888 9999999999999876 458
Q ss_pred eecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH-
Q 004264 588 KISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAW- 666 (765)
Q Consensus 588 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~- 666 (765)
||||||.|...... ..+.+.-+..|.|||++.+.+|+...|+||.||.||||.||+..|......+...+.-...
T Consensus 577 KLCDfGSA~~~~en----eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 577 KLCDFGSASFASEN----EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred eeccCccccccccc----cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 99999999875322 2223444667999999999999999999999999999999999987655433221110000
Q ss_pred --------------Hhh---------ccCC--------ccccccc------cc-----cCccCHHHHHHHHHHHHHcccc
Q 004264 667 --------------LLW---------NDGR--------ALGLMDT------CL-----EDSFVESQVLRCIQVGLLCVQK 704 (765)
Q Consensus 667 --------------~~~---------~~~~--------~~~l~d~------~l-----~~~~~~~~~~~l~~li~~cl~~ 704 (765)
..+ .... +...+.+ .+ .+.-....+..+.+|+..|+..
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 000 0000 0111111 00 1112234566788899999999
Q ss_pred CCCCCCCHHHHHH
Q 004264 705 LPEDRPDMSSVVF 717 (765)
Q Consensus 705 dP~~RPs~~evl~ 717 (765)
||++|.|..+.+.
T Consensus 733 dP~KRit~nqAL~ 745 (752)
T KOG0670|consen 733 DPEKRITVNQALK 745 (752)
T ss_pred ChhhcCCHHHHhc
Confidence 9999999988775
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=231.74 Aligned_cols=261 Identities=23% Similarity=0.227 Sum_probs=193.5
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecC------
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED------ 515 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~------ 515 (765)
..+|.-...+|.|.- .|-.+.+ -.++.||+|++... .....++..+|...+..++|+||++++.++.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777788899988 5555543 35889999998653 4456678899999999999999999999987543
Q ss_pred ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccc
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA 595 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla 595 (765)
..|+|||+|. .+|...+. -.++-.++..|+.|++.|++|||+.+ |+||||||+||++..+..+||.|||+|
T Consensus 95 e~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 6789999995 56766664 23677788899999999999999999 999999999999999999999999999
Q ss_pred eeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHH-------------
Q 004264 596 RIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLI------------- 662 (765)
Q Consensus 596 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~------------- 662 (765)
+.-... -..+..+.|+-|.|||++.+-.|.+.+||||+||++.||++|+.-|.+.+.-+...++
T Consensus 166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 874322 3445678899999999999888999999999999999999999887643322111111
Q ss_pred ---HHHHHhhc------cCCccc-cccccccC--ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 663 ---GHAWLLWN------DGRALG-LMDTCLED--SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 663 ---~~~~~~~~------~~~~~~-l~d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..+..... .-...+ +.|..... +.+.....-..+++.+||-.+|++|.+++++++.
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 01111100 000011 12221111 1112334446688999999999999999999875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=247.14 Aligned_cols=196 Identities=25% Similarity=0.346 Sum_probs=165.1
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccCh--------hhHHHHHHHHHHHhccc---cCceEeeeeeeee
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSG--------QGLEEFMNEVVLIGKLQ---HRNLVGLLGSCIE 513 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~~Ev~~l~~l~---h~niv~~~~~~~~ 513 (765)
.+|+..+.+|+|+||.|+.+.++ +...|++|.+.+... .......-|+.||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45888999999999999999876 456788887765311 11223556999999997 9999999999999
Q ss_pred cCceEEEEEec-CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccc
Q 004264 514 EDERMLIYEYM-PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDF 592 (765)
Q Consensus 514 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DF 592 (765)
.+.+||+||-- ++.+|.+++ .....+++.++..|++||+.|+++||+.+ |||||||-+|+.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999964 455677777 33456999999999999999999999999 999999999999999999999999
Q ss_pred ccceeeCCCCcccccccccccccccCcccccCCCCC-ccccchHHHHHHHHHHhCCCCCC
Q 004264 593 GLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTIS-MKSDVFSLGVLLVEIVSGKMNRG 651 (765)
Q Consensus 593 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~k~DvwSlG~ll~elltG~~p~~ 651 (765)
|.+..... .....++||..|.|||++.+.+|- ..-|||++|++||.++....|+.
T Consensus 715 gsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99987532 233468999999999999999884 55899999999999998887753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=226.19 Aligned_cols=199 Identities=32% Similarity=0.474 Sum_probs=172.5
Q ss_pred cccccccccCCceeEEEEEeCC-CcEEEEEEccccChh-hHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecC
Q 004264 448 FSEANMIGKGGFGPVYMGKLST-GQEIAAKRLSKNSGQ-GLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
|.+.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|+..+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5567889999999999999765 889999999876544 67789999999999999999999999999999999999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+++|.+++..... .+++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 9999998854321 1789999999999999999999998 999999999999999999999999999887543211
Q ss_pred ccccccccccccCcccc-cCCCCCccccchHHHHHHHHHHhCCCCCCC
Q 004264 606 QTERVAGTHGYMSPEYA-NDGTISMKSDVFSLGVLLVEIVSGKMNRGF 652 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~-~~~~~s~k~DvwSlG~ll~elltG~~p~~~ 652 (765)
......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22345677889999998 667788899999999999999999999853
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-26 Score=223.73 Aligned_cols=251 Identities=18% Similarity=0.310 Sum_probs=189.7
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhcc-ccCceEeeee-eeeecCceEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRNLVGLLG-SCIEEDERMLI 520 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~~~~-~~~~~~~~~lV 520 (765)
..+.|.|.+.||+|.||.+.+++++ ..+.+|+|-+.+... ..++|.+|...--.| .|.||+..++ .|...+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3467999999999999999999975 567899998876432 357899998776666 4899998776 46677788899
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE-e-cCCCCeecccccceee
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL-D-INLNPKISDFGLARIF 598 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll-~-~~~~vkL~DFGla~~~ 598 (765)
+||++.|+|..-+.. ..+.+....+++.|++.||.|+|+++ +||||||.+|||| + +..+|||+|||+.+..
T Consensus 101 qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999999877733 34778889999999999999999999 9999999999999 3 3357999999999865
Q ss_pred CCCCcccccccccccccccCcccccCC-----CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYANDG-----TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR 673 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 673 (765)
+. .......+..|.+||..... ...+.+|||.||+|++.+++|..||......+. .-+.|..|..++
T Consensus 174 g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~---~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 174 GT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK---PYWEWEQWLKRK 245 (378)
T ss_pred Cc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc---hHHHHHHHhccc
Confidence 32 22234456779999976432 246789999999999999999999974443333 334455565555
Q ss_pred ccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 004264 674 ALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVV 716 (765)
Q Consensus 674 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 716 (765)
...+++.. .....++.++..+-+..+|++|=-..++.
T Consensus 246 ~~~~P~~F------~~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 246 NPALPKKF------NPFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred CccCchhh------cccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 44333321 11234566788889999999994333333
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=200.62 Aligned_cols=115 Identities=47% Similarity=0.775 Sum_probs=101.2
Q ss_pred ccccCCCeEEcCCCeEEEEEecCCCCCCeEEEEEEeCCCCcEEEeecCCCCCCCCCceEEEeeCCceEEEcCCCCeEEEe
Q 004264 32 KFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSS 111 (765)
Q Consensus 32 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~s 111 (765)
+.|..|++|+|+++.|++|||.+......+++|||....+++||.||++.|. ...+.|.|+.||+|+|+|.+|.+||+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g~~vW~S 80 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSGTVVWSS 80 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence 5788999999999999999999976545889999984338899999999984 567899999999999999999999999
Q ss_pred ccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCCC
Q 004264 112 NSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYP 151 (765)
Q Consensus 112 ~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~P 151 (765)
++.+.....+|+|+|||||||++. .+.+||||||||
T Consensus 81 ~~~~~~~~~~~~L~ddGnlvl~~~----~~~~~W~Sf~~P 116 (116)
T cd00028 81 NTTRVNGNYVLVLLDDGNLVLYDS----DGNFLWQSFDYP 116 (116)
T ss_pred cccCCCCceEEEEeCCCCEEEECC----CCCEEEcCCCCC
Confidence 987534567899999999999983 578999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=230.91 Aligned_cols=267 Identities=21% Similarity=0.334 Sum_probs=198.4
Q ss_pred hHHHHhcCcccccccccCCceeEEEEEeC----CCcEEEEEEccccChhhHHHHHHHHHHHhccc-cCceEeeeeeeeec
Q 004264 440 TITTATNHFSEANMIGKGGFGPVYMGKLS----TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEE 514 (765)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~ 514 (765)
.+....+.|..+++||+|.|++||++.+. ..+.||+|.+...+. ..++.+|+++|..+. +.||+++.+++...
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34556678999999999999999999753 467899999865433 356889999999995 99999999999999
Q ss_pred CceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec-CCCCeecccc
Q 004264 515 DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI-NLNPKISDFG 593 (765)
Q Consensus 515 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~vkL~DFG 593 (765)
+...+|+||+++....+++.. ++...+..+++.++.||+++|.+| ||||||||.|+|.+. .++-.|.|||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred CeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence 999999999999999888843 678899999999999999999999 999999999999975 4678999999
Q ss_pred cceeeCCCC------------------------------------------cccccccccccccccCcccccC-CCCCcc
Q 004264 594 LARIFGGDD------------------------------------------EEAQTERVAGTHGYMSPEYAND-GTISMK 630 (765)
Q Consensus 594 la~~~~~~~------------------------------------------~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k 630 (765)
+|....... .........||++|.|||++.. +..+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 998321100 0000113579999999999876 457999
Q ss_pred ccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH-----------HH------hhccCCcccc-----------ccccc
Q 004264 631 SDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHA-----------WL------LWNDGRALGL-----------MDTCL 682 (765)
Q Consensus 631 ~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~-----------~~------~~~~~~~~~l-----------~d~~l 682 (765)
+||||.|+|++.+++++.||-....+ ...+.+.+ .. .+...++..+ ...+.
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd-~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDD-ADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred cceeeccceeehhhccccccccCccc-cchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 99999999999999999998543322 21111100 00 1110111111 01111
Q ss_pred cCc--------cCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 683 EDS--------FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 683 ~~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
+.. ........+++++.+|++.||.+|.|+++.++.
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 101 111122367899999999999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-25 Score=240.54 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=201.9
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
.++|+....+|+|.+|.|||+++ ..++..|+|.++-.......-.++|+-+++..+|+||+.+++.+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 46788899999999999999986 46888999999877777778889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+.+|+|.+..+- ..++++..+....+..+++|+|||+.+ -+|||||-.||++++.+.+|++|||.+-.+...
T Consensus 94 cgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat-- 165 (829)
T KOG0576|consen 94 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT-- 165 (829)
T ss_pred cCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh--
Confidence 999999888743 356888899999999999999999999 899999999999999999999999998765321
Q ss_pred ccccccccccccccCcccc---cCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCc--cccc
Q 004264 604 EAQTERVAGTHGYMSPEYA---NDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRA--LGLM 678 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~---~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~ 678 (765)
-.....+.||+.|||||+. +.+.|..++|||+.|+...|+-.-+.|.-..++.. +..+..+... ..+-
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-------~l~LmTkS~~qpp~lk 238 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-------ALFLMTKSGFQPPTLK 238 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-------HHHHhhccCCCCCccc
Confidence 1223468899999999976 45679999999999999999987776643333322 1112111111 1111
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
|+ .....-+-+++..|+..+|.+||+++.+++
T Consensus 239 Dk-------~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 DK-------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CC-------ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11 123445778999999999999999988763
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.7e-24 Score=190.44 Aligned_cols=113 Identities=49% Similarity=0.810 Sum_probs=98.8
Q ss_pred ccccCCCeEEcCCCeEEEEEecCCCCCCeEEEEEEeCCCCcEEEeecCCCCCCCCCceEEEeeCCceEEEcCCCCeEEEe
Q 004264 32 KFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSS 111 (765)
Q Consensus 32 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~s 111 (765)
+.|..|++|+|+++.|++|||.+... ..+.+|||+..++++||+||++.|+.+ .+.|.|+.||+|+|++.+|.+||+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSSRTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCCCcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEEe
Confidence 56889999999999999999998654 578999998433889999999999754 4899999999999999999999999
Q ss_pred ccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCC
Q 004264 112 NSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDY 150 (765)
Q Consensus 112 ~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~ 150 (765)
++..+....+|+|+|+|||||++ ..+++|||||||
T Consensus 80 ~t~~~~~~~~~~L~ddGnlvl~~----~~~~~~W~Sf~~ 114 (114)
T smart00108 80 NTTGANGNYVLVLLDDGNLVIYD----SDGNFLWQSFDY 114 (114)
T ss_pred cccCCCCceEEEEeCCCCEEEEC----CCCCEEeCCCCC
Confidence 98644556789999999999998 456799999997
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=262.14 Aligned_cols=197 Identities=20% Similarity=0.240 Sum_probs=139.0
Q ss_pred cccc-CceEeeeeee-------eecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcE
Q 004264 498 KLQH-RNLVGLLGSC-------IEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQV 569 (765)
Q Consensus 498 ~l~h-~niv~~~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 569 (765)
.++| +||++++++| .+....++++|++ +++|.+++... ...+++.+++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3455 5777788877 2334667888987 56999998532 345899999999999999999999999 9
Q ss_pred EecccCCCcEEEec-------------------CCCCeecccccceeeCCCCcc--------------cccccccccccc
Q 004264 570 IHRDLKASNILLDI-------------------NLNPKISDFGLARIFGGDDEE--------------AQTERVAGTHGY 616 (765)
Q Consensus 570 vH~Dlkp~NIll~~-------------------~~~vkL~DFGla~~~~~~~~~--------------~~~~~~~gt~~Y 616 (765)
+||||||+||||+. ++.+|++|||+++........ .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 455677777777643210000 001124578889
Q ss_pred cCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHH
Q 004264 617 MSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQ 696 (765)
Q Consensus 617 ~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~ 696 (765)
+|||++.+..++.++|||||||+||||++|..|+.... ..... .... .+.+.. .........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~----~~~~----~~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSS----LRHR----VLPPQI-----LLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHH----HHHh----hcChhh-----hhcCHHHHH
Confidence 99999999999999999999999999999887743111 00000 0000 011100 111234557
Q ss_pred HHHHccccCCCCCCCHHHHHHH
Q 004264 697 VGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 697 li~~cl~~dP~~RPs~~evl~~ 718 (765)
++.+||+.+|.+||+|.||++.
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8889999999999999999853
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.5e-23 Score=201.94 Aligned_cols=166 Identities=19% Similarity=0.168 Sum_probs=123.9
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 606 (765)
|+|.+++... ...+++..++.++.||++||.|||+.+ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-----
Confidence 6788888532 346999999999999999999999886 999999999999999 9999876432
Q ss_pred cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCcc
Q 004264 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSF 686 (765)
Q Consensus 607 ~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 686 (765)
...||+.|+|||++.+..++.++||||||+++|||++|+.||....... ............ ...... ..
T Consensus 63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~----~~~~~~---~~ 131 (176)
T smart00750 63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPA----DDPRDR---SN 131 (176)
T ss_pred --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhcc----CCcccc---cc
Confidence 2267899999999999999999999999999999999999985432211 111111100000 000000 01
Q ss_pred CHHHH--HHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 687 VESQV--LRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 687 ~~~~~--~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..... ..+.+++.+||+.+|++||++.++++.+..
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 11122 258899999999999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-22 Score=214.11 Aligned_cols=258 Identities=23% Similarity=0.254 Sum_probs=192.4
Q ss_pred CcccccccccCCceeEEEEEeCCC--cEEEEEEccccChhhHHHHHHHHHHHhcccc----CceEeeeeee-eecCceEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLSTG--QEIAAKRLSKNSGQGLEEFMNEVVLIGKLQH----RNLVGLLGSC-IEEDERML 519 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~~~--~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h----~niv~~~~~~-~~~~~~~l 519 (765)
+|++.++||+|+||.||++..... ..+|+|.-..........+..|+.++..+.+ +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999986553 4788887665433333378889999988873 5899999988 47778899
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC-----CCCeeccccc
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN-----LNPKISDFGL 594 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~vkL~DFGl 594 (765)
||+.+ |.+|.++..... .+.++..+.+.|+.|++.+|++||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 788988775444 567999999999999999999999999 9999999999999754 4689999999
Q ss_pred ce--eeCCCCcc------cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 004264 595 AR--IFGGDDEE------AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAW 666 (765)
Q Consensus 595 a~--~~~~~~~~------~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~ 666 (765)
++ .+...... ......+||..|+++....+...+.+.|+||++.++.|++.|..||................
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 99 43222211 11224669999999999999999999999999999999999999985444322211111110
Q ss_pred HhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 667 LLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 667 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
....... .... ....+.++...+-..+..++|....+...|..
T Consensus 254 -------~~~~~~~--~~~~---~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 254 -------RKLLTDR--FGDL---KPEEFAKILEYIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred -------hhhcccc--ccCC---ChHHHHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence 0011111 1111 12334455555566899999999999988755
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=215.39 Aligned_cols=177 Identities=18% Similarity=0.208 Sum_probs=135.9
Q ss_pred HHHhcCcccccccccCCceeEEEEEeC--CCcEEEEEEcccc-----ChhhHHHHHHHHHHHhccccCceEeeeeeeeec
Q 004264 442 TTATNHFSEANMIGKGGFGPVYMGKLS--TGQEIAAKRLSKN-----SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE 514 (765)
Q Consensus 442 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~l~~~-----~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~ 514 (765)
....++|.+.+.||+|+||+||+|+.. +++.+|||++... .....+.+.+|+++|++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 445678999999999999999999864 4677899987533 12235678999999999999998853322 2
Q ss_pred CceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEeccc-CCCcEEEecCCCCeecccc
Q 004264 515 DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDL-KASNILLDINLNPKISDFG 593 (765)
Q Consensus 515 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dl-kp~NIll~~~~~vkL~DFG 593 (765)
...+|||||+++++|.... . .. ...++.|++++|.|||+.+ |+|||| ||+|||++.++++||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~~---~----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR---P----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHhC---c----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 4679999999999996321 1 11 1467889999999999999 999999 9999999999999999999
Q ss_pred cceeeCCCCcccc------cccccccccccCcccccCCC------CCccccch
Q 004264 594 LARIFGGDDEEAQ------TERVAGTHGYMSPEYANDGT------ISMKSDVF 634 (765)
Q Consensus 594 la~~~~~~~~~~~------~~~~~gt~~Y~aPE~~~~~~------~s~k~Dvw 634 (765)
+++.+........ .....++..|+|||++.... .+...|-|
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9998754432211 13567888899999986432 33446666
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=186.94 Aligned_cols=257 Identities=20% Similarity=0.274 Sum_probs=193.8
Q ss_pred hcCcccccccccCCceeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHhcccc-CceEeeeeeeeecCceEEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQH-RNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h-~niv~~~~~~~~~~~~~lV~E 522 (765)
..+|.++++||+|+||.+|.|. ..+|.+||||.-..... .-++..|..+.+.|++ ..|.++..+..++....+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4689999999999999999997 57899999998655433 2467789999999985 678888889999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC---CCCeecccccceeeC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN---LNPKISDFGLARIFG 599 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~vkL~DFGla~~~~ 599 (765)
.+ +-+|+++..-.. ..++..+++-++-|++.-++|+|..+ +|||||||+|+|..-+ .++.|+|||+|+.+.
T Consensus 92 LL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 88 779988874333 34788899999999999999999999 9999999999999644 468999999999885
Q ss_pred CCCcccc-----cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCc
Q 004264 600 GDDEEAQ-----TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRA 674 (765)
Q Consensus 600 ~~~~~~~-----~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (765)
....... .....||.+|.+--...+...+.+-|+-|+|.+|..+.-|..||............+... +.+.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~----EkK~ 241 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS----EKKM 241 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH----Hhhc
Confidence 4433322 235779999999988888888999999999999999999999998665543322222221 2221
Q ss_pred cccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 675 LGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 675 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...++ .+...++ .++.-.+.-|-+.--++-|...-+.++
T Consensus 242 s~~ie-~LC~G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrql 280 (341)
T KOG1163|consen 242 STPIE-VLCKGFP----AEFAMYLNYCRGLGFEEKPDYMYLRQL 280 (341)
T ss_pred CCCHH-HHhCCCc----HHHHHHHHHHhhcCCCCCCcHHHHHHH
Confidence 11111 1111222 234455566777777777776555443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-22 Score=195.05 Aligned_cols=245 Identities=22% Similarity=0.329 Sum_probs=192.0
Q ss_pred ccccccCCceeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCCC
Q 004264 451 ANMIGKGGFGPVYMGKLSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKS 528 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gs 528 (765)
..+|.+...|..|+|+++ |..+++|++... .....+.|..|.-.|+.+.||||+.+++.|....+..++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 457889999999999985 567788888643 34445789999999999999999999999999999999999999999
Q ss_pred hhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEec-ccCCCcEEEecCCCCeecccccceeeCCCCccccc
Q 004264 529 LDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHR-DLKASNILLDINLNPKISDFGLARIFGGDDEEAQT 607 (765)
Q Consensus 529 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~-Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~ 607 (765)
|...+++. .+-..+..++.+++.+|++|++|||+.. +++-| -|....+++|++.+++|.- +-+++. .+.
T Consensus 274 lynvlhe~-t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarism-ad~kfs------fqe 343 (448)
T KOG0195|consen 274 LYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISM-ADTKFS------FQE 343 (448)
T ss_pred HHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheec-ccceee------eec
Confidence 99998653 3445788899999999999999999987 34444 5889999999999888742 111111 011
Q ss_pred ccccccccccCcccccCCCC---CccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 608 ERVAGTHGYMSPEYANDGTI---SMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 608 ~~~~gt~~Y~aPE~~~~~~~---s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
....-.+.|++||.++..+- -.++|+|||+++||||.|...||....+.+..-.+.. +.+..
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial---------------eglrv 408 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL---------------EGLRV 408 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh---------------ccccc
Confidence 12334678999999987654 3579999999999999999999998887765332211 12233
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.+++.....+.+++.-|+..||.+||.+..|+-.||+
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 4444456678899999999999999999999999986
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-20 Score=195.89 Aligned_cols=262 Identities=27% Similarity=0.365 Sum_probs=197.4
Q ss_pred cccccccccCCceeEEEEEeCCCcEEEEEEccccChh---hHHHHHHHHHHHhccccC-ceEeeeeeeeecCceEEEEEe
Q 004264 448 FSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQ---GLEEFMNEVVLIGKLQHR-NLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~~Ev~~l~~l~h~-niv~~~~~~~~~~~~~lV~E~ 523 (765)
|.+.+.||.|+|+.||++... +.+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999976 78899998765332 467899999999999988 799999999777778999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC-CCeecccccceeeCCCC
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL-NPKISDFGLARIFGGDD 602 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~vkL~DFGla~~~~~~~ 602 (765)
+.++++.+++........+.......++.|++.++.|+|+.+ ++||||||+||+++..+ .++++|||.++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966633221136889999999999999999999999 99999999999999988 79999999998665433
Q ss_pred ccc----ccccccccccccCcccccC---CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcc
Q 004264 603 EEA----QTERVAGTHGYMSPEYAND---GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRAL 675 (765)
Q Consensus 603 ~~~----~~~~~~gt~~Y~aPE~~~~---~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (765)
... ......++..|+|||.+.+ ..+....|+||+|++++++++|..|+...... ................
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 322 2356789999999999988 67899999999999999999999996544321 0011111111111100
Q ss_pred ccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 676 GLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 676 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.................+.+++..++..+|..|.++.+....
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000002223456788889999999999999887753
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-20 Score=186.78 Aligned_cols=201 Identities=21% Similarity=0.304 Sum_probs=170.7
Q ss_pred CcccccccccCCceeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHhccc-cCceEeeeeeeeecCceEEEEEec
Q 004264 447 HFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
+|.+.++||+|+||.++.|+ +-+++.||||.-...+ ..-++..|...++.|. .+.|..++.+..++.+..||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 68899999999999999997 4578999999754433 2356778888888885 789999999999999999999998
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC-----CCCeecccccceeeC
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN-----LNPKISDFGLARIFG 599 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~vkL~DFGla~~~~ 599 (765)
|-||+++.--. +..++..++..++.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+|+.+.
T Consensus 107 -GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 -GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred -CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 77998887433 345999999999999999999999999 9999999999999543 458999999999886
Q ss_pred CCCcccc-----cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCC
Q 004264 600 GDDEEAQ-----TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHP 655 (765)
Q Consensus 600 ~~~~~~~-----~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~ 655 (765)
....... .....||.+||+--...+.+.+.+-|+-|||-++++.+-|..||...-.
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 5443322 3457899999999999999999999999999999999999999976543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.8e-21 Score=220.00 Aligned_cols=254 Identities=21% Similarity=0.262 Sum_probs=187.2
Q ss_pred cccccccCCceeEEEEEeC-CCcEEEEEEcc----c-cC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 450 EANMIGKGGFGPVYMGKLS-TGQEIAAKRLS----K-NS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 450 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~----~-~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
..+.+|.|.+|.|+..... ..+..+.|.+. . .. .+....+..|+.+=..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4568999999977776532 33334444332 1 11 1112225667777888999999998888887777777799
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|++. +|..++... ..+...++.-+++|+++|+.|+|+.| |.||||||+|++++.++.+||+|||.+..+.-..
T Consensus 402 ~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 888887432 35778888999999999999999999 9999999999999999999999999998876554
Q ss_pred cc--cccccccccccccCcccccCCCCCcc-ccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 603 EE--AQTERVAGTHGYMSPEYANDGTISMK-SDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 603 ~~--~~~~~~~gt~~Y~aPE~~~~~~~s~k-~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
+. ......+|...|+|||.+.+..|.+. .||||.|+++..|++|+.||......+.... .........+.
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-------~~~~~~~~~~~ 547 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-------TNNYSDQRNIF 547 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-------hhccccccccc
Confidence 44 44456889999999999999999764 8999999999999999999876554443220 00000000000
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
. -..........+...++.+||+.+|.+|-|+++|++.
T Consensus 548 ~-~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 548 E-GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred c-ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0 0011222334567789999999999999999999853
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.3e-21 Score=217.35 Aligned_cols=251 Identities=18% Similarity=0.203 Sum_probs=182.0
Q ss_pred CcccccccccCCceeEEEEEeCCCcEEEEEEccccC-hhhHHHHHHHHHHH--hccccCceEeeeeeeeecCceEEEEEe
Q 004264 447 HFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNS-GQGLEEFMNEVVLI--GKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~Ev~~l--~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
++...+.||++.|=+|.++++++|. |+||++.+.. ....+.|.++++-+ ..++|||++++...-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666789999999999999998887 9999987654 33455555544444 445899999998887777888899999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC-C
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD-D 602 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~-~ 602 (765)
+.+ +|.+.+ ..+..+...+...|+-|++.||..+|+.+ |+|+|||.+||||++-.-+.|+||...+...-. +
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 866 566666 34556888889999999999999999999 999999999999999999999999887643211 1
Q ss_pred cccc----cccccccccccCcccccCC----------C-CCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 004264 603 EEAQ----TERVAGTHGYMSPEYANDG----------T-ISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAW 666 (765)
Q Consensus 603 ~~~~----~~~~~gt~~Y~aPE~~~~~----------~-~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~ 666 (765)
.... ........+|+|||.+... . .+++.||||+||+++||++ |+++|...+ ..
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----------L~ 245 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----------LL 245 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----------HH
Confidence 1111 1223344569999987431 2 6789999999999999988 577764211 11
Q ss_pred HhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 667 LLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 667 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
. ++.+. ...++..++. + +...+.++++.|++.||.+|.++++.++.-.+
T Consensus 246 a-Yr~~~-~~~~e~~Le~-I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 246 A-YRSGN-ADDPEQLLEK-I---EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred h-HhccC-ccCHHHHHHh-C---cCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 1 11111 1111111110 0 11247789999999999999999999998654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.4e-20 Score=185.43 Aligned_cols=174 Identities=13% Similarity=0.131 Sum_probs=135.7
Q ss_pred HHHhcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHH---H------HHHHHHHHhccccCceEeeeeeee
Q 004264 442 TTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLE---E------FMNEVVLIGKLQHRNLVGLLGSCI 512 (765)
Q Consensus 442 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~---~------~~~Ev~~l~~l~h~niv~~~~~~~ 512 (765)
....++|.+.++||.|+||.||.... +++.+|+|.+........+ . +.+|+..+.++.|++|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 34578999999999999999999766 5778999999754322222 2 678999999999999999988866
Q ss_pred ec--------CceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC
Q 004264 513 EE--------DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN 584 (765)
Q Consensus 513 ~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 584 (765)
.. ...+|||||++|.+|.++.. ++. ....+++.+|..+|+.+ ++|||+||+||+++.+
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~ 171 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN 171 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence 43 35789999999999977631 222 24568999999999999 9999999999999998
Q ss_pred CCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh
Q 004264 585 LNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645 (765)
Q Consensus 585 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt 645 (765)
+ ++|+|||.......... . ..+.....|..++|+|+||+.+..+..
T Consensus 172 g-i~liDfg~~~~~~e~~a---~-----------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKA---K-----------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred C-EEEEECCCcccccchhh---H-----------HHHHHHhHhcccccccceeEeehHHHH
Confidence 8 99999998876421111 0 113445567789999999999887653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-19 Score=179.63 Aligned_cols=139 Identities=16% Similarity=0.104 Sum_probs=108.3
Q ss_pred ccccccCCceeEEEEEeCCCcEEEEEEccccChh--h------------------------HHHHHHHHHHHhccccCce
Q 004264 451 ANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQ--G------------------------LEEFMNEVVLIGKLQHRNL 504 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~------------------------~~~~~~Ev~~l~~l~h~ni 504 (765)
.+.||+|+||.||+|..++|+.||+|++...... . .....+|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999998653210 0 1123459999999987776
Q ss_pred EeeeeeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHh-hhcCCCcEEecccCCCcEEEec
Q 004264 505 VGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL-HQDSKLQVIHRDLKASNILLDI 583 (765)
Q Consensus 505 v~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~L-H~~~~~~ivH~Dlkp~NIll~~ 583 (765)
...... .....+|||||++++++..... ....++...+..++.|++.+|.+| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~--~~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPI--LLKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEE--EecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 433322 1223489999999987754432 124588999999999999999999 6888 99999999999998
Q ss_pred CCCCeecccccceee
Q 004264 584 NLNPKISDFGLARIF 598 (765)
Q Consensus 584 ~~~vkL~DFGla~~~ 598 (765)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.7e-19 Score=173.46 Aligned_cols=140 Identities=18% Similarity=0.174 Sum_probs=110.6
Q ss_pred ccccccCCceeEEEEEeCCCcEEEEEEccccChh--------------------------hHHHHHHHHHHHhccccCce
Q 004264 451 ANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQ--------------------------GLEEFMNEVVLIGKLQHRNL 504 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--------------------------~~~~~~~Ev~~l~~l~h~ni 504 (765)
.+.||+|++|.||+|...+|+.||||++...... ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998754210 01224578999999998887
Q ss_pred EeeeeeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhh-cCCCcEEecccCCCcEEEec
Q 004264 505 VGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ-DSKLQVIHRDLKASNILLDI 583 (765)
Q Consensus 505 v~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~ 583 (765)
.....+... ..+|||||++++++...... ...++......++.|++.++.++|+ .+ |+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 444333222 35899999998865433221 2346788899999999999999999 88 99999999999999
Q ss_pred CCCCeecccccceeeC
Q 004264 584 NLNPKISDFGLARIFG 599 (765)
Q Consensus 584 ~~~vkL~DFGla~~~~ 599 (765)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.4e-18 Score=168.34 Aligned_cols=185 Identities=18% Similarity=0.126 Sum_probs=138.5
Q ss_pred cccccccCCceeEEEEEeCCCcEEEEEEccccChh----hHHHHHHHHHHHhccc-cCceEeeeeeeeecCceEEEEEec
Q 004264 450 EANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQ----GLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 450 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
+...|++|+||+||.+.. .+..++.+.+.....- ....+.+|+++|++|+ |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999998776 6777887777644321 1235889999999995 5788888875 4568999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEeccc-CCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDL-KASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dl-kp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
.|.+|...+. . ....++.|++++|.++|+.+ |+|||| ||+|||++.++.++|+|||++........
T Consensus 81 ~G~~L~~~~~---------~-~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPP---------R-GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhh---------h-hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9998864431 1 12357789999999999999 999999 79999999999999999999986543321
Q ss_pred c----cc-------cccccccccccCcccccCC-CCC-ccccchHHHHHHHHHHhCCCCCCC
Q 004264 604 E----AQ-------TERVAGTHGYMSPEYANDG-TIS-MKSDVFSLGVLLVEIVSGKMNRGF 652 (765)
Q Consensus 604 ~----~~-------~~~~~gt~~Y~aPE~~~~~-~~s-~k~DvwSlG~ll~elltG~~p~~~ 652 (765)
. .. ......++.|++|+...-. ..+ ...+.++-|+.+|.++|++.+.-.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 00 0112356778888755432 223 567999999999999999987543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.8e-19 Score=207.06 Aligned_cols=202 Identities=21% Similarity=0.252 Sum_probs=165.5
Q ss_pred hHHHHhcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccc---cCceEeeeeeeeecCc
Q 004264 440 TITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ---HRNLVGLLGSCIEEDE 516 (765)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~---h~niv~~~~~~~~~~~ 516 (765)
++....+.|.|.+.||+|+||.||+|...+++.+|+|+-.....- +|.-=.+++.+|+ -+-|+++..++...+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 345567889999999999999999999888999999987544321 1111122333333 3456667777777888
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec-------CCCCee
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI-------NLNPKI 589 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-------~~~vkL 589 (765)
-+||+||.+.|+|.+++. ..+.+++..+..++.||++-+++||..+ |||+||||+|.||.. ...++|
T Consensus 769 S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred ceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence 999999999999999994 6677999999999999999999999999 999999999999942 345899
Q ss_pred cccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCC
Q 004264 590 SDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNR 650 (765)
Q Consensus 590 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~ 650 (765)
+|||.+..+............++|-.+--+|+..+.+++..+|.|.|+.+++-|+.|+...
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q 903 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME 903 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH
Confidence 9999998775544555566788899999999999999999999999999999999998653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.3e-18 Score=176.23 Aligned_cols=233 Identities=22% Similarity=0.276 Sum_probs=149.9
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhcccc----------CceEeeeeeee
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQH----------RNLVGLLGSCI 512 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h----------~niv~~~~~~~ 512 (765)
.....+.||.|+++.||.+++. +++++++|++.-. .....+++++|.-.+..+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3455678999999999999976 5889999997633 34456777777766655422 12222222211
Q ss_pred ---------ecC--------ceEEEEEecCCCChhHHhhc---ccc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEe
Q 004264 513 ---------EED--------ERMLIYEYMPHKSLDYFIFD---RER-SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIH 571 (765)
Q Consensus 513 ---------~~~--------~~~lV~E~~~~gsL~~~l~~---~~~-~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH 571 (765)
... ..+++|+-+ .++|.+++.. ... ...+....++.+..|+++.+++||+.| ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 111 235677776 5677766532 111 123445566778899999999999999 999
Q ss_pred cccCCCcEEEecCCCCeecccccceeeCCCCcccccccccccccccCcccccC--------CCCCccccchHHHHHHHHH
Q 004264 572 RDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND--------GTISMKSDVFSLGVLLVEI 643 (765)
Q Consensus 572 ~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~k~DvwSlG~ll~el 643 (765)
+||||+|++++.+|.++|+||+.....+.... ....+..|.+||.... ..++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999998876432111 1234577999997643 2578899999999999999
Q ss_pred HhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCC
Q 004264 644 VSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDR 709 (765)
Q Consensus 644 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 709 (765)
.+|+.||+...+...... .+. .+. ...+.+..||..+|+.+|++|
T Consensus 244 WC~~lPf~~~~~~~~~~~---------------~f~-----~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW---------------DFS-----RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG---------------GGT-----TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc---------------cch-----hcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999986544322111 111 222 445667788999999999988
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=7e-18 Score=184.49 Aligned_cols=215 Identities=23% Similarity=0.374 Sum_probs=162.4
Q ss_pred HhccccCceEeeeeeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcE-Eeccc
Q 004264 496 IGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQV-IHRDL 574 (765)
Q Consensus 496 l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i-vH~Dl 574 (765)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....+++--...+.++|++||+|||... | .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence 4578999999999999999999999999999999999965 3445888889999999999999999886 5 99999
Q ss_pred CCCcEEEecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCC-------CCccccchHHHHHHHHHHhCC
Q 004264 575 KASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGT-------ISMKSDVFSLGVLLVEIVSGK 647 (765)
Q Consensus 575 kp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-------~s~k~DvwSlG~ll~elltG~ 647 (765)
++.|.++|....+||+|||+.................-..-|.|||.+.+.. .+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999998764311112222233455699999997641 467799999999999999999
Q ss_pred CCCCCCCCCCcc-cHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 648 MNRGFRHPGHRH-NLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 648 ~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
.||......... .++... .. .....+-+.+... .+....++.++..||..+|++||++.+|...++..
T Consensus 156 ~~~~~~~~~~~~~eii~~~----~~-~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRV----KK-GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred CccccccccCChHHHHHHH----Hh-cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 999764433222 222221 11 1111111111111 02233688999999999999999999999888653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1e-18 Score=190.62 Aligned_cols=251 Identities=23% Similarity=0.301 Sum_probs=186.9
Q ss_pred ccccCCceeEEEEE----eCCCcEEEEEEccccChh--hHHHHHHHHHHHhccc-cCceEeeeeeeeecCceEEEEEecC
Q 004264 453 MIGKGGFGPVYMGK----LSTGQEIAAKRLSKNSGQ--GLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 453 ~LG~G~fg~Vy~~~----~~~~~~vavK~l~~~~~~--~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
.+|+|.||.|++++ .+.++.+++|.+.+.... .......|..++...+ ||.++++...+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999775 345778999988764211 1125566888888887 9999999999999999999999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+|.|...+ .....+.+.....+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-..
T Consensus 81 gg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~---- 150 (612)
T KOG0603|consen 81 GGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE---- 150 (612)
T ss_pred cchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhh----
Confidence 99887666 33344666667777788999999999999 999999999999999999999999999875221
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCc
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDS 685 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 685 (765)
+..+||..|||||++. .....+|.||||++++||++|..||.. +... .++. .+-.
T Consensus 151 --~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~---------------~Il~--~~~~ 205 (612)
T KOG0603|consen 151 --KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMK---------------RILK--AELE 205 (612)
T ss_pred --hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHH---------------HHhh--hccC
Confidence 1228999999999998 667789999999999999999999875 1100 0111 1122
Q ss_pred cCHHHHHHHHHHHHHccccCCCCCCCH--HHHHHHHhc-----------CCCCCCCCCCCCccccc
Q 004264 686 FVESQVLRCIQVGLLCVQKLPEDRPDM--SSVVFLLAN-----------DGVTLPQPRQPGFFTER 738 (765)
Q Consensus 686 ~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl~~L~~-----------~~~~l~~p~~p~~~~~~ 738 (765)
.+.........++..++..+|..|--. ..+.+.++. .....+.|-.|+.-.++
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~ 271 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITER 271 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchh
Confidence 344445556677888888999998765 344333322 11234566666665543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.2e-17 Score=162.83 Aligned_cols=135 Identities=18% Similarity=0.224 Sum_probs=105.6
Q ss_pred cccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhcc-----ccCceEeeeeeeeecC---c-eEEE
Q 004264 450 EANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-----QHRNLVGLLGSCIEED---E-RMLI 520 (765)
Q Consensus 450 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-----~h~niv~~~~~~~~~~---~-~~lV 520 (765)
-.+.||+|+|+.||. +++....+||+.........+.+.+|+.+++++ .||||+++++++.++. . ..+|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 356899999999996 544444579988765444567899999999999 5799999999998864 2 3378
Q ss_pred EEe--cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHH-HHhhhcCCCcEEecccCCCcEEEec----CCCCeecccc
Q 004264 521 YEY--MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGL-LYLHQDSKLQVIHRDLKASNILLDI----NLNPKISDFG 593 (765)
Q Consensus 521 ~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~vkL~DFG 593 (765)
+|| +.+++|.+++... .+++. ..++.|++.++ +|||+++ |+||||||+|||++. +.+++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 5589999999432 24444 35677888777 9999999 999999999999974 3479999944
Q ss_pred cc
Q 004264 594 LA 595 (765)
Q Consensus 594 la 595 (765)
-+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.8e-16 Score=160.81 Aligned_cols=143 Identities=17% Similarity=0.130 Sum_probs=111.8
Q ss_pred cCcccccccccCCceeEEEEE--eCCCcEEEEEEccccChh------------------------hHHHHHHHHHHHhcc
Q 004264 446 NHFSEANMIGKGGFGPVYMGK--LSTGQEIAAKRLSKNSGQ------------------------GLEEFMNEVVLIGKL 499 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~Ev~~l~~l 499 (765)
..|.+.+.||+|++|.||+|. ..+|+.||+|++...... ....+..|+.++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358899999999999999998 568999999998643210 112356899999999
Q ss_pred ccC--ceEeeeeeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCC
Q 004264 500 QHR--NLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKAS 577 (765)
Q Consensus 500 ~h~--niv~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~ 577 (765)
.+. .+.++++. ...++||||+++.+|...... ...........++.||+.+|.+||+.+ .|+||||||+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~ 178 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY 178 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence 753 34444432 235899999999888665422 223556667899999999999999886 4999999999
Q ss_pred cEEEecCCCCeecccccceee
Q 004264 578 NILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 578 NIll~~~~~vkL~DFGla~~~ 598 (765)
||+++ ++.++|+|||.+...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 889999999999864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.7e-16 Score=157.78 Aligned_cols=134 Identities=21% Similarity=0.314 Sum_probs=112.8
Q ss_pred cccccCCceeEEEEEeCCCcEEEEEEccccCh--------hhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 452 NMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSG--------QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--------~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
+.||+|++|.||+|.. .+..+++|+...... .....+.+|+.++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 677888997653221 1124578899999999999988777777778889999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
+++++|.+++... .. .+..++.+++.+|.++|+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999887421 12 78899999999999999999 99999999999999 78999999999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.1e-17 Score=175.83 Aligned_cols=124 Identities=30% Similarity=0.430 Sum_probs=111.1
Q ss_pred ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccc
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA 595 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla 595 (765)
..++.|+++...+|.+++..+......++...+.++.|++.+++| ++ .+|+|+||.||++..+.++||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999877777778999999999999999999 66 999999999999999999999999999
Q ss_pred eeeCCCC----cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh
Q 004264 596 RIFGGDD----EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645 (765)
Q Consensus 596 ~~~~~~~----~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt 645 (765)
....... .....+...||..||+||.+.+..|+.|+||||||+||+|++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 8765443 2334556789999999999999999999999999999999997
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.5e-16 Score=154.90 Aligned_cols=144 Identities=19% Similarity=0.155 Sum_probs=112.7
Q ss_pred hHHHHhcCcccccccccCCceeEEEEEeCCCcEEEEEEccccCh----------------------hhHHHHHHHHHHHh
Q 004264 440 TITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSG----------------------QGLEEFMNEVVLIG 497 (765)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~----------------------~~~~~~~~Ev~~l~ 497 (765)
++......|.+.+.||+|+||.||++..++++.+|||++..... .....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 34444445888899999999999999988899999998654220 01123667899999
Q ss_pred ccccCc--eEeeeeeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccC
Q 004264 498 KLQHRN--LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLK 575 (765)
Q Consensus 498 ~l~h~n--iv~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlk 575 (765)
.+.|++ +.+.++ ....++||||+++++|..... ......++.+++.++.++|+.+ |+|+|||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 998774 444443 245589999999999876541 1345678899999999999998 9999999
Q ss_pred CCcEEEecCCCCeecccccceeeC
Q 004264 576 ASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 576 p~NIll~~~~~vkL~DFGla~~~~ 599 (765)
|+||++++++.++|+|||++....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.6e-16 Score=159.88 Aligned_cols=197 Identities=21% Similarity=0.257 Sum_probs=139.2
Q ss_pred ccCceEeeeeeeee---------------------------cCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHH
Q 004264 500 QHRNLVGLLGSCIE---------------------------EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIIT 552 (765)
Q Consensus 500 ~h~niv~~~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 552 (765)
+|||||++.++|.+ ....|+||...+ .+|..++..+ ..+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC----CCchHHHHHHHH
Confidence 59999999988764 234678888764 4777777433 356677778999
Q ss_pred HHHHHHHHhhhcCCCcEEecccCCCcEEEe--cCC--CCeecccccceeeCCCCc----ccccccccccccccCcccccC
Q 004264 553 GIARGLLYLHQDSKLQVIHRDLKASNILLD--INL--NPKISDFGLARIFGGDDE----EAQTERVAGTHGYMSPEYAND 624 (765)
Q Consensus 553 qia~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~vkL~DFGla~~~~~~~~----~~~~~~~~gt~~Y~aPE~~~~ 624 (765)
|+++|+.|||+++ |.|||+|.+|||+. ++. .+.|+|||++-.-....- .......-|.-.-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 99999999999993 443 468899999865322111 111123456777899999865
Q ss_pred CC------CCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHH
Q 004264 625 GT------ISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVG 698 (765)
Q Consensus 625 ~~------~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li 698 (765)
.+ --.|+|.|+.|.+.||++....||....+..... ..+++..+..+.+.+ ...+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~------r~Yqe~qLPalp~~v---------pp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT------RTYQESQLPALPSRV---------PPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech------hhhhhhhCCCCcccC---------ChHHHHHH
Confidence 32 2358999999999999999999997633321110 112233333333332 33467899
Q ss_pred HHccccCCCCCCCHHHHHHHH
Q 004264 699 LLCVQKLPEDRPDMSSVVFLL 719 (765)
Q Consensus 699 ~~cl~~dP~~RPs~~evl~~L 719 (765)
...|+.||.+||+..-....|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 999999999999987666655
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.5e-16 Score=154.48 Aligned_cols=130 Identities=25% Similarity=0.377 Sum_probs=106.6
Q ss_pred ccccCCceeEEEEEeCCCcEEEEEEccccC--------hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 453 MIGKGGFGPVYMGKLSTGQEIAAKRLSKNS--------GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 453 ~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
.||+|+||.||+|.. +++.+++|+..... .....++.+|+.++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 57889999865321 112356788999999999887655555566677789999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
++++|.+.+.... ..++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988773211 078999999999999999 99999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-16 Score=128.25 Aligned_cols=64 Identities=61% Similarity=1.253 Sum_probs=55.9
Q ss_pred CCCCCceEEeccccCCCCc--cccccCChHhHHHHhhccCCcccccccccCCCCcceeecccccccc
Q 004264 336 CPSGEGFLKLPRMKLPENY--WSNKSMNLKECEAECTKNCSCRAYANSDVTGGGSGCLMWFGDLVDL 400 (765)
Q Consensus 336 C~~~~~f~~~~~~~~p~~~--~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~~~~C~~w~gdli~l 400 (765)
|..+|+|+++++|++|++. ....++++++|++.||+||||+||+|.++. ++++|++|+++|+++
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 5567999999999999986 444679999999999999999999987665 668999999999875
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.2e-16 Score=176.89 Aligned_cols=139 Identities=19% Similarity=0.289 Sum_probs=112.6
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEcccc-------ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCce
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKN-------SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDER 517 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~-------~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~ 517 (765)
...|...+.||+|+||.||++.......++.++..+. .....+++.+|+.++++++|++++....++......
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 4455678899999999999998755443333323221 112235688999999999999998887777777788
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999988873 35678999999999999999 9999999999999 678999999999986
Q ss_pred e
Q 004264 598 F 598 (765)
Q Consensus 598 ~ 598 (765)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.7e-16 Score=178.45 Aligned_cols=213 Identities=22% Similarity=0.291 Sum_probs=145.1
Q ss_pred hcCcccccccccCCceeEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLST-GQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
..+|..++.|..|++|.||..+++. .+.+|+ +++++.-.. + + |+.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~lil-R---n---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLIL-R---N---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccchhh-h---c---cccccCCccee------------------
Confidence 3678889999999999999998764 567787 443322110 0 0 33333344443
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC--
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD-- 601 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~-- 601 (765)
|+-...+ +..++++... +.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+++.-...
T Consensus 136 ---gDc~tll---k~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLL---KNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhc---ccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 2222222 2223344333 78899999999 999999999999999999999999998763211
Q ss_pred -----------CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhc
Q 004264 602 -----------DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWN 670 (765)
Q Consensus 602 -----------~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 670 (765)
..+...+.++||+.|+|||++....|...+|.|++|+|+||.+-|..||....+++.......-...|.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp 278 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 278 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence 111123457999999999999999999999999999999999999999988776653222211111111
Q ss_pred cCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 004264 671 DGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSS 714 (765)
Q Consensus 671 ~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 714 (765)
++ +.....+...++.+.|+.+|..|--...
T Consensus 279 E~--------------dea~p~Ea~dli~~LL~qnp~~Rlgt~g 308 (1205)
T KOG0606|consen 279 EE--------------DEALPPEAQDLIEQLLRQNPLCRLGTGG 308 (1205)
T ss_pred cc--------------CcCCCHHHHHHHHHHHHhChHhhcccch
Confidence 11 1222334567788889999999964333
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.8e-14 Score=135.08 Aligned_cols=135 Identities=22% Similarity=0.209 Sum_probs=114.2
Q ss_pred cccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhcccc--CceEeeeeeeeecCceEEEEEecCCC
Q 004264 450 EANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQH--RNLVGLLGSCIEEDERMLIYEYMPHK 527 (765)
Q Consensus 450 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h--~niv~~~~~~~~~~~~~lV~E~~~~g 527 (765)
+.+.||+|.++.||++...+ +.+++|....... ...+.+|+.+++.++| .++++++.+....+..++++||+++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999755 7899998865443 5678899999999986 58999998888888899999999988
Q ss_pred ChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 528 SLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 528 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
.+..+ +......++.+++++|+++|......++|+|++|+||++++.+.++++|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77433 4566677899999999999996444599999999999999989999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.4e-14 Score=141.63 Aligned_cols=136 Identities=19% Similarity=0.209 Sum_probs=97.8
Q ss_pred ccccccCCceeEEEEEeCCCcEEEEEEccccChh--hHHH----------------------HHHHHHHHhccccCc--e
Q 004264 451 ANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQ--GLEE----------------------FMNEVVLIGKLQHRN--L 504 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~~~~----------------------~~~Ev~~l~~l~h~n--i 504 (765)
.+.||+|+||.||+|...+++.||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999988643211 1111 134556666654432 3
Q ss_pred EeeeeeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhh-cCCCcEEecccCCCcEEEec
Q 004264 505 VGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ-DSKLQVIHRDLKASNILLDI 583 (765)
Q Consensus 505 v~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~ 583 (765)
.+.+++ ...++||||++++.+......... . ...+..++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 334332 346899999999554221111100 1 15678899999999999999 87 99999999999999
Q ss_pred CCCCeecccccceee
Q 004264 584 NLNPKISDFGLARIF 598 (765)
Q Consensus 584 ~~~vkL~DFGla~~~ 598 (765)
++.++|+|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 899999999999765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.8e-15 Score=171.91 Aligned_cols=255 Identities=24% Similarity=0.317 Sum_probs=189.2
Q ss_pred cCcccccccccCCceeEEEEEeCC--CcEEEEEEccccC--hhhHHHHHHHHHHHhccc-cCceEeeeeeeeecCceEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLST--GQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~~~lV 520 (765)
..|.+.+.||+|+|+.|-...... ...+++|.+.... .........|..+-+.+. |+|++++++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 457777889999999998876533 3456666665432 333445556888888887 99999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhh-hcCCCcEEecccCCCcEEEecCC-CCeecccccceee
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLH-QDSKLQVIHRDLKASNILLDINL-NPKISDFGLARIF 598 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~vkL~DFGla~~~ 598 (765)
.||..++++...+.. ......+....-.++.|+..++.|+| ..+ +.|+||||+|.+++..+ .++++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999998777731 11224667777889999999999999 888 99999999999999999 9999999999988
Q ss_pred CC-CCcccccccccc-cccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcc
Q 004264 599 GG-DDEEAQTERVAG-THGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRAL 675 (765)
Q Consensus 599 ~~-~~~~~~~~~~~g-t~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (765)
.. ..........+| ++.|.|||...+. ...+..|+||.|+++.-+++|..|+......+.... .+.+.+
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~------~~~~~~-- 247 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS------SWKSNK-- 247 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce------eecccc--
Confidence 76 455555556778 9999999999885 457789999999999999999999876554331100 011111
Q ss_pred ccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 004264 676 GLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVV 716 (765)
Q Consensus 676 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 716 (765)
......+.. .......++...++..+|..|.+.+++.
T Consensus 248 ~~~~~~~~~----~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 248 GRFTQLPWN----SISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cccccCccc----cCChhhhhcccccccCCchhcccccccc
Confidence 000001111 1122344677788889999999988875
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-13 Score=141.97 Aligned_cols=135 Identities=19% Similarity=0.264 Sum_probs=104.1
Q ss_pred cccc-cCCceeEEEEEeCCCcEEEEEEccccC-------------hhhHHHHHHHHHHHhccccCce--EeeeeeeeecC
Q 004264 452 NMIG-KGGFGPVYMGKLSTGQEIAAKRLSKNS-------------GQGLEEFMNEVVLIGKLQHRNL--VGLLGSCIEED 515 (765)
Q Consensus 452 ~~LG-~G~fg~Vy~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~Ev~~l~~l~h~ni--v~~~~~~~~~~ 515 (765)
..|| .||.|+||++... +..+++|++.... ......+.+|+.++.+|+|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4577 8899999998874 6788998875321 1223567889999999998774 66776654432
Q ss_pred c----eEEEEEecCC-CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeec
Q 004264 516 E----RMLIYEYMPH-KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKIS 590 (765)
Q Consensus 516 ~----~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~ 590 (765)
. .++|||++++ .+|.+++.. ..++.. .+.+|+.+|.+||+.| |+|+||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 3599999997 688888732 223433 3578999999999999 9999999999999998999999
Q ss_pred ccccceee
Q 004264 591 DFGLARIF 598 (765)
Q Consensus 591 DFGla~~~ 598 (765)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99999763
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.3e-12 Score=143.64 Aligned_cols=140 Identities=21% Similarity=0.222 Sum_probs=99.9
Q ss_pred cccccCCceeEEEEEeCCCcEEEEEEccccChhhH----------------------------------------HHHHH
Q 004264 452 NMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGL----------------------------------------EEFMN 491 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~----------------------------------------~~~~~ 491 (765)
+.||+|++|.||+|++++|+.||||+......... -.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999999999999999864321110 01444
Q ss_pred HHHHHhccc----cCceEeeeeee-eecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHH-HHHHhhhcC
Q 004264 492 EVVLIGKLQ----HRNLVGLLGSC-IEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIAR-GLLYLHQDS 565 (765)
Q Consensus 492 Ev~~l~~l~----h~niv~~~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-aL~~LH~~~ 565 (765)
|+..+.+++ |.+-+.+-..+ ......+|||||++|.+|.+....... .. .+..++.++++ .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 555555542 22223322222 224567999999999999877632211 11 24456666666 478899988
Q ss_pred CCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 566 ~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
++|+|+||.||+++.+++++++|||++..+.
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.32 E-value=2e-12 Score=107.05 Aligned_cols=71 Identities=23% Similarity=0.369 Sum_probs=58.4
Q ss_pred CCCCCceEEeccccCCCCccccccCChHhHHHHhhc---cCCcccccccccCCCCcceeeccccc-cccccccCCccccc
Q 004264 336 CPSGEGFLKLPRMKLPENYWSNKSMNLKECEAECTK---NCSCRAYANSDVTGGGSGCLMWFGDL-VDLRECSEGYIWGQ 411 (765)
Q Consensus 336 C~~~~~f~~~~~~~~p~~~~~~~~~s~~~C~~~Cl~---nCsC~a~~~~~~~~~~~~C~~w~gdl-i~l~~~~~~~~~~~ 411 (765)
|....+|+++.+|++|++.. ++++||++.|++ ||||+||+|.+. +.||++|++++ ++++.... .+.
T Consensus 5 ~~~~g~fl~~~~~klpd~~~----~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~~---~g~ 74 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA----NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEFS---HGF 74 (80)
T ss_pred eecCCeEEEeecccCCcccc----cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhccC---CCc
Confidence 34557899999999998754 689999999999 999999997543 35899999999 99887643 367
Q ss_pred ceEEe
Q 004264 412 DFFIR 416 (765)
Q Consensus 412 ~~~lr 416 (765)
++|+|
T Consensus 75 ~Ly~r 79 (80)
T cd00129 75 DLYEN 79 (80)
T ss_pred eeEeE
Confidence 78876
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.3e-12 Score=127.08 Aligned_cols=205 Identities=22% Similarity=0.257 Sum_probs=141.1
Q ss_pred HHHhccccCceEeeeeeeeec-----CceEEEEEecCCCChhHHhhcc-ccCCCCChHHHHHHHHHHHHHHHHhhhcCCC
Q 004264 494 VLIGKLQHRNLVGLLGSCIEE-----DERMLIYEYMPHKSLDYFIFDR-ERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567 (765)
Q Consensus 494 ~~l~~l~h~niv~~~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 567 (765)
.-|-++-|.|||+++.|..+. .+..++.|||+.|++..+|... +....+....-.+|.-||..||.|||+-. .
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 344456799999998887643 4578899999999999999764 33456777788889999999999999875 6
Q ss_pred cEEecccCCCcEEEecCCCCeeccccc--ceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh
Q 004264 568 QVIHRDLKASNILLDINLNPKISDFGL--ARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645 (765)
Q Consensus 568 ~ivH~Dlkp~NIll~~~~~vkL~DFGl--a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt 645 (765)
+|+|+++.-+.|++..++-+|+.---- ....-............+.++|.|||+-..-..+.++|||+||+..+||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 799999999999999988888752111 111001111122234567789999998888888899999999999999998
Q ss_pred CCCCCCCCC-CCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 004264 646 GKMNRGFRH-PGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719 (765)
Q Consensus 646 G~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 719 (765)
+..-..... ....+.-+.. -+..+-+... ..++..|++..|..||+|.+++...
T Consensus 278 lEiq~tnseS~~~~ee~ia~--------~i~~len~lq------------r~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIAN--------VIIGLENGLQ------------RGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred heeccCCCcceeehhhhhhh--------heeeccCccc------------cCcCcccccCCCCCCcchhhhhcCc
Confidence 875321111 1111000000 0111111111 2466789999999999999987543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.7e-11 Score=119.09 Aligned_cols=130 Identities=19% Similarity=0.122 Sum_probs=97.4
Q ss_pred cccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceE-eeeeeeeecCceEEEEEecCCCChh
Q 004264 452 NMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLV-GLLGSCIEEDERMLIYEYMPHKSLD 530 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv-~~~~~~~~~~~~~lV~E~~~~gsL~ 530 (765)
+.|+.|.++.||+++.. ++.+++|....... ....+.+|+.+++.+.+.+++ +++.. .....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence 56899999999999865 77899998765432 223567899999998765544 34433 234568999999998875
Q ss_pred HHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcC--CCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 531 YFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS--KLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 531 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
... .....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 80 ~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 320 111345678999999999987 23369999999999999 67899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.7e-11 Score=104.19 Aligned_cols=80 Identities=45% Similarity=0.982 Sum_probs=62.2
Q ss_pred CCCCCCC---CceEEeccccCCCCccccccCChHhHHHHhhccCCcccccccccCCCCcceeeccccccccccccCCccc
Q 004264 333 PSDCPSG---EGFLKLPRMKLPENYWSNKSMNLKECEAECTKNCSCRAYANSDVTGGGSGCLMWFGDLVDLRECSEGYIW 409 (765)
Q Consensus 333 ~~~C~~~---~~f~~~~~~~~p~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~~~~C~~w~gdli~l~~~~~~~~~ 409 (765)
++.|... ++|+.++++++|+......++++++|++.||+||+|+||++.+ ++++|.+|.+.+.+.+.....
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~--- 75 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSG--- 75 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhhccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCC---
Confidence 3456544 6899999999998763337789999999999999999999653 356899999999886654322
Q ss_pred ccceEEeec
Q 004264 410 GQDFFIRVP 418 (765)
Q Consensus 410 ~~~~~lr~~ 418 (765)
+...|+|++
T Consensus 76 ~~~~yiKv~ 84 (84)
T cd01098 76 GGTLYLRLA 84 (84)
T ss_pred CcEEEEEeC
Confidence 467888874
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=6.2e-11 Score=133.65 Aligned_cols=144 Identities=17% Similarity=0.239 Sum_probs=94.2
Q ss_pred cCcccccccccCCceeEEEEEeCC-CcEEEEEEccccChhh----------------------------------HH---
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLST-GQEIAAKRLSKNSGQG----------------------------------LE--- 487 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~----------------------------------~~--- 487 (765)
..|+. +.||+|++|.||+|++++ |+.||||++....... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35666 789999999999999987 9999999997542110 11
Q ss_pred ---HHHHHHHHHhccc----cCceEeeeeeeee-cCceEEEEEecCCCChhHHhhccccC---CCCChHHHHHHHHHHHH
Q 004264 488 ---EFMNEVVLIGKLQ----HRNLVGLLGSCIE-EDERMLIYEYMPHKSLDYFIFDRERS---KLLPWKKRFSIITGIAR 556 (765)
Q Consensus 488 ---~~~~Ev~~l~~l~----h~niv~~~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~qia~ 556 (765)
.+.+|+..+.+++ +...+.+-..+.+ ....+|||||+.|+.+.++..-...+ ..+....+..++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~----- 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF----- 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH-----
Confidence 1334444444442 3333333333322 45678999999999997753111111 012222222223
Q ss_pred HHHHhhhcCCCcEEecccCCCcEEEecCC----CCeecccccceeeCC
Q 004264 557 GLLYLHQDSKLQVIHRDLKASNILLDINL----NPKISDFGLARIFGG 600 (765)
Q Consensus 557 aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~vkL~DFGla~~~~~ 600 (765)
..++..| ++|+|+||.||+++.++ +++++|||++..+..
T Consensus 274 --~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 --TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred --HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3444566 99999999999999888 999999999988743
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.6e-11 Score=132.12 Aligned_cols=248 Identities=21% Similarity=0.289 Sum_probs=178.8
Q ss_pred cCccccccccc--CCceeEEEEEe---CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccc-cCceEeeeeeeeecCce
Q 004264 446 NHFSEANMIGK--GGFGPVYMGKL---STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDER 517 (765)
Q Consensus 446 ~~y~~~~~LG~--G~fg~Vy~~~~---~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~~ 517 (765)
..|-+.+.+|. |.+|.||.+.. .+++.+|+|+-+.. .++....=.+|+....+++ |++.++....+..++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34666778999 99999999986 46778899884432 2233344456777777775 99999988888889999
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHH----HHHHhhhcCCCcEEecccCCCcEEEecC-CCCeeccc
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIAR----GLLYLHQDSKLQVIHRDLKASNILLDIN-LNPKISDF 592 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~vkL~DF 592 (765)
++=+|++. .+|..+.. .....++....+.++.+... ||.++|... |+|-|+||.||++..+ ...++.||
T Consensus 194 fiqtE~~~-~sl~~~~~--~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCH--TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhh--cccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999885 56655553 23345788888889998888 999999998 9999999999999998 88999999
Q ss_pred ccceeeCCCCcccc---cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhh
Q 004264 593 GLARIFGGDDEEAQ---TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLW 669 (765)
Q Consensus 593 Gla~~~~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 669 (765)
|+...+........ ..+..+...|++||.++ +.++.+.|||++|.++.+..++-......--. .|...
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--------~W~~~ 338 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS--------SWSQL 338 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC--------Ccccc
Confidence 99998865442211 12346777899999875 56688999999999999999987654322100 11111
Q ss_pred ccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 004264 670 NDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVV 716 (765)
Q Consensus 670 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 716 (765)
..+. +. .++-.....++..++.++++.+|..|++.+.+.
T Consensus 339 r~~~---ip-----~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 339 RQGY---IP-----LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred cccc---Cc-----hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 1111 11 111112223444588899999999999987765
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.3e-10 Score=109.82 Aligned_cols=137 Identities=12% Similarity=0.072 Sum_probs=98.6
Q ss_pred ccccccCCceeEEEEEeCC-------CcEEEEEEccccC------------h----------hhHHHH----HHHHHHHh
Q 004264 451 ANMIGKGGFGPVYMGKLST-------GQEIAAKRLSKNS------------G----------QGLEEF----MNEVVLIG 497 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~------------~----------~~~~~~----~~Ev~~l~ 497 (765)
...||.|.-+.||.|...+ +..+|||+..... . ...+.+ .+|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998543 4789999875310 0 002223 37999999
Q ss_pred cccc--CceEeeeeeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHh-hhcCCCcEEeccc
Q 004264 498 KLQH--RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL-HQDSKLQVIHRDL 574 (765)
Q Consensus 498 ~l~h--~niv~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~L-H~~~~~~ivH~Dl 574 (765)
++.. -++.+++++ ...+|||||+.+..+..... ....++......+..+++.+|..| |+.+ |||+||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 9863 355555553 56789999998754421111 111244556677889999999998 8888 999999
Q ss_pred CCCcEEEecCCCCeecccccceee
Q 004264 575 KASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 575 kp~NIll~~~~~vkL~DFGla~~~ 598 (765)
++.||+++ ++.++|+|||.+...
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeC
Confidence 99999997 468999999999865
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.7e-09 Score=120.00 Aligned_cols=167 Identities=18% Similarity=0.263 Sum_probs=126.4
Q ss_pred eCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCCChhHHhhccccCCCCChHH
Q 004264 467 LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKK 546 (765)
Q Consensus 467 ~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~ 546 (765)
..++.++.|...+...........+-++-|+.++||||+++++.+.++...|||+|.+. .|...+.. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 44678888888876655445567788899999999999999999999999999999874 44444422 22455
Q ss_pred HHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCC
Q 004264 547 RFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGT 626 (765)
Q Consensus 547 ~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 626 (765)
....+.||+.||.+||..+ .++|++|.-..|++++.|..||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 6667899999999999766 599999999999999999999999998876533222 111222233466776554332
Q ss_pred CCccccchHHHHHHHHHHhCC
Q 004264 627 ISMKSDVFSLGVLLVEIVSGK 647 (765)
Q Consensus 627 ~s~k~DvwSlG~ll~elltG~ 647 (765)
-..|.|.||++++|++.|.
T Consensus 182 --~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred --cchhhhhHHHHHHHHhCcc
Confidence 3469999999999999993
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.3e-09 Score=103.19 Aligned_cols=131 Identities=21% Similarity=0.298 Sum_probs=100.5
Q ss_pred cccccCCceeEEEEEeCCCcEEEEEEc-ccc--C-----hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 452 NMIGKGGFGPVYMGKLSTGQEIAAKRL-SKN--S-----GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~~~~vavK~l-~~~--~-----~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
..+++|+-+.+|.+.+.+ ..+++|.- .|. . .....+..+|+.+|.+++--.|.-..-+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 358899999999997643 33555543 332 1 11234567899999998765555555566778888999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
+++..|.+.+... ...++..+-+.+.-||..+ |+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998888432 3567777888888999999 99999999999998765 99999999985
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.1e-09 Score=111.02 Aligned_cols=142 Identities=16% Similarity=0.238 Sum_probs=108.7
Q ss_pred cccccCCceeEEEEEeCCCcEEEEEEccccCh-hhHHHHHHHHHHHhccccC--ceEeeeeeeeec---CceEEEEEecC
Q 004264 452 NMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSG-QGLEEFMNEVVLIGKLQHR--NLVGLLGSCIEE---DERMLIYEYMP 525 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~h~--niv~~~~~~~~~---~~~~lV~E~~~ 525 (765)
+.|+.|..+.||+++..+|+.+++|....... .....+.+|+.+++.+++. .+.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778999998765332 2356788999999999753 456677666553 25689999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcC----------------------------------------
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS---------------------------------------- 565 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~---------------------------------------- 565 (765)
+.++...+.. ..++...+..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988665421 23666777788888888888888531
Q ss_pred -------------CCcEEecccCCCcEEEec--CCCCeeccccccee
Q 004264 566 -------------KLQVIHRDLKASNILLDI--NLNPKISDFGLARI 597 (765)
Q Consensus 566 -------------~~~ivH~Dlkp~NIll~~--~~~vkL~DFGla~~ 597 (765)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.7e-10 Score=125.37 Aligned_cols=247 Identities=21% Similarity=0.173 Sum_probs=175.4
Q ss_pred hcCcccccccccCCceeEEEEEe--CCCcEEEEEEccccChhhH--HHHHHHHHHHhccc-cCceEeeeeeeeecCceEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL--STGQEIAAKRLSKNSGQGL--EEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~--~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~~~l 519 (765)
..+|..+..||.|.|+.|++... .++..|++|.+.+...... ..-..|+.+...+. |.++++....+..-.+.++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 45788889999999999998763 4677899998876533222 22345776766664 8888888888888888889
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC-CCCeecccccceee
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN-LNPKISDFGLARIF 598 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~vkL~DFGla~~~ 598 (765)
=-||+.++++...+ .....+++..++++..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|||+...+
T Consensus 344 p~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred chhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence 99999999987766 33445788899999999999999999999 9999999999999876 78899999998753
Q ss_pred CCCCcccccccccccccc-cCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 599 GGDDEEAQTERVAGTHGY-MSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y-~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
.... ......+..| .+|+......+..++|++|||.-+.|.+++..-...... +.....+.....
T Consensus 418 ~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----------~~~i~~~~~p~~ 483 (524)
T KOG0601|consen 418 AFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----------SLTIRSGDTPNL 483 (524)
T ss_pred ceec----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc----------ceeeecccccCC
Confidence 2111 1112223334 356666677889999999999999999998753211000 111111111111
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+. ....+..+...++..++..||.+.++..+.+-
T Consensus 484 ---------~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 484 ---------PG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ---------Cc-hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 11 11334456667888999999999888776543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.4e-09 Score=99.82 Aligned_cols=143 Identities=24% Similarity=0.307 Sum_probs=105.1
Q ss_pred cccccccCCceeEEEEEeCCCcEEEEE-Ecccc-------ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 450 EANMIGKGGFGPVYMGKLSTGQEIAAK-RLSKN-------SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 450 ~~~~LG~G~fg~Vy~~~~~~~~~vavK-~l~~~-------~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
....|-||+-+.|+++..+ |+..+|| ++.+. .....++..+|+.+|.+++--.|.-..-++.+.....|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4568999999999999875 5555555 34432 2233567889999999987555544444566777788999
Q ss_pred EecCC-CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCC---Ceeccccccee
Q 004264 522 EYMPH-KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLN---PKISDFGLARI 597 (765)
Q Consensus 522 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---vkL~DFGla~~ 597 (765)
||+++ .++.+++...-... .........++.|-+.+.-||.++ |||+||..+||++..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 46777775433222 223333678889999999999999 999999999999976543 58999999975
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.3e-08 Score=107.67 Aligned_cols=168 Identities=23% Similarity=0.336 Sum_probs=128.8
Q ss_pred eeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeee----cCceEEEEEecCC-CChhHHh
Q 004264 460 GPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE----EDERMLIYEYMPH-KSLDYFI 533 (765)
Q Consensus 460 g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~----~~~~~lV~E~~~~-gsL~~~l 533 (765)
.+.||+.. -+|..|++|+++-...+.......-+++++++.|.|+|++.+++.. +...+|||+|.++ .+|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 46788874 5899999999954433333344466889999999999999998873 4578899999886 5676666
Q ss_pred hccc------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 534 FDRE------------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 534 ~~~~------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
+... .+...++...|.++.|+..||.++|+.| +..+-|.|.+|+++.+.+++|+..|....+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 5432 2235778999999999999999999999 888999999999999999999888877765332
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCC
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMN 649 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p 649 (765)
.. |-+.+ -.+-|.=-||.+++-|.||...
T Consensus 447 ~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 20 11111 1256888999999999999754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.3e-08 Score=97.88 Aligned_cols=125 Identities=22% Similarity=0.220 Sum_probs=84.6
Q ss_pred eEEEEEeCCCcEEEEEEccccC--------------------------hhhHHHHHHHHHHHhccccC--ceEeeeeeee
Q 004264 461 PVYMGKLSTGQEIAAKRLSKNS--------------------------GQGLEEFMNEVVLIGKLQHR--NLVGLLGSCI 512 (765)
Q Consensus 461 ~Vy~~~~~~~~~vavK~l~~~~--------------------------~~~~~~~~~Ev~~l~~l~h~--niv~~~~~~~ 512 (765)
.||.|..+++..+|+|+..... ........+|..+|.++... ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899999999999999875310 01123467899999999755 45666544
Q ss_pred ecCceEEEEEecC--CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHH-hhhcCCCcEEecccCCCcEEEecCCCCee
Q 004264 513 EEDERMLIYEYMP--HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLY-LHQDSKLQVIHRDLKASNILLDINLNPKI 589 (765)
Q Consensus 513 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~-LH~~~~~~ivH~Dlkp~NIll~~~~~vkL 589 (765)
...+|||||++ +..+..+.... ++......++.+++..+.. +|+.+ |+|+||.+.||+++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 24579999999 66665443211 1234556777888885555 57888 9999999999999988 9999
Q ss_pred cccccceee
Q 004264 590 SDFGLARIF 598 (765)
Q Consensus 590 ~DFGla~~~ 598 (765)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999999864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.4e-09 Score=125.56 Aligned_cols=251 Identities=18% Similarity=0.159 Sum_probs=168.5
Q ss_pred HHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccc---cChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceE
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSK---NSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~ 518 (765)
...+.+.+.+-+-+|.++.+..+.-. .+...+.|.... -.....+....+-.++-.-+||.+++....+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 45577888888999999999877532 233333333222 11222233334444444445677777666666677889
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
||++|+.+++|...++... ..+..........+..++++||... +.|+|++|.|+++..+++.++.||+.....
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999887775432 3444455556667888999999987 999999999999999999999999844332
Q ss_pred CCC-------------------------Ccc----cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCC
Q 004264 599 GGD-------------------------DEE----AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMN 649 (765)
Q Consensus 599 ~~~-------------------------~~~----~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p 649 (765)
+.. ... .......+|+.|.+||.+.+......+|.|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 110 000 112246789999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 004264 650 RGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMS 713 (765)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 713 (765)
|....+.....-+. .+ .. +. ...+.....+..+++...+..+|.+|-.|.
T Consensus 1035 ~na~tpq~~f~ni~-------~~-~~----~~--p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIFENIL-------NR-DI----PW--PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhhhhccc-------cC-CC----CC--CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 87666543211100 00 00 00 111222233455667777888999997776
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=7e-08 Score=100.23 Aligned_cols=136 Identities=17% Similarity=0.101 Sum_probs=97.7
Q ss_pred CCceeEEEEEeCCCcEEEEEEccccChh-hHH----------HHHHHHHHHhccccCc--eEeeeeeeee-----cCceE
Q 004264 457 GGFGPVYMGKLSTGQEIAAKRLSKNSGQ-GLE----------EFMNEVVLIGKLQHRN--LVGLLGSCIE-----EDERM 518 (765)
Q Consensus 457 G~fg~Vy~~~~~~~~~vavK~l~~~~~~-~~~----------~~~~Ev~~l~~l~h~n--iv~~~~~~~~-----~~~~~ 518 (765)
-....|.+... +|+.+.||+....... ..+ .+.+|...+.+|...+ .++++++... ....+
T Consensus 33 ~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~ 111 (268)
T PRK15123 33 LEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSF 111 (268)
T ss_pred CCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeE
Confidence 33344667655 5778999977433211 111 3778999998885433 3344555443 23568
Q ss_pred EEEEecCCC-ChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec-------CCCCeec
Q 004264 519 LIYEYMPHK-SLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI-------NLNPKIS 590 (765)
Q Consensus 519 lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-------~~~vkL~ 590 (765)
||+|++++. +|.+++.... ....+...+..++.+++..+.-||..| |+|+|+++.|||++. +..+.|+
T Consensus 112 LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 112 IITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred EEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEE
Confidence 999999986 8888874321 234556777889999999999999999 999999999999985 4678999
Q ss_pred cccccee
Q 004264 591 DFGLARI 597 (765)
Q Consensus 591 DFGla~~ 597 (765)
||+.++.
T Consensus 188 Dl~r~~~ 194 (268)
T PRK15123 188 DLHRAQI 194 (268)
T ss_pred ECCcccc
Confidence 9998864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.9e-07 Score=98.18 Aligned_cols=260 Identities=14% Similarity=0.083 Sum_probs=156.6
Q ss_pred cccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhcc-ccCceEeeeee------e-eecCceEEEE
Q 004264 450 EANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRNLVGLLGS------C-IEEDERMLIY 521 (765)
Q Consensus 450 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~------~-~~~~~~~lV~ 521 (765)
....||+|+.+.+|-.- .-+..+.|++.+.......+.. ..|... .||-+-.-+.+ . ..+...-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 34679999999999542 2344577888776544333322 233332 35533221111 0 1112244667
Q ss_pred EecCCCC-hhHHhhc---cccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 522 EYMPHKS-LDYFIFD---RERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 522 E~~~~gs-L~~~l~~---~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
+.+++.- ...++.. ++......|...++.++.++.+.+-||+.| .+-+|+.++|+|+.+++.|.|.|=.....
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 7666542 2333322 223345789999999999999999999999 99999999999999999999998554443
Q ss_pred eCCCCcccccccccccccccCccccc-----CCCCCccccchHHHHHHHHHHhC-CCCCCCCCCCCc-ccHHHHHHHhhc
Q 004264 598 FGGDDEEAQTERVAGTHGYMSPEYAN-----DGTISMKSDVFSLGVLLVEIVSG-KMNRGFRHPGHR-HNLIGHAWLLWN 670 (765)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~k~DvwSlG~ll~elltG-~~p~~~~~~~~~-~~~~~~~~~~~~ 670 (765)
. .........+|...|.+||.-. +..-+...|.|.||+++++++.| +.|+..-..... ..-.+. ...
T Consensus 167 ~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~---~Ia 240 (637)
T COG4248 167 N---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET---DIA 240 (637)
T ss_pred c---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh---hhh
Confidence 2 2223333577889999999754 34457789999999999999987 889865332111 110000 000
Q ss_pred cCCccccccccc-----cCccCHHH-HHHHHHHHHHcccc--CCCCCCCHHHHHHHHhcCC
Q 004264 671 DGRALGLMDTCL-----EDSFVESQ-VLRCIQVGLLCVQK--LPEDRPDMSSVVFLLANDG 723 (765)
Q Consensus 671 ~~~~~~l~d~~l-----~~~~~~~~-~~~l~~li~~cl~~--dP~~RPs~~evl~~L~~~~ 723 (765)
.+......+... ...++... ...+..+..+|+.. .+.-|||++-.+..|....
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 111111111100 01122111 22345566677765 3568999999988886543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.2e-07 Score=95.45 Aligned_cols=136 Identities=18% Similarity=0.155 Sum_probs=99.3
Q ss_pred cccccccccCCceeEEEEEeCCCcEEEEEEcccc--------------------C--hhhHHHHHHHHHHHhccccC--c
Q 004264 448 FSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKN--------------------S--GQGLEEFMNEVVLIGKLQHR--N 503 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--------------------~--~~~~~~~~~Ev~~l~~l~h~--n 503 (765)
..+.++||-|.-+.||.|..++|.++|||.=... + .......++|.++|++|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4567889999999999999999999999953211 0 11234467899999999755 5
Q ss_pred eEeeeeeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec
Q 004264 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI 583 (765)
Q Consensus 504 iv~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 583 (765)
+.+.+++ +.-.+||||+++..|...- +.....-.++..|++-+..+-+.| |||+|+++-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 6666654 4557999999997764332 123334445555555555554666 999999999999999
Q ss_pred CCCCeecccccceee
Q 004264 584 NLNPKISDFGLARIF 598 (765)
Q Consensus 584 ~~~vkL~DFGla~~~ 598 (765)
+|.+.++||-.+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999877653
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.1e-07 Score=85.82 Aligned_cols=88 Identities=23% Similarity=0.320 Sum_probs=64.0
Q ss_pred eEEEeeCCceEEEcCC-CCeEEEeccCCCc-CccEEEEecCCCeeEeeccCCCcccceeeecCCCCCcccCcCeecceee
Q 004264 89 VLTFSNNGSLLLLNQE-KSAIWSSNSSRTL-ENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLK 166 (765)
Q Consensus 89 ~l~~~~~g~l~l~~~~-~~~~w~s~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~~ 166 (765)
++.++.||+||+++.. +.+||++++.... ....+.|+++|||||++ ..+.++|+| +|-
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~----~~g~~vW~S-----~t~----------- 82 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYD----GDGRVVWSS-----NTT----------- 82 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEe----CCCCEEEEe-----ccc-----------
Confidence 4556789999999875 5899999975433 33688999999999998 346789997 111
Q ss_pred cccceEEEeccCCCCCCCcceEEeecCCCCceEEEecCCeeeeeeC
Q 004264 167 TGFERYLTPWRSADDPTPGEFSLRLDISALPELVIISGSRKEARSG 212 (765)
Q Consensus 167 ~~~~~~l~S~~s~~dps~G~ysl~~~~~g~~~~~~~~~~~~~~~sg 212 (765)
...|.|.+.|+++|...++-.. ..+.|.+.
T Consensus 83 ---------------~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf 112 (114)
T smart00108 83 ---------------GANGNYVLVLLDDGNLVIYDSD-GNFLWQSF 112 (114)
T ss_pred ---------------CCCCceEEEEeCCCCEEEECCC-CCEEeCCC
Confidence 1346788999999997765433 35677653
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.4e-07 Score=83.79 Aligned_cols=88 Identities=22% Similarity=0.249 Sum_probs=64.2
Q ss_pred EEEee-CCceEEEcCC-CCeEEEeccCCC-cCccEEEEecCCCeeEeeccCCCcccceeeecCCCCCcccCcCeecceee
Q 004264 90 LTFSN-NGSLLLLNQE-KSAIWSSNSSRT-LENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLK 166 (765)
Q Consensus 90 l~~~~-~g~l~l~~~~-~~~~w~s~~~~~-~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~~ 166 (765)
+.++. ||+||+++.. +.+||++|+... ...+.+.|+++|||||++ .++.++|+|=-
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~----~~g~~vW~S~~----------------- 82 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYD----GSGTVVWSSNT----------------- 82 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEc----CCCcEEEEecc-----------------
Confidence 44565 9999999765 589999997642 345678999999999998 45678999610
Q ss_pred cccceEEEeccCCCCCCCcceEEeecCCCCceEEEecCCeeeeeeCC
Q 004264 167 TGFERYLTPWRSADDPTPGEFSLRLDISALPELVIISGSRKEARSGP 213 (765)
Q Consensus 167 ~~~~~~l~S~~s~~dps~G~ysl~~~~~g~~~~~~~~~~~~~~~sg~ 213 (765)
..+.|.+.+.|+++|...++-.+ ..+.|.+..
T Consensus 83 --------------~~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf~ 114 (116)
T cd00028 83 --------------TRVNGNYVLVLLDDGNLVLYDSD-GNFLWQSFD 114 (116)
T ss_pred --------------cCCCCceEEEEeCCCCEEEECCC-CCEEEcCCC
Confidence 01246789999999987765433 466787653
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.52 E-value=4.4e-07 Score=91.08 Aligned_cols=124 Identities=23% Similarity=0.223 Sum_probs=91.5
Q ss_pred CCcEEEEEEccccC-------hhhHHHHHHHHHHHhccccC--ceEeeeeeeeecC----ceEEEEEecCCC-ChhHHhh
Q 004264 469 TGQEIAAKRLSKNS-------GQGLEEFMNEVVLIGKLQHR--NLVGLLGSCIEED----ERMLIYEYMPHK-SLDYFIF 534 (765)
Q Consensus 469 ~~~~vavK~l~~~~-------~~~~~~~~~Ev~~l~~l~h~--niv~~~~~~~~~~----~~~lV~E~~~~g-sL~~~l~ 534 (765)
.++.+.+|.+.... ......+.+|...+.+|... ...+.+++..... ..+||+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 35566666543221 12344678899888888533 3455566555432 348999999984 7888885
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC---CCeecccccceee
Q 004264 535 DRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL---NPKISDFGLARIF 598 (765)
Q Consensus 535 ~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~vkL~DFGla~~~ 598 (765)
.... .+......++.++++.+.-||+.| |+|+|+++.|||++.+. .+.|+||+.++..
T Consensus 111 ~~~~---~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWEQ---LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhcc---cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 4222 566778889999999999999999 99999999999999887 8999999988764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=6.6e-07 Score=100.58 Aligned_cols=140 Identities=17% Similarity=0.210 Sum_probs=93.0
Q ss_pred cccccCCceeEEEEEeCCCcEEEEEEccccChhh------------------------------HH----------HHHH
Q 004264 452 NMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQG------------------------------LE----------EFMN 491 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~------------------------------~~----------~~~~ 491 (765)
+.|+.++-|.||+|++++|+.||||+........ .+ .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5799999999999999999999999986432110 00 1334
Q ss_pred HHHHHhccc-----cCceEeeeeee-eecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHH-HHHhhhc
Q 004264 492 EVVLIGKLQ-----HRNLVGLLGSC-IEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARG-LLYLHQD 564 (765)
Q Consensus 492 Ev~~l~~l~-----h~niv~~~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~a-L~~LH~~ 564 (765)
|...+.+++ .++ +++=..+ ......+|+|||++|..+.+...-.. ..++. ..++..++++ +..+=..
T Consensus 211 EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~---k~ia~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDR---KELAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCH---HHHHHHHHHHHHHHHHhc
Confidence 444444442 222 2222222 23567899999999999988753222 22342 2333333333 2333335
Q ss_pred CCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 565 SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 565 ~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
| ++|.|.+|.||+++.++++.+.|||+...+..
T Consensus 285 g---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 G---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred C---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 6 99999999999999999999999999987653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=4.7e-08 Score=109.22 Aligned_cols=153 Identities=20% Similarity=0.239 Sum_probs=101.5
Q ss_pred HHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc-------ccccccccccccccCccccc
Q 004264 551 ITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE-------EAQTERVAGTHGYMSPEYAN 623 (765)
Q Consensus 551 ~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~-------~~~~~~~~gt~~Y~aPE~~~ 623 (765)
+.+++.|+.|+|... .+||+.|.|++|.++.++..||+.|+.+.......+ ........-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 344569999999876 599999999999999999999999998865433111 00111123455699999999
Q ss_pred CCCCCccccchHHHHHHHHHHhC-CCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHcc
Q 004264 624 DGTISMKSDVFSLGVLLVEIVSG-KMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCV 702 (765)
Q Consensus 624 ~~~~s~k~DvwSlG~ll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl 702 (765)
+...+.++|+||+|+++|.+..| +.-+.......... .....+....-.+......++.+=+.+.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-------------~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-------------FSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhh-------------hhhcccccccccccccCcHHHHHHHHHHh
Confidence 98889999999999999999954 44333222111100 00111111111222333445666667789
Q ss_pred ccCCCCCCCHHHHHHH
Q 004264 703 QKLPEDRPDMSSVVFL 718 (765)
Q Consensus 703 ~~dP~~RPs~~evl~~ 718 (765)
..++.-||++.++...
T Consensus 250 ~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLSI 265 (700)
T ss_pred cCCcccCcchhhhhcc
Confidence 9999999988776543
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.6e-06 Score=76.53 Aligned_cols=99 Identities=23% Similarity=0.382 Sum_probs=70.2
Q ss_pred CeEEcCCCeEEEEEecCCCCCCeEEEEEEeCCCCcEEEee-cCCCCCCCCCceEEEeeCCceEEEcCCCCeEEEeccCCC
Q 004264 38 ETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVA-NRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRT 116 (765)
Q Consensus 38 ~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~a-n~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~s~~~~~ 116 (765)
+++.+.+|.+.|-|..+|+ |-|. + ..++++|.. +...... ..+.+.|..||||||+|..+.++|+|.. .
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl~-~-~~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~--~ 81 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVLY-D-SNGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFD--Y 81 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEEE-E-TTTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTT--S
T ss_pred cccccccccccceECCCCe-----EEEE-c-CCCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecC--C
Confidence 4565655999999999987 4444 2 336789999 5454421 5789999999999999999999999943 3
Q ss_pred cCccEEEEec--CCCeeEeeccCCCcccceeeecCCC
Q 004264 117 LENPVAHLLD--SGNLVLRDNISRSSEEYMWQSFDYP 151 (765)
Q Consensus 117 ~~~~~~~l~d--~GNlvl~~~~~~~~~~~~WqSFd~P 151 (765)
.....+..++ +||++ +. ....+.|.|=+.|
T Consensus 82 ptdt~L~~q~l~~~~~~-~~----~~~~~sw~s~~dp 113 (114)
T PF01453_consen 82 PTDTLLPGQKLGDGNVT-GK----NDSLTSWSSNTDP 113 (114)
T ss_dssp SS-EEEEEET--TSEEE-EE----STSSEEEESS---
T ss_pred CccEEEeccCcccCCCc-cc----cceEEeECCCCCC
Confidence 4567788888 89998 65 3356789876555
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.34 E-value=5.9e-06 Score=81.54 Aligned_cols=139 Identities=15% Similarity=0.150 Sum_probs=103.1
Q ss_pred cccCCceeEEEEEeCCCcEEEEEEcccc------ChhhHHHHHHHHHHHhccccC--ceEeeeeeeeec----CceEEEE
Q 004264 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKN------SGQGLEEFMNEVVLIGKLQHR--NLVGLLGSCIEE----DERMLIY 521 (765)
Q Consensus 454 LG~G~fg~Vy~~~~~~~~~vavK~l~~~------~~~~~~~~~~Ev~~l~~l~h~--niv~~~~~~~~~----~~~~lV~ 521 (765)
-|+||-+.|++.... |+.+-+|+-... .+.+...|.+|...|.+|... .+.+++...... -.-+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467899999987764 446888887521 144677899999999998633 344555222221 2357999
Q ss_pred EecCC-CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCC--Ceeccccccee
Q 004264 522 EYMPH-KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLN--PKISDFGLARI 597 (765)
Q Consensus 522 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--vkL~DFGla~~ 597 (765)
|-+.+ .+|.+++.... -...+...+..++.++++.+.-||+.+ +.|+|+-+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 57877774322 224677778899999999999999999 999999999999986667 99999987764
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.32 E-value=6.6e-06 Score=83.71 Aligned_cols=140 Identities=16% Similarity=0.126 Sum_probs=85.1
Q ss_pred cccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCc--eEeeeeeeeecCceEEEEEecCCCC-
Q 004264 452 NMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRN--LVGLLGSCIEEDERMLIYEYMPHKS- 528 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n--iv~~~~~~~~~~~~~lV~E~~~~gs- 528 (765)
.+||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+++++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 25568888876533 2345688999999986443 4667777777777789999999963
Q ss_pred hhHHhh--------------c---cccC---CCCChHHHHH-HHHH----------HHH-HHHHhhh-cCCCcEEecccC
Q 004264 529 LDYFIF--------------D---RERS---KLLPWKKRFS-IITG----------IAR-GLLYLHQ-DSKLQVIHRDLK 575 (765)
Q Consensus 529 L~~~l~--------------~---~~~~---~~l~~~~~~~-i~~q----------ia~-aL~~LH~-~~~~~ivH~Dlk 575 (765)
+...+. . .-+. .......... +..+ +.+ ...+|.+ .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 211110 0 0000 0011111100 1000 011 1122221 123347999999
Q ss_pred CCcEEEecCCCCeeccccccee
Q 004264 576 ASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 576 p~NIll~~~~~vkL~DFGla~~ 597 (765)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.26 E-value=7.4e-06 Score=81.89 Aligned_cols=155 Identities=16% Similarity=0.169 Sum_probs=103.8
Q ss_pred cccchHhHHHHhcCcccccc---cccCCceeEEEEEeCCCcEEEEEEccccChhh------------------------H
Q 004264 434 PLYDLATITTATNHFSEANM---IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQG------------------------L 486 (765)
Q Consensus 434 ~~~~~~~~~~~~~~y~~~~~---LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~------------------------~ 486 (765)
...+...+....++..+... |++|.-+.||+|...++..+|+|++....... .
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~ 112 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF 112 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence 34556666777777776655 45677778999998889999999986432111 0
Q ss_pred HHHHHHHHHHhccc--cCceEeeeeeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhh-
Q 004264 487 EEFMNEVVLIGKLQ--HRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ- 563 (765)
Q Consensus 487 ~~~~~Ev~~l~~l~--h~niv~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~- 563 (765)
....+|+..|.++. +-.+.+.+.+ ...+|||||+....+-.-. -..-.+.......+..++++.+.-|-.
T Consensus 113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~---LkDv~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 113 AWARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPR---LKDVPLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCC---cccCCcCchhHHHHHHHHHHHHHHHHHh
Confidence 11345777777764 3333444433 2457999999765221100 111123333577778888888887766
Q ss_pred cCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 564 ~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
.+ +||+||+.-|||+. ++.+.|+||+.|....
T Consensus 186 a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 186 AG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred cC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 66 99999999999999 8899999999997653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.7e-05 Score=78.57 Aligned_cols=139 Identities=15% Similarity=0.157 Sum_probs=92.2
Q ss_pred HHhcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHH---------HHHHHHhccccC---ceEeeeee
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFM---------NEVVLIGKLQHR---NLVGLLGS 510 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~---------~Ev~~l~~l~h~---niv~~~~~ 510 (765)
....+|.+.+++-......|.+-.. +++.+++|..........+.|+ +++..+.+++.. ....++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3457788888888887777777665 5788999987654433333322 233333333222 22222222
Q ss_pred -----eeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC
Q 004264 511 -----CIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL 585 (765)
Q Consensus 511 -----~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 585 (765)
+......+|+|||++|..|.++.. +++ .++..|++++.-||+.| +.|+|.+|.|++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-
Confidence 222345578999999988865531 222 24456778899999999 9999999999999855
Q ss_pred CCeeccccccee
Q 004264 586 NPKISDFGLARI 597 (765)
Q Consensus 586 ~vkL~DFGla~~ 597 (765)
.++++||+..+.
T Consensus 172 ~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 GIRIIDTQGKRM 183 (229)
T ss_pred cEEEEECccccc
Confidence 499999987764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.5e-06 Score=63.77 Aligned_cols=43 Identities=47% Similarity=0.660 Sum_probs=38.0
Q ss_pred CCCCCCCCCCCcccccccccccCCCCc---ccccCCceeeeeecCC
Q 004264 723 GVTLPQPRQPGFFTERGFTVGALSSHE---KCHSENALSITIQEGR 765 (765)
Q Consensus 723 ~~~l~~p~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 765 (765)
...||.|++|+|+.++...+.+++++. ..+|.|++|||+++||
T Consensus 3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 446999999999999999888888733 6889999999999999
|
; GO: 0004674 protein serine/threonine kinase activity |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.5e-05 Score=81.19 Aligned_cols=143 Identities=20% Similarity=0.158 Sum_probs=84.5
Q ss_pred cccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCc--eEeeeeeeee---cCceEEEEEecCC
Q 004264 452 NMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRN--LVGLLGSCIE---EDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n--iv~~~~~~~~---~~~~~lV~E~~~~ 526 (765)
+.|+.|..+.||+....+ +.+++|..... .....+.+|+.+++.+.... +.+++..... ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 578999999999999877 69999987544 45677889999999886432 4556654322 2346899999999
Q ss_pred CChhH----------------Hhhc--cc--cCCCCChHH---------HHHH------------HHHHHH-HHHHhhh-
Q 004264 527 KSLDY----------------FIFD--RE--RSKLLPWKK---------RFSI------------ITGIAR-GLLYLHQ- 563 (765)
Q Consensus 527 gsL~~----------------~l~~--~~--~~~~l~~~~---------~~~i------------~~qia~-aL~~LH~- 563 (765)
..+.. .+.. .. ......... .... ...+.+ .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 98877 1110 00 001111100 0000 011222 2333332
Q ss_pred ---cCCCcEEecccCCCcEEEe-cCCCCeeccccccee
Q 004264 564 ---DSKLQVIHRDLKASNILLD-INLNPKISDFGLARI 597 (765)
Q Consensus 564 ---~~~~~ivH~Dlkp~NIll~-~~~~vkL~DFGla~~ 597 (765)
.....++|+|+.|.||+++ +++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1334599999999999999 556667999998864
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.12 E-value=4.9e-06 Score=69.13 Aligned_cols=59 Identities=39% Similarity=0.869 Sum_probs=47.0
Q ss_pred CceEEeccccCCCCcc-ccccCChHhHHHHhhc-cCCcccccccccCCCCcceeecc-ccccccc
Q 004264 340 EGFLKLPRMKLPENYW-SNKSMNLKECEAECTK-NCSCRAYANSDVTGGGSGCLMWF-GDLVDLR 401 (765)
Q Consensus 340 ~~f~~~~~~~~p~~~~-~~~~~s~~~C~~~Cl~-nCsC~a~~~~~~~~~~~~C~~w~-gdli~l~ 401 (765)
..|+.++++++++... .....++++|++.|++ +|+|.||+|.. ++.+|.+|. +.+.+..
T Consensus 4 ~~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~ 65 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDAR 65 (78)
T ss_pred ceeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccce
Confidence 4699999999985542 2456799999999999 99999999754 456899999 6665554
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.4e-05 Score=87.83 Aligned_cols=140 Identities=16% Similarity=0.200 Sum_probs=89.6
Q ss_pred cccccCCceeEEEEEeCCCcEEEEEEccccChhh-------------------------------HH------HHHHHHH
Q 004264 452 NMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQG-------------------------------LE------EFMNEVV 494 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-------------------------------~~------~~~~Ev~ 494 (765)
+.||.-+.|.||+|++++|+.||||+.+...... .+ .|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999999999999999876532111 01 1344444
Q ss_pred HHhcc----ccCc---eEeeeeeee-ecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHH-HHhhhcC
Q 004264 495 LIGKL----QHRN---LVGLLGSCI-EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGL-LYLHQDS 565 (765)
Q Consensus 495 ~l~~l----~h~n---iv~~~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL-~~LH~~~ 565 (765)
...+. .|-+ -|++=..+. ....++|+||||+|..+.+.-.-.. ..++.. +++..+.++. +.+=..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~---~i~~~l~~~~~~qIf~~G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPH---DILNKLVEAYLEQIFKTG 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHH---HHHHHHHHHHHHHHHhcC
Confidence 33333 3444 111222222 2357899999999998876643222 224444 3444444432 2223345
Q ss_pred CCcEEecccCCCcEEEec----CCCCeecccccceeeC
Q 004264 566 KLQVIHRDLKASNILLDI----NLNPKISDFGLARIFG 599 (765)
Q Consensus 566 ~~~ivH~Dlkp~NIll~~----~~~vkL~DFGla~~~~ 599 (765)
++|+|-+|.||++.. ++.+.+.|||+...+.
T Consensus 322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred ---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999984 6789999999998764
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.03 E-value=1.4e-05 Score=78.65 Aligned_cols=105 Identities=24% Similarity=0.218 Sum_probs=83.7
Q ss_pred HHHHHHHhcccc-CceEeeeeeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCc
Q 004264 490 MNEVVLIGKLQH-RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQ 568 (765)
Q Consensus 490 ~~Ev~~l~~l~h-~niv~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 568 (765)
.+|.-+++.+++ +++.+++|+| ..++|.||...+++......-..--..+|..|.+|+.++++.+++|+..-...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358889999976 6999999998 34789999987765321100011123689999999999999999999866666
Q ss_pred EEecccCCCcEEEecCCCCeecccccceee
Q 004264 569 VIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 569 ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
+..+|++|+|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999999999999999999999877653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.02 E-value=4.5e-05 Score=78.70 Aligned_cols=141 Identities=14% Similarity=0.089 Sum_probs=85.2
Q ss_pred ccccCCc-eeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccc-cCceEeeeeeeeecCceEEEEEecCCCChh
Q 004264 453 MIGKGGF-GPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDERMLIYEYMPHKSLD 530 (765)
Q Consensus 453 ~LG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~~~lV~E~~~~gsL~ 530 (765)
.|..|.. ..||+.... +..+++|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555655 788998764 4778888875433 345678999988885 334556777766666789999999998876
Q ss_pred HHhh-------------------cccc-CCCCCh--HHHHHHHH--------------------HHHHHHHHhhh----c
Q 004264 531 YFIF-------------------DRER-SKLLPW--KKRFSIIT--------------------GIARGLLYLHQ----D 564 (765)
Q Consensus 531 ~~l~-------------------~~~~-~~~l~~--~~~~~i~~--------------------qia~aL~~LH~----~ 564 (765)
.... .... ..++.. ........ .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4321 0000 001110 00000000 01111112211 1
Q ss_pred CCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 565 SKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 565 ~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
....++|+|+.|.|||++++..+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 123489999999999999987788999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.89 E-value=2.2e-06 Score=94.92 Aligned_cols=193 Identities=20% Similarity=0.134 Sum_probs=138.2
Q ss_pred HHHHhcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCc-eEeeeeeeeecCceEE
Q 004264 441 ITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRN-LVGLLGSCIEEDERML 519 (765)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n-iv~~~~~~~~~~~~~l 519 (765)
++..+..+...+.+++++.++++|.+....+....+.+... ....-++++|.+++||| .++.++-+..++...+
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 34445566667789999999999988544455555544322 44556889999999999 7777777777888899
Q ss_pred EEEecCCC-ChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 520 IYEYMPHK-SLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 520 V~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
+++++..+ +-....- ...-.+..-....+.+.-.++++++|+.. -+|+| ||+..+ +..|..||+....+
T Consensus 312 ~~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQL 381 (829)
T ss_pred hhhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCccc
Confidence 99998876 2211110 00011222333344555667899999875 58888 777765 67899999998877
Q ss_pred CCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCC
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRG 651 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~ 651 (765)
.+.. ......+++.++|||+.+...+..+.|+|++|.-..+|--|-.|..
T Consensus 382 ~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 382 TRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred Cccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 5443 2335778999999999999999999999999998888877777643
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.85 E-value=7.6e-05 Score=70.74 Aligned_cols=130 Identities=18% Similarity=0.188 Sum_probs=90.8
Q ss_pred cccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCCCh
Q 004264 450 EANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSL 529 (765)
Q Consensus 450 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gsL 529 (765)
+.+.|++|++|.||++.+. +..+|+|+-..++ ....+..|+++|..++-.++.+-+..+- .-.+.|||+.|..|
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhhcCcch
Confidence 4568999999999999985 5588888765443 3478899999999998665544332222 22355999999888
Q ss_pred hHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccC-CCcEEEecCCCCeecccccceee
Q 004264 530 DYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLK-ASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 530 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlk-p~NIll~~~~~vkL~DFGla~~~ 598 (765)
.+..... + .+-...+++.-.-|...| |-|+.|. |..++|..+..+.|+||..|...
T Consensus 100 ~~~~~~~------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 100 GKLEIGG------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhcc------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 6554210 1 122334556655666677 9999984 66677767779999999999853
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00013 Score=88.53 Aligned_cols=79 Identities=15% Similarity=0.332 Sum_probs=58.0
Q ss_pred ccccccCCceeEEEEEeCCC---cEEEEEEccccC-hhhHHHHHHHHHHHhccc-cCce--Eeeeeeeeec---CceEEE
Q 004264 451 ANMIGKGGFGPVYMGKLSTG---QEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQ-HRNL--VGLLGSCIEE---DERMLI 520 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~-h~ni--v~~~~~~~~~---~~~~lV 520 (765)
.++|+.|.+..+|+.....+ +.+++|+..... ......+.+|+.+|+.+. |.++ .+++.++.+. ...++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999876554 467888765432 223457889999999996 6654 7777777654 467899
Q ss_pred EEecCCCCh
Q 004264 521 YEYMPHKSL 529 (765)
Q Consensus 521 ~E~~~~gsL 529 (765)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00012 Score=75.01 Aligned_cols=73 Identities=12% Similarity=0.166 Sum_probs=46.2
Q ss_pred cccccCCce-eEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccC---ceEeeeeeeeec---CceEEEEEec
Q 004264 452 NMIGKGGFG-PVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHR---NLVGLLGSCIEE---DERMLIYEYM 524 (765)
Q Consensus 452 ~~LG~G~fg-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~---niv~~~~~~~~~---~~~~lV~E~~ 524 (765)
+.|+.|+.. .||+. +..+++|..... .....+.+|+++++.+... -+.++++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777766 58875 245777865442 2345788999999887532 233444433322 2347899999
Q ss_pred CCCChh
Q 004264 525 PHKSLD 530 (765)
Q Consensus 525 ~~gsL~ 530 (765)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00037 Score=68.94 Aligned_cols=132 Identities=16% Similarity=0.203 Sum_probs=92.4
Q ss_pred ccccccCCceeEEEEEeCCCcEEEEEEccccC----------------hhhHHHHHHHHHHHhccc------cCceEeee
Q 004264 451 ANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNS----------------GQGLEEFMNEVVLIGKLQ------HRNLVGLL 508 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~Ev~~l~~l~------h~niv~~~ 508 (765)
...||+|+.-.||. +++.....||+..... ....++..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 35799999999884 5667778888886554 223566777877766665 78999999
Q ss_pred eeeeecCceEEEEEecCC------CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEe
Q 004264 509 GSCIEEDERMLIYEYMPH------KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD 582 (765)
Q Consensus 509 ~~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 582 (765)
|...+....-+|+|.+.. -+|.+++.. +.++. ...+. +-+-..||-+.. |+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999999999998654 356666632 22444 33333 334445666666 99999999999996
Q ss_pred cCC----CCeecc-cccc
Q 004264 583 INL----NPKISD-FGLA 595 (765)
Q Consensus 583 ~~~----~vkL~D-FGla 595 (765)
... .+.|+| ||..
T Consensus 153 ~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred ecCCCceEEEEEeCCCCc
Confidence 432 467776 4433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00024 Score=72.81 Aligned_cols=74 Identities=15% Similarity=0.201 Sum_probs=49.0
Q ss_pred cccccCCceeEEEEEeCC--CcEEEEEEccccChhhHHHHHHHHHHHhccccCce-EeeeeeeeecCceEEEEEecCCCC
Q 004264 452 NMIGKGGFGPVYMGKLST--GQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNL-VGLLGSCIEEDERMLIYEYMPHKS 528 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~ni-v~~~~~~~~~~~~~lV~E~~~~gs 528 (765)
+.|..|-...+|+....+ ++.+++|+....... .-...+|+.+++.+....+ .++++.+. ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 467888888999998764 678999977543221 1233478888888854333 34443322 248999999977
Q ss_pred hh
Q 004264 529 LD 530 (765)
Q Consensus 529 L~ 530 (765)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 63
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00021 Score=74.41 Aligned_cols=139 Identities=16% Similarity=0.083 Sum_probs=78.7
Q ss_pred ccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCce-EeeeeeeeecCceEEEEEecCCCChhH
Q 004264 453 MIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNL-VGLLGSCIEEDERMLIYEYMPHKSLDY 531 (765)
Q Consensus 453 ~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~ni-v~~~~~~~~~~~~~lV~E~~~~gsL~~ 531 (765)
.+..|-...+|+.. .+++.+++|..........-...+|..+++.+....+ .+++... ...+|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 35667788899887 3567888887654322211235788899988864333 3333332 2368999999877642
Q ss_pred H-----------------hhccc-cCCCCChHHH-HHHHHHH---------HHHHHHhhhc-----CCCcEEecccCCCc
Q 004264 532 F-----------------IFDRE-RSKLLPWKKR-FSIITGI---------ARGLLYLHQD-----SKLQVIHRDLKASN 578 (765)
Q Consensus 532 ~-----------------l~~~~-~~~~l~~~~~-~~i~~qi---------a~aL~~LH~~-----~~~~ivH~Dlkp~N 578 (765)
. ++... ...+++.... ..+..++ ...+..+... ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 01111 0111111111 1111111 1112222111 12348999999999
Q ss_pred EEEecCCCCeeccccccee
Q 004264 579 ILLDINLNPKISDFGLARI 597 (765)
Q Consensus 579 Ill~~~~~vkL~DFGla~~ 597 (765)
|++++++ +.|+||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 89999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00049 Score=73.14 Aligned_cols=77 Identities=13% Similarity=0.078 Sum_probs=56.3
Q ss_pred cccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhcccc---CceEeeeeeeee---cCceEEEEEe
Q 004264 450 EANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQH---RNLVGLLGSCIE---EDERMLIYEY 523 (765)
Q Consensus 450 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h---~niv~~~~~~~~---~~~~~lV~E~ 523 (765)
..+.||+|..+.||+....+++ +++|..+... ....+..|...|+.|.. -.+.++++.+.. .+..+||||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGN-PMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCCC-EEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 3467999999999998866664 6666643211 23578899999998853 357788877754 3568999999
Q ss_pred cCCCCh
Q 004264 524 MPHKSL 529 (765)
Q Consensus 524 ~~~gsL 529 (765)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00074 Score=74.02 Aligned_cols=75 Identities=15% Similarity=0.140 Sum_probs=54.6
Q ss_pred cccccCCceeEEEEEeCCC-cEEEEEEcccc------C-hhhHHHHHHHHHHHhccc---cCceEeeeeeeeecCceEEE
Q 004264 452 NMIGKGGFGPVYMGKLSTG-QEIAAKRLSKN------S-GQGLEEFMNEVVLIGKLQ---HRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~~-~~vavK~l~~~------~-~~~~~~~~~Ev~~l~~l~---h~niv~~~~~~~~~~~~~lV 520 (765)
+.||.|.+..||++...+| +.++||.-... . +...+++..|.+.|+.+. -.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998877 48999985411 1 234567788888888863 2356666655 44667899
Q ss_pred EEecCCCC
Q 004264 521 YEYMPHKS 528 (765)
Q Consensus 521 ~E~~~~gs 528 (765)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0011 Score=64.99 Aligned_cols=125 Identities=22% Similarity=0.356 Sum_probs=90.3
Q ss_pred cCcccccccccCCc-eeEEEEEeCCCcEEEEEEccc---cC--------h----------hhHHHHHHHHHHHhccc---
Q 004264 446 NHFSEANMIGKGGF-GPVYMGKLSTGQEIAAKRLSK---NS--------G----------QGLEEFMNEVVLIGKLQ--- 500 (765)
Q Consensus 446 ~~y~~~~~LG~G~f-g~Vy~~~~~~~~~vavK~l~~---~~--------~----------~~~~~~~~Ev~~l~~l~--- 500 (765)
.+++..+.||.|.- |.||++++ +|+.+|+|.+.. .. . .....|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 77888999999999 99999998 577999999321 00 0 11235778998888885
Q ss_pred cCce--Eeeeeeeeec------------------CceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHH
Q 004264 501 HRNL--VGLLGSCIEE------------------DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLY 560 (765)
Q Consensus 501 h~ni--v~~~~~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~ 560 (765)
+.++ |+.+|+..-. ..+.||.||++... .....-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccchhHHHHHHHHHHH
Confidence 3455 8888887422 12357777775532 1123345678888899
Q ss_pred hhhcCCCcEEecccCCCcEEEecCCCCeecccccc
Q 004264 561 LHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA 595 (765)
Q Consensus 561 LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla 595 (765)
+|+.+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99999 999999999965 4589999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00091 Score=71.14 Aligned_cols=143 Identities=19% Similarity=0.176 Sum_probs=85.6
Q ss_pred ccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCc--eEeeeee------eeecCceEEEEE
Q 004264 451 ANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRN--LVGLLGS------CIEEDERMLIYE 522 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n--iv~~~~~------~~~~~~~~lV~E 522 (765)
.+.|..|....+|+....+ ..+++|+... .....+..|+.++..|++.. +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567788888999987644 4788898764 23456777888888885432 4444432 123445689999
Q ss_pred ecCCCChhH----Hh----------hcccc--C------CCCChHHHH----------HHHHHHHHHHHHhhh----cCC
Q 004264 523 YMPHKSLDY----FI----------FDRER--S------KLLPWKKRF----------SIITGIARGLLYLHQ----DSK 566 (765)
Q Consensus 523 ~~~~gsL~~----~l----------~~~~~--~------~~l~~~~~~----------~i~~qia~aL~~LH~----~~~ 566 (765)
|++|..+.. .. +.... . ....|.... .....+..++.++.+ ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 00 00000 0 001111110 011113334445443 112
Q ss_pred CcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 567 LQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 567 ~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
..++|+|+.|.||+++++..+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3499999999999999887778999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0011 Score=79.01 Aligned_cols=198 Identities=19% Similarity=0.165 Sum_probs=133.5
Q ss_pred HHHHHHHHHHhccccCceEeeeeeeeecCceE----EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhh
Q 004264 487 EEFMNEVVLIGKLQHRNLVGLLGSCIEEDERM----LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLH 562 (765)
Q Consensus 487 ~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH 562 (765)
.....|...+.++.|+|++.++.+..++...- +..|++..-++...+. .-..++....+.+..++.+||+|+|
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHH
Confidence 33455778888999999999999887654333 3346777777777663 3345888888899999999999999
Q ss_pred hcCCCcEEecccCCC---cEEEecCCCCeec--ccccceeeCCCCcccccccccccccccCcccccCCCCCc--cccchH
Q 004264 563 QDSKLQVIHRDLKAS---NILLDINLNPKIS--DFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISM--KSDVFS 635 (765)
Q Consensus 563 ~~~~~~ivH~Dlkp~---NIll~~~~~vkL~--DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~--k~DvwS 635 (765)
+.. ..|.-+..+ +--.+..+.+.+. ||+..+.+....... ...-+..+.+||......... ..|+|.
T Consensus 304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHH
Confidence 986 555544444 4444556666666 888887764322211 223345578888887766544 479999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 004264 636 LGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSV 715 (765)
Q Consensus 636 lG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 715 (765)
+|.++..+..|..+-.... .+.+.+..... ..+......|+..++++|+++.++
T Consensus 378 lgll~~~~~~~~~i~~~~~----------------------~~~~~l~~~~~----~~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSA----------------------VPVSLLDVLST----SELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHHHhhhhhcCccccccc----------------------chhhhhccccc----hhhhhhhhhhcchhhhhccchhhh
Confidence 9999999999875521100 00011110110 035567778999999999999999
Q ss_pred HHHH
Q 004264 716 VFLL 719 (765)
Q Consensus 716 l~~L 719 (765)
+.+.
T Consensus 432 l~~~ 435 (1351)
T KOG1035|consen 432 LTHP 435 (1351)
T ss_pred hhch
Confidence 8765
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0012 Score=70.58 Aligned_cols=141 Identities=26% Similarity=0.290 Sum_probs=83.0
Q ss_pred cccccCCceeEEEEEeCC-------CcEEEEEEccccChhhHHHHHHHHHHHhccccCceE-eeeeeeeecCceEEEEEe
Q 004264 452 NMIGKGGFGPVYMGKLST-------GQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLV-GLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv-~~~~~~~~~~~~~lV~E~ 523 (765)
+.|..|-...+|+....+ ++.+++|+..... .......+|..++..+....+. ++++++. ..+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 456667777899988655 5789999875543 2234567888888888643333 4444442 2368999
Q ss_pred cCCCChhHHh-----------------hccccCC------CCC--hHHHHH--------------------------HHH
Q 004264 524 MPHKSLDYFI-----------------FDRERSK------LLP--WKKRFS--------------------------IIT 552 (765)
Q Consensus 524 ~~~gsL~~~l-----------------~~~~~~~------~l~--~~~~~~--------------------------i~~ 552 (765)
++|..+.... +...... ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9987764311 1100000 000 101101 111
Q ss_pred HHHHHHHHhhh------cCCCcEEecccCCCcEEEecC----CCCeeccccccee
Q 004264 553 GIARGLLYLHQ------DSKLQVIHRDLKASNILLDIN----LNPKISDFGLARI 597 (765)
Q Consensus 553 qia~aL~~LH~------~~~~~ivH~Dlkp~NIll~~~----~~vkL~DFGla~~ 597 (765)
.+.+.+..|.. .....++|+|+.|.||+++++ +.++|+||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22222334432 234469999999999999985 8899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0036 Score=67.39 Aligned_cols=142 Identities=18% Similarity=0.191 Sum_probs=77.2
Q ss_pred cccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCc--eEeeeee------eeecCceEEEEEe
Q 004264 452 NMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRN--LVGLLGS------CIEEDERMLIYEY 523 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n--iv~~~~~------~~~~~~~~lV~E~ 523 (765)
+.|+.|....+|+....++ .+++|++... ....+..|+.+++.|.... +.+++.. ....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4567777789999886555 6888987521 2234455666666664222 2233321 1224567899999
Q ss_pred cCCCChhH-----------Hh---hccccC------C--CCCh-HHHHH------------HHHH-HHHHHHHhhhc---
Q 004264 524 MPHKSLDY-----------FI---FDRERS------K--LLPW-KKRFS------------IITG-IARGLLYLHQD--- 564 (765)
Q Consensus 524 ~~~gsL~~-----------~l---~~~~~~------~--~l~~-~~~~~------------i~~q-ia~aL~~LH~~--- 564 (765)
++|..+.. .+ +..... . .+.+ ..... .+.+ +...+..+.+.
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99975421 11 100000 0 0111 11111 1111 11122333211
Q ss_pred -CCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 565 -SKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 565 -~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
-...++|+|++|.||+++.+...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 123499999999999999665568999998864
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0053 Score=65.03 Aligned_cols=147 Identities=15% Similarity=0.199 Sum_probs=82.8
Q ss_pred ccccccccCCceeEEEEEeCCCcEEEEEEccc--cChhhHHHHHHHHHHHhcccc--CceEeeeeeeeecC--ceEEEEE
Q 004264 449 SEANMIGKGGFGPVYMGKLSTGQEIAAKRLSK--NSGQGLEEFMNEVVLIGKLQH--RNLVGLLGSCIEED--ERMLIYE 522 (765)
Q Consensus 449 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~Ev~~l~~l~h--~niv~~~~~~~~~~--~~~lV~E 522 (765)
.+.+.+..|..-.+|..... ++.+++. ... ..........+|..+|+.+.- .-+.+.++.|.++. ..+.||+
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred ceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 33444544444455555543 7778888 331 223344566778888887753 23445566676666 6799999
Q ss_pred ecCCCChhHHhhccccC-----------------------------------CCCChHHHHHHHH--------HHHHHHH
Q 004264 523 YMPHKSLDYFIFDRERS-----------------------------------KLLPWKKRFSIIT--------GIARGLL 559 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~-----------------------------------~~l~~~~~~~i~~--------qia~aL~ 559 (765)
|+++..+...+...... +...+...++.++ ...+-..
T Consensus 106 ~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~ 185 (321)
T COG3173 106 WVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK 185 (321)
T ss_pred EecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence 99984332221100000 0000111110000 1112233
Q ss_pred Hhhhc-----CCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 560 YLHQD-----SKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 560 ~LH~~-----~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
+|++. +...++|+|+++.||+++.+.-+-|.||+++..
T Consensus 186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 44332 345699999999999999998899999999975
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0055 Score=64.38 Aligned_cols=30 Identities=27% Similarity=0.515 Sum_probs=25.5
Q ss_pred cEEecccCCCcEEEecCCC-Ceeccccccee
Q 004264 568 QVIHRDLKASNILLDINLN-PKISDFGLARI 597 (765)
Q Consensus 568 ~ivH~Dlkp~NIll~~~~~-vkL~DFGla~~ 597 (765)
.++|+|++|.||+++++++ .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0049 Score=66.98 Aligned_cols=141 Identities=16% Similarity=0.206 Sum_probs=82.1
Q ss_pred cccccCCceeEEEEEeCC-----CcEEEEEEccccChhhHHHHHHHHHHHhccccCceE-eeeeeeeecCceEEEEEecC
Q 004264 452 NMIGKGGFGPVYMGKLST-----GQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLV-GLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv-~~~~~~~~~~~~~lV~E~~~ 525 (765)
+.|..|-.-.+|+....+ ++.+++|+.......... ..+|..+++.+...++. ++++.+..+ .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 456667788899987532 367889988655433322 36799998888644443 344544322 5899998
Q ss_pred CCChhHHh-----------------hccc-c--CCCCChHHHHHHHHHH-----------------HHHHHHh----hh-
Q 004264 526 HKSLDYFI-----------------FDRE-R--SKLLPWKKRFSIITGI-----------------ARGLLYL----HQ- 563 (765)
Q Consensus 526 ~gsL~~~l-----------------~~~~-~--~~~l~~~~~~~i~~qi-----------------a~aL~~L----H~- 563 (765)
+.++...- +... . .....+..+.++..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 87774210 1100 0 0011122222332211 1111122 21
Q ss_pred cCCCcEEecccCCCcEEEec-CCCCeeccccccee
Q 004264 564 DSKLQVIHRDLKASNILLDI-NLNPKISDFGLARI 597 (765)
Q Consensus 564 ~~~~~ivH~Dlkp~NIll~~-~~~vkL~DFGla~~ 597 (765)
.....++|+|+++.||++++ ++.++|+||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 12335899999999999986 46799999988864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0014 Score=67.92 Aligned_cols=148 Identities=17% Similarity=0.152 Sum_probs=101.8
Q ss_pred ccchHhHHHHhcC---cccccccccCCceeEEEEEeCCCcEEEEEEccc---------cCh-------------hhHHHH
Q 004264 435 LYDLATITTATNH---FSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSK---------NSG-------------QGLEEF 489 (765)
Q Consensus 435 ~~~~~~~~~~~~~---y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~---------~~~-------------~~~~~~ 489 (765)
.|++-.++....+ +.+.++||-|.-+.||.+-..+|++.++|.-.- ... ...-..
T Consensus 78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa 157 (465)
T KOG2268|consen 78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA 157 (465)
T ss_pred cchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence 4666677666654 778899999999999999999999999885321 000 012235
Q ss_pred HHHHHHHhcccc-Cc-eEeeeeeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCC
Q 004264 490 MNEVVLIGKLQH-RN-LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567 (765)
Q Consensus 490 ~~Ev~~l~~l~h-~n-iv~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 567 (765)
.+|...|+.|.. .. +.+.+++ +.-++|||++.+-.|...- ...+... +...+..-+--|...|
T Consensus 158 ~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~---ly~~lm~~Iv~la~~G-- 222 (465)
T KOG2268|consen 158 TKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPT---LYDDLMGLIVRLANHG-- 222 (465)
T ss_pred HHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee------ecCChHH---HHHHHHHHHHHHHHcC--
Confidence 678888888853 22 4444443 3457899999888774332 1122223 3334444555667777
Q ss_pred cEEecccCCCcEEEecCCCCeecccccceee
Q 004264 568 QVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 568 ~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
+||+|..-=||++++++.++++||-.....
T Consensus 223 -lIHgDFNEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 223 -LIHGDFNEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred -ceecccchheeEEecCCCEEEeechHhhcc
Confidence 999999999999999999999999876543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.013 Score=62.77 Aligned_cols=144 Identities=20% Similarity=0.182 Sum_probs=82.1
Q ss_pred ccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCc--eEeeeeee------eecCceEEEEE
Q 004264 451 ANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRN--LVGLLGSC------IEEDERMLIYE 522 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n--iv~~~~~~------~~~~~~~lV~E 522 (765)
.+.++.|....+|+....++ .+++|+..... ...+...|++++..|.... +.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789999876544 67788765422 1345566777777774322 33443321 12345689999
Q ss_pred ecCCCChhH----H----------hhccccC--CC-------CChHHHH------------HHHHHHHHHHHHhhh----
Q 004264 523 YMPHKSLDY----F----------IFDRERS--KL-------LPWKKRF------------SIITGIARGLLYLHQ---- 563 (765)
Q Consensus 523 ~~~~gsL~~----~----------l~~~~~~--~~-------l~~~~~~------------~i~~qia~aL~~LH~---- 563 (765)
|++|..+.. . ++..... .. ..|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999865421 0 1110000 00 0111100 001123334555532
Q ss_pred cCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 564 ~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
.-...++|+|+++.||+++.++.+.|+||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 1223599999999999999887778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.01 Score=62.47 Aligned_cols=73 Identities=16% Similarity=0.202 Sum_probs=48.3
Q ss_pred ccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccc---cCceEeeeeeeeecCceEEEEEecCCC
Q 004264 451 ANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ---HRNLVGLLGSCIEEDERMLIYEYMPHK 527 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~---h~niv~~~~~~~~~~~~~lV~E~~~~g 527 (765)
.+.|+.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+.+++++....+..+||+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4568889999999987 577889999775 233457888998888884 345778888888777889999999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.0022 Score=52.52 Aligned_cols=51 Identities=14% Similarity=0.313 Sum_probs=35.5
Q ss_pred EEeccccCCCCc-cccccCChHhHHHHhhccCCcccccccccCCCCcceeecccc
Q 004264 343 LKLPRMKLPENY-WSNKSMNLKECEAECTKNCSCRAYANSDVTGGGSGCLMWFGD 396 (765)
Q Consensus 343 ~~~~~~~~p~~~-~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~~~~C~~w~gd 396 (765)
..++++.++... ......+.++|+..|+.+|+|.||.|.. +...|+++...
T Consensus 7 ~~~~~~~~~g~d~~~~~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~~ 58 (73)
T cd01100 7 RQGSNVDFRGGDLSTVFASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSSE 58 (73)
T ss_pred cccCCCccccCCcceeecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccCC
Confidence 334556665543 2223568999999999999999999753 24569887764
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.016 Score=61.37 Aligned_cols=141 Identities=17% Similarity=0.131 Sum_probs=95.2
Q ss_pred cccccccCCceeEEEEEeCCCcEEEEEEccccC------------------------hh--hHHHHHHHHHHHhccccCc
Q 004264 450 EANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNS------------------------GQ--GLEEFMNEVVLIGKLQHRN 503 (765)
Q Consensus 450 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~------------------------~~--~~~~~~~Ev~~l~~l~h~n 503 (765)
+..-|..|.-+.||.+...+|..+|||+++... +. ..-....|+.-|.+|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 345678899999999999999999999885320 00 0112456777788775433
Q ss_pred eEeeeeeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec
Q 004264 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI 583 (765)
Q Consensus 504 iv~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 583 (765)
|.-.--.. -...+|||+|+...... ........++...+..+-.|++.-|.-|-+.+ .+||.||.--|+|+-
T Consensus 228 IP~PePIl--Lk~hVLVM~FlGrdgw~---aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 228 IPCPEPIL--LKNHVLVMEFLGRDGWA---APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH- 299 (520)
T ss_pred CCCCCcee--eecceEeeeeccCCCCc---CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-
Confidence 21111101 12346999999753321 11122335677788888889999888887766 499999999999986
Q ss_pred CCCCeecccccceee
Q 004264 584 NLNPKISDFGLARIF 598 (765)
Q Consensus 584 ~~~vkL~DFGla~~~ 598 (765)
+|.+.|+|-+.+...
T Consensus 300 dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEH 314 (520)
T ss_pred CCEEEEEEccccccC
Confidence 568999998877653
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.043 Score=60.17 Aligned_cols=73 Identities=12% Similarity=0.075 Sum_probs=50.9
Q ss_pred ccccccCCceeEEEEEeCCCcEEEEEEcccc-----C--hhhHHHHHHHHHHHhccc---cCceEeeeeeeeecCceEEE
Q 004264 451 ANMIGKGGFGPVYMGKLSTGQEIAAKRLSKN-----S--GQGLEEFMNEVVLIGKLQ---HRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~-----~--~~~~~~~~~Ev~~l~~l~---h~niv~~~~~~~~~~~~~lV 520 (765)
.+.||.|....||+...+ ++.++||+-... . +....+-..|+..|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 467899999999998864 567999986521 1 123445556677776664 246777887766 456889
Q ss_pred EEecCC
Q 004264 521 YEYMPH 526 (765)
Q Consensus 521 ~E~~~~ 526 (765)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.032 Score=60.02 Aligned_cols=72 Identities=13% Similarity=0.144 Sum_probs=49.5
Q ss_pred ccccCCceeEEEEEeCCC-cEEEEEEccc-------cChhhHHHHHHHHHHHhccc--cCc-eEeeeeeeeecCceEEEE
Q 004264 453 MIGKGGFGPVYMGKLSTG-QEIAAKRLSK-------NSGQGLEEFMNEVVLIGKLQ--HRN-LVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 453 ~LG~G~fg~Vy~~~~~~~-~~vavK~l~~-------~~~~~~~~~~~Ev~~l~~l~--h~n-iv~~~~~~~~~~~~~lV~ 521 (765)
.||.|....||++..+++ +.++||.-.. .-+....+...|...|+... -|. +.+++ +.+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence 479999999999998755 6899997542 12344566677888887763 343 44444 33556667999
Q ss_pred EecCC
Q 004264 522 EYMPH 526 (765)
Q Consensus 522 E~~~~ 526 (765)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99865
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.0098 Score=59.80 Aligned_cols=30 Identities=33% Similarity=0.461 Sum_probs=21.8
Q ss_pred cEEecccCCCcEEE-ecCCCCeeccccccee
Q 004264 568 QVIHRDLKASNILL-DINLNPKISDFGLARI 597 (765)
Q Consensus 568 ~ivH~Dlkp~NIll-~~~~~vkL~DFGla~~ 597 (765)
.++|+|+.|.||++ +.++.++|+||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8899999999998875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.035 Score=59.99 Aligned_cols=141 Identities=16% Similarity=0.183 Sum_probs=79.5
Q ss_pred cccccCCceeEEEEEeCC----CcEEEEEEccccChhhHHHHHHHHHHHhccccCceE-eeeeeeeecCceEEEEEecCC
Q 004264 452 NMIGKGGFGPVYMGKLST----GQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLV-GLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv-~~~~~~~~~~~~~lV~E~~~~ 526 (765)
+.|..|-...+|+....+ +..|++|+....... .-...+|..+++.+...++. ++++++. +. +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC--Cc--EeehhhcC
Confidence 355557777888886533 237888887654332 22346788899888755443 4455442 22 58999988
Q ss_pred CChhHH-------h----------hccc-c--CCCCChHHHHHHHHHH----------------------HH---HHHHh
Q 004264 527 KSLDYF-------I----------FDRE-R--SKLLPWKKRFSIITGI----------------------AR---GLLYL 561 (765)
Q Consensus 527 gsL~~~-------l----------~~~~-~--~~~l~~~~~~~i~~qi----------------------a~---aL~~L 561 (765)
.+|... + +... . ..+..+..+.++..++ .+ .+..+
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 766321 1 1100 0 0011122222222221 11 11111
Q ss_pred h-h-cCCCcEEecccCCCcEEEec-CCCCeeccccccee
Q 004264 562 H-Q-DSKLQVIHRDLKASNILLDI-NLNPKISDFGLARI 597 (765)
Q Consensus 562 H-~-~~~~~ivH~Dlkp~NIll~~-~~~vkL~DFGla~~ 597 (765)
. . .....++|+|+.+.|||+++ ++.++++||..|-.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 1 11234899999999999975 57899999998864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 765 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-52 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-50 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-39 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-31 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-31 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-29 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-26 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-26 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-26 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-26 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-26 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-25 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-24 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-24 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-24 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-24 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-24 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-24 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-24 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-24 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-22 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-22 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-20 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-17 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 390 bits (1004), Expect = e-131
Identities = 96/307 (31%), Positives = 150/307 (48%), Gaps = 19/307 (6%)
Query: 430 DIEVPLYDLATITTATNHFSE------ANMIGKGGFGPVYMGKLSTGQEIAAKRLSK--- 480
D + + TN+F E N +G+GGFG VY G ++ +A K+L+
Sbjct: 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVD 67
Query: 481 -NSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERS 539
+ + ++F E+ ++ K QH NLV LLG + D+ L+Y YMP+ SL + + +
Sbjct: 68 ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127
Query: 540 KLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599
L W R I G A G+ +LH++ IHRD+K++NILLD KISDFGLAR
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRH 659
+ T R+ GT YM+PE G I+ KSD++S GV+L+EI++G
Sbjct: 185 KFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREP--Q 241
Query: 660 NLIGHAWLLWNDGRAL-GLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718
L+ + ++ + + +D + D + V V C+ + RPD+ V L
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
Query: 719 LANDGVT 725
L +
Sbjct: 301 LQEMTAS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 387 bits (996), Expect = e-129
Identities = 120/318 (37%), Positives = 176/318 (55%), Gaps = 14/318 (4%)
Query: 414 FIRVPSS---ELGLENWKVDIEVPLYDLATITTATNHFSEANMIGKGGFGPVYMGKLSTG 470
F VP+ E+ L K + L + A+++FS N++G+GGFG VY G+L+ G
Sbjct: 1 FFDVPAEEDPEVHLGQLKR------FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG 54
Query: 471 QEIAAKRLSKNSGQGLE-EFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSL 529
+A KRL + QG E +F EV +I HRNL+ L G C+ ER+L+Y YM + S+
Sbjct: 55 TLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114
Query: 530 DYFIFDRERSKL-LPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPK 588
+ +R S+ L W KR I G ARGL YLH ++IHRD+KA+NILLD
Sbjct: 115 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174
Query: 589 ISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKM 648
+ DFGLA++ D T V GT G+++PEY + G S K+DVF GV+L+E+++G+
Sbjct: 175 VGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 233
Query: 649 NRGFRHP--GHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLP 706
L+ L + + L+D L+ ++ + +V + IQV LLC Q P
Sbjct: 234 AFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSP 293
Query: 707 EDRPDMSSVVFLLANDGV 724
+RP MS VV +L DG+
Sbjct: 294 MERPKMSEVVRMLEGDGL 311
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 351 bits (902), Expect = e-115
Identities = 103/283 (36%), Positives = 155/283 (54%), Gaps = 4/283 (1%)
Query: 438 LATITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIG 497
L + ATN+F +IG G FG VY G L G ++A KR + S QG+EEF E+ +
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 498 KLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKL-LPWKKRFSIITGIAR 556
+H +LV L+G C E +E +LIY+YM + +L ++ + + + W++R I G AR
Sbjct: 91 FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 557 GLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGY 616
GL YLH + +IHRD+K+ NILLD N PKI+DFG+++ D+ + V GT GY
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGY 207
Query: 617 MSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676
+ PEY G ++ KSDV+S GV+L E++ + P NL A N+G+
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719
++D L D + + + C+ EDRP M V++ L
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 265 bits (678), Expect = 1e-82
Identities = 67/325 (20%), Positives = 118/325 (36%), Gaps = 42/325 (12%)
Query: 419 SSELGLENWKVDIEVPLYDLATITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRL 478
+LG EN + + +G FG V+ +L + +A K
Sbjct: 11 GVDLGTENLYFQ--------------SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIF 55
Query: 479 SKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE----EDERMLIYEYMPHKSLDYFIF 534
Q + EV + ++H N++ +G+ + + LI + SL F+
Sbjct: 56 PIQDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL- 113
Query: 535 DRERSKLLPWKKRFSIITGIARGLLYLHQD-------SKLQVIHRDLKASNILLDINLNP 587
++ ++ W + I +ARGL YLH+D K + HRD+K+ N+LL NL
Sbjct: 114 ---KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170
Query: 588 KISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG-----TISMKSDVFSLGVLLVE 642
I+DFGLA F T GT YM+PE ++ D++++G++L E
Sbjct: 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE 230
Query: 643 IVSGKMNRGFRHPGHRHNLIGHAWLLWN-----DGRALGLMDTCLEDSFVESQVLRCI-Q 696
+ S + + + L D + + + + +
Sbjct: 231 LASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCE 290
Query: 697 VGLLCVQKLPEDRPDMSSVVFLLAN 721
C E R V +
Sbjct: 291 TIEECWDHDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 220 bits (561), Expect = 2e-65
Identities = 65/328 (19%), Positives = 123/328 (37%), Gaps = 51/328 (15%)
Query: 444 ATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNE--VVLIGKLQH 501
++ +IG+G +G VY G L + +A K S + Q F+NE + + ++H
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQ---NFINEKNIYRVPLMEH 66
Query: 502 RNLVGLLGSCIE-----EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIAR 556
N+ + E +L+ EY P+ SL ++ W + + R
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHSVTR 122
Query: 557 GLLYLHQD------SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG------DDEE 604
GL YLH + K + HRDL + N+L+ + ISDFGL+ G +E+
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 605 AQTERVAGTHGYMSPEYANDGTISM--------KSDVFSLGVLLVEIVSGKMNRGFRHPG 656
GT YM+PE +G +++ + D+++LG++ EI +
Sbjct: 183 NAAISEVGTIRYMAPEVL-EGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241
Query: 657 HRHNLIGHAWLLWN------------DGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQK 704
+ + + + + + + E+S + I+ C +
Sbjct: 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE---DCWDQ 298
Query: 705 LPEDRPDMSSVVFLLANDGVTLPQPRQP 732
E R +A + + +
Sbjct: 299 DAEARLTAQXAEERMAELMMIWERNKSV 326
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 3e-57
Identities = 70/268 (26%), Positives = 125/268 (46%), Gaps = 21/268 (7%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRL--SKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSC 511
IG G FG V+ + G ++A K L + + EF+ EV ++ +L+H N+V +G+
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 512 IEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIH 571
+ ++ EY+ SL + + L ++R S+ +A+G+ YLH ++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVH 162
Query: 572 RDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKS 631
R+LK+ N+L+D K+ DFGL+R+ ++ AGT +M+PE D + KS
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLK--ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 632 DVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQV 691
DV+S GV+L E+ + + P N + + L + + V + +
Sbjct: 221 DVYSFGVILWELATLQQ------PWGNLNPAQVVAAVGFKCKRLEIPRNL--NPQVAAII 272
Query: 692 LRCIQVGLLCVQKLPEDRPDMSSVVFLL 719
C P RP ++++ LL
Sbjct: 273 EGCW-------TNEPWKRPSFATIMDLL 293
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 3e-57
Identities = 72/279 (25%), Positives = 109/279 (39%), Gaps = 32/279 (11%)
Query: 454 IGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512
+GKG FG TG+ + K L + + F+ EV ++ L+H N++ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 513 EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHR 572
++ I EY+ +L I + PW +R S IA G+ YLH + +IHR
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 573 DLKASNILLDINLNPKISDFGLARIFGGDDEEAQTER------------VAGTHGYMSPE 620
DL + N L+ N N ++DFGLAR+ + + + R V G +M+PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 621 YANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680
N + K DVFS G++L EI+ R G L
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRV--NADPDYLPRTMDFG---LNVRGFLDRYCPPN 247
Query: 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719
C + C PE RP + L
Sbjct: 248 CPPS------FFPIT---VRCCDLDPEKRPSFVKLEHWL 277
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 8e-55
Identities = 71/290 (24%), Positives = 116/290 (40%), Gaps = 29/290 (10%)
Query: 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLV 505
++G+G FG V K +++A K++ S + F+ E+ + ++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIV 64
Query: 506 GLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
L G+C+ + L+ EY SL + E S ++G+ YLH
Sbjct: 65 KLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 566 KLQVIHRDLKASNILLDINLN-PKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND 624
+IHRDLK N+LL KI DFG A D + G+ +M+PE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 625 GTISMKSDVFSLGVLLVEIVSGKMNRGFRHP--GHRHNLIGHAWLLWNDGRALGLMDTCL 682
S K DVFS G++L E+++ + P W + N R L+
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK------PFDEIGGPAFRIMWAVHNGTR-PPLIKNLP 230
Query: 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGVTLPQPRQP 732
+ + + C K P RP M +V ++ + P +P
Sbjct: 231 KP------IESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-54
Identities = 84/282 (29%), Positives = 132/282 (46%), Gaps = 40/282 (14%)
Query: 452 NMIGKGGFGPVYMGKLSTGQEIAAKRL----SKNSGQGLEEFMNEVVLIGKLQHRNLVGL 507
+IG GGFG VY G E+A K ++ Q +E E L L+H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
G C++E L+ E+ L+ + K +P + IARG+ YLH ++ +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 568 QVIHRDLKASNILLD--------INLNPKISDFGLARIFGGDDEEAQTER--VAGTHGYM 617
+IHRDLK+SNIL+ N KI+DFGLAR E +T + AG + +M
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR------EWHRTTKMSAAGAYAWM 181
Query: 618 SPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677
+PE S SDV+S GVLL E+++G++ P + + A+ + + AL +
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEV------PFRGIDGLAVAYGVAMNKLALPI 235
Query: 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719
TC E + ++ C P RP ++++ L
Sbjct: 236 PSTCPE------PFAKLME---DCWNPDPHSRPSFTNILDQL 268
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 5e-53
Identities = 68/291 (23%), Positives = 125/291 (42%), Gaps = 42/291 (14%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQG-------LEEFMNEVVLIG 497
N IGKGGFG V+ G+ + +A K L +G +EF EV ++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 498 KLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARG 557
L H N+V L G ++ E++P L + + +++ + W + ++ IA G
Sbjct: 79 NLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALG 134
Query: 558 LLYLHQDSKLQVIHRDLKASNILLD-----INLNPKISDFGLARIFGGDDEEAQTERVAG 612
+ Y+ ++HRDL++ NI L + K++DFGL++ + G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLG 188
Query: 613 THGYMSPE--YANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHP--GHRHNLIGHAWLL 668
+M+PE A + + + K+D +S ++L I++G+ P + + I ++
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG------PFDEYSYGKIKFINMI 242
Query: 669 WNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719
+G + + C + I+ LC P+ RP S +V L
Sbjct: 243 REEGLRPTIPEDCPPR------LRNVIE---LCWSGDPKKRPHFSYIVKEL 284
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-51
Identities = 64/200 (32%), Positives = 104/200 (52%), Gaps = 13/200 (6%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSC 511
IG G FG VY GK ++A K L+ + Q L+ F NEV ++ K +H N++ +G
Sbjct: 32 IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 512 IEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIH 571
+ ++ ++ SL + + E KK I ARG+ YLH +IH
Sbjct: 90 TAP-QLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA---KSIIH 143
Query: 572 RDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE---YANDGTIS 628
RDLK++NI L + KI DFGLA Q E+++G+ +M+PE + S
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 629 MKSDVFSLGVLLVEIVSGKM 648
+SDV++ G++L E+++G++
Sbjct: 204 FQSDVYAFGIVLYELMTGQL 223
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 6e-50
Identities = 41/204 (20%), Positives = 86/204 (42%), Gaps = 17/204 (8%)
Query: 452 NMIGKGGFGPVYMGKLSTGQEIAAKRL--SKNSGQGLEEFMNEVVLIGKLQHRNLVGLLG 509
+ + G ++ G+ G +I K L S + +F E + H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 510 SCIEEDER--MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
+C LI +MP+ SL + + + + +ARG+ +LH +
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFLHT-LEP 132
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE---YAND 624
+ L + ++++D ++ +IS + F Q+ +++PE +
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEALQKKPE 185
Query: 625 GTISMKSDVFSLGVLLVEIVSGKM 648
T +D++S VLL E+V+ ++
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREV 209
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-48
Identities = 64/282 (22%), Positives = 117/282 (41%), Gaps = 37/282 (13%)
Query: 452 NMIGKGGFGPVYMGKLSTGQEIAAKRL--SKNSGQGLEEFMNEVVLIGKLQHRNLVGLLG 509
+IGKG FG VY G+ E+A + + +++ L+ F EV+ + +H N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 510 SCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQV 569
+C+ +I ++L + R+ +L K I I +G+ YLH +
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---I 151
Query: 570 IHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTER---VAGTHGYMSPE------ 620
+H+DLK+ N+ D N I+DFGL I G + ++ G +++PE
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 621 ---YANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677
+ S SDVF+LG + E+ + + P W + +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREW------PFKTQPAEAIIWQMGTGMKPNLS 264
Query: 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719
++ + +L C E+RP + ++ +L
Sbjct: 265 QIGMGKE--ISDILLFCW-------AFEQEERPTFTKLMDML 297
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-47
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 29/220 (13%)
Query: 452 NMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNE--VVLIGKLQHRNLVGLLG 509
+GKG +G V+ G G+ +A K S + + + E + L+H N++G +
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 510 SCIEED----ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD- 564
S + + LI Y SL ++ + L I+ IA GL +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 565 ----SKLQVIHRDLKASNILLDINLNPKISDFGLARIF---GGDDEEAQTERVAGTHGYM 617
K + HRDLK+ NIL+ N I+D GLA + + RV GT YM
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYM 184
Query: 618 SPE------YANDGTISMKSDVFSLGVLLVEIVSGKMNRG 651
+PE + + D+++ G++L E+ ++ G
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-46
Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 27/219 (12%)
Query: 452 NMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNE--VVLIGKLQHRNLVGLLG 509
IGKG +G V+MGK G+++A K + E + ++H N++G +
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 510 SCIEEDER----MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD- 564
+ I+ LI +Y + SL ++ +S L K + GL +LH +
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 565 ----SKLQVIHRDLKASNILLDINLNPKISDFGLARIF--GGDDEEAQTERVAGTHGYMS 618
K + HRDLK+ NIL+ N I+D GLA F ++ + GT YM
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 619 PE------YANDGTISMKSDVFSLGVLLVEIVSGKMNRG 651
PE N + +D++S G++L E+ ++ G
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 452 NMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNE--VVLIGKLQHRNLVGLLG 509
IGKG FG V+ GK G+E+A K S + + E + L+H N++G +
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 510 SCIEED----ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD- 564
+ +++ + L+ +Y H SL ++ + + + A GL +LH +
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 565 ----SKLQVIHRDLKASNILLDINLNPKISDFGLARIF---GGDDEEAQTERVAGTHGYM 617
K + HRDLK+ NIL+ N I+D GLA + A RV GT YM
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRYM 218
Query: 618 SPE------YANDGTISMKSDVFSLGVLLVEIVSGKMNRG 651
+PE ++D++++G++ EI G
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-43
Identities = 57/198 (28%), Positives = 89/198 (44%), Gaps = 15/198 (7%)
Query: 454 IGKGGFGPVYMGKL-STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSC 511
IG+G FG V+ G+L + +A K + +F+ E ++ + H N+V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 512 IEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIH 571
++ ++ E + F+ R L K ++ A G+ YL IH
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIH 236
Query: 572 RDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGY----MSPEYANDGTI 627
RDL A N L+ KISDFG++R ++ + G +PE N G
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVKWTAPEALNYGRY 292
Query: 628 SMKSDVFSLGVLLVEIVS 645
S +SDV+S G+LL E S
Sbjct: 293 SSESDVWSFGILLWETFS 310
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-42
Identities = 66/202 (32%), Positives = 98/202 (48%), Gaps = 20/202 (9%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513
IG G FG V++G ++A K + + E+F+ E ++ KL H LV L G C+E
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 514 EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRD 573
+ L+ E+M H L ++ R + L + + + G+ YL + VIHRD
Sbjct: 75 QAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRD 129
Query: 574 LKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG------YMSPEYANDGTI 627
L A N L+ N K+SDFG+ R D + T G + SPE +
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-------GTKFPVKWASPEVFSFSRY 182
Query: 628 SMKSDVFSLGVLLVEIVS-GKM 648
S KSDV+S GVL+ E+ S GK+
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKI 204
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-42
Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 452 NMIGKGGFGPVYMGKLSTGQE-----IAAKRLSKNSGQG-LEEFMNEVVLIGKLQHRNLV 505
++G G FG VY G E +A K L + + +E ++E ++ + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 506 GLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
LLG C+ LI + MP L ++ RE + + + IA+G+ YL
Sbjct: 81 RLLGICLTS-TVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL---E 134
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG-----YMSPE 620
+++HRDL A N+L+ + KI+DFGLA++ G +++E G +M+ E
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-----EGGKVPIKWMALE 189
Query: 621 YANDGTISMKSDVFSLGVLLVEIVS 645
+ +SDV+S GV + E+++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-42
Identities = 62/202 (30%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513
+G G FG V +GK ++A K + K +EF E + KL H LV G C +
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 514 EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRD 573
E ++ EY+ + L ++ R K L + + + G+ +L Q IHRD
Sbjct: 75 EYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRD 129
Query: 574 LKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG------YMSPEYANDGTI 627
L A N L+D +L K+SDFG+ R D + G + +PE +
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV-------GTKFPVKWSAPEVFHYFKY 182
Query: 628 SMKSDVFSLGVLLVEIVS-GKM 648
S KSDV++ G+L+ E+ S GKM
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKM 204
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 8e-42
Identities = 61/202 (30%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513
+G G FG V GK ++A K + K +EF+ E ++ L H LV L G C +
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 514 EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRD 573
+ +I EYM + L ++ RE ++ + + + YL Q +HRD
Sbjct: 91 QRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRD 145
Query: 574 LKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG------YMSPEYANDGTI 627
L A N L++ K+SDFGL+R D+ + G + PE
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-------GSKFPVRWSPPEVLMYSKF 198
Query: 628 SMKSDVFSLGVLLVEIVS-GKM 648
S KSD+++ GVL+ EI S GKM
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKM 220
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 9e-42
Identities = 71/296 (23%), Positives = 118/296 (39%), Gaps = 58/296 (19%)
Query: 454 IGKGGFGPVYMGKL-----STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLL 508
+GKG FG V + + +TG +A K+L + +F E+ ++ L +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 509 GSCIEEDER--MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSK 566
G + L+ EY+P L F+ + L + + I +G+ YL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS--- 145
Query: 567 LQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG-----YMSPEY 621
+ +HRDL A NIL++ + KI+DFGLA++ D + V G + +PE
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAPES 201
Query: 622 ANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680
+D S +SDV+S GV+L E+ + + + M
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKS-------------------CSPSAEFLRMMG 242
Query: 681 CLEDSFVESQVLRCIQVG-----------------LLCVQKLPEDRPDMSSVVFLL 719
C D S++L ++ G LC P+DRP S++ L
Sbjct: 243 CERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 454 IGKGGFGPVYMGKL-----STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLL 508
+GKG FG V M + +TG+ +A K+L ++ + L +F E+ ++ LQH N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 509 GSCIEEDER--MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSK 566
G C R LI EY+P+ SL ++ ++ + + K + I +G+ YL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT--- 132
Query: 567 LQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG-----YMSPEY 621
+ IHRDL NIL++ KI DFGL ++ D E G + +PE
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPIFWYAPES 188
Query: 622 ANDGTISMKSDVFSLGVLLVEIVS 645
+ S+ SDV+S GV+L E+ +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 74/287 (25%), Positives = 114/287 (39%), Gaps = 49/287 (17%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNL 504
F E +IG GGFG V+ K G+ KR+ N+ E+ EV + KL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 505 VGLLGSCIEEDERM----------------LIYEYMPHKSLDYFIFDRERSKLLPWKKRF 548
V G D + E+ +L+ +I ++ R + L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 549 SIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTE 608
+ I +G+ Y+H ++I+RDLK SNI L KI DFGL D + ++
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS- 181
Query: 609 RVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLL 668
GT YMSPE + + D+++LG++L E +
Sbjct: 182 --KGTLRYMSPEQISSQDYGKEVDLYALGLILAE-----LLHVCDTAFETSKFFTD---- 230
Query: 669 WNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSV 715
L D + D F + + + LL K PEDRP+ S +
Sbjct: 231 --------LRDGIISDIF--DKKEKTLLQKLL--SKKPEDRPNTSEI 265
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-41
Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 454 IGKGGFGPVYMGKL-----STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLL 508
+GKG FG V M + +TG+ +A K+L ++ + L +F E+ ++ LQH N+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 509 GSCIEEDER--MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSK 566
G C R LI EY+P+ SL ++ ++ + + K + I +G+ YL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT--- 163
Query: 567 LQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG-----YMSPEY 621
+ IHRDL NIL++ KI DFGL ++ D E G + +PE
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAPES 219
Query: 622 ANDGTISMKSDVFSLGVLLVEIVS 645
+ S+ SDV+S GV+L E+ +
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFT 243
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 7e-41
Identities = 64/232 (27%), Positives = 101/232 (43%), Gaps = 30/232 (12%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLS-KNSGQGLEEFMNEVVLIGKLQHRN 503
F +G+GGFG V+ K A KR+ N E+ M EV + KL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 504 LVGLLGSCIEEDE---------RMLIY---EYMPHKSLDYFIFDRERSKLLPWKKRFSII 551
+V + +E++ ++ +Y + ++L ++ R + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 552 TGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVA 611
IA + +LH ++HRDLK SNI ++ K+ DFGL D+EE
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 612 ----------GTHGYMSPEYANDGTISMKSDVFSLGVLLVEIV---SGKMNR 650
GT YMSPE + + S K D+FSLG++L E++ S +M R
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMER 233
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 454 IGKGGFGPVYMGKL-----STGQEIAAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVGL 507
+G+G FG V + + +TG+++A K L SG + + E+ ++ L H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 508 LGSCIEEDER--MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
G C E+ LI E++P SL ++ + + K++ I +G+ YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS-- 144
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG-----YMSPE 620
Q +HRDL A N+L++ KI DFGL + D E + +PE
Sbjct: 145 -RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY----TVKDDRDSPVFWYAPE 199
Query: 621 YANDGTISMKSDVFSLGVLLVEIVS 645
+ SDV+S GV L E+++
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 452 NMIGKGGFGPVYMGKLSTG----QEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVG 506
+IG+G FG VY G L A K L++ + +F+ E +++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 507 LLGSCIEEDE-RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
LLG C+ + +++ YM H L FI R + K +A+G+ YL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL---A 145
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG------YMSP 619
+ +HRDL A N +LD K++DFGLAR D + + V G +M+
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMAL 201
Query: 620 EYANDGTISMKSDVFSLGVLLVEIVS 645
E + KSDV+S GVLL E+++
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-40
Identities = 68/195 (34%), Positives = 104/195 (53%), Gaps = 13/195 (6%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513
+G G FG V+M + ++A K + K +E F+ E ++ LQH LV L +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 514 EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRD 573
E +I E+M SL F+ E SK P K IA G+ ++ + IHRD
Sbjct: 255 E-PIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFI---EQRNYIHRD 309
Query: 574 LKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG---YMSPEYANDGTISMK 630
L+A+NIL+ +L KI+DFGLAR+ ++ A+ G + +PE N G+ ++K
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSFTIK 365
Query: 631 SDVFSLGVLLVEIVS 645
SDV+S G+LL+EIV+
Sbjct: 366 SDVWSFGILLMEIVT 380
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 454 IGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512
+G G +G VY G +A K L K +EEF+ E ++ +++H NLV LLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 513 EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHR 572
E +I E+M + +L ++ + R + + + T I+ + YL K IHR
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL---EKKNFIHR 135
Query: 573 DLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG-----YMSPEYANDGTI 627
DL A N L+ N K++DFGL+R+ GD A + +PE
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 628 SMKSDVFSLGVLLVEIVS-GKM 648
S+KSDV++ GVLL EI + G
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMS 211
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 454 IGKGGFGPVYMGKLSTGQE-----IAAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVGL 507
+G G FG V+ G E + K + SG Q + + ++ IG L H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
LG C L+ +Y+P SL + R+ L + + IA+G+ YL +
Sbjct: 81 LGLCPGS-SLQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMYYL---EEH 134
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG-----YMSPEYA 622
++HR+L A N+LL +++DFG+A + DD++ + +M+ E
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY-----SEAKTPIKWMALESI 189
Query: 623 NDGTISMKSDVFSLGVLLVEIVS 645
+ G + +SDV+S GV + E+++
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMT 212
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-40
Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 452 NMIGKGGFGPVYMGKLSTGQE-----IAAKRLSKNSGQG-LEEFMNEVVLIGKLQHRNLV 505
++G G FG VY G E +A K L + + +E ++E ++ + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 506 GLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
LLG C+ LI + MP L ++ RE + + + IA+G+ YL
Sbjct: 81 RLLGICLTS-TVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL---E 134
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG-----YMSPE 620
+++HRDL A N+L+ + KI+DFGLA++ G +++E G +M+ E
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-----EGGKVPIKWMALE 189
Query: 621 YANDGTISMKSDVFSLGVLLVEIVS 645
+ +SDV+S GV + E+++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-40
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 452 NMIGKGGFGPVYMGKLSTGQE----IAAKRLSKNSGQG-LEEFMNEVVLIGKLQHRNLVG 506
+IGKG FG VY G+ + A K LS+ + +E F+ E +L+ L H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 507 LLGSCIEEDER-MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
L+G + + ++ YM H L FI R + K S +ARG+ YL +
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYL---A 141
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG-----YMSPE 620
+ + +HRDL A N +LD + K++DFGLAR + + + H + + E
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ---HRHARLPVKWTALE 198
Query: 621 YANDGTISMKSDVFSLGVLLVEIVS 645
+ KSDV+S GVLL E+++
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-40
Identities = 70/201 (34%), Positives = 107/201 (53%), Gaps = 18/201 (8%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513
+G G FG V+MG + ++A K L K + F+ E L+ +LQH+ LV L +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 514 EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRD 573
E +I EYM + SL F+ KL K + IA G+ ++ + IHRD
Sbjct: 80 E-PIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFI---EERNYIHRD 134
Query: 574 LKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG-----YMSPEYANDGTIS 628
L+A+NIL+ L+ KI+DFGLAR+ ++ A+ + +PE N GT +
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAR------EGAKFPIKWTAPEAINYGTFT 188
Query: 629 MKSDVFSLGVLLVEIVS-GKM 648
+KSDV+S G+LL EIV+ G++
Sbjct: 189 IKSDVWSFGILLTEIVTHGRI 209
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-40
Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 454 IGKGGFGPVYMGKLSTG----QEIAAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVGLL 508
IG G G V G+L +A K L + +F++E ++G+ H N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQ 568
G M++ EYM + SLD F+ R + ++ G+ G+ YL S L
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 569 VIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG------YMSPEYA 622
+HRDL A N+L+D NL K+SDFGL+R+ D + A T T G + +PE
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT-----TTGGKIPIRWTAPEAI 226
Query: 623 NDGTISMKSDVFSLGVLLVEIVS 645
T S SDV+S GV++ E+++
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLA 249
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-40
Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 24/205 (11%)
Query: 454 IGKGGFGPVYMGKL-----STGQEIAAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVGL 507
+G+G FG V + TG+ +A K L ++G Q + E+ ++ L H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 508 LGSCIEEDER--MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
G C + L+ EY+P SL ++ + + I G+ YLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA-- 152
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG-----YMSPE 620
IHRDL A N+LLD + KI DFGLA+ E G + +PE
Sbjct: 153 -QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWYAPE 207
Query: 621 YANDGTISMKSDVFSLGVLLVEIVS 645
+ SDV+S GV L E+++
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-40
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 454 IGKGGFGPVYMGKLSTGQE---IAAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVGLLG 509
+G G FG V G ++ +A K L + + EE M E ++ +L + +V L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 510 SCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQV 569
C + + ML+ E L F+ + + +P ++ ++ G+ YL +
Sbjct: 78 VC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKNF 131
Query: 570 IHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG-----YMSPEYAND 624
+HRDL A N+LL KISDFGL++ G DD A + G + +PE N
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY----TARSAGKWPLKWYAPECINF 187
Query: 625 GTISMKSDVFSLGVLLVEIVS 645
S +SDV+S GV + E +S
Sbjct: 188 RKFSSRSDVWSYGVTMWEALS 208
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-40
Identities = 70/203 (34%), Positives = 104/203 (51%), Gaps = 21/203 (10%)
Query: 454 IGKGGFGPVYMG--KLSTGQEI--AAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVGLL 508
+G G FG V G KL + +EI A K L + +F+ E ++G+ H N++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQ 568
G + M++ EYM + SLD F+ R+ + ++ GIA G+ YL S +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 569 VIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG------YMSPEYA 622
+HRDL A NIL++ NL K+SDFGL R+ D E A T T G + SPE
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT-----TRGGKIPIRWTSPEAI 222
Query: 623 NDGTISMKSDVFSLGVLLVEIVS 645
+ SDV+S G++L E++S
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMS 245
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-40
Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 9/198 (4%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAK--RLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLG 509
IG+G FG + K G++ K +S+ S + EE EV ++ ++H N+V
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 510 SCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQV 569
S E ++ +Y L I + ++ L + I L ++H ++
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVHDR---KI 146
Query: 570 IHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISM 629
+HRD+K+ NI L + ++ DFG+AR+ E A+ GT Y+SPE + +
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEICENKPYNN 204
Query: 630 KSDVFSLGVLLVEIVSGK 647
KSD+++LG +L E+ + K
Sbjct: 205 KSDIWALGCVLYELCTLK 222
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-39
Identities = 61/193 (31%), Positives = 95/193 (49%), Gaps = 7/193 (3%)
Query: 454 IGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512
+G G +G VY G +A K L K +EEF+ E ++ +++H NLV LLG C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 513 EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHR 572
E +I E+M + +L ++ + R + + + T I+ + YL K IHR
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL---EKKNFIHR 342
Query: 573 DLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSD 632
+L A N L+ N K++DFGL+R+ D + +PE S+KSD
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 633 VFSLGVLLVEIVS 645
V++ GVLL EI +
Sbjct: 402 VWAFGVLLWEIAT 414
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 67/208 (32%), Positives = 107/208 (51%), Gaps = 23/208 (11%)
Query: 454 IGKGGFGPVYMGKLSTGQE-----IAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGL 507
IG G FG VY G L T +A K L + + +F+ E ++G+ H N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
G + M+I EYM + +LD F+ RE+ + ++ GIA G+ YL + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG------YMSPEY 621
+HRDL A NIL++ NL K+SDFGL+R+ D E T T G + +PE
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT-----TSGGKIPIRWTAPEA 221
Query: 622 ANDGTISMKSDVFSLGVLLVEIVS-GKM 648
+ + SDV+S G+++ E+++ G+
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 72/283 (25%), Positives = 125/283 (44%), Gaps = 39/283 (13%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRL---SKNSGQGLEEFMNEVVLIGKLQH 501
+F IG+G F VY L G +A K++ + + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFI-FDRERSKLLPWKKRFSIITGIARGLLY 560
N++ S IE++E ++ E L I +++ +L+P + + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 561 LHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE 620
+H +V+HRD+K +N+ + K+ D GL R F A + + GT YMSPE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 621 YANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHP--GHRHNLIGHAWLLWNDGRALGLM 678
++ + KSD++SLG LL E+ + + P G + NL L
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQ------SPFYGDKMNL-------------YSLC 247
Query: 679 DTCLEDSFVE------SQVLRCIQVGLLCVQKLPEDRPDMSSV 715
+ + S+ LR Q+ +C+ PE RPD++ V
Sbjct: 248 KKIEQCDYPPLPSDHYSEELR--QLVNMCINPDPEKRPDVTYV 288
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 61/198 (30%), Positives = 94/198 (47%), Gaps = 23/198 (11%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513
IGKG FG V +G G ++A K + ++ + F+ E ++ +L+H NLV LLG +E
Sbjct: 29 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 514 EDER-MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHR 572
E ++ EYM SL ++ R R +L + + YL +HR
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL---EGNNFVHR 141
Query: 573 DLKASNILLDINLNPKISDFGLARIFGGDDEEAQTE-----RVAGTHGYMSPEYANDGTI 627
DL A N+L+ + K+SDFGL + + Q + + +PE +
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVK------WTAPEALREKKF 191
Query: 628 SMKSDVFSLGVLLVEIVS 645
S KSDV+S G+LL EI S
Sbjct: 192 STKSDVWSFGILLWEIYS 209
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 55/225 (24%), Positives = 90/225 (40%), Gaps = 21/225 (9%)
Query: 440 TITTATNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGK 498
+ H+ +G+GGF V + + L G A KR+ + Q EE E +
Sbjct: 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL 82
Query: 499 LQHRNLVGLLGSCIEEDERM----LIYEYMPHKSLDYFIFDRERSK-LLPWKKRFSIITG 553
H N++ L+ C+ E L+ + +L I + L + ++ G
Sbjct: 83 FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI----FGGDDEEAQTER 609
I RGL +H HRDLK +NILL P + D G G + +
Sbjct: 143 ICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 610 VAGTHG---YMSPE----YANDGTISMKSDVFSLGVLLVEIVSGK 647
A Y +PE ++ I ++DV+SLG +L ++ G+
Sbjct: 200 WAAQRCTISYRAPELFSVQSHC-VIDERTDVWSLGCVLYAMMFGE 243
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 452 NMIGKGGFGPVYMGKLSTG----QEIAAKRLSKNSGQG-LEEFMNEVVLIGKLQHRNLVG 506
+IG+G FG VY G L A K L++ + G + +F+ E +++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 507 LLGSCIEEDE-RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
LLG C+ + +++ YM H L FI R + K +A+G+ +L +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL---A 209
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG-----YMSPE 620
+ +HRDL A N +LD K++DFGLAR + ++ T +M+ E
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH---NKTGAKLPVKWMALE 266
Query: 621 YANDGTISMKSDVFSLGVLLVEIVS 645
+ KSDV+S GVLL E+++
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 58/204 (28%), Positives = 86/204 (42%), Gaps = 22/204 (10%)
Query: 454 IGKGGFGPVYMG--KLSTGQEI--AAKRL---SKNSGQGLEEFMNEVVLIGKLQHRNLVG 506
+G G FG V G +G+ + A K L + + +++F+ EV + L HRNL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSK 566
L G + ++ E P SL + R+ +A G+ YL
Sbjct: 86 LYGVVLTP-PMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYL---ES 139
Query: 567 LQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG-----YMSPEY 621
+ IHRDL A N+LL KI DFGL R +D+ V H + +PE
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY----VMQEHRKVPFAWCAPES 195
Query: 622 ANDGTISMKSDVFSLGVLLVEIVS 645
T S SD + GV L E+ +
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFT 219
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-39
Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 21/202 (10%)
Query: 454 IGKGGFGPVYMGKLSTG---QEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLL 508
+G G FG V G + +A K L +E + E ++ +L + +V ++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQ 568
G C E ML+ E L+ ++ ++ + K ++ ++ G+ YL +
Sbjct: 85 GICEAE-SWMLVMEMAELGPLNKYL--QQNRHV-KDKNIIELVHQVSMGMKYL---EESN 137
Query: 569 VIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG-----YMSPEYAN 623
+HRDL A N+LL KISDFGL++ D+ A THG + +PE N
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY----KAQTHGKWPVKWYAPECIN 193
Query: 624 DGTISMKSDVFSLGVLLVEIVS 645
S KSDV+S GVL+ E S
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFS 215
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 6e-39
Identities = 61/198 (30%), Positives = 94/198 (47%), Gaps = 23/198 (11%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513
IGKG FG V +G G ++A K + ++ + F+ E ++ +L+H NLV LLG +E
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 514 EDER-MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHR 572
E ++ EYM SL ++ R R +L + + YL +HR
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL---EGNNFVHR 313
Query: 573 DLKASNILLDINLNPKISDFGLARIFGGDDEEAQTE-----RVAGTHGYMSPEYANDGTI 627
DL A N+L+ + K+SDFGL + + Q + + +PE +
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVK------WTAPEALREKKF 363
Query: 628 SMKSDVFSLGVLLVEIVS 645
S KSDV+S G+LL EI S
Sbjct: 364 STKSDVWSFGILLWEIYS 381
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 22/202 (10%)
Query: 454 IGKGGFGPVYMGKL--STGQEI--AAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLL 508
+G+G FG VY G G++I A K K+ + E+FM+E V++ L H ++V L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQ 568
G EE +I E P+ L +++ L I + + YL +
Sbjct: 80 GIIEEE-PTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYL---ESIN 133
Query: 569 VIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG-----YMSPEYAN 623
+HRD+ NIL+ K+ DFGL+R +D + +MSPE N
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY------YKASVTRLPIKWMSPESIN 187
Query: 624 DGTISMKSDVFSLGVLLVEIVS 645
+ SDV+ V + EI+S
Sbjct: 188 FRRFTTASDVWMFAVCMWEILS 209
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 454 IGKGGFGPVYMGKL------STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGL 507
+G+G FG V++ + +A K L + S ++F E L+ LQH+++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYF------------IFDRERSKLLPWKKRFSIITGIA 555
G C E ++++EYM H L+ F + L + ++ + +A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 556 RGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG 615
G++YL + L +HRDL N L+ L KI DFG++R D RV G
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRV-GGRT 220
Query: 616 -----YMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKM 648
+M PE + +SDV+S GV+L EI + GK
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 259
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAK--RLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLG 509
IG G +G + S G+ + K + + ++EV L+ +L+H N+V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 510 SCIEEDERML--IYEYMPHKSLDYFI-FDRERSKLLPWKKRFSIITGIARGLLYLHQ--D 564
I+ L + EY L I + + L + ++T + L H+ D
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 565 SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND 624
V+HRDLK +N+ LD N K+ DFGLARI D A+T GT YMSPE N
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNR 190
Query: 625 GTISMKSDVFSLGVLLVEIVSGK 647
+ + KSD++SLG LL E+ +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALM 213
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-38
Identities = 65/192 (33%), Positives = 101/192 (52%), Gaps = 7/192 (3%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513
+G+G FG V+MG + +A K L K E F+ E ++ KL+H LV L E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 514 EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRD 573
E ++ EYM SL F+ K L + + IA G+ Y+ ++ +HRD
Sbjct: 251 E-PIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYV---ERMNYVHRD 305
Query: 574 LKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDV 633
L+A+NIL+ NL K++DFGLAR+ ++ A+ + +PE A G ++KSDV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDV 364
Query: 634 FSLGVLLVEIVS 645
+S G+LL E+ +
Sbjct: 365 WSFGILLTELTT 376
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 71/217 (32%), Positives = 99/217 (45%), Gaps = 34/217 (15%)
Query: 452 NMIGKGGFGPVYMGKLSTGQE---IAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLVG 506
++IG+G FG V ++ A KR+ + S +F E+ ++ KL H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYF-------------IFDRERSKLLPWKKRFSIITG 553
LLG+C L EY PH +L F + L ++
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGT 613
+ARG+ YL S+ Q IHRDL A NIL+ N KI+DFGL+R E V T
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVY----VKKT 199
Query: 614 HG-----YMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
G +M+ E N + SDV+S GVLL EIVS
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 52/202 (25%), Positives = 84/202 (41%), Gaps = 22/202 (10%)
Query: 454 IGKGGFGPVYMGKLSTGQE----IAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLL 508
IG+G FG V+ G + + +A K S E+F+ E + + + H ++V L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQ 568
G E +I E L F+ + R L ++ L YL +
Sbjct: 83 GVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL---ESKR 136
Query: 569 VIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG-----YMSPEYAN 623
+HRD+ A N+L+ N K+ DFGL+R + G +M+PE N
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESIN 190
Query: 624 DGTISMKSDVFSLGVLLVEIVS 645
+ SDV+ GV + EI+
Sbjct: 191 FRRFTSASDVWMFGVCMWEILM 212
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-38
Identities = 65/192 (33%), Positives = 101/192 (52%), Gaps = 7/192 (3%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513
+G+G FG V+MG + +A K L K E F+ E ++ KL+H LV L E
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 514 EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRD 573
E ++ EYM SL F+ K L + + IA G+ Y+ ++ +HRD
Sbjct: 334 EP-IYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYV---ERMNYVHRD 388
Query: 574 LKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDV 633
L+A+NIL+ NL K++DFGLAR+ ++ A+ + +PE A G ++KSDV
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDV 447
Query: 634 FSLGVLLVEIVS 645
+S G+LL E+ +
Sbjct: 448 WSFGILLTELTT 459
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 68/217 (31%), Positives = 96/217 (44%), Gaps = 33/217 (15%)
Query: 454 IGKGGFGPVYMGKL------STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVG 506
+G+ FG VY G L Q +A K L G EEF +E +L +LQH N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYF-------------IFDRERSKLLPWKKRFSIITG 553
LLG ++ +I+ Y H L F DR L ++
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGT 613
IA G+ YL S V+H+DL N+L+ LN KISD GL R + A +
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYK-LLG 188
Query: 614 HG-----YMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+ +M+PE G S+ SD++S GV+L E+ S
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 33/220 (15%)
Query: 454 IGKGGFGPVYMGKL------STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGL 507
+G+G FG V++ + +A K L + ++F E L+ LQH ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYF-------------IFDRERSKLLPWKKRFSIITGI 554
G C + D ++++EYM H L+ F R+ L + I + I
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 555 ARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTH 614
A G++YL + +HRDL N L+ NL KI DFG++R D RV G H
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRV-GGH 194
Query: 615 G-----YMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKM 648
+M PE + +SDV+S GV+L EI + GK
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-38
Identities = 64/211 (30%), Positives = 93/211 (44%), Gaps = 27/211 (12%)
Query: 454 IGKGGFGPVYMGKL------STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVG 506
+G G FG VY G++ + ++A K L + S Q +F+ E ++I K H+N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDR----ERSKLLPWKKRFSIITGIARGLLYLH 562
+G ++ R ++ E M L F+ + + L + IA G YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156
Query: 563 QDSKLQVIHRDLKASNILLDI---NLNPKISDFGLARIFGGDDEEAQTERVAGTHGY--- 616
+ IHRD+ A N LL KI DFG+AR D A R G
Sbjct: 157 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRK-GGCAMLPV 209
Query: 617 --MSPEYANDGTISMKSDVFSLGVLLVEIVS 645
M PE +G + K+D +S GVLL EI S
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-38
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 452 NMIGKGGFGPVYMGKL----STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLV 505
++G+G FG V G L T ++A K + + S + +EEF++E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 506 GLLGSCIEED-----ERMLIYEYMPHKSLDYFIFDR---ERSKLLPWKKRFSIITGIARG 557
LLG CIE + M+I +M + L ++ K +P + + IA G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 558 LLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG-- 615
+ YL S +HRDL A N +L ++ ++DFGL++ + G
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-----KIYSGDYYRQGRIAKM 211
Query: 616 ---YMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+++ E D + KSDV++ GV + EI +
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 452 NMIGKGGFGPVYMGKL----STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLV 505
M+GKG FG V +L + ++A K L + + +EEF+ E + + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 506 GLLGSCIEEDER------MLIYEYMPHKSLDYFIFDR---ERSKLLPWKKRFSIITGIAR 556
L+G + + M+I +M H L F+ E LP + + IA
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 557 GLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG- 615
G+ YL S IHRDL A N +L ++ ++DFGL+R + G
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-----KIYSGDYYRQGCASK 200
Query: 616 ----YMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+++ E D ++ SDV++ GV + EI++
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-37
Identities = 64/211 (30%), Positives = 93/211 (44%), Gaps = 27/211 (12%)
Query: 454 IGKGGFGPVYMGKL------STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVG 506
+G G FG VY G++ + ++A K L + S Q +F+ E ++I K H+N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDR----ERSKLLPWKKRFSIITGIARGLLYLH 562
+G ++ R ++ E M L F+ + + L + IA G YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197
Query: 563 QDSKLQVIHRDLKASNILLDI---NLNPKISDFGLARIFGGDDEEAQTERVAGTHGY--- 616
+ IHRD+ A N LL KI DFG+AR D A R G
Sbjct: 198 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRK-GGCAMLPV 250
Query: 617 --MSPEYANDGTISMKSDVFSLGVLLVEIVS 645
M PE +G + K+D +S GVLL EI S
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-37
Identities = 76/324 (23%), Positives = 126/324 (38%), Gaps = 28/324 (8%)
Query: 337 PSGEGFLKLPRMKLPENYWSNKSMNLKECEAECTKNCSCRAYANSDVTGGGSGCLMWFGD 396
P G F L + L E + + C + + A + T +
Sbjct: 224 PEGTKFDTLWQ--LVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQ 281
Query: 397 LVDLRECSEGY------IWGQDFFIRVPSSELGLENWKVDIEVPLYDLATITTATNHFSE 450
S+GY I D +P E+ D E + ++
Sbjct: 282 RRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIAD 341
Query: 451 ANMIGKGGFGPVYMGKLSTGQE---IAAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVG 506
+G G FG V G ++ +A K L + + EE M E ++ +L + +V
Sbjct: 342 I-ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSK 566
L+G C + + ML+ E L F+ + + +P ++ ++ G+ YL +
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 454
Query: 567 LQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG-----YMSPEY 621
+HR+L A N+LL KISDFGL++ G DD A + G + +PE
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY----TARSAGKWPLKWYAPEC 510
Query: 622 ANDGTISMKSDVFSLGVLLVEIVS 645
N S +SDV+S GV + E +S
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALS 534
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 52/227 (22%), Positives = 94/227 (41%), Gaps = 29/227 (12%)
Query: 445 TNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRN 503
+ F E ++G+G FG V + + A K++ + L ++EV+L+ L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFI---------FDR--ERSKLLPWKKRFSIIT 552
+V + +E + + KS + +D + + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 553 GIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVA- 611
I L Y+H +IHRDLK NI +D + N KI DFGLA+ + + +
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 612 -----------GTHGYMSPE-YANDGTISMKSDVFSLGVLLVEIVSG 646
GT Y++ E G + K D++SLG++ E++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 29/213 (13%)
Query: 454 IGKGGFGPVYMGKL--------STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLV 505
+G+G F ++ G E+ K L K E F ++ KL H++LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 506 GLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
G C+ DE +L+ E++ SLD ++ ++ + + + +A + +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFL---E 130
Query: 566 KLQVIHRDLKASNILLDINLNP--------KISDFGLARIFGGDDEEAQTERVAGTHGYM 617
+ +IH ++ A NILL + K+SD G++ D ER+ ++
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL--QERIP----WV 184
Query: 618 SPEYANDGTI-SMKSDVFSLGVLLVEIVS-GKM 648
PE + ++ +D +S G L EI S G
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAK--RLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGS 510
IG+G F VY G T E+A + K + + F E ++ LQH N+V S
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 511 CI---EEDERMLIY-EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSK 566
+ + +++ E M +L ++ +R K++ K S I +GL +LH +
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 567 LQVIHRDLKASNILLDINL-NPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG 625
+IHRDLK NI + + KI D GLA + + V GT +M+PE +
Sbjct: 151 -PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEEK 205
Query: 626 TISMKSDVFSLGVLLVEIVSGK 647
DV++ G+ ++E+ + +
Sbjct: 206 -YDESVDVYAFGMCMLEMATSE 226
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 31/213 (14%)
Query: 454 IGKGGFGPVYMGKL------STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVG 506
+G+G FG VY G +A K +++ S + EF+NE ++ + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIIT---------GIARG 557
LLG + ++I E M L ++ R + + + IA G
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 558 LLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGY- 616
+ YL + + +HRDL A N ++ + KI DFG+ R D E R G G
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRK-GGKGLL 202
Query: 617 ----MSPEYANDGTISMKSDVFSLGVLLVEIVS 645
MSPE DG + SDV+S GV+L EI +
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-36
Identities = 52/202 (25%), Positives = 82/202 (40%), Gaps = 22/202 (10%)
Query: 454 IGKGGFGPVYMG--KLSTGQEI--AAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLL 508
IG+G FG V+ G + A K S E+F+ E + + + H ++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQ 568
G E +I E L F+ + R L ++ L YL +
Sbjct: 458 GVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ESKR 511
Query: 569 VIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG-----YMSPEYAN 623
+HRD+ A N+L+ N K+ DFGL+R + G +M+PE N
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESIN 565
Query: 624 DGTISMKSDVFSLGVLLVEIVS 645
+ SDV+ GV + EI+
Sbjct: 566 FRRFTSASDVWMFGVCMWEILM 587
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 62/219 (28%), Positives = 95/219 (43%), Gaps = 35/219 (15%)
Query: 454 IGKGGFGPVYMGKL------STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLV 505
+G+G FG V +T + +A K L + + M+E+ ++ + H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 506 GLLGSCIEEDE-RMLIYEYMPHKSL-DY------------FIFDRERSKLLPWKKRFSII 551
LLG+C + M+I E+ +L Y + L +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 552 TGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVA 611
+A+G+ +L + + IHRDL A NILL KI DFGLAR D + V
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-----DYVR 206
Query: 612 GTHG-----YMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+M+PE D +++SDV+S GVLL EI S
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 23/211 (10%)
Query: 452 NMIGKGGFGPVYMGKLSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNL--VGL 507
IG GG V+ Q A K ++ Q L+ + NE+ + KLQ + + L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
I + ++ E + L+ ++ ++ + +R S + + +HQ
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 146
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE------- 620
++H DLK +N L+ + K+ DFG+A D + GT YM PE
Sbjct: 147 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 621 ----YANDGTISMKSDVFSLGVLLVEIVSGK 647
+ IS KSDV+SLG +L + GK
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 41/225 (18%)
Query: 454 IGKGGFGPVYMGKL------STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVG 506
+G+G FG V + +A K L +N S L + ++E ++ ++ H +++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 507 LLGSCIEEDERMLIYEYMPHKSL---------------------DYFIFDRERSKLLPWK 545
L G+C ++ +LI EY + SL + D + L
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 546 KRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605
S I++G+ YL ++++++HRDL A NIL+ KISDFGL+R +D
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY- 206
Query: 606 QTERVAGTHG-----YMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
V + G +M+ E D + +SDV+S GVLL EIV+
Sbjct: 207 ----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 23/223 (10%)
Query: 440 TITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIG 497
I+ +S IG GG V+ Q A K ++ Q L+ + NE+ +
Sbjct: 3 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 62
Query: 498 KLQHRNL--VGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIA 555
KLQ + + L I + ++ E + L+ ++ ++ + +R S +
Sbjct: 63 KLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNML 118
Query: 556 RGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG 615
+ +HQ ++H DLK +N L+ + K+ DFG+A D + GT
Sbjct: 119 EAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 174
Query: 616 YMSPE-----------YANDGTISMKSDVFSLGVLLVEIVSGK 647
YM PE + IS KSDV+SLG +L + GK
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-36
Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 36/220 (16%)
Query: 454 IGKGGFGPVYMGKL--------STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRN 503
+G+G FG V M + +A K L + + + L + ++E+ ++ + +H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSL-DY------------FIFDRERSKLLPWKKRFSI 550
++ LLG+C ++ +I EY +L +Y + +R + + +K S
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 551 ITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERV 610
+ARG+ YL + + IHRDL A N+L+ N KI+DFGLAR D
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY-----K 214
Query: 611 AGTHG-----YMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
T+G +M+PE D + +SDV+S GVL+ EI +
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 36/220 (16%)
Query: 454 IGKGGFGPVYMGKL--------STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRN 503
+G+G FG V M + +A K L + + + L + ++E+ ++ + +H+N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSL-DY------------FIFDRERSKLLPWKKRFSI 550
++ LLG+C ++ +I EY +L +Y + +R + + +K S
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 551 ITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERV 610
+ARG+ YL + + IHRDL A N+L+ N KI+DFGLAR D
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY-----K 260
Query: 611 AGTHG-----YMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
T+G +M+PE D + +SDV+S GVL+ EI +
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 60/220 (27%), Positives = 88/220 (40%), Gaps = 36/220 (16%)
Query: 454 IGKGGFGPVYMGKL------STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLV 505
+G G FG V +A K L + E M+E+ ++ L H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 506 GLLGSCIEEDERMLIYEYMPHKSLDYF---------------IFDRERSKLLPWKKRFSI 550
LLG+C ++I EY + L F + L + S
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 551 ITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERV 610
+A+G+ +L + IHRDL A NILL KI DFGLAR D V
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS-----NYV 202
Query: 611 AGTHG-----YMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+ +M+PE + + +SDV+S G+ L E+ S
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 23/223 (10%)
Query: 440 TITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIG 497
I+ +S IG GG V+ Q A K ++ Q L+ + NE+ +
Sbjct: 50 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 109
Query: 498 KLQHRNL--VGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIA 555
KLQ + + L I + ++ E + L+ ++ ++ + +R S +
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNML 165
Query: 556 RGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG 615
+ +HQ ++H DLK +N L+ + K+ DFG+A D + G
Sbjct: 166 EAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVN 221
Query: 616 YMSPE-----------YANDGTISMKSDVFSLGVLLVEIVSGK 647
YM PE + IS KSDV+SLG +L + GK
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 32/216 (14%)
Query: 454 IGKGGFGPVYMGKL------STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLV 505
+G G FG V ++A K L E M+E+ ++ L QH N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 506 GLLGSCIEEDERMLIYEYMPHKSL-----------DYFIFDRERSKLLPWKKRFSIITGI 554
LLG+C ++I EY + L + + + + +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 555 ARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTH 614
A+G+ +L + IHRD+ A N+LL KI DFGLAR D + +
Sbjct: 174 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY-----IVKGN 225
Query: 615 G-----YMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
+M+PE D +++SDV+S G+LL EI S
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAKRLSKNS--GQGLEE-FMNEVVLIGKLQHRNLVGLL 508
+GKGGF + T + A K + K+ E E+ + L H+++VG
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 509 GSCIEEDERM-LIYEYMPHKSLDYFIFD--RERSKLLPWKKRFSIITGIARGLLYLHQDS 565
G E+++ + ++ E +SL + + R L + R+ + I G YLH+
Sbjct: 108 G-FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQYLHR-- 159
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG 625
+VIHRDLK N+ L+ +L KI DFGLA D E + + GT Y++PE +
Sbjct: 160 -NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKK 216
Query: 626 TISMKSDVFSLGVLLVEIVSGK 647
S + DV+S+G ++ ++ GK
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGK 238
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-35
Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 36/220 (16%)
Query: 454 IGKGGFGPVYMGKL--------STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRN 503
+G+G FG V + + + ++A K L + + + L + ++E+ ++ + +H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSL-DY------------FIFDRERSKLLPWKKRFSI 550
++ LLG+C ++ +I EY +L +Y + + L K S
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 551 ITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERV 610
+ARG+ YL + + IHRDL A N+L+ + KI+DFGLAR D
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY-----K 248
Query: 611 AGTHG-----YMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
T+G +M+PE D + +SDV+S GVLL EI +
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 62/226 (27%), Positives = 95/226 (42%), Gaps = 43/226 (19%)
Query: 454 IGKGGFGPVYMGKL------STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVG 506
IG+G FG V+ + +A K L + S +F E L+ + + N+V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYF---------------------IFDRERSKLLPWK 545
LLG C L++EYM + L+ F L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 546 KRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR-IFGGDDEE 604
++ I +A G+ YL S+ + +HRDL N L+ N+ KI+DFGL+R I+ D +
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 605 AQTE-----RVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
A R +M PE + +SDV++ GV+L EI S
Sbjct: 232 ADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAKRLSKNS--GQGLEE-FMNEVVLIGKLQHRNLVGLL 508
+GKGGF + T + A K + K+ E E+ + L H+++VG
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 509 GSCIEEDERM-LIYEYMPHKSLDYFIFD--RERSKLLPWKKRFSIITGIARGLLYLHQDS 565
G E+++ + ++ E +SL + + R L + R+ + I G YLH+
Sbjct: 82 G-FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQYLHR-- 133
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG 625
+VIHRDLK N+ L+ +L KI DFGLA D E + + GT Y++PE +
Sbjct: 134 -NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKK 190
Query: 626 TISMKSDVFSLGVLLVEIVSGK 647
S + DV+S+G ++ ++ GK
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGK 212
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 66/203 (32%), Positives = 103/203 (50%), Gaps = 17/203 (8%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSC 511
++GKG +G VY G+ LS IA K + + + + E+ L L+H+N+V LGS
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 512 IEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIAR----GLLYLHQDSKL 567
E + E +P SL + RSK P K I + GL YLH +
Sbjct: 89 SENGFIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN--- 141
Query: 568 QVIHRDLKASNILLDI-NLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGT 626
Q++HRD+K N+L++ + KISDFG ++ G + +T GT YM+PE + G
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGP 199
Query: 627 I--SMKSDVFSLGVLLVEIVSGK 647
+D++SLG ++E+ +GK
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGK 222
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 25/205 (12%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNS--GQGLEE-FMNEVVLIGKLQHRNLVGLLG 509
+GKG F VY + + TG E+A K + K + G+ + NEV + +L+H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 510 SCIEEDERM-LIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARGLLYLH 562
E+ + L+ E + + +++ K FS + I G+LYLH
Sbjct: 79 -YFEDSNYVYLVLEMCHNGEM----NRYLKNR----VKPFSENEARHFMHQIITGMLYLH 129
Query: 563 QDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA 622
++HRDL SN+LL N+N KI+DFGLA E+ T + GT Y+SPE A
Sbjct: 130 S---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIA 184
Query: 623 NDGTISMKSDVFSLGVLLVEIVSGK 647
++SDV+SLG + ++ G+
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-34
Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 41/225 (18%)
Query: 454 IGKGGFGPVYMGKL------STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLV 505
+G G FG V ++A K L + E M+E+ ++ +L H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 506 GLLGSCIEEDERMLIYEYMPHKSL-----------DYFIFDRERSKLLPWKKRFSIITG- 553
LLG+C LI+EY + L + E K L ++ +++T
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 554 --------IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605
+A+G+ +L +HRDL A N+L+ KI DFGLAR D
Sbjct: 173 DLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY- 228
Query: 606 QTERVAGTHG-----YMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
V + +M+PE +G ++KSDV+S G+LL EI S
Sbjct: 229 ----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 50/206 (24%), Positives = 78/206 (37%), Gaps = 16/206 (7%)
Query: 447 HFSEANMIGKGGFGPVYMG-KLSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKL-QHR 502
F + +G G +G V+ G+ A KR + + EV K+ QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 503 NLVGLLGSCIEEDERMLIY-EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
V L + EE + + E SL LP + + + L +L
Sbjct: 118 CCVRLEQA-WEEGGILYLQTELCGP-SLQQHC--EAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
H ++H D+K +NI L K+ DFGL G + + G YM+PE
Sbjct: 174 HS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEVQ--EGDPRYMAPEL 227
Query: 622 ANDGTISMKSDVFSLGVLLVEIVSGK 647
+DVFSLG+ ++E+
Sbjct: 228 LQGS-YGTAADVFSLGLTILEVACNM 252
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 51/212 (24%), Positives = 92/212 (43%), Gaps = 24/212 (11%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGS 510
++G+G V+ G+ TG A K + S + ++ M E ++ KL H+N+V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA- 74
Query: 511 CIEEDERMLIY---EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
EE E+ P SL + + + LP + ++ + G+ +L +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---EN 131
Query: 568 QVIHRDLKASNILL----DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAN 623
++HR++K NI+ D K++DFG AR DDE+ + + GT Y+ P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVS--LYGTEEYLHPDMYE 188
Query: 624 DGTISM--------KSDVFSLGVLLVEIVSGK 647
+ D++S+GV +G
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 57/231 (24%), Positives = 89/231 (38%), Gaps = 25/231 (10%)
Query: 440 TITTATNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGK 498
T+ ++ +GGF VY + + +G+E A KRL N + + EV + K
Sbjct: 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKK 81
Query: 499 LQ-HRNLVGLLGSCIEEDERM-------LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSI 550
L H N+V + E L+ + L F+ E L I
Sbjct: 82 LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141
Query: 551 ITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD-------DE 603
R + ++H+ K +IHRDLK N+LL K+ DFG A
Sbjct: 142 FYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 604 EAQTERVAGTHG---YMSPE----YANDGTISMKSDVFSLGVLLVEIVSGK 647
A E + Y +PE Y+N I K D+++LG +L + +
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSN-FPIGEKQDIWALGCILYLLCFRQ 250
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 51/212 (24%), Positives = 92/212 (43%), Gaps = 24/212 (11%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGS 510
++G+G V+ G+ TG A K + S + ++ M E ++ KL H+N+V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA- 74
Query: 511 CIEEDERMLIY---EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
EE E+ P SL + + + LP + ++ + G+ +L +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---EN 131
Query: 568 QVIHRDLKASNILL----DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAN 623
++HR++K NI+ D K++DFG AR DDE+ + + GT Y+ P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVS--LYGTEEYLHPDMYE 188
Query: 624 DGTISM--------KSDVFSLGVLLVEIVSGK 647
+ D++S+GV +G
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-31
Identities = 49/220 (22%), Positives = 91/220 (41%), Gaps = 28/220 (12%)
Query: 448 FSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEV-VLIGKLQHRNLVG 506
F +++G G G + + +++A KR+ + EV +L +H N++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIR 82
Query: 507 LLGSCIEEDERM--LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD 564
C E+D + + E +L ++ ++ + +++ GL +LH
Sbjct: 83 YF--CTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS- 136
Query: 565 SKLQVIHRDLKASNILL-----DINLNPKISDFGLARIFGGDDEE-AQTERVAGTHGYMS 618
L ++HRDLK NIL+ + ISDFGL + ++ V GT G+++
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 619 PEY---ANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHP 655
PE + D+FS G + ++S HP
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEG-----SHP 229
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 50/208 (24%), Positives = 83/208 (39%), Gaps = 30/208 (14%)
Query: 452 NMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEF-MNEVVLIGKLQHRNLVGLLG 509
+G+G FG V+ K TG + A K++ LE F + E+V L +V L G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYG 117
Query: 510 SCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRF--SIITGIAR----GLLYLHQ 563
+ E + E + SL +L+ GL YLH
Sbjct: 118 AVREGPWVNIFMELLEGGSL---------GQLIKQMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 564 DSKLQVIHRDLKASNILLDINLNP-KISDFGLARIFGGDDEEAQTER---VAGTHGYMSP 619
+++H D+KA N+LL + + + DFG A D + GT +M+P
Sbjct: 169 R---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 620 EYANDGTISMKSDVFSLGVLLVEIVSGK 647
E K D++S +++ +++G
Sbjct: 226 EVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 7e-31
Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 19/208 (9%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEE-FMNEVVLIGKLQHRNLVGLLGS 510
+G GGFG V TG+++A K+ + E + E+ ++ KL H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR-E 79
Query: 511 CIEEDERM-------LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
+ +++ L EY L ++ E L ++++ I+ L YLH+
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 564 DSKLQVIHRDLKASNILLDINLNP---KISDFGLARIFGGDDEEAQTERVAGTHGYMSPE 620
++IHRDLK NI+L KI D G A+ E GT Y++PE
Sbjct: 140 ---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELCTE--FVGTLQYLAPE 193
Query: 621 YANDGTISMKSDVFSLGVLLVEIVSGKM 648
++ D +S G L E ++G
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 56/214 (26%), Positives = 109/214 (50%), Gaps = 13/214 (6%)
Query: 438 LATITTATN---HFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEV 493
L +I + + ++ IG+G G VY ++TGQE+A ++++ E +NE+
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 494 VLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITG 553
+++ + ++ N+V L S + DE ++ EY+ SL D + + ++
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGT 613
+ L +LH + IHRD+K+ NILL ++ + K++DFG + + T + GT
Sbjct: 125 CLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179
Query: 614 HGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
+M+PE K D++SLG++ +E++ G+
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 57/229 (24%), Positives = 84/229 (36%), Gaps = 36/229 (15%)
Query: 445 TNHFSEANMIGKGGFGPVYMG-KLSTGQEIAAKR--LSKNSGQGLEEFMNEVVLIGKL-Q 500
T F E IG G FG V+ K G A KR + + EV L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 501 HRNLVGLLGSCIEEDERMLIY-EYMPHKSLDYFIFDRERS-KLLPWKKRFSIITGIARGL 558
H ++V + ED+ MLI EY SL I + R + ++ + RGL
Sbjct: 70 HSHVVRYFSA-WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 559 LYLHQDSKLQVIHRDLKASNILLDINLNP-------------------KISDFGLARIFG 599
Y+H ++H D+K SNI + P KI D G
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 600 GDDEEAQTERVAGTHGYMSPE-YANDGTISMKSDVFSLGVLLVEIVSGK 647
Q E G +++ E + T K+D+F+L + +V +
Sbjct: 186 ----SPQVEE--GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 51/219 (23%), Positives = 96/219 (43%), Gaps = 33/219 (15%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKN-----------------SGQGLEEFMNEVVLI 496
+ +G F + + + + A K+ K+ ++F NE+ +I
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 497 GKLQHRNLVGLLGSCIEEDERM-LIYEYMPHKSL-DY----FIFDRERSKLLPWKKRFSI 550
+++ + G I + + +IYEYM + S+ + F+ D+ + +P + I
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 551 ITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERV 610
I + Y+H ++ + HRD+K SNIL+D N K+SDFG + D++ +
Sbjct: 157 IKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM--VDKKIKG--S 210
Query: 611 AGTHGYMSPE--YANDGTISMKSDVFSLGVLLVEIVSGK 647
GT+ +M PE K D++SLG+ L +
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 55/202 (27%), Positives = 104/202 (51%), Gaps = 12/202 (5%)
Query: 448 FSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVG 506
IG+G G V + + +G+++A K + Q E NEVV++ QH N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSK 566
+ S + +E ++ E++ +L D L ++ ++ + + L YLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 567 LQVIHRDLKASNILLDINLNPKISDFGL-ARIFGGDDEEAQTERVAGTHGYMSPEYANDG 625
IHRD+K+ +ILL ++ K+SDFG A+I + + + + GT +M+PE +
Sbjct: 163 ---IHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRS 216
Query: 626 TISMKSDVFSLGVLLVEIVSGK 647
+ + D++SLG++++E+V G+
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGE 238
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLS---KNSGQGLEEFMNEVVLIGKLQHRNLVGLLG 509
+G GG VY+ + ++A K + + + L+ F EV +L H+N+V ++
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 510 SCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQV 569
E+D L+ EY+ +L +I L + I G+ + H +++
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHD---MRI 132
Query: 570 IHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISM 629
+HRD+K NIL+D N KI DFG+A+ + QT V GT Y SPE A
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 630 KSDVFSLGVLLVEIVSGK 647
+D++S+G++L E++ G+
Sbjct: 192 CTDIYSIGIVLYEMLVGE 209
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 54/209 (25%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 445 TNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRN 503
+ +G G FG VY K TG AAK + S + LE+++ E+ ++ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
+V LLG+ + + ++ E+ P ++D + E + L + + + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE--- 620
IHRDLKA N+L+ + + +++DFG++ ++ + GT +M+PE
Sbjct: 136 KRI---IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 190
Query: 621 --YANDGTISMKSDVFSLGVLLVEIVSGK 647
D K+D++SLG+ L+E+ +
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 2e-29
Identities = 30/227 (13%), Positives = 72/227 (31%), Gaps = 22/227 (9%)
Query: 440 TITTATNHFSEANMIGKGGFGPVYMGK------LSTGQEIAAKRLSKNSGQGLEEFMNEV 493
+ +++G+G F VY Q+ K + +
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 494 VLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFI--FDRERSKLLPWKKRFSII 551
+ + + + ++ +L+ E + +L I + K++P S
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 552 TGIARGLLYLHQDSKLQVIHRDLKASNILL-----------DINLNPKISDFGLARIFGG 600
+ + +H ++IH D+K N +L D++ + D G +
Sbjct: 179 MRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
+ T G+ E ++ + + D F + + ++ G
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-29
Identities = 47/192 (24%), Positives = 86/192 (44%), Gaps = 15/192 (7%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512
+G G FG V+ +TG+ AK ++ NE+ ++ +L H L+ L +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 513 EEDERMLIYEYMPHKSLDYFIFDR--ERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVI 570
++ E +LI E++ L FDR + + + + GL ++H+ ++
Sbjct: 119 DKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIV 171
Query: 571 HRDLKASNILLDINLNP--KISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTIS 628
H D+K NI+ + KI DFGLA DE + T + +PE + +
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKV--TTATAEFAAPEIVDREPVG 228
Query: 629 MKSDVFSLGVLL 640
+D++++GVL
Sbjct: 229 FYTDMWAIGVLG 240
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 61/202 (30%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 452 NMIGKGGFGPVYMGK-LSTGQEIAAKRLSKN--SGQGLEE-FMNEVVLIGKLQHRNLVGL 507
+GKG FG VY+ + + +A K L K G+E EV + L+H N++ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 508 LGSCIEEDERM-LIYEYMPHKSLDYFIFDR-ERSKLLPWKKRFSIITGIARGLLYLHQDS 565
G + R+ LI EY P ++ + ++ ++ + IT +A L Y H
Sbjct: 75 YG-YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCH--- 126
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG 625
+VIHRD+K N+LL KI+DFG + + GT Y+ PE
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTD--LCGTLDYLPPEMIEGR 182
Query: 626 TISMKSDVFSLGVLLVEIVSGK 647
K D++SLGVL E + GK
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGK 204
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-28
Identities = 59/239 (24%), Positives = 93/239 (38%), Gaps = 43/239 (17%)
Query: 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEV-VLIGKLQHRNL 504
N ++G G G V G+ +A KR+ + + + E+ +L H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 505 VGLLGSCIEEDERM--LIYEYMPHKSLDYFI----FDRERSKLLPWKKRFSIITGIARGL 558
+ C E +R + E +L + E KL S++ IA G+
Sbjct: 72 IRYY--CSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 559 LYLHQDSKLQVIHRDLKASNILLDI-------------NLNPKISDFGLARIFGGDDEEA 605
+LH L++IHRDLK NIL+ NL ISDFGL +
Sbjct: 129 AHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 606 QTER--VAGTHGYMSPEYANDGTISM-------KSDVFSLGVLLVEIVSGKMNRGFRHP 655
+T +GT G+ +PE + D+FS+G + I+S +HP
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG-----KHP 239
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQG-LEEFMNEVVLIGKLQHRN 503
+ F + + +G G G V+ +G +A K + + + E+ ++ +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARG 557
+VG G+ + E + E+M SLD ++L R + + +G
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLD---------QVLKKAGRIPEQILGKVSIAVIKG 143
Query: 558 LLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYM 617
L YL K +++HRD+K SNIL++ K+ DFG++ D A + GT YM
Sbjct: 144 LTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANS--FVGTRSYM 197
Query: 618 SPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
SPE S++SD++S+G+ LVE+ G+
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-28
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGS 510
+G G +G V + + T E A K + K S + + EV ++ L H N++ L
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 511 CIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARGLLYLHQD 564
++ L+ E L FD + +F+ II + G+ YLH+
Sbjct: 105 FEDKRNYYLVMECYKGGEL----FDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHK- 154
Query: 565 SKLQVIHRDLKASNILL---DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
++HRDLK N+LL + + KI DFGL+ +F ++++ ER+ GT Y++PE
Sbjct: 155 --HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF--ENQKKMKERL-GTAYYIAPEV 209
Query: 622 ANDGTISMKSDVFSLGVLLVEIVSGKM 648
K DV+S+GV+L +++G
Sbjct: 210 LR-KKYDEKCDVWSIGVILFILLAGYP 235
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 61/201 (30%), Positives = 102/201 (50%), Gaps = 10/201 (4%)
Query: 448 FSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVG 506
F +G+G +G VY TGQ +A K++ L+E + E+ ++ + ++V
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSK 566
GS + + ++ EY S+ I R R+K L + +I+ +GL YLH K
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146
Query: 567 LQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGT 626
IHRD+KA NILL+ + K++DFG+A + T V GT +M+PE +
Sbjct: 147 ---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQEIG 201
Query: 627 ISMKSDVFSLGVLLVEIVSGK 647
+ +D++SLG+ +E+ GK
Sbjct: 202 YNCVADIWSLGITAIEMAEGK 222
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAK----RLSKNSGQGLEEFMNEVVLIGKLQHRNLVGL 507
++G GG V++ + L +++A K L+++ F E L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP-SFYLRFRREAQNAAALNHPAIVAV 77
Query: 508 LGSCIEEDERMLIY----EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
+ E + EY+ +L + + K+ +I + L + HQ
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQ 134
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE-AQTERVAGTHGYMSPEYA 622
+IHRD+K +NI++ K+ DFG+AR QT V GT Y+SPE A
Sbjct: 135 ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 623 NDGTISMKSDVFSLGVLLVEIVSGK 647
++ +SDV+SLG +L E+++G+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 59/198 (29%), Positives = 103/198 (52%), Gaps = 15/198 (7%)
Query: 448 FSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVG 506
S+ ++G G FG V+ + +TG ++AAK + + EE NE+ ++ +L H NL+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDR--ERSKLLPWKKRFSIITGIARGLLYLHQD 564
L + +++ +L+ EY+ L FDR + S L + I G+ ++HQ
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICEGIRHMHQ- 205
Query: 565 SKLQVIHRDLKASNILL-DINLNP-KISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA 622
+ ++H DLK NIL + + KI DFGLAR + E+ + GT +++PE
Sbjct: 206 --MYILHLDLKPENILCVNRDAKQIKIIDFGLARRY-KPREKLKV--NFGTPEFLAPEVV 260
Query: 623 NDGTISMKSDVFSLGVLL 640
N +S +D++S+GV+
Sbjct: 261 NYDFVSFPTDMWSVGVIA 278
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQG---LEEFMNEVVLIGKLQHRNLVGL- 507
++G+GG G VY + + +A K +S+ E G+LQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 508 -LGSCIEEDERM-LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
G E D ++ + + L + + L + +I+ I L H
Sbjct: 101 DFG---EIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA- 153
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG 625
HRD+K NIL+ + + DFG+A D++ Q GT YM+PE ++
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASA-TTDEKLTQLGNTVGTLYYMAPERFSES 210
Query: 626 TISMKSDVFSLGVLLVEIVSGK 647
+ ++D+++L +L E ++G
Sbjct: 211 HATYRADIYALTCVLYECLTGS 232
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-28
Identities = 68/207 (32%), Positives = 99/207 (47%), Gaps = 28/207 (13%)
Query: 452 NMIGKGGFGPVYMGK-LSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLL 508
M+GKG FG V K T QE A K ++K + + EV L+ KL H N++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARGLLYLH 562
+ ++ E L FD + +KRFS II + G+ Y+H
Sbjct: 88 EILEDSSSFYIVGELYTGGEL----FDE-----IIKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 563 QDSKLQVIHRDLKASNILL---DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSP 619
+ ++HRDLK NILL + + + KI DFGL+ F +R+ GT Y++P
Sbjct: 139 K---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRI-GTAYYIAP 192
Query: 620 EYANDGTISMKSDVFSLGVLLVEIVSG 646
E GT K DV+S GV+L ++SG
Sbjct: 193 EVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 23/230 (10%), Positives = 52/230 (22%), Gaps = 43/230 (18%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAKRLSK---NSGQGLEEFMNEVVLIGKLQHRNLVGLL 508
+ G V++ + + ++ A K + NS LE +L +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 509 GSC--------------------------IEEDERMLIYEYMP---HKSLDYFIFDRERS 539
+L+ F
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 540 KLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599
+ + R L ++H N+ + + + D G
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 600 GDDEEAQTERVAGTHGYMSPEYANDGTISM--KSDVFSLGVLLVEIVSGK 647
+ + Y E+ N T + + + LG+ + +
Sbjct: 246 -----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 24/221 (10%)
Query: 440 TITTATNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSG-QGLEEFMNEV-VLI 496
++ + +G+G +G V + + +GQ +A KR+ Q + + ++ + +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 497 GKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS--IITGI 554
+ V G+ E + + E M SLD F +++ + I+ I
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFY-----KQVIDKGQTIPEDILGKI 114
Query: 555 AR----GLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERV 610
A L +LH SKL VIHRD+K SN+L++ K+ DFG++ D+ A+
Sbjct: 115 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKD-ID 169
Query: 611 AGTHGYMSPE----YANDGTISMKSDVFSLGVLLVEIVSGK 647
AG YM+PE N S+KSD++SLG+ ++E+ +
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 26/197 (13%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512
IG+G +G V + T AAK++ K + ++ F E+ ++ L H N++ L +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 513 EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARGLLYLHQDSK 566
+ + L+ E L F+R + K+ F I+ + + Y H+
Sbjct: 77 DNTDIYLVMELCTGGEL----FER-----VVHKRVFRESDAARIMKDVLSAVAYCHK--- 124
Query: 567 LQVIHRDLKASNILL---DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAN 623
L V HRDLK N L + K+ DFGLA F + +V GT Y+SP+
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTKV-GTPYYVSPQVLE 181
Query: 624 DGTISMKSDVFSLGVLL 640
G + D +S GV++
Sbjct: 182 -GLYGPECDEWSAGVMM 197
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 7e-28
Identities = 59/252 (23%), Positives = 93/252 (36%), Gaps = 27/252 (10%)
Query: 415 IRVPSSELGLENWKVDIEVPLYDLATITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIA 474
IR+P+ EL E KV EV LA + H P + +
Sbjct: 39 IRLPNRELARE--KVMREVKA--LAKL----EHPGIVRYFNAWLETPPEKWQEEMDEIWL 90
Query: 475 AKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY---EYMPHKSLDY 531
+ V I ++ + +G ++ +Y + ++L
Sbjct: 91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD 150
Query: 532 FIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISD 591
++ R + I IA + +LH ++HRDLK SNI ++ K+ D
Sbjct: 151 WMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGD 207
Query: 592 FGLARIFGGDDEEAQTERVA----------GTHGYMSPEYANDGTISMKSDVFSLGVLLV 641
FGL D+EE GT YMSPE + S K D+FSLG++L
Sbjct: 208 FGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILF 267
Query: 642 EIVSG---KMNR 650
E++ +M R
Sbjct: 268 ELLYSFSTQMER 279
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 72/271 (26%), Positives = 123/271 (45%), Gaps = 37/271 (13%)
Query: 447 HFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLS-KNSGQGLEEFMNEVVLIGKLQHRNL 504
F++ IGKG FG V+ G T + +A K + + + +E+ E+ ++ + +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 505 VGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD 564
GS +++ + +I EY+ S D L + +I+ I +GL YLH +
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSE 138
Query: 565 SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND 624
K IHRD+KA+N+LL + K++DFG+A + T GT +M+PE
Sbjct: 139 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 193
Query: 625 GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC--- 681
K+D++SLG+ +E+ G P H L H + L L+
Sbjct: 194 SAYDSKADIWSLGITAIELARG-------EPPH-SEL--HPM------KVLFLIPKNNPP 237
Query: 682 -LEDSFVESQVLR-CIQVGLLCVQKLPEDRP 710
LE ++ S+ L+ ++ C+ K P RP
Sbjct: 238 TLEGNY--SKPLKEFVE---ACLNKEPSFRP 263
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-28
Identities = 68/208 (32%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLG 509
+GKG FG V + K TGQE A K +SK E + EV L+ +L H N++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 510 SCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARGLLYLHQ 563
++ L+ E L FD + +KRFS II + G+ Y+H+
Sbjct: 94 FFEDKGYFYLVGEVYTGGEL----FDE-----IISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 564 DSKLQVIHRDLKASNILL---DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE 620
+++HRDLK N+LL + N +I DFGL+ F + + +++ GT Y++PE
Sbjct: 145 ---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKI-GTAYYIAPE 198
Query: 621 YANDGTISMKSDVFSLGVLLVEIVSGKM 648
+ GT K DV+S GV+L ++SG
Sbjct: 199 VLH-GTYDEKCDVWSTGVILYILLSGCP 225
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 52/206 (25%), Positives = 82/206 (39%), Gaps = 33/206 (16%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAK-----RLSKNSGQGLEEFMNEVVLIGKLQHRNLVGL 507
IGKG F V TGQ+ A K + + + G E+ E + L+H ++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 508 LGSCIEEDERM--LIYEYMPHKSLDYFIFDR--ERSKLLPWKKRFS------IITGIARG 557
L + + M +++E+M L +R+ +S + I
Sbjct: 92 LETY--SSDGMLYMVFEFMDGADL----CFEIVKRADA---GFVYSEAVASHYMRQILEA 142
Query: 558 LLYLHQDSKLQVIHRDLKASNILL---DINLNPKISDFGLARIFGGDDEEAQTERVAGTH 614
L Y H +IHRD+K +LL + + K+ FG+A G A GT
Sbjct: 143 LRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTP 197
Query: 615 GYMSPEYANDGTISMKSDVFSLGVLL 640
+M+PE DV+ GV+L
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 64/199 (32%), Positives = 93/199 (46%), Gaps = 28/199 (14%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGS 510
+GKG FG V K T QE A K ++K + + EV L+ KL H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 511 CIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARGLLYLHQD 564
+ ++ E L FD + KRFS II + G+ Y+H+
Sbjct: 90 LEDSSSFYIVGELYTGGEL----FDEIIKR-----KRFSEHDAARIIKQVFSGITYMHK- 139
Query: 565 SKLQVIHRDLKASNILL---DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
++HRDLK NILL + + + KI DFGL+ F + + + GT Y++PE
Sbjct: 140 --HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEV 194
Query: 622 ANDGTISMKSDVFSLGVLL 640
GT K DV+S GV+L
Sbjct: 195 LR-GTYDEKCDVWSAGVIL 212
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 27/200 (13%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQG-LEEFMNEVVLIGKLQHRNLVGLLGSC 511
+G G FG V++ + S+G E K ++K+ Q +E+ E+ ++ L H N++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 512 IEEDERM--LIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARGLLYLHQ 563
ED ++ E L +R S K S ++ + L Y H
Sbjct: 90 --EDYHNMYIVMETCEGGEL----LERIVSAQ-ARGKALSEGYVAELMKQMMNALAYFHS 142
Query: 564 DSKLQVIHRDLKASNILL---DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE 620
V+H+DLK NIL + KI DFGLA +F DE + AGT YM+PE
Sbjct: 143 ---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF-KSDEHSTN--AAGTALYMAPE 196
Query: 621 YANDGTISMKSDVFSLGVLL 640
++ K D++S GV++
Sbjct: 197 VFK-RDVTFKCDIWSAGVVM 215
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 445 TNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLS---KNSGQGLEEFMNEVVLIGKLQ 500
FS+ IG G FG VY + + + +A K++S K S + ++ + EV + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 501 HRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLY 560
H N + G + E L+ EY + D K L + ++ G +GL Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 561 LHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ-TER--VAGTHGYM 617
LH + IHRD+KA NILL K+ DFG A + GT +M
Sbjct: 170 LHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSA---------SIMAPANSFVGTPYWM 217
Query: 618 SPE---YANDGTISMKSDVFSLGVLLVEIVSGK 647
+PE ++G K DV+SLG+ +E+ K
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 44/192 (22%), Positives = 83/192 (43%), Gaps = 16/192 (8%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512
+G+G FG V+ S+ + AK + G E+ ++ +HRN++ L S
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 513 EEDERMLIYEYMPHKSLDYFIFDR--ERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVI 570
+E ++I+E++ + F+R + L ++ S + + L +LH +
Sbjct: 72 SMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIG 124
Query: 571 HRDLKASNILLDINLNP--KISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTIS 628
H D++ NI+ + KI +FG AR + Y +PE +S
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLF-TAPEYYAPEVHQHDVVS 181
Query: 629 MKSDVFSLGVLL 640
+D++SLG L+
Sbjct: 182 TATDMWSLGTLV 193
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSG-QGLEEFMNEV-VLIGKLQHRNLVGLLGS 510
IG+G +G V +GQ +A KR+ + ++ + ++ V++ +V G+
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 511 CIEEDERMLIYEYMPHKSLD--YFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQ 568
E + + E M S D Y ++P + I + L +L L+
Sbjct: 90 LFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK--ENLK 146
Query: 569 VIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE----YAND 624
+IHRD+K SNILLD + N K+ DFG++ D A+T R AG YM+PE A+
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKT-RDAGCRPYMAPERIDPSASR 203
Query: 625 GTISMKSDVFSLGVLLVEIVSGK 647
++SDV+SLG+ L E+ +G+
Sbjct: 204 QGYDVRSDVWSLGITLYELATGR 226
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 20/201 (9%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKN--SGQGLEE-FMNEVVLIGKLQHRNLVGLLG 509
+GKG FG VY+ + +A K L K+ +G+E E+ + L+H N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 510 SCIEEDERM-LIYEYMPHKSLDYFIFD--RERSKLLPWKKRFSIITGIARGLLYLHQDSK 566
+ +R+ L+ E+ P L + ++ + + + +A L Y H +
Sbjct: 82 Y-FHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSAT-FMEELADALHYCH---E 132
Query: 567 LQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGT 626
+VIHRD+K N+L+ KI+DFG + +T + GT Y+ PE T
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRT--MCGTLDYLPPEMIEGKT 188
Query: 627 ISMKSDVFSLGVLLVEIVSGK 647
K D++ GVL E + G
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGM 209
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSG-QGLEEFMNEV-VLIGKLQHRNLVGLLGS 510
+G G G V+ + TG IA K++ ++ + + + ++ V++ +V G+
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 511 CIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVI 570
I + + E M + + +P + + I + L YL K VI
Sbjct: 93 FITNTDVFIAMELMGTCAEK---LKKRMQGPIPERILGKMTVAIVKALYYLK--EKHGVI 147
Query: 571 HRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE-----YANDG 625
HRD+K SNILLD K+ DFG++ D++A+ R AG YM+PE
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKD-RSAGCAAYMAPERIDPPDPTKP 204
Query: 626 TISMKSDVFSLGVLLVEIVSGK 647
+++DV+SLG+ LVE+ +G+
Sbjct: 205 DYDIRADVWSLGISLVELATGQ 226
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 30/199 (15%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512
+G G F V++ K TG+ A K + K+ NE+ ++ K++H N+V L
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 513 EEDERMLIYEYMPHKSLDYFIFDR--ERSKLLPWKKRFS------IITGIARGLLYLHQD 564
L+ + + L FDR ER ++ +I + + YLH
Sbjct: 77 STTHYYLVMQLVSGGEL----FDRILERGV-------YTEKDASLVIQQVLSAVKYLH-- 123
Query: 565 SKLQVIHRDLKASNILL---DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
+ ++HRDLK N+L + N I+DFGL+++ + GT GY++PE
Sbjct: 124 -ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME----QNGIMSTACGTPGYVAPEV 178
Query: 622 ANDGTISMKSDVFSLGVLL 640
S D +S+GV+
Sbjct: 179 LAQKPYSKAVDCWSIGVIT 197
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 43/308 (13%), Positives = 82/308 (26%), Gaps = 74/308 (24%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAKRLSK---NSGQGLEEFMNEVVLIGKLQH------- 501
++G+ TG+ +++ EV+ + L+
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 502 ---------RNLVGLLGSC-----IEEDERMLIYEY---MPHKSLDYF-----IFDRER- 538
+LV ++ M + P + +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 539 SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598
K L R + + R L LH ++H L+ +I+LD ++ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 599 GGDDEEAQTERVAGTHGYMSPEY----------ANDGTISMKSDVFSLGVLLVEIVSGKM 648
G + G+ PE + ++ D ++LG+ + I
Sbjct: 262 G------ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA-- 313
Query: 649 NRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPED 708
P D ALG + Q +R + G L + ED
Sbjct: 314 ----DLP-------------NTDDAALGGSEWIFRSCKNIPQPVRALLEGFL--RYPKED 354
Query: 709 RPDMSSVV 716
R +
Sbjct: 355 RLLPLQAM 362
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-26
Identities = 50/205 (24%), Positives = 87/205 (42%), Gaps = 23/205 (11%)
Query: 445 TNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRN 503
+H+ +G G FG V+ +TG AAK + E E+ + L+H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARG 557
LV L + +++E ++IYE+M L F++ + + S + + +G
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGEL----FEK----VADEHNKMSEDEAVEYMRQVCKG 267
Query: 558 LLYLHQDSKLQVIHRDLKASNILLDINLNP--KISDFGLARIFGGDDEEAQTERVAGTHG 615
L ++H+ +H DLK NI+ + K+ DFGL GT
Sbjct: 268 LCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAE 321
Query: 616 YMSPEYANDGTISMKSDVFSLGVLL 640
+ +PE A + +D++S+GVL
Sbjct: 322 FAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 32/204 (15%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSK------NSGQGLEEFMNEVVLIGKLQHRNLVG 506
+G G F V + TG+E AAK + K G EE EV ++ +++H N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARGLLY 560
L + + +LI E + L FD L K+ + + I G+ Y
Sbjct: 73 LHDIFENKTDVVLILELVSGGEL----FDF-----LAEKESLTEDEATQFLKQILDGVHY 123
Query: 561 LHQDSKLQVIHRDLKASNILLDINLNP----KISDFGLARIFGGDDEEAQTERVAGTHGY 616
LH ++ H DLK NI+L P K+ DFG+A E + + GT +
Sbjct: 124 LHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGNEFKN--IFGTPEF 177
Query: 617 MSPEYANDGTISMKSDVFSLGVLL 640
++PE N + +++D++S+GV+
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 32/204 (15%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSK------NSGQGLEEFMNEVVLIGKLQHRNLVG 506
+G G F V + STG E AAK + K G EE EV ++ ++ H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARGLLY 560
L + +LI E + L FD L K+ S I I G+ Y
Sbjct: 80 LHDVYENRTDVVLILELVSGGEL----FDF-----LAQKESLSEEEATSFIKQILDGVNY 130
Query: 561 LHQDSKLQVIHRDLKASNILLDINLNP----KISDFGLARIFGGDDEEAQTERVAGTHGY 616
LH ++ H DLK NI+L P K+ DFGLA +D GT +
Sbjct: 131 LHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIF-GTPEF 184
Query: 617 MSPEYANDGTISMKSDVFSLGVLL 640
++PE N + +++D++S+GV+
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 27/199 (13%)
Query: 454 IGKGGFGPVYMG-KLSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGS 510
+GKG F V +TG E AAK ++ S + ++ E + KLQH N+V L S
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 511 CIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARGLLYLHQD 564
EE L+++ + L F+ + ++ +S I I + Y H
Sbjct: 74 IQEESFHYLVFDLVTGGEL----FED-----IVAREFYSEADASHCIQQILESIAYCH-- 122
Query: 565 SKLQVIHRDLKASNILL---DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
++HR+LK N+LL K++DFGLA D E AGT GY+SPE
Sbjct: 123 -SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHG--FAGTPGYLSPEV 178
Query: 622 ANDGTISMKSDVFSLGVLL 640
S D+++ GV+L
Sbjct: 179 LKKDPYSKPVDIWACGVIL 197
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-26
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 39/218 (17%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKN-------------SGQGLEEFMNEVVLIGKL 499
+G G +G V + K + E A K + K+ + EE NE+ L+ L
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 500 QHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITG 553
H N++ L ++ L+ E+ L F++ + + +F I+
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQ-----IINRHKFDECDAANIMKQ 154
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILL---DINLNPKISDFGLARIFGGDDEEAQTERV 610
I G+ YLH+ ++HRD+K NILL + LN KI DFGL+ F + +R+
Sbjct: 155 ILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDYKLRDRL 209
Query: 611 AGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKM 648
GT Y++PE + K DV+S GV++ ++ G
Sbjct: 210 -GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP 245
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 30/240 (12%), Positives = 67/240 (27%), Gaps = 54/240 (22%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAKRLSK---NSGQGLEEFMNEVVLIGKLQ-------- 500
++G+ TG+ +++ EV+ + L+
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 501 -----------------HRNLVGLLG--SCIEEDERMLIYEYMPHKSLDYF--IFDR-ER 538
+ ++ + + R +Y M + +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 539 SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598
K L R + + R L LH ++H L+ +I+LD ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 599 GGDDEEAQTERVAGTHGYMSPEY-----------ANDGTISMKSDVFSLGVLLVEIVSGK 647
G + + G+ PE ++ D ++LG+++ I
Sbjct: 257 G------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 28/217 (12%)
Query: 438 LATITTA--TNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEE--FMNE 492
+ATIT T + +GKG F V + GQE AA ++ + E
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 493 VVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS--- 549
+ L+H N+V L S EE LI++ + L F+ ++ + +S
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAR-----EYYSEAD 111
Query: 550 ---IITGIARGLLYLHQDSKLQVIHRDLKASNILL---DINLNPKISDFGLARIFGGDDE 603
I I +L+ HQ + V+HR+LK N+LL K++DFGLA G+ +
Sbjct: 112 ASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168
Query: 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLL 640
AGT GY+SPE D+++ GV+L
Sbjct: 169 AWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 32/204 (15%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSK------NSGQGLEEFMNEVVLIGKLQHRNLVG 506
+G G F V + STG E AAK + K G EE EV ++ ++ H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARGLLY 560
L + +LI E + L FD L K+ S I I G+ Y
Sbjct: 80 LHDVYENRTDVVLILELVSGGEL----FDF-----LAQKESLSEEEATSFIKQILDGVNY 130
Query: 561 LHQDSKLQVIHRDLKASNILLDINLNP----KISDFGLARIFGGDDEEAQTERVAGTHGY 616
LH ++ H DLK NI+L P K+ DFGLA +D GT +
Sbjct: 131 LHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIF-GTPEF 184
Query: 617 MSPEYANDGTISMKSDVFSLGVLL 640
++PE N + +++D++S+GV+
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 59/199 (29%), Positives = 90/199 (45%), Gaps = 27/199 (13%)
Query: 454 IGKGGFGPVYMG-KLSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGS 510
+GKG F V +TG E AAK ++ S + ++ E + KLQH N+V L S
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 511 CIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARGLLYLHQD 564
EE L+++ + L F+ + ++ +S I I + Y H
Sbjct: 97 IQEESFHYLVFDLVTGGEL----FED-----IVAREFYSEADASHCIQQILESIAYCHS- 146
Query: 565 SKLQVIHRDLKASNILL---DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
++HR+LK N+LL K++DFGLA +D EA GT GY+SPE
Sbjct: 147 --NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFA-GTPGYLSPEV 201
Query: 622 ANDGTISMKSDVFSLGVLL 640
S D+++ GV+L
Sbjct: 202 LKKDPYSKPVDIWACGVIL 220
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 20/197 (10%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHR-NLVGLLG 509
+G+G F V STGQE AAK L K E ++E+ ++ + ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 510 SCIEEDERMLIYEYMPHKSLDYFIFDR---ERSKLLPWKKRFSIITGIARGLLYLHQDSK 566
E +LI EY + F E ++++ +I I G+ YLHQ
Sbjct: 97 VYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ--- 149
Query: 567 LQVIHRDLKASNILL---DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAN 623
++H DLK NILL + KI DFG++R E + GT Y++PE N
Sbjct: 150 NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIM-GTPEYLAPEILN 206
Query: 624 DGTISMKSDVFSLGVLL 640
I+ +D++++G++
Sbjct: 207 YDPITTATDMWNIGIIA 223
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLS-KNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSC 511
IG G V +++A KR++ + ++E + E+ + + H N+V S
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 512 IEEDERMLIYEYMPHKSL-DYFIFDRERSKLLPWKKRFSIITGIAR----GLLYLHQDSK 566
+ +DE L+ + + S+ D + + S I I R GL YLH++ +
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ 142
Query: 567 LQVIHRDLKASNILLDINLNPKISDFGL-ARIFGGDDEEAQTER--VAGTHGYMSPE-YA 622
IHRD+KA NILL + + +I+DFG+ A + G D R GT +M+PE
Sbjct: 143 ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 623 NDGTISMKSDVFSLGVLLVEIVSGK 647
K+D++S G+ +E+ +G
Sbjct: 200 QVRGYDFKADIWSFGITAIELATGA 224
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 32/204 (15%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSK------NSGQGLEEFMNEVVLIGKLQHRNLVG 506
+G G F V + STG + AAK + K G E+ EV ++ ++QH N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARGLLY 560
L + + +LI E + L FD L K+ + + I G+ Y
Sbjct: 79 LHEVYENKTDVILILELVAGGEL----FDF-----LAEKESLTEEEATEFLKQILNGVYY 129
Query: 561 LHQDSKLQVIHRDLKASNILL----DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGY 616
LH LQ+ H DLK NI+L KI DFGLA D GT +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF-GTPEF 183
Query: 617 MSPEYANDGTISMKSDVFSLGVLL 640
++PE N + +++D++S+GV+
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 53/244 (21%), Positives = 88/244 (36%), Gaps = 54/244 (22%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAK-----RLSKNSGQGLEEFMNEVVLIGKLQHRNLVGL 507
IG+G +G V + T A K ++ + + + +E EV L+ KL H N+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 508 LGSCIEEDERM-LIYEYMPHKSLDYFIFDRERSKLLPWKKRF------------------ 548
E+++ + L+ E L +
Sbjct: 94 YE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 549 -------------------SIITGIARGLLYLHQDSKLQVIHRDLKASNILL--DINLNP 587
+I+ I L YLH + HRD+K N L + +
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEI 209
Query: 588 KISDFGLARIFGGDD--EEAQTERVAGTHGYMSPE--YANDGTISMKSDVFSLGVLLVEI 643
K+ DFGL++ F + E AGT +++PE + + K D +S GVLL +
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 644 VSGK 647
+ G
Sbjct: 270 LMGA 273
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 5e-26
Identities = 45/215 (20%), Positives = 85/215 (39%), Gaps = 28/215 (13%)
Query: 453 MIGKGGFGPVYMGK---LSTGQEIAAKRLSKNSG--QGLEEFMNEVVLIGKLQHRNLVGL 507
I GG G +Y+ ++ G+ + K L +SG + M E + ++ H ++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVN-GRPVVLKGL-VHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 508 L--GSCIEEDERMLIY---EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLH 562
+ + Y EY+ +SL + LP + + + I L YLH
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH 199
Query: 563 QDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA 622
+ +++ DLK NI+L K+ D G + GT G+ +PE
Sbjct: 200 S---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN------SFGYLYGTPGFQAPEIV 249
Query: 623 NDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGH 657
++ +D++++G L + R R+
Sbjct: 250 -RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG 283
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 28/210 (13%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSK----NSGQGLEEFMNEVVLIGKLQHRNLVGLL 508
+G+G +G V T A K L K G E+ L+ +L+H+N++ L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 509 GSCIEEDERM--LIYEYMPHKSLDYFIFDR-ERSKLLPWKKR--FS-IITGIARGLLYLH 562
E+++ ++ EY + + D + + F +I G+ YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126
Query: 563 QDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA 622
++H+D+K N+LL KIS G+A + G+ + PE A
Sbjct: 127 S---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 623 N-----DGTISMKSDVFSLGVLLVEIVSGK 647
N G K D++S GV L I +G
Sbjct: 184 NGLDTFSGF---KVDIWSAGVTLYNITTGL 210
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 57/209 (27%), Positives = 85/209 (40%), Gaps = 33/209 (15%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-HRNLVGLLGS 510
++G+G V L T QE A K + K G EV ++ + Q HRN++ L+
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 511 CIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARGLLYLHQD 564
EED L++E M S+ + + F+ ++ +A L +LH
Sbjct: 80 FEEEDRFYLVFEKMRGGSI----LSHIHKR-----RHFNELEASVVVQDVASALDFLHN- 129
Query: 565 SKLQVIHRDLKASNILL---DINLNPKISDFGLARIF--GGDDEEAQTER---VAGTHGY 616
+ HRDLK NIL + KI DF L GD T G+ Y
Sbjct: 130 --KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 617 MSPEYANDGTISMKS-----DVFSLGVLL 640
M+PE + D++SLGV+L
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 38/210 (18%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGL---------EEFMNEVVLIGKL-QHR 502
+G+G V T +E A K + G E + EV ++ K+ H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 503 NLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIAR 556
N++ L + L+++ M L FD L K S I+ +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGEL----FDY-----LTEKVTLSEKETRKIMRALLE 135
Query: 557 GLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGY 616
+ LH KL ++HRDLK NILLD ++N K++DFG + E+ + V GT Y
Sbjct: 136 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLRE--VCGTPSY 189
Query: 617 MSPE------YANDGTISMKSDVFSLGVLL 640
++PE N + D++S GV++
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 37/208 (17%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEE--------FMNEVVLIGKLQHRNL 504
+G G G V + T +++A K +SK E+ ++ KL H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 505 VGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARGL 558
+ + + ++ ++ E M L FD+ KR + +
Sbjct: 78 IKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGN-----KRLKEATCKLYFYQMLLAV 127
Query: 559 LYLHQDSKLQVIHRDLKASNILL---DINLNPKISDFGLARIFGGDDEEAQTERVAGTHG 615
YLH + +IHRDLK N+LL + + KI+DFG ++I G+ +T + GT
Sbjct: 128 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRT--LCGTPT 181
Query: 616 YMSPE---YANDGTISMKSDVFSLGVLL 640
Y++PE + D +SLGV+L
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 53/198 (26%), Positives = 80/198 (40%), Gaps = 28/198 (14%)
Query: 454 IGKGGFGPVYMG-KLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512
IG G + +T E A K + K+ EE +L+ QH N++ L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPNIITLKDVYD 86
Query: 513 EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARGLLYLHQDSK 566
+ ++ E M L D+ + K FS ++ I + + YLH
Sbjct: 87 DGKYVYVVTELMKGGEL----LDKILRQ-----KFFSEREASAVLFTITKTVEYLH---A 134
Query: 567 LQVIHRDLKASNILL---DINLNP-KISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA 622
V+HRDLK SNIL N +I DFG A+ ++ T T +++PE
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFVAPEVL 192
Query: 623 NDGTISMKSDVFSLGVLL 640
D++SLGVLL
Sbjct: 193 ERQGYDAACDIWSLGVLL 210
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 28/198 (14%)
Query: 454 IGKGGFGPVYMG-KLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-HRNLVGLLGSC 511
+G+G F + Q A K +SK E+ + + H N+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 512 IEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARGLLYLHQDS 565
++ L+ E + L F+R + K K FS I+ + + ++H
Sbjct: 76 HDQLHTFLVMELLNGGEL----FERIKKK-----KHFSETEASYIMRKLVSAVSHMHD-- 124
Query: 566 KLQVIHRDLKASNILL---DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA 622
+ V+HRDLK N+L + NL KI DFG AR+ D++ +T T Y +PE
Sbjct: 125 -VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELL 181
Query: 623 NDGTISMKSDVFSLGVLL 640
N D++SLGV+L
Sbjct: 182 NQNGYDESCDLWSLGVIL 199
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 67/225 (29%), Positives = 103/225 (45%), Gaps = 22/225 (9%)
Query: 437 DLATITTATNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVL 495
DL+ + F ++G G +G VY G+ + TGQ A K + +G EE E+ +
Sbjct: 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINM 73
Query: 496 IGKL-QHRNLVGLLGS------CIEEDERMLIYEYMPHKSL-DYFIFDRERSKLLPWKKR 547
+ K HRN+ G+ +D+ L+ E+ S+ D + + L +
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTLKEEWI 131
Query: 548 FSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQT 607
I I RGL +LHQ +VIHRD+K N+LL N K+ DFG++ T
Sbjct: 132 AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 608 ERVAGTHGYMSPE-----YANDGTISMKSDVFSLGVLLVEIVSGK 647
GT +M+PE D T KSD++SLG+ +E+ G
Sbjct: 189 --FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 37/209 (17%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQG--------LEEFMNEVVLIGKL-QHRN 503
IG+G V +TG E A K + + + E E ++ ++ H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARG 557
++ L+ S L+++ M L FD L K S I+ +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGEL----FDY-----LTEKVALSEKETRSIMRSLLEA 212
Query: 558 LLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYM 617
+ +LH ++HRDLK NILLD N+ ++SDFG + E+ + + GT GY+
Sbjct: 213 VSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHL-EPGEKLRE--LCGTPGYL 266
Query: 618 SPE------YANDGTISMKSDVFSLGVLL 640
+PE + D+++ GV+L
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEE-FMNEVVLIGKLQHRNLVGLLGSC 511
+G+G +G V + T + +A K + E E+ + L H N+V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 512 IEEDERM-LIYEYMPHKSLDYFIFDR--ERSKLLPWKKRF---SIITGIARGLLYLHQDS 565
E L EY L FDR + + ++ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG-- 123
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE----- 620
+ + HRD+K N+LLD N KISDFGLA +F ++ E ++ GT Y++PE
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 621 -YANDGTISMKSDVFSLGVLLVEIVSG 646
+ DV+S G++L +++G
Sbjct: 183 EF--HAE---PVDVWSCGIVLTAMLAG 204
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-25
Identities = 50/208 (24%), Positives = 86/208 (41%), Gaps = 37/208 (17%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEE--------FMNEVVLIGKLQHRNL 504
+G G G V + T +++A + +SK E+ ++ KL H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 505 VGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARGL 558
+ + + ++ ++ E M L FD+ KR + +
Sbjct: 203 IKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGN-----KRLKEATCKLYFYQMLLAV 252
Query: 559 LYLHQDSKLQVIHRDLKASNILL---DINLNPKISDFGLARIFGGDDEEAQTERVAGTHG 615
YLH + +IHRDLK N+LL + + KI+DFG ++I G E + + GT
Sbjct: 253 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGTPT 306
Query: 616 YMSPE---YANDGTISMKSDVFSLGVLL 640
Y++PE + D +SLGV+L
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 43/224 (19%), Positives = 89/224 (39%), Gaps = 18/224 (8%)
Query: 437 DLATITTATNHFSEANMIGKG--GFGPVYMGK-LSTGQEIAAKR--LSKNSGQGLEEFMN 491
+++ + +IGKG V + + TG+ + +R L S + +
Sbjct: 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75
Query: 492 EVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSL-DYFIFDRERSKLLPWKKRFSI 550
E+ + H N+V + I ++E ++ +M + S D + + I
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYI 133
Query: 551 ITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQT--- 607
+ G+ + L Y+H +HR +KAS+IL+ ++ +S + +
Sbjct: 134 LQGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190
Query: 608 --ERVAGTHGYMSPE--YANDGTISMKSDVFSLGVLLVEIVSGK 647
+ ++SPE N KSD++S+G+ E+ +G
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 66/202 (32%), Positives = 104/202 (51%), Gaps = 19/202 (9%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGS 510
IGKG F V + + + TG+E+A K + K + L++ EV ++ L H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF-E 81
Query: 511 CIEEDERM-LIYEYMPHKSL-DYFIFDRERSKLLPWKKRFS-IITGIARGLLYLHQDSKL 567
IE ++ + LI EY + DY + R K + +F I++ + Y HQ
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDY-LVAHGRMKEKEARSKFRQIVSAVQ----YCHQ---K 133
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE-YANDGT 626
+++HRDLKA N+LLD ++N KI+DFG + F + G Y +PE +
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAF--CGAPPYAAPELFQGKKY 190
Query: 627 ISMKSDVFSLGVLLVEIVSGKM 648
+ DV+SLGV+L +VSG +
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSL 212
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEE-FMNEVVLIGKLQHRNLVGLLGSC 511
+G+G +G V + T + +A K + E E+ + L H N+V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 512 IEEDERM-LIYEYMPHKSLDYFIFDR--ERSKLLPWKKRF---SIITGIARGLLYLHQDS 565
E L EY L FDR + + ++ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG-- 123
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE----- 620
+ + HRD+K N+LLD N KISDFGLA +F ++ E ++ GT Y++PE
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 621 -YANDGTISMKSDVFSLGVLLVEIVSG 646
+ DV+S G++L +++G
Sbjct: 183 EF--HAE---PVDVWSCGIVLTAMLAG 204
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 52/197 (26%), Positives = 87/197 (44%), Gaps = 27/197 (13%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512
+G+G VY K T + A K L K + + E+ ++ +L H N++ L
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 513 EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARGLLYLHQDSK 566
E L+ E + L FDR + K +S + I + YLH+
Sbjct: 119 TPTEISLVLELVTGGEL----FDR-----IVEKGYYSERDAADAVKQILEAVAYLHE--- 166
Query: 567 LQVIHRDLKASNILL---DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAN 623
++HRDLK N+L + KI+DFGL++I + + + V GT GY +PE
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPGYCAPEILR 223
Query: 624 DGTISMKSDVFSLGVLL 640
+ D++S+G++
Sbjct: 224 GCAYGPEVDMWSVGIIT 240
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-23
Identities = 70/215 (32%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 446 NHFSEANMIGKGGFGPVYMG-KLSTGQEIAAKRLSKN---SGQGLEEFMNE---VVLIGK 498
N FS +IG+GGFG VY K TG+ A K L K QG +NE + L+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 499 LQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITG 553
+V + + D+ I + M L Y + F RF
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-------RF-YAAE 300
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGT 613
I GL ++H V++RDLK +NILLD + + +ISD GLA F + GT
Sbjct: 301 IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGT 353
Query: 614 HGYMSPEYANDGTISMKS-DVFSLGVLLVEIVSGK 647
HGYM+PE G S D FSLG +L +++ G
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 59/242 (24%), Positives = 95/242 (39%), Gaps = 73/242 (30%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKN-------------------SGQGLEEFMN-- 491
IGKG +G V + + A K LSK + G +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 492 -----EVVLIGKLQHRNLVGLLGSCIEEDERMLIY---EYMPHKSLDYFIFDRERSKLLP 543
E+ ++ KL H N+V L+ +++ +Y E + + + +P
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----ME------VP 129
Query: 544 WKKRFS----------IITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFG 593
K S +I GI YLH ++IHRD+K SN+L+ + + KI+DFG
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 594 LARIFGGDDEEAQTERVAGTHGYMSPE--------YANDGTISMKSDVFSLGVLLVEIVS 645
++ F G D GT +M+PE + G DV+++GV L V
Sbjct: 183 VSNEFKGSDALLSN--TVGTPAFMAPESLSETRKIF--SGK---ALDVWAMGVTLYCFVF 235
Query: 646 GK 647
G+
Sbjct: 236 GQ 237
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQH 501
+ F + ++G+GGFG V+ ++ +TG+ A K+L+K +G + M E ++ K+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 502 RNLVGLLGSCIEEDERM-LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSI------ITGI 554
R +V L E + L+ M + Y I++ + F I
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN-----PGFQEPRAIFYTAQI 298
Query: 555 ARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTH 614
GL +LHQ +I+RDLK N+LLD + N +ISD GLA + + AGT
Sbjct: 299 VSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTP 353
Query: 615 GYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
G+M+PE D F+LGV L E+++ +
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN--EVVLIGKLQHRNLVGLLGS 510
IG+G +G V+ + TGQ +A K+ ++ + + + E+ ++ +L+H NLV LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 511 CIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVI 570
+ L++EY H L + +P SI + + + H+ I
Sbjct: 71 FRRKRRLHLVFEYCDHTVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCI 124
Query: 571 HRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE-------YAN 623
HRD+K NIL+ + K+ DFG AR+ G + + VA T Y SPE Y
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLLTGPS-DYYDDEVA-TRWYRSPELLVGDTQY-- 180
Query: 624 DGTISMKSDVFSLGVLLVEIVSGK 647
DV+++G + E++SG
Sbjct: 181 ----GPPVDVWAIGCVFAELLSGV 200
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 48/209 (22%), Positives = 84/209 (40%), Gaps = 26/209 (12%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKN--------SGQGLEEFMNEVVLIGKLQHRNL 504
+G G FG V+ +E+ K + K L + E+ ++ +++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 505 VGLLGSCIEEDERMLIYEYMPHKS-LDYFIFDRERSKLLPWKKR--FS-IITGIARGLLY 560
+ +L I E++ H S LD F F +L F +++ + Y
Sbjct: 92 IKVLD--IFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG----Y 145
Query: 561 LHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE 620
L +IHRD+K NI++ + K+ DFG A GT Y +PE
Sbjct: 146 LRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPE 199
Query: 621 -YANDGTISMKSDVFSLGVLLVEIVSGKM 648
+ + +++SLGV L +V +
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEEN 228
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 48/209 (22%), Positives = 78/209 (37%), Gaps = 46/209 (22%)
Query: 453 MIGKGGFGPVYMG-KLSTGQEIAAKRLSKNSGQGLEEFMNEV-VLIGKLQHRNLVGLLGS 510
++G G G V TGQ+ A K L + + EV ++V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILD- 89
Query: 511 CIEEDERMLIYEYMPHKSLDYFI----------FDRERSKLLPWKKRFS------IITGI 554
+YE M H I F R + + + F+ I+ I
Sbjct: 90 ---------VYENMHHGKRCLLIIMECMEGGELFSRIQER---GDQAFTEREAAEIMRDI 137
Query: 555 ARGLLYLHQDSKLQVIHRDLKASNILL---DINLNPKISDFGLARIFGGDDEEAQTERVA 611
+ +LH + HRD+K N+L + + K++DFG A+ QT
Sbjct: 138 GTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQT--PC 190
Query: 612 GTHGYMSPEYANDGTISMKSDVFSLGVLL 640
T Y++PE D++SLGV++
Sbjct: 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 13/207 (6%)
Query: 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQH 501
N F + ++GKGGFG V ++ +TG+ A K+L K +G +NE ++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 502 RNLVGLLGSCIEEDERM-LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLY 560
R +V L E + + L+ M L + I+ ++ + F I GL
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF-YAAEICCGLED 301
Query: 561 LHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE 620
LH + ++++RDLK NILLD + + +ISD GLA + GT GYM+PE
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPE 355
Query: 621 YANDGTISMKSDVFSLGVLLVEIVSGK 647
+ + D ++LG LL E+++G+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-22
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 32/208 (15%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAK--RLSKNSGQGLEEF----MNEVVLIGKLQHRNLVG 506
+G+G +G V + TG+ +A K S + + M E+ L+ +L+H NLV
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD----KMVKKIAMREIKLLKQLRHENLVN 88
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSK 566
LL C ++ L++E++ H LD + + L + + I G+ + H
Sbjct: 89 LLEVCKKKKRWYLVFEFVDHTILDDL--ELFPNGLDYQVVQ-KYLFQIINGIGFCHSH-- 143
Query: 567 LQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE------ 620
+IHRD+K NIL+ + K+ DFG AR E + VA T Y +PE
Sbjct: 144 -NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA-TRWYRAPELLVGDV 200
Query: 621 -YANDGTISMKSDVFSLGVLLVEIVSGK 647
Y DV+++G L+ E+ G+
Sbjct: 201 KY------GKAVDVWAIGCLVTEMFMGE 222
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-22
Identities = 54/226 (23%), Positives = 101/226 (44%), Gaps = 38/226 (16%)
Query: 440 TITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMN-EVVLIGK 498
T ++ +IG G FG V+ KL E+A K++ ++ + F N E+ ++
Sbjct: 34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRI 88
Query: 499 LQHRNLVGLL------GSCIEEDERMLIYEYMP---HKSLDYFIFDRERSKLLPWKKRFS 549
++H N+V L G +E L+ EY+P +++ ++ + + +P
Sbjct: 89 VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHY---AKLKQTMPMLLIKL 145
Query: 550 IITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNP-KISDFGLARIFGGDDEEAQTE 608
+ + R L Y+H + + HRD+K N+LLD K+ DFG A+I E
Sbjct: 146 YMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVS 200
Query: 609 RVAGTHGYMSPE-------YANDGTISMKSDVFSLGVLLVEIVSGK 647
+ + Y +PE Y + D++S G ++ E++ G+
Sbjct: 201 YIC-SRYYRAPELIFGATNY------TTNIDIWSTGCVMAELMQGQ 239
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 3e-22
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 39/213 (18%)
Query: 452 NMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEF--------MNEVVLIGKLQHRN 503
IG+G +G VY + + G+ A K++ LE+ + E+ ++ +L+H N
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILKELKHSN 61
Query: 504 LVGLLGSCIEEDERMLIYEYMPH--KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
+V L + +L++E++ K L D L + S + + G+ Y
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKL----LDVCEGGLESVTAK-SFLLQLLNGIAYC 116
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE- 620
H +V+HRDLK N+L++ KI+DFGLAR F G T + T Y +P+
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRAPDV 171
Query: 621 ------YANDGTISMKSDVFSLGVLLVEIVSGK 647
Y S D++S+G + E+V+G
Sbjct: 172 LMGSKKY------STTIDIWSVGCIFAEMVNGT 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 41/212 (19%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSK---NSGQGLEEFMNEVVLIGKLQHRNLVGLLG 509
+G+G FG V + T Q++A K +S+ E+ + L+H +++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 510 SCIEEDERMLIYEYMPHKSLDYFI--------FDR--ERSKLLPWKKR--FS-IITGIAR 556
Y+ + + + FD E+ ++ + R F II I
Sbjct: 75 -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE- 122
Query: 557 GLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGY 616
Y H + +++HRDLK N+LLD NLN KI+DFGL+ I D +T G+ Y
Sbjct: 123 ---YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKT--SCGSPNY 173
Query: 617 MSPE-YANDGTISMKSDVFSLGVLLVEIVSGK 647
+PE + DV+S G++L ++ G+
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-22
Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 31/218 (14%)
Query: 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMN-EVVLIGKLQHR 502
+++ +IG G FG VY KL +G+ +A K++ ++ + F N E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 503 NLVGLLGSCIEEDERM------LIYEYMP---HKSLDYFIFDRERSKLLPWKKRFSIITG 553
N+V L E+ L+ +Y+P ++ ++ + LP +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY---SRAKQTLPVIYVKLYMYQ 164
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNP-KISDFGLARIFGGDDEEAQTERVAG 612
+ R L Y+H + HRD+K N+LLD + K+ DFG A+ E +
Sbjct: 165 LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYIC- 218
Query: 613 THGYMSPEY---ANDGTISMKSDVFSLGVLLVEIVSGK 647
+ Y +PE A D T S+ DV+S G +L E++ G+
Sbjct: 219 SRYYRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 254
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSK---NSGQGLEEFMNEVVLIGKLQHRNLVGLLG 509
+G G FG V +G+ TG ++A K L++ S + + E+ + +H +++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY- 77
Query: 510 SCIEEDERM-LIYEYMPHKSL-DYFIFDRERSKLLPWKKRFS-IITGIARGLLYLHQDSK 566
I ++ EY+ L DY I R + + ++ F I++ + Y H +
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDY-ICKHGRVEEMEARRLFQQILSAVD----YCH---R 129
Query: 567 LQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE-YANDG 625
V+HRDLK N+LLD ++N KI+DFGL+ + D E +T G+ Y +PE +
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRT--SCGSPNYAAPEVISGRL 186
Query: 626 TISMKSDVFSLGVLLVEIVSGKM 648
+ D++S GV+L ++ G +
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTL 209
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 5e-22
Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 39/213 (18%)
Query: 452 NMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEF--------MNEVVLIGKLQHRN 503
+G+G +G VY K S G+ +A KR+ L+ + E+ L+ +L H N
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLKELHHPN 80
Query: 504 LVGLLGSCIEEDERMLIYEYMPH--KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
+V L+ E L++E+M K + D ++ L + + + + RG+ +
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEKDLKKV----LDENKTGLQDSQIK-IYLYQLLRGVAHC 135
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE- 620
HQ +++HRDLK N+L++ + K++DFGLAR F G + T V T Y +P+
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDV 190
Query: 621 ------YANDGTISMKSDVFSLGVLLVEIVSGK 647
Y S D++S+G + E+++GK
Sbjct: 191 LMGSKKY------STSVDIWSIGCIFAEMITGK 217
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 64/209 (30%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN------EVVLIGKLQHR--NL 504
+G GGFG VY G +S +A K + K+ E N EVVL+ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 505 VGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD 564
+ LL D +LI E P D F F ER L R S + + + H
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN- 167
Query: 565 SKLQVIHRDLKASNILLDIN-LNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAN 623
V+HRD+K NIL+D+N K+ DFG + D GT Y PE+
Sbjct: 168 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTD--FDGTRVYSPPEWIR 221
Query: 624 ----DGTISMKSDVFSLGVLLVEIVSGKM 648
G + V+SLG+LL ++V G +
Sbjct: 222 YHRYHGR---SAAVWSLGILLYDMVCGDI 247
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 31/211 (14%)
Query: 452 NMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN-----EVVLIGKLQHRNLV 505
+ +G+G F VY + +T Q +A K++ ++ +N E+ L+ +L H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 506 GLLGSCIEEDERMLIYEYMPH--KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
GLL + + L++++M + + L P + + + +GL YLHQ
Sbjct: 76 GLLDAFGHKSNISLVFDFMETDLEVI----IKDNSLVLTPSHIK-AYMLMTLQGLEYLHQ 130
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE--- 620
++HRDLK +N+LLD N K++DFGLA+ F G A T +V T Y +PE
Sbjct: 131 H---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TRWYRAPELLF 185
Query: 621 ----YANDGTISMKSDVFSLGVLLVEIVSGK 647
Y + D++++G +L E++
Sbjct: 186 GARMY------GVGVDMWAVGCILAELLLRV 210
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 2e-21
Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 32/221 (14%)
Query: 443 TATNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN-----EVVLI 496
++++ F + +G G + VY G +TG +A K + +S EE E+ L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS----EEGTPSTAIREISLM 57
Query: 497 GKLQHRNLVGLLGSCIEEDERMLIYEYMPH---KSLDYFIFDRERSKLLPWKKRFSIITG 553
+L+H N+V L E++ L++E+M + K +D L +
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK-YFQWQ 116
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGT 613
+ +GL + H++ +++HRDLK N+L++ K+ DFGLAR F G + V T
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-T 171
Query: 614 HGYMSPE-------YANDGTISMKSDVFSLGVLLVEIVSGK 647
Y +P+ Y S D++S G +L E+++GK
Sbjct: 172 LWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 25/218 (11%)
Query: 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRN 503
+ F M G+G FG V +GK TG +A K++ ++ E + + L H N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPN 80
Query: 504 LVGLL---GSCIEEDER----MLIYEYMP---HKSLDYFIFDRERSKLLPWKKRFSIITG 553
+V L + E D R ++ EY+P H+ + + P +
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVA---PPPILIKVFLFQ 137
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLD-INLNPKISDFGLARIFGGDDEEAQTERVAG 612
+ R + LH S + V HRD+K N+L++ + K+ DFG A+ E +
Sbjct: 138 LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS--EPNVAYIC- 193
Query: 613 THGYMSPEY---ANDGTISMKSDVFSLGVLLVEIVSGK 647
+ Y +PE T ++ D++S+G + E++ G+
Sbjct: 194 SRYYRAPELIFGNQHYTTAV--DIWSVGCIFAEMMLGE 229
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 56/209 (26%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 448 FSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRN 503
F ++G+G F V + + +T +E A K L K + E ++ +L H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITGIARGL 558
V L + ++++ Y + L +I FD + RF I L
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RF-YTAEIVSAL 143
Query: 559 LYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMS 618
YLH +IHRDLK NILL+ +++ +I+DFG A++ + ++A+ GT Y+S
Sbjct: 144 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200
Query: 619 PEYANDGTISMKSDVFSLGVLLVEIVSGK 647
PE + + SD+++LG ++ ++V+G
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 3e-21
Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 42/214 (19%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSK---NSGQGLEEFMNEVVLIGKLQHRNLVGLLG 509
+G G FG V +GK TG ++A K L++ S + + E+ + +H +++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81
Query: 510 SCIEEDERMLIYEYMPHKSLDYFI---------FDR--ERSKLLPWKKR--FS-IITGIA 555
Y+ + S + + FD + +L + R F I++G+
Sbjct: 82 -----------YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD 130
Query: 556 RGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG 615
Y H + V+HRDLK N+LLD ++N KI+DFGL+ + D E +T G+
Sbjct: 131 ----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRT--SCGSPN 180
Query: 616 YMSPE-YANDGTISMKSDVFSLGVLLVEIVSGKM 648
Y +PE + + D++S GV+L ++ G +
Sbjct: 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTL 214
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 4e-21
Identities = 45/204 (22%), Positives = 77/204 (37%), Gaps = 37/204 (18%)
Query: 454 IGKGGFGPVYMG-KLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-HRNLVGLLGSC 511
+G G G V T ++ A K L + EV L + ++V ++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 124
Query: 512 IEEDERM------LIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARGLL 559
E+ ++ E + L F R + + + F+ I+ I +
Sbjct: 125 --ENLYAGRKCLLIVMECLDGGEL----FSRIQDR---GDQAFTEREASEIMKSIGEAIQ 175
Query: 560 YLHQDSKLQVIHRDLKASNILL---DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGY 616
YLH + + HRD+K N+L N K++DFG A+ T T Y
Sbjct: 176 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTT--PCYTPYY 229
Query: 617 MSPEYANDGTISMKSDVFSLGVLL 640
++PE D++SLGV++
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 37/230 (16%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN------EVVLIGKL----QH 501
++GKGGFG V+ G L+ ++A K + +N G + EV L+ K+ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
++ LL ++ ML+ E P + D F + E+ L R + + +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSRC-FFGQVVAAIQHC 155
Query: 562 HQDSKLQVIHRDLKASNILLDI-NLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE 620
H V+HRD+K NIL+D+ K+ DFG + DE GT Y PE
Sbjct: 156 HS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTD--FDGTRVYSPPE 208
Query: 621 YAN----DGTISMKSDVFSLGVLLVEIVSG--------KMNRG-FRHPGH 657
+ + + V+SLG+LL ++V G ++ P H
Sbjct: 209 WISRHQYHAL---PATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAH 255
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 42/217 (19%)
Query: 452 NMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEF--------MNEVVLIGKLQHR 502
+G+G +G VY T + +A KR+ LE + EV L+ +LQHR
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLLKELQHR 93
Query: 503 NLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLH 562
N++ L LI+EY + L ++ +++ + + S + + G+ + H
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 563 QDSKLQVIHRDLKASNILLDINLNP-----KISDFGLARIFGGDDEEAQTERVAGTHGYM 617
+ +HRDLK N+LL ++ KI DFGLAR F G T + T Y
Sbjct: 150 SR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII-TLWYR 204
Query: 618 SPE-------YANDGTISMKSDVFSLGVLLVEIVSGK 647
PE Y S D++S+ + E++
Sbjct: 205 PPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 8e-21
Identities = 50/180 (27%), Positives = 84/180 (46%), Gaps = 27/180 (15%)
Query: 452 NMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEF--------MNEVVLIGKLQHR 502
IG+G +G V+ K T + +A KR+ L++ + E+ L+ +L+H+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLKELKHK 61
Query: 503 NLVGLLGSCIEEDERMLIYEYMPH--KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLY 560
N+V L + + L++E+ K FD L P + S + + +GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKY----FDSCNGDLDPEIVK-SFLFQLLKGLGF 116
Query: 561 LHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE 620
H V+HRDLK N+L++ N K+++FGLAR F G + V T Y P+
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYRPPD 171
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 35/217 (16%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN-----EVVLIGKL 499
+ + + +G+G + VY GK T +A K + EE EV L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH----EEGAPCTAIREVSLLKDL 57
Query: 500 QHRNLVGLLGSCIEEDERMLIYEYMPH--KSLDYFIFDRERSKLLPWKKRFSIITGIARG 557
+H N+V L E L++EY+ K D + + + + + RG
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQY----LDDCGNIINMHNVK-LFLFQLLRG 112
Query: 558 LLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYM 617
L Y H+ +V+HRDLK N+L++ K++DFGLAR + V T Y
Sbjct: 113 LAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYR 167
Query: 618 SPE-------YANDGTISMKSDVFSLGVLLVEIVSGK 647
P+ Y S + D++ +G + E+ +G+
Sbjct: 168 PPDILLGSTDY------STQIDMWGVGCIFYEMATGR 198
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-20
Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 454 IGKGGFGPVYMGK---LSTGQEIAAKRLSKNSGQGLE-EFMNEVVLIGKLQHRNLVGLLG 509
+G+G +G VY K ++ A K++ G+ E+ L+ +L+H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEG---TGISMSACREIALLRELKHPNVISLQK 85
Query: 510 SCIEEDER--MLIYEYMPH---KSLDYFIFDRERSKLLPWKKRF--SIITGIARGLLYLH 562
+ +R L+++Y H + + + K + + S++ I G+ YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 563 QDSKLQVIHRDLKASNILLDINLNP----KISDFGLARIFG 599
+ V+HRDLK +NIL+ KI+D G AR+F
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 55/225 (24%), Positives = 87/225 (38%), Gaps = 36/225 (16%)
Query: 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEE--FMN---------EV 493
+ ++ I G +G V G S G +A KR+ G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 494 VLIGKLQHRNLVGLL-----GSCIEEDERMLIYEYMP---HKSLDYFIFDRERSKLLPWK 545
L+ H N++GL + L+ E M + + +R + P
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQ-----VIHDQRIVISPQH 135
Query: 546 KRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605
++ + I GL LH + V+HRDL NILL N + I DF LAR D
Sbjct: 136 IQY-FMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN-- 189
Query: 606 QTERVAGTHGYMSPE---YANDGTISMKSDVFSLGVLLVEIVSGK 647
+T V Y +PE T + D++S G ++ E+ + K
Sbjct: 190 KTHYVT-HRWYRAPELVMQFKGFTKLV--DMWSAGCVMAEMFNRK 231
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 54/227 (23%), Positives = 102/227 (44%), Gaps = 42/227 (18%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEF----MNEVVLIGKLQ 500
+ + + IG+G FG V+ + TGQ++A K++ + + E F + E+ ++ L+
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLK 74
Query: 501 HRNLVGLLGSCIEEDERM--------LIYEYMPH--KSLDYFIFDRERSKLLPWKKRFSI 550
H N+V L+ C + L++++ H L K + + +
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL----LSNVLVKFTLSEIK-RV 129
Query: 551 ITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ---T 607
+ + GL Y+H++ +++HRD+KA+N+L+ + K++DFGLAR F T
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 608 ERVAGTHGYMSPE-------YANDGTISMKSDVFSLGVLLVEIVSGK 647
RV T Y PE Y D++ G ++ E+ +
Sbjct: 187 NRVV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 446 NHFSEANMIGKGGFGPVYMG-KLSTGQEIAAKRLSKNSGQGLEEF---MNEVVLIGKLQH 501
+HF IGKG FG V + K T + A K ++K E E+ ++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 502 RNLVGLLGSCIEEDERM-LIYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITGIA 555
LV L S +++E M ++ + + L Y + F E KL I +
Sbjct: 75 PFLVNLWYS-FQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF--------ICELV 125
Query: 556 RGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG 615
L YL ++IHRD+K NILLD + + I+DF +A + + + T +AGT
Sbjct: 126 MALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT--MAGTKP 179
Query: 616 YMSPE--YANDGTISMKS-DVFSLGVLLVEIVSGK 647
YM+PE + G + D +SLGV E++ G+
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 26/220 (11%)
Query: 444 ATNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLS-KNSGQGLEEF----MNEVVLIG 497
AT+ + IG G +G VY + +G +A K + N G G + EV L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 498 KLQ---HRNLVGLL----GSCIEEDERM-LIYEYMPH--KSLDYFIFDRERSKLLPWKKR 547
+L+ H N+V L+ S + + ++ L++E++ ++ D+ LP +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTY----LDKAPPPGLPAETI 122
Query: 548 FSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQT 607
++ RGL +LH + ++HRDLK NIL+ K++DFGLARI+ + A T
Sbjct: 123 KDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALT 177
Query: 608 ERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
V T Y +PE T + D++S+G + E+ K
Sbjct: 178 PVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 44/223 (19%)
Query: 445 TNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN---------EVV 494
+ +G G +G V +G+++A K+LS+ F + E++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-------PFQSEIFAKRAYRELL 75
Query: 495 LIGKLQHRNLVGLL-----GSCIEEDERM-LIYEYMP---HKSLDYFIFDRERSKLLPWK 545
L+ +QH N++GLL S + L+ +M K + K K
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM--------GLKFSEEK 127
Query: 546 KRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605
++ ++ + +GL Y+H V+HRDLK N+ ++ + KI DFGLAR +
Sbjct: 128 IQY-LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA----DAE 179
Query: 606 QTERVAGTHGYMSPEYA-NDGTISMKSDVFSLGVLLVEIVSGK 647
T V T Y +PE + + D++S+G ++ E+++GK
Sbjct: 180 MTGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 46/213 (21%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN-EVVLIGKLQHRNLVGLLGSC 511
IG G FG + + T + +A K + + G ++E + E++ L+H N+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 512 IEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS----------IITGIARGLLYL 561
+ +I EY L ++R + RFS +++G++ Y
Sbjct: 86 LTPTHLAIIMEYASGGEL----YER-----ICNAGRFSEDEARFFFQQLLSGVS----YC 132
Query: 562 HQDSKLQVIHRDLKASNILLDINLNP--KISDFGLARIFGGDDEEAQTERVAGTHGYMSP 619
H +Q+ HRDLK N LLD + P KI DFG ++ + ++ GT Y++P
Sbjct: 133 H---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKS--TVGTPAYIAP 186
Query: 620 E------YANDGTISMKSDVFSLGVLLVEIVSG 646
E Y DG +DV+S GV L ++ G
Sbjct: 187 EVLLRQEY--DGK---IADVWSCGVTLYVMLVG 214
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 35/219 (15%)
Query: 445 TNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN---------EVV 494
+ IG G G V + +A K+LS+ F N E+V
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-------PFQNQTHAKRAYRELV 76
Query: 495 LIGKLQHRNLVGLL------GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRF 548
L+ + H+N++GLL S E + ++ E M +L I + +L + +
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI----QMELDHERMSY 131
Query: 549 SIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTE 608
++ + G+ +LH +IHRDLK SNI++ + KI DFGLAR T
Sbjct: 132 -LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 185
Query: 609 RVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
V T Y +PE D++S+G ++ E++ G
Sbjct: 186 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 3e-19
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 35/219 (15%)
Query: 445 TNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN---------EVV 494
+ IG G G V + +A K+LS+ F N E+V
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-------PFQNQTHAKRAYRELV 113
Query: 495 LIGKLQHRNLVGLL-----GSCIEEDERM-LIYEYMPHKSLDYFIFDRERSKLLPWKKRF 548
L+ + H+N++ LL +EE + + L+ E M L I + +L + +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI----QMELDHERMSY 168
Query: 549 SIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTE 608
++ + G+ +LH +IHRDLK SNI++ + KI DFGLAR T
Sbjct: 169 -LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 222
Query: 609 RVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
V T Y +PE D++S+G ++ E+V K
Sbjct: 223 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-19
Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 45/226 (19%)
Query: 445 TNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN---------EVV 494
++ + IG+G +G V +A K++S F + E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 495 LIGKLQHRNLVGLL-----GSCIEEDERMLIYEYMP---HKSLDYFIFDRERSKLLPWKK 546
++ + +H N++G+ + + + ++ + M +K L +++ L
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL--------KTQHLSNDH 129
Query: 547 RFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606
+ I RGL Y+H + V+HRDLK SN+LL+ + KI DFGLAR+ D +
Sbjct: 130 ICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 607 --TERVAGTHGYMSPE---YANDGTISMKSDVFSLGVLLVEIVSGK 647
TE VA T Y +PE + T S+ D++S+G +L E++S +
Sbjct: 187 FLTEYVA-TRWYRAPEIMLNSKGYTKSI--DIWSVGCILAEMLSNR 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 56/234 (23%), Positives = 96/234 (41%), Gaps = 52/234 (22%)
Query: 445 TNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN---------EVV 494
+ + + +G GG G V+ + +A K++ + E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 495 LIGKLQHRNLVGLL--------------GSCIEEDERMLIYEYMP---HKSLDYFIFDRE 537
+I +L H N+V + GS E + ++ EYM L E
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL-------E 113
Query: 538 RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD-INLNPKISDFGLAR 596
+ LL R + + RGL Y+H + V+HRDLK +N+ ++ +L KI DFGLAR
Sbjct: 114 QGPLLEEHARL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLAR 169
Query: 597 IFGGDDEEAQ--TERVAGTHGYMSPE-YANDGTISMKSDVFSLGVLLVEIVSGK 647
I +E + T Y SP + + D+++ G + E+++GK
Sbjct: 170 IMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 55/220 (25%), Positives = 102/220 (46%), Gaps = 36/220 (16%)
Query: 448 FSEANMIGKGGFGPVYMGK--LSTGQEIAAKRLSKNSGQGLEEFMN--------EVVLIG 497
+ IG+G +G V+ + + G+ +A KR+ ++ EV ++
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAVLR 66
Query: 498 KLQ---HRNLVGLL----GSCIEEDERM-LIYEYMPH--KSLDYFIFDRERSKLLPWKKR 547
L+ H N+V L S + + ++ L++E++ + D+ +P +
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY----LDKVPEPGVPTETI 122
Query: 548 FSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQT 607
++ + RGL +LH +V+HRDLK NIL+ + K++DFGLARI+ + A T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALT 177
Query: 608 ERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
V T Y +PE + + D++S+G + E+ K
Sbjct: 178 SVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 47/172 (27%), Positives = 69/172 (40%), Gaps = 14/172 (8%)
Query: 479 SKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRER 538
K G + + V I R L + S + + + + D +
Sbjct: 128 YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYK 187
Query: 539 SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598
L + +A+G+ +L + + IHRDL A NILL KI DFGLAR
Sbjct: 188 -DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243
Query: 599 GGDDEEAQTERVAGTHG-----YMSPEYANDGTISMKSDVFSLGVLLVEIVS 645
D + V +M+PE D +++SDV+S GVLL EI S
Sbjct: 244 YKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 35/162 (21%), Positives = 62/162 (38%), Gaps = 19/162 (11%)
Query: 452 NMIGKGGFGPVYMGKL------STGQEIAAKRLSKNSGQG-LEEFMNEV-VLIGKLQHRN 503
+G+G FG V +T + +A K L + + M+E+ +LI H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 504 LVGLLGSCIEEDER-MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLH 562
+V LLG+C + M+I E+ +L ++ KR + +G +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQ 137
Query: 563 QDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604
+ I DLK + + + S F + +EE
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 43/223 (19%)
Query: 445 TNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN---------EVV 494
+ + +G G +G V TG ++A K+L + F + E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-------PFQSELFAKRAYRELR 76
Query: 495 LIGKLQHRNLVGLL------GSCIEEDERMLIYEYMP---HKSLDYFIFDRERSKLLPWK 545
L+ ++H N++GLL + + + L+ +M K + + + L
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM--------KHEKLGED 128
Query: 546 KRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605
+ ++ + +GL Y+H +IHRDLK N+ ++ + KI DFGLAR +
Sbjct: 129 RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA----DSE 181
Query: 606 QTERVAGTHGYMSPEYA-NDGTISMKSDVFSLGVLLVEIVSGK 647
T V T Y +PE N + D++S+G ++ E+++GK
Sbjct: 182 MTGYVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 8e-17
Identities = 55/252 (21%), Positives = 99/252 (39%), Gaps = 63/252 (25%)
Query: 443 TATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMN-EVVLIGKLQ 500
T++ +S +G G FG V +G+ A K++ ++ + N E+ ++ L
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLD 58
Query: 501 HRNLVGLL--------------------------------------GSCIEEDERMLIYE 522
H N++ L+ + + +I E
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 523 YMP---HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNI 579
Y+P HK L FI +P I + R + ++H L + HRD+K N+
Sbjct: 119 YVPDTLHKVLKSFIRSGRS---IPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNL 172
Query: 580 LLDINLNP-KISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY---ANDGTISMKSDVFS 635
L++ N K+ DFG A+ E + + Y +PE A + T S+ D++S
Sbjct: 173 LVNSKDNTLKLCDFGSAKKL--IPSEPSVAYIC-SRFYRAPELMLGATEYTPSI--DLWS 227
Query: 636 LGVLLVEIVSGK 647
+G + E++ GK
Sbjct: 228 IGCVFGELILGK 239
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 27/216 (12%)
Query: 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEE---FMNEVVLIGKLQH 501
F +IG+G FG V + KL + + A K L+K E F E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 502 RNLVGLLGSCIEEDERMLIYEYMP------HKSLDYFIFDRERSKLLPWKKRFSIITGIA 555
+ + L + +++ L+ +Y S E + RF + +
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-------RF-YLAEMV 185
Query: 556 RGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG 615
+ +H +L +HRD+K NIL+D+N + +++DFG +D Q+ GT
Sbjct: 186 IAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLK-LMEDGTVQSSVAVGTPD 241
Query: 616 YMSPE-----YANDGTISMKSDVFSLGVLLVEIVSG 646
Y+SPE G + D +SLGV + E++ G
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 43/223 (19%)
Query: 445 TNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN---------EVV 494
+ + +G G +G V TG +A K+LS+ F + E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80
Query: 495 LIGKLQHRNLVGLL------GSCIEEDERMLIYEYMP---HKSLDYFIFDRERSKLLPWK 545
L+ ++H N++GLL S E ++ L+ M + + + + L
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--------KCQKLTDD 132
Query: 546 KRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605
+I I RGL Y+H +IHRDLK SN+ ++ + KI DFGLAR +
Sbjct: 133 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT----ADE 185
Query: 606 QTERVAGTHGYMSPEYA-NDGTISMKSDVFSLGVLLVEIVSGK 647
T VA T Y +PE N + D++S+G ++ E+++G+
Sbjct: 186 MTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 37/200 (18%), Positives = 76/200 (38%), Gaps = 35/200 (17%)
Query: 445 TNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN---------EVV 494
+ + ++IG G +G V + +A K++ + F + E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104
Query: 495 LIGKLQHRNLVGLL-----GSCIEEDERMLIYEYMP---HKSLDYFIFDRERSKLLPWKK 546
++ +L H ++V +L + DE ++ E K R L
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLF------RTPVYLTELHI 158
Query: 547 RFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606
+ ++ + G+ Y+H ++HRDLK +N L++ + + K+ DFGLAR +
Sbjct: 159 KT-LLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214
Query: 607 TERVAGTHGYMSPEYANDGT 626
++ M+
Sbjct: 215 QLPISPREDDMNLVTFPHTK 234
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 44/225 (19%), Positives = 93/225 (41%), Gaps = 34/225 (15%)
Query: 436 YDLATIT-TATNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEV 493
Y+ + + + +G+G + V+ ++ +++ K L + + E+
Sbjct: 25 YESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREI 81
Query: 494 VLIGKLQ-HRNLVGLLGSCIEEDERM--LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSI 550
++ L+ N++ L + R L++E++ + L + RF
Sbjct: 82 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRF-Y 135
Query: 551 ITGIARGLLYLHQDSKLQVIHRDLKASNILLDI-NLNPKISDFGLARIFGGDDEEAQTER 609
+ I + L Y H S ++HRD+K N+++D + ++ D+GLA + R
Sbjct: 136 MYEILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVR 190
Query: 610 VAGTHGYMSPE-------YANDGTISMKSDVFSLGVLLVEIVSGK 647
VA + + PE Y S+ D++SLG +L ++ K
Sbjct: 191 VA-SRYFKGPELLVDYQMY----DYSL--DMWSLGCMLASMIFRK 228
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 29/218 (13%)
Query: 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQH 501
+ F +IG+G F V + K+ TGQ A K ++K + F E ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 502 RNLVGLLGSCIEEDERMLIYEYMP------HKSLDYFIFDRERSKLLPWKKRFSIITGIA 555
R + L + +E+ L+ EY S E + RF + I
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-------RF-YLAEIV 172
Query: 556 RGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG 615
+ +H+ L +HRD+K NILLD + +++DFG D ++ GT
Sbjct: 173 MAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLK-LRADGTVRSLVAVGTPD 228
Query: 616 YMSPE-------YANDGTISMKSDVFSLGVLLVEIVSG 646
Y+SPE G+ + D ++LGV E+ G
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 5e-16
Identities = 49/256 (19%), Positives = 101/256 (39%), Gaps = 62/256 (24%)
Query: 445 TNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN---------EVV 494
+++ ++IG+G +G VY+ +T + +A K++++ F + E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREIT 77
Query: 495 LIGKLQHRNLVGLL-----GSCIEEDERMLIYEYMP---HKSLDYFIFDRERSKLLPWKK 546
++ +L+ ++ L ++ DE ++ E K + L
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF------KTPIFLTEEHI 131
Query: 547 RFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606
+ I+ + G ++H+ +IHRDLK +N LL+ + + K+ DFGLAR + +
Sbjct: 132 KT-ILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187
Query: 607 ---------------------TERVAGTHGYMSPE---YANDGTISMKSDVFSLGVLLVE 642
T V T Y +PE + T S+ D++S G + E
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSI--DIWSTGCIFAE 244
Query: 643 IVSGKMNRGFRHPGHR 658
+++ +
Sbjct: 245 LLNMLQSHINDPTNRF 260
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 58/238 (24%), Positives = 97/238 (40%), Gaps = 62/238 (26%)
Query: 445 TNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN---------EVV 494
++ F +++G+G +G V TG+ +A K++ F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 495 LIGKLQHRNLVGLL-----GSCIEEDERMLIYEYMP---HKSLDYFIFDRERSKLL-PWK 545
++ +H N++ + S +E +I E M H+ + +++L
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI--------STQMLSDDH 113
Query: 546 KRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605
++ I R + LH VIHRDLK SN+L++ N + K+ DFGLARI +
Sbjct: 114 IQY-FIYQTLRAVKVLH--GS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
Query: 606 Q---------TERVAGTHGYMSPE-------YANDGTISMKSDVFSLGVLLVEIVSGK 647
E VA T Y +PE Y S DV+S G +L E+ +
Sbjct: 170 SEPTGQQSGMVEFVA-TRWYRAPEVMLTSAKY------SRAMDVWSCGCILAELFLRR 220
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEF---MNEVVLIGKLQH 501
N F ++GKG FG V + K +TG+ A K L K +E + E ++ +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 502 RNLVGLLGSCIEEDERM-LIYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITGIA 555
L L + +R+ + EY L + + F +R++ I
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY--------GAEIV 258
Query: 556 RGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG 615
L YLH S+ V++RDLK N++LD + + KI+DFGL + D +T GT
Sbjct: 259 SALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPE 314
Query: 616 YMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
Y++PE D D + LGV++ E++ G+
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 28/215 (13%)
Query: 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEE---FMNEVVLIGKLQH 501
+ +IG+G FG V + + ST + A K LSK + F E ++
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 502 RNLVGLLGSCIEEDERMLIYEYMP------HKSLDYFIFDRERSKLLPWKKRFSIITGIA 555
+V L + ++ ++ EYMP + + + + RF +
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL--MSNYDVPEKWA-------RF-YTAEVV 178
Query: 556 RGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG 615
L +H + IHRD+K N+LLD + + K++DFG + + + GT
Sbjct: 179 LALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPD 234
Query: 616 YMSPE----YANDGTISMKSDVFSLGVLLVEIVSG 646
Y+SPE DG + D +S+GV L E++ G
Sbjct: 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 59/233 (25%), Positives = 94/233 (40%), Gaps = 27/233 (11%)
Query: 424 LENWKVDIEVPLYDLATITTATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSK-- 480
L K D + T + F +G G FG V + K +G A K L K
Sbjct: 19 LAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 481 --NSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFI----- 533
Q +E +NE ++ + LV L S + ++ EY+ + +
Sbjct: 79 VVKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR 137
Query: 534 FDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFG 593
F + RF I YLH L +I+RDLK N+L+D +++DFG
Sbjct: 138 FSEPHA-------RF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 594 LARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSG 646
A+ G +T + GT ++PE + D ++LGVL+ E+ +G
Sbjct: 187 FAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 42/204 (20%), Positives = 72/204 (35%), Gaps = 58/204 (28%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEV-VLIGKLQHRNLVGLLGSC 511
+G G G V T ++ A K L + EV + Q ++V ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 80
Query: 512 IEEDERM------LIYEYMPHKSLDYFIFDRERSKLLPWKKRFS------IITGIARGLL 559
E+ ++ E + L F R + + + F+ I+ I +
Sbjct: 81 --ENLYAGRKCLLIVMECLDGGEL----FSRIQDR---GDQAFTEREASEIMKSIGEAIQ 131
Query: 560 YLHQDSKLQVIHRDLKASNILL---DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGY 616
YLH + + HRD+K N+L N K++DFG A+ G Y
Sbjct: 132 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG-------------EKY 175
Query: 617 MSPEYANDGTISMKSDVFSLGVLL 640
D++SLGV++
Sbjct: 176 -----------DKSCDMWSLGVIM 188
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.8 bits (191), Expect = 5e-15
Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 25/213 (11%)
Query: 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNE-VVLIGKLQ 500
F+ ++GKG FG V + + T + A K L K+ +E M E VL +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 501 HRNLVGLLGSCIEEDERM-LIYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITGI 554
L L SC + +R+ + EY+ L Y I F + F I
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VF-YAAEI 451
Query: 555 ARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTH 614
A GL +L +I+RDLK N++LD + KI+DFG+ + D +T GT
Sbjct: 452 AIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTP 506
Query: 615 GYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
Y++PE D ++ GVLL E+++G+
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 453 MIGKGGFGPVYMGKL-STGQEIAAKRLSK---NSGQGLEEFMNE-VVLIGKLQHRNLVGL 507
+IG+G + V + +L T + A K + K N + ++ E V H LVGL
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 508 LGSCIEEDERM-LIYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITGIARGLLYL 561
SC + + R+ + EY+ L + + E + RF I+ L YL
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAE-ISLALNYL 126
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
H+ +I+RDLK N+LLD + K++D+G+ + + T GT Y++PE
Sbjct: 127 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEI 181
Query: 622 ANDGTISMKSDVFSLGVLLVEIVSGK 647
D ++LGVL+ E+++G+
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 24/205 (11%)
Query: 453 MIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEF---MNEVVLIGKLQHRNLVGLL 508
++GKG FG V + + +TG+ A K L K +E + E ++ +H L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 509 GSCIEEDERM-LIYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITGIARGLLYLH 562
+ +R+ + EY L + + F ER++ I L YLH
Sbjct: 72 -YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY--------GAEIVSALEYLH 122
Query: 563 QDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA 622
V++RD+K N++LD + + KI+DFGL + D +T GT Y++PE
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVL 177
Query: 623 NDGTISMKSDVFSLGVLLVEIVSGK 647
D D + LGV++ E++ G+
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 453 MIGKGGFGPVYMGKL-STGQEIAAKRLSK---NSGQGLEEFMNE-VVLIGKLQHRNLVGL 507
+IG+G + V + +L T + A + + K N + ++ E V H LVGL
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 508 LGSCIEEDERM-LIYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITGIARGLLYL 561
SC + + R+ + EY+ L + + E + RF I+ L YL
Sbjct: 119 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAE-ISLALNYL 169
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
H+ +I+RDLK N+LLD + K++D+G+ + + T GT Y++PE
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEI 224
Query: 622 ANDGTISMKSDVFSLGVLLVEIVSGK 647
D ++LGVL+ E+++G+
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 453 MIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEF---MNE-VVLIGKLQHRNLVGL 507
M+GKG FG V++ + T Q A K L K+ ++ M E VL +H L +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 508 LGSCIEEDERM-LIYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITGIARGLLYL 561
+ E + + EY+ L Y I FD R+ F I GL +L
Sbjct: 84 F-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-------TF-YAAEIILGLQFL 134
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
H +++RDLK NILLD + + KI+DFG+ + D + T GT Y++PE
Sbjct: 135 H---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEI 189
Query: 622 ANDGTISMKSDVFSLGVLLVEIVSG 646
+ D +S GVLL E++ G
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 453 MIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNE-VVLIGKLQHRNLVGL 507
++GKG FG V + ++ TG A K L K+ +E M E +L H L L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITGIARGLLYLH 562
D + E++ L + I FD R+ RF I L++LH
Sbjct: 90 FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA-------RF-YAAEIISALMFLH 141
Query: 563 QDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA 622
+I+RDLK N+LLD + K++DFG+ + + T GT Y++PE
Sbjct: 142 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPEIL 196
Query: 623 NDGTISMKSDVFSLGVLLVEIVSGK 647
+ D +++GVLL E++ G
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 25/206 (12%)
Query: 453 MIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNE-VVLIGKLQHRNLVGL 507
++GKG FG V + + T + A K L K+ +E M E VL + L L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 508 LGSCIEEDERM-LIYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITGIARGLLYL 561
SC + +R+ + EY+ L Y I F + F IA GL +L
Sbjct: 87 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VF-YAAEIAIGLFFL 137
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
+I+RDLK N++LD + KI+DFG+ + D +T GT Y++PE
Sbjct: 138 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEI 192
Query: 622 ANDGTISMKSDVFSLGVLLVEIVSGK 647
D ++ GVLL E+++G+
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 453 MIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEF---MNE-VVLIGKLQHRNLVGL 507
+IGKG FG V + + + A K L K + +E M+E VL+ ++H LVGL
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 508 LGSCIEEDERM-LIYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITGIARGLLYL 561
+ +++ + +Y+ L Y + F R+ RF IA L YL
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-------RF-YAAEIASALGYL 155
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
H L +++RDLK NILLD + ++DFGL + + T GT Y++PE
Sbjct: 156 H---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLAPEV 210
Query: 622 ANDGTISMKSDVFSLGVLLVEIVSGK 647
+ D + LG +L E++ G
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 27/204 (13%)
Query: 453 MIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEF---MNEVVLIGKLQHRNLVGLL 508
+G G FG V++ + G+ A K L K L++ +E +++ + H ++ +
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITG------IARGLLYLH 562
G+ + + +I +Y+ L + + + + RF + L YLH
Sbjct: 73 GTFQDAQQIFMIMDYIEGGEL-FSLLRKSQ--------RFPNPVAKFYAAEVCLALEYLH 123
Query: 563 QDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA 622
+I+RDLK NILLD N + KI+DFG A+ T + GT Y++PE
Sbjct: 124 ---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVV 175
Query: 623 NDGTISMKSDVFSLGVLLVEIVSG 646
+ + D +S G+L+ E+++G
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLAG 199
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 64/247 (25%), Positives = 109/247 (44%), Gaps = 70/247 (28%)
Query: 445 TNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMN---------EVV 494
+ +GKG +G V+ TG+ +A K++ F N E++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-------AFQNSTDAQRTFREIM 60
Query: 495 LIGKLQ-HRNLVGLLGSCIEEDER--MLIYEYMP---HKSLDYFIFDRERSKLL-PWKKR 547
++ +L H N+V LL +++R L+++YM H + R+ +L P K+
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVI--------RANILEPVHKQ 112
Query: 548 FSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ- 606
+ ++ + + + YLH S ++HRD+K SNILL+ + K++DFGL+R F
Sbjct: 113 Y-VVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168
Query: 607 -------------------TERVAGTHGYMSPE-------YANDGTISMKSDVFSLGVLL 640
T+ VA T Y +PE Y + D++SLG +L
Sbjct: 169 IPLSINENTENFDDDQPILTDYVA-TRWYRAPEILLGSTKY------TKGIDMWSLGCIL 221
Query: 641 VEIVSGK 647
EI+ GK
Sbjct: 222 GEILCGK 228
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 9e-14
Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 30/217 (13%)
Query: 446 NHFSEANMIGKGGFGPVYMGKL----STGQEIAAKRLSKNS----GQGLEEFMNEVVLIG 497
F ++GKGG+G V+ + +TG+ A K L K + E ++
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 498 KLQHRNLVGLLGSCIEEDERM-LIYEYMP------HKSLDYFIFDRERSKLLPWKKRFSI 550
+++H +V L+ + ++ LI EY+ + IF + + F
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREG-IFMEDTA-------CF-Y 126
Query: 551 ITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERV 610
+ I+ L +LH + +I+RDLK NI+L+ + K++DFGL + D T
Sbjct: 127 LAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--F 181
Query: 611 AGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
GT YM+PE + D +SLG L+ ++++G
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 2e-13
Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 446 NHFSEANMIGKGGFGPVYMGKLS----TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKL 499
+ F ++G+G FG V++ K Q A K L K + + E ++ ++
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 500 QHRNLVGLLGSCIEEDERM-LIYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSIITG 553
H +V L + + ++ LI +++ L + F E +F +
Sbjct: 84 NHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-------KF-YLAE 134
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGT 613
+A L +LH L +I+RDLK NILLD + K++DFGL++ +++A + GT
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 614 HGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
YM+PE N + +D +S GVL+ E+++G
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 4e-13
Identities = 25/125 (20%), Positives = 51/125 (40%), Gaps = 18/125 (14%)
Query: 26 DSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITD 85
+ L++G+ + G++L + N + Y S T VW +N
Sbjct: 2 NLLTNGEGLYAGQSLDVE--PYHFIMQEDCNL------VLYDHS--TSVWASNTGILGKK 51
Query: 86 KNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMW 145
++G+ ++ + E ++W+S+S R N V L + GN+V+ + +W
Sbjct: 52 -GCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS-------DIW 103
Query: 146 QSFDY 150
+ Y
Sbjct: 104 STGTY 108
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 21/199 (10%), Positives = 54/199 (27%), Gaps = 43/199 (21%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSG---QGLEEFMNEVVLIGKLQHRNLVGLLG 509
G + + +++A + L+E ++ + + ++ + +L
Sbjct: 39 HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL- 97
Query: 510 SCIEEDERMLI-YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQ 568
+ L+ E++ SL + + P + +A H+
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQ----EVADTSPSP-VGAIRAMQSLAAAADAAHRA---G 149
Query: 569 VIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTIS 628
V S + +S G V M +
Sbjct: 150 VALSIDHPSRVR--------VSIDGDV--------------VLAYPATMPDA-------N 180
Query: 629 MKSDVFSLGVLLVEIVSGK 647
+ D+ +G L ++ +
Sbjct: 181 PQDDIRGIGASLYALLVNR 199
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 8e-12
Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 30/219 (13%)
Query: 446 NHFSEANMIGKGGFGPVYMGKLS----TGQEIAAKRLSKNS----GQGLEEFMNE-VVLI 496
+F ++G G +G V++ + TG+ A K L K + + E E VL
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 497 GKLQHRNLVGLLGSCIEEDERM-LIYEYMPHKSLDYFI-----FDRERSKLLPWKKRFSI 550
Q LV L + + ++ LI +Y+ L + F +
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-------QI-Y 164
Query: 551 ITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERV 610
+ I L +LH KL +I+RD+K NILLD N + ++DFGL++ DE +
Sbjct: 165 VGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDF 220
Query: 611 AGTHGYMSPE--YANDGTISMKSDVFSLGVLLVEIVSGK 647
GT YM+P+ D D +SLGVL+ E+++G
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 2e-11
Identities = 28/122 (22%), Positives = 48/122 (39%), Gaps = 18/122 (14%)
Query: 26 DSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITD 85
+SLSS + G +L S+ L N + Y S VW +N
Sbjct: 2 NSLSSPNSLFTGHSLEVG-PSYRLIMQGDCNF------VLYDS--GKPVWASNTGG--LG 50
Query: 86 KNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMW 145
LT NNG+L++ +Q IW + ++ ++ V L N+V+ + +W
Sbjct: 51 SGCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGPV-------VW 103
Query: 146 QS 147
+
Sbjct: 104 AT 105
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 1e-10
Identities = 28/123 (22%), Positives = 53/123 (43%), Gaps = 17/123 (13%)
Query: 25 ADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPIT 84
+D L+SG + G +L + + N L ++ + W + N
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYDNNRAV---WASGTNGK-- 48
Query: 85 DKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYM 144
VL N+G+L++ + + AIW+SN++R N L N+V+ DN + + +
Sbjct: 49 ASGCVLKMQNDGNLVIYSGSR-AIWASNTNRQNGNYYLILQRDRNVVIYDNSNNA----I 103
Query: 145 WQS 147
W +
Sbjct: 104 WAT 106
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 48/237 (20%), Positives = 89/237 (37%), Gaps = 48/237 (20%)
Query: 446 NHFSEANMIGKGGFGPVYMGKLSTGQEI------AAKRLSKNSGQGLEEF-----MNEVV 494
+ IG+GGFG +Y+ +++ + + K ++G E +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 495 LIGKLQHRNLVGLLG----------SCIEEDERMLIYEYMPHKSL-DYFIFDRERSKLLP 543
I K + LG + R +I + L + +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-------- 145
Query: 544 WKKRFSIIT--GIARGLL----YLHQDSKLQVIHRDLKASNILLDINLNPKI--SDFGLA 595
KRFS T ++ +L Y+H+ +H D+KASN+LL+ ++ D+GLA
Sbjct: 146 -AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
Query: 596 RIF---GGDDEEAQTERVA--GTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
+ G A + GT + S + N S + D+ LG +++ ++G
Sbjct: 202 YRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 2e-10
Identities = 19/122 (15%), Positives = 44/122 (36%), Gaps = 19/122 (15%)
Query: 26 DSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITD 85
+ L SG+ + +L + ++ L + N + Y++ +W +N +
Sbjct: 3 NVLLSGQTLHADHSLQAG--AYTLTIQNKCNL------VKYQNG--RQIWASNTDRR--G 50
Query: 86 KNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMW 145
LT ++G+L++ + + +W S L G V+ + +W
Sbjct: 51 SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPV-------LW 103
Query: 146 QS 147
Sbjct: 104 SL 105
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 3e-10
Identities = 24/122 (19%), Positives = 46/122 (37%), Gaps = 19/122 (15%)
Query: 26 DSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITD 85
+ L SG+ ++ GE L + + N + Y +W N D
Sbjct: 2 NILYSGETLSPGEFLNN--GRYVFIMQEDCNL------VLYDVD--KPIWATNTGGL--D 49
Query: 86 KNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMW 145
+ L+ ++G+L++ + + IW+SN+ N V L N+V+ W
Sbjct: 50 RRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTA-------RW 102
Query: 146 QS 147
+
Sbjct: 103 AT 104
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 6e-10
Identities = 18/110 (16%), Positives = 42/110 (38%), Gaps = 10/110 (9%)
Query: 23 FAADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHP 82
+ L S + + D L + + + L N + K S +VW + +
Sbjct: 4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCNL------VLTKGSKTNIVWESGTSG- 54
Query: 83 ITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVL 132
++ + ++G L + + + ++ SN+ + V L +G V+
Sbjct: 55 -RGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVV 103
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 3e-04
Identities = 13/71 (18%), Positives = 31/71 (43%), Gaps = 5/71 (7%)
Query: 78 NRNHPITDKNGVLTFSNNGSLLL-LNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNI 136
N + ++ L ++ +L+L + + +W S +S ++ L SG L + D+
Sbjct: 16 YDNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDR 75
Query: 137 SRSSEEYMWQS 147
+ ++ S
Sbjct: 76 LNT----VFVS 82
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 7e-10
Identities = 31/199 (15%), Positives = 56/199 (28%), Gaps = 46/199 (23%)
Query: 444 ATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRL--------SKNSGQGLEEFMNEVVL 495
T IG+G FG V+ +A K + + + + EE + E+++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 496 IGKLQ---------HRNLVGLLGSCI-------------------EEDERMLIYEYMPHK 527
+L +GL + + +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 528 SLDYFIF-------DRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNIL 580
F ++ R+KL SI+ + L L+ HRDL N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 581 LDINLNPKISDFGLARIFG 599
L K+ +
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 49/234 (20%), Positives = 88/234 (37%), Gaps = 45/234 (19%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAA---KRLSKNSGQGLEEF-----MNEVVLI 496
N + IG GGFG +Y+ + ++ A K + +G E + + I
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 497 GKLQHRNLVGLLG----------SCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKK 546
K R + LG R ++ E + L K+
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ---------KISGQNG 146
Query: 547 RFSIITG--IARGLL----YLHQDSKLQVIHRDLKASNILLDINLNPKI--SDFGLARIF 598
F T + +L Y+H++ +H D+KA+N+LL ++ +D+GL+ +
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
Query: 599 ---GGDDEEAQTERVA--GTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
G + + R GT + S + +S +SDV LG ++ + GK
Sbjct: 204 CPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 41/235 (17%), Positives = 83/235 (35%), Gaps = 44/235 (18%)
Query: 446 NHFSEANMIGKGGFGPVYMGK---------LSTGQEIAAKRLSKNSGQGLEEFM------ 490
+ + + G +Y Q+ + K +K+ E+
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 491 -NEVVLIGKLQHRNLVG---LLGSCIEEDE-RMLIYEYMPHKSLDYFIFDRERSKLLPWK 545
+V KL L+ +G + +D+ R L+ + +SL D K
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSP------K 153
Query: 546 KRFSIITG--IARGLL----YLHQDSKLQVIHRDLKASNILLDINLNPKI--SDFGLARI 597
S + +A LL +LH++ +H ++ A NI +D ++ + +G A
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
Query: 598 FGGDDE-----EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
+ + E G ++S + S +SD+ SLG +++ + G
Sbjct: 211 YCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 47/225 (20%), Positives = 90/225 (40%), Gaps = 48/225 (21%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ----------- 500
+G G F V++ K + +A K + + E +E+ L+ ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 501 HRNLVGLLGS-----------CIEEDERMLIYEYMPHKSLDYFIFDRERSKL-LPWKKRF 548
+++ LL + ++E + ++L I E + L + K+
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVM-------VFEVL-GENLLALIKKYEHRGIPLIYVKQI 136
Query: 549 SIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNP------KISDFGLARIFGGDD 602
S + GL Y+H + +IH D+K N+L++I +P KI+D G A
Sbjct: 137 SK--QLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC----WY 188
Query: 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
+E T + Y SPE +D++S L+ E+++G
Sbjct: 189 DEHYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-08
Identities = 24/112 (21%), Positives = 43/112 (38%), Gaps = 13/112 (11%)
Query: 21 FSFAADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRN 80
F + L SG+ + L + ++ +L N + Y W +N +
Sbjct: 2 IPFTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCNL------VLYG---GKYGWQSNTH 50
Query: 81 HPITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVL 132
++ L ++ G L++ + + IWSS SS V L D G V+
Sbjct: 51 G--NGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI 100
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 5e-05
Identities = 16/70 (22%), Positives = 30/70 (42%), Gaps = 6/70 (8%)
Query: 78 NRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNIS 137
+ +T KN L + +L+L W SN+ E+ L G L+++D+
Sbjct: 16 YGDGRLTAKNHQLVMQGDCNLVL--YGGKYGWQSNTHGNGEHCFLRLNHKGELIIKDDDF 73
Query: 138 RSSEEYMWQS 147
++ +W S
Sbjct: 74 KT----IWSS 79
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-08
Identities = 24/136 (17%), Positives = 47/136 (34%), Gaps = 27/136 (19%)
Query: 23 FAADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHP 82
+ L SG+ + L + F+L N + Y + ++ R+
Sbjct: 1 LGTNYLLSGQTLDTEGHLKNG--DFDLVMQDDCNL------VLYNGNWQSNTANNGRDC- 51
Query: 83 ITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEE 142
LT ++ G L++ N + S +W S + N A + G LV+
Sbjct: 52 ------KLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGP------- 98
Query: 143 YMWQSFDYPSDTLLPG 158
+++ D + G
Sbjct: 99 SVFK-----IDPWVRG 109
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 40/172 (23%), Positives = 61/172 (35%), Gaps = 39/172 (22%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNL 504
+F IG G FG + +GK L T + +A K S ++ L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-------YKQL 61
Query: 505 VGLLG------SCIEEDERMLIYEYMPHKSL-DYFIFDRERSKLLPWKKRFSIITG--IA 555
G ++ E + SL D F + FS+ T IA
Sbjct: 62 GSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC---------DRTFSLKTVLMIA 111
Query: 556 RGLL----YLHQDSKLQVIHRDLKASNILLDINLNPK-----ISDFGLARIF 598
L+ Y+H + +I+RD+K N L+ N I DF LA+ +
Sbjct: 112 IQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 35/172 (20%), Positives = 65/172 (37%), Gaps = 39/172 (22%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNL 504
H+ IG+G FG ++ G L Q++A K + S ++ L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT-------YKLL 62
Query: 505 VGLLGSC------IEEDERMLIYEYMPHKSL-DYFIFDRERSKLLPWKKRFSIITG--IA 555
G G E +L+ + + SL D ++FS+ T A
Sbjct: 63 AGCTGIPNVYYFGQEGLHNVLVIDLLG-PSLEDLLDL---------CGRKFSVKTVAMAA 112
Query: 556 RGLL----YLHQDSKLQVIHRDLKASNILLDINLNPK-----ISDFGLARIF 598
+ +L +H+ S +++RD+K N L+ + + DFG+ + +
Sbjct: 113 KQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 43/167 (25%), Positives = 71/167 (42%), Gaps = 31/167 (18%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNL 504
N + IG G FG +Y+G ++ G+E+A K + E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQ--GG 64
Query: 505 VG---LLGSCIEEDERMLIYEYMPHKSL-DYFIFDRERSKLLPWKKRFSIITG--IARGL 558
VG + E D +++ E + SL D F F ++FS+ T +A +
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC---------SRKFSLKTVLLLADQM 114
Query: 559 L----YLHQDSKLQVIHRDLKASNILLDINLNPK---ISDFGLARIF 598
+ Y+H + IHRD+K N L+ + I DFGLA+ +
Sbjct: 115 ISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 4e-07
Identities = 46/259 (17%), Positives = 77/259 (29%), Gaps = 69/259 (26%)
Query: 67 KSSPRTVVWVAN---RNHPITDK--NGV--LTFSNNGS--LLLLNQEK-----SAIWSSN 112
K+ WVA ++ + K + L N S +L +K W+S
Sbjct: 163 KT------WVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR 216
Query: 113 SSRT---------LENPVAHLLDSGN-----LVLRDNISRSSEEYMWQSFDYPSDTLL-- 156
S + ++ + LL S LVL N+ + W +F+ LL
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL-LNVQNAK---AWNAFNLSCKILLTT 272
Query: 157 --PGMKLGWNLKTGFERYLTPWRSADDPTPGE----FSLRLDISA--LPELV------II 202
+ + T L TP E LD LP V +
Sbjct: 273 RFKQVTDFLSAATTTHISLDHHSMT--LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRL 330
Query: 203 SGSRKEARSGP--WNGQQFGGIPRVKNSI--FIPKLEHTED-ELYFTFRPFNDKV-ITRL 256
S + R G W+ + ++ I + LE E +++ F I
Sbjct: 331 SIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIP-- 388
Query: 257 LVNESGTLQRLVWNETSTE 275
+ L + W +
Sbjct: 389 ----TILLSLI-WFDVIKS 402
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 40/158 (25%), Positives = 69/158 (43%), Gaps = 29/158 (18%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLV-GLLGS 510
IG G FG +Y+G + T +E+A K + + L E + LQ + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLL---YESKIYRILQGGTGIPNVRWF 71
Query: 511 CIEEDERMLIYEYMPHKSL-DYFIFDRERSKLLPWKKRFSIITG--IARGLL----YLHQ 563
+E D +L+ + + SL D F F ++ S+ T +A ++ ++H
Sbjct: 72 GVEGDYNVLVMDLLG-PSLEDLFNFC---------SRKLSLKTVLMLADQMINRVEFVHS 121
Query: 564 DSKLQVIHRDLKASNILLDINLNPK---ISDFGLARIF 598
S +HRD+K N L+ + I DFGLA+ +
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 37/178 (20%), Positives = 59/178 (33%), Gaps = 58/178 (32%)
Query: 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASN 578
+++E + L +I + + LP II + +GL YLH +K ++IH D+K N
Sbjct: 122 MVFEVL-GHHLLKWI-IKSNYQGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPEN 177
Query: 579 ILLDIN-------------------------------------------------LNPKI 589
ILL +N L KI
Sbjct: 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKI 237
Query: 590 SDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
+D G A E T Y S E + +D++S + E+ +G
Sbjct: 238 ADLGNACWVHKHFTEDIQ-----TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-06
Identities = 14/109 (12%), Positives = 34/109 (31%), Gaps = 17/109 (15%)
Query: 39 TLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSL 98
++ + + N + Y ++ +W N +G L
Sbjct: 24 EILFGTHVYRFIMQTDCNL------VLYDNN--NPIWATNTGGL--GNGCRAVLQPDGVL 73
Query: 99 LLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQS 147
+++ E +W S + + V L N+V+ + +W +
Sbjct: 74 VVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGDA-------LWAT 115
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 52/226 (23%), Positives = 85/226 (37%), Gaps = 46/226 (20%)
Query: 445 TNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHR- 502
+ + ++IGKG FG V + +A K + KN L + EV L+ +
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK-IIKNKKAFLNQAQIEVRLLELMNKHD 111
Query: 503 -----NLVGLLGS-------CI-EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFS 549
+V L C+ E +Y+ + + + + R
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRK---------- 161
Query: 550 IITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNP--KISDFGLARIFGGDDEEAQT 607
+ LL+L +L +IH DLK NILL KI DFG + +
Sbjct: 162 FAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC----QLGQRIY 216
Query: 608 ERVAGTHGYMSPE------YANDGTISMKSDVFSLGVLLVEIVSGK 647
+ + Y SPE Y + D++SLG +LVE+ +G+
Sbjct: 217 QYIQSRF-YRSPEVLLGMPY------DLAIDMWSLGCILVEMHTGE 255
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 47.4 bits (111), Expect = 8e-06
Identities = 37/165 (22%), Positives = 57/165 (34%), Gaps = 23/165 (13%)
Query: 22 SFAADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNH 81
L + + ++ G+ L+S Q F+L GN L I + VWVAN
Sbjct: 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGN-----LVIQDNGAT---VWVANEQQ 62
Query: 82 PIT------DKNGVLTFSNNGSLLLLNQEKSAIWSS-----NSSRTLENPVAHLLDSGNL 130
P + +K L F L + + +W + S+ L D GN+
Sbjct: 63 PFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNI 122
Query: 131 VLRD--NISRSSEEYMWQSFDYPSDTLLPGMKL--GWNLKTGFER 171
VL D + + S L PG +L G G +
Sbjct: 123 VLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASK 167
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 51/212 (24%), Positives = 84/212 (39%), Gaps = 36/212 (16%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHR------NLV 505
+IGKG FG V Q +A K + +N + + E+ ++ L+ + N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 506 GLLGS-------CI-EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARG 557
+L + C+ E M +YE + F R I +
Sbjct: 163 HMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRK----------FAHSILQC 212
Query: 558 LLYLHQDSKLQVIHRDLKASNILLDINLNP--KISDFGLARIFGGDDEEAQTERVAGTHG 615
L LH K ++IH DLK NILL K+ DFG + + + +
Sbjct: 213 LDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVYTYIQSRF- 264
Query: 616 YMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
Y +PE M D++SLG +L E+++G
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 2e-04
Identities = 20/96 (20%), Positives = 36/96 (37%), Gaps = 5/96 (5%)
Query: 45 QSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQE 104
QS +L + T+ L ++ + VW N NG + +L +
Sbjct: 145 QSLQLSPYRLSMETDCNLVLFDRDDR---VWSTNTAGK--GTGCRAVLQPNGRMDVLTNQ 199
Query: 105 KSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSS 140
A+W+S +SR+ V L NL + ++
Sbjct: 200 NIAVWTSGNSRSAGRYVFVLQPDRNLAIYGGALWTT 235
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 3e-04
Identities = 26/192 (13%), Positives = 54/192 (28%), Gaps = 20/192 (10%)
Query: 24 AADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPI 83
+ S + + ++L S SF S N L ++ W +N
Sbjct: 7 LSHEGSHPQTLHAAQSLELS--SFRFTMQSDCN-----LVLFDSDVRV---WASNTAGA- 55
Query: 84 TDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEY 143
++G L++L + + WSS + ++ N V L + + S
Sbjct: 56 --TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTS 113
Query: 144 MWQSFDYPSDTLLPGMKLGWNLKTGFERYLTPWRSADDPTPGEFSLRLDISALPELVIIS 203
S ++ N + T + L ++ LV+
Sbjct: 114 NKGSVVVANNGNSILYSTQGNDNHPQTLHATQS-----LQLSPYRLSMETD--CNLVLFD 166
Query: 204 GSRKEARSGPWN 215
+ +
Sbjct: 167 RDDRVWSTNTAG 178
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 765 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.85 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.85 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.83 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.82 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.79 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.76 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.75 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.71 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.66 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.66 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.61 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.6 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.59 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.4 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.35 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.3 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.24 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.21 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.2 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.02 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.91 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.83 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.8 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.5 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.34 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.3 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.28 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.17 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.16 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.93 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.91 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.67 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.64 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.5 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.34 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.32 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.23 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.2 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.1 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.02 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.95 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.79 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.62 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.53 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.46 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.7 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.38 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 90.87 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 80.81 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=435.43 Aligned_cols=258 Identities=29% Similarity=0.412 Sum_probs=215.0
Q ss_pred cCcccccccccCCceeEEEEEeC------CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS------TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++++|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56888999999999999999863 467899999988777778899999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccc----------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCee
Q 004264 520 IYEYMPHKSLDYFIFDRE----------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKI 589 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL 589 (765)
||||+++|+|.+++.... ....+++..++.|+.||++||+|||+++ ||||||||+||||++++++||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999996532 2356999999999999999999999998 999999999999999999999
Q ss_pred cccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHh
Q 004264 590 SDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLL 668 (765)
Q Consensus 590 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 668 (765)
+|||+|+...............||+.|+|||++.+..|+.++|||||||+||||+| |+.||......+ ....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~~~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIEC 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH
Confidence 99999987644333333445679999999999999999999999999999999999 899987543221 1122
Q ss_pred hccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 669 WNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 669 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
...+.....+ .....++.+|+.+||+.||++|||+++|++.|++.
T Consensus 243 i~~~~~~~~p---------~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 243 ITQGRVLQRP---------RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCCCCC---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2233322221 22345688999999999999999999999999863
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=437.22 Aligned_cols=258 Identities=27% Similarity=0.371 Sum_probs=207.7
Q ss_pred cCcccccccccCCceeEEEEEeC------CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS------TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+.+|++++|||||+++++|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56788899999999999999864 477899999988777778899999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccc------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCC
Q 004264 520 IYEYMPHKSLDYFIFDRE------------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNP 587 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~v 587 (765)
||||+++|+|.+++.... ...++++..++.|+.||++||+|||+.+ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999986532 2246899999999999999999999998 9999999999999999999
Q ss_pred eecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 004264 588 KISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAW 666 (765)
Q Consensus 588 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~ 666 (765)
||+|||+++...............||+.|+|||++.+..|+.++|||||||+||||+| |+.||......+ ..
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~ 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-------AI 270 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-------HH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-------HH
Confidence 9999999997754444444446789999999999999999999999999999999999 899986543221 11
Q ss_pred HhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 667 LLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 667 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
.....+.....+ .....++.+|+.+||+.||++||||+||+++|+..
T Consensus 271 ~~i~~g~~~~~p---------~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 271 DCITQGRELERP---------RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp HHHHHTCCCCCC---------TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHcCCCCCCc---------ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 222223222211 22345678999999999999999999999999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=427.34 Aligned_cols=263 Identities=27% Similarity=0.410 Sum_probs=204.9
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
+++++.++||+|+||+||+|+++ ..||||+++.. .....++|.+|+.++++++|||||++++++.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 56788899999999999999875 36999998643 45567889999999999999999999998865 568999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++|+|.+++... ...+++..++.|+.||++||+|||+++ ||||||||+||||++++++||+|||+|+.......
T Consensus 113 ~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999998543 346999999999999999999999998 99999999999999999999999999987654444
Q ss_pred ccccccccccccccCcccccC---CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYAND---GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~---~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
........||+.|||||++.+ .+|+.++|||||||+||||+||+.||....... ........+.....+.
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~~~p~~~- 260 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGYASPDLS- 260 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTCCCCCST-
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCCCCcc-
Confidence 444456789999999999864 469999999999999999999999996433221 1111111221111111
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCCCCC
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGVTLP 727 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~ 727 (765)
..+......+.+|+.+||+.||++||||.||+++|+....++|
T Consensus 261 ----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 261 ----KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp ----TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred ----cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 1112234567899999999999999999999999987554443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=429.44 Aligned_cols=258 Identities=28% Similarity=0.369 Sum_probs=212.6
Q ss_pred cCcccccccccCCceeEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS------TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~ 518 (765)
.++++.++||+|+||+||+|++. +++.||||++... .....++|.+|+.++++++|||||+++++|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34566789999999999999862 4678999999754 3345678999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhccc-------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC
Q 004264 519 LIYEYMPHKSLDYFIFDRE-------------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL 585 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 585 (765)
|||||+++|+|.+++.... ....+++..++.|+.|||+||+|||+.+ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 9999999999999996432 1246899999999999999999999998 99999999999999999
Q ss_pred CCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHH
Q 004264 586 NPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGH 664 (765)
Q Consensus 586 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~ 664 (765)
++||+|||+++...............||+.|+|||++.++.|+.++|||||||+||||+| |+.||......+
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~------- 255 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------- 255 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH-------
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence 999999999987654443344456789999999999999999999999999999999998 899986543221
Q ss_pred HHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 665 AWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 665 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
.......+.....+ ......+.+|+.+||+.||++||||+||+++|+..
T Consensus 256 ~~~~i~~~~~~~~p---------~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 256 VVEMIRNRQVLPCP---------DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHcCCCCCCc---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 12222233322222 22345678999999999999999999999999763
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=425.00 Aligned_cols=250 Identities=23% Similarity=0.336 Sum_probs=202.6
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
++|++.++||+|+||+||+|+. .+++.||||++.+. .....+.+.+|+.+|++|+|||||++++++.+.+..+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999986 46899999999754 34456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++|+|.+++... ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+.+..
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~-- 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-- 177 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH--
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC--
Confidence 99999999998543 2345789999999999999999999999 99999999999999999999999999987632
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
........+||+.|+|||++.+..|+.++|||||||+||||++|+.||......+ +. . ....+....
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~---~-~i~~~~~~~------ 244 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN---LV---L-KIISGSFPP------ 244 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH---H-HHHHTCCCC------
T ss_pred CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HH---H-HHHcCCCCC------
Confidence 1122335789999999999999999999999999999999999999996543221 11 1 111122111
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.+.....++.+|+.+||+.||++|||++|+++
T Consensus 245 ---~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 ---VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122356789999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=423.16 Aligned_cols=249 Identities=23% Similarity=0.329 Sum_probs=208.2
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
+.|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+|||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999864 68999999997665555677899999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++|+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 224 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 224 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence 99999998853 35899999999999999999999999 9999999999999999999999999999874332
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||....+.+ .. .....+... .+
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~----~~i~~~~~~-----~~-- 290 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AM----KMIRDNLPP-----RL-- 290 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH----HHHHHSSCC-----CC--
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HH----HHHHcCCCC-----CC--
Confidence 23345789999999999999999999999999999999999999996543221 11 111111110 11
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
........++.+|+.+||+.||++|||++|+++
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011122356788999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=418.83 Aligned_cols=248 Identities=22% Similarity=0.314 Sum_probs=209.7
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||+||+|+. .+++.||+|++.+. .....+.+.+|+++|++|+|||||++++++.+.+..+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999986 46899999999754 2344678999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++|+|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999953 346999999999999999999999999 999999999999999999999999999988655
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
.........+||+.|+|||++.+..|+.++||||+||+||||++|+.||......+ +.. ....+.. .+
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~----~i~~~~~-~~---- 253 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---IFA----KIIKLEY-DF---- 253 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHTCC-CC----
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHcCCC-CC----
Confidence 55555557899999999999999999999999999999999999999996533211 111 1111111 11
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVV 716 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 716 (765)
+.....++.+|+.+||+.||++|||++|++
T Consensus 254 -----p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 -----PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -----CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -----CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 111234577899999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=420.68 Aligned_cols=251 Identities=22% Similarity=0.251 Sum_probs=204.7
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
+.|++.++||+|+||.||+|++. +|+.||||+++.... ..+|+.++++++|||||++++++.+++..+|||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 56888899999999999999964 689999999975422 247999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC-CCeecccccceeeCCCCc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL-NPKISDFGLARIFGGDDE 603 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~vkL~DFGla~~~~~~~~ 603 (765)
++|+|.+++.. .+.+++..+..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+|+.+.....
T Consensus 133 ~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999953 346999999999999999999999999 99999999999999887 699999999998754322
Q ss_pred cc---ccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 604 EA---QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 604 ~~---~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
.. .....+||+.|||||++.+..|+.++|||||||+||||++|+.||...........+. .....
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------~~~~~------ 274 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA------SEPPP------ 274 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH------HSCCG------
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH------cCCCC------
Confidence 11 2234689999999999999999999999999999999999999997655443321111 11100
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
....+......+.+++.+||+.||++|||+.||++.|..
T Consensus 275 --~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 275 --IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp --GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 001122234567889999999999999999999988865
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=421.99 Aligned_cols=262 Identities=27% Similarity=0.377 Sum_probs=214.5
Q ss_pred HHHhcCcccccccccCCceeEEEEEeCC------CcEEEEEEccccC-hhhHHHHHHHHHHHhcccc-CceEeeeeeeee
Q 004264 442 TTATNHFSEANMIGKGGFGPVYMGKLST------GQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQH-RNLVGLLGSCIE 513 (765)
Q Consensus 442 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h-~niv~~~~~~~~ 513 (765)
....++|++.++||+|+||+||+|++.. ++.||||++.... ....+.|.+|+.+|.++.| ||||+++++|.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 3345789999999999999999998532 3679999997653 3456789999999999965 999999999976
Q ss_pred c-CceEEEEEecCCCChhHHhhcccc-------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcE
Q 004264 514 E-DERMLIYEYMPHKSLDYFIFDRER-------------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNI 579 (765)
Q Consensus 514 ~-~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NI 579 (765)
. +..+||||||++|+|.+++..... ...+++..++.++.|||+||+|||+++ ||||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccce
Confidence 5 568999999999999999965322 345899999999999999999999999 99999999999
Q ss_pred EEecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCc
Q 004264 580 LLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHR 658 (765)
Q Consensus 580 ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~ 658 (765)
|+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||.......
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~- 295 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE- 295 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence 999999999999999998765544445556789999999999999999999999999999999998 899986543321
Q ss_pred ccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 659 HNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.......++.....++ ....++.+++.+||+.||++|||+++|+++|++
T Consensus 296 -----~~~~~i~~g~~~~~p~---------~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 296 -----EFCRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp -----HHHHHHHHTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----HHHHHHHcCCCCCCCc---------cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 1122222333222222 223467899999999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=424.30 Aligned_cols=249 Identities=23% Similarity=0.333 Sum_probs=208.3
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
+.|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999864 68999999998665556677899999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++|+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+.+....
T Consensus 231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-- 301 (423)
T 4fie_A 231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 301 (423)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--
T ss_pred CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--
Confidence 99999998843 34899999999999999999999999 9999999999999999999999999999874332
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||....+.+. . .....+.... +.
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~----~~i~~~~~~~-----~~- 368 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---M----KMIRDNLPPR-----LK- 368 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H----HHHHHSCCCC-----CS-
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---H----HHHHcCCCCC-----Cc-
Confidence 233457899999999999999999999999999999999999999965332211 1 1111111111 10
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
........+.+|+.+||+.||++|||+.|+++
T Consensus 369 -~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 369 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp -CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11112346788999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=405.03 Aligned_cols=246 Identities=24% Similarity=0.337 Sum_probs=197.1
Q ss_pred ccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeee----cCceEEEE
Q 004264 449 SEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE----EDERMLIY 521 (765)
Q Consensus 449 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~----~~~~~lV~ 521 (765)
++.++||+|+||.||+|.+. +++.||+|++.+. .....+.|.+|+.+|++|+|||||++++++.+ ....+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999864 6889999998653 34456789999999999999999999999875 34579999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec-CCCCeecccccceeeCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI-NLNPKISDFGLARIFGG 600 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~vkL~DFGla~~~~~ 600 (765)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ .+||||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999953 346899999999999999999999875 35999999999999984 78999999999986432
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
......+||+.|+|||++.+ .|+.++|||||||+||||++|+.||...... .........+.....+
T Consensus 185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~------~~~~~~i~~~~~~~~~-- 251 (290)
T 3fpq_A 185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASF-- 251 (290)
T ss_dssp ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGG--
T ss_pred ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH------HHHHHHHHcCCCCCCC--
Confidence 22345789999999999875 6999999999999999999999999643221 1111122222111111
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
+.....++.+|+.+||+.||++|||++|+++
T Consensus 252 ------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 ------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112235778999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=405.84 Aligned_cols=266 Identities=22% Similarity=0.281 Sum_probs=201.7
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecC----ceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED----ERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~----~~~lV~ 521 (765)
++|.+.++||+|+||+||+|++ +|+.||||++...... ...+..|+.++.+++|||||++++++.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 5688889999999999999997 5899999999654322 223345666777899999999999998765 579999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcC-----CCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS-----KLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
||+++|+|.+++.. ..+++..+.+++.|+++||+|||++. ..+||||||||+||||+.++++||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999953 34899999999999999999999871 2249999999999999999999999999999
Q ss_pred eeCCCCccc--ccccccccccccCcccccCC------CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcc--------c
Q 004264 597 IFGGDDEEA--QTERVAGTHGYMSPEYANDG------TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRH--------N 660 (765)
Q Consensus 597 ~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~------~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~--------~ 660 (765)
......... ......||+.|+|||++.+. .++.++|||||||+||||+||+.|+......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 875443322 22346799999999999764 4678999999999999999998887543322110 0
Q ss_pred HHHHHHHhhccCCcccccccccc-CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 661 LIGHAWLLWNDGRALGLMDTCLE-DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
............. +++.+. ...+.+....+.+|+.+||+.||++||||.||+++|++
T Consensus 237 ~~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 1111111111111 111111 11233456778899999999999999999999999976
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=400.40 Aligned_cols=245 Identities=23% Similarity=0.346 Sum_probs=190.0
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||+||+|+. .+++.||+|++.+. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999986 46899999999754 2334567999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+ +|+|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6788888843 346999999999999999999999999 999999999999999999999999999875322
Q ss_pred CcccccccccccccccCcccccCCCC-CccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTI-SMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
......+||+.|+|||++.+..| +.++||||+||++|||++|+.||...... .+ ......+.. .+
T Consensus 166 ---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~----~~~i~~~~~-~~--- 231 (275)
T 3hyh_A 166 ---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VL----FKNISNGVY-TL--- 231 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHTCC-CC---
T ss_pred ---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HH----HHHHHcCCC-CC---
Confidence 22335789999999999998876 57999999999999999999999643221 11 111111111 11
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
+.....++.+|+.+||+.||++|||++|+++
T Consensus 232 ------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 ------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ------CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1112345778999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=407.83 Aligned_cols=247 Identities=23% Similarity=0.279 Sum_probs=196.1
Q ss_pred cCcccccccccCCceeEEEEEeC----CCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS----TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
++|++.+.||+|+||+||+|+.. .++.||+|++.+.. .....++.+|+.+|++++|||||++++++.+++..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999852 46789999997542 2234468899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+++|+|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999954 346999999999999999999999999 9999999999999999999999999998653
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
... ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||......+ +.. ....+.. .
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~----~i~~~~~-~--- 244 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TMT----MILKAKL-G--- 244 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCCC-C---
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---HHH----HHHcCCC-C---
Confidence 322 22335789999999999999999999999999999999999999997543221 111 1111111 1
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDM-----SSVVF 717 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 717 (765)
.+.....++.+|+.+||+.||++|||+ +|+++
T Consensus 245 ------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 ------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 111223457899999999999999984 67763
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=393.61 Aligned_cols=251 Identities=25% Similarity=0.366 Sum_probs=189.8
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCc-------
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE------- 516 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~------- 516 (765)
++|++.+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+.+|++|+|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4699999999999999999986 468999999987543 3455789999999999999999999999986553
Q ss_pred -----eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecc
Q 004264 517 -----RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISD 591 (765)
Q Consensus 517 -----~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~D 591 (765)
.++||||+++|+|.+++.........++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 6899999999999999976544445667778999999999999999999 99999999999999999999999
Q ss_pred cccceeeCCCCccc----------ccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccH
Q 004264 592 FGLARIFGGDDEEA----------QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNL 661 (765)
Q Consensus 592 FGla~~~~~~~~~~----------~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~ 661 (765)
||+|+.+....... .....+||+.|+|||++.+..|+.++|||||||+||||++ ||.... ..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HH
Confidence 99999875432211 1234679999999999999999999999999999999996 553110 00
Q ss_pred HHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 662 IGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 662 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
. ............ .........+.+++.+||+.||++|||+.|+++
T Consensus 234 ~-~~~~~~~~~~~p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 V-RTLTDVRNLKFP---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp H-HHHHHHHTTCCC---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H-HHHHHHhcCCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 111111111111 111122334668999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=384.10 Aligned_cols=279 Identities=37% Similarity=0.604 Sum_probs=246.2
Q ss_pred hHHHHhcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 440 TITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
++...+++|++.+.||+|+||.||+|+..+++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 34456789999999999999999999988899999999987766677889999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhcccc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 520 IYEYMPHKSLDYFIFDRER-SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999999865332 235899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
.............||+.|+|||++.+..++.++||||||+++|||++|+.||....+.+......+.......+.....+
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence 54333333345678999999999999999999999999999999999999998877777777776666666677777778
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
++.+...........+.+++.+||+.||++|||+.+|++.|+.
T Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 8777777788889999999999999999999999999999976
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=394.64 Aligned_cols=267 Identities=20% Similarity=0.266 Sum_probs=202.1
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeee------cC
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE------ED 515 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~------~~ 515 (765)
.++|++.+.||+|+||+||+|+. .+|+.||||++.+. .....+.+.+|+.+|++|+|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 36799999999999999999986 47899999999754 33445778899999999999999999998764 36
Q ss_pred ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccc
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA 595 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla 595 (765)
..+|||||++ |+|.+++.. .+.+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 678888843 456999999999999999999999999 999999999999999999999999999
Q ss_pred eeeCCCC--cccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccC
Q 004264 596 RIFGGDD--EEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDG 672 (765)
Q Consensus 596 ~~~~~~~--~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 672 (765)
+.+.... ........+||+.|+|||++.+. .++.++||||+||++|||++|+.||......+....+..........
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 8764322 22233467899999999998875 56999999999999999999999997654332221111110000000
Q ss_pred Ccc--------cccccccc-CccC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 673 RAL--------GLMDTCLE-DSFV-----ESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 673 ~~~--------~l~d~~l~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
... ..+..... ...+ ......+++|+.+||+.||++|||++|+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00000000 0000 0113457789999999999999999999863
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=381.44 Aligned_cols=202 Identities=24% Similarity=0.356 Sum_probs=172.6
Q ss_pred HHHHhcCcccccccccCCceeEEEEEeC----CCcEEEEEEccccChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecC
Q 004264 441 ITTATNHFSEANMIGKGGFGPVYMGKLS----TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEED 515 (765)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~ 515 (765)
+....++|++.++||+|+||+||+|+.+ .++.||+|++.+.. ...++.+|+++|+++ +||||+++++++.+.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 3456688999999999999999999753 46789999986543 345788999999998 6999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC-CCCeeccccc
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN-LNPKISDFGL 594 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~vkL~DFGl 594 (765)
+.++||||+++++|.+++. .+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 9999999999999999882 3899999999999999999999999 9999999999999977 7999999999
Q ss_pred ceeeCCCCc--------------------------ccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCC
Q 004264 595 ARIFGGDDE--------------------------EAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGK 647 (765)
Q Consensus 595 a~~~~~~~~--------------------------~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~ 647 (765)
|+....... .......+||+.|+|||++.+. .|+.++||||+||++|||++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 987543211 1112345799999999999876 5899999999999999999999
Q ss_pred CCCCCC
Q 004264 648 MNRGFR 653 (765)
Q Consensus 648 ~p~~~~ 653 (765)
.||...
T Consensus 245 ~Pf~~~ 250 (361)
T 4f9c_A 245 YPFYKA 250 (361)
T ss_dssp SSSSCC
T ss_pred CCCCCC
Confidence 998543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=378.21 Aligned_cols=290 Identities=38% Similarity=0.651 Sum_probs=245.7
Q ss_pred ccccchHhHHHHhcCcccccccccCCceeEEEEEeCCCcEEEEEEccccCh-hhHHHHHHHHHHHhccccCceEeeeeee
Q 004264 433 VPLYDLATITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSG-QGLEEFMNEVVLIGKLQHRNLVGLLGSC 511 (765)
Q Consensus 433 ~~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~h~niv~~~~~~ 511 (765)
...+++.++....++|++.+.||+|+||.||+|+..+++.||+|++..... .....+.+|+.++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456888999999999999999999999999999988899999999976432 2234689999999999999999999999
Q ss_pred eecCceEEEEEecCCCChhHHhhccc-cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeec
Q 004264 512 IEEDERMLIYEYMPHKSLDYFIFDRE-RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKIS 590 (765)
Q Consensus 512 ~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~ 590 (765)
.+....++||||+++++|.+++.... ....+++..+..++.||+.||+|||+....+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999996543 33458999999999999999999999911129999999999999999999999
Q ss_pred ccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCC--CCCcccHHHHHHHh
Q 004264 591 DFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRH--PGHRHNLIGHAWLL 668 (765)
Q Consensus 591 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~--~~~~~~~~~~~~~~ 668 (765)
|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .........+....
T Consensus 177 Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 99999876433322 2334569999999999999999999999999999999999999996321 22334455555556
Q ss_pred hccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 004264 669 WNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDG 723 (765)
Q Consensus 669 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 723 (765)
........+.+..+...........+.+++.+||+.+|++|||+++|+++|++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 6666777788888888888899999999999999999999999999999998743
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=402.73 Aligned_cols=252 Identities=22% Similarity=0.302 Sum_probs=209.0
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
++|++.+.||+|+||.||+|+.. +|+.||+|++.+......+.+.+|+.+|++|+|||||++++++.+....+|||||+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 68999999999999999999864 68999999998776667788999999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC--CCCeecccccceeeCCCC
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN--LNPKISDFGLARIFGGDD 602 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~--~~vkL~DFGla~~~~~~~ 602 (765)
++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 99999998843 2346899999999999999999999999 9999999999999854 89999999999987432
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||......+. . ........ .+.+..
T Consensus 311 --~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~---~----~~i~~~~~-~~~~~~- 379 (573)
T 3uto_A 311 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---L----RNVKSCDW-NMDDSA- 379 (573)
T ss_dssp --SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---H----HHHHTTCC-CCCSGG-
T ss_pred --CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---H----HHHHhCCC-CCCccc-
Confidence 223356899999999999999999999999999999999999999965433211 1 11111111 011111
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.......+.+|+.+||+.||++|||+.|+++.
T Consensus 380 ----~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 380 ----FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11123457789999999999999999999873
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=398.03 Aligned_cols=249 Identities=27% Similarity=0.309 Sum_probs=200.6
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHH---HHHHHHhccccCceEeeeeeeeecCce
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFM---NEVVLIGKLQHRNLVGLLGSCIEEDER 517 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~---~Ev~~l~~l~h~niv~~~~~~~~~~~~ 517 (765)
-++|++.++||+|+||.||+|+.. +|+.||+|++.+.. ......+. .++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 468999999999999999999864 68999999997531 12223333 446777788999999999999999999
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
||||||++||+|..++.. .+.+++..+..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999954 346999999999999999999999999 99999999999999999999999999998
Q ss_pred eCCCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 598 FGGDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
+... .....+||+.|+|||++.. ..|+.++|||||||+||||++|+.||......+...+..... ...
T Consensus 342 ~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~----~~~--- 410 (689)
T 3v5w_A 342 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----TMA--- 410 (689)
T ss_dssp CSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH----HCC---
T ss_pred cCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc----CCC---
Confidence 6432 2335789999999999975 579999999999999999999999997544433221111110 111
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPD-----MSSVVF 717 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 717 (765)
..++.....++.+|+..||+.||++|++ ++||++
T Consensus 411 -------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 -------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 0111222456789999999999999998 678763
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=362.85 Aligned_cols=235 Identities=19% Similarity=0.214 Sum_probs=180.5
Q ss_pred hhcccccccCCCccccCCCeEEcCCCeEEEEEecCCCCCCeEEEEEEeCCCCcEEEeecCCCCCCCC----CceEEEeeC
Q 004264 20 EFSFAADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDK----NGVLTFSNN 95 (765)
Q Consensus 20 ~~~~~~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~----~~~l~~~~~ 95 (765)
+++++.|+|.+|++|++|++|+|++|.|+||||.++ ++|+ |+ +.+ +||+|||++|+.++ +++|+|+.|
T Consensus 9 ~~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~-~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~ 80 (276)
T 3m7h_A 9 FNGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD-NGA-TVWVANEQQPFSSTIPLRNKKAPLAFY 80 (276)
T ss_dssp CCCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE-TTE-EEEECSTTSTTEEEEECCCTTCCSEEE
T ss_pred eccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC-CCC-eEEECCCCCCcCCcccccceEEEEeCC
Confidence 346678999999999999999999999999999554 6787 77 666 99999999999775 789999999
Q ss_pred CceEE--EcCCCCeEEEeccCCC-----cCccEEEEecCCCeeEeeccCCCcccceeeecCCCCCcccCcCeecceeecc
Q 004264 96 GSLLL--LNQEKSAIWSSNSSRT-----LENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLKTG 168 (765)
Q Consensus 96 g~l~l--~~~~~~~~w~s~~~~~-----~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~~~~ 168 (765)
|+||| .|++|.+||+|++... ..++.|+|+|+|||||++ +.+|||| |||||+|||||||.++++|
T Consensus 81 G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~------~~~lWqS--~ptdtlLpg~~~~~~l~~g 152 (276)
T 3m7h_A 81 VQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD------SLALWNG--TPAIPLVPGAIDSLLLAPG 152 (276)
T ss_dssp ESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE------EEEEEES--CTTSCCCCSCTTCEEECSS
T ss_pred CcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC------CceeeCc--ccccccccccccccccccC
Confidence 99999 7888999999997642 345789999999999996 4689999 9999999999999999987
Q ss_pred cceEEEeccCCCCCCCcceEEeecCCCCceEEEec-CCeeeeeeCCCCCccccCccccccceeeeeeeecCceeEEEEee
Q 004264 169 FERYLTPWRSADDPTPGEFSLRLDISALPELVIIS-GSRKEARSGPWNGQQFGGIPRVKNSIFIPKLEHTEDELYFTFRP 247 (765)
Q Consensus 169 ~~~~l~S~~s~~dps~G~ysl~~~~~g~~~~~~~~-~~~~~~~sg~w~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (765)
.. | ++.+||++|.|+++++++|. ++++. +..+||++|+|++... .-.+........+..++.....+ .
T Consensus 153 ~~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~~--~l~l~~dGnLvl~d~~~~~vWsS--~ 221 (276)
T 3m7h_A 153 SE--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGAV--RAVFQGDGNLVVYGAGNAVLWHS--H 221 (276)
T ss_dssp EE--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTCC--EEEECTTSCEEEECTTSCEEEEC--S
T ss_pred cc--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCccE--EEEEcCCCeEEEEeCCCcEEEEe--c
Confidence 55 5 67899999999999999995 44454 4689999999975321 00111111111111112222222 2
Q ss_pred cCCceeEEEEEccCCcEEEEEEecCCCceEEEEecCC
Q 004264 248 FNDKVITRLLVNESGTLQRLVWNETSTEWRMLYSWPF 284 (765)
Q Consensus 248 ~~~~~~~rl~l~~~G~l~~~~w~~~~~~W~~~~~~p~ 284 (765)
......+|++|+.||++++|.| ...|..++..|.
T Consensus 222 t~~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 222 TGGHASAVLRLQANGSIAILDE---KPVWARFGFQPT 255 (276)
T ss_dssp CTTCTTCEEEECTTSCEEEEEE---EEEEESSSCCTT
T ss_pred CCCCCCEEEEEcCCccEEEEcC---CCeEEccCccCC
Confidence 2223358999999999999998 345766665554
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=352.81 Aligned_cols=284 Identities=33% Similarity=0.494 Sum_probs=232.8
Q ss_pred cccccchHhHHHHhcCcccc------cccccCCceeEEEEEeCCCcEEEEEEcccc----ChhhHHHHHHHHHHHhcccc
Q 004264 432 EVPLYDLATITTATNHFSEA------NMIGKGGFGPVYMGKLSTGQEIAAKRLSKN----SGQGLEEFMNEVVLIGKLQH 501 (765)
Q Consensus 432 ~~~~~~~~~~~~~~~~y~~~------~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~----~~~~~~~~~~Ev~~l~~l~h 501 (765)
..+.|++.++..++++|... +.||+|+||.||+|.. +++.+|+|++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45678889999999998887 8899999999999987 6889999998653 23446789999999999999
Q ss_pred CceEeeeeeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE
Q 004264 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL 581 (765)
Q Consensus 502 ~niv~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll 581 (765)
|||+++++++.+.+..++||||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999876555567999999999999999999999999 9999999999999
Q ss_pred ecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccH
Q 004264 582 DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNL 661 (765)
Q Consensus 582 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~ 661 (765)
+.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 9999999999999987654433333445679999999998865 589999999999999999999999976554332222
Q ss_pred HHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 662 IGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 662 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
+.... ......+...++..+ ..........+.+++.+||+.+|++|||+.+|+++|++.
T Consensus 246 ~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 246 IKEEI-EDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHH-HTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHh-hhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 21111 111122233333333 234566778899999999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=365.25 Aligned_cols=262 Identities=26% Similarity=0.432 Sum_probs=204.5
Q ss_pred HhcCcccccccccCCceeEEEEEeCCCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
..++|++.+.||+|+||.||+|+. .++.||+|++.... ....+++.+|+.++++++||||+++++++.+....++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 356899999999999999999987 68889999987543 444578999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++........+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 99999999999965443445899999999999999999999875 34999999999999999999999999999865322
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....+.. ... ..........
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~---~~~~~~~~~~----- 259 (309)
T 3p86_A 193 F--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VVA---AVGFKCKRLE----- 259 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHH---HHHHSCCCCC-----
T ss_pred c--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHhcCCCCC-----
Confidence 1 12234678999999999999999999999999999999999999986443221 111 1110111111
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCC
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGV 724 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 724 (765)
.+......+.+++.+||+.+|++|||+.+|+++|+....
T Consensus 260 ----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 260 ----IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred ----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111223457899999999999999999999999987443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=358.87 Aligned_cols=258 Identities=27% Similarity=0.414 Sum_probs=211.9
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
.++|.+.+.||+|+||.||++... +++.+|+|++........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 367999999999999999999874 6889999999877777788999999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999998542 345899999999999999999999999 99999999999999999999999999987643322
Q ss_pred cc------------ccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCccc--HHHHHHHhh
Q 004264 604 EA------------QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHN--LIGHAWLLW 669 (765)
Q Consensus 604 ~~------------~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~--~~~~~~~~~ 669 (765)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|..|+....+..... ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~--- 240 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL--- 240 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH---
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc---
Confidence 11 1114679999999999999999999999999999999999999886544322111 011000
Q ss_pred ccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 004264 670 NDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDG 723 (765)
Q Consensus 670 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 723 (765)
+.. .+......+.+++.+||+.||++|||+.+|++.|+...
T Consensus 241 ---------~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 241 ---------DRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp ---------HHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------ccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000 01111234778999999999999999999999998744
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=367.08 Aligned_cols=258 Identities=28% Similarity=0.414 Sum_probs=212.1
Q ss_pred hcCcccccccccCCceeEEEEEeC--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeec
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS--------TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEE 514 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~ 514 (765)
.++|++.+.||+|+||.||+|+.. ++..||+|++... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 368999999999999999999852 3457999999765 344567899999999999 899999999999999
Q ss_pred CceEEEEEecCCCChhHHhhcccc-------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE
Q 004264 515 DERMLIYEYMPHKSLDYFIFDRER-------------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL 581 (765)
Q Consensus 515 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll 581 (765)
+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999865431 235889999999999999999999999 9999999999999
Q ss_pred ecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 004264 582 DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHN 660 (765)
Q Consensus 582 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~ 660 (765)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--- 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 9999999999999997754443333445667889999999999999999999999999999999 999986543221
Q ss_pred HHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 661 LIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+. .....+.... .+......+.+++.+||+.+|++||++.+|++.|++
T Consensus 314 ~~----~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 361 (370)
T 2psq_A 314 LF----KLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361 (370)
T ss_dssp HH----HHHHTTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH----HHHhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11 1111222111 112234568899999999999999999999999976
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=358.77 Aligned_cols=265 Identities=22% Similarity=0.301 Sum_probs=210.4
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCc----eEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE----RMLI 520 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~----~~lV 520 (765)
.++|++.++||+|+||.||+|+.. ++.||||++.... .....+.+|+.++++++||||+++++++.+... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468999999999999999999875 7899999996543 334556679999999999999999999988654 6999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhc----------CCCcEEecccCCCcEEEecCCCCeec
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD----------SKLQVIHRDLKASNILLDINLNPKIS 590 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~----------~~~~ivH~Dlkp~NIll~~~~~vkL~ 590 (765)
|||+++++|.+++.. ..+++..++.++.||+.||+|||+. + |+||||||+|||++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 999999999999853 3489999999999999999999998 7 9999999999999999999999
Q ss_pred ccccceeeCCCCcccccccccccccccCcccccCC-----CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHH-
Q 004264 591 DFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG-----TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGH- 664 (765)
Q Consensus 591 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~- 664 (765)
|||+++.+.............||+.|+|||++.+. .++.++||||||+++|||++|+.||..............
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 99999987655444444456899999999999873 566789999999999999999999976554332222111
Q ss_pred --------HHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 665 --------AWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 665 --------~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.............+... .........+.+++.+||+.||++|||+.+|++.|++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDY---WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGG---GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCcccc---ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11111111111111111 1123455678999999999999999999999999976
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=353.46 Aligned_cols=252 Identities=24% Similarity=0.386 Sum_probs=208.5
Q ss_pred HhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
..++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 346899999999999999999985 5788999999976655567789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999853 24899999999999999999999999 9999999999999999999999999998764332
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....+.. ........+.. ..
T Consensus 171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~~-~~----- 236 (297)
T 3fxz_A 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTP-EL----- 236 (297)
T ss_dssp C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSC-CC-----
T ss_pred c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCC-CC-----
Confidence 2 2334679999999999999999999999999999999999999986433221 11111111110 00
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..+......+.+++.+||+.||++|||+.++++.
T Consensus 237 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 237 --QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111223457799999999999999999999863
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=351.42 Aligned_cols=262 Identities=23% Similarity=0.328 Sum_probs=212.8
Q ss_pred cccchHhHHHHhcC----------cccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccC
Q 004264 434 PLYDLATITTATNH----------FSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHR 502 (765)
Q Consensus 434 ~~~~~~~~~~~~~~----------y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~ 502 (765)
+.+++.++..+++. |...+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 44566666666543 777889999999999999975 7999999999876666678899999999999999
Q ss_pred ceEeeeeeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEe
Q 004264 503 NLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD 582 (765)
Q Consensus 503 niv~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 582 (765)
||+++++++...+..++||||+++++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 999999999999999999999999999998842 35899999999999999999999998 99999999999999
Q ss_pred cCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHH
Q 004264 583 INLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLI 662 (765)
Q Consensus 583 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~ 662 (765)
.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||....+.. ..
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---~~ 250 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AM 250 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH
T ss_pred CCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH
Confidence 999999999999987643322 2235679999999999999999999999999999999999999986433211 11
Q ss_pred HHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 663 GHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 663 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..........+. ........+.+++.+||+.||++|||+.++++.
T Consensus 251 ----~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 251 ----KRLRDSPPPKLK-------NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ----HHHHHSSCCCCT-------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----HHHhcCCCCCcC-------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111111110 011123457789999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=356.93 Aligned_cols=257 Identities=28% Similarity=0.400 Sum_probs=207.4
Q ss_pred hcCcccccccccCCceeEEEEEeC----CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS----TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
.++|++.+.||+|+||.||+|++. .+..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999874 3456999999764 44556789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999998532 346899999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCccc-ccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 600 GDDEEA-QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 600 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+ .......+...
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~~~~~-- 273 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-------VISSVEEGYRL-- 273 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTCCC--
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHcCCCC--
Confidence 432221 2223456778999999999999999999999999999999 999985433221 11111111111
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
..+......+.+++..||+.||++|||+.+|+++|+..
T Consensus 274 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 274 -------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11122345688999999999999999999999999874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=356.24 Aligned_cols=248 Identities=27% Similarity=0.367 Sum_probs=206.0
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
.++|++.+.||+|+||.||+|+. .+++.||+|++.+. .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999987 57899999998754 3445677899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++... +.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999998543 45899999999999999999999999 999999999999999999999999999866432
Q ss_pred CcccccccccccccccCcccccCCCCC-ccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTIS-MKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
.......||+.|+|||++.+..+. .++||||||+++|||++|+.||....... .......+..
T Consensus 168 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~------ 231 (328)
T 3fe3_A 168 ---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE-------LRERVLRGKY------ 231 (328)
T ss_dssp ---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC------
T ss_pred ---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC------
Confidence 223456899999999999988875 79999999999999999999986533211 1111111111
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..+......+.+++.+||+.||.+|||++++++.
T Consensus 232 ----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 ----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111123457789999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=363.18 Aligned_cols=268 Identities=28% Similarity=0.391 Sum_probs=214.6
Q ss_pred cchHhHHHHhcCcccccccccCCceeEEEEEe------CCCcEEEEEEcccc-ChhhHHHHHHHHHHHhcc-ccCceEee
Q 004264 436 YDLATITTATNHFSEANMIGKGGFGPVYMGKL------STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLVGL 507 (765)
Q Consensus 436 ~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~~ 507 (765)
++........++|++.+.||+|+||.||+|++ .+++.||||++... .....+.+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34445555678999999999999999999973 34678999999764 344457899999999999 79999999
Q ss_pred eeeeeecCc-eEEEEEecCCCChhHHhhcccc------------------------------------------------
Q 004264 508 LGSCIEEDE-RMLIYEYMPHKSLDYFIFDRER------------------------------------------------ 538 (765)
Q Consensus 508 ~~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------ 538 (765)
++++.+.+. .++||||+++++|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999999965432
Q ss_pred ---------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 539 ---------------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 539 ---------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122889999999999999999999999 99999999999999999999999999987654444
Q ss_pred ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
........+|+.|+|||++.+..++.++||||||+++|||++ |+.||........ .......+......
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~~~~~~~---- 318 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMRAP---- 318 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHTCCCCCC----
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHHcCCCCCCC----
Confidence 334445678999999999999999999999999999999998 9999865443221 11111122111111
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
......+.+++..||+.+|++|||+.+|+++|+.
T Consensus 319 -----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 319 -----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp -----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 1123457899999999999999999999999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=359.14 Aligned_cols=255 Identities=24% Similarity=0.408 Sum_probs=199.9
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcE----EEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQE----IAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~----vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~ 518 (765)
.++|++.+.||+|+||.||+|++. +++. ||+|++... .....+++.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 367999999999999999999854 4443 588887543 3455678999999999999999999999998754 78
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
+|+||+.+++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999998543 346899999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
.............+|..|+|||++.+..++.++||||||+++|||++ |+.||........ . .....+...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~----~~~~~~~~~-- 238 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---S----SILEKGERL-- 238 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H----HHHHTTCCC--
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH---H----HHHHcCCCC--
Confidence 55444444445567889999999999999999999999999999999 9999865433221 1 111111111
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..+......+.+++.+||+.+|++||++.+|+++|+.
T Consensus 239 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 275 (327)
T 3poz_A 239 -------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275 (327)
T ss_dssp -------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHH
T ss_pred -------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 1112234467899999999999999999999999865
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=346.04 Aligned_cols=273 Identities=21% Similarity=0.274 Sum_probs=215.6
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecC--ceEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED--ERMLI 520 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~--~~~lV 520 (765)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999875 58899999997543 344677889999999999999999999998765 77999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE----ecCCCCeecccccce
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL----DINLNPKISDFGLAR 596 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~vkL~DFGla~ 596 (765)
|||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976555556999999999999999999999999 9999999999999 777789999999998
Q ss_pred eeCCCCcccccccccccccccCccccc--------CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcc-cHHHHHHH
Q 004264 597 IFGGDDEEAQTERVAGTHGYMSPEYAN--------DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRH-NLIGHAWL 667 (765)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~-~~~~~~~~ 667 (765)
...... ......||+.|+|||++. +..++.++||||||+++|||++|+.||......... ........
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 764332 223467899999999986 578999999999999999999999999754432221 11111111
Q ss_pred hhccCCcccc---cc--------ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 004264 668 LWNDGRALGL---MD--------TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDG 723 (765)
Q Consensus 668 ~~~~~~~~~l---~d--------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 723 (765)
......+..+ .. -.............+.+++.+||+.||++|||++|+++..+...
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1111111000 00 01112344566778899999999999999999999999987643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=346.44 Aligned_cols=253 Identities=30% Similarity=0.430 Sum_probs=208.4
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecC
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
++|++.+.||+|+||.||+|+..+++.||+|++..... ..+++.+|+.++++++||||+++++++.+....++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 67899999999999999999998889999999975432 34679999999999999999999999999999999999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++....... .
T Consensus 89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 162 (269)
T 4hcu_A 89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 162 (269)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-c
Confidence 9999999853 2346899999999999999999999999 99999999999999999999999999986533211 1
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+ .......+...
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-------~~~~~~~~~~~--------- 226 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGFRL--------- 226 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCCC---------
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhcCccC---------
Confidence 2224556778999999999999999999999999999999 999986433211 11111111110
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..+......+.+++..||+.+|++||++.+++++|++
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 1111123457899999999999999999999999976
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=351.87 Aligned_cols=258 Identities=28% Similarity=0.395 Sum_probs=212.9
Q ss_pred hcCcccccccccCCceeEEEEEe------CCCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCce
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL------STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDER 517 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~ 517 (765)
.++|.+.+.||+|+||.||+|+. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 47899999999999999999985 24578999999754 345567899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhcccc---------------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCC
Q 004264 518 MLIYEYMPHKSLDYFIFDRER---------------------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKA 576 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp 576 (765)
++||||+++++|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999965432 234889999999999999999999999 99999999
Q ss_pred CcEEEecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCC
Q 004264 577 SNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHP 655 (765)
Q Consensus 577 ~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~ 655 (765)
+||+++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999998755444333445667889999999999999999999999999999999 9999865443
Q ss_pred CCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 656 GHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.. +. .....+.... .+......+.+++.+||+.||++||++.+|++.|++
T Consensus 259 ~~---~~----~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 259 ER---LF----NLLKTGHRME---------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp GG---HH----HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH---HH----HHhhcCCcCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 22 11 1111221111 111224567899999999999999999999999976
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=353.28 Aligned_cols=254 Identities=23% Similarity=0.341 Sum_probs=204.5
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999865 78899999986442 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++++|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999884 3345899999999999999999999999 9999999999999999999999999998764433
Q ss_pred cccccccccccccccCcccccCCCC-CccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTI-SMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~-s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
.........||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... . ..+...... ..+
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~-----~~~~~~~~~--~~~- 230 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-Y-----SDWKEKKTY--LNP- 230 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-H-----HHHHTTCTT--STT-
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-H-----HHHhccccc--CCc-
Confidence 3333446789999999999988775 78999999999999999999999754433211 1 111111100 000
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 231 -----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 -----WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 01123456789999999999999999999865
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=348.60 Aligned_cols=265 Identities=26% Similarity=0.393 Sum_probs=206.6
Q ss_pred hcCcccccccccCCceeEEEEEe-----CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeec--Cce
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-----STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE--DER 517 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~--~~~ 517 (765)
.++|++.+.||+|+||.||+++. .+++.||+|++........+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46899999999999999999983 36889999999877777778899999999999999999999998653 568
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999998543 235899999999999999999999999 99999999999999999999999999987
Q ss_pred eCCCCcc-cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCC---------CcccHHHHHHH
Q 004264 598 FGGDDEE-AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPG---------HRHNLIGHAWL 667 (765)
Q Consensus 598 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~---------~~~~~~~~~~~ 667 (765)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6433221 1222355777899999999999999999999999999999999887532110 00000111111
Q ss_pred hhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 004264 668 LWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDG 723 (765)
Q Consensus 668 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 723 (765)
....+... ..+......+.+++.+||+.+|++|||+.+|+++|+...
T Consensus 244 ~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 244 LLKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccCcC---------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11111111 112223456889999999999999999999999997643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.52 Aligned_cols=266 Identities=23% Similarity=0.268 Sum_probs=204.2
Q ss_pred HhcCcccccccccCCceeEEEEEeCCCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
..++|++.+.||+|+||.||+|+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 457899999999999999999999889999999987542 233567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++ +|.+.+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99985 67666643 2345899999999999999999999999 999999999999999999999999999876432
Q ss_pred CcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc----
Q 004264 602 DEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG---- 676 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 676 (765)
.. ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+...........+..
T Consensus 173 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 173 VR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp CC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred cc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 22 2234578999999999876 5689999999999999999999999976555443222211110000000000
Q ss_pred ---------cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 677 ---------LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 677 ---------l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
..+.............++.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000111122346789999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=365.66 Aligned_cols=256 Identities=26% Similarity=0.341 Sum_probs=208.2
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 367889999999999999999975 78899999987543 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 99999999998542 345899999999999999999999999 9999999999999999999999999998753322
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
.........++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+.....
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~---- 336 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREFVEKGGRLPC---- 336 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHHHHHTTCCCCC----
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCCC----
Confidence 2222222345778999999999999999999999999999998 999986433211 1111222221111
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+......+.+++.+||+.||++|||+++|++.|+.
T Consensus 337 -----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 337 -----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 11123467899999999999999999999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=363.69 Aligned_cols=262 Identities=27% Similarity=0.381 Sum_probs=214.7
Q ss_pred HhcCcccccccccCCceeEEEEEeC--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeee
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS--------TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIE 513 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~ 513 (765)
..++|.+.+.||+|+||.||+|+.. .+..||+|++... .....+++.+|+.+++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3478999999999999999999852 2357999999764 344567899999999999 89999999999999
Q ss_pred cCceEEEEEecCCCChhHHhhcccc-------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEE
Q 004264 514 EDERMLIYEYMPHKSLDYFIFDRER-------------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNIL 580 (765)
Q Consensus 514 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIl 580 (765)
.+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999965432 245899999999999999999999999 999999999999
Q ss_pred EecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 004264 581 LDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRH 659 (765)
Q Consensus 581 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~ 659 (765)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--- 300 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 300 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999987754443344445677889999999999999999999999999999999 99998643321
Q ss_pred cHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCC
Q 004264 660 NLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGV 724 (765)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 724 (765)
........+...... ......+.+++.+||+.+|++|||+.+|++.|++...
T Consensus 301 ----~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 301 ----ELFKLLKEGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp ----HHHHHHHTTCCCCCC---------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHHcCCCCCCC---------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 112222222211111 1223467899999999999999999999999987544
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=342.94 Aligned_cols=256 Identities=27% Similarity=0.383 Sum_probs=210.5
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
.++|++.+.||+|+||.||+++..++..||+|++.... ...+++.+|+.++++++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 46899999999999999999999888899999997543 23567999999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999998543 345899999999999999999999999 999999999999999999999999999876443222
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
. .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+.....
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~------ 226 (268)
T 3sxs_A 161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-------VVLKVSQGHRLYR------ 226 (268)
T ss_dssp E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTCCCCC------
T ss_pred c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-------HHHHHHcCCCCCC------
Confidence 2 223456778999999999999999999999999999999 999986433221 1111111111111
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDG 723 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 723 (765)
+......+.+++.+||+.+|++|||+.+|++.|+...
T Consensus 227 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 227 ---PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp ---CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred ---CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1111345789999999999999999999999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=349.49 Aligned_cols=259 Identities=18% Similarity=0.169 Sum_probs=208.2
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV~E 522 (765)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999986 5788999999865432 24688999999999 89999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCC-----Ceeccccccee
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLN-----PKISDFGLARI 597 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----vkL~DFGla~~ 597 (765)
|+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998543 356999999999999999999999999 999999999999998887 99999999997
Q ss_pred eCCCCccc-----ccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccC
Q 004264 598 FGGDDEEA-----QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDG 672 (765)
Q Consensus 598 ~~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 672 (765)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~---- 235 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT---- 235 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH----
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh----
Confidence 64433221 123578999999999999999999999999999999999999999866544332222211110
Q ss_pred CccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 673 RALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 673 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
... .....+... .. ++.+++..||+.+|.+||++.+|++.|+.
T Consensus 236 ~~~-~~~~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 236 KRA-TPIEVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp HHH-SCHHHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred hcc-CCHHHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 000 000000011 12 68899999999999999999999998864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=362.82 Aligned_cols=257 Identities=29% Similarity=0.419 Sum_probs=197.2
Q ss_pred hcCcccccccccCCceeEEEEEeC----CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS----TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
.++|++.+.||+|+||.||+|+.. .+..||||++... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999864 5678999999754 34456789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+++++|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999853 2346899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCccc-ccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 600 GDDEEA-QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 600 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
...... ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+ + ......+..
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~----~~~i~~~~~--- 268 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---V----IKAVDEGYR--- 268 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---H----HHHHHTTEE---
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCC---
Confidence 332221 1122345778999999999999999999999999999998 999986433211 1 111111111
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
...+......+.+++.+||+.+|++||++.+|+++|++.
T Consensus 269 ------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 269 ------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 111122345688999999999999999999999999763
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=351.76 Aligned_cols=249 Identities=25% Similarity=0.326 Sum_probs=205.3
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
.++|++.+.||+|+||.||+++.. +++.||+|++.+. .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 368999999999999999999865 6899999999754 233467789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||+++++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999988853 345899999999999999999999999 99999999999999999999999999986432
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .+.. ....+..
T Consensus 158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~----~i~~~~~------ 222 (337)
T 1o6l_A 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFE----LILMEEI------ 222 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCC------
T ss_pred CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHHH----HHHcCCC------
Confidence 22 2233578999999999999999999999999999999999999998643221 1111 1111110
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRP-----DMSSVVFL 718 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 718 (765)
.++......+.+++.+||+.||++|| ++++|++.
T Consensus 223 ----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 ----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11112234678899999999999999 89999753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=364.33 Aligned_cols=258 Identities=28% Similarity=0.400 Sum_probs=208.2
Q ss_pred hcCcccccccccCCceeEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCce
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS------TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDER 517 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~ 517 (765)
.++|++.+.||+|+||.||+|++. .++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367899999999999999999843 4668999999754 455566889999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhccc----cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC---CCeec
Q 004264 518 MLIYEYMPHKSLDYFIFDRE----RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL---NPKIS 590 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~vkL~ 590 (765)
++||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999986542 2245899999999999999999999999 99999999999999554 59999
Q ss_pred ccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhh
Q 004264 591 DFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLW 669 (765)
Q Consensus 591 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 669 (765)
|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+ .....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-------~~~~i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEFV 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH
Confidence 9999986533222233334667899999999999999999999999999999998 999986433211 11111
Q ss_pred ccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 670 NDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 670 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..+..... +......+.+|+.+||+.+|++||++.+|++.|+.
T Consensus 300 ~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 300 TSGGRMDP---------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp HTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HcCCCCCC---------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 12221111 11223457899999999999999999999999966
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=341.64 Aligned_cols=262 Identities=24% Similarity=0.331 Sum_probs=203.9
Q ss_pred HhcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhc--cccCceEeeeeeeeec----Cce
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGK--LQHRNLVGLLGSCIEE----DER 517 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~--l~h~niv~~~~~~~~~----~~~ 517 (765)
..++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++.+. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 357899999999999999999987 6889999998653 33455666666666 7899999999987653 457
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhh--------hcCCCcEEecccCCCcEEEecCCCCee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLH--------QDSKLQVIHRDLKASNILLDINLNPKI 589 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~vkL 589 (765)
++||||+++++|.+++. ...+++..++.++.||+.||+||| +.+ |+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 89999999999999983 235899999999999999999999 777 999999999999999999999
Q ss_pred cccccceeeCCCCccc--ccccccccccccCcccccCC------CCCccccchHHHHHHHHHHhC----------CCCCC
Q 004264 590 SDFGLARIFGGDDEEA--QTERVAGTHGYMSPEYANDG------TISMKSDVFSLGVLLVEIVSG----------KMNRG 651 (765)
Q Consensus 590 ~DFGla~~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~------~~s~k~DvwSlG~ll~elltG----------~~p~~ 651 (765)
+|||+++......... ......||+.|+|||.+.+. .++.++||||||+++|||++| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999998765433321 12235799999999999877 456799999999999999999 77775
Q ss_pred CCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 652 FRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
...+....... .............+. ...........+.+++.+||+.||++|||+.+|+++|++
T Consensus 235 ~~~~~~~~~~~-~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 235 DVVPNDPSFED-MRKVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TTSCSSCCHHH-HHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCCCcchhh-hhHHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 54433322111 111111111111111 122334567789999999999999999999999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=354.24 Aligned_cols=264 Identities=29% Similarity=0.391 Sum_probs=213.8
Q ss_pred HHHhcCcccccccccCCceeEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeec
Q 004264 442 TTATNHFSEANMIGKGGFGPVYMGKLS------TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE 514 (765)
Q Consensus 442 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~ 514 (765)
....++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 345678999999999999999999864 3478999999765 344467899999999999999999999999999
Q ss_pred CceEEEEEecCCCChhHHhhcccc---------------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecc
Q 004264 515 DERMLIYEYMPHKSLDYFIFDRER---------------------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRD 573 (765)
Q Consensus 515 ~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~D 573 (765)
+..++||||+++++|.+++..... ...+++..++.++.||++||.|||+.+ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 999999999999999999865321 256899999999999999999999999 99999
Q ss_pred cCCCcEEEecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCC
Q 004264 574 LKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGF 652 (765)
Q Consensus 574 lkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~ 652 (765)
|||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999987643322223334667899999999999999999999999999999999 9999864
Q ss_pred CCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCC
Q 004264 653 RHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGV 724 (765)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 724 (765)
.... ........+...... ......+.+++.+||+.+|++||++.+|+++|++...
T Consensus 280 ~~~~-------~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 280 MAHE-------EVIYYVRDGNILACP---------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp SCHH-------HHHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CChH-------HHHHHHhCCCcCCCC---------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 3321 111122223222111 1223467899999999999999999999999987543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=353.21 Aligned_cols=261 Identities=25% Similarity=0.399 Sum_probs=194.7
Q ss_pred HHhcCcccccccccCCceeEEEEEeCCCc----EEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCc
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKLSTGQ----EIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE 516 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~----~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~ 516 (765)
...++|++.+.||+|+||.||+|+..... .||+|++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 34578999999999999999999865432 7999999754 34556789999999999999999999999988765
Q ss_pred e------EEEEEecCCCChhHHhhcccc---CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCC
Q 004264 517 R------MLIYEYMPHKSLDYFIFDRER---SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNP 587 (765)
Q Consensus 517 ~------~lV~E~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~v 587 (765)
. ++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence 5 999999999999999865332 225899999999999999999999999 9999999999999999999
Q ss_pred eecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 004264 588 KISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAW 666 (765)
Q Consensus 588 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~ 666 (765)
||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ...
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~--- 250 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYN--- 250 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH---
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHH---
Confidence 9999999987654333333334567788999999999999999999999999999999 899986543322 111
Q ss_pred HhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 667 LLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 667 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
....+.... .+......+.+++.+||+.||++|||+.++++.|++.
T Consensus 251 -~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 251 -YLIGGNRLK---------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp -HHHTTCCCC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHhcCCCCC---------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111111 1112235688999999999999999999999999873
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=346.03 Aligned_cols=259 Identities=24% Similarity=0.329 Sum_probs=205.5
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
.++|++.+.||+|+||.||+++.. .++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999864 6889999998543 344567889999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++++||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999998543 45899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ........ .......
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~-~~~~~~~-- 233 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQ-DSVPNVT-- 233 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHS-SCCCCHH--
T ss_pred ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhh-ccCCCcc--
Confidence 221 2223467999999999999999999999999999999999999998643321 11111111 1111110
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcC
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRP-DMSSVVFLLAND 722 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~ 722 (765)
..........+.+++.+|++.||++|| +++++.+.|+..
T Consensus 234 ---~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 234 ---TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp ---HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred ---hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 011112235678999999999999998 999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=354.84 Aligned_cols=263 Identities=25% Similarity=0.365 Sum_probs=210.3
Q ss_pred HhcCcccccccccCCceeEEEEEe------CCCcEEEEEEcccc-ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecC
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL------STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEED 515 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~ 515 (765)
..++|++.+.||+|+||.||+|+. ..++.||+|++... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 347899999999999999999985 24567999999754 233457899999999999 8999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhccccC--------------------CCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccC
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRERS--------------------KLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLK 575 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlk 575 (765)
..++||||+++++|.+++...... ..+++..++.++.||+.||+|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999654321 34789999999999999999999999 9999999
Q ss_pred CCcEEEecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCC
Q 004264 576 ASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRH 654 (765)
Q Consensus 576 p~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~ 654 (765)
|+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654433333445667889999999999999999999999999999998 999986544
Q ss_pred CCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCC
Q 004264 655 PGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGV 724 (765)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 724 (765)
.... .......+... ..+......+.+++.+||+.||++|||+.+|+++|+....
T Consensus 280 ~~~~------~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 280 VDAN------FYKLIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CSHH------HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cHHH------HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 3211 11111111111 1111224567889999999999999999999999987544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=353.15 Aligned_cols=252 Identities=23% Similarity=0.275 Sum_probs=205.2
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccCh------hhHHHHHHHHHHHhccccCceEeeeeeeeecCc
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSG------QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE 516 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~ 516 (765)
..++|++.+.||+|+||.||+++.. +++.||+|++.+... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4578999999999999999999865 688999999976432 135789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC----CCeeccc
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL----NPKISDF 592 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~vkL~DF 592 (765)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999843 346899999999999999999999999 99999999999998776 7999999
Q ss_pred ccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccC
Q 004264 593 GLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDG 672 (765)
Q Consensus 593 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 672 (765)
|+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+ .. .....+
T Consensus 164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~---~~----~~i~~~ 233 (361)
T 2yab_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TL----ANITAV 233 (361)
T ss_dssp SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH----HHHHTT
T ss_pred CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HH----HHHHhc
Confidence 9998764322 2335679999999999999999999999999999999999999986533211 11 111111
Q ss_pred CccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 673 RALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 673 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
... . ++. ........+.+++..||+.||++|||+.|+++
T Consensus 234 ~~~-~-~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 SYD-F-DEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCC-C-CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCC-C-Cch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 110 0 000 00112345778999999999999999999985
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=348.52 Aligned_cols=253 Identities=25% Similarity=0.340 Sum_probs=201.0
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCc------
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE------ 516 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~------ 516 (765)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999975 7899999998754 33456789999999999999999999999876542
Q ss_pred ---------------------------------------------------eEEEEEecCCCChhHHhhccccCCCCChH
Q 004264 517 ---------------------------------------------------RMLIYEYMPHKSLDYFIFDRERSKLLPWK 545 (765)
Q Consensus 517 ---------------------------------------------------~~lV~E~~~~gsL~~~l~~~~~~~~l~~~ 545 (765)
.++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 78999999999999999766555566777
Q ss_pred HHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc----------ccccccccccc
Q 004264 546 KRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE----------AQTERVAGTHG 615 (765)
Q Consensus 546 ~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~----------~~~~~~~gt~~ 615 (765)
.++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999999 999999999999999999999999999987543221 12234579999
Q ss_pred ccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHH
Q 004264 616 YMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCI 695 (765)
Q Consensus 616 Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~ 695 (765)
|+|||++.+..++.++||||||+++|||++|..|+.. . ............ +.........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~-~~~~~~~~~~~~---------~~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------R-VRIITDVRNLKF---------PLLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------H-HHHHHHHHTTCC---------CHHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------H-HHHHHHhhccCC---------CcccccCChhHH
Confidence 9999999999999999999999999999998765310 0 001111111111 111122334567
Q ss_pred HHHHHccccCCCCCCCHHHHHHH
Q 004264 696 QVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 696 ~li~~cl~~dP~~RPs~~evl~~ 718 (765)
+++.+||+.||++|||+.++++.
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 89999999999999999999863
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=344.61 Aligned_cols=254 Identities=24% Similarity=0.350 Sum_probs=205.7
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
.++|++.+.||+|+||.||++...+++.||+|++..... ..+++.+|+.++++++||||+++++++.+....++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 468999999999999999999998888999999975432 3467999999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 175 (283)
T 3gen_A 102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY- 175 (283)
T ss_dssp TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence 999999998542 345899999999999999999999999 99999999999999999999999999987643211
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+...
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~-------- 240 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGLRL-------- 240 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTCCC--------
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-------HHHHHhcccCC--------
Confidence 11223456788999999999999999999999999999998 999986433221 11111111111
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..+......+.+++.+||+.+|++|||++++++.|++
T Consensus 241 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 241 -YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp -CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 0111113467899999999999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=346.43 Aligned_cols=266 Identities=25% Similarity=0.389 Sum_probs=205.0
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecC
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
++|++.+.||+|+||.||+++.. ++.||+|++... ...+.+.+|+.++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 57889999999999999999874 788999998643 34578999999999999999999999887 45899999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCC-CeecccccceeeCCCCcc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLN-PKISDFGLARIFGGDDEE 604 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-vkL~DFGla~~~~~~~~~ 604 (765)
+++|.+++........+++..++.++.||++||+|||+.+..+|+||||||+|||++.++. +||+|||+++.....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999976544445789999999999999999999932223999999999999998887 799999999865321
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+. ...+......
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~-~~~~~~~~~~------ 226 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWA-VHNGTRPPLI------ 226 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHH-HHTTCCCCCB------
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHH-HhcCCCCCcc------
Confidence 223568999999999999999999999999999999999999986433221 111111 1112111111
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCCCCCCCCCCCcc
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGVTLPQPRQPGFF 735 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~p~~~ 735 (765)
......+.+++.+||+.+|++|||+.+|+++|+.....++.+..|..+
T Consensus 227 ---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~ 274 (307)
T 2eva_A 227 ---KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY 274 (307)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCCC
T ss_pred ---cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcccc
Confidence 112345778999999999999999999999998765555555555444
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.26 Aligned_cols=259 Identities=27% Similarity=0.374 Sum_probs=211.6
Q ss_pred hcCcccccccccCCceeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCc
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL------STGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDE 516 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~ 516 (765)
.++|++.+.||+|+||.||+|+. ..++.||+|++.... ....+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46899999999999999999984 346789999997543 34567899999999999 89999999999999999
Q ss_pred eEEEEEecCCCChhHHhhcccc---------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE
Q 004264 517 RMLIYEYMPHKSLDYFIFDRER---------------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL 581 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll 581 (765)
.++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999865432 225899999999999999999999999 9999999999999
Q ss_pred ecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 004264 582 DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHN 660 (765)
Q Consensus 582 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~ 660 (765)
+.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence 9999999999999987755444333445667889999999999999999999999999999999 9999865433211
Q ss_pred HHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 661 LIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
. ......+.. ...+......+.+++.+||+.||++|||+.+|+++|++
T Consensus 257 ~----~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 257 F----YKMIKEGFR---------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp H----HHHHHHTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H----HHHhccCCC---------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 1 111111111 01111223567899999999999999999999999976
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=340.03 Aligned_cols=263 Identities=16% Similarity=0.162 Sum_probs=211.2
Q ss_pred HhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV~ 521 (765)
..++|++.+.||+|+||.||+|+. .+++.||+|++.... ..+.+.+|+.+++++ +|+|++++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 346899999999999999999985 578899999986543 234678899999999 7999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCC-----Ceecccccce
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLN-----PKISDFGLAR 596 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----vkL~DFGla~ 596 (765)
||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 86 e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 99999998543 345899999999999999999999999 999999999999987776 9999999999
Q ss_pred eeCCCCcc-----cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhcc
Q 004264 597 IFGGDDEE-----AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWND 671 (765)
Q Consensus 597 ~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 671 (765)
........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 87543322 1233567999999999999999999999999999999999999999765544332222221111100
Q ss_pred CCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 004264 672 GRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDG 723 (765)
Q Consensus 672 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 723 (765)
.....+ .......+.+++.+||+.+|++||++++|++.|++..
T Consensus 240 ~~~~~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 240 TPLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp SCHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ccHHHH---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 111000 1112356789999999999999999999999997743
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=347.23 Aligned_cols=253 Identities=23% Similarity=0.297 Sum_probs=205.2
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccCh------hhHHHHHHHHHHHhccccCceEeeeeeeeecCc
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSG------QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE 516 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~ 516 (765)
..++|++.+.||+|+||.||++... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3467999999999999999999875 688999999875422 246789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC----CCeeccc
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL----NPKISDF 592 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~vkL~DF 592 (765)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 9999999999999999843 346899999999999999999999999 99999999999998877 7999999
Q ss_pred ccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccC
Q 004264 593 GLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDG 672 (765)
Q Consensus 593 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 672 (765)
|+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+ .... ....
T Consensus 163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~----~~~~ 232 (326)
T 2y0a_A 163 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLAN----VSAV 232 (326)
T ss_dssp TTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHH----HHHT
T ss_pred CCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHH----HHhc
Confidence 9998764322 2234679999999999999999999999999999999999999986432211 1111 1011
Q ss_pred CccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 673 RALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 673 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.. ..... ........+.+++.+||+.||++|||+.++++.
T Consensus 233 ~~-~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 233 NY-EFEDE-----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CC-CCCHH-----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CC-CcCcc-----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 10 00000 001123457789999999999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=348.27 Aligned_cols=255 Identities=24% Similarity=0.353 Sum_probs=203.1
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcE----EEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQE----IAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~----vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
++|++.+.||+|+||.||+|++. +++. +++|.+.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57999999999999999999864 4444 7788775432 333456788999999999999999999886 567899
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999998543 346899999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||......... .....+......
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~~~~ 239 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-------DLLEKGERLAQP 239 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH-------HHHHTTCBCCCC
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH-------HHHHcCCCCCCC
Confidence 5544444445678889999999999999999999999999999999 99998764433211 111122211111
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
.. ....+.+++.+||+.+|++||++.+|++.|++.
T Consensus 240 ~~---------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 240 QI---------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp TT---------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred Cc---------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 122356899999999999999999999999764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=342.04 Aligned_cols=261 Identities=22% Similarity=0.280 Sum_probs=199.6
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
++|++.+.||+|+||.||+|+...++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999998889999999986543 22346788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++ +|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 986 888777432 345899999999999999999999999 9999999999999999999999999998764221
Q ss_pred ccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC---cc---c
Q 004264 604 EAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR---AL---G 676 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~---~ 676 (765)
.......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ ............. +. +
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHHCCCChhhchhhhc
Confidence 12224578999999999976 458999999999999999999999986543221 1111111111100 00 0
Q ss_pred --cccc-------cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 677 --LMDT-------CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 677 --l~d~-------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
..++ .............+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 0000111123456789999999999999999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=339.98 Aligned_cols=263 Identities=22% Similarity=0.255 Sum_probs=200.7
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999875 6889999998754 33345778899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|++++.+..+. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99875444443 22356999999999999999999999999 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccCCC-CCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC---cc---
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGT-ISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR---AL--- 675 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~-~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~--- 675 (765)
.......+|+.|+|||.+.+.. ++.++||||||+++|||++|..|+-.... ................ +.
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhhc
Confidence 2223467899999999998766 89999999999999999999888532221 1111111111111100 00
Q ss_pred ccccc---------cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 676 GLMDT---------CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 676 ~l~d~---------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.+.+. .............+.+++.+||+.||++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000 00001112234567799999999999999999999863
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=368.62 Aligned_cols=255 Identities=27% Similarity=0.395 Sum_probs=210.2
Q ss_pred cCcccccccccCCceeEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLST-GQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
++|++.+.||+|+||.||+|.+.. +..||||++.... ...++|.+|+.+|++++||||+++++++.+....++||||+
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 568889999999999999999764 7899999997543 34678999999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 299 ~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 299 TYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp TTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred CCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 9999999996432 345899999999999999999999999 999999999999999999999999999976433221
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
......++..|+|||.+.+..++.++||||||++||||++ |+.||....... +.. ....+...
T Consensus 375 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~~~-------- 438 (495)
T 1opk_A 375 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYE----LLEKDYRM-------- 438 (495)
T ss_dssp -CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----HHHTTCCC--------
T ss_pred -ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCCCC--------
Confidence 2223456788999999999999999999999999999999 999986543221 111 11111111
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
..+......+.+|+.+||+.+|++|||+.+|+++|+..
T Consensus 439 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 439 -ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 11122345678999999999999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.66 Aligned_cols=252 Identities=31% Similarity=0.441 Sum_probs=196.4
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccC----hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNS----GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||.||+|... ++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 67999999999999999999974 8899999987542 233578899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec--------CCCCeecccc
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI--------NLNPKISDFG 593 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~--------~~~vkL~DFG 593 (765)
||+++++|.+++. .+.+++..++.++.||+.||+|||+.+..+|+||||||+||+++. ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999883 345899999999999999999999998666999999999999986 7789999999
Q ss_pred cceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC
Q 004264 594 LARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR 673 (765)
Q Consensus 594 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 673 (765)
+++...... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... ...........
T Consensus 162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~ 231 (271)
T 3dtc_A 162 LAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYGVAMNKL 231 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHTSCC
T ss_pred ccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHhhhcCCC
Confidence 998653322 22457899999999999999999999999999999999999998643321 11111111111
Q ss_pred ccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 674 ALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 674 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.. ..+......+.+++.+||+.+|++|||+.+++++|+.
T Consensus 232 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 232 AL---------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CC---------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11 1112223568899999999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=365.23 Aligned_cols=256 Identities=29% Similarity=0.444 Sum_probs=208.4
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
.++|++.+.||+|+||.||+|...++..||||++.... ...+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 36788899999999999999999888999999997543 35688999999999999999999999986 66789999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 265 ~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~- 339 (454)
T 1qcf_A 265 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY- 339 (454)
T ss_dssp TTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-
T ss_pred CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-
Confidence 9999999996432 235789999999999999999999999 99999999999999999999999999987632211
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
.......++..|+|||.+....++.++||||||++||||++ |+.||......+ .. .....+....
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~----~~i~~~~~~~------- 405 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VI----RALERGYRMP------- 405 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HH----HHHHHTCCCC-------
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCCCC-------
Confidence 11223456788999999999999999999999999999999 999986433211 11 1111111111
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDG 723 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 723 (765)
.+......+.+|+.+||+.||++|||+++|+++|+...
T Consensus 406 --~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 406 --RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred --CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 11123456889999999999999999999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=350.54 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=204.6
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 67999999999999999999865 5788999998653 2334678899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+.+++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999853 345899999999999999999999999 999999999999999999999999999876432
Q ss_pred CcccccccccccccccCcccccC---CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYAND---GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
.......||+.|+|||++.+ ..++.++||||||+++|||++|+.||................ ...
T Consensus 169 ---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~----~~~----- 236 (384)
T 4fr4_A 169 ---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE----TTV----- 236 (384)
T ss_dssp ---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH----HCC-----
T ss_pred ---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----hcc-----
Confidence 22345789999999999974 458999999999999999999999997554433222211111 110
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPD-MSSVVF 717 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 717 (765)
..++......+.+|+.+||+.||++||+ +++|++
T Consensus 237 -----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 -----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0111222456789999999999999998 777764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=364.69 Aligned_cols=256 Identities=28% Similarity=0.404 Sum_probs=203.9
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecC
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
++|++.+.||+|+||.||+|.+..+..||||++.... ...+++.+|+.++++++||||+++++++.+ +..++||||++
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 5688899999999999999999888889999997543 345789999999999999999999999876 67899999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 262 ~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~ 336 (452)
T 1fmk_A 262 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 336 (452)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce-e
Confidence 99999999542 2345899999999999999999999999 99999999999999999999999999987643221 1
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .......+....
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~~~-------- 401 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRMP-------- 401 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCC--------
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC--------
Confidence 1223456788999999999999999999999999999999 999986433211 111112221111
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCC
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGV 724 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 724 (765)
.+......+.+++.+||+.+|++|||+++|+++|+....
T Consensus 402 -~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 402 -CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred -CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 112234567899999999999999999999999987544
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=346.74 Aligned_cols=266 Identities=25% Similarity=0.351 Sum_probs=212.0
Q ss_pred hcCcccccccccCCceeEEEEEe-----CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeee--ecCce
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-----STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI--EEDER 517 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~--~~~~~ 517 (765)
.++|++.+.||+|+||.||+++. ..++.||+|++........+.+.+|+.++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36799999999999999999983 467899999998877777788999999999999999999999887 45568
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 8999999999999998543 235899999999999999999999999 99999999999999999999999999998
Q ss_pred eCCCCcc-cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCC--------CcccHHHHHHHh
Q 004264 598 FGGDDEE-AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPG--------HRHNLIGHAWLL 668 (765)
Q Consensus 598 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~--------~~~~~~~~~~~~ 668 (765)
....... .......+|..|+|||.+.+..++.++||||||+++|+|++|+.||...... ............
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 7543322 2223456888899999999999999999999999999999999997532211 000011111111
Q ss_pred hccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCC
Q 004264 669 WNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGV 724 (765)
Q Consensus 669 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 724 (765)
...+. ....+......+.+++.+||+.||++|||+.+|+++|+....
T Consensus 257 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 257 LEEGQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred hhccc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11111 111222334568899999999999999999999999987543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=348.47 Aligned_cols=260 Identities=27% Similarity=0.406 Sum_probs=211.0
Q ss_pred HhcCcccccccccCCceeEEEEEeC--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeee
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS--------TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIE 513 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~ 513 (765)
..++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.+++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3478999999999999999999853 4678999999754 344567899999999999 89999999999999
Q ss_pred cCceEEEEEecCCCChhHHhhcccc-------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEE
Q 004264 514 EDERMLIYEYMPHKSLDYFIFDRER-------------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNIL 580 (765)
Q Consensus 514 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIl 580 (765)
.+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999965432 234889999999999999999999999 999999999999
Q ss_pred EecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 004264 581 LDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRH 659 (765)
Q Consensus 581 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~ 659 (765)
++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-- 267 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 267 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--
Confidence 99999999999999998755443333445567889999999999999999999999999999999 999986432211
Q ss_pred cHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 660 NLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
.......+.... .+......+.+++.+||+.+|++||++.+|++.|++.
T Consensus 268 -----~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 268 -----LFKLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp -----HHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHHHHhcCCCCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111121111 1112234678999999999999999999999999763
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=349.27 Aligned_cols=254 Identities=22% Similarity=0.280 Sum_probs=204.0
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-----hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-----GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~ 518 (765)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999864 68999999986421 224678999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhccc-cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCC---Ceeccccc
Q 004264 519 LIYEYMPHKSLDYFIFDRE-RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLN---PKISDFGL 594 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---vkL~DFGl 594 (765)
+||||+++++|.+.+.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988775432 3345899999999999999999999999 999999999999987654 99999999
Q ss_pred ceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCc
Q 004264 595 ARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRA 674 (765)
Q Consensus 595 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (765)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... . .......+..
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~----~~~~i~~~~~ 249 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----R----LFEGIIKGKY 249 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----H----HHHHHHHTCC
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----H----HHHHHHcCCC
Confidence 988653221 22346799999999999999999999999999999999999999864211 1 1111111111
Q ss_pred cccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 675 LGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 675 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
. ..+.... .....+.+++.+||+.||++|||+.++++
T Consensus 250 ~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 K--MNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp C--CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--CCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0000000 12346789999999999999999999985
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=354.38 Aligned_cols=249 Identities=23% Similarity=0.318 Sum_probs=199.6
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~ 518 (765)
..++|++.+.||+|+||.||+|+.. +++.||+|++.+. .....+.+.+|+.+++.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999999999999865 6889999999754 233456788999999988 6999999999999999999
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
+||||+++++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999988543 45899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
... .......+||+.|+|||++.+..++.++||||||+++|||++|+.||......+ +. .....+..
T Consensus 175 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~----~~i~~~~~---- 241 (353)
T 3txo_A 175 ICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---LF----EAILNDEV---- 241 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HHHHHCCC----
T ss_pred ccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH---HH----HHHHcCCC----
Confidence 222 222335789999999999999999999999999999999999999996543221 11 11111111
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDM------SSVVF 717 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 717 (765)
.++......+.+++.+||+.||++||++ ++|++
T Consensus 242 ------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 ------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1111223457789999999999999998 67764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=349.09 Aligned_cols=259 Identities=24% Similarity=0.356 Sum_probs=196.7
Q ss_pred HhcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCce--
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDER-- 517 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~-- 517 (765)
..++|++.+.||+|+||.||+++. .+++.||+|++... .......+.+|+.++++++||||+++++++......
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 347899999999999999999996 57889999999764 334456789999999999999999999998876544
Q ss_pred --EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccc
Q 004264 518 --MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA 595 (765)
Q Consensus 518 --~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla 595 (765)
++||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 9999999999999998543 45899999999999999999999999 999999999999999999999999999
Q ss_pred eeeCCCCcc-cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCc
Q 004264 596 RIFGGDDEE-AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRA 674 (765)
Q Consensus 596 ~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (765)
+........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||....+.. ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCC
Confidence 876433222 22334678999999999999999999999999999999999999986433211 11111111111
Q ss_pred cccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHH-HHHHhc
Q 004264 675 LGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSV-VFLLAN 721 (765)
Q Consensus 675 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev-l~~L~~ 721 (765)
. .. .........+.+++.+||+.||++||++.++ ...|.+
T Consensus 238 ~---~~----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 238 P---PS----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp C---HH----HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred C---cc----cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 0 00 0011123457899999999999999965554 455544
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=351.73 Aligned_cols=252 Identities=25% Similarity=0.320 Sum_probs=196.9
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHhcccc--CceEeeeeeeeecCceEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQH--RNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h--~niv~~~~~~~~~~~~~lV 520 (765)
.++|++.+.||+|+||.||++...+++.||+|++... .....+.+.+|+.++++++| +||+++++++.+....++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4679999999999999999999988999999998643 34556789999999999976 9999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|| +.+++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++....
T Consensus 88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 568899999854 346899999999999999999999999 99999999999997 57899999999987754
Q ss_pred CCcccccccccccccccCcccccC-----------CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhh
Q 004264 601 DDEEAQTERVAGTHGYMSPEYAND-----------GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLW 669 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 669 (765)
...........||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... .........
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~ 234 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII 234 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHh
Confidence 433333445679999999999865 6789999999999999999999999853221 111111111
Q ss_pred ccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 670 NDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 670 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
... .....+......+.+++..||+.||++|||+.++++.
T Consensus 235 ~~~---------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 235 DPN---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CTT---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCC---------cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111 1111111123457799999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=352.17 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=199.3
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~l 519 (765)
.++|++.++||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999875 57889999997642 23345688899999887 89999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+++++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999988854 345899999999999999999999999 9999999999999999999999999998632
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCc--ccHHHHHHHhhccCCcccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHR--HNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~l 677 (765)
.. .......+||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ................
T Consensus 205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--- 279 (396)
T 4dc2_A 205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--- 279 (396)
T ss_dssp CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC---
T ss_pred cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc---
Confidence 22 2223457899999999999999999999999999999999999999965432211 1111111111111111
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCH
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDM 712 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 712 (765)
.++......+.+|+.+||+.||++||++
T Consensus 280 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 -------RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1112234467899999999999999996
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=350.38 Aligned_cols=256 Identities=24% Similarity=0.398 Sum_probs=198.6
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcE----EEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQE----IAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~----vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~ 518 (765)
.++|++.+.||+|+||.||+|... +++. |++|.+... .....+++.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 367999999999999999999854 4444 577777543 3445788999999999999999999999998754 78
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
+|+||+.+++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999998543 345899999999999999999999999 999999999999999999999999999887
Q ss_pred CCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ .. ....+....
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~----~~~~~~~~~- 239 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SS----ILEKGERLP- 239 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH----HHHTTCCCC-
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HH----HHHcCCCCC-
Confidence 54443333344567888999999999999999999999999999999 9999865443321 11 111111111
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
.+......+.+++.+||+.||++||++.+|++.|++.
T Consensus 240 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 276 (327)
T 3lzb_A 240 --------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp --------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1112234578999999999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=342.41 Aligned_cols=263 Identities=23% Similarity=0.269 Sum_probs=206.5
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeee----cCceEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE----EDERML 519 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~----~~~~~l 519 (765)
.++|++.+.||+|+||.||+++. .+++.||+|++........+.+.+|+.++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46899999999999999999986 5789999999977666777889999999999999999999999873 347889
Q ss_pred EEEecCCCChhHHhhcc-ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 520 IYEYMPHKSLDYFIFDR-ERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
||||+++++|.+++... .....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999988653 23456899999999999999999999999 999999999999999999999999998865
Q ss_pred CCCCccc-------ccccccccccccCcccccCCC---CCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHh
Q 004264 599 GGDDEEA-------QTERVAGTHGYMSPEYANDGT---ISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLL 668 (765)
Q Consensus 599 ~~~~~~~-------~~~~~~gt~~Y~aPE~~~~~~---~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~ 668 (765)
....... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||........ .... .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~-~--- 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL-A--- 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH-H---
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH-H---
Confidence 3211110 112345799999999997654 78999999999999999999999853211110 0100 0
Q ss_pred hccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCC
Q 004264 669 WNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGV 724 (765)
Q Consensus 669 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 724 (765)
..... .. .........+.+++.+||+.||++||++.+|++.|+....
T Consensus 260 ~~~~~--~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 260 VQNQL--SI-------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HHCC----C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hhccC--CC-------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 00000 00 0111223468899999999999999999999999988554
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=359.00 Aligned_cols=255 Identities=24% Similarity=0.255 Sum_probs=204.8
Q ss_pred HHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
...++|++.+.||+|+||.||++.. .+++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 4567899999999999999999986 478899999987543 3445678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEe---cCCCCeecccccce
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD---INLNPKISDFGLAR 596 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~vkL~DFGla~ 596 (765)
||||+.+++|.+.+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++
T Consensus 88 v~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999888854 345899999999999999999999999 99999999999998 45789999999998
Q ss_pred eeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 597 IFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... . .......+...
T Consensus 162 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~----~~~~i~~~~~~- 231 (444)
T 3soa_A 162 EVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---R----LYQQIKAGAYD- 231 (444)
T ss_dssp CCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---H----HHHHHHHTCCC-
T ss_pred EecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---H----HHHHHHhCCCC-
Confidence 764322 2223467999999999999999999999999999999999999998643321 1 11111111111
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...+.. ......+.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~-----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 FPSPEW-----DTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CCTTTT-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCcccc-----ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111100 1123457799999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=351.41 Aligned_cols=253 Identities=21% Similarity=0.255 Sum_probs=207.0
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
.++|++.+.||+|+||.||+|... +++.+|+|++..........+.+|+.++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999865 6889999999876666667899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec--CCCCeecccccceeeCCC
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI--NLNPKISDFGLARIFGGD 601 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~vkL~DFGla~~~~~~ 601 (765)
+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999988532 345899999999999999999999999 999999999999974 477999999999986432
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..... ....... ++.
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~----i~~~~~~--~~~- 271 (387)
T 1kob_A 205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQN----VKRCDWE--FDE- 271 (387)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHH----HHHCCCC--CCS-
T ss_pred c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHHH----HHhCCCC--CCc-
Confidence 2 223457899999999999999999999999999999999999998653321 11111 1111110 000
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.........+.+++.+||+.||++|||+.++++.
T Consensus 272 ---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 272 ---DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ---STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1111223467899999999999999999999974
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=345.94 Aligned_cols=263 Identities=24% Similarity=0.346 Sum_probs=212.6
Q ss_pred HHHhcCcccccccccCCceeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeec
Q 004264 442 TTATNHFSEANMIGKGGFGPVYMGKLS------TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE 514 (765)
Q Consensus 442 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~ 514 (765)
....++|++.+.||+|+||.||+|+.. .++.||+|++.... ......+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 445678999999999999999999754 36789999997543 34456789999999999999999999999999
Q ss_pred CceEEEEEecCCCChhHHhhcccc-------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCC
Q 004264 515 DERMLIYEYMPHKSLDYFIFDRER-------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNP 587 (765)
Q Consensus 515 ~~~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~v 587 (765)
+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence 999999999999999999864321 245789999999999999999999999 9999999999999999999
Q ss_pred eecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 004264 588 KISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAW 666 (765)
Q Consensus 588 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~ 666 (765)
||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ...
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~ 250 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-------QVL 250 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-------HHH
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH-------HHH
Confidence 9999999986643332233334567889999999999999999999999999999999 88887643221 111
Q ss_pred HhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 004264 667 LLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDG 723 (765)
Q Consensus 667 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 723 (765)
.....+..... +......+.+++.+||+.+|++|||+.++++.|++..
T Consensus 251 ~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 251 RFVMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 11222222111 1122345788999999999999999999999998743
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=359.36 Aligned_cols=249 Identities=27% Similarity=0.385 Sum_probs=205.0
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecC-ceEEEEEe
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED-ERMLIYEY 523 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~-~~~lV~E~ 523 (765)
.++|++.+.||+|+||.||+|... ++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 367889999999999999999875 7799999997643 4578999999999999999999999987765 78999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 99999999996532 234789999999999999999999999 999999999999999999999999999864321
Q ss_pred ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. . .....+.....
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~----~~i~~~~~~~~----- 407 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V----PRVEKGYKMDA----- 407 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---H----HHHHTTCCCCC-----
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHHcCCCCCC-----
Confidence 112356889999999999999999999999999999998 9999876544332 1 11122221111
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+......+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 408 ----p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 408 ----PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 12234567899999999999999999999999976
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.28 Aligned_cols=260 Identities=27% Similarity=0.410 Sum_probs=195.7
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
.++|++.++||+|+||.||+|+.. ..+|+|++... .....+.+.+|+.++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 468999999999999999999864 36999998644 345567899999999999999999999965 5567899999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 99999999988432 356899999999999999999999999 9999999999999999999999999998765433
Q ss_pred cccccccccccccccCccccc---CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYAN---DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~---~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
.........||+.|+|||.+. +..++.++||||||+++|||++|+.||......+ . .......+.....+.
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~----~~~~~~~~~~~~~~~ 248 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--Q----IIEMVGRGSLSPDLS 248 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--H----HHHHHHHTSCCCCTT
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--H----HHHHhcccccCcchh
Confidence 333344567999999999987 6678999999999999999999999986433221 1 111111222111111
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDG 723 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 723 (765)
. ........+.+++.+||+.+|++|||+.+|+++|+...
T Consensus 249 ~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 249 K-----VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp S-----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred h-----ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1 11122356889999999999999999999999998743
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=342.28 Aligned_cols=244 Identities=23% Similarity=0.291 Sum_probs=203.4
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 67999999999999999999865 68999999997542 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 99999999999854 345899999999999999999999999 99999999999999999999999999987532
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
......||+.|+|||++.+..++.++||||||+++|||++|+.||....... . ..... .+..
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~---~~~i~-~~~~------- 220 (318)
T 1fot_A 159 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---T---YEKIL-NAEL------- 220 (318)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHHHH-HCCC-------
T ss_pred ----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H---HHHHH-hCCC-------
Confidence 2235679999999999999999999999999999999999999986433211 1 11111 1110
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRP-----DMSSVVF 717 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 717 (765)
.++......+.+++.+||+.||++|| ++++|++
T Consensus 221 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 01112234677899999999999999 8999984
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.25 Aligned_cols=262 Identities=24% Similarity=0.399 Sum_probs=206.5
Q ss_pred cCcccccccccCCceeEEEEEe-----CCCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeec--Cce
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-----STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE--DER 517 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~--~~~ 517 (765)
++|++.+.||+|+||.||+|++ .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5689999999999999999983 46889999999754 334567899999999999999999999999876 678
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 9999999999999998543 345899999999999999999999999 99999999999999999999999999998
Q ss_pred eCCCCcc-cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCC--------CCCcccHHHHHHHh
Q 004264 598 FGGDDEE-AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRH--------PGHRHNLIGHAWLL 668 (765)
Q Consensus 598 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~--------~~~~~~~~~~~~~~ 668 (765)
....... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.... +.............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 7543322 22334668888999999999999999999999999999999998854211 11111111111111
Q ss_pred hccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 669 WNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 669 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
...+... ..+......+.+++.+||+.||++|||+.+|+++|+.
T Consensus 256 ~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 256 LKEGKRL---------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHTTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HhccCCC---------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 1122111 1122234568899999999999999999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=340.15 Aligned_cols=249 Identities=25% Similarity=0.325 Sum_probs=195.3
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccCh--------------------------hhHHHHHHHHHHHh
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSG--------------------------QGLEEFMNEVVLIG 497 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--------------------------~~~~~~~~Ev~~l~ 497 (765)
.++|++.+.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 36899999999999999999986 4688999999865421 12356889999999
Q ss_pred ccccCceEeeeeeeee--cCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccC
Q 004264 498 KLQHRNLVGLLGSCIE--EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLK 575 (765)
Q Consensus 498 ~l~h~niv~~~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlk 575 (765)
+++||||+++++++.+ ....++||||+++++|.+++ ....+++..++.++.||+.||+|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999998765 2346899999999999999999999999 9999999
Q ss_pred CCcEEEecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCC---CCccccchHHHHHHHHHHhCCCCCCC
Q 004264 576 ASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGT---ISMKSDVFSLGVLLVEIVSGKMNRGF 652 (765)
Q Consensus 576 p~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~k~DvwSlG~ll~elltG~~p~~~ 652 (765)
|+|||++.++++||+|||+++....... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987643322 223467999999999998765 47889999999999999999999864
Q ss_pred CCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 653 RHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.... ... ........ ...+ .......+.+++.+||+.||++|||+.||++
T Consensus 243 ~~~~---~~~----~~~~~~~~-~~~~-------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERIM---CLH----SKIKSQAL-EFPD-------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSHH---HHH----HHHHHCCC-CCCS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccHH---HHH----HHHhcccC-CCCC-------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 3211 111 11111111 0000 0112345789999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=348.98 Aligned_cols=260 Identities=27% Similarity=0.375 Sum_probs=210.1
Q ss_pred HhcCcccccccccCCceeEEEEEeCC------CcEEEEEEccccC-hhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecC
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLST------GQEIAAKRLSKNS-GQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEED 515 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~ 515 (765)
..++|++.+.||+|+||.||+|.... .+.||+|++.... ....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 45789999999999999999998642 2479999997643 34567799999999999 8999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhcccc-----------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRER-----------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN 584 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 584 (765)
..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 99999999999999999865321 345799999999999999999999998 9999999999999999
Q ss_pred CCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHH
Q 004264 585 LNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIG 663 (765)
Q Consensus 585 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~ 663 (765)
+.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~----- 275 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK----- 275 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-----
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-----
Confidence 9999999999987654433333344667889999999999999999999999999999998 8889865432211
Q ss_pred HHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 664 HAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 664 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.......+... ..+......+.+++..||+.+|.+|||+.+|+++|+.
T Consensus 276 -~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 276 -FYKLVKDGYQM---------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp -HHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 11111111110 0111123467889999999999999999999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=343.68 Aligned_cols=252 Identities=20% Similarity=0.246 Sum_probs=204.8
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
.++|++.+.||+|+||.||++... +++.+|+|.+... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 478999999999999999999865 5788999988654 33456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec--CCCCeecccccceeeCCC
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI--NLNPKISDFGLARIFGGD 601 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~vkL~DFGla~~~~~~ 601 (765)
+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999998843 2346899999999999999999999999 999999999999987 789999999999886432
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
. ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||....... ... ....+... .+..
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~----~i~~~~~~--~~~~ 225 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIE----NIMNAEYT--FDEE 225 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH----HHHHTCCC--CCHH
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---HHH----HHHcCCCC--CChh
Confidence 2 2234678999999999999999999999999999999999999986533211 111 11111110 0000
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
. .......+.+++.+||+.||++|||+.|+++.
T Consensus 226 ~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 A----FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp H----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred h----hccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 00123467899999999999999999999863
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=349.82 Aligned_cols=263 Identities=19% Similarity=0.265 Sum_probs=205.5
Q ss_pred hcCcccccccccC--CceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 445 TNHFSEANMIGKG--GFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 445 ~~~y~~~~~LG~G--~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
.++|++.++||+| +||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 99999999975 6899999999754 24456778899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+++++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+....
T Consensus 104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999986532 345899999999999999999999999 9999999999999999999999999987653
Q ss_pred CCCc-----ccccccccccccccCcccccC--CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccC
Q 004264 600 GDDE-----EAQTERVAGTHGYMSPEYAND--GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDG 672 (765)
Q Consensus 600 ~~~~-----~~~~~~~~gt~~Y~aPE~~~~--~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 672 (765)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||............. .+
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-------~~ 252 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL-------NG 252 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh-------cC
Confidence 2211 111223578999999999987 679999999999999999999999997544332210000 00
Q ss_pred Cccccccc------------------------------------cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 004264 673 RALGLMDT------------------------------------CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVV 716 (765)
Q Consensus 673 ~~~~l~d~------------------------------------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 716 (765)
....+++. .............+.+|+.+||+.||++|||+.|++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 00000000 000011122345688999999999999999999998
Q ss_pred HH
Q 004264 717 FL 718 (765)
Q Consensus 717 ~~ 718 (765)
+.
T Consensus 333 ~h 334 (389)
T 3gni_B 333 NH 334 (389)
T ss_dssp TS
T ss_pred cC
Confidence 54
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=351.52 Aligned_cols=214 Identities=25% Similarity=0.286 Sum_probs=185.4
Q ss_pred cccccccchHhHHHHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccc-----cCc
Q 004264 430 DIEVPLYDLATITTATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-----HRN 503 (765)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-----h~n 503 (765)
+.+...+++.+.....++|++.++||+|+||.||+|+. .+++.||||++.. .....+.+..|+.++++++ |||
T Consensus 19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCC
Confidence 44556677777777889999999999999999999987 4688999999864 3344567788999999986 999
Q ss_pred eEeeeeeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec
Q 004264 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI 583 (765)
Q Consensus 504 iv~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 583 (765)
|+++++++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDD 172 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESC
T ss_pred eecccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcc
Confidence 999999999999999999999 999999886433 235899999999999999999999999 999999999999975
Q ss_pred -------------------------CCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHH
Q 004264 584 -------------------------NLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGV 638 (765)
Q Consensus 584 -------------------------~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ 638 (765)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 247 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGC 247 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHH
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHH
Confidence 788999999999874322 23467899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 004264 639 LLVEIVSGKMNRGFRH 654 (765)
Q Consensus 639 ll~elltG~~p~~~~~ 654 (765)
++|||++|+.||....
T Consensus 248 il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 248 VLAELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHHHHSSCSCCCSS
T ss_pred HHHHHHHCCCCCCCCc
Confidence 9999999999997543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=341.28 Aligned_cols=256 Identities=27% Similarity=0.382 Sum_probs=210.7
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
..++|++.+.||+|+||.||+|... .++.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4578999999999999999999975 47889999987543 346789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999998543 2355899999999999999999999999 9999999999999999999999999998764332
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
. .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||....... .... ......
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~----~~~~~~------- 230 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL----LEKDYR------- 230 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH----HHTTCC-------
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HhccCC-------
Confidence 2 22234567888999999999999999999999999999999 999986543322 1111 111111
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
...+......+.+++.+||+.||++|||+.+|+++|+.
T Consensus 231 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 231 --MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 11111223567899999999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=345.03 Aligned_cols=267 Identities=27% Similarity=0.383 Sum_probs=213.6
Q ss_pred chHhHHHHhcCcccccccccCCceeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHhcc-ccCceEeee
Q 004264 437 DLATITTATNHFSEANMIGKGGFGPVYMGKL------STGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKL-QHRNLVGLL 508 (765)
Q Consensus 437 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l-~h~niv~~~ 508 (765)
.........++|++.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.+++++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3344445568899999999999999999974 356789999997643 34456899999999999 799999999
Q ss_pred eeeeecC-ceEEEEEecCCCChhHHhhcccc-------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEeccc
Q 004264 509 GSCIEED-ERMLIYEYMPHKSLDYFIFDRER-------------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDL 574 (765)
Q Consensus 509 ~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dl 574 (765)
+++...+ ..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9988755 48999999999999999965432 123789999999999999999999999 999999
Q ss_pred CCCcEEEecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCC
Q 004264 575 KASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFR 653 (765)
Q Consensus 575 kp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~ 653 (765)
||+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987654443334445678889999999999999999999999999999998 99998654
Q ss_pred CCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 654 HPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..... .......+..... +......+.+++.+||+.+|++|||+.+|++.|++
T Consensus 255 ~~~~~------~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 307 (316)
T 2xir_A 255 KIDEE------FCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307 (316)
T ss_dssp CCSHH------HHHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred chhHH------HHHHhccCccCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 33211 1111111211111 11123457899999999999999999999999976
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=346.88 Aligned_cols=246 Identities=22% Similarity=0.332 Sum_probs=201.7
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|.+.+.||+|+||.||+|.. .+++.||+|++.+.. ......+.+|+.+++.++||||+++++++......++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6899999999999999999996 578899999986532 223457889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+ +|+|.+++... +.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 67887777443 45899999999999999999999999 999999999999999999999999999875332
Q ss_pred CcccccccccccccccCcccccCCCC-CccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTI-SMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
.......||+.|+|||.+.+..+ ++++||||||+++|+|++|+.||........... +..
T Consensus 162 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~----------------i~~ 222 (336)
T 3h4j_B 162 ---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----------------VNS 222 (336)
T ss_dssp ---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC----------------CCS
T ss_pred ---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH----------------HHc
Confidence 22335679999999999998876 7899999999999999999999975443221110 000
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.. ...+......+.+++.+||+.||.+|||++|+++.
T Consensus 223 ~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 223 CV-YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp SC-CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CC-CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00 01111223457799999999999999999999853
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=358.96 Aligned_cols=264 Identities=20% Similarity=0.240 Sum_probs=208.7
Q ss_pred chHhHHHHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeee
Q 004264 437 DLATITTATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512 (765)
Q Consensus 437 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~ 512 (765)
.+.++....++|++.++||+|+||.||+|+.. +++.||+|++.+.. ......+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 44556667789999999999999999999976 47889999987532 122334889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccc
Q 004264 513 EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDF 592 (765)
Q Consensus 513 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DF 592 (765)
+.+..+|||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999999542 346899999999999999999999999 999999999999999999999999
Q ss_pred ccceeeCCCCcccccccccccccccCccccc-----CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 004264 593 GLARIFGGDDEEAQTERVAGTHGYMSPEYAN-----DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWL 667 (765)
Q Consensus 593 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~ 667 (765)
|+++........ .....+||+.|+|||++. ...++.++||||||+++|||++|+.||......+. ....
T Consensus 220 Gla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~---~~~i-- 293 (437)
T 4aw2_A 220 GSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKI-- 293 (437)
T ss_dssp TTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHH--
T ss_pred hhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH---HHhh--
Confidence 999876433222 223468999999999987 56799999999999999999999999975432211 1111
Q ss_pred hhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 004264 668 LWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPED--RPDMSSVVFL 718 (765)
Q Consensus 668 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 718 (765)
........+... .......+.+++.+||+.+|++ ||+++|+++.
T Consensus 294 -~~~~~~~~~p~~------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 294 -MNHKERFQFPTQ------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp -HTHHHHCCCCSS------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred -hhccccccCCcc------cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 100000011100 0112345778999999888888 9999999863
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=350.34 Aligned_cols=253 Identities=24% Similarity=0.304 Sum_probs=204.9
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
..++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4578999999999999999999864 6889999999754 344567789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC---CCeeccccccee
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL---NPKISDFGLARI 597 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~vkL~DFGla~~ 597 (765)
|||+++++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++.
T Consensus 107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999888843 346899999999999999999999999 99999999999998654 599999999987
Q ss_pred eCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 598 FGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .+ ......+... .
T Consensus 181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~----~~~i~~~~~~-~ 249 (362)
T 2bdw_A 181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RL----YAQIKAGAYD-Y 249 (362)
T ss_dssp CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHTCCC-C
T ss_pred ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HH----HHHHHhCCCC-C
Confidence 64322 223467999999999999999999999999999999999999998643221 11 1111111110 0
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..+. .......+.+++.+||+.||++||++.++++.
T Consensus 250 ~~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 PSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CTTG-----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred Cccc-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1000 01123457789999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=349.08 Aligned_cols=267 Identities=18% Similarity=0.224 Sum_probs=200.1
Q ss_pred hcCcccccccccCCceeEEEEEeC----CCcEEEEEEccccChh-----------hHHHHHHHHHHHhccccCceEeeee
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS----TGQEIAAKRLSKNSGQ-----------GLEEFMNEVVLIGKLQHRNLVGLLG 509 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~-----------~~~~~~~Ev~~l~~l~h~niv~~~~ 509 (765)
.++|++.+.||+|+||.||+|... .+..+|+|++...... ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999975 5778999998764321 1223667888999999999999999
Q ss_pred eeee----cCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC
Q 004264 510 SCIE----EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL 585 (765)
Q Consensus 510 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 585 (765)
++.+ ....++||||+ +++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67899999999 99999998543 26899999999999999999999998 99999999999999887
Q ss_pred --CCeecccccceeeCCCCcc-----cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCc
Q 004264 586 --NPKISDFGLARIFGGDDEE-----AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHR 658 (765)
Q Consensus 586 --~vkL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~ 658 (765)
.+||+|||+++.+...... .......||..|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999876432111 112346799999999999999999999999999999999999999964322211
Q ss_pred ccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCC
Q 004264 659 HNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGV 724 (765)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 724 (765)
........... .....+..... .......+.+++..||+.+|++||++++|+++|++...
T Consensus 269 --~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 --AVQTAKTNLLD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp --HHHHHHHHHHH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred --HHHHHHHhhcc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11111111100 00000000000 00223468899999999999999999999999987554
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=338.50 Aligned_cols=254 Identities=24% Similarity=0.322 Sum_probs=194.9
Q ss_pred hcCcccccccccCCceeEEEEEeCC----CcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLST----GQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
.++|++.+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4689999999999999999998643 456999998754 3445678999999999999999999999974 567899
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999998543 345899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
..... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ .... ...+....
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~----i~~~~~~~-- 237 (281)
T 1mp8_A 168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGR----IENGERLP-- 237 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HHTTCCCC--
T ss_pred ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHH----HHcCCCCC--
Confidence 32221 1223456788999999999999999999999999999997 999986543322 1111 11111111
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.+......+.+++.+||+.||++|||+.+|+++|+.
T Consensus 238 -------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 238 -------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 111223567899999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=337.12 Aligned_cols=253 Identities=30% Similarity=0.421 Sum_probs=207.9
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecC
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
++|++.+.||+|+||.||++...+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 67899999999999999999988888999999976433 34689999999999999999999999999999999999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 160 (267)
T 3t9t_A 87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT 160 (267)
T ss_dssp TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc-cc
Confidence 99999998543 345899999999999999999999999 9999999999999999999999999998753221 11
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
......++..|+|||.+.+..++.++||||||+++|+|++ |+.||....... .......+...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~i~~~~~~--------- 224 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGFRL--------- 224 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCCC---------
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-------HHHHHhcCCcC---------
Confidence 1223556788999999998999999999999999999999 899986432211 11111111110
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..+......+.+++.+||+.+|++||++.+++++|++
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 0111123457899999999999999999999999976
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=349.85 Aligned_cols=266 Identities=19% Similarity=0.257 Sum_probs=204.4
Q ss_pred HhcCcccccccccCCceeEEEEEeCC------CcEEEEEEccccChhhH-----------HHHHHHHHHHhccccCceEe
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLST------GQEIAAKRLSKNSGQGL-----------EEFMNEVVLIGKLQHRNLVG 506 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~~~-----------~~~~~Ev~~l~~l~h~niv~ 506 (765)
..++|++.+.||+|+||.||+|.+.. ++.||+|++........ ..+..|+..++.++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 44689999999999999999998754 47899999876542211 12344666777889999999
Q ss_pred eeeeeeec----CceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEe
Q 004264 507 LLGSCIEE----DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD 582 (765)
Q Consensus 507 ~~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 582 (765)
+++++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999875 4589999999 9999999854 2356999999999999999999999999 99999999999999
Q ss_pred --cCCCCeecccccceeeCCCCccc-----ccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCC
Q 004264 583 --INLNPKISDFGLARIFGGDDEEA-----QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHP 655 (765)
Q Consensus 583 --~~~~vkL~DFGla~~~~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~ 655 (765)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998764322111 11235699999999999999999999999999999999999999975433
Q ss_pred CCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 656 GHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
... ......... ...+..+++.++... .....+.+++..||+.+|++||++.+|+++|++
T Consensus 267 ~~~--~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 267 DPK--YVRDSKIRY-RENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp CHH--HHHHHHHHH-HHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred CHH--HHHHHHHHh-hhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 211 111111111 112333344433211 123467789999999999999999999999876
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=343.86 Aligned_cols=249 Identities=23% Similarity=0.340 Sum_probs=200.2
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV 520 (765)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999975 5889999999754 334456788999999987 899999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999988542 45899999999999999999999999 99999999999999999999999999986432
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcc--cHHHHHHHhhccCCccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRH--NLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~ 678 (765)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ...............
T Consensus 163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence 22 2233578999999999999999999999999999999999999999653221111 111111111111111
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCH
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDM 712 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 712 (765)
..+......+.+++.+||+.||++||++
T Consensus 237 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ------RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1111223467889999999999999996
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=342.47 Aligned_cols=264 Identities=23% Similarity=0.312 Sum_probs=189.8
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467999999999999999999864 68899999987543 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccc---cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 523 YMPHKSLDYFIFDRE---RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
|++ ++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58888875432 2245899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhcc---CCcc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWND---GRAL 675 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 675 (765)
.... ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.. ......... ..+.
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL---KLIFDIMGTPNESLWP 234 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCTTTCG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChhHhh
Confidence 3221 2234578999999999976 46899999999999999999999999754432211 111111100 0000
Q ss_pred c---cc--c------------ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 676 G---LM--D------------TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 676 ~---l~--d------------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
. +. . ..+...........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 00 0 00000011112346889999999999999999999885
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=341.51 Aligned_cols=247 Identities=23% Similarity=0.281 Sum_probs=194.7
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~l 519 (765)
..++|++.++||+|+||+||+|+.. +++.||||++... ......++..|+..+.++ +||||+++++++.++...++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3468999999999999999999975 7899999998653 233444556666666665 89999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 135 v~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 99999 66888877543 346999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
... ......||+.|+|||++.+ .++.++||||||+++|||++|..++... ..+.....+...
T Consensus 209 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~~~~~~~~~---- 270 (311)
T 3p1a_A 209 TAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQQLRQGYLP---- 270 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHHHHTTTCCC----
T ss_pred cCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHHHHhccCCC----
Confidence 322 2334568999999999876 7999999999999999999997664321 011111111111
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..........+.+++.+||+.||++|||+.++++.
T Consensus 271 ----~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 271 ----PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 11111224568899999999999999999999863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=354.27 Aligned_cols=252 Identities=24% Similarity=0.326 Sum_probs=197.7
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccc--cCceEeeeeeeeecCceEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQ--HRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~--h~niv~~~~~~~~~~~~~lV 520 (765)
.++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.+|++++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3569999999999999999999888999999998643 3455678999999999996 59999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|| +.+++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 6788999998543 36889999999999999999999999 99999999999995 57899999999987654
Q ss_pred CCcccccccccccccccCcccccC-----------CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhh
Q 004264 601 DDEEAQTERVAGTHGYMSPEYAND-----------GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLW 669 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 669 (765)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .........
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~ 281 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII 281 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHh
Confidence 333333345679999999999865 4689999999999999999999999864321 111111111
Q ss_pred ccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 670 NDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 670 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...... ..+......+.+|+.+||+.||++||++.+|++.
T Consensus 282 ~~~~~~---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 DPNHEI---------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CTTSCC---------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CccccC---------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111111 1111113457789999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=345.15 Aligned_cols=266 Identities=26% Similarity=0.394 Sum_probs=200.9
Q ss_pred HhHHHHhcCcccccccccCCceeEEEEEeC----CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeee
Q 004264 439 ATITTATNHFSEANMIGKGGFGPVYMGKLS----TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512 (765)
Q Consensus 439 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~ 512 (765)
..+....++|.+.+.||+|+||.||+|... .++.||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 334445678999999999999999999754 3457999998754 3445678999999999999999999999998
Q ss_pred ecC-----ceEEEEEecCCCChhHHhhcc---ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC
Q 004264 513 EED-----ERMLIYEYMPHKSLDYFIFDR---ERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN 584 (765)
Q Consensus 513 ~~~-----~~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 584 (765)
+.. ..++||||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 765 349999999999999988542 23456899999999999999999999998 9999999999999999
Q ss_pred CCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHH
Q 004264 585 LNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIG 663 (765)
Q Consensus 585 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~ 663 (765)
+.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ...
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~ 260 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYD 260 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHH
Confidence 9999999999987644332233334567889999999999999999999999999999999 888886543321 111
Q ss_pred HHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 004264 664 HAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDG 723 (765)
Q Consensus 664 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 723 (765)
. ...+..... +......+.+++.+||+.+|++||++.+|+++|++..
T Consensus 261 ~----~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 261 Y----LLHGHRLKQ---------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp H----HHTTCCCCC---------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H----HHcCCCCCC---------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 111111111 1122346889999999999999999999999998743
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=346.06 Aligned_cols=245 Identities=22% Similarity=0.248 Sum_probs=204.6
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
.++|++.+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 368999999999999999999875 68999999986542 23457788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999998543 35899999999999999999999999 99999999999999999999999999997643
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||....+.. .......+.. .
T Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~-~---- 256 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKV-R---- 256 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-C----
T ss_pred C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-------HHHHHHcCCC-C----
Confidence 2 234679999999999999999999999999999999999999986433211 1111111211 1
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPD-----MSSVVF 717 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 717 (765)
.+......+.+++.+||+.||++||+ +++|++
T Consensus 257 -----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 -----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11122346789999999999999998 888874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=349.39 Aligned_cols=250 Identities=25% Similarity=0.338 Sum_probs=203.4
Q ss_pred HHHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCc
Q 004264 442 TTATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDE 516 (765)
Q Consensus 442 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~ 516 (765)
....++|++.+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345578999999999999999999975 68899999997542 33456788899999887 89999999999999999
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999999854 245899999999999999999999999 9999999999999999999999999998
Q ss_pred eeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 597 IFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ +. .....+..
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~----~~i~~~~~-- 235 (345)
T 1xjd_A 167 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LF----HSIRMDNP-- 235 (345)
T ss_dssp CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HHHHHCCC--
T ss_pred hcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---HH----HHHHhCCC--
Confidence 643222 22345789999999999999999999999999999999999999986433211 11 11111110
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMS-SVV 716 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 716 (765)
.++......+.+++.+||+.||++||++. +|+
T Consensus 236 --------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 --------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11111234677899999999999999997 665
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=356.17 Aligned_cols=261 Identities=21% Similarity=0.257 Sum_probs=207.6
Q ss_pred chHhHHHHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeee
Q 004264 437 DLATITTATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512 (765)
Q Consensus 437 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~ 512 (765)
.+..+....++|++.+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34455667789999999999999999999875 58899999986531 122345789999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccc
Q 004264 513 EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDF 592 (765)
Q Consensus 513 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DF 592 (765)
+....++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+||
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecc
Confidence 99999999999999999998853 24899999999999999999999999 999999999999999999999999
Q ss_pred ccceeeCCCCcccccccccccccccCcccccCCC----CCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHh
Q 004264 593 GLARIFGGDDEEAQTERVAGTHGYMSPEYANDGT----ISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLL 668 (765)
Q Consensus 593 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~ 668 (765)
|+++....... ......+||+.|+|||++.+.. ++.++||||||+++|||++|+.||........ ... .
T Consensus 213 G~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~---i 285 (410)
T 3v8s_A 213 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YSK---I 285 (410)
T ss_dssp TTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHH---H
T ss_pred ceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH---HHH---H
Confidence 99987643322 2233578999999999998765 88999999999999999999999965432211 111 1
Q ss_pred hccCCccccccccccCccCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 004264 669 WNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPED--RPDMSSVVFL 718 (765)
Q Consensus 669 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 718 (765)
..........+. ......+.+|+.+||+.+|.+ ||+++||++.
T Consensus 286 ~~~~~~~~~p~~-------~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 286 MNHKNSLTFPDD-------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HTHHHHCCCCTT-------CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred HhccccccCCCc-------ccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 100000001100 012345778999999999988 9999999964
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=335.19 Aligned_cols=252 Identities=22% Similarity=0.336 Sum_probs=202.8
Q ss_pred hcCcccccccccCCceeEEEEEeCC-C-------cEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCc
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLST-G-------QEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE 516 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~-------~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~ 516 (765)
.++|++.+.||+|+||.||+|+... + +.||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3679999999999999999998643 3 4699999987766777889999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCC--------Ce
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLN--------PK 588 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------vk 588 (765)
.++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999998543 234899999999999999999999999 999999999999998887 99
Q ss_pred ecccccceeeCCCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 004264 589 ISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWL 667 (765)
Q Consensus 589 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~ 667 (765)
|+|||++..... .....+|..|+|||.+.+ ..++.++||||||+++|||++|..|+...... .... .
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----~~~~-~ 229 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-----QRKL-Q 229 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHH-H
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-----HHHH-H
Confidence 999999875421 123567889999999987 77999999999999999999965543221111 1111 1
Q ss_pred hhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCC
Q 004264 668 LWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGV 724 (765)
Q Consensus 668 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 724 (765)
..... ..+... ....+.+++.+||+.||++|||+.++++.|+....
T Consensus 230 ~~~~~--~~~~~~---------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 230 FYEDR--HQLPAP---------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHTT--CCCCCC---------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred Hhhcc--CCCCCC---------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11110 011111 12246789999999999999999999999987443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=332.67 Aligned_cols=254 Identities=27% Similarity=0.461 Sum_probs=201.9
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhh-------HHHHHHHHHHHhccccCceEeeeeeeeecCc
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQG-------LEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE 516 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~-------~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~ 516 (765)
.++|++.+.||+|+||.||+|+. .+++.||+|++....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36899999999999999999986 478899999986532211 267899999999999999999999986554
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCC-----Ceecc
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLN-----PKISD 591 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----vkL~D 591 (765)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 7999999999998887543 346899999999999999999999875 34999999999999988776 99999
Q ss_pred cccceeeCCCCcccccccccccccccCcccc--cCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhh
Q 004264 592 FGLARIFGGDDEEAQTERVAGTHGYMSPEYA--NDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLW 669 (765)
Q Consensus 592 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~--~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 669 (765)
||+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||......... ......
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~ 243 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK----FINMIR 243 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH----HHHHHH
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH----HHHHHh
Confidence 999985422 23346789999999998 4556899999999999999999999999754433211 111111
Q ss_pred ccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 670 NDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 670 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..+.. ...+......+.+++.+||+.||++|||+++|++.|++
T Consensus 244 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 EEGLR---------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HSCCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ccCCC---------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 11111 11112224568899999999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=335.04 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=206.6
Q ss_pred cCccccc-ccccCCceeEEEEEeC---CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 446 NHFSEAN-MIGKGGFGPVYMGKLS---TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 446 ~~y~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
++|.+.+ .||+|+||.||+|... .++.||+|++... .....+++.+|+.++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 5666666 8999999999999853 5778999999764 344567899999999999999999999999 56678999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999853 3346899999999999999999999999 99999999999999999999999999998754
Q ss_pred CCccc-ccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 601 DDEEA-QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 601 ~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ . ......+....
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~----~~~i~~~~~~~-- 233 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---V----MAFIEQGKRME-- 233 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---H----HHHHHTTCCCC--
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---H----HHHHhcCCcCC--
Confidence 33221 2223456889999999998899999999999999999998 999986543321 1 11111222111
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.+......+.+++..||+.+|++||++.+|++.|++
T Consensus 234 -------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 269 (287)
T 1u59_A 234 -------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269 (287)
T ss_dssp -------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 112234568899999999999999999999999976
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.95 Aligned_cols=250 Identities=22% Similarity=0.218 Sum_probs=181.0
Q ss_pred cccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccc-cCceEeeeeeeeecCceEEEEEecCCCCh
Q 004264 452 NMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDERMLIYEYMPHKSL 529 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~~~lV~E~~~~gsL 529 (765)
+.||+|+||.||++... +++.||+|++.+. ....+.+|+.+++++. ||||+++++++.+....++||||+++++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 78999999999999875 6889999999653 3467789999999997 99999999999999999999999999999
Q ss_pred hHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC---CCeecccccceeeCCCCcccc
Q 004264 530 DYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL---NPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 530 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~vkL~DFGla~~~~~~~~~~~ 606 (765)
.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++...... ..
T Consensus 94 ~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~ 165 (325)
T 3kn6_A 94 FERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QP 165 (325)
T ss_dssp HHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Cc
Confidence 999854 346899999999999999999999999 99999999999998765 79999999998754322 22
Q ss_pred cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCcc
Q 004264 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSF 686 (765)
Q Consensus 607 ~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 686 (765)
.....+|+.|+|||.+.+..++.++||||||+++|||++|+.||.....................+.... ....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~------~~~~ 239 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF------EGEA 239 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC------CSHH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC------Cccc
Confidence 2346789999999999999999999999999999999999999976544322222222222222222110 0000
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 687 VESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 687 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.......+.+++..||+.||++|||++++++.
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 01124567899999999999999999999844
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=332.94 Aligned_cols=261 Identities=21% Similarity=0.258 Sum_probs=203.2
Q ss_pred HhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeee-eecCceEEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSC-IEEDERMLIY 521 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~-~~~~~~~lV~ 521 (765)
..++|++.+.||+|+||.||+|+. .+++.||+|++..... ..++.+|+.++++++|++++..+..+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999986 5788999998754332 24578899999999988766666555 6677889999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE---ecCCCCeecccccceee
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL---DINLNPKISDFGLARIF 598 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~vkL~DFGla~~~ 598 (765)
||+ +++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999998532 345899999999999999999999999 9999999999999 78899999999999987
Q ss_pred CCCCccc-----ccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC
Q 004264 599 GGDDEEA-----QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR 673 (765)
Q Consensus 599 ~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 673 (765)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 5433221 22356789999999999999999999999999999999999999987655444333332211110000
Q ss_pred ccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 674 ALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 674 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
. +..... ....+.+++..||+.+|++||++++|+++|++
T Consensus 239 ~-----~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 239 I-----EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp H-----HHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred h-----hhhhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 0 000011 13468899999999999999999999999976
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=338.21 Aligned_cols=255 Identities=31% Similarity=0.451 Sum_probs=206.8
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
.++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 36799999999999999999998888899999997543 34578999999999999999999999876 45689999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 90 ~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 164 (279)
T 1qpc_A 90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY- 164 (279)
T ss_dssp TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred CCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc-
Confidence 9999999985422 225899999999999999999999999 99999999999999999999999999987643322
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ......+....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~----~~~~~~~~~~~------- 230 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EV----IQNLERGYRMV------- 230 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH----HHHHHTTCCCC-------
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HH----HHHHhcccCCC-------
Confidence 12223556788999999998999999999999999999999 89898643221 11 11111111111
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
.+......+.+++..|++.+|++|||+.+|+++|+..
T Consensus 231 --~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 231 --RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 1112235678999999999999999999999999763
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=338.68 Aligned_cols=265 Identities=22% Similarity=0.310 Sum_probs=200.1
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999975 58899999986543 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999888743 345899999999999999999999999 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHhhccCC
Q 004264 603 EEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHA--------WLLWNDGR 673 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 673 (765)
. ......+|..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+....+... ...+....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 2 2234578999999999876 67899999999999999999999998654432221111110 00011111
Q ss_pred cc---ccccccccCc---cCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 674 AL---GLMDTCLEDS---FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 674 ~~---~l~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.. .+.++..... ........+.+++.+||+.||++|||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 0111100000 001223457899999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=331.94 Aligned_cols=254 Identities=23% Similarity=0.342 Sum_probs=206.2
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 468999999999999999999875 6889999998643 33446788999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999988842 345899999999999999999999999 9999999999999999999999999998764333
Q ss_pred cccccccccccccccCcccccCCCC-CccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTI-SMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~-s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
.........|++.|+|||.+.+..+ +.++||||||+++|||++|+.||......... . ..+...... ...
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~----~~~~~~~~~--~~~- 230 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--Y----SDWKEKKTY--LNP- 230 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH--H----HHHHTTCTT--STT-
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH--H----HHhhhcccc--cCc-
Confidence 3333345678999999999988765 78999999999999999999999754433211 1 111111110 000
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.......+.+++.+||+.||++|||+.++++.
T Consensus 231 -----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 231 -----WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 01123457789999999999999999999863
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.30 Aligned_cols=248 Identities=23% Similarity=0.286 Sum_probs=193.6
Q ss_pred hcCcccccccccCCceeEEEEEe----CCCcEEEEEEccccC----hhhHHHHHHHHHHHhccccCceEeeeeeeeecCc
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL----STGQEIAAKRLSKNS----GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE 516 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~ 516 (765)
.++|++.+.||+|+||.||+++. .+++.+|+|++.+.. ......+.+|+.++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36899999999999999999986 478999999997642 2345568899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999998853 345889999999999999999999999 9999999999999999999999999998
Q ss_pred eeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 597 IFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..... . ....
T Consensus 170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i---~-~~~~-- 238 (327)
T 3a62_A 170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK---TIDKI---L-KCKL-- 238 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHH---H-HTCC--
T ss_pred ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH---HHHHH---H-hCCC--
Confidence 643221 22234679999999999999999999999999999999999999986433211 11111 1 1110
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRP-----DMSSVVF 717 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 717 (765)
..+......+.+++.+||+.||++|| ++.++++
T Consensus 239 --------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 --------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 01112234678999999999999999 7778875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=344.82 Aligned_cols=263 Identities=23% Similarity=0.225 Sum_probs=203.1
Q ss_pred hHHHHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc-----ChhhHHHHHHHHHHHhccccCceEeeeeeeee
Q 004264 440 TITTATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN-----SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513 (765)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~ 513 (765)
.+....++|++.+.||+|+||.||+|.. .+++.+|+|++.+. .....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 3456778999999999999999999986 46788999998653 33456789999999999999999999999999
Q ss_pred cCceEEEEEecCCCChhHHhhccc-------------------------------------cCCCCChHHHHHHHHHHHH
Q 004264 514 EDERMLIYEYMPHKSLDYFIFDRE-------------------------------------RSKLLPWKKRFSIITGIAR 556 (765)
Q Consensus 514 ~~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qia~ 556 (765)
.+..++||||+++++|.+++.... ....+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 999999999999999999884210 0122467778899999999
Q ss_pred HHHHhhhcCCCcEEecccCCCcEEEecCC--CCeecccccceeeCCCCcc--cccccccccccccCcccccC--CCCCcc
Q 004264 557 GLLYLHQDSKLQVIHRDLKASNILLDINL--NPKISDFGLARIFGGDDEE--AQTERVAGTHGYMSPEYAND--GTISMK 630 (765)
Q Consensus 557 aL~~LH~~~~~~ivH~Dlkp~NIll~~~~--~vkL~DFGla~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~--~~~s~k 630 (765)
||+|||+.+ |+||||||+|||++.++ .+||+|||+++.+...... .......||+.|+|||.+.+ ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999999 99999999999998776 8999999999876432221 12335679999999999975 678999
Q ss_pred ccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCC
Q 004264 631 SDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRP 710 (765)
Q Consensus 631 ~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 710 (765)
+||||||+++|||++|+.||......+ ........... ...+ ........+.+++.+||+.+|++||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~~--~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDAD------TISQVLNKKLC--FENP-----NYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCC--TTSG-----GGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcccc--cCCc-----ccccCCHHHHHHHHHHcCCChhHCC
Confidence 999999999999999999986443221 11111111110 0001 0111234678999999999999999
Q ss_pred CHHHHHHH
Q 004264 711 DMSSVVFL 718 (765)
Q Consensus 711 s~~evl~~ 718 (765)
++.++++.
T Consensus 324 s~~~~l~h 331 (345)
T 3hko_A 324 DAMRALQH 331 (345)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhcC
Confidence 99999863
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=339.56 Aligned_cols=268 Identities=25% Similarity=0.307 Sum_probs=199.7
Q ss_pred HHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC-----hhhHHHHHHHHHHHhccc---cCceEeeeeeeee
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS-----GQGLEEFMNEVVLIGKLQ---HRNLVGLLGSCIE 513 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~Ev~~l~~l~---h~niv~~~~~~~~ 513 (765)
...++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467999999999999999999996 568899999986432 112346677888877775 9999999999987
Q ss_pred cC-----ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCe
Q 004264 514 ED-----ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPK 588 (765)
Q Consensus 514 ~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vk 588 (765)
.. ..++||||+. ++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 65 4789999997 58988885433 234899999999999999999999999 99999999999999999999
Q ss_pred ecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHh
Q 004264 589 ISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLL 668 (765)
Q Consensus 589 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~ 668 (765)
|+|||+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+......
T Consensus 161 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 161 LADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp ECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999865322 2233567899999999999999999999999999999999999998654432211111111000
Q ss_pred hccCCccc---ccccccc-------CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 669 WNDGRALG---LMDTCLE-------DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 669 ~~~~~~~~---l~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.....+.. +...... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00111100 0000000 00111223567899999999999999999999863
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=348.26 Aligned_cols=271 Identities=21% Similarity=0.280 Sum_probs=212.7
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecC--ceEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED--ERMLI 520 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~--~~~lV 520 (765)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999875 58899999997543 344677889999999999999999999998765 67999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE----ecCCCCeecccccce
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL----DINLNPKISDFGLAR 596 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~vkL~DFGla~ 596 (765)
|||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976555555999999999999999999999999 9999999999999 677779999999998
Q ss_pred eeCCCCcccccccccccccccCcccccC--------CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCc-ccHHHHHHH
Q 004264 597 IFGGDDEEAQTERVAGTHGYMSPEYAND--------GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHR-HNLIGHAWL 667 (765)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~-~~~~~~~~~ 667 (765)
..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ .........
T Consensus 165 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 165 ELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp ECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred EccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 76432 22234679999999999865 5678899999999999999999999975443222 222211111
Q ss_pred hhccCCcccc---cc--------ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 668 LWNDGRALGL---MD--------TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 668 ~~~~~~~~~l---~d--------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
......+..+ .+ ..............+.+++..||+.||++||++.++++.|+.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 1100000000 00 011123445667788899999999999999999999988865
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=346.14 Aligned_cols=253 Identities=21% Similarity=0.232 Sum_probs=193.7
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
.++|++.+.||+|+||.||+++.. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999975 788999999975432 336788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCC--CeecccccceeeCCC
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLN--PKISDFGLARIFGGD 601 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--vkL~DFGla~~~~~~ 601 (765)
+++++|.+++... +.+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~- 170 (361)
T 3uc3_A 98 ASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 170 (361)
T ss_dssp CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc-
Confidence 9999999988543 35899999999999999999999999 999999999999987765 99999999985322
Q ss_pred CcccccccccccccccCcccccCCCCCcc-ccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMK-SDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k-~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
........||+.|+|||++.+..++.+ +||||||+++|+|++|+.||............ ..... .... .+.+
T Consensus 171 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~--~~~~~-~~~~-~~~~- 243 (361)
T 3uc3_A 171 --HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT--IQRIL-SVKY-SIPD- 243 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH--HHHHH-TTCC-CCCT-
T ss_pred --cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH--HHHHh-cCCC-CCCC-
Confidence 122234679999999999988888666 89999999999999999999755433221111 11111 1110 0000
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.......+.+|+.+||+.+|++|||+.++++.
T Consensus 244 ------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 ------DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00123457799999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=355.19 Aligned_cols=263 Identities=22% Similarity=0.252 Sum_probs=207.0
Q ss_pred chHhHHHHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeee
Q 004264 437 DLATITTATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512 (765)
Q Consensus 437 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~ 512 (765)
.+.++....++|++.+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|+.++.+++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34455566789999999999999999999974 68999999997532 223345889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccc
Q 004264 513 EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDF 592 (765)
Q Consensus 513 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DF 592 (765)
+.+..+|||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 999999999999999999998542 236899999999999999999999999 999999999999999999999999
Q ss_pred ccceeeCCCCcccccccccccccccCccccc-------CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 004264 593 GLARIFGGDDEEAQTERVAGTHGYMSPEYAN-------DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHA 665 (765)
Q Consensus 593 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~ 665 (765)
|+++....... ......+||+.|+|||++. ...++.++||||||+++|||++|+.||......+. ....
T Consensus 207 Gla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~i 282 (412)
T 2vd5_A 207 GSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET---YGKI 282 (412)
T ss_dssp TTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHH
T ss_pred hhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH---HHHH
Confidence 99987643322 1223468999999999987 46789999999999999999999999965432211 1111
Q ss_pred HHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 004264 666 WLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDR---PDMSSVVFL 718 (765)
Q Consensus 666 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~ 718 (765)
........+ +. ........+.+++.+||+ +|++| |+++||++.
T Consensus 283 ---~~~~~~~~~--p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 283 ---VHYKEHLSL--PL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ---HTHHHHCCC--C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ---HhcccCcCC--Cc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 000000000 00 011123467789999999 99998 589998753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=345.86 Aligned_cols=249 Identities=24% Similarity=0.299 Sum_probs=203.1
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~ 518 (765)
..++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3478999999999999999999975 4788999999754 233456788999999988 7999999999999999999
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
+||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999998543 35899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ +.. ....+..
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~----~i~~~~~---- 238 (353)
T 2i0e_A 172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQ----SIMEHNV---- 238 (353)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCCC----
T ss_pred ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---HHH----HHHhCCC----
Confidence 3221 22345789999999999999999999999999999999999999986433211 111 1111111
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPD-----MSSVVF 717 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 717 (765)
.++......+.+++.+||+.||++||+ +++|++
T Consensus 239 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 ------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 111123456789999999999999995 577764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=348.86 Aligned_cols=262 Identities=23% Similarity=0.317 Sum_probs=206.2
Q ss_pred cCc-ccccccccCCceeEEEEEe-----CCCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeec--Cc
Q 004264 446 NHF-SEANMIGKGGFGPVYMGKL-----STGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE--DE 516 (765)
Q Consensus 446 ~~y-~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~--~~ 516 (765)
++| ++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 455 8999999999999998864 267889999997653 44567899999999999999999999999884 57
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
.++||||+++++|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence 8999999999999999843 23899999999999999999999999 9999999999999999999999999999
Q ss_pred eeCCCCcc-cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCC--------cccHHHHHHH
Q 004264 597 IFGGDDEE-AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGH--------RHNLIGHAWL 667 (765)
Q Consensus 597 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~--------~~~~~~~~~~ 667 (765)
........ .......++..|+|||.+.+..++.++||||||+++|||++|+.||....... ..........
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 87543322 22334567888999999999999999999999999999999999975321100 0000000111
Q ss_pred hhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 004264 668 LWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDG 723 (765)
Q Consensus 668 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 723 (765)
. ++.......+......+.+|+.+||+.||++|||+.+|+++|+...
T Consensus 263 ~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 263 L---------LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp H---------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H---------HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1 1111111222233456889999999999999999999999998743
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=347.48 Aligned_cols=248 Identities=26% Similarity=0.309 Sum_probs=196.8
Q ss_pred ccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCC
Q 004264 449 SEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHK 527 (765)
Q Consensus 449 ~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~g 527 (765)
...+.||+|+||.||+|+. .+++.||+|++........+++.+|+.++++++||||+++++++.+.+..+|||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3357899999999999986 468899999998776667788999999999999999999999999999999999999999
Q ss_pred ChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE--ecCCCCeecccccceeeCCCCccc
Q 004264 528 SLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL--DINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 528 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll--~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 172 ~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--- 243 (373)
T 2x4f_A 172 ELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--- 243 (373)
T ss_dssp EEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---
T ss_pred cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---
Confidence 998888542 245899999999999999999999999 9999999999999 456789999999999864332
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCc
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDS 685 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 685 (765)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ..... . .... .+....
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~i---~-~~~~-~~~~~~---- 311 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE---TLNNI---L-ACRW-DLEDEE---- 311 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHH---H-HTCC-CSCSGG----
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH---H-hccC-CCChhh----
Confidence 2234579999999999999999999999999999999999999986543211 11111 1 1111 001110
Q ss_pred cCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 686 FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 686 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.......+.+++.+||+.||++|||+.++++
T Consensus 312 -~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 312 -FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp -GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0112346789999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=330.97 Aligned_cols=262 Identities=21% Similarity=0.252 Sum_probs=206.8
Q ss_pred HhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeee-eecCceEEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSC-IEEDERMLIY 521 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~-~~~~~~~lV~ 521 (765)
..++|++.+.||+|+||.||+|+. .+++.||+|++..... .+++.+|+.++++++|++++..+..+ .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 347899999999999999999996 5789999999865433 24688999999999988766655554 5677789999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE---ecCCCCeecccccceee
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL---DINLNPKISDFGLARIF 598 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~vkL~DFGla~~~ 598 (765)
||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 99999998532 346899999999999999999999999 9999999999999 48899999999999987
Q ss_pred CCCCccc-----ccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC
Q 004264 599 GGDDEEA-----QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR 673 (765)
Q Consensus 599 ~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 673 (765)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 5433221 12356799999999999999999999999999999999999999986554443333322211110000
Q ss_pred ccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 674 ALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 674 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
. +.+.. .....+.+++.+||+.||++||++++|++.|++.
T Consensus 239 ~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 239 I-----EVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp H-----HHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred h-----HHHHh----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 0 00011 1234578999999999999999999999999763
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=334.80 Aligned_cols=266 Identities=24% Similarity=0.334 Sum_probs=202.5
Q ss_pred hHHHHhcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhcc--ccCceEeeeeeeeec---
Q 004264 440 TITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL--QHRNLVGLLGSCIEE--- 514 (765)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l--~h~niv~~~~~~~~~--- 514 (765)
......++|++.+.||+|+||.||+|+.. ++.||+|++.... ...+..|.+++..+ +||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 33455689999999999999999999875 8999999986432 24455566666554 899999999999887
Q ss_pred -CceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhc--------CCCcEEecccCCCcEEEecCC
Q 004264 515 -DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD--------SKLQVIHRDLKASNILLDINL 585 (765)
Q Consensus 515 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~--------~~~~ivH~Dlkp~NIll~~~~ 585 (765)
...++||||+++++|.+++.. ..+++..++.++.||+.||.|||+. + |+||||||+|||++.++
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNG 179 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTS
T ss_pred CCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCC
Confidence 688999999999999999843 2489999999999999999999998 7 99999999999999999
Q ss_pred CCeecccccceeeCCCCcccc--cccccccccccCcccccCCCCCcc------ccchHHHHHHHHHHhC----------C
Q 004264 586 NPKISDFGLARIFGGDDEEAQ--TERVAGTHGYMSPEYANDGTISMK------SDVFSLGVLLVEIVSG----------K 647 (765)
Q Consensus 586 ~vkL~DFGla~~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~s~k------~DvwSlG~ll~elltG----------~ 647 (765)
.+||+|||+++.+........ .....||+.|+|||++.+..+..+ +||||||+++|||++| +
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 999999999987643322211 224579999999999988776665 9999999999999999 5
Q ss_pred CCCCCCCCCCcccHHHHHHHhhccCCcccccccccc-CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 648 MNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE-DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 648 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
.||....+..... ............ .+... ..........+.+++.+||+.||++|||+.+|++.|++.
T Consensus 260 ~p~~~~~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 260 LPYHDLVPSDPSY--EDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CTTTTTSCSSCCH--HHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ccHhhhcCCCCch--hhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 5554333222211 111111111111 11111 111235677899999999999999999999999999763
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=344.39 Aligned_cols=251 Identities=14% Similarity=0.143 Sum_probs=203.9
Q ss_pred HhcCcccccccccCCceeEEEEE------eCCCcEEEEEEccccChhhHHHHHHHHHHHhccc---cCceEeeeeeeeec
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGK------LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ---HRNLVGLLGSCIEE 514 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~---h~niv~~~~~~~~~ 514 (765)
..++|.+.+.||+|+||.||+|. ...++.||+|++.... ..++..|+.++++++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45779999999999999999994 4568899999997654 346777777777776 99999999999999
Q ss_pred CceEEEEEecCCCChhHHhhccc--cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec---------
Q 004264 515 DERMLIYEYMPHKSLDYFIFDRE--RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI--------- 583 (765)
Q Consensus 515 ~~~~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~--------- 583 (765)
+..++||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 99999999999999999996432 3456999999999999999999999998 999999999999998
Q ss_pred --CCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccH
Q 004264 584 --NLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNL 661 (765)
Q Consensus 584 --~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~ 661 (765)
++.+||+|||+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--- 293 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--- 293 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence 899999999999876433334444567899999999999999999999999999999999999999853322110
Q ss_pred HHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHhc
Q 004264 662 IGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDR-PDMSSVVFLLAN 721 (765)
Q Consensus 662 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~ 721 (765)
. +........ ....+.+++..|++.+|.+| |+++++.+.|++
T Consensus 294 -----------~----~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 294 -----------K----PEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp -----------E----ECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred -----------e----echhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 0 111111111 13456688889999999999 678888888865
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=330.47 Aligned_cols=249 Identities=28% Similarity=0.416 Sum_probs=183.9
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36799999999999999999986 578999999986532 22357789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999853 2356899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ..... +.
T Consensus 165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~------~~ 229 (278)
T 3cok_A 165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN-------KVVLA------DY 229 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSS------CC
T ss_pred CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-------HHhhc------cc
Confidence 222 1224578999999999999999999999999999999999999987544322110 00000 00
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
..+......+.+++.+||+.||++|||++++++
T Consensus 230 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 ----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 111122346779999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=331.85 Aligned_cols=251 Identities=21% Similarity=0.276 Sum_probs=204.6
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
..++|++.+.||+|+||.||+|... ++..+|+|++........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4578999999999999999999865 567899999987666667889999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE---ecCCCCeecccccceeeC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL---DINLNPKISDFGLARIFG 599 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~vkL~DFGla~~~~ 599 (765)
|+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||++ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999888854 345899999999999999999999999 9999999999999 788999999999998764
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
... ......+|+.|+|||.+.+. ++.++||||||+++|||++|+.||......+ .......+... ...
T Consensus 161 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~-~~~ 228 (277)
T 3f3z_A 161 PGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-------VMLKIREGTFT-FPE 228 (277)
T ss_dssp TTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC-CCH
T ss_pred Ccc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCC-CCc
Confidence 322 22346789999999998754 8999999999999999999999986433211 11111111110 000
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
... ......+.+++.+||+.||++|||+.++++
T Consensus 229 ~~~-----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 KDW-----LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHH-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhh-----hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 012346789999999999999999999985
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=357.57 Aligned_cols=249 Identities=25% Similarity=0.328 Sum_probs=194.4
Q ss_pred HhcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
..++|++.+.||+|+||.||++.. .+++.||+|++.+. .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 346899999999999999999986 46889999999753 33445678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhh-cCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ-DSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
||||+++++|.+++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++..
T Consensus 226 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999988853 3468999999999999999999998 88 999999999999999999999999999864
Q ss_pred CCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
... ........||+.|+|||++.+..++.++||||||+++|||++|+.||....... +... .. ....
T Consensus 300 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~---i~-~~~~---- 366 (446)
T 4ejn_A 300 IKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFEL---IL-MEEI---- 366 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH---HH-HCCC----
T ss_pred cCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHHH---HH-hCCC----
Confidence 222 222335789999999999999999999999999999999999999986433211 1111 11 1110
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRP-----DMSSVVF 717 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 717 (765)
.++......+.+|+.+||+.||++|| +++++++
T Consensus 367 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 ------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 01111234577999999999999999 9999985
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=353.06 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=206.2
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
.++|.+.+.||+|+||.||+|+.. +++.||||++.+.. ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367999999999999999999975 78999999997542 23356789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||+++++|.+++.. .+.+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999843 346899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCcccccccccccccccCcccccCCCC-CccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTI-SMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
. .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... .+. .....+.. ..
T Consensus 169 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~----~~i~~~~~-~~-- 235 (476)
T 2y94_A 169 G---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLF----KKICDGIF-YT-- 235 (476)
T ss_dssp T---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHH----HHHHTTCC-CC--
T ss_pred c---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHH----HHHhcCCc-CC--
Confidence 2 22334679999999999998776 78999999999999999999998643321 111 11111111 00
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhc
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF--LLAN 721 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 721 (765)
+......+.+++.+||+.||++|||+.+|++ .+.+
T Consensus 236 -------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 236 -------PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred -------CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 1112345778999999999999999999996 3444
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=332.61 Aligned_cols=248 Identities=26% Similarity=0.329 Sum_probs=200.4
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
+.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3468999999999999999999865 56789999986532 2235678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999988543 45899999999999999999999998 9999999999999999999999999986543
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
. .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+ .........
T Consensus 161 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~------ 223 (279)
T 3fdn_A 161 S----SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVE------ 223 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTC------
T ss_pred c----ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-------HHHHHHhCC------
Confidence 2 12234678999999999999999999999999999999999999986432211 111111111
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...+......+.+++.+||+.+|++|||+.+|++.
T Consensus 224 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ----CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ----CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01111123457789999999999999999999964
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=340.24 Aligned_cols=262 Identities=23% Similarity=0.261 Sum_probs=200.6
Q ss_pred hcCcccc-cccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEEE
Q 004264 445 TNHFSEA-NMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 445 ~~~y~~~-~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV~ 521 (765)
.++|.+. +.||+|+||.||+|.. .+++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3678885 7899999999999985 47899999999876666678899999999985 7999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCC---Ceecccccceee
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLN---PKISDFGLARIF 598 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---vkL~DFGla~~~ 598 (765)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++...
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999998543 45899999999999999999999999 999999999999988776 999999999865
Q ss_pred CCCCc-----ccccccccccccccCcccccC-----CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccH-------
Q 004264 599 GGDDE-----EAQTERVAGTHGYMSPEYAND-----GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNL------- 661 (765)
Q Consensus 599 ~~~~~-----~~~~~~~~gt~~Y~aPE~~~~-----~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~------- 661 (765)
..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 32211 111223569999999999875 5689999999999999999999999976554321110
Q ss_pred -HHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 662 -IGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 662 -~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..........+.. ....... ......+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~i~~~~~-~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGKY-EFPDKDW-----AHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCCC-CCCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccCc-ccCchhc-----ccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0111111111111 0110000 0123467899999999999999999999974
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=332.37 Aligned_cols=255 Identities=27% Similarity=0.364 Sum_probs=202.5
Q ss_pred HhcCcccccccccCCceeEEEEEeCC----CcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLST----GQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~ 518 (765)
..++|++.+.||+|+||.||+|+... +..||+|++... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34689999999999999999998542 335999998765 34456789999999999999999999998765 4578
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999998542 345899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ .... ...+.....
T Consensus 164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~----~~~~~~~~~ 235 (281)
T 3cc6_A 164 EDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGV----LEKGDRLPK 235 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHH----HHHTCCCCC
T ss_pred cccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHH----HhcCCCCCC
Confidence 432221 1223557888999999999999999999999999999998 999986543322 1111 111111111
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 236 ---------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 236 ---------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp ---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence 11123457899999999999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=343.43 Aligned_cols=252 Identities=21% Similarity=0.266 Sum_probs=189.6
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
..++|++.+.||+|+||.||+|+.. +++.||+|++.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4578999999999999999999975 57889999997543 34678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec---CCCCeecccccceeeC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI---NLNPKISDFGLARIFG 599 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~vkL~DFGla~~~~ 599 (765)
|+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999998843 345899999999999999999999999 999999999999975 8899999999998753
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... . .......... ....
T Consensus 203 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~----~~~~i~~~~~-~~~~ 272 (349)
T 2w4o_A 203 HQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--F----MFRRILNCEY-YFIS 272 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--H----HHHHHHTTCC-CCCT
T ss_pred cc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--H----HHHHHHhCCC-ccCC
Confidence 22 22234678999999999999999999999999999999999999986433221 0 1111111111 0111
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
+ ........+.+++.+||+.||++|||+.++++.
T Consensus 273 ~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 273 P-----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp T-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c-----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 111223467899999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=337.54 Aligned_cols=259 Identities=19% Similarity=0.205 Sum_probs=199.1
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
-++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999965 68899999987542 33457889999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999998543 45899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
... .......+++.|+|||.+.+..++.++||||||+++|||++|+.||...... ........... ..
T Consensus 187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~----~~ 254 (309)
T 2h34_A 187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIP----RP 254 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCC----CG
T ss_pred ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCC----Cc
Confidence 221 1222457899999999999999999999999999999999999998643211 11111111110 00
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcCCC
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRP-DMSSVVFLLANDGV 724 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~ 724 (765)
..........+.+++.+||+.||++|| +++++++.|++...
T Consensus 255 ---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 255 ---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp ---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred ---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 011111234577899999999999999 99999999987544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=338.53 Aligned_cols=253 Identities=23% Similarity=0.280 Sum_probs=205.4
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccCh------hhHHHHHHHHHHHhccccCceEeeeeeeeecCc
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSG------QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE 516 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~ 516 (765)
..++|++.+.||+|+||.||+++.. +++.||+|++..... ...+++.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 4567999999999999999999875 688999999875422 136789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC----CCeeccc
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL----NPKISDF 592 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~vkL~DF 592 (765)
.++||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++ .+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 9999999999999999853 345899999999999999999999999 99999999999999887 7999999
Q ss_pred ccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccC
Q 004264 593 GLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDG 672 (765)
Q Consensus 593 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 672 (765)
|+++...... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+ .. ......
T Consensus 164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~----~~i~~~ 233 (321)
T 2a2a_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TL----ANITSV 233 (321)
T ss_dssp TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH----HHHHTT
T ss_pred ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH---HH----HHHHhc
Confidence 9998764322 2234678999999999999999999999999999999999999986432211 11 111111
Q ss_pred CccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 673 RALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 673 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.. . .++. ........+.+++.+||+.||++|||+.++++.
T Consensus 234 ~~-~-~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 234 SY-D-FDEE----FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CC-C-CCHH----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cc-c-cChh----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 10 0 0000 001123457899999999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=342.15 Aligned_cols=264 Identities=22% Similarity=0.275 Sum_probs=194.0
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChh-hHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQ-GLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
++|++.+.||+|+||.||+|+.. +++.||+|++...... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999875 6889999998654322 122456799999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
++ ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 98 4787777432 346899999999999999999999999 9999999999999999999999999998653221
Q ss_pred ccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc--
Q 004264 604 EAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT-- 680 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~-- 680 (765)
.......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+...........+......
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 22234578999999999876 56899999999999999999999999754432211111110000000001110000
Q ss_pred -------ccc----CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 681 -------CLE----DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 681 -------~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
... ..........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000 0001112345789999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=330.73 Aligned_cols=252 Identities=25% Similarity=0.305 Sum_probs=204.0
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
..++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999864 5889999998653 344567788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCC---Ceeccccccee
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLN---PKISDFGLARI 597 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---vkL~DFGla~~ 597 (765)
|||+++++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999998887543 45899999999999999999999999 999999999999987655 99999999987
Q ss_pred eCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 598 FGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
..... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... .. .....+... .
T Consensus 158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~----~~~~~~~~~-~ 226 (284)
T 3kk8_A 158 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LY----AQIKAGAYD-Y 226 (284)
T ss_dssp CCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HHHHHTCCC-C
T ss_pred cccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH---HH----HHHHhcccc-C
Confidence 64322 2234678999999999999999999999999999999999999985432211 11 111111110 0
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
..+. .......+.+++.+||+.||++|||+.++++
T Consensus 227 ~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 227 PSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CTTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred Cchh-----hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1110 0112345779999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=342.86 Aligned_cols=260 Identities=24% Similarity=0.292 Sum_probs=190.7
Q ss_pred HhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccc-cCceEeeeeeeee--------
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIE-------- 513 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~-------- 513 (765)
...+|++.++||+|+||.||+++. .+++.||+|++........+.+.+|+.+++++. ||||+++++++..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 345799999999999999999996 478899999997777777788999999999996 9999999999843
Q ss_pred cCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccc
Q 004264 514 EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFG 593 (765)
Q Consensus 514 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFG 593 (765)
....++||||+. |+|.+++........+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 345789999996 788888865445567999999999999999999999874 349999999999999999999999999
Q ss_pred cceeeCCCCccc----------ccccccccccccCcccc---cCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCccc
Q 004264 594 LARIFGGDDEEA----------QTERVAGTHGYMSPEYA---NDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHN 660 (765)
Q Consensus 594 la~~~~~~~~~~----------~~~~~~gt~~Y~aPE~~---~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~ 660 (765)
+++......... ......+|+.|+|||++ .+..++.++||||||+++|||++|+.||........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-- 261 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI-- 261 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh--
Confidence 998765332211 11135689999999998 567789999999999999999999999864322110
Q ss_pred HHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCC
Q 004264 661 LIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGV 724 (765)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 724 (765)
. .+... . .........+.+++.+||+.||++||++.++++.|+....
T Consensus 262 -~--------~~~~~-~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 262 -V--------NGKYS-I-------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp -------------CC-C-------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -h--------cCccc-C-------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 00000 0 0000111236789999999999999999999999977443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=336.84 Aligned_cols=264 Identities=26% Similarity=0.395 Sum_probs=208.7
Q ss_pred hcCcccccccccCCceeEEEEEe-----CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecC--ce
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-----STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED--ER 517 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~--~~ 517 (765)
.++|++.+.||+|+||.||+++. .+++.||+|++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46799999999999999999983 468899999998777677788999999999999999999999887654 78
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999998543 345899999999999999999999999 99999999999999999999999999998
Q ss_pred eCCCCccc-ccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCC---------CCcccHHHHHHH
Q 004264 598 FGGDDEEA-QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHP---------GHRHNLIGHAWL 667 (765)
Q Consensus 598 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~---------~~~~~~~~~~~~ 667 (765)
........ ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ............
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 75433221 12234577789999999999999999999999999999999988753210 000000111111
Q ss_pred hhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 668 LWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 668 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
....+... ..+......+.+++.+||+.+|++|||+.+|++.|++.
T Consensus 275 ~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 275 LLKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhcCCCC---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111111 11122345688999999999999999999999999763
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=333.56 Aligned_cols=250 Identities=29% Similarity=0.385 Sum_probs=204.9
Q ss_pred HHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeee--------
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE-------- 513 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~-------- 513 (765)
....+|++.+.||+|+||.||+|+.. +++.||+|++.... ..+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 34578999999999999999999975 78999999997543 356789999999999999999998864
Q ss_pred --------cCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC
Q 004264 514 --------EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL 585 (765)
Q Consensus 514 --------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 585 (765)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK 159 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence 445799999999999999986432 356899999999999999999999999 99999999999999999
Q ss_pred CCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 004264 586 NPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHA 665 (765)
Q Consensus 586 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~ 665 (765)
.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|||++|..|+... ...
T Consensus 160 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~ 227 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKF 227 (284)
T ss_dssp EEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHH
T ss_pred CEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHH
Confidence 99999999998764432 223457899999999999999999999999999999999998875310 111
Q ss_pred HHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCC
Q 004264 666 WLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGV 724 (765)
Q Consensus 666 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 724 (765)
......+.. ... ....+.+++.+||+.||++|||+.++++.|.....
T Consensus 228 ~~~~~~~~~--------~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 228 FTDLRDGII--------SDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHHHHTTCC--------CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred HHHhhcccc--------ccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 111111111 111 22346789999999999999999999999987544
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=341.15 Aligned_cols=256 Identities=29% Similarity=0.427 Sum_probs=200.2
Q ss_pred cCcccccccccCCceeEEEEEeCC-----CcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLST-----GQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
++|++.+.||+|+||.||+|.... +..||+|++... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 578889999999999999998643 235999999754 33445678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 99999999999998542 346899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCccc-ccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 600 GDDEEA-QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 600 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... . .......+....
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~----~~~~~~~~~~~~- 270 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---E----VMKAINDGFRLP- 270 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---H----HHHHHHTTCCCC-
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---H----HHHHHHCCCcCC-
Confidence 332211 1223456788999999999999999999999999999999 99998543221 1 111111221111
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
.+......+.+++.+||+.+|++||++.+|+++|++.
T Consensus 271 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 271 --------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp --------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1112234678999999999999999999999999763
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=333.98 Aligned_cols=262 Identities=24% Similarity=0.359 Sum_probs=200.1
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
.++|++.+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999986 57899999998752 344567889999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhcc-ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 521 YEYMPHKSLDYFIFDR-ERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
|||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999988542 23456899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
.... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ... ..............
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~~~~~~~~- 259 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS-LCKKIEQCDYPPLP- 259 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHH-HHHHHHTTCSCCCC-
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHH-HHHHhhcccCCCCc-
Confidence 3221 222457899999999999999999999999999999999999998643221 111 11111122211111
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCC
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGV 724 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 724 (765)
.......+.+++.+||+.||++||++.+|+++|++..+
T Consensus 260 -------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 260 -------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp -------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 11123467899999999999999999999999987544
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=366.28 Aligned_cols=257 Identities=28% Similarity=0.402 Sum_probs=208.6
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
.++|++.++||+|+||.||+|.+..+..||||++.... ...++|.+|+.+|++++|+||+++++++.+ +..+|||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 46788999999999999999999888889999997543 345789999999999999999999999876 6789999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 344 ~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~ 418 (535)
T 2h8h_A 344 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y 418 (535)
T ss_dssp TTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-H
T ss_pred cCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-e
Confidence 999999999542 2345899999999999999999999999 9999999999999999999999999998753211 1
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
.......++..|+|||.+.+..++.++||||||++||||++ |+.||......+ .......+....
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~~~------- 484 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRMP------- 484 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-------HHHHHHTTCCCC-------
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC-------
Confidence 11223456788999999999999999999999999999999 899986433211 111122221111
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCC
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGV 724 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 724 (765)
.+......+.+|+.+||+.||++|||+++|+++|+..-.
T Consensus 485 --~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 485 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred --CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 111234567899999999999999999999999987443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=349.71 Aligned_cols=265 Identities=23% Similarity=0.328 Sum_probs=193.3
Q ss_pred HHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccc-cCceEeeeeeeeecC--c
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEED--E 516 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~--~ 516 (765)
...++|++.+.||+|+||.||+|.. .+++.||+|++.+. .....+++.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 4567899999999999999999986 46889999998653 3455677889999999997 999999999998654 6
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
.++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999998 588888743 35889999999999999999999999 9999999999999999999999999998
Q ss_pred eeCCCC-------------------cccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCC
Q 004264 597 IFGGDD-------------------EEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPG 656 (765)
Q Consensus 597 ~~~~~~-------------------~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~ 656 (765)
.+.... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 763211 1112234689999999999987 67999999999999999999999999754432
Q ss_pred CcccHHHHHHHhhccCCcc-----------ccc----------cccccCcc------------CHHHHHHHHHHHHHccc
Q 004264 657 HRHNLIGHAWLLWNDGRAL-----------GLM----------DTCLEDSF------------VESQVLRCIQVGLLCVQ 703 (765)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~-----------~l~----------d~~l~~~~------------~~~~~~~l~~li~~cl~ 703 (765)
+....+ .......... ..+ .......+ .......+.+|+.+||+
T Consensus 238 ~~~~~i---~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 238 NQLERI---IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp HHHHHH---HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred HHHHHH---HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 211111 1100000000 000 00000000 00123457899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 004264 704 KLPEDRPDMSSVVFL 718 (765)
Q Consensus 704 ~dP~~RPs~~evl~~ 718 (765)
.||++|||++|+++.
T Consensus 315 ~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 315 FNPNKRISANDALKH 329 (388)
T ss_dssp SSGGGSCCHHHHTTS
T ss_pred cCcccCCCHHHHhCC
Confidence 999999999999876
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=333.87 Aligned_cols=253 Identities=26% Similarity=0.385 Sum_probs=202.8
Q ss_pred cCccccc-ccccCCceeEEEEEe---CCCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 446 NHFSEAN-MIGKGGFGPVYMGKL---STGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 446 ~~y~~~~-~LG~G~fg~Vy~~~~---~~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
++|.+.+ .||+|+||.||+|.. ..++.||+|++.... ....+++.+|+.++++++||||+++++++ +.+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 5788887 999999999999954 346789999997542 33467899999999999999999999998 6678899
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 95 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 9999999999999854 345899999999999999999999999 9999999999999999999999999998775
Q ss_pred CCCccc-ccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 600 GDDEEA-QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 600 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+....
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~- 240 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMG- 240 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCC-
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCCC-
Confidence 433221 1223456788999999998899999999999999999999 999986533211 111222222111
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.+......+.+++.+||+.||++||++.+|++.|++
T Consensus 241 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 241 --------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 112234568899999999999999999999999976
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=329.05 Aligned_cols=252 Identities=18% Similarity=0.282 Sum_probs=203.6
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeec--CceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE--DERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~--~~~~lV~ 521 (765)
++|++.+.||+|+||.||+|+.. ++.+|+|++... .....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 57899999999999999999985 889999998754 345567899999999999999999999999887 7889999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++.... ...+++..++.++.||+.||+|||+.+ ..|+||||||+||+++.++.++|.|||++....
T Consensus 89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-- 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-- 164 (271)
T ss_dssp ECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred cccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence 9999999999996432 235899999999999999999999864 349999999999999999999999888876421
Q ss_pred CcccccccccccccccCcccccCCCCCc---cccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISM---KSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~---k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
.....+|+.|+|||.+.+..++. ++||||||+++|||++|+.||...... .........+....
T Consensus 165 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~-- 231 (271)
T 3kmu_A 165 -----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEGLRPT-- 231 (271)
T ss_dssp -----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHHSCCCCC--
T ss_pred -----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHhcCCCCC--
Confidence 12356889999999998776554 799999999999999999998643321 11111111221111
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
.+......+.+++..||+.||++|||++++++.|++.
T Consensus 232 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 232 -------IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1112234578999999999999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=333.38 Aligned_cols=258 Identities=28% Similarity=0.368 Sum_probs=202.0
Q ss_pred HhcCcccccccccCCceeEEEEEeCC----CcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeee-ecCce
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLST----GQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI-EEDER 517 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~-~~~~~ 517 (765)
...+|++.+.||+|+||.||+|...+ ...+|+|++... .....+.+.+|+.++++++||||+++++++. .+...
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 44678899999999999999998542 235899988754 3445678999999999999999999999865 45678
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
++||||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 103 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 999999999999999854 3345889999999999999999999999 99999999999999999999999999987
Q ss_pred eCCCCcc--cccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCc
Q 004264 598 FGGDDEE--AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRA 674 (765)
Q Consensus 598 ~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (765)
....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..|+......+. ... ...+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~~----~~~~~~ 250 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVY----LLQGRR 250 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HHH----HHTTCC
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HHH----HhcCCC
Confidence 6432211 12224567888999999999999999999999999999999 5555544333221 111 111111
Q ss_pred cccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 675 LGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 675 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
... +......+.+++.+||+.+|++|||+++|+++|++.
T Consensus 251 ~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 251 LLQ---------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp CCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 111234578999999999999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=341.14 Aligned_cols=258 Identities=27% Similarity=0.400 Sum_probs=203.7
Q ss_pred hcCcccccccccCCceeEEEEEe------CCCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCce
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL------STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDER 517 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~ 517 (765)
.++|++.+.||+|+||.||+|+. .+++.||+|++... ......++.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46899999999999999999984 35678999999754 445567899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhcccc----CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec---CCCCeec
Q 004264 518 MLIYEYMPHKSLDYFIFDRER----SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI---NLNPKIS 590 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~vkL~ 590 (765)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999965432 245889999999999999999999999 999999999999984 4569999
Q ss_pred ccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhh
Q 004264 591 DFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLW 669 (765)
Q Consensus 591 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 669 (765)
|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... . .....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~----~~~~~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---E----VLEFV 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H----HHHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---H----HHHHH
Confidence 9999986543333333334667889999999999999999999999999999998 98888643221 1 11111
Q ss_pred ccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 670 NDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 670 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..+..... +......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 259 ~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 259 TSGGRMDP---------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp HTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hcCCCCCC---------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 12211111 11223467899999999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=339.68 Aligned_cols=244 Identities=21% Similarity=0.252 Sum_probs=201.8
Q ss_pred HHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccCh--------hhHHHHHHHHHHHhccccCceEeeeeeeee
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSG--------QGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--------~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~ 513 (765)
...++|++.+.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 3457899999999999999999985 5688999999875421 133467789999999999999999999999
Q ss_pred cCceEEEEEecCCC-ChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccc
Q 004264 514 EDERMLIYEYMPHK-SLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDF 592 (765)
Q Consensus 514 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DF 592 (765)
.+..++||||+..+ +|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 99999999999777 99888843 345899999999999999999999999 999999999999999999999999
Q ss_pred ccceeeCCCCcccccccccccccccCcccccCCCC-CccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhcc
Q 004264 593 GLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTI-SMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWND 671 (765)
Q Consensus 593 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 671 (765)
|+++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 175 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------- 236 (335)
T 3dls_A 175 GSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------- 236 (335)
T ss_dssp TTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred ccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence 9998764322 2234679999999999998877 88999999999999999999998532110
Q ss_pred CCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 672 GRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 672 ~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...... .+......+.+++..||+.||++|||+.+|++.
T Consensus 237 ------~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ------VEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ------TTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ------HhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 011123457899999999999999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=336.95 Aligned_cols=264 Identities=23% Similarity=0.324 Sum_probs=195.8
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHH--HhccccCceEeeeeeeee-----cCce
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVL--IGKLQHRNLVGLLGSCIE-----EDER 517 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~--l~~l~h~niv~~~~~~~~-----~~~~ 517 (765)
.++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++|+||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 36899999999999999999976 68899999986543 2344444444 455899999999986543 2356
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhc---------CCCcEEecccCCCcEEEecCCCCe
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD---------SKLQVIHRDLKASNILLDINLNPK 588 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~---------~~~~ivH~Dlkp~NIll~~~~~vk 588 (765)
++||||+++++|.+++... ..++..++.++.||++||+|||+. + |+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 8999999999999998432 358899999999999999999998 7 99999999999999999999
Q ss_pred ecccccceeeCCCCc------ccccccccccccccCcccccC-------CCCCccccchHHHHHHHHHHhCCCCCCCCCC
Q 004264 589 ISDFGLARIFGGDDE------EAQTERVAGTHGYMSPEYAND-------GTISMKSDVFSLGVLLVEIVSGKMNRGFRHP 655 (765)
Q Consensus 589 L~DFGla~~~~~~~~------~~~~~~~~gt~~Y~aPE~~~~-------~~~s~k~DvwSlG~ll~elltG~~p~~~~~~ 655 (765)
|+|||+++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|..|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987643221 112224579999999999987 4567899999999999999999877643322
Q ss_pred CC-cccHH----------HHHHHhh-ccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 656 GH-RHNLI----------GHAWLLW-NDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 656 ~~-~~~~~----------~~~~~~~-~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
.. ..... ....... .......+.+.. .........+.+|+.+||+.||++|||++||++.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW---KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC---CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc---ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 11 11110 0011111 111111111111 11234566799999999999999999999999999763
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=340.98 Aligned_cols=264 Identities=23% Similarity=0.350 Sum_probs=199.8
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 68999999999999999999875 58899999986542 3345668899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 105 FVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp CCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999999887632 345899999999999999999999999 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHH--------HHHHhhccC-
Q 004264 603 EEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIG--------HAWLLWNDG- 672 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~--------~~~~~~~~~- 672 (765)
. ......+|+.|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+. .....+...
T Consensus 179 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 179 E--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred c--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 1 22345789999999999875 78999999999999999999999986544322111100 000001000
Q ss_pred -----CccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 673 -----RALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 673 -----~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
....+................+.+++.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111111111101111123456889999999999999999999885
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=332.13 Aligned_cols=253 Identities=24% Similarity=0.357 Sum_probs=198.6
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
..++|.+.+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 3468999999999999999999864 68899999987543 345678999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhcc-ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE---ecCCCCeeccccccee
Q 004264 522 EYMPHKSLDYFIFDR-ERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL---DINLNPKISDFGLARI 597 (765)
Q Consensus 522 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~vkL~DFGla~~ 597 (765)
||+++++|.+++... .....+++..++.++.||+.||+|||+.+ |+||||||+||++ +.++.+||+|||+++.
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999998888543 23456999999999999999999999999 9999999999999 4567899999999987
Q ss_pred eCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 598 FGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
.... .......+|+.|+|||.+. ..++.++||||||+++|||++|+.||......+ .... .........
T Consensus 177 ~~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~---~~~~--~~~~~~~~~-- 245 (285)
T 3is5_A 177 FKSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE---VQQK--ATYKEPNYA-- 245 (285)
T ss_dssp -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH--HHHCCCCCC--
T ss_pred cCCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH---HHhh--hccCCcccc--
Confidence 5432 2223467899999999986 568999999999999999999999986433211 1110 011111100
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.. ... ....+.+++.+||+.||++|||+.||++
T Consensus 246 ~~---~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 246 VE---CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp C-----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cc---cCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 001 1345778999999999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=352.43 Aligned_cols=262 Identities=23% Similarity=0.251 Sum_probs=195.4
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecC------
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED------ 515 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~------ 515 (765)
.++|++.+.||+|+||.||+|... +++.||||++.+. .....+++.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999864 6889999999754 4445678899999999999999999999997553
Q ss_pred ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccc
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA 595 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla 595 (765)
..++||||++++ |.+.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 569999999876 444442 23889999999999999999999999 999999999999999999999999999
Q ss_pred eeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHH-----------
Q 004264 596 RIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGH----------- 664 (765)
Q Consensus 596 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~----------- 664 (765)
+..... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||......+....+..
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 876432 223357899999999999999999999999999999999999999975432211111100
Q ss_pred -----HHHhhcc-CC-----cccccccccc---CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 665 -----AWLLWND-GR-----ALGLMDTCLE---DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 665 -----~~~~~~~-~~-----~~~l~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
....... .. ....+...+. ..........+.+|+.+||+.||++|||++|+++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 00 0000000000 00111225568899999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=333.88 Aligned_cols=256 Identities=30% Similarity=0.359 Sum_probs=202.2
Q ss_pred cCcccccccccCCceeEEEEEeCC-C---cEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCce-EE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLST-G---QEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDER-ML 519 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~-~l 519 (765)
-.|.+.+.||+|+||.||+|+..+ + ..+|+|++... .....+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 356677899999999999998532 2 36999998754 344567899999999999999999999999876665 99
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+.+++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 101 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999854 3356889999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCc--ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCC-CCCCCCCcccHHHHHHHhhccCCccc
Q 004264 600 GDDE--EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNR-GFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 600 ~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
.... ........++..|+|||.+.+..++.++||||||+++|+|++|..|+ ....+. ..... ...+....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~---~~~~~----~~~~~~~~ 248 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF---DLTHF----LAQGRRLP 248 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG---GHHHH----HHTTCCCC
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH---HHHHH----hhcCCCCC
Confidence 3221 12223466788999999999999999999999999999999966554 322221 11111 11111111
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
.+......+.+++.+||+.+|++|||+++++++|++.
T Consensus 249 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 249 ---------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111234678999999999999999999999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=356.34 Aligned_cols=254 Identities=27% Similarity=0.377 Sum_probs=207.9
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
..++|++.+.||+|+||.||+++.. +++.||+|++.+. .......+.+|+.+|++++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 4567999999999999999999874 6899999999653 23345678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999886432 334899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+... .....
T Consensus 338 ~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~---i~~~~------ 405 (576)
T 2acx_A 338 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL---VKEVP------ 405 (576)
T ss_dssp TTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH---HHHCC------
T ss_pred cCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH---hhccc------
Confidence 322 223468999999999999999999999999999999999999999765433221111111 10110
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRP-----DMSSVVF 717 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 717 (765)
..++......+.+|+.+||+.||++|| +++||++
T Consensus 406 ----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 ----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 011122235678999999999999999 7888874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=345.24 Aligned_cols=257 Identities=28% Similarity=0.371 Sum_probs=194.3
Q ss_pred cCcccccccccCCceeEEEEEeC--CC--cEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeee-cCceEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS--TG--QEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE-EDERML 519 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~--~~--~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~-~~~~~l 519 (765)
..|++.+.||+|+||.||+|+.. ++ ..+|+|.+... .....+++.+|+.++++++||||+++++++.+ .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 45778899999999999999853 22 35899998654 34556789999999999999999999998754 457899
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+++++|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999853 2345789999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCcc--cccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 600 GDDEE--AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 600 ~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
..... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+. ... ...+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~----~~~~~~~~ 316 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVY----LLQGRRLL 316 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHH----HHTTCCCC
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHH----HHcCCCCC
Confidence 32211 11223557788999999999999999999999999999999 6677754433321 111 11222111
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDG 723 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 723 (765)
. +......+.+++.+||+.+|++||++.+|++.|+...
T Consensus 317 ~---------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 317 Q---------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp C---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 1112345789999999999999999999999998743
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=330.03 Aligned_cols=247 Identities=24% Similarity=0.319 Sum_probs=200.4
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~l 519 (765)
..++|++.+.||+|+||.||+|... +++.||+|++... ......++.+|+.++.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4578999999999999999999875 7899999998753 344567788999999999 89999999999999999999
Q ss_pred EEEecCCCChhHHhhcccc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC--------------
Q 004264 520 IYEYMPHKSLDYFIFDRER-SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN-------------- 584 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-------------- 584 (765)
||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999865322 256899999999999999999999999 9999999999999844
Q ss_pred -----CCCeecccccceeeCCCCcccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCc
Q 004264 585 -----LNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHR 658 (765)
Q Consensus 585 -----~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~ 658 (765)
..+||+|||++...... ....||+.|+|||.+.+. .++.++||||||+++|+|++|+.++....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred ccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence 47999999999876432 134589999999999876 66789999999999999999987653211
Q ss_pred ccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 659 HNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.+.....+....+. ......+.+++.+||+.||++|||+.++++.
T Consensus 236 ------~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 ------QWHEIRQGRLPRIP---------QVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ------HHHHHHTTCCCCCS---------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ------HHHHHHcCCCCCCC---------cccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11122222222211 1123457899999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=329.31 Aligned_cols=251 Identities=23% Similarity=0.302 Sum_probs=201.2
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccCh------hhHHHHHHHHHHHhccccCceEeeeeeeeecCce
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSG------QGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDER 517 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~ 517 (765)
.++|++.+.||+|+||.||+++.. +++.+|+|++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467999999999999999999875 689999999865421 2367899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC----CCeecccc
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL----NPKISDFG 593 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~vkL~DFG 593 (765)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999853 345899999999999999999999999 99999999999998877 89999999
Q ss_pred cceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC
Q 004264 594 LARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR 673 (765)
Q Consensus 594 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 673 (765)
++....... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+ .........
T Consensus 158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~ 227 (283)
T 3bhy_A 158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-------TLTNISAVN 227 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTC
T ss_pred cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-------HHHHhHhcc
Confidence 998764322 2234568999999999999999999999999999999999999986433211 111111111
Q ss_pred ccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 674 ALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 674 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.. ... .........+.+++.+||+.||++||++.++++
T Consensus 228 ~~--~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 YD--FDE----EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CC--CCH----HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cC--Ccc----hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00 000 000112345789999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=338.77 Aligned_cols=267 Identities=20% Similarity=0.283 Sum_probs=199.9
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeee--------c
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE--------E 514 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~--------~ 514 (765)
++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 6899999999999999999997 578999999986542 2234578899999999999999999999987 3
Q ss_pred CceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccc
Q 004264 515 DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGL 594 (765)
Q Consensus 515 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGl 594 (765)
+..++||||+++ +|...+.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999986 56555533 2345899999999999999999999999 99999999999999999999999999
Q ss_pred ceeeCCCCc--ccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhcc
Q 004264 595 ARIFGGDDE--EAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWND 671 (765)
Q Consensus 595 a~~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 671 (765)
++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+.........
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 987653222 122234678999999999876 56899999999999999999999998754432221111111100000
Q ss_pred CCcccc--------ccccccCccC-HHH------HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 672 GRALGL--------MDTCLEDSFV-ESQ------VLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 672 ~~~~~l--------~d~~l~~~~~-~~~------~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...... +......... ... ...+.+|+.+||+.||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 000000 0000000000 011 2347799999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=345.65 Aligned_cols=245 Identities=24% Similarity=0.290 Sum_probs=190.8
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHH-HhccccCceEeeeeeeeecCceEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVL-IGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~-l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
.++|++.+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 468999999999999999999975 57889999997643 2334566777776 567899999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999998854 345889999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ... ... .... .
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~---~i~-~~~~-~--- 257 (373)
T 2r5t_A 191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYD---NIL-NKPL-Q--- 257 (373)
T ss_dssp CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH---HHH---HHH-HSCC-C---
T ss_pred cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---HHH---HHH-hccc-C---
Confidence 221 22345789999999999999999999999999999999999999986432211 111 111 1110 0
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSS 714 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 714 (765)
.+......+.+++.+||+.||++||++.+
T Consensus 258 ------~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 258 ------LKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ------CCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ------CCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 11112345778999999999999999853
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=332.73 Aligned_cols=265 Identities=22% Similarity=0.314 Sum_probs=208.6
Q ss_pred hHHHHhcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhc--cccCceEeeeeeeeecC--
Q 004264 440 TITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGK--LQHRNLVGLLGSCIEED-- 515 (765)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~--l~h~niv~~~~~~~~~~-- 515 (765)
......++|++.+.||+|+||.||+|+. +++.||+|++... ..+.+.+|++++.. ++||||+++++++....
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 3455678999999999999999999997 5899999998643 34667888888887 78999999999998876
Q ss_pred --ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhh--------hcCCCcEEecccCCCcEEEecCC
Q 004264 516 --ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLH--------QDSKLQVIHRDLKASNILLDINL 585 (765)
Q Consensus 516 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH--------~~~~~~ivH~Dlkp~NIll~~~~ 585 (765)
..++||||+++++|.+++.. ..+++..++.++.||+.||+||| +.+ |+||||||+|||++.++
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTS
T ss_pred cceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCC
Confidence 78999999999999999853 34899999999999999999999 777 99999999999999999
Q ss_pred CCeecccccceeeCCCCccc--ccccccccccccCcccccCC------CCCccccchHHHHHHHHHHhC----------C
Q 004264 586 NPKISDFGLARIFGGDDEEA--QTERVAGTHGYMSPEYANDG------TISMKSDVFSLGVLLVEIVSG----------K 647 (765)
Q Consensus 586 ~vkL~DFGla~~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~------~~s~k~DvwSlG~ll~elltG----------~ 647 (765)
++||+|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||++| +
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 99999999998875433221 22346799999999999876 334789999999999999999 6
Q ss_pred CCCCCCCCCCcccHHHHHHHhhccCCccccccccccC-ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 648 MNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED-SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 648 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.||....+.... . ............ .+.+.. .........+.+++.+||+.||++|||+.+|+++|++
T Consensus 265 ~p~~~~~~~~~~-~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 265 LPYYDLVPSDPS-V-EEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp CTTTTTSCSSCC-H-HHHHHHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cCccccCcCccc-H-HHHHHHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 676544332211 1 111111111111 111111 1233566789999999999999999999999999976
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=338.31 Aligned_cols=255 Identities=30% Similarity=0.399 Sum_probs=202.0
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcE--EEEEEcccc-ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQE--IAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~--vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV 520 (765)
++|++.+.||+|+||.||+|+.. ++.. +++|++... .....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67999999999999999999864 4554 489988653 334456789999999999 899999999999999999999
Q ss_pred EEecCCCChhHHhhccc-------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCC
Q 004264 521 YEYMPHKSLDYFIFDRE-------------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNP 587 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~v 587 (765)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986532 2346899999999999999999999999 9999999999999999999
Q ss_pred eecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 004264 588 KISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAW 666 (765)
Q Consensus 588 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~ 666 (765)
||+|||+++.... ........++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ...
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELY 251 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHH
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-------HHH
Confidence 9999999974321 112223456888999999999999999999999999999998 99998643321 111
Q ss_pred HhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 667 LLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 667 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
.....+... ..+......+.+++.+||+.+|++|||+.++++.|+..
T Consensus 252 ~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 252 EKLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp HHGGGTCCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhhcCCCC---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 112122111 11112235678999999999999999999999998763
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=340.19 Aligned_cols=251 Identities=20% Similarity=0.201 Sum_probs=191.9
Q ss_pred cCcccc-cccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhc-cccCceEeeeeeeee----cCceE
Q 004264 446 NHFSEA-NMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGK-LQHRNLVGLLGSCIE----EDERM 518 (765)
Q Consensus 446 ~~y~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~-l~h~niv~~~~~~~~----~~~~~ 518 (765)
++|.+. +.||+|+||.||++... +++.||||++... ..+.+|+.++.+ .+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 567666 68999999999999865 6889999998642 456788888755 589999999999876 56789
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec---CCCCeecccccc
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI---NLNPKISDFGLA 595 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~vkL~DFGla 595 (765)
|||||+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 9999999999999986432 345899999999999999999999999 999999999999987 788999999999
Q ss_pred eeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCccc-HHHHHHHhhccCCc
Q 004264 596 RIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHN-LIGHAWLLWNDGRA 674 (765)
Q Consensus 596 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~ 674 (765)
+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ..... ..+..
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~~ 284 (400)
T 1nxk_A 212 KETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQY 284 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTCC
T ss_pred cccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCcc
Confidence 875322 22335678999999999999999999999999999999999999997655433211 11111 11111
Q ss_pred cccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 675 LGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 675 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
....+. .......+.+|+..||+.||++|||+.+|++.
T Consensus 285 -~~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 -EFPNPE-----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -CCCTTT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -cCCCcc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 011100 01123457899999999999999999999974
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=339.23 Aligned_cols=252 Identities=22% Similarity=0.278 Sum_probs=200.6
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV~ 521 (765)
..++|++.+.||+|+||.||++... +++.||+|++.+... ...+|++++.++ +||||+++++++.+....++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4578999999999999999999875 688999999976533 235688888887 7999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC----CCCeeccccccee
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN----LNPKISDFGLARI 597 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~vkL~DFGla~~ 597 (765)
||+++++|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999998853 345899999999999999999999999 9999999999998543 3499999999997
Q ss_pred eCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 598 FGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..........+.. ....+... +
T Consensus 170 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~----~i~~~~~~-~ 242 (342)
T 2qr7_A 170 LRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA----RIGSGKFS-L 242 (342)
T ss_dssp CBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH----HHHHCCCC-C
T ss_pred CcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH----HHccCCcc-c
Confidence 643322 2334678999999999998889999999999999999999999997543322211111 11122211 0
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
...........+.+++.+||+.||++||++.++++
T Consensus 243 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 243 -----SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp -----CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -----CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01111122456778999999999999999999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=339.92 Aligned_cols=266 Identities=23% Similarity=0.239 Sum_probs=192.9
Q ss_pred HHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
...++|++.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3457899999999999999999985 478899999997543 2234567899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEe-----cCCCCeeccccc
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD-----INLNPKISDFGL 594 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~-----~~~~vkL~DFGl 594 (765)
||||+++ +|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++ ..+.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999985 88888843 335899999999999999999999999 99999999999995 445599999999
Q ss_pred ceeeCCCCcccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC
Q 004264 595 ARIFGGDDEEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR 673 (765)
Q Consensus 595 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 673 (765)
++...... .......+|+.|+|||++.+. .++.++||||||+++|||++|+.||......+....+...........
T Consensus 184 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 184 ARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 98764222 122345689999999999874 589999999999999999999999865432211111110000000000
Q ss_pred cc-------------ccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 674 AL-------------GLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 674 ~~-------------~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.. ......+...........+.+|+.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 000000000011112356789999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=330.75 Aligned_cols=249 Identities=27% Similarity=0.386 Sum_probs=196.6
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeec-CceEEEEEe
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE-DERMLIYEY 523 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~-~~~~lV~E~ 523 (765)
.++|++.+.||+|+||.||+++. .++.||+|++.... ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 36799999999999999999987 48899999997543 457889999999999999999999987654 478999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 99999999985432 224789999999999999999999999 999999999999999999999999999865322
Q ss_pred ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .. .....+...
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~----~~~~~~~~~------- 233 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKGYKM------- 233 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH----HHHTTTCCC-------
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHhcCCCC-------
Confidence 123457889999999999999999999999999999998 999986543221 11 111112111
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..+......+.+++.+||+.||++||++.++++.|++
T Consensus 234 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 234 --DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 1111223567899999999999999999999999976
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.60 Aligned_cols=249 Identities=25% Similarity=0.360 Sum_probs=204.8
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
..++|.+.+.||+|+||.||++... +++.+|+|++.+. .....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3468999999999999999999875 5778999998654 33456778999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 119 v~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999998743 345899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
.... ......||..|+|||++.+..++.++||||||+++|||++|+.||......+ .......+.. .+
T Consensus 193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~-~~-- 260 (335)
T 2owb_A 193 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------TYLRIKKNEY-SI-- 260 (335)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCC-CC--
T ss_pred cCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-------HHHHHhcCCC-CC--
Confidence 3222 2234678999999999999999999999999999999999999986432211 1111111111 01
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
+......+.+++.+||+.||++||++.++++
T Consensus 261 -------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 261 -------PKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112245778999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=341.73 Aligned_cols=247 Identities=28% Similarity=0.397 Sum_probs=199.4
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
.+.|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35699999999999999999986 578899999987532 33456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||+. |+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 577666643 2356899999999999999999999999 99999999999999999999999999986532
Q ss_pred CCcccccccccccccccCccccc---CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYAN---DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
.....||+.|+|||++. +..++.++||||||+++|||++|+.||...... ........ +.....
T Consensus 207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~-~~~~~~ 273 (348)
T 1u5q_A 207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQ-NESPAL 273 (348)
T ss_dssp ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH-SCCCCC
T ss_pred ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHh-cCCCCC
Confidence 22467899999999984 577999999999999999999999998543221 11111111 111111
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
. .......+.+++.+||+.+|++|||++++++.
T Consensus 274 ~--------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 274 Q--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp C--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred C--------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1 11123457789999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=364.68 Aligned_cols=253 Identities=26% Similarity=0.369 Sum_probs=200.4
Q ss_pred Cccccc-ccccCCceeEEEEEeC---CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 447 HFSEAN-MIGKGGFGPVYMGKLS---TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 447 ~y~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++.+.+ .||+|+||.||+|.+. ++..||||++.... ....+++.+|+.+|++++||||+++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 444444 7999999999999763 45679999997643 3457889999999999999999999999876 5689999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 415 E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 415 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp ECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999999853 2456899999999999999999999999 999999999999999999999999999876432
Q ss_pred Cccc-ccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 602 DEEA-QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 602 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
.... ......+++.|+|||++.+..++.++||||||++||||++ |+.||......+ .......+.....
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~~~-- 560 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRMEC-- 560 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHTTCCCCC--
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCCCC--
Confidence 2211 1123345688999999999999999999999999999998 999987544321 1112222222111
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+......+.+|+..||+.+|++||++.+|+++|+.
T Consensus 561 -------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 561 -------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp -------CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred -------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 12234568899999999999999999999999976
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=330.55 Aligned_cols=252 Identities=26% Similarity=0.358 Sum_probs=199.7
Q ss_pred CcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecC
Q 004264 447 HFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
+|.....||+|+||.||+|.. .+++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 455556899999999999986 4678999999987666667889999999999999999999999999999999999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec-CCCCeecccccceeeCCCCcc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI-NLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~vkL~DFGla~~~~~~~~~ 604 (765)
+++|.+++........+++..+..++.||+.||.|||+.+ |+|+||||+||+++. ++.+||+|||+++.......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence 9999999976544456778999999999999999999999 999999999999998 89999999999987643221
Q ss_pred cccccccccccccCcccccCCC--CCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 605 AQTERVAGTHGYMSPEYANDGT--ISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~--~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
......|++.|+|||.+.+.. ++.++||||||+++|+|++|+.||........ ..........
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~--------- 243 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-----AMFKVGMFKV--------- 243 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-----HHHHHHHHCC---------
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-----HHHhhccccc---------
Confidence 223467899999999997654 88999999999999999999999864322110 0000000000
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
....+......+.+++.+||+.||++||++.++++
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 01111222456778999999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=332.44 Aligned_cols=255 Identities=23% Similarity=0.324 Sum_probs=203.9
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
..++|.+.+.||+|+||.||+++.. +++.||+|++........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 4568999999999999999999865 689999999986655555678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE---ecCCCCeecccccceeeC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL---DINLNPKISDFGLARIFG 599 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~vkL~DFGla~~~~ 599 (765)
|+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999888543 35899999999999999999999999 9999999999999 788999999999997643
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .+. ....++.. ....
T Consensus 161 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~----~~i~~~~~-~~~~ 228 (304)
T 2jam_A 161 N----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLF----EKIKEGYY-EFES 228 (304)
T ss_dssp C----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH----HHHHHCCC-CCCT
T ss_pred C----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHcCCC-CCCc
Confidence 2 1223456899999999999999999999999999999999999998643321 111 11111111 0000
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhc
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF--LLAN 721 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 721 (765)
.........+.+++.+||+.||++||++.++++ .+.+
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 229 -----PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp -----TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred -----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 111122356789999999999999999999986 3444
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.91 Aligned_cols=245 Identities=22% Similarity=0.280 Sum_probs=202.5
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67999999999999999999875 57789999986532 223567899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 999999999988543 35899999999999999999999999 999999999999999999999999999765322
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......+ . .........
T Consensus 168 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~-~~~~~~~~~------- 229 (284)
T 2vgo_A 168 ----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------T-HRRIVNVDL------- 229 (284)
T ss_dssp ----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------H-HHHHHTTCC-------
T ss_pred ----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------H-HHHHhcccc-------
Confidence 1234678999999999999999999999999999999999999986432211 1 111111110
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
..+......+.+++.+||+.+|++||++.++++
T Consensus 230 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 ---KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 111122345778999999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=344.10 Aligned_cols=263 Identities=23% Similarity=0.328 Sum_probs=202.9
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
.++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 468999999999999999999875 6889999998765 34456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhc-CCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD-SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
|+++++|.+++... ..+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 184 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence 99999999998543 3589999999999999999999996 8 99999999999999999999999999975421
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHH---------H-------
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGH---------A------- 665 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~---------~------- 665 (765)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....... .
T Consensus 185 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 185 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 122346789999999999999999999999999999999999999865332111000000 0
Q ss_pred -------HHhhccCCccccccccc----cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 666 -------WLLWNDGRALGLMDTCL----EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 666 -------~~~~~~~~~~~l~d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
..........+.++... ...........+.+++.+||+.||++|||+.++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000000000000000 00011112346889999999999999999999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=334.81 Aligned_cols=265 Identities=22% Similarity=0.295 Sum_probs=208.1
Q ss_pred cccchHhHHHHhcCcccc-cccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccc-cCceEeee
Q 004264 434 PLYDLATITTATNHFSEA-NMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQ-HRNLVGLL 508 (765)
Q Consensus 434 ~~~~~~~~~~~~~~y~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~-h~niv~~~ 508 (765)
+...+.......++|.+. +.||+|+||.||+|... +++.||+|++... .......+.+|+.+++++. ||||++++
T Consensus 16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 344455566777889888 89999999999999865 6899999998754 2334678999999999995 69999999
Q ss_pred eeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec---CC
Q 004264 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI---NL 585 (765)
Q Consensus 509 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~ 585 (765)
+++.+....++||||+++++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBC
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCC
Confidence 9999999999999999999999888432 2356899999999999999999999999 999999999999987 78
Q ss_pred CCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 004264 586 NPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHA 665 (765)
Q Consensus 586 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~ 665 (765)
.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...
T Consensus 172 ~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~- 244 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET---YLN- 244 (327)
T ss_dssp CEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH-
T ss_pred cEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHH-
Confidence 99999999998764322 22346799999999999999999999999999999999999999864332111 110
Q ss_pred HHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 666 WLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 666 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
....... . ...........+.+++.+||+.||++|||++++++.
T Consensus 245 ---i~~~~~~-~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 245 ---ISQVNVD-Y-----SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ---HHHTCCC-C-----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ---HHhcccc-c-----CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0011100 0 001111223457789999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=340.63 Aligned_cols=254 Identities=24% Similarity=0.317 Sum_probs=202.8
Q ss_pred cCcccccccccCCceeEEEEEe----CCCcEEEEEEccccC----hhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCc
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL----STGQEIAAKRLSKNS----GQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDE 516 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~ 516 (765)
++|++.+.||+|+||.||+++. .+++.||||++.+.. ....+.+.+|+.+++++ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 6799999999999999999986 478999999987532 23345677899999999 69999999999999999
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++++||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999998543 35899999999999999999999999 9999999999999999999999999998
Q ss_pred eeCCCCcccccccccccccccCcccccC--CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCc
Q 004264 597 IFGGDDEEAQTERVAGTHGYMSPEYAND--GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRA 674 (765)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (765)
.+..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+.. .... ..
T Consensus 208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~--~~~~-~~- 282 (355)
T 1vzo_A 208 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--RILK-SE- 282 (355)
T ss_dssp ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH--HHHH-CC-
T ss_pred ecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH--HHhc-cC-
Confidence 7643222 22234679999999999986 3578999999999999999999999975544332211111 1110 00
Q ss_pred cccccccccCccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 004264 675 LGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRP-----DMSSVVFLL 719 (765)
Q Consensus 675 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 719 (765)
...+......+.+|+.+||+.||++|| +++++++..
T Consensus 283 ---------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 ---------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ---------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 111122234577899999999999999 999998754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=351.74 Aligned_cols=256 Identities=26% Similarity=0.373 Sum_probs=207.4
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
..++|.+.+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 3478999999999999999999975 68999999997542 2345678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccc-cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 520 IYEYMPHKSLDYFIFDRE-RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++++||+|||+++.+
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 999999999999886533 2446999999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. ........
T Consensus 340 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~---~~i~~~~~---- 410 (543)
T 3c4z_A 340 KAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK---QRVLEQAV---- 410 (543)
T ss_dssp CTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHH---HHHHHCCC----
T ss_pred cCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHH---HHHhhccc----
Confidence 43322 2234689999999999999999999999999999999999999997654322211111 11111110
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDM-----SSVVF 717 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 717 (765)
.++......+.+++.+||+.||++||++ ++|++
T Consensus 411 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 ------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1112224567789999999999999975 66663
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=333.78 Aligned_cols=264 Identities=23% Similarity=0.369 Sum_probs=187.5
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3478999999999999999999864 68899999986542 334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhcc-----ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 522 EYMPHKSLDYFIFDR-----ERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 522 E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999988542 12346899999999999999999999999 9999999999999999999999999998
Q ss_pred eeCCCCc---ccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccC
Q 004264 597 IFGGDDE---EAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDG 672 (765)
Q Consensus 597 ~~~~~~~---~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 672 (765)
....... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....+... ... .. ..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~---~~-~~ 242 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---LML---TL-QN 242 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHH---HH-TS
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---HHH---Hh-cc
Confidence 7643221 111234578999999999876 5689999999999999999999999875443221 111 11 11
Q ss_pred CccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 673 RALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 673 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.....................+.+++.+||+.||++||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111111111111111122346788999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.52 Aligned_cols=250 Identities=25% Similarity=0.354 Sum_probs=205.2
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
..++|.+.+.||+|+||.||++... .++.+|+|++.+. .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 3468999999999999999999975 5788999998654 23456778999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+++++|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 9999999999988743 345899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
.... ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||......+ .......+.. .+
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~-~~-- 234 (294)
T 2rku_A 167 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------TYLRIKKNEY-SI-- 234 (294)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC-CC--
T ss_pred cCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhhccC-CC--
Confidence 3222 2234678999999999999999999999999999999999999986433211 1111111111 01
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
+......+.+++.+||+.||++|||++++++.
T Consensus 235 -------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 -------PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -------ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11123457789999999999999999999963
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=337.35 Aligned_cols=265 Identities=23% Similarity=0.290 Sum_probs=197.4
Q ss_pred HHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChh-----hHHHHHHHHHHHhccccCceEeeeeeeeecCc
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQ-----GLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE 516 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~ 516 (765)
...++|++.+.||+|+||.||+|+.. +++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999975 5889999998753221 12468899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
.++||||+++ +|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 78777743 3346889999999999999999999999 9999999999999999999999999998
Q ss_pred eeCCCCcccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC--
Q 004264 597 IFGGDDEEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR-- 673 (765)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 673 (765)
.+.... .......+|+.|+|||.+.+. .++.++||||||+++|||++|..||......+ .............
T Consensus 161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEE 235 (346)
T ss_dssp TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTT
T ss_pred eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHcCCCChh
Confidence 764322 222346789999999999764 58999999999999999999999986543221 1111111111110
Q ss_pred -cc---ccccccc---cCccC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 674 -AL---GLMDTCL---EDSFV-----ESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 674 -~~---~l~d~~l---~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
+. .+.+... ....+ ......+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 0111000 00011 1223568899999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.08 Aligned_cols=262 Identities=15% Similarity=0.186 Sum_probs=203.9
Q ss_pred hcCcccccccccCCceeEEEEEeCC---------CcEEEEEEccccChhhHHHHHHHHHHHhccccCceEe---------
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLST---------GQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVG--------- 506 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~--------- 506 (765)
.++|++.+.||+|+||.||+|+... ++.||+|++... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999998753 789999998654 46789999999999999988
Q ss_pred ------eeeeeee-cCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcE
Q 004264 507 ------LLGSCIE-EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNI 579 (765)
Q Consensus 507 ------~~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NI 579 (765)
+++++.. ....++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 5666665 67889999999 999999996432 356999999999999999999999999 99999999999
Q ss_pred EEecCC--CCeecccccceeeCCCCcc-----cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCC
Q 004264 580 LLDINL--NPKISDFGLARIFGGDDEE-----AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGF 652 (765)
Q Consensus 580 ll~~~~--~vkL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~ 652 (765)
|++.++ .+||+|||+++.+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999876432211 112345799999999999999999999999999999999999999976
Q ss_pred CCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 653 RHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
..+... .+.. ....+ ......+.+..... ......+.+++.+||+.||++||++++|+++|++.
T Consensus 271 ~~~~~~-~~~~-~~~~~-~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 271 CLPNTE-DIMK-QKQKF-VDKPGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp GTTCHH-HHHH-HHHHH-HHSCCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CCcCHH-HHHH-HHHhc-cCChhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 543221 1111 11111 11111222211110 01135578899999999999999999999999763
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=347.04 Aligned_cols=260 Identities=22% Similarity=0.273 Sum_probs=206.5
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhcccc-CceEeeeeeeeecCceEEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQH-RNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h-~niv~~~~~~~~~~~~~lV~E 522 (765)
.++|++.++||+|+||.||+|+. .+++.||||++..... ..++.+|+.+++.++| +++..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 47899999999999999999986 5689999998765432 2457899999999986 566667777778888999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE---ecCCCCeecccccceeeC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL---DINLNPKISDFGLARIFG 599 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~vkL~DFGla~~~~ 599 (765)
|+ +++|.+++... ...+++..++.|+.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999998532 346999999999999999999999999 9999999999999 688999999999999875
Q ss_pred CCCccc-----ccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCc
Q 004264 600 GDDEEA-----QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRA 674 (765)
Q Consensus 600 ~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (765)
...... ......||..|+|||.+.+..++.++||||||++||||++|+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 433221 122567999999999999999999999999999999999999999765554333222222111111111
Q ss_pred cccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 675 LGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 675 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..+. . ....++.+|+..||+.+|++||++.+|+++|+.
T Consensus 238 ~~l~-----~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 238 EALC-----R----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275 (483)
T ss_dssp HHHH-----T----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred HHHh-----c----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 1111 1 113467899999999999999999999998865
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=328.57 Aligned_cols=249 Identities=26% Similarity=0.399 Sum_probs=205.7
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
.+.|++.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 36799999999999999999986 468899999987543 4456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999998842 45899999999999999999999999 9999999999999999999999999998764332
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
. ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||....+.. .. .....+... .+
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~~~~~-----~~ 239 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VL----FLIPKNNPP-----TL 239 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH----HHHHHSCCC-----CC
T ss_pred c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HH----HHhhcCCCC-----CC
Confidence 1 2234678999999999999999999999999999999999999986433211 11 111111111 11
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
... ....+.+++..||+.+|++|||+.+|++.
T Consensus 240 ~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 EGN----YSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CSS----CCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ccc----cCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111 23457899999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=326.88 Aligned_cols=252 Identities=21% Similarity=0.275 Sum_probs=199.3
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC----hhhHHHHHHHHHHHhccccCceEeeeeeee--ecCce
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS----GQGLEEFMNEVVLIGKLQHRNLVGLLGSCI--EEDER 517 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~--~~~~~ 517 (765)
.++|.+.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999974 68899999997542 344678999999999999999999999984 45688
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
++||||++++ |.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999887 65555432 2456899999999999999999999999 99999999999999999999999999998
Q ss_pred eCCCCcccccccccccccccCcccccCCC--CCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcc
Q 004264 598 FGGDDEEAQTERVAGTHGYMSPEYANDGT--ISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRAL 675 (765)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (765)
..............+|..|+|||.+.+.. ++.++||||||+++|||++|+.||...... ........+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~i~~~~~- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-------KLFENIGKGSY- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCC-
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-------HHHHHHhcCCC-
Confidence 75433333344567899999999998654 478999999999999999999998643211 11111111111
Q ss_pred ccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 676 GLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 676 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
. .+......+.+++.+||+.||++|||+.++++.
T Consensus 231 ~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 A---------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp C---------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred C---------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 111123457789999999999999999999964
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=343.67 Aligned_cols=254 Identities=21% Similarity=0.263 Sum_probs=192.3
Q ss_pred HHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--------hhhHHHHHHHHHHHhccccCceEeeeeeeee
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--------GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~ 513 (765)
...++|.+.+.||+|+||.||+|... +++.||+|++.+.. ......+.+|+.+|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45689999999999999999999864 67899999986532 122335789999999999999999999875
Q ss_pred cCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC---CCCeec
Q 004264 514 EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN---LNPKIS 590 (765)
Q Consensus 514 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~vkL~ 590 (765)
.+..++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ ..+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 4568999999999999888843 346899999999999999999999999 9999999999999754 459999
Q ss_pred ccccceeeCCCCcccccccccccccccCcccccC---CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 004264 591 DFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND---GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWL 667 (765)
Q Consensus 591 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~ 667 (765)
|||+++..... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........ +...
T Consensus 285 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~--- 356 (419)
T 3i6u_A 285 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQ--- 356 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHH---
T ss_pred ecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHH---
Confidence 99999876422 22335679999999999864 6788999999999999999999999975432211 1111
Q ss_pred hhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 668 LWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 668 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...+...... . ........+.+++.+||+.||++|||+.++++.
T Consensus 357 -i~~~~~~~~~-~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 357 -ITSGKYNFIP-E-----VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp -HHTTCCCCCH-H-----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -HhcCCCCCCc-h-----hhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1111111000 0 001123467899999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=342.97 Aligned_cols=264 Identities=20% Similarity=0.250 Sum_probs=198.2
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCc------eE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE------RM 518 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~------~~ 518 (765)
..+|++.+.||+|+||.||+|+...+..+|+|++..... ...+|+.++++++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 357999999999999999999988777899998865432 22379999999999999999999976543 78
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEe-cCCCCeeccccccee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD-INLNPKISDFGLARI 597 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~vkL~DFGla~~ 597 (765)
+||||++++.+............+++..+..++.||++||+|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999988766555433344567999999999999999999999999 99999999999999 789999999999987
Q ss_pred eCCCCcccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHh
Q 004264 598 FGGDDEEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHA--------WLL 668 (765)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~--------~~~ 668 (765)
...... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+... ...
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 643222 2346789999999998765 5899999999999999999999999754422111111000 000
Q ss_pred ----hccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 669 ----WNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 669 ----~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
+................+.......+.+|+.+||+.||++|||+.|+++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000000000000011111234568899999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=335.45 Aligned_cols=256 Identities=22% Similarity=0.325 Sum_probs=204.8
Q ss_pred hHHHHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--------hhhHHHHHHHHHHHhcc-ccCceEeeee
Q 004264 440 TITTATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--------GQGLEEFMNEVVLIGKL-QHRNLVGLLG 509 (765)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~Ev~~l~~l-~h~niv~~~~ 509 (765)
......++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 34456678999999999999999999975 78999999986542 12245678999999999 7999999999
Q ss_pred eeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCee
Q 004264 510 SCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKI 589 (765)
Q Consensus 510 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL 589 (765)
++......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999853 345899999999999999999999999 999999999999999999999
Q ss_pred cccccceeeCCCCcccccccccccccccCcccccC------CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHH
Q 004264 590 SDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND------GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIG 663 (765)
Q Consensus 590 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~ 663 (765)
+|||++..+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ...
T Consensus 242 ~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~- 314 (365)
T 2y7j_A 242 SDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LML- 314 (365)
T ss_dssp CCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH-
T ss_pred EecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HHH-
Confidence 9999998764322 2235679999999999863 46899999999999999999999998643211 111
Q ss_pred HHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 664 HAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 664 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.....+... ...+.. . .....+.+++.+||+.||++|||+.++++
T Consensus 315 ---~~i~~~~~~-~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 315 ---RMIMEGQYQ-FSSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ---HHHHHTCCC-CCHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHHHhCCCC-CCCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111110 000000 0 11345788999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=329.53 Aligned_cols=259 Identities=24% Similarity=0.284 Sum_probs=205.3
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeee--cCceEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE--EDERML 519 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~--~~~~~l 519 (765)
.++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999875 6889999998753 34456789999999999999999999998854 567899
Q ss_pred EEEecCCCChhHHhhccc-cCCCCChHHHHHHHHHHHHHHHHhhhcC--CCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 520 IYEYMPHKSLDYFIFDRE-RSKLLPWKKRFSIITGIARGLLYLHQDS--KLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999986532 2345899999999999999999999986 2349999999999999999999999999998
Q ss_pred eeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 597 IFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... . .......+....
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~----~~~~i~~~~~~~ 235 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---E----LAGKIREGKFRR 235 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHHTCCCC
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---H----HHHHHhhccccc
Confidence 7643221 122457899999999999999999999999999999999999998654321 1 111122222211
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+ +......+.+++.+||+.+|++||++.+|++.+..
T Consensus 236 ~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 236 I---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp C---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred C---------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1 11223567899999999999999999999998743
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=362.02 Aligned_cols=249 Identities=24% Similarity=0.303 Sum_probs=204.7
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~ 518 (765)
..++|++.+.||+|+||.||+|+.. +++.||||++.+. .....+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4478999999999999999999865 5788999999753 233456788999999988 6999999999999999999
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
|||||+++++|..++... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999998543 45899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
.... .......||+.|+|||++.+..|+.++||||||++||||++|+.||......+ + ......+..
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~---~----~~~i~~~~~---- 559 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---L----FQSIMEHNV---- 559 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHHSSCC----
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH---H----HHHHHhCCC----
Confidence 3222 22345789999999999999999999999999999999999999996543211 1 111111111
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDM-----SSVVF 717 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 717 (765)
.++.....++.+|+..||+.||++||++ ++|++
T Consensus 560 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 ------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1122234567899999999999999997 77763
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=338.36 Aligned_cols=260 Identities=21% Similarity=0.288 Sum_probs=195.3
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecC------
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED------ 515 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~------ 515 (765)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+++.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999986 46899999998653 3444677899999999999999999999998753
Q ss_pred ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccc
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA 595 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla 595 (765)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 8899988853 35899999999999999999999999 999999999999999999999999999
Q ss_pred eeeCCCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------H
Q 004264 596 RIFGGDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHA--------W 666 (765)
Q Consensus 596 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~--------~ 666 (765)
+..... .....+|+.|+|||++.+ ..++.++||||+||+++||++|+.||......+....+... .
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 875321 234678999999999887 68999999999999999999999999754332111111000 0
Q ss_pred HhhccCC-------ccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 667 LLWNDGR-------ALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 667 ~~~~~~~-------~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
....... ......... ..........+.+|+.+||+.||++|||+.++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000000 000000000 01111223567899999999999999999999974
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=339.99 Aligned_cols=253 Identities=11% Similarity=0.084 Sum_probs=182.3
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhcc--ccCceEeee-------eeee
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKL--QHRNLVGLL-------GSCI 512 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l--~h~niv~~~-------~~~~ 512 (765)
.+|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45889999999999999999964 78899999998643 24456778886555555 599988855 3333
Q ss_pred ec-----------------CceEEEEEecCCCChhHHhhccccCCCCChHHH------HHHHHHHHHHHHHhhhcCCCcE
Q 004264 513 EE-----------------DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKR------FSIITGIARGLLYLHQDSKLQV 569 (765)
Q Consensus 513 ~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qia~aL~~LH~~~~~~i 569 (765)
.. ...++||||++ ++|.+++.... ..+++..+ +.++.||+.||+|||+.+ |
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i 215 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence 22 33799999999 89999996542 23466666 788899999999999999 9
Q ss_pred EecccCCCcEEEecCCCCeecccccceeeCCCCcccccccccccccccCcccccC--CCCCccccchHHHHHHHHHHhCC
Q 004264 570 IHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND--GTISMKSDVFSLGVLLVEIVSGK 647 (765)
Q Consensus 570 vH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~k~DvwSlG~ll~elltG~ 647 (765)
+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++||||||+++|||++|+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999987532 1113556799999999987 67999999999999999999999
Q ss_pred CCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 648 MNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 648 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.||....+..... +........................+.+|+.+||+.||++|||+.++++
T Consensus 291 ~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9997664432110 0000000000011110111123456789999999999999999999974
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=347.19 Aligned_cols=242 Identities=15% Similarity=0.173 Sum_probs=188.6
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHH---HHhccccCceEeee-------ee
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVV---LIGKLQHRNLVGLL-------GS 510 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ev~---~l~~l~h~niv~~~-------~~ 510 (765)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+. ++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999996 56899999998743 3445678999994 55556799999998 55
Q ss_pred eeecC-----------------ceEEEEEecCCCChhHHhhcccc----CCCCChHHHHHHHHHHHHHHHHhhhcCCCcE
Q 004264 511 CIEED-----------------ERMLIYEYMPHKSLDYFIFDRER----SKLLPWKKRFSIITGIARGLLYLHQDSKLQV 569 (765)
Q Consensus 511 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 569 (765)
+.+.+ ..++||||+ +|+|.+++..... ...+++..++.|+.||+.||+|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 44442 378999999 6899999864321 112345888899999999999999999 9
Q ss_pred EecccCCCcEEEecCCCCeecccccceeeCCCCcccccccccccccccCcccccCC-----------CCCccccchHHHH
Q 004264 570 IHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG-----------TISMKSDVFSLGV 638 (765)
Q Consensus 570 vH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~s~k~DvwSlG~ 638 (765)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986321 2234567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 639 LLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 639 ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
++|||++|+.||........... +.... .. ....+.+++.+||+.||++|||+.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~---------------~~~~~--~~----~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEW---------------IFRSC--KN----IPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCSGG---------------GGSSC--CC----CCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccchhh---------------hhhhc--cC----CCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999865443221111 11100 11 1345778999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=345.17 Aligned_cols=195 Identities=23% Similarity=0.385 Sum_probs=154.9
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeec-----Cc
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE-----DE 516 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~-----~~ 516 (765)
.++|++.+.||+|+||.||+|+.. +++.||||++.+. .....+++.+|+.+|++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999864 6889999998653 344567899999999999999999999998543 56
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
.++||||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999984 688888743 346899999999999999999999999 9999999999999999999999999998
Q ss_pred eeCCCCcc-------------------------cccccccccccccCcccc-cCCCCCccccchHHHHHHHHHHhC
Q 004264 597 IFGGDDEE-------------------------AQTERVAGTHGYMSPEYA-NDGTISMKSDVFSLGVLLVEIVSG 646 (765)
Q Consensus 597 ~~~~~~~~-------------------------~~~~~~~gt~~Y~aPE~~-~~~~~s~k~DvwSlG~ll~elltG 646 (765)
........ ......+||+.|+|||++ .+..++.++|||||||+||||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 76422111 122346789999999976 566799999999999999999994
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=313.80 Aligned_cols=217 Identities=13% Similarity=0.173 Sum_probs=169.9
Q ss_pred ccccccCCCccccCCCeEEcCCCeEEEEEecCCCCCCeEEEEEEeCCCCcEEEeecCCCCCCCCCceEEEeeCCceEEEc
Q 004264 23 FAADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLN 102 (765)
Q Consensus 23 ~~~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~ 102 (765)
++.|+|.+|++|.+|++| ++|.|+|||+.+++ +.+|. .+++||+|||+.| ..+.|+|+.||||||+|
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~ly~---~~~~vW~an~~~~---~~~~l~l~~dGnLvl~d 72 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD---SDVRVWASNTAGA---TGCRAVLQSDGLLVILT 72 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEEEE---SSSEEECCCCCSC---SCCBCCBCSSSCBCCBC
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEEEE---CCEEEEECCCCCC---CCeEEEEcCCCcEEEEc
Confidence 467999999999999999 59999999998876 33443 2799999999988 57899999999999999
Q ss_pred CCCCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCCCCCcc-cCcCeeccee-eccc-----ceEEEe
Q 004264 103 QEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTL-LPGMKLGWNL-KTGF-----ERYLTP 175 (765)
Q Consensus 103 ~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PtDtl-Lpg~klg~~~-~~~~-----~~~l~S 175 (765)
++|++||+|++........|+|+|+|||||++ . ++||||||||||+ |||| |.+. .+|+ ++.|+
T Consensus 73 ~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~----~---~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~- 142 (236)
T 1dlp_A 73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG----P---GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLH- 142 (236)
T ss_dssp TTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC----S---EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEEC-
T ss_pred CCCcEEEeCCccccCCcEEEEEeCCCCEEEec----C---CEEECCCCCCcccccCCc--cceEEecCCcCCCccceEE-
Confidence 99999999997644455689999999999995 2 8999999999888 6776 5555 5555 56777
Q ss_pred ccCCCCCCCcceEEeecCCCCceEEEecCCeeeeeeCCCCCccccCccccccceeeeeeeecCceeEEEEeecCCceeEE
Q 004264 176 WRSADDPTPGEFSLRLDISALPELVIISGSRKEARSGPWNGQQFGGIPRVKNSIFIPKLEHTEDELYFTFRPFNDKVITR 255 (765)
Q Consensus 176 ~~s~~dps~G~ysl~~~~~g~~~~~~~~~~~~~~~sg~w~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r 255 (765)
+..||++|.|++.++++| +++++++..+||++++|++. +...+.+......+.+..++.+...++..... ..+|
T Consensus 143 --s~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~~~~-~~~r 216 (236)
T 1dlp_A 143 --ATQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSA-GRYV 216 (236)
T ss_dssp --SSCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEEEEEETTTEEEEECCCCCSS-SCCE
T ss_pred --cCcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcEEEEeCCCcEEEEeCCCCCC-CCEE
Confidence 478999999999999999 67788888899999999754 55566652111112222344455544444333 4689
Q ss_pred EEEccCCcEEEEE
Q 004264 256 LLVNESGTLQRLV 268 (765)
Q Consensus 256 l~l~~~G~l~~~~ 268 (765)
++|+.||++++|.
T Consensus 217 l~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 217 FVLQPDRNLAIYG 229 (236)
T ss_dssp EEECSSSCEEEEC
T ss_pred EEEcCCCcEEEeC
Confidence 9999999999984
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=330.82 Aligned_cols=258 Identities=26% Similarity=0.359 Sum_probs=197.1
Q ss_pred hcCcccccccccCCceeEEEEEeC--CCc--EEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCce
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS--TGQ--EIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDER 517 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~--~~~--~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~ 517 (765)
.++|++.+.||+|+||.||+|++. +++ .||+|++... .....+.+.+|+.++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 367999999999999999999853 233 6899998754 3345678999999999999999999999988765 8
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
++|+||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999998643 245899999999999999999999999 99999999999999999999999999988
Q ss_pred eCCCCccc-ccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcc
Q 004264 598 FGGDDEEA-QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRAL 675 (765)
Q Consensus 598 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (765)
........ ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... .. ...........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~---~~~~~~~~~~~ 244 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QI---LHKIDKEGERL 244 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH---HHHHHTSCCCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HH---HHHHHccCCCC
Confidence 75433221 2234567888999999999899999999999999999999 99998643321 11 11111111111
Q ss_pred ccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 004264 676 GLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDG 723 (765)
Q Consensus 676 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 723 (765)
. .+......+.+++.+||+.+|++||++.+|++.|++..
T Consensus 245 ~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 245 P---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp C---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred C---------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 0 11122456889999999999999999999999998743
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=340.85 Aligned_cols=269 Identities=21% Similarity=0.256 Sum_probs=199.6
Q ss_pred chHhHHHHhcCcccccccccCCceeEEEEEeCCCcEEEEEEccccC-----------hhhHHHHHHHHHHHhccccCceE
Q 004264 437 DLATITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNS-----------GQGLEEFMNEVVLIGKLQHRNLV 505 (765)
Q Consensus 437 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~-----------~~~~~~~~~Ev~~l~~l~h~niv 505 (765)
.+.++....++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 3567788889999999999999999999998889999999986432 12247899999999999999999
Q ss_pred eeeeeeeec-----CceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEE
Q 004264 506 GLLGSCIEE-----DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNIL 580 (765)
Q Consensus 506 ~~~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIl 580 (765)
++++++... ...++||||+. ++|.+.+.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999998653 35799999998 577777643 3346899999999999999999999999 999999999999
Q ss_pred EecCCCCeecccccceeeCCCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcc
Q 004264 581 LDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRH 659 (765)
Q Consensus 581 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~ 659 (765)
++.++.+||+|||+++..... .......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+.
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~- 242 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ- 242 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred EcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 999999999999999854322 22234678999999999887 6799999999999999999999999875432211
Q ss_pred cHHHHHHHhhccCC-------------------ccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 660 NLIGHAWLLWNDGR-------------------ALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 660 ~~~~~~~~~~~~~~-------------------~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
............ ......... ..........+.+++.+||+.||++|||+.++++.
T Consensus 243 --~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 243 --LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAW-TAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp --HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCH-HHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhH-HhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 111111110000 000000000 01111223457899999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=347.08 Aligned_cols=200 Identities=23% Similarity=0.407 Sum_probs=168.0
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeec-----Cc
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE-----DE 516 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~-----~~ 516 (765)
.++|++.+.||+|+||.||+|+.. +++.||||++.+. .....+++.+|+.+|++++|+||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 478999999999999999999864 5788999999753 344567899999999999999999999999876 57
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
.++||||+. ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999986 589888843 346899999999999999999999999 9999999999999999999999999999
Q ss_pred eeCCCCcc--------------------cccccccccccccCcccc-cCCCCCccccchHHHHHHHHHHhCCCCCC
Q 004264 597 IFGGDDEE--------------------AQTERVAGTHGYMSPEYA-NDGTISMKSDVFSLGVLLVEIVSGKMNRG 651 (765)
Q Consensus 597 ~~~~~~~~--------------------~~~~~~~gt~~Y~aPE~~-~~~~~s~k~DvwSlG~ll~elltG~~p~~ 651 (765)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 86433211 123457899999999986 56679999999999999999998665543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=334.49 Aligned_cols=259 Identities=24% Similarity=0.318 Sum_probs=199.4
Q ss_pred hHhHHHHhcCcccccccccCCceeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccc--cCceEeeeeeeee
Q 004264 438 LATITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQ--HRNLVGLLGSCIE 513 (765)
Q Consensus 438 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~--h~niv~~~~~~~~ 513 (765)
+..+....++|++.+.||+|+||.||++...+++.||+|++... .....+.+.+|+.++++++ |+||+++++++.+
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 33444556789999999999999999999888999999998643 3455678999999999997 5999999999999
Q ss_pred cCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccc
Q 004264 514 EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFG 593 (765)
Q Consensus 514 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFG 593 (765)
.+..++||| +.+++|.+++.. ...+++..++.++.||++||.|||+.+ |+||||||+|||+++ +.+||+|||
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCS
T ss_pred CCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecc
Confidence 999999999 668899999854 346899999999999999999999999 999999999999965 889999999
Q ss_pred cceeeCCCCcccccccccccccccCcccccC-----------CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHH
Q 004264 594 LARIFGGDDEEAQTERVAGTHGYMSPEYAND-----------GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLI 662 (765)
Q Consensus 594 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~ 662 (765)
+++...............|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~ 246 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I 246 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----H
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----H
Confidence 9987654333333335678999999999876 47889999999999999999999998643211 1
Q ss_pred HHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 663 GHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 663 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
............. ..+......+.+++.+||+.||++||++.++++.
T Consensus 247 ~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 247 SKLHAIIDPNHEI---------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHHHCTTSCC---------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHhccccc---------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1111111111111 1111113467889999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=330.65 Aligned_cols=253 Identities=24% Similarity=0.383 Sum_probs=198.9
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
..++|++.+.||+|+||.||+|+.. +++.+|+|++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3478999999999999999999975 588999999987666677889999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999888542 345899999999999999999999999 999999999999999999999999997643111
Q ss_pred cccccccccccccccCcccc-----cCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 603 EEAQTERVAGTHGYMSPEYA-----NDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~-----~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
........||..|+|||++ .+..++.++||||||+++|+|++|+.|+....... ...... .......
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~~~ 242 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIA-KSDPPTL 242 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHH-HSCCCCC
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHh-ccCCccc
Confidence 1112245789999999998 46788999999999999999999999986433211 111111 1111111
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
. .+......+.+++.+||+.||++|||+.++++
T Consensus 243 ~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 L-------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp S-------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred C-------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1 11122346789999999999999999999876
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=327.15 Aligned_cols=251 Identities=27% Similarity=0.389 Sum_probs=199.5
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
..++|++.+.||+|+||.||+|... +++.||+|++.... ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999875 58899999987543 34678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999999853 2356899999999999999999999999 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ...... ........
T Consensus 180 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~~~~---- 246 (314)
T 3com_A 180 A--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR------AIFMIP-TNPPPTFR---- 246 (314)
T ss_dssp S--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHH-HSCCCCCS----
T ss_pred c--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHh-cCCCcccC----
Confidence 2 2234578999999999999999999999999999999999999986433211 111111 11110010
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.+......+.+++.+||+.||++|||+.++++
T Consensus 247 ---~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 247 ---KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 01112346789999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.36 Aligned_cols=268 Identities=25% Similarity=0.362 Sum_probs=199.6
Q ss_pred HhcCcccccccccCCceeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
..++|++.+.||+|+||.||+|+... .+|+|++... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 45789999999999999999998753 5999998643 2333456788999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||+++ ++.+||+|||+++.....
T Consensus 109 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 109 SLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp BCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred ecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 99999999999853 2346899999999999999999999999 99999999999998 679999999998765322
Q ss_pred Cc---ccccccccccccccCcccccC---------CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhh
Q 004264 602 DE---EAQTERVAGTHGYMSPEYAND---------GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLW 669 (765)
Q Consensus 602 ~~---~~~~~~~~gt~~Y~aPE~~~~---------~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 669 (765)
.. ........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||....... .....
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~ 255 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-------IIWQM 255 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-------HHHHH
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHh
Confidence 11 122234568999999999874 457899999999999999999999986433211 11111
Q ss_pred ccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCCCCCCCCCCCc
Q 004264 670 NDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGVTLPQPRQPGF 734 (765)
Q Consensus 670 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~p~~ 734 (765)
..+......... ....+.+++..||+.+|++|||+.+|+++|+...........|+.
T Consensus 256 ~~~~~~~~~~~~--------~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~ 312 (319)
T 2y4i_B 256 GTGMKPNLSQIG--------MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGH 312 (319)
T ss_dssp HTTCCCCCCCSS--------CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------------
T ss_pred ccCCCCCCCcCC--------CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcc
Confidence 122111111111 123477999999999999999999999999886654444444443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=335.43 Aligned_cols=262 Identities=21% Similarity=0.250 Sum_probs=202.4
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccc--------cCceEeeeeeee---
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ--------HRNLVGLLGSCI--- 512 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~--------h~niv~~~~~~~--- 512 (765)
.++|++.++||+|+||.||+|+. .+++.||+|++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 47899999999999999999986 46788999999643 445678899999999985 788999999988
Q ss_pred -ecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhc-CCCcEEecccCCCcEEEecCC-----
Q 004264 513 -EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD-SKLQVIHRDLKASNILLDINL----- 585 (765)
Q Consensus 513 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivH~Dlkp~NIll~~~~----- 585 (765)
.....++||||+.+ +|.+.+... ....+++..++.++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVLGH-HLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEeccCc-cHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 55688999999955 444444332 234589999999999999999999998 8 99999999999998765
Q ss_pred --------------------------------------------CCeecccccceeeCCCCcccccccccccccccCccc
Q 004264 586 --------------------------------------------NPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621 (765)
Q Consensus 586 --------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~ 621 (765)
.+||+|||+++..... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 8999999999875322 234578999999999
Q ss_pred ccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH---Hhhcc-------------------CCcccccc
Q 004264 622 ANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAW---LLWND-------------------GRALGLMD 679 (765)
Q Consensus 622 ~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~---~~~~~-------------------~~~~~l~d 679 (765)
+.+..++.++||||||+++|||++|+.||................ ..... +....+.+
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 999999999999999999999999999997665443322111111 10000 00000000
Q ss_pred ccc---------cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 680 TCL---------EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 680 ~~l---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
... ....+......+.+|+.+||+.||++|||+.||++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000 01234566778999999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=364.27 Aligned_cols=247 Identities=26% Similarity=0.385 Sum_probs=196.9
Q ss_pred cccccCCceeEEEEEe---CCCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCC
Q 004264 452 NMIGKGGFGPVYMGKL---STGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~---~~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
+.||+|+||.||+|.+ ..++.||||++.... ....+++.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 4799999999999964 246789999997542 344688999999999999999999999986 4568899999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc-c
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE-A 605 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~-~ 605 (765)
++|.+++.. ...+++..++.|+.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999953 345899999999999999999999999 999999999999999999999999999876433221 1
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+ .......+......
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~~~p------ 594 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMGCP------ 594 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCCCC------
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCCCC------
Confidence 2223456788999999999999999999999999999998 999986543221 11222222222111
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
......+.+|+..||+.||++||++.+|+++|+.
T Consensus 595 ---~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 595 ---AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp ---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1234568899999999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.85 Aligned_cols=253 Identities=24% Similarity=0.343 Sum_probs=187.0
Q ss_pred HhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC-hh-hHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS-GQ-GLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~-~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
..++|++.+.||+|+||.||+++. .+++.||+|++.... .. ..+.+.++..+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 347899999999999999999986 578899999997542 22 233445555668889999999999999999999999
Q ss_pred EEecCCCChhHHhhc-cccCCCCChHHHHHHHHHHHHHHHHhhhc-CCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 521 YEYMPHKSLDYFIFD-RERSKLLPWKKRFSIITGIARGLLYLHQD-SKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
|||+++ +|.+++.. ......+++..++.++.||+.||+|||++ + |+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999974 77776643 23345799999999999999999999998 8 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCcccc----cCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCc
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYA----NDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRA 674 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (765)
.... ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||...... ............
T Consensus 161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~- 231 (290)
T 3fme_A 161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEEPS- 231 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHSCC-
T ss_pred cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhccCC-
Confidence 4322 22235789999999996 5667899999999999999999999998642211 111111111111
Q ss_pred cccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 675 LGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 675 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.... .......+.+++.+||+.+|++|||+.++++
T Consensus 232 ~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 PQLP--------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCCC--------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCcc--------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1111 1112345789999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=324.06 Aligned_cols=248 Identities=22% Similarity=0.345 Sum_probs=195.6
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
.++|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999975 78999999986532 23456889999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999998543 35899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCcccccccccccccccCcccccCCCC-CccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTI-SMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
.. ......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...... . .......+.. .
T Consensus 164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~----~~~~~~~~~~-~--- 229 (276)
T 2h6d_A 164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---T----LFKKIRGGVF-Y--- 229 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHHCCC-C---
T ss_pred Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---H----HHHHhhcCcc-c---
Confidence 21 2224568999999999988765 68999999999999999999998643211 1 1111111110 0
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.+......+.+++.+||+.||++|||+.+|++.
T Consensus 230 ------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 ------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011123457789999999999999999999974
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=349.96 Aligned_cols=252 Identities=26% Similarity=0.315 Sum_probs=202.3
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
..++|++.++||+|+||.||+++.. +++.||+|++.+. .......+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999875 7889999998643 233467899999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEe---cCCCCeeccccccee
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD---INLNPKISDFGLARI 597 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~vkL~DFGla~~ 597 (765)
|||+.+++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999998888543 45899999999999999999999999 99999999999995 456799999999987
Q ss_pred eCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 598 FGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
+... .......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+ . ......+....-
T Consensus 174 ~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~----~~~i~~~~~~~~ 242 (486)
T 3mwu_A 174 FQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---I----LKRVETGKYAFD 242 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHHHTCCCSC
T ss_pred CCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H----HHHHHhCCCCCC
Confidence 6432 22234679999999999976 59999999999999999999999986543221 1 111111211100
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
. + ........+.+++.+||+.+|++|||+.++++.
T Consensus 243 ~-~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 L-P-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp S-G-----GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred C-c-----ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0 001123457799999999999999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=350.78 Aligned_cols=251 Identities=24% Similarity=0.310 Sum_probs=198.2
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
..++|++.+.||+|+||.||+|+.. +++.+|+|++.+.. ......+.+|+.++++++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999975 68899999987542 33457789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC---CCCeeccccccee
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN---LNPKISDFGLARI 597 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~vkL~DFGla~~ 597 (765)
|||+++++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.. +.+||+|||+++.
T Consensus 115 ~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999998887543 45899999999999999999999999 9999999999999764 4599999999987
Q ss_pred eCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 598 FGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
..... ......||+.|+|||++. ..++.++||||+|+++|+|++|+.||....+.+ .......+... .
T Consensus 189 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~-~ 256 (494)
T 3lij_A 189 FENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-------ILRKVEKGKYT-F 256 (494)
T ss_dssp CBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC-C
T ss_pred CCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC-C
Confidence 64322 233467999999999986 569999999999999999999999996543321 11111111111 0
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
..+.. ......+.+++.+||+.+|++|||+.++++
T Consensus 257 ~~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 DSPEW-----KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CSGGG-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Cchhc-----ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 01100 112345779999999999999999999984
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=324.78 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=198.1
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeee----cCceE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE----EDERM 518 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~----~~~~~ 518 (765)
+.|.+.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45788889999999999999864 6778999998653 34556789999999999999999999998875 35589
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEe-cCCCCeeccccccee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD-INLNPKISDFGLARI 597 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~vkL~DFGla~~ 597 (765)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999853 245899999999999999999999875 3499999999999997 789999999999976
Q ss_pred eCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 598 FGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
.... ......||+.|+|||.+. +.++.++||||||+++|+|++|+.||...... .........+.....
T Consensus 182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~ 250 (290)
T 1t4h_A 182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPAS 250 (290)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGG
T ss_pred cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------HHHHHHHhccCCccc
Confidence 4322 223457899999999887 45899999999999999999999998643221 111111112211111
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.+......+.+++..||+.||++|||+.+|++.
T Consensus 251 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 251 --------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp --------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111112457899999999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=328.48 Aligned_cols=257 Identities=14% Similarity=0.193 Sum_probs=199.7
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccc-cCceEeeeeeeee--cCceEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIE--EDERMLI 520 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~--~~~~~lV 520 (765)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... .+.+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36899999999999999999985 578899999986433 467899999999997 9999999999988 6678999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC-CCeecccccceeeC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL-NPKISDFGLARIFG 599 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~vkL~DFGla~~~~ 599 (765)
|||+.+++|.+++. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999988873 3889999999999999999999999 99999999999999776 89999999998764
Q ss_pred CCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH---------hh
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWL---------LW 669 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~---------~~ 669 (765)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ....... ..
T Consensus 183 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 183 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHHHHH
T ss_pred CCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH--HHHHHHHhcCCchhhhHH
Confidence 322 2234578999999999987 6799999999999999999999999854322110 0000000 00
Q ss_pred ccCC--------------ccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 670 NDGR--------------ALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 670 ~~~~--------------~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.... .....+..............+.+++.+||+.||++|||++|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 000000111111111234568899999999999999999999863
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=339.51 Aligned_cols=265 Identities=20% Similarity=0.226 Sum_probs=196.0
Q ss_pred HHHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeec------
Q 004264 442 TTATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE------ 514 (765)
Q Consensus 442 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~------ 514 (765)
....++|++.+.||+|+||.||+|+. .+++.||+|++..... ...+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999986 5789999999865432 234799999999999999999998543
Q ss_pred --------------------------------CceEEEEEecCCCChhHHhhcc-ccCCCCChHHHHHHHHHHHHHHHHh
Q 004264 515 --------------------------------DERMLIYEYMPHKSLDYFIFDR-ERSKLLPWKKRFSIITGIARGLLYL 561 (765)
Q Consensus 515 --------------------------------~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~L 561 (765)
...++||||++ ++|.+.+... .....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 33789999998 5777766532 3345699999999999999999999
Q ss_pred hhcCCCcEEecccCCCcEEEe-cCCCCeecccccceeeCCCCcccccccccccccccCcccccCC-CCCccccchHHHHH
Q 004264 562 HQDSKLQVIHRDLKASNILLD-INLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVL 639 (765)
Q Consensus 562 H~~~~~~ivH~Dlkp~NIll~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~l 639 (765)
|+.+ |+||||||+|||++ .++.+||+|||+++...... ......+|+.|+|||.+.+. .++.++||||+|++
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9999 99999999999998 68899999999999764332 22345789999999998875 48999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcccHHHHH--------HHhhcc----CCccccccccccCccCHHHHHHHHHHHHHccccCCC
Q 004264 640 LVEIVSGKMNRGFRHPGHRHNLIGHA--------WLLWND----GRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPE 707 (765)
Q Consensus 640 l~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~----~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~ 707 (765)
+|||++|+.||......+....+... ...... .....+.........+......+.+|+.+||+.||+
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 99999999999754432211111000 000000 000000001111111222345688999999999999
Q ss_pred CCCCHHHHHH
Q 004264 708 DRPDMSSVVF 717 (765)
Q Consensus 708 ~RPs~~evl~ 717 (765)
+|||+.|+++
T Consensus 312 ~R~t~~e~l~ 321 (383)
T 3eb0_A 312 LRINPYEAMA 321 (383)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhc
Confidence 9999999984
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=351.21 Aligned_cols=251 Identities=26% Similarity=0.330 Sum_probs=204.2
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
..++|++.+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4568999999999999999999875 78999999986532 3456789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE---ecCCCCeecccccce
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL---DINLNPKISDFGLAR 596 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~vkL~DFGla~ 596 (765)
||||+.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999999888854 345899999999999999999999999 9999999999999 467899999999998
Q ss_pred eeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 597 IFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
.+.... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||....+.+ . ......+....
T Consensus 178 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~----~~~i~~~~~~~ 246 (484)
T 3nyv_A 178 HFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---I----LKKVEKGKYTF 246 (484)
T ss_dssp HBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHHHCCCCC
T ss_pred Eccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---H----HHHHHcCCCCC
Confidence 764322 2234679999999999876 69999999999999999999999986543221 1 11111221110
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
-. + ........+.+++.+||+.+|++|||+.++++
T Consensus 247 ~~-~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 EL-P-----QWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CS-G-----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC-c-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00 0 00122346789999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=341.64 Aligned_cols=258 Identities=21% Similarity=0.267 Sum_probs=192.5
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecC------ceE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED------ERM 518 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~------~~~ 518 (765)
.+|++.+.||+|+||.||+|++. +++.||||++..... ...+|+.+|++++||||+++++++.... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46889999999999999999975 689999999865422 2347999999999999999999886422 367
Q ss_pred EEEEecCCCChhHHhhc-cccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC-CCCeecccccce
Q 004264 519 LIYEYMPHKSLDYFIFD-RERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN-LNPKISDFGLAR 596 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~vkL~DFGla~ 596 (765)
+||||+++ +|...+.. ......+++..+..++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999986 45444432 233457999999999999999999999999 9999999999999965 568999999999
Q ss_pred eeCCCCcccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhc-----
Q 004264 597 IFGGDDEEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWN----- 670 (765)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~----- 670 (765)
.+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+. +........
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~---l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ---LVEIIKVLGTPTRE 279 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCSCCHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHH
Confidence 7643222 2346789999999999765 799999999999999999999999975432211 111111100
Q ss_pred -----cCCccccccccccC-----ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 671 -----DGRALGLMDTCLED-----SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 671 -----~~~~~~l~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.....+..-+.+.. .+.......+.+|+.+||+.||++||++.|+++
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00001100011100 011122456889999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.10 Aligned_cols=262 Identities=21% Similarity=0.292 Sum_probs=194.2
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeee-----------
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI----------- 512 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~----------- 512 (765)
.++|++.+.||+|+||.||+|... +++.||+|++........+++.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999975 48899999998777777788999999999999999999998873
Q ss_pred ---ecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEe-cCCCCe
Q 004264 513 ---EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD-INLNPK 588 (765)
Q Consensus 513 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~vk 588 (765)
+....++||||++ ++|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+||+++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 4467899999998 689888842 45889999999999999999999999 99999999999998 567899
Q ss_pred ecccccceeeCCCCc-ccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 004264 589 ISDFGLARIFGGDDE-EAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAW 666 (765)
Q Consensus 589 L~DFGla~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~ 666 (765)
|+|||+++....... ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+. .....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ---MQLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Confidence 999999987643221 122234567899999998865 6789999999999999999999999875442211 11100
Q ss_pred Hhhcc---CCcccc-------cccccc-C-----ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 667 LLWND---GRALGL-------MDTCLE-D-----SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 667 ~~~~~---~~~~~l-------~d~~l~-~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
..... ....++ +..... . .........+.+++.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000 000000 000000 0 001122456889999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=325.13 Aligned_cols=252 Identities=22% Similarity=0.277 Sum_probs=196.2
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC--------hhhHHHHHHHHHHHhccccCceEeeeeeeeec
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS--------GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE 514 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~ 514 (765)
..++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4578999999999999999999864 57899999986532 12234588999999999999999999998765
Q ss_pred CceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCC---Ceecc
Q 004264 515 DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLN---PKISD 591 (765)
Q Consensus 515 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---vkL~D 591 (765)
. .++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 8999999999999988843 346899999999999999999999999 999999999999987654 99999
Q ss_pred cccceeeCCCCcccccccccccccccCccccc---CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHh
Q 004264 592 FGLARIFGGDDEEAQTERVAGTHGYMSPEYAN---DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLL 668 (765)
Q Consensus 592 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~ 668 (765)
||+++..... .......||+.|+|||++. ...++.++||||||+++|+|++|+.||........ +....
T Consensus 161 fg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~--- 232 (322)
T 2ycf_A 161 FGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI--- 232 (322)
T ss_dssp CTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHH---
T ss_pred Cccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHH---
Confidence 9999876432 1223457899999999974 56789999999999999999999999975443221 11111
Q ss_pred hccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 669 WNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 669 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
..+.... . +.. .......+.+++.+||+.||++||++.++++
T Consensus 233 -~~~~~~~-~-~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 -TSGKYNF-I-PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -HHTCCCC-C-HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HhCcccc-C-chh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1111110 0 000 0112346789999999999999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.57 Aligned_cols=253 Identities=21% Similarity=0.270 Sum_probs=203.0
Q ss_pred HHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---------hhhHHHHHHHHHHHhccc-cCceEeeeeee
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---------GQGLEEFMNEVVLIGKLQ-HRNLVGLLGSC 511 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~ 511 (765)
...++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999875 68899999986532 123467889999999996 99999999999
Q ss_pred eecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecc
Q 004264 512 IEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISD 591 (765)
Q Consensus 512 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~D 591 (765)
......++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999999854 345899999999999999999999999 99999999999999999999999
Q ss_pred cccceeeCCCCcccccccccccccccCccccc------CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 004264 592 FGLARIFGGDDEEAQTERVAGTHGYMSPEYAN------DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHA 665 (765)
Q Consensus 592 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~ 665 (765)
||++....... ......+++.|+|||.+. ...++.++||||||+++|+|++|+.||....... .
T Consensus 168 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~ 237 (298)
T 1phk_A 168 FGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------M 237 (298)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------H
T ss_pred ccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-------H
Confidence 99998764322 223467899999999985 5578999999999999999999999986432211 1
Q ss_pred HHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 666 WLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 666 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
......+... ...+ ........+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~-~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 238 LRMIMSGNYQ-FGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHTCCC-CCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHhcCCcc-cCcc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111111111 0000 01122456789999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=350.08 Aligned_cols=253 Identities=25% Similarity=0.306 Sum_probs=201.0
Q ss_pred HHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccCh-------------hhHHHHHHHHHHHhccccCceEeee
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSG-------------QGLEEFMNEVVLIGKLQHRNLVGLL 508 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------------~~~~~~~~Ev~~l~~l~h~niv~~~ 508 (765)
...++|.+.++||+|+||.||+|+.. +++.+|+|++.+... ...+.+.+|+.++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 34678999999999999999999875 578899999875421 3357789999999999999999999
Q ss_pred eeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC---
Q 004264 509 GSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL--- 585 (765)
Q Consensus 509 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 585 (765)
+++.+....++||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999998888543 45899999999999999999999999 99999999999998776
Q ss_pred CCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 004264 586 NPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHA 665 (765)
Q Consensus 586 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~ 665 (765)
.+||+|||+++...... ......||+.|+|||++. +.++.++||||+|+++|+|++|+.||......+ +
T Consensus 187 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~---- 255 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD---I---- 255 (504)
T ss_dssp SEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----
T ss_pred cEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---H----
Confidence 69999999998764322 233467999999999987 469999999999999999999999997543221 1
Q ss_pred HHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 666 WLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 666 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
......+....-. +.. ......+.+++.+||+.||.+|||++++++.
T Consensus 256 ~~~i~~~~~~~~~-~~~-----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 256 IKKVEKGKYYFDF-NDW-----KNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHHHCCCCCCH-HHH-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHcCCCCCCc-ccc-----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1111111110000 000 0123457899999999999999999999853
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=331.75 Aligned_cols=259 Identities=29% Similarity=0.415 Sum_probs=199.1
Q ss_pred chHhHHHHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhcc-ccCceEeeeeeeee-
Q 004264 437 DLATITTATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIE- 513 (765)
Q Consensus 437 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~- 513 (765)
++.++....++|++.+.||+|+||.||+|+. .+++.||+|++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3444455678999999999999999999986 478899999986543 3346889999999999 79999999999987
Q ss_pred -----cCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCe
Q 004264 514 -----EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPK 588 (765)
Q Consensus 514 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vk 588 (765)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence 467899999999999999986432 346899999999999999999999999 99999999999999999999
Q ss_pred ecccccceeeCCCCcccccccccccccccCccccc-----CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHH
Q 004264 589 ISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAN-----DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIG 663 (765)
Q Consensus 589 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~ 663 (765)
|+|||++........ ......|++.|+|||++. +..++.++||||||+++|+|++|+.||....+..
T Consensus 170 l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------ 241 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------ 241 (326)
T ss_dssp ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------
T ss_pred EeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------
Confidence 999999987643211 223457899999999987 5678999999999999999999999985433211
Q ss_pred HHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 664 HAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 664 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
...... ........ .. .....+.+++.+||+.||++||++.++++
T Consensus 242 ~~~~~~-~~~~~~~~----~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 242 ALFLIP-RNPAPRLK----SK----KWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHH-HSCCCCCS----CS----CSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHhh-cCccccCC----cc----ccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111111 11111111 11 12346788999999999999999999987
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=330.16 Aligned_cols=257 Identities=22% Similarity=0.295 Sum_probs=204.6
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChh-----------------hHHHHHHHHHHHhccccCceEee
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQ-----------------GLEEFMNEVVLIGKLQHRNLVGL 507 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-----------------~~~~~~~Ev~~l~~l~h~niv~~ 507 (765)
.++|++.+.||+|+||.||+|.. +++.||+|++...... ..+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999998 8999999998653221 12789999999999999999999
Q ss_pred eeeeeecCceEEEEEecCCCChhHH------hhccccCCCCChHHHHHHHHHHHHHHHHhhh-cCCCcEEecccCCCcEE
Q 004264 508 LGSCIEEDERMLIYEYMPHKSLDYF------IFDRERSKLLPWKKRFSIITGIARGLLYLHQ-DSKLQVIHRDLKASNIL 580 (765)
Q Consensus 508 ~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivH~Dlkp~NIl 580 (765)
++++.+.+..++||||+++++|.++ +.. .....+++..++.++.||+.||.|||+ .+ |+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999988 422 224679999999999999999999999 88 999999999999
Q ss_pred EecCCCCeecccccceeeCCCCcccccccccccccccCcccccCC-CCCc-cccchHHHHHHHHHHhCCCCCCCCCCCCc
Q 004264 581 LDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG-TISM-KSDVFSLGVLLVEIVSGKMNRGFRHPGHR 658 (765)
Q Consensus 581 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~-k~DvwSlG~ll~elltG~~p~~~~~~~~~ 658 (765)
++.++.+||+|||++...... ......++..|+|||.+.+. .++. ++||||||+++|||++|+.||.......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~- 259 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV- 259 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-
Confidence 999999999999999876432 23356789999999999887 6766 9999999999999999999987544321
Q ss_pred ccHHHHHHHhhccCCcccccc-------cccc---CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 659 HNLIGHAWLLWNDGRALGLMD-------TCLE---DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~l~d-------~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
. .......+... ... +... ..........+.+++.+||+.||++|||+.++++
T Consensus 260 -~----~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 -E----LFNNIRTKNIE-YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -H----HHHHHTSCCCC-CCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -H----HHHHHhccCcC-CccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 11111122111 110 0000 0000223456789999999999999999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=334.39 Aligned_cols=263 Identities=21% Similarity=0.294 Sum_probs=201.2
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeec-----Cce
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE-----DER 517 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~-----~~~ 517 (765)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999864 6788999999753 334457889999999999999999999998765 368
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
++||||+. ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 488888743 34899999999999999999999999 99999999999999999999999999987
Q ss_pred eCCCCccc-ccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcc
Q 004264 598 FGGDDEEA-QTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRAL 675 (765)
Q Consensus 598 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (765)
........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+. .........
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~~~~~ 254 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL---GILGSPSQE 254 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH---HHHCSCCHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH---HHhCCCCHH
Confidence 64322211 1234689999999998654 558999999999999999999999997654433221111 110000000
Q ss_pred ---------------ccccccc--cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 676 ---------------GLMDTCL--EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 676 ---------------~l~d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.+..... ...........+.+|+.+||+.||++|||+.++++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 000011123467899999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=342.06 Aligned_cols=200 Identities=23% Similarity=0.270 Sum_probs=172.8
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhcc------ccCceEeeeeeeeecCc
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL------QHRNLVGLLGSCIEEDE 516 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l------~h~niv~~~~~~~~~~~ 516 (765)
...+|++.+.||+|+||.||+|... +++.||||++... ....+++.+|+.+++.+ .|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 4578999999999999999999865 5889999999653 34456788899888887 46799999999999999
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCC--Ceeccccc
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLN--PKISDFGL 594 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--vkL~DFGl 594 (765)
.++||||+. ++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999996 58888775432 245899999999999999999999999 999999999999999887 99999999
Q ss_pred ceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCC
Q 004264 595 ARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRH 654 (765)
Q Consensus 595 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~ 654 (765)
++.... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 249 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 249 SCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 976432 2234678999999999999999999999999999999999999987554
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.84 Aligned_cols=262 Identities=21% Similarity=0.246 Sum_probs=192.1
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecC------
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED------ 515 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~------ 515 (765)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 368999999999999999999864 6889999998753 3445677889999999999999999999997665
Q ss_pred ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccc
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA 595 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla 595 (765)
..++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999975 6766663 24889999999999999999999999 999999999999999999999999999
Q ss_pred eeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHH------------
Q 004264 596 RIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIG------------ 663 (765)
Q Consensus 596 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~------------ 663 (765)
+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+.
T Consensus 175 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 175 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred cccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 875322 12234678999999999999999999999999999999999999996543211100000
Q ss_pred ----HHHHhhcc-CC-----ccccccccccC---ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 664 ----HAWLLWND-GR-----ALGLMDTCLED---SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 664 ----~~~~~~~~-~~-----~~~l~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
........ .. ...+......+ .........+.+|+.+||+.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000 00 00000000000 1112235678899999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=326.55 Aligned_cols=264 Identities=18% Similarity=0.193 Sum_probs=203.5
Q ss_pred HhcCcccccccccCCceeEEEEEe--CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCc------eEeeeeeeeecC
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL--STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRN------LVGLLGSCIEED 515 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n------iv~~~~~~~~~~ 515 (765)
..++|++.+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|+.++++++|++ ++++++++.+.+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 346899999999999999999986 36788999998653 345677889999999997765 999999999999
Q ss_pred ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec------------
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI------------ 583 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~------------ 583 (765)
..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred cEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 999999999 889988885432 235889999999999999999999999 999999999999987
Q ss_pred -------CCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCC
Q 004264 584 -------NLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPG 656 (765)
Q Consensus 584 -------~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~ 656 (765)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 678999999999874321 23467899999999999999999999999999999999999998754332
Q ss_pred CcccHHHHHH--------HhhccCCcc--------c----------cccccc-cCccCHHHHHHHHHHHHHccccCCCCC
Q 004264 657 HRHNLIGHAW--------LLWNDGRAL--------G----------LMDTCL-EDSFVESQVLRCIQVGLLCVQKLPEDR 709 (765)
Q Consensus 657 ~~~~~~~~~~--------~~~~~~~~~--------~----------l~d~~l-~~~~~~~~~~~l~~li~~cl~~dP~~R 709 (765)
+....+.... ......... . ...+.. ...........+.+++.+||+.||++|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 2111111100 000000000 0 000000 011223456778999999999999999
Q ss_pred CCHHHHHHH
Q 004264 710 PDMSSVVFL 718 (765)
Q Consensus 710 Ps~~evl~~ 718 (765)
||+.||++.
T Consensus 321 pt~~ell~h 329 (339)
T 1z57_A 321 ITLREALKH 329 (339)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999853
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=332.97 Aligned_cols=258 Identities=23% Similarity=0.302 Sum_probs=183.9
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeec------C
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE------D 515 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~------~ 515 (765)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999985 56889999998653 344567888999999999999999999998754 5
Q ss_pred ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccc
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA 595 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla 595 (765)
..++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999998 6889888743 45899999999999999999999999 999999999999999999999999999
Q ss_pred eeeCCCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC-
Q 004264 596 RIFGGDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR- 673 (765)
Q Consensus 596 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~- 673 (765)
+.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+ ........
T Consensus 180 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i---~~~~g~p~~ 251 (367)
T 2fst_X 180 RHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LRLVGTPGA 251 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCCH
T ss_pred ccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCCH
Confidence 87532 1234678999999999887 68999999999999999999999999654432111111 11100000
Q ss_pred ----------cccccccccc-CccC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 674 ----------ALGLMDTCLE-DSFV-----ESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 674 ----------~~~l~d~~l~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
....+..... .... ......+.+|+.+||+.||++|||+.++++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000000 0000 0113457899999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=337.24 Aligned_cols=268 Identities=21% Similarity=0.300 Sum_probs=183.0
Q ss_pred hcCccc-ccccccCCceeEEEEEeC---CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeee--cCceE
Q 004264 445 TNHFSE-ANMIGKGGFGPVYMGKLS---TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE--EDERM 518 (765)
Q Consensus 445 ~~~y~~-~~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~--~~~~~ 518 (765)
.+.|++ .++||+|+||.||+|+.. +++.||+|++..... ...+.+|+.+|++++||||+++++++.. ....+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 355766 457999999999999865 578899999975432 3468899999999999999999999965 66889
Q ss_pred EEEEecCCCChhHHhhccc------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE----ecCCCCe
Q 004264 519 LIYEYMPHKSLDYFIFDRE------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL----DINLNPK 588 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~vk 588 (765)
+||||+.+ +|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999975 6666654221 1234899999999999999999999999 9999999999999 6778999
Q ss_pred ecccccceeeCCCCc-ccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCc------cc
Q 004264 589 ISDFGLARIFGGDDE-EAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHR------HN 660 (765)
Q Consensus 589 L~DFGla~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~------~~ 660 (765)
|+|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ..
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999987643221 1223356789999999999874 589999999999999999999999965443210 01
Q ss_pred HHHHHHHhhccC---Ccccc---cc------ccccC---ccCH---------HHHHHHHHHHHHccccCCCCCCCHHHHH
Q 004264 661 LIGHAWLLWNDG---RALGL---MD------TCLED---SFVE---------SQVLRCIQVGLLCVQKLPEDRPDMSSVV 716 (765)
Q Consensus 661 ~~~~~~~~~~~~---~~~~l---~d------~~l~~---~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~evl 716 (765)
.+.......... .+..+ .+ ..... .... .....+.+|+.+||+.||++|||++|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 111111111000 00000 00 00000 0000 0134577899999999999999999999
Q ss_pred HH
Q 004264 717 FL 718 (765)
Q Consensus 717 ~~ 718 (765)
+.
T Consensus 333 ~h 334 (405)
T 3rgf_A 333 QD 334 (405)
T ss_dssp TS
T ss_pred cC
Confidence 64
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=333.68 Aligned_cols=272 Identities=20% Similarity=0.242 Sum_probs=191.3
Q ss_pred hHHHHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCc--
Q 004264 440 TITTATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE-- 516 (765)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~-- 516 (765)
......++|++.+.||+|+||.||+|+.. +++.||||++.... .......+|+..++.++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34566789999999999999999999874 68899999986543 233456778888899999999999999976544
Q ss_pred -----eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhh--hcCCCcEEecccCCCcEEEec-CCCCe
Q 004264 517 -----RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLH--QDSKLQVIHRDLKASNILLDI-NLNPK 588 (765)
Q Consensus 517 -----~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH--~~~~~~ivH~Dlkp~NIll~~-~~~vk 588 (765)
.++||||++++.+..+.........+++..+..++.||+.||.||| +.+ |+||||||+|||++. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence 7899999987544333322344556899999999999999999999 888 999999999999997 89999
Q ss_pred ecccccceeeCCCCcccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHH---
Q 004264 589 ISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGH--- 664 (765)
Q Consensus 589 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~--- 664 (765)
|+|||+++...... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||...........+..
T Consensus 173 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 249 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249 (360)
T ss_dssp ECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence 99999998764322 22345789999999998765 489999999999999999999999975432211111100
Q ss_pred -----HHHhhccCC-ccccccc------cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 665 -----AWLLWNDGR-ALGLMDT------CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 665 -----~~~~~~~~~-~~~l~d~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.+....... .....+. .............+.+|+.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000 0000000 00011112245678899999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=320.82 Aligned_cols=254 Identities=22% Similarity=0.352 Sum_probs=193.2
Q ss_pred HhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeee---------
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE--------- 513 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~--------- 513 (765)
..++|++.+.||+|+||.||+|+. .+++.||+|++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 356899999999999999999996 4788999999964 33456789999999999999999999998865
Q ss_pred ----cCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCee
Q 004264 514 ----EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKI 589 (765)
Q Consensus 514 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL 589 (765)
....++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 45678999999999999999642 345788999999999999999999999 999999999999999999999
Q ss_pred cccccceeeCCCCc------------ccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCC
Q 004264 590 SDFGLARIFGGDDE------------EAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPG 656 (765)
Q Consensus 590 ~DFGla~~~~~~~~------------~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~ 656 (765)
+|||+++....... ........|++.|+|||.+.+. .++.++||||||+++|||++ |+....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-- 232 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-- 232 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence 99999987542211 1122346789999999999864 78999999999999999998 332110
Q ss_pred CcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 657 HRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
. ............ ..............+.+++.+||+.||++|||+.++++.
T Consensus 233 ---~-~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 233 ---E-RVNILKKLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ---H-HHHHHHHHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---h-HHHHHHhccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 0 011111111111 011112223334567899999999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=326.45 Aligned_cols=263 Identities=24% Similarity=0.320 Sum_probs=199.9
Q ss_pred HhcCcccccccccCCceeEEEEEe--CCCcEEEEEEccccC--hhhHHHHHHHHHHHhcc---ccCceEeeeeeee----
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL--STGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKL---QHRNLVGLLGSCI---- 512 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l---~h~niv~~~~~~~---- 512 (765)
..++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 467889999986432 12223566788777776 7999999999987
Q ss_pred -ecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecc
Q 004264 513 -EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISD 591 (765)
Q Consensus 513 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~D 591 (765)
.....++||||+. ++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 5667899999998 58988885432 335899999999999999999999999 99999999999999999999999
Q ss_pred cccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhcc
Q 004264 592 FGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWND 671 (765)
Q Consensus 592 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 671 (765)
||+++.... ........+|..|+|||.+.+..++.++||||||+++|||++|+.||......+. ..........
T Consensus 164 fg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~ 237 (326)
T 1blx_A 164 FGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGL 237 (326)
T ss_dssp CCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCC
T ss_pred CcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCC
Confidence 999987532 2223356789999999999999999999999999999999999999875432211 1111111100
Q ss_pred C---Cccc---cccc-------cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 672 G---RALG---LMDT-------CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 672 ~---~~~~---l~d~-------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
. .+.. .... .............+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 0000 0000 0000111223456789999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=327.68 Aligned_cols=206 Identities=24% Similarity=0.283 Sum_probs=174.1
Q ss_pred hHhHHHHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccc-cC-----ceEeeeee
Q 004264 438 LATITTATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-HR-----NLVGLLGS 510 (765)
Q Consensus 438 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~-----niv~~~~~ 510 (765)
+.......++|++.+.||+|+||.||+|+.. +++.||||++... .....++..|+.+++.++ |+ +|++++++
T Consensus 46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 3344556789999999999999999999865 6788999999643 344567888999988885 44 59999999
Q ss_pred eeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhh--cCCCcEEecccCCCcEEEe--cCCC
Q 004264 511 CIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ--DSKLQVIHRDLKASNILLD--INLN 586 (765)
Q Consensus 511 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~--~~~~~ivH~Dlkp~NIll~--~~~~ 586 (765)
+...+..++||||+.+ +|.+++.... ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++ .++.
T Consensus 125 ~~~~~~~~lv~e~~~~-~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~ 199 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLSY-NLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSA 199 (382)
T ss_dssp EEETTEEEEEEECCCC-BHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCC
T ss_pred eccCCceEEEEecCCC-CHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCc
Confidence 9999999999999965 8888885433 2458999999999999999999995 56 99999999999995 4778
Q ss_pred CeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCC
Q 004264 587 PKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRH 654 (765)
Q Consensus 587 vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~ 654 (765)
+||+|||+++..... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 200 ~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp EEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999876322 234678999999999999999999999999999999999999997544
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=323.60 Aligned_cols=262 Identities=21% Similarity=0.275 Sum_probs=199.5
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccc-----------cCceEeeeeeee
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-----------HRNLVGLLGSCI 512 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-----------h~niv~~~~~~~ 512 (765)
.++|++.+.||+|+||.||+|+. .+++.||+|++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 36899999999999999999986 56889999999643 334567889999999886 889999999998
Q ss_pred ecC----ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhc-CCCcEEecccCCCcEEEecC---
Q 004264 513 EED----ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD-SKLQVIHRDLKASNILLDIN--- 584 (765)
Q Consensus 513 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivH~Dlkp~NIll~~~--- 584 (765)
... ..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++ + |+||||||+|||++.+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 789999999 889998885432 34589999999999999999999998 8 9999999999999543
Q ss_pred ---CCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccH
Q 004264 585 ---LNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNL 661 (765)
Q Consensus 585 ---~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~ 661 (765)
+.+||+|||+++..... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 47999999999876322 2345789999999999999999999999999999999999999976543222111
Q ss_pred HHHH---HHhhc------------------cCCccccccc--------cc--cCccCHHHHHHHHHHHHHccccCCCCCC
Q 004264 662 IGHA---WLLWN------------------DGRALGLMDT--------CL--EDSFVESQVLRCIQVGLLCVQKLPEDRP 710 (765)
Q Consensus 662 ~~~~---~~~~~------------------~~~~~~l~d~--------~l--~~~~~~~~~~~l~~li~~cl~~dP~~RP 710 (765)
.... ..... .......+.. .+ ....+......+.+|+.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 1111 11000 0000000000 00 1123456677899999999999999999
Q ss_pred CHHHHHH
Q 004264 711 DMSSVVF 717 (765)
Q Consensus 711 s~~evl~ 717 (765)
|+.||++
T Consensus 327 t~~ell~ 333 (373)
T 1q8y_A 327 DAGGLVN 333 (373)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=328.63 Aligned_cols=264 Identities=22% Similarity=0.274 Sum_probs=199.1
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeec-----Cc
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE-----DE 516 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~-----~~ 516 (765)
..++|.+.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3478999999999999999999875 6889999999653 344456788999999999999999999988764 67
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
.++||||+. ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999997 588888743 35899999999999999999999999 9999999999999999999999999998
Q ss_pred eeCCCCccc--------ccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 004264 597 IFGGDDEEA--------QTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWL 667 (765)
Q Consensus 597 ~~~~~~~~~--------~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~ 667 (765)
......... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+. ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ---LLLIFG 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHH
Confidence 764322111 1223578999999998764 7799999999999999999999999875432111 000000
Q ss_pred hhccCC----ccc--------ccccccc------CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 668 LWNDGR----ALG--------LMDTCLE------DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 668 ~~~~~~----~~~--------l~d~~l~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...... ... .+..... ..........+.+++.+||+.||++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 000 0000000 00011223567899999999999999999999873
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=332.49 Aligned_cols=257 Identities=21% Similarity=0.300 Sum_probs=195.9
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCce----
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDER---- 517 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~---- 517 (765)
.++|.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999864 6889999999754 334467889999999999999999999999887655
Q ss_pred --EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccc
Q 004264 518 --MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA 595 (765)
Q Consensus 518 --~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla 595 (765)
++||||+. ++|.+++ ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIM-----GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 5777766 234899999999999999999999999 999999999999999999999999999
Q ss_pred eeeCCCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC-
Q 004264 596 RIFGGDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR- 673 (765)
Q Consensus 596 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~- 673 (765)
+.... ......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+. ............
T Consensus 192 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~ 263 (371)
T 4exu_A 192 RHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGT 263 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCH
T ss_pred ccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCcH
Confidence 86532 1234678999999999987 7899999999999999999999999965432211 111100000000
Q ss_pred ----------ccccccccc---cC---ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 674 ----------ALGLMDTCL---ED---SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 674 ----------~~~l~d~~l---~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
......... .. .........+.+|+.+||+.||++|||+.++++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000000 00 0011224568899999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=323.44 Aligned_cols=255 Identities=25% Similarity=0.340 Sum_probs=179.0
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHH-HHhccccCceEeeeeeeeecCceEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVV-LIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~-~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
.++|++.+.||+|+||.||+|... +++.||+|++.... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 368899999999999999999874 68899999997643 334455666665 777789999999999999999999999
Q ss_pred EecCCCChhHHhhcc--ccCCCCChHHHHHHHHHHHHHHHHhhhc-CCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 522 EYMPHKSLDYFIFDR--ERSKLLPWKKRFSIITGIARGLLYLHQD-SKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 522 E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
||+++ +|.+++... .....+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 777666431 2245689999999999999999999998 8 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCcccc----cCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCc
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYA----NDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRA 674 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (765)
.... ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||........ .......+..
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~~~ 247 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD------QLTQVVKGDP 247 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCC
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH------HHHHHhcCCC
Confidence 4321 22234789999999998 466789999999999999999999999864322100 0000001111
Q ss_pred cccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 675 LGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 675 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
..+ ...........+.+++.+||+.||++||++.+|++
T Consensus 248 ~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 PQL-----SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCC-----CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC-----CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111 11111122456889999999999999999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=353.83 Aligned_cols=255 Identities=24% Similarity=0.303 Sum_probs=202.1
Q ss_pred HhcCcccccccccCCceeEEEEEeCC----CcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLST----GQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~ 518 (765)
..++|++.+.||+|+||.||+|.... +..+|+|++... .....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 34789999999999999999998642 457999998754 3444578999999999999999999999985 46789
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999998543 345899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ .. .....+....+
T Consensus 542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~----~~i~~~~~~~~ 613 (656)
T 2j0j_A 542 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI----GRIENGERLPM 613 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH----HHHHHTCCCCC
T ss_pred CCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HH----HHHHcCCCCCC
Confidence 433221 1223556789999999999999999999999999999997 999986433221 11 11111111111
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+......+.+++.+||+.||++|||+.+|+++|+.
T Consensus 614 ---------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 614 ---------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp ---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11223567899999999999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=317.72 Aligned_cols=253 Identities=26% Similarity=0.311 Sum_probs=202.6
Q ss_pred HHHhcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceE
Q 004264 442 TTATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 442 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~ 518 (765)
....++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345678999999999999999999875 6889999998653 2345678999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC---CCCeecccccc
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN---LNPKISDFGLA 595 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~vkL~DFGla 595 (765)
+|+||+++++|.+.+... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999998887543 35899999999999999999999999 9999999999999764 46999999999
Q ss_pred eeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcc
Q 004264 596 RIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRAL 675 (765)
Q Consensus 596 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (765)
....... ......+++.|+|||.+.+ .++.++||||||+++|+|++|+.||......+ .......+...
T Consensus 172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~ 240 (287)
T 2wei_A 172 TCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYA 240 (287)
T ss_dssp GTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC
T ss_pred eeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCC
Confidence 8764322 1223468899999999876 48999999999999999999999986533211 11111122111
Q ss_pred ccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 676 GLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 676 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
... +. .......+.+++.+||+.+|++|||+.++++
T Consensus 241 ~~~-~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 FDL-PQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCS-GG-----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCc-hh-----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000 00 0112345789999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=325.83 Aligned_cols=256 Identities=20% Similarity=0.279 Sum_probs=195.7
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCc-----
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE----- 516 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~----- 516 (765)
.++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367999999999999999999864 6889999999753 33445788999999999999999999999987654
Q ss_pred -eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccc
Q 004264 517 -RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA 595 (765)
Q Consensus 517 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla 595 (765)
.++||||+. ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 57877662 24899999999999999999999999 999999999999999999999999999
Q ss_pred eeeCCCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccC--
Q 004264 596 RIFGGDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDG-- 672 (765)
Q Consensus 596 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-- 672 (765)
+..... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ...........
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~ 245 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGT 245 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCCH
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCH
Confidence 865321 224578999999999887 6789999999999999999999999975432211 11111000000
Q ss_pred ----------------CccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 673 ----------------RALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 673 ----------------~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.......... ..........+.+++.+||+.||++|||+.++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000000 01112234568899999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.21 Aligned_cols=245 Identities=24% Similarity=0.386 Sum_probs=190.2
Q ss_pred HHHHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccCh------hhHHHHHHHHHHHhcc----ccCceEeeee
Q 004264 441 ITTATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSG------QGLEEFMNEVVLIGKL----QHRNLVGLLG 509 (765)
Q Consensus 441 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~~Ev~~l~~l----~h~niv~~~~ 509 (765)
.....++|++.+.||+|+||.||+|+. .+++.||+|++..... .....+.+|+.++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 345568899999999999999999986 4688999999975432 1233456799999998 8999999999
Q ss_pred eeeecCceEEEEEe-cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEe-cCCCC
Q 004264 510 SCIEEDERMLIYEY-MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD-INLNP 587 (765)
Q Consensus 510 ~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~v 587 (765)
++.+.+..++|+|+ +.+++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++ .++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 99999999999999 789999999854 335899999999999999999999999 99999999999999 88999
Q ss_pred eecccccceeeCCCCcccccccccccccccCcccccCCCCC-ccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 004264 588 KISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTIS-MKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAW 666 (765)
Q Consensus 588 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~ 666 (765)
||+|||+++..... ......++..|+|||++.+..+. .++||||||+++|||++|+.||.... ...
T Consensus 180 kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~~~ 246 (312)
T 2iwi_A 180 KLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------EIL 246 (312)
T ss_dssp EECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHH
T ss_pred EEEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------HHh
Confidence 99999999876432 22346689999999999877664 58999999999999999999985311 000
Q ss_pred HhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 667 LLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 667 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.... ..+......+.+++.+||+.+|++|||+.++++.
T Consensus 247 ----~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 ----EAEL----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ----HTCC----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----hhcc----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0111123457789999999999999999999973
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.71 Aligned_cols=253 Identities=20% Similarity=0.205 Sum_probs=172.5
Q ss_pred HhcCccccc-ccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeee----cCce
Q 004264 444 ATNHFSEAN-MIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE----EDER 517 (765)
Q Consensus 444 ~~~~y~~~~-~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~----~~~~ 517 (765)
..++|.+.+ .||+|+||.||+|... +++.||+|++.... ....+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 457899855 6999999999999875 68999999986532 122223334566789999999999876 4458
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec---CCCCeeccccc
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI---NLNPKISDFGL 594 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~vkL~DFGl 594 (765)
++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 99999999999999986432 346899999999999999999999999 999999999999976 45599999999
Q ss_pred ceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCc
Q 004264 595 ARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRA 674 (765)
Q Consensus 595 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (765)
++..... ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||............. .....+.
T Consensus 178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~- 249 (336)
T 3fhr_A 178 AKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRIRLGQ- 249 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhhhccc-
Confidence 9875322 2234678999999999999999999999999999999999999986544322110000 0000000
Q ss_pred cccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 675 LGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 675 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
..... .........+.+++.+||+.||++|||+.++++
T Consensus 250 ~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 250 YGFPN-----PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -CCCT-----TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccCc-----hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 011122456789999999999999999999997
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=331.51 Aligned_cols=253 Identities=23% Similarity=0.287 Sum_probs=188.0
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEEEEec
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
+.|.+.+.||+|+||+||.+...+++.||||++... ..+.+.+|+.+++++ +||||+++++++.+....++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 446667889999999998777778999999998653 235678999999986 8999999999999999999999999
Q ss_pred CCCChhHHhhccccCC----CCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC-------------CCC
Q 004264 525 PHKSLDYFIFDRERSK----LLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN-------------LNP 587 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~v 587 (765)
. ++|.+++....... ...+..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999986533211 1234456789999999999999999 9999999999999754 479
Q ss_pred eecccccceeeCCCCccc--ccccccccccccCcccccC-------CCCCccccchHHHHHHHHHHh-CCCCCCCCCCCC
Q 004264 588 KISDFGLARIFGGDDEEA--QTERVAGTHGYMSPEYAND-------GTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGH 657 (765)
Q Consensus 588 kL~DFGla~~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-------~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~ 657 (765)
||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 999999999875432221 2234679999999999976 678999999999999999999 999986432211
Q ss_pred cccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 658 RHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.. ... ...... .+...........+.+++.+||+.||++|||+.+|++
T Consensus 248 ----~~-i~~--~~~~~~-----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 ----SN-IIR--GIFSLD-----EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ----HH-HHH--TCCCCC-----CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HH-Hhc--CCCCcc-----cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 00 000 000110 1111223445677899999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=320.16 Aligned_cols=263 Identities=17% Similarity=0.193 Sum_probs=199.0
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CC-cEEEEEEccccChhhHHHHHHHHHHHhccccCc------eEeeeeeeeecC
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TG-QEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRN------LVGLLGSCIEED 515 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~-~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n------iv~~~~~~~~~~ 515 (765)
..++|++.+.||+|+||.||+|... ++ +.||+|++... ....+.+.+|+.++++++|++ ++.+++++....
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 3478999999999999999999864 34 68999998643 345677889999999998766 999999999999
Q ss_pred ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE--------------
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL-------------- 581 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll-------------- 581 (765)
..++||||+. ++|.+.+... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 96 ~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 96 HMCIAFELLG-KNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEEECCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eEEEEEeccC-CChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 9999999994 5555555332 2245899999999999999999999998 9999999999999
Q ss_pred -----ecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCC
Q 004264 582 -----DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPG 656 (765)
Q Consensus 582 -----~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~ 656 (765)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 67889999999999874321 23467899999999999999999999999999999999999999754322
Q ss_pred CcccHHHHHH--------HhhccCCccc----cc--------------cc-cccCccCHHHHHHHHHHHHHccccCCCCC
Q 004264 657 HRHNLIGHAW--------LLWNDGRALG----LM--------------DT-CLEDSFVESQVLRCIQVGLLCVQKLPEDR 709 (765)
Q Consensus 657 ~~~~~~~~~~--------~~~~~~~~~~----l~--------------d~-~l~~~~~~~~~~~l~~li~~cl~~dP~~R 709 (765)
+....+.... .......... .. .+ .............+.+|+.+||+.||++|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 1111111000 0000000000 00 00 00001122345678899999999999999
Q ss_pred CCHHHHHH
Q 004264 710 PDMSSVVF 717 (765)
Q Consensus 710 Ps~~evl~ 717 (765)
||+.++++
T Consensus 326 pt~~e~l~ 333 (355)
T 2eu9_A 326 ITLAEALL 333 (355)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999984
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=323.68 Aligned_cols=244 Identities=25% Similarity=0.365 Sum_probs=198.2
Q ss_pred HHHhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccCh------hhHHHHHHHHHHHhccc--cCceEeeeeeee
Q 004264 442 TTATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSG------QGLEEFMNEVVLIGKLQ--HRNLVGLLGSCI 512 (765)
Q Consensus 442 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~~Ev~~l~~l~--h~niv~~~~~~~ 512 (765)
....++|++.+.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34557899999999999999999985 5688999999865421 12345678999999996 599999999999
Q ss_pred ecCceEEEEEecCC-CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEe-cCCCCeec
Q 004264 513 EEDERMLIYEYMPH-KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD-INLNPKIS 590 (765)
Q Consensus 513 ~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~vkL~ 590 (765)
+.+..++|+|++.+ ++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999986 899998854 345899999999999999999999999 99999999999999 78899999
Q ss_pred ccccceeeCCCCcccccccccccccccCcccccCCCC-CccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhh
Q 004264 591 DFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTI-SMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLW 669 (765)
Q Consensus 591 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 669 (765)
|||+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... . . .
T Consensus 193 Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~-~---~ 256 (320)
T 3a99_A 193 DFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------E-I---I 256 (320)
T ss_dssp CCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H-H---H
T ss_pred eCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------h-h---h
Confidence 99999876432 2234578999999999987665 788999999999999999999985321 0 0 0
Q ss_pred ccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 670 NDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 670 ~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.+.. . .... ....+.+++.+||+.||++|||+++|++.
T Consensus 257 -~~~~--~----~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 257 -RGQV--F----FRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -HCCC--C----CSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -cccc--c----cccc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0100 0 0111 23457799999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=313.87 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=178.4
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhh-HHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQG-LEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~-~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ... .+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 367899999999999999999975 68999999997543 222 334445556788889999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhc-CCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD-SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
||+ ++.+..+... ....+++..++.++.||+.||.|||+. + |+||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 4555554422 235689999999999999999999995 8 99999999999999999999999999986543
Q ss_pred CCcccccccccccccccCccccc-----CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYAN-----DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRAL 675 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (765)
.. ......+++.|+|||++. ...++.++||||||+++|||++|+.||...... ..... ... .+...
T Consensus 178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~---~~~-~~~~~ 248 (318)
T 2dyl_A 178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLT---KVL-QEEPP 248 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHH---HHH-HSCCC
T ss_pred Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHHH---HHh-ccCCC
Confidence 22 223457899999999994 567899999999999999999999998642211 11111 111 11111
Q ss_pred ccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 676 GLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 676 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.+... ......+.+++.+||+.||++||++.+|++
T Consensus 249 ~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 LLPGH-------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCSS-------SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCcc-------CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11100 012345778999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=328.37 Aligned_cols=251 Identities=20% Similarity=0.313 Sum_probs=187.4
Q ss_pred HhcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEEEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV~E 522 (765)
...+|.+.++||+|+||+|+.....+++.||||++..... ..+.+|+.+|+++ +||||+++++++.+....++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 3456899999999999997665566899999999965432 2356899999999 79999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec-----CCCCeeccccccee
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI-----NLNPKISDFGLARI 597 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~vkL~DFGla~~ 597 (765)
|+. ++|.+++.... ....+..++.++.||+.||+|||+.+ |+||||||+|||++. ...+||+|||+++.
T Consensus 99 ~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 99 LCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 996 58988885432 23555677899999999999999999 999999999999953 23578999999987
Q ss_pred eCCCCc-ccccccccccccccCccccc---CCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccC
Q 004264 598 FGGDDE-EAQTERVAGTHGYMSPEYAN---DGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDG 672 (765)
Q Consensus 598 ~~~~~~-~~~~~~~~gt~~Y~aPE~~~---~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 672 (765)
...... ........||+.|+|||++. ...++.++|||||||++|||++ |+.||....... ........
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~ 245 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGAC 245 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTTCC
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhccC
Confidence 643221 12233567999999999998 4567889999999999999999 888985332211 11111111
Q ss_pred CccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 673 RALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 673 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.. ... .........+.+|+.+||+.||++|||+.+|++
T Consensus 246 ~~-~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 SL-DCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CC-TTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Cc-ccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 10 000 111233455778999999999999999999983
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=340.45 Aligned_cols=264 Identities=22% Similarity=0.248 Sum_probs=198.7
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeee------cCc
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE------EDE 516 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~------~~~ 516 (765)
.++|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 37899999999999999999986 46889999998754 44556789999999999999999999998765 677
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCC---Ceecccc
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLN---PKISDFG 593 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---vkL~DFG 593 (765)
.++||||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976555557999999999999999999999999 999999999999997765 8999999
Q ss_pred cceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCc-cc-HHHHH-HHhhc
Q 004264 594 LARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHR-HN-LIGHA-WLLWN 670 (765)
Q Consensus 594 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~-~~-~~~~~-~~~~~ 670 (765)
+++...... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ .. ..... .....
T Consensus 170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 998764322 22346789999999999999999999999999999999999999864311000 00 00000 00000
Q ss_pred cCCcc---ccccccc-cCccCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 004264 671 DGRAL---GLMDTCL-EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSS 714 (765)
Q Consensus 671 ~~~~~---~l~d~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 714 (765)
..... ....... ...........+.+++..||+.||++|||+.+
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 00000 0000000 11233445678899999999999999999966
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=341.38 Aligned_cols=237 Identities=21% Similarity=0.293 Sum_probs=192.7
Q ss_pred hcCcccccccccCCceeEEEEEeC--CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCc-----
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS--TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE----- 516 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~----- 516 (765)
.++|++.+.||+|+||.||++.+. +++.||||++... .......+.+|+.++++++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999875 5889999998654 34456678999999999999999999999998776
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
.+|||||+++++|.+++.. .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999887632 5899999999999999999999999 9999999999999986 89999999998
Q ss_pred eeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 597 IFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
..... ....||+.|+|||++.+.. +.++||||||+++|+|++|..|+........
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------------------ 284 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------------------ 284 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC------------------
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc------------------
Confidence 76432 3467999999999987664 8899999999999999999888653211110
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHh
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPD-MSSVVFLLA 720 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~ 720 (765)
. ...........+.+|+.+||+.||++||+ ++++...|.
T Consensus 285 -~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 285 -P----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp -C----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -c----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0 01111122356789999999999999995 666666554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=301.92 Aligned_cols=229 Identities=10% Similarity=0.029 Sum_probs=183.1
Q ss_pred HhcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
..++|++.+.||+|+||.||+|+.. .++.||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 3468999999999999999999975 48899999997642 3445789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+++++|.+++.. + .....+.+++.||+.||+|||+.+ |+||||||+|||++.++.+||++++
T Consensus 109 v~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EEECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------
Confidence 9999999999999832 1 345578899999999999999999 9999999999999999999998543
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
|++ +++.++||||||+++|||++|+.||............ ...+.
T Consensus 175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~------------~~~~~ 219 (286)
T 3uqc_A 175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------------ERDTA 219 (286)
T ss_dssp ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC------------CBCTT
T ss_pred ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH------------HHHhc
Confidence 333 3688999999999999999999999765443211000 00000
Q ss_pred cccc--CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 680 TCLE--DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 680 ~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
.... ..........+.+++.+||+.||++| |+.++++.|+..
T Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 0000 01111223457899999999999999 999999999773
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=296.15 Aligned_cols=227 Identities=20% Similarity=0.214 Sum_probs=177.8
Q ss_pred hcCcccc-cccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHH-hccccCceEeeeeeeee----cCce
Q 004264 445 TNHFSEA-NMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLI-GKLQHRNLVGLLGSCIE----EDER 517 (765)
Q Consensus 445 ~~~y~~~-~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l-~~l~h~niv~~~~~~~~----~~~~ 517 (765)
.++|.+. +.||+|+||.||++.. .+++.||+|++... ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567776 7799999999999986 46889999998642 4567888888 55689999999999987 6788
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec---CCCCeeccccc
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI---NLNPKISDFGL 594 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~vkL~DFGl 594 (765)
++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999986532 346899999999999999999999999 999999999999998 78899999999
Q ss_pred ceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCc
Q 004264 595 ARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRA 674 (765)
Q Consensus 595 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (765)
+.... +..++.++||||||+++|||++|+.||......... ....
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~ 211 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMK 211 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSC
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHH
Confidence 97542 245678999999999999999999998654332110 0000
Q ss_pred cccccccccCccC----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 675 LGLMDTCLEDSFV----ESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 675 ~~l~d~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
..+..... ..+ ......+.+++.+||+.||++|||+.++++
T Consensus 212 ~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 212 TRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000000 011 112456889999999999999999999996
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=313.99 Aligned_cols=241 Identities=16% Similarity=0.182 Sum_probs=178.7
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHhcccc-Cce---------------
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQH-RNL--------------- 504 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h-~ni--------------- 504 (765)
...|...+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+.+++.++| +|.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34577889999999999999995 578999999987432 2336789999999999976 221
Q ss_pred Eee------eeeeee-----cCceEEEEEecCCCChhHHhhc----cccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcE
Q 004264 505 VGL------LGSCIE-----EDERMLIYEYMPHKSLDYFIFD----RERSKLLPWKKRFSIITGIARGLLYLHQDSKLQV 569 (765)
Q Consensus 505 v~~------~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 569 (765)
+.+ ..++.. ....+++|+++ +++|.+++.. ......+++..++.++.||++||+|||+.+ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 111 111111 12356666654 6889888742 122445788899999999999999999999 9
Q ss_pred EecccCCCcEEEecCCCCeecccccceeeCCCCcccccccccccccccCcccc----------cCCCCCccccchHHHHH
Q 004264 570 IHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA----------NDGTISMKSDVFSLGVL 639 (765)
Q Consensus 570 vH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~----------~~~~~s~k~DvwSlG~l 639 (765)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999874321 334567 999999999 56678999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 004264 640 LVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVV 716 (765)
Q Consensus 640 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 716 (765)
+|||++|+.||.......... .++... ... ...+.+|+.+||+.||++||++.+++
T Consensus 307 l~elltg~~Pf~~~~~~~~~~---------------~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSE---------------WIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSG---------------GGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHCCCCCCCcchhhhHH---------------HHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999986543322111 111111 111 25588999999999999999976664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-34 Score=305.95 Aligned_cols=242 Identities=16% Similarity=0.121 Sum_probs=182.1
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEccccC--------hhhHHHHHHHHHHHhccc---------cCceEee
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNS--------GQGLEEFMNEVVLIGKLQ---------HRNLVGL 507 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~Ev~~l~~l~---------h~niv~~ 507 (765)
.++|++.+.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999997 68999999997542 233478899999999886 5555555
Q ss_pred ee-----------------eeee-------------cCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHH
Q 004264 508 LG-----------------SCIE-------------EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARG 557 (765)
Q Consensus 508 ~~-----------------~~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~a 557 (765)
.+ ++.+ ....++||||+++|++.+.+.. ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 44 4443 6789999999999976555522 458999999999999999
Q ss_pred HHHhh-hcCCCcEEecccCCCcEEEecCC--------------------CCeecccccceeeCCCCcccccccccccccc
Q 004264 558 LLYLH-QDSKLQVIHRDLKASNILLDINL--------------------NPKISDFGLARIFGGDDEEAQTERVAGTHGY 616 (765)
Q Consensus 558 L~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y 616 (765)
|+||| +.+ |+||||||+|||++.++ .+||+|||+++.... ....||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecc
Confidence 99999 899 99999999999999887 899999999997642 135799999
Q ss_pred cCcccccCCCCCccccchHHHHH-HHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHH
Q 004264 617 MSPEYANDGTISMKSDVFSLGVL-LVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCI 695 (765)
Q Consensus 617 ~aPE~~~~~~~s~k~DvwSlG~l-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~ 695 (765)
+|||++.+.. +.++||||++++ .+++++|..||... .............. ................++.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQM---TFKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTC---CCSSCCCSHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhh---ccCcccchhhhhhcCHHHH
Confidence 9999998776 899999998777 77888898886310 00000100100000 0011111122334567899
Q ss_pred HHHHHccccCCCCCCCHHHHH
Q 004264 696 QVGLLCVQKLPEDRPDMSSVV 716 (765)
Q Consensus 696 ~li~~cl~~dP~~RPs~~evl 716 (765)
+|+.+||+.| |++|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 9999999966 899988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-28 Score=280.52 Aligned_cols=185 Identities=16% Similarity=0.132 Sum_probs=131.2
Q ss_pred ccccCCceeEEEEE-eCCCcEEEEEEcccc----------ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEE
Q 004264 453 MIGKGGFGPVYMGK-LSTGQEIAAKRLSKN----------SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 453 ~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~----------~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV 520 (765)
..+.|++|.+..++ .-.|+.+++|.+.+. .....++|.+|+++|+++ +|+||+++++++.++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45667777666554 335889999999654 123456799999999999 699999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||++|++|.+++.. .++++.. +|+.||+.||+|||++| ||||||||+||||+.++++||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999953 3445544 58899999999999999 99999999999999999999999999987643
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCC
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMN 649 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p 649 (765)
.. ......+||+.|+|||++.+ .+..++|+||+|+++++|.++..+
T Consensus 392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 22 22335789999999999975 467789999999999988776543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.2e-25 Score=251.30 Aligned_cols=185 Identities=21% Similarity=0.225 Sum_probs=146.3
Q ss_pred ccccccccCCceeEEEEEeCCCcEEEEEEccccC--------hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 449 SEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNS--------GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 449 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
...++||+|+||.||++.. .++.+++|+..... ....+++.+|+.++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 57788888764321 11245689999999999999999777777788889999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||+++++|.+++.. +..++.||++||+|||+++ |+||||||+|||++. ++||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999843 5689999999999999999 999999999999998 999999999998743
Q ss_pred CCccc-----ccccccccccccCcccccC--CCCCccccchHHHHHHHHHHhCCCCC
Q 004264 601 DDEEA-----QTERVAGTHGYMSPEYAND--GTISMKSDVFSLGVLLVEIVSGKMNR 650 (765)
Q Consensus 601 ~~~~~-----~~~~~~gt~~Y~aPE~~~~--~~~s~k~DvwSlG~ll~elltG~~p~ 650 (765)
..... ......||+.|+|||++.. ..|+.++|+|+..+-..+.+.++.++
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 22211 1235789999999999987 56888899999999999988877654
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.7e-22 Score=173.65 Aligned_cols=105 Identities=18% Similarity=0.377 Sum_probs=92.8
Q ss_pred ccccCCCccccCCCeEEcCCCeEEEEEecCCCCCCeEEEEEEeCCCCcEEEeecCCCCCCCCCceEEEeeCCceEEEcCC
Q 004264 25 ADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQE 104 (765)
Q Consensus 25 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (765)
.|+|.+||.|.+|++|+| |.|.|.|+.+|+ |.++. ..++||+|||++|.. ..+.|+|+.||||||+|++
T Consensus 1 kn~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~---~~~~vW~ant~~~~~-~~~~L~l~~dGnLvL~d~~ 69 (105)
T 4h3o_A 1 RNILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD---HSTSTWASNTEIGGK-SGCSAVLQSDGNFVVYDSS 69 (105)
T ss_dssp CCEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTTC-CSCEEEECTTSCEEEECTT
T ss_pred CCCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE---CCEEEEEecCCCCCC-ccEEEEEeCCccEEEECCC
Confidence 378999999999999988 889999999998 66654 468999999999964 4689999999999999999
Q ss_pred CCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeee
Q 004264 105 KSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQS 147 (765)
Q Consensus 105 ~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqS 147 (765)
+++||+|++.......+|+|+||||||||+. +||||
T Consensus 70 ~~~vWss~t~~~~~~~~l~L~ddGNlVly~~-------~~W~S 105 (105)
T 4h3o_A 70 GRSLWASHSTRGSGNYILILQDDGNVIIYGS-------DIWST 105 (105)
T ss_dssp CCEEEECCCCCCSSCEEEEECTTSCEEEEES-------EEEEC
T ss_pred cEEEEEecCCCCCCCEEEEEeCCCeEEEECC-------cEecC
Confidence 9999999987666677899999999999972 59998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=4.6e-22 Score=208.66 Aligned_cols=151 Identities=15% Similarity=0.103 Sum_probs=122.3
Q ss_pred hHHHHhcCcccccccccCCceeEEEEEeCCCcEEEEEEccccCh------------------hhHHHHHHHHHHHhcccc
Q 004264 440 TITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSG------------------QGLEEFMNEVVLIGKLQH 501 (765)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~Ev~~l~~l~h 501 (765)
.+......|.+.+.||+|+||.||+|...+++.||+|++..... .....+.+|+.++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 33444556778899999999999999997799999999864321 23567899999999999
Q ss_pred CceEeeeeeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE
Q 004264 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL 581 (765)
Q Consensus 502 ~niv~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll 581 (765)
| +++.+++. .+..++||||+++++|.+ +. ......++.||+.||.|||+.+ |+||||||+|||+
T Consensus 163 -~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~---------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 163 -G-LAVPKVYA-WEGNAVLMELIDAKELYR-VR---------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp -T-SSSCCEEE-EETTEEEEECCCCEEGGG-CC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred -C-CCcCeEEe-ccceEEEEEecCCCcHHH-cc---------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 5 67776554 456799999999999987 41 1334579999999999999999 9999999999999
Q ss_pred ecCCCCeecccccceeeCCCCcccccccccccccccCccccc
Q 004264 582 DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAN 623 (765)
Q Consensus 582 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 623 (765)
+ ++.+||+|||+++.. ..+.|||++.
T Consensus 227 ~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~ 252 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVEV---------------GEEGWREILE 252 (282)
T ss_dssp E-TTEEEECCCTTCEET---------------TSTTHHHHHH
T ss_pred E-CCcEEEEECCCCeEC---------------CCCCHHHHHH
Confidence 9 999999999999742 3578899875
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4.2e-21 Score=170.47 Aligned_cols=110 Identities=25% Similarity=0.411 Sum_probs=96.0
Q ss_pred ccccCCCccccCCCeEEcCCCeEEEEEecCCCCCCeEEEEEEeCCCCcEEEeecCCCCCCCCCceEEEeeCCceEEEcCC
Q 004264 25 ADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQE 104 (765)
Q Consensus 25 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (765)
.|+|.+|+.|..|++|+ ++|.|.|+|+.+|+ + ++|+ .+++||.+|++.| +..+.+.|..||||||+|.+
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~--~~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~~~~ 69 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD--SGKPVWASNTGGL--GSGCRLTLHNNGNLVIYDQS 69 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE--TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE--CCEEEEECCCCCC--CCcEEEEEeCCCCEEEECCC
Confidence 37899999999999999 99999999999887 3 5666 4799999999877 34689999999999999999
Q ss_pred CCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCCCC
Q 004264 105 KSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPS 152 (765)
Q Consensus 105 ~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~Pt 152 (765)
|.+||+|++....+...++|+|+|||||++ . ++||||+||.
T Consensus 70 ~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~----~---~~W~S~~~~~ 110 (110)
T 3a0c_A 70 NRVIWQTKTNGKEDHYVLVLQQDRNVVIYG----P---VVWATGSGPA 110 (110)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEEC----S---EEEECSCCC-
T ss_pred CcEEEecCCCCCCCCEEEEEeCCccEEEEC----C---CEecCCCcCC
Confidence 999999997655556789999999999996 2 7999999983
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=9.2e-21 Score=170.43 Aligned_cols=108 Identities=16% Similarity=0.312 Sum_probs=94.9
Q ss_pred ccccccCCCccccCCCeEE--cCCCeEEEEEecCCCCCCeEEEEEEeCCCCcEEEeecCCCCCCCCCceEEEeeCCceEE
Q 004264 23 FAADSLSSGKFITDGETLV--SSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLL 100 (765)
Q Consensus 23 ~~~~~l~~g~~l~~~~~l~--s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l 100 (765)
++.|+|.+|++|.+|++|+ |++|.|+|+|+.+|+ + +||+. +++||+||++.| +.++.|.|+.||||||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~--~~~vW~sn~~~~--~~~~~l~l~~dGNLVl 75 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN-----L-VLYDN--NNPIWATNTGGL--GNGCRAVLQPDGVLVV 75 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC--CEEEEeCCCccC--CCceEEEEccCCEEEE
Confidence 4678999999999999999 999999999999886 2 56764 799999999977 4568999999999999
Q ss_pred EcCCCCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeee
Q 004264 101 LNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQS 147 (765)
Q Consensus 101 ~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqS 147 (765)
+|.++.+||+|++....+...++|+|+|||||++ .++|||
T Consensus 76 ~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~-------~~~W~S 115 (119)
T 1b2p_A 76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG-------DALWAT 115 (119)
T ss_dssp ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE-------SEEEEC
T ss_pred EeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC-------ccEeCC
Confidence 9999999999997644556789999999999997 179998
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=3e-20 Score=166.59 Aligned_cols=110 Identities=18% Similarity=0.325 Sum_probs=94.7
Q ss_pred ccccCCCccccCCCeEEcCCCeEEEEEecCCCCCCeEEEEEEeCCCCcEEEeecCCCCCCCCCceEEEeeCCceEEEcCC
Q 004264 25 ADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQE 104 (765)
Q Consensus 25 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (765)
.|+|.+||+|.+|++|+ +|.|+|+|+.+|+ +. +|+ ..++||+||++.| +.++.|.|+.||||||+|.+
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----lv-ly~--~~~~vW~sn~~~~--~~~~~l~l~~~GnLvl~d~~ 69 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----LV-KYQ--NGRQIWASNTDRR--GSGCRLTLLSDGNLVIYDHN 69 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----EE-EEE--TTEEEEECSCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----EE-EEe--CCEEEEeCCCCCC--CCceEEEECCCCcEEEECCC
Confidence 48999999999999998 7999999998886 22 354 4789999999988 35689999999999999999
Q ss_pred CCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCCCCC
Q 004264 105 KSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSD 153 (765)
Q Consensus 105 ~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PtD 153 (765)
+.+||+|++....+...++|+|+|||||++ . ++||||.++..
T Consensus 70 ~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~----~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 70 NNDVWGSACWGDNGKYALVLQKDGRFVIYG----P---VLWSLGPNGCR 111 (115)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEEC----S---EEECSSTTCBC
T ss_pred ceEEEEcCCCCCCCCEEEEEeCCCeEEEEC----C---CEEECCCCCCc
Confidence 999999997644456789999999999996 2 79999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.82 E-value=5.3e-20 Score=164.19 Aligned_cols=110 Identities=27% Similarity=0.472 Sum_probs=93.6
Q ss_pred ccccCCCccccCCCeEEcCCCeEEEEEecCCCCCCeEEEEEEeCCCCcEEEeecCCCCCCCCCceEEEeeCCceEEEcCC
Q 004264 25 ADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQE 104 (765)
Q Consensus 25 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (765)
+|+|.+||+|.+|++| ++|.|+|+|+.+|+ + ++|+. +++||++|++.+ +.++.|.|..+|||||+| +
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn-----l-vl~~~--~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~ 67 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN-----L-VLYDN--NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-G 67 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-T
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc-----E-EEEEC--CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-C
Confidence 4899999999999999 58999999999987 2 34554 789999999864 456899999999999999 8
Q ss_pred CCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCCC
Q 004264 105 KSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYP 151 (765)
Q Consensus 105 ~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~P 151 (765)
+.++|+|++....+...++|+++|||||++ ..+.++||||++.
T Consensus 68 ~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~----~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYD----NSNNAIWATHTNV 110 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEEC----TTSCEEEECCCCC
T ss_pred CEEEEECCccCCCCCEEEEEeCCCcEEEEC----CCCceEEECCCcc
Confidence 889999987644556789999999999997 3457999999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.1e-19 Score=158.23 Aligned_cols=103 Identities=24% Similarity=0.420 Sum_probs=88.6
Q ss_pred cccCCCccccCCCeEEcCCCeEEEEEecCCCCCCeEEEEEEeCCCCcEEEeecCCCCCCCCCceEEEeeCCceEEEcCCC
Q 004264 26 DSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEK 105 (765)
Q Consensus 26 ~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~ 105 (765)
++|.+||+|.+|++|+ +|.|.|+|+.+|+ +.+ |.. .++||++|++.+ +..+.|.|+.||||||+|.++
T Consensus 2 ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~--~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~~ 69 (109)
T 3dzw_A 2 NILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV--DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPRN 69 (109)
T ss_dssp CEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEE-EET--TEEEEECCCTTS--SSSCEEEECTTSCEEEECTTS
T ss_pred CCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC--CEEEEECCcccC--CCCEEEEEeCCCCEEEECCCC
Confidence 6899999999999996 7999999999987 333 543 689999999876 456899999999999999999
Q ss_pred CeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeee
Q 004264 106 SAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQS 147 (765)
Q Consensus 106 ~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqS 147 (765)
.++|+|++.......+|+|+||||||||+. ++|||
T Consensus 70 ~~~W~S~t~~~~~~~~~~L~ddGNlvly~~-------~~W~s 104 (109)
T 3dzw_A 70 NPIWASNTGGENGNYVCVLQKDRNVVIYGT-------ARWAT 104 (109)
T ss_dssp CEEEECCCCCSSSCEEEEECTTSCEEEEES-------CCCCC
T ss_pred CEEEECCCCCCCCCEEEEEeCCCEEEEECC-------CEEeC
Confidence 999999976544457899999999999972 79997
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.4e-18 Score=154.00 Aligned_cols=105 Identities=24% Similarity=0.380 Sum_probs=88.8
Q ss_pred ccccccCCCccccCCCeEEcCCCeEEEEEecCCCCCCeEEEEEEeCCCCcEEEeecCCCCCCCCCceEEEeeCCceEEEc
Q 004264 23 FAADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLN 102 (765)
Q Consensus 23 ~~~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~ 102 (765)
++.|+|.+||.|..|+.|+| |.|.|.|..+|+ |.+ |.. .+||.+|++.. +..+.|.|+.||||||+|
T Consensus 4 ~~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~~---~~vW~snt~~~--~~~~~l~l~~dGNLvl~d 70 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVL-YGG---KYGWQSNTHGN--GEHCFLRLNHKGELIIKD 70 (110)
T ss_dssp CBTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----EEE-ECS---SSCEECCCTTS--SSSCEEEECTTSCEEEEC
T ss_pred cccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----EEE-ECC---eEEEECCCcCC--CcCEEEEEeCCCcEEEEe
Confidence 67899999999999999998 559998888886 555 433 58999999864 446799999999999999
Q ss_pred CCCCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeee
Q 004264 103 QEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQS 147 (765)
Q Consensus 103 ~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqS 147 (765)
.++.++|+|++.......+|+|+||||||||+ .++|+|
T Consensus 71 ~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~-------~~~W~t 108 (110)
T 3r0e_B 71 DDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG-------PAIFET 108 (110)
T ss_dssp TTCCEEEECCCCCSSSCCEEEECTTSCEEEEC-------SEEEES
T ss_pred CCCCEEEEcCCcCCCCCEEEEEcCCccEEEec-------CCEecC
Confidence 99999999997644455789999999999996 279997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.75 E-value=6.5e-18 Score=150.52 Aligned_cols=108 Identities=19% Similarity=0.299 Sum_probs=92.0
Q ss_pred ccccccCCCccccCCCeEEcCCCeEEEEEecCCCCCCeEEEEEEeCCCCcEEEeecCCCCCCCCCceEEEeeCCceEEEc
Q 004264 23 FAADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLN 102 (765)
Q Consensus 23 ~~~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~ 102 (765)
++.|+|.+||.|..|+.|.+ |.|.|.|+.+|+ |.++ .....++||.+|+..+ +..+.|.|+.||||||+|
T Consensus 4 ~~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~-~~~~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~d 73 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLT-KGSKTNIVWESGTSGR--GQHCFMRLGHSGELDITD 73 (113)
T ss_dssp CCSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEE-ETTTTEEEEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred ccCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEE-ECCCCEEEEECCcccC--CcCEEEEEeCCCcEEEEC
Confidence 46799999999999999974 899999999887 6664 3324789999999876 346899999999999999
Q ss_pred CCCCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeee
Q 004264 103 QEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQS 147 (765)
Q Consensus 103 ~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqS 147 (765)
.++.++|+|++.......+|+|+||||||||+ .+||+|
T Consensus 74 ~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~-------~~~W~s 111 (113)
T 3mez_B 74 DRLNTVFVSNTVGQEGDYVLILQINGQAVVYG-------PAVWST 111 (113)
T ss_dssp TTSCEEEECSCCCSSSCCEEEECTTSCEEEEC-------SEEEES
T ss_pred CCCCEEEECCCcCCCCCEEEEEcCCceEEEec-------CCEecC
Confidence 99999999998654455789999999999996 379997
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=3.1e-18 Score=177.14 Aligned_cols=136 Identities=15% Similarity=0.138 Sum_probs=107.4
Q ss_pred cccccccccCCceeEEEEEe-CCCcE--EEEEEccccCh------------------------hhHHHHHHHHHHHhccc
Q 004264 448 FSEANMIGKGGFGPVYMGKL-STGQE--IAAKRLSKNSG------------------------QGLEEFMNEVVLIGKLQ 500 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~-~~~~~--vavK~l~~~~~------------------------~~~~~~~~Ev~~l~~l~ 500 (765)
|++.+.||+|+||.||+|.. .+|+. ||||++..... .....+.+|+.+|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999997 68888 99998754311 11236889999999998
Q ss_pred cCce--EeeeeeeeecCceEEEEEecCC-C----ChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhh-hcCCCcEEec
Q 004264 501 HRNL--VGLLGSCIEEDERMLIYEYMPH-K----SLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLH-QDSKLQVIHR 572 (765)
Q Consensus 501 h~ni--v~~~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH-~~~~~~ivH~ 572 (765)
|+++ ..++.. ...+|||||+.+ | +|.+.... .++..+..++.||+.+|.||| +.+ |+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 8764 333332 367899999942 3 66655421 235577899999999999999 888 9999
Q ss_pred ccCCCcEEEecCCCCeecccccceee
Q 004264 573 DLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 573 Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
||||+|||++. .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999864
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.7e-17 Score=146.64 Aligned_cols=109 Identities=24% Similarity=0.395 Sum_probs=91.2
Q ss_pred ccccccCCCccccCCCeEEcCCCeEEEEEecCCCCCCeEEEEEEeCCCCcEEEeecCCCCCCCCCceEEEeeCCceEEEc
Q 004264 23 FAADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLN 102 (765)
Q Consensus 23 ~~~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~ 102 (765)
+|.|+|.+||.|..|+.| .+|.|.|.|+.+|+ |-+ |. .+|.+|+..+ +..+.|+|+.||||||+|
T Consensus 1 ~~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----Lvl-~~-----~~Wssnt~~~--~~~~~l~l~~dGnLvl~d 65 (109)
T 3r0e_A 1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----LVL-YN-----GNWQSNTANN--GRDCKLTLTDYGELVIKN 65 (109)
T ss_dssp CCCSEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ET-----TTEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred CccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----EEE-Ee-----CeEEcCCCCC--CCcEEEEEcCCCeEEEEe
Confidence 478999999999999999 57999999999887 333 32 1699999875 457899999999999999
Q ss_pred CCCCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCCCCCcccCc
Q 004264 103 QEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPG 158 (765)
Q Consensus 103 ~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PtDtlLpg 158 (765)
.++.++|++++.......+|+|+||||||||+ .++|+| .|.+||
T Consensus 66 ~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~-------~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 66 GDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG-------PSVFKI-----DPWVRG 109 (109)
T ss_dssp TTSCEEEECCCCCSSSCCEEEEETTTEEEEEC-------SEEEEE-----CTTSCC
T ss_pred CCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe-------cCEECC-----CCccCC
Confidence 99999999997654455789999999999996 379996 677665
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2.3e-16 Score=140.49 Aligned_cols=95 Identities=20% Similarity=0.359 Sum_probs=77.9
Q ss_pred CCCCCceEEEeeCCceEEEcCCCCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCCCCCcccCcCeec
Q 004264 83 ITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLG 162 (765)
Q Consensus 83 ~~~~~~~l~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PtDtlLpg~klg 162 (765)
+.+...+|.|+.||+|+|++. +.+||++++........|+|+++|||||++ .+.++||||+
T Consensus 16 L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-----~~~~~W~S~~------------- 76 (112)
T 1xd5_A 16 LAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-----GSRAIWASNT------------- 76 (112)
T ss_dssp EEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-----TTEEEEECCC-------------
T ss_pred EeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-----CCEEEEECCc-------------
Confidence 334567899999999999988 789999997644445789999999999997 2468999993
Q ss_pred ceeecccceEEEeccCCCCCCCcceEEeecCCCCceEEEec-CCeeeeeeCCCCC
Q 004264 163 WNLKTGFERYLTPWRSADDPTPGEFSLRLDISALPELVIIS-GSRKEARSGPWNG 216 (765)
Q Consensus 163 ~~~~~~~~~~l~S~~s~~dps~G~ysl~~~~~g~~~~~~~~-~~~~~~~sg~w~g 216 (765)
+|++|.|++.++++|. ++++. +..+||++++|+|
T Consensus 77 ------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 ------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp ------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred ------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 4567899999999998 44454 5689999999986
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=2.1e-16 Score=140.07 Aligned_cols=90 Identities=21% Similarity=0.312 Sum_probs=74.6
Q ss_pred CCCceEEEeeCCceEEEcCCCCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCCCCCcccCcCeecce
Q 004264 85 DKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWN 164 (765)
Q Consensus 85 ~~~~~l~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~ 164 (765)
+...+|.|+.||||||++ .+.+||++|+........|+|+++|||||++ ..+.++||||
T Consensus 19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~----~~~~~~W~S~---------------- 77 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYD----QSNRVIWQTK---------------- 77 (110)
T ss_dssp TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEEC----TTCCEEEECC----------------
T ss_pred CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEEC----CCCcEEEecC----------------
Confidence 346789999999999999 5789999998654456789999999999998 3567999998
Q ss_pred eecccceEEEeccCCCCCCCcceEEeecCCCCceEEEecCCeeeeeeCCC
Q 004264 165 LKTGFERYLTPWRSADDPTPGEFSLRLDISALPELVIISGSRKEARSGPW 214 (765)
Q Consensus 165 ~~~~~~~~l~S~~s~~dps~G~ysl~~~~~g~~~~~~~~~~~~~~~sg~w 214 (765)
+++++|.|++.++++|. ++++++ +||+++++
T Consensus 78 ---------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 ---------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp ---------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred ---------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 34567899999999998 455554 89999876
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=8.2e-17 Score=173.39 Aligned_cols=150 Identities=15% Similarity=0.165 Sum_probs=107.1
Q ss_pred ccchHhHHHHhcC---cccccccccCCceeEEEEEeCCCcEEEEEEccccC--------------hhhHH--------HH
Q 004264 435 LYDLATITTATNH---FSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNS--------------GQGLE--------EF 489 (765)
Q Consensus 435 ~~~~~~~~~~~~~---y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--------------~~~~~--------~~ 489 (765)
.|++-.+....++ |++.+.||+|+||.||+|...+|+.||||+++... ..... ..
T Consensus 81 gyD~LAL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A 160 (397)
T 4gyi_A 81 GLDYLALHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAA 160 (397)
T ss_dssp HHHHHHHHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHH
Confidence 3455555555554 99999999999999999999999999999875310 00011 12
Q ss_pred HHHHHHHhccccCceEeeeeeeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcE
Q 004264 490 MNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQV 569 (765)
Q Consensus 490 ~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 569 (765)
.+|...|.++++.++.-.. .+. ....+|||||+++.+|..+. .......++.||+.+|.+||+.+ |
T Consensus 161 ~kE~~nL~rL~~~gv~vp~-p~~-~~~~~LVME~i~G~~L~~l~---------~~~~~~~l~~qll~~l~~lH~~g---I 226 (397)
T 4gyi_A 161 IKEFAFMKALYEEGFPVPE-PIA-QSRHTIVMSLVDALPMRQVS---------SVPDPASLYADLIALILRLAKHG---L 226 (397)
T ss_dssp HHHHHHHHHHHHTTCSCCC-EEE-EETTEEEEECCSCEEGGGCC---------CCSCHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHHHHhcCCCCCe-eee-ccCceEEEEecCCccHhhhc---------ccHHHHHHHHHHHHHHHHHHHCC---C
Confidence 3466666666544432111 111 12347999999998886543 12344678899999999999999 9
Q ss_pred EecccCCCcEEEecCCC----------Ceecccccceee
Q 004264 570 IHRDLKASNILLDINLN----------PKISDFGLARIF 598 (765)
Q Consensus 570 vH~Dlkp~NIll~~~~~----------vkL~DFGla~~~ 598 (765)
|||||||.|||+++++. +.|+||+.+...
T Consensus 227 VHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 227 IHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred cCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 99999999999988773 899999988754
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.61 E-value=2e-15 Score=133.81 Aligned_cols=103 Identities=19% Similarity=0.312 Sum_probs=84.6
Q ss_pred ccccCCCccccCCCeEEcCCCeEEEEEecCCCCCCeEEEEEEeCCCCcEEEeecCCCCCCCCCceEEEeeCCceEEEcCC
Q 004264 25 ADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQE 104 (765)
Q Consensus 25 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (765)
+|+|.+||.|..|+.| .+|.|.|.|+.+|+ |.+ |... . ||.+|+..+ +..+.|.|+.||||||+|.+
T Consensus 2 ~~~l~~gq~L~~g~~L--~~g~~~L~~q~dGn-----Lvl-~~~~--~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~~ 68 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQL--SYESAAFVMQGDCN-----LVL-YNEA--G-GFQSNTHGR--GVDCTLRLNNRGQLEIHSAN 68 (111)
T ss_dssp TTEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ECSS--C-CEECCCTTS--CSSCEEEECTTSCEEEECSS
T ss_pred cCEeCCCCEeCCCCEE--ecCCEEEEEccCCe-----EEE-ECCC--C-EEECCcccC--CcCEEEEEcCCCcEEEEeCC
Confidence 5789999999999999 47999999999887 444 4322 3 999999876 34689999999999999998
Q ss_pred CC-eEEEeccCC--CcCccEEEEecCCCeeEeeccCCCcccceeee
Q 004264 105 KS-AIWSSNSSR--TLENPVAHLLDSGNLVLRDNISRSSEEYMWQS 147 (765)
Q Consensus 105 ~~-~~w~s~~~~--~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqS 147 (765)
+. ++|+|++.. .....+|+|++|||||||+ .++|+|
T Consensus 69 ~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~-------~~~W~s 107 (111)
T 3mez_A 69 SNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG-------PAIWST 107 (111)
T ss_dssp CSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC-------SEEEEC
T ss_pred CCEEEEEeccccCCCCcCEEEEECCCCeEEEec-------cCEEcc
Confidence 76 599999632 2345789999999999996 479997
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.60 E-value=2.8e-15 Score=134.57 Aligned_cols=87 Identities=21% Similarity=0.254 Sum_probs=72.6
Q ss_pred CceEEEeeCCceEEEcCCCCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCCCCCcccCcCeecceee
Q 004264 87 NGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLK 166 (765)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~~ 166 (765)
..+|.|+.||||+|++. +.+||++|+........|+|+|+|||||++ ..+.++||||
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d----~~~~~lW~S~------------------ 87 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVIT----NENVTVWQSP------------------ 87 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEEC----TTCCEEEECS------------------
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEe----CCCcEEEcCC------------------
Confidence 45799999999999987 789999997654455789999999999998 4567999998
Q ss_pred cccceEEEeccCCCCCCCcceEEeecCCCCceEEEecCCeeeeeeCC
Q 004264 167 TGFERYLTPWRSADDPTPGEFSLRLDISALPELVIISGSRKEARSGP 213 (765)
Q Consensus 167 ~~~~~~l~S~~s~~dps~G~ysl~~~~~g~~~~~~~~~~~~~~~sg~ 213 (765)
++|++|.|++.++++|. ++++. .+||++|+
T Consensus 88 -------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 -------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp -------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred -------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 35678999999999998 44554 38999886
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=4.5e-15 Score=132.76 Aligned_cols=91 Identities=27% Similarity=0.377 Sum_probs=75.0
Q ss_pred CceEEEeeCCceEEEcCCCCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCCCCCcccCcCeecceee
Q 004264 87 NGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLK 166 (765)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~~ 166 (765)
...|.|+.||||+|++ .+.+||++|+.....++.++|+++|||||++ ..+.++|||||+
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d----~~~~~vW~S~~~---------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYD----HNNNDVWGSACW---------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEEC----TTCCEEEECCCC----------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEEC----CCceEEEEcCCC----------------
Confidence 5679999999999998 5789999997644445789999999999998 346799999997
Q ss_pred cccceEEEeccCCCCCCCcceEEeecCCCCceEEEecCCeeeeeeCCCCCc
Q 004264 167 TGFERYLTPWRSADDPTPGEFSLRLDISALPELVIISGSRKEARSGPWNGQ 217 (765)
Q Consensus 167 ~~~~~~l~S~~s~~dps~G~ysl~~~~~g~~~~~~~~~~~~~~~sg~w~g~ 217 (765)
+++|.|++.++++|. +++++. ++|++++|...
T Consensus 80 ---------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 ---------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp ---------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred ---------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 346789999999998 455544 89999999643
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.40 E-value=6.8e-13 Score=117.94 Aligned_cols=94 Identities=17% Similarity=0.265 Sum_probs=72.5
Q ss_pred CCCCCCCceEEEeeCCceEEEcC-CCCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCCCCCcccCcC
Q 004264 81 HPITDKNGVLTFSNNGSLLLLNQ-EKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGM 159 (765)
Q Consensus 81 ~p~~~~~~~l~~~~~g~l~l~~~-~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PtDtlLpg~ 159 (765)
+|+.+...+|.|+.||||||++. .+.++|++++........|+|+++|||||++ ..+.++|||-. -
T Consensus 19 ~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d----~~~~~iW~S~t-----~---- 85 (113)
T 3mez_B 19 AQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITD----DRLNTVFVSNT-----V---- 85 (113)
T ss_dssp CEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEEC----TTSCEEEECSC-----C----
T ss_pred CEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEEC----CCCCEEEECCC-----c----
Confidence 34445577999999999999998 5899999998644445789999999999998 34568999711 0
Q ss_pred eecceeecccceEEEeccCCCCCCCcceEEeecCCCCceEEEecCCeeeeeeCC
Q 004264 160 KLGWNLKTGFERYLTPWRSADDPTPGEFSLRLDISALPELVIISGSRKEARSGP 213 (765)
Q Consensus 160 klg~~~~~~~~~~l~S~~s~~dps~G~ysl~~~~~g~~~~~~~~~~~~~~~sg~ 213 (765)
...|.|.+.++.+|...++ . .+.|.+++
T Consensus 86 ----------------------~~~~~~~~~L~~dGnlvly--~--~~~W~s~~ 113 (113)
T 3mez_B 86 ----------------------GQEGDYVLILQINGQAVVY--G--PAVWSTAA 113 (113)
T ss_dssp ----------------------CSSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred ----------------------CCCCCEEEEEcCCceEEEe--c--CCEecCCC
Confidence 0135689999999987665 2 68898874
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=3.3e-12 Score=132.03 Aligned_cols=114 Identities=22% Similarity=0.439 Sum_probs=88.7
Q ss_pred ccccccCCCcc----ccCCCeEEcCC----CeEEEEEecCCCCCCeEEEEEEeCCCCcEEEeecCCCCCCCCCceEEEee
Q 004264 23 FAADSLSSGKF----ITDGETLVSSF----QSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSN 94 (765)
Q Consensus 23 ~~~~~l~~g~~----l~~~~~l~s~~----g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~ 94 (765)
...|++.||+. |..|+.|+|++ |.|.|.|...|+ .+ + |. ...+++|.+++.++ +. ..|.++.
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S~~dps~G~fsl~l~~dGn---lv--L-y~-~~~~~yW~Sgt~~~--~~-~~l~l~~ 203 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGDGN---LV--A-YG-PNGAATWNAGTQGK--GA-VRAVFQG 203 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECTTCEEEETTEEEEECTTSC---EE--E-EC-TTSSEEEECCCTTT--TC-CEEEECT
T ss_pred ccccccccccccccccccCcccccCCCCCCceEEEeecCCce---EE--E-Ee-CCCeEEEECCCCCC--cc-EEEEEcC
Confidence 46799999999 88898887643 556666654442 33 3 32 23689999999877 33 7899999
Q ss_pred CCceEEEcCCCCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCC-CCC
Q 004264 95 NGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDY-PSD 153 (765)
Q Consensus 95 ~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~-PtD 153 (765)
+|+|+++|.++.++|++++... ...+|+|++||||||++. +++|||||| |+.
T Consensus 204 dGnLvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~~------~~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 204 DGNLVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILDE------KPVWARFGFQPTY 256 (276)
T ss_dssp TSCEEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEEE------EEEEESSSCCTTS
T ss_pred CCeEEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEcC------CCeEEccCccCCc
Confidence 9999999999899999997633 457899999999999972 589999998 444
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.30 E-value=5.8e-12 Score=111.45 Aligned_cols=91 Identities=13% Similarity=0.161 Sum_probs=69.7
Q ss_pred CCCceEEEeeCCceEEEcCCCCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCCCCCcccCcCeecce
Q 004264 85 DKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWN 164 (765)
Q Consensus 85 ~~~~~l~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~ 164 (765)
+....|.|+.||||||++.++ +|++++........|+|+++|||||++. ....++|||.-+
T Consensus 19 ~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~---~~~~~vW~S~t~-------------- 79 (111)
T 3mez_A 19 YESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSA---NSNTPVWVYPRS-------------- 79 (111)
T ss_dssp ETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECS---SCSSCSEEESSS--------------
T ss_pred cCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeC---CCCEEEEEeccc--------------
Confidence 446789999999999999877 9999986544457899999999999984 223369998521
Q ss_pred eecccceEEEeccCCCCCCCcceEEeecCCCCceEEEecCCeeeeeeCC
Q 004264 165 LKTGFERYLTPWRSADDPTPGEFSLRLDISALPELVIISGSRKEARSGP 213 (765)
Q Consensus 165 ~~~~~~~~l~S~~s~~dps~G~ysl~~~~~g~~~~~~~~~~~~~~~sg~ 213 (765)
.....|.|.+.++.+|...++ . .++|.+++
T Consensus 80 ---------------~~~~~~~~~l~Lq~dGNlvly--~--~~~W~s~t 109 (111)
T 3mez_A 80 ---------------VNTVRGNYAATLGPDQHVTIY--G--PAIWSTPA 109 (111)
T ss_dssp ---------------CCCCSSCCEEEECTTSCEEEE--C--SEEEECCC
T ss_pred ---------------cCCCCcCEEEEECCCCeEEEe--c--cCEEccCC
Confidence 111347899999999987665 2 78898764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=9.9e-12 Score=128.33 Aligned_cols=146 Identities=14% Similarity=-0.018 Sum_probs=114.9
Q ss_pred HHhcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccc-cCceEeeeeeeeecCceEEEE
Q 004264 443 TATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 443 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~~~lV~ 521 (765)
..-..|++...++.|+.+.||++... ++.+++|+...........+.+|+.+++.+. +..+.++++++......++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 34467888888999999999999864 6889999986532222346889999999985 667888999998888999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcC------------------------------------
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS------------------------------------ 565 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~------------------------------------ 565 (765)
||++|.+|.+.+. +......++.+++++|..||+..
T Consensus 90 e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 90 SEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999976631 12334578889999999999810
Q ss_pred --------------------CCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 566 --------------------KLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 566 --------------------~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13499999999999998765667999998864
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.9e-11 Score=107.99 Aligned_cols=86 Identities=21% Similarity=0.317 Sum_probs=66.6
Q ss_pred CceEEEeeCCceEEEcCCCCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCCCCCcccCcCeecceee
Q 004264 87 NGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLK 166 (765)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~~ 166 (765)
...|.|+.||||||++. .++|++++........++|+++|||||++ ..+.++|||-.+
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d----~~~~~iW~S~t~---------------- 82 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKD----DDFKTIWSSRSS---------------- 82 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEEC----TTCCEEEECCCC----------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEe----CCCCEEEEcCCc----------------
Confidence 46899999999999987 59999998654445789999999999998 346789997321
Q ss_pred cccceEEEeccCCCCCCCcceEEeecCCCCceEEEecCCeeeeeeCC
Q 004264 167 TGFERYLTPWRSADDPTPGEFSLRLDISALPELVIISGSRKEARSGP 213 (765)
Q Consensus 167 ~~~~~~l~S~~s~~dps~G~ysl~~~~~g~~~~~~~~~~~~~~~sg~ 213 (765)
...|.|.+.++.+|...++ . .+.|.+|+
T Consensus 83 ---------------~~~~~~~~~L~~dGNlvly--~--~~~W~t~~ 110 (110)
T 3r0e_B 83 ---------------SKQGEYVLILQDDGFGVIY--G--PAIFETSS 110 (110)
T ss_dssp ---------------CSSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred ---------------CCCCCEEEEEcCCccEEEe--c--CCEecCCC
Confidence 0135688999999987665 2 47888763
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=3.4e-11 Score=106.30 Aligned_cols=88 Identities=17% Similarity=0.259 Sum_probs=67.6
Q ss_pred CCceEEEeeCCceEEEcCCCCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCCCCCcccCcCeeccee
Q 004264 86 KNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNL 165 (765)
Q Consensus 86 ~~~~l~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~ 165 (765)
....|.|+.||||||++. +.++|++++........++|+++|||||++ ..+.++|||....
T Consensus 19 g~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~----~~~~~~W~S~t~~-------------- 79 (109)
T 3dzw_A 19 GRYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYS----PRNNPIWASNTGG-------------- 79 (109)
T ss_dssp TTEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEEC----TTSCEEEECCCCC--------------
T ss_pred CCEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEEC----CCCCEEEECCCCC--------------
Confidence 356899999999999988 689999997654445789999999999998 3457899973210
Q ss_pred ecccceEEEeccCCCCCCCcceEEeecCCCCceEEEecCCeeeeeeCC
Q 004264 166 KTGFERYLTPWRSADDPTPGEFSLRLDISALPELVIISGSRKEARSGP 213 (765)
Q Consensus 166 ~~~~~~~l~S~~s~~dps~G~ysl~~~~~g~~~~~~~~~~~~~~~sg~ 213 (765)
..+.|.+.++.+|...++ . .+.|.++.
T Consensus 80 -----------------~~~~~~~~L~ddGNlvly--~--~~~W~s~t 106 (109)
T 3dzw_A 80 -----------------ENGNYVCVLQKDRNVVIY--G--TARWATGT 106 (109)
T ss_dssp -----------------SSSCEEEEECTTSCEEEE--E--SCCCCCCC
T ss_pred -----------------CCCCEEEEEeCCCEEEEE--C--CCEEeCCC
Confidence 125688999999987655 2 36777664
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.20 E-value=3.3e-11 Score=106.21 Aligned_cols=90 Identities=19% Similarity=0.366 Sum_probs=69.4
Q ss_pred CCCCCCceEEEeeCCceEEEcCCCCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCCCCCcccCcCee
Q 004264 82 PITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKL 161 (765)
Q Consensus 82 p~~~~~~~l~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PtDtlLpg~kl 161 (765)
|+.+....|.|+.||||||+++ +|++++........++|+++|||||++. .+.++|+|- |
T Consensus 17 ~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~----~~~~vWss~-----t------- 76 (109)
T 3r0e_A 17 HLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNG----DGSTVWKSG-----A------- 76 (109)
T ss_dssp EEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECT----TSCEEEECC-----C-------
T ss_pred EeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeC----CCCEEEcCC-----C-------
Confidence 3344567899999999999984 7999987544567899999999999983 457899751 1
Q ss_pred cceeecccceEEEeccCCCCCCCcceEEeecCCCCceEEEecCCeeeeeeCCC
Q 004264 162 GWNLKTGFERYLTPWRSADDPTPGEFSLRLDISALPELVIISGSRKEARSGPW 214 (765)
Q Consensus 162 g~~~~~~~~~~l~S~~s~~dps~G~ysl~~~~~g~~~~~~~~~~~~~~~sg~w 214 (765)
....+.|.+.++++|...++ ..+.|.+++|
T Consensus 77 -------------------~~~~~~~~~~L~~dGNlvly----~~~~W~s~t~ 106 (109)
T 3r0e_A 77 -------------------QSVKGNYAAVVHPDGRLVVF----GPSVFKIDPW 106 (109)
T ss_dssp -------------------CCSSSCCEEEEETTTEEEEE----CSEEEEECTT
T ss_pred -------------------cCCCcCEEEEEcCCCeEEEE----ecCEECCCCc
Confidence 01235788999999986655 2789999987
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.11 E-value=1.1e-10 Score=120.03 Aligned_cols=138 Identities=17% Similarity=0.122 Sum_probs=102.5
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCc--eEeeeeeeeecCceEEEEEe
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRN--LVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n--iv~~~~~~~~~~~~~lV~E~ 523 (765)
.++.+....+.|..+.||++...+|+.+++|+.... ....+.+|+.+++.+++.+ +.+++++...++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 455554444456669999998877888999987643 2245788999999986544 55688888777788999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcC--------------------------------------
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS-------------------------------------- 565 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-------------------------------------- 565 (765)
++|.+|. ... . ....++.++++.|..||+..
T Consensus 97 i~G~~l~--~~~------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SSH------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TSC------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cCc------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9998884 210 1 12356777888888888743
Q ss_pred -----------------CCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 566 -----------------KLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 566 -----------------~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776677999999864
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.02 E-value=9.1e-10 Score=96.17 Aligned_cols=78 Identities=23% Similarity=0.341 Sum_probs=60.9
Q ss_pred CceEEEeeCCceEEEcCCCCeEEEeccCCCc-CccEEEEecCCCeeEeeccCCCcccceeeecCCCCCcccCcCeeccee
Q 004264 87 NGVLTFSNNGSLLLLNQEKSAIWSSNSSRTL-ENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNL 165 (765)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~s~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~ 165 (765)
.-+|.|+.||||||++. +.+||++|+.... ..+.+.|++||||||++ ..+++||+|-
T Consensus 20 ~y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d----~~~~~vWss~----------------- 77 (105)
T 4h3o_A 20 PYHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYD----SSGRSLWASH----------------- 77 (105)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEEC----TTCCEEEECC-----------------
T ss_pred CEEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEEC----CCcEEEEEec-----------------
Confidence 35799999999999985 5799999976443 35689999999999998 4567899861
Q ss_pred ecccceEEEeccCCCCCCCcceEEeecCCCCceEE
Q 004264 166 KTGFERYLTPWRSADDPTPGEFSLRLDISALPELV 200 (765)
Q Consensus 166 ~~~~~~~l~S~~s~~dps~G~ysl~~~~~g~~~~~ 200 (765)
+....|.|.+.++++|...++
T Consensus 78 --------------t~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 78 --------------STRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp --------------CCCCSSCEEEEECTTSCEEEE
T ss_pred --------------CCCCCCCEEEEEeCCCeEEEE
Confidence 112346788999999987654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.91 E-value=2.9e-09 Score=115.13 Aligned_cols=142 Identities=14% Similarity=0.185 Sum_probs=106.4
Q ss_pred cccccccCCceeEEEEEeCCCcEEEEEEcc--ccC-hhhHHHHHHHHHHHhccc--cCceEeeeeeeeec---CceEEEE
Q 004264 450 EANMIGKGGFGPVYMGKLSTGQEIAAKRLS--KNS-GQGLEEFMNEVVLIGKLQ--HRNLVGLLGSCIEE---DERMLIY 521 (765)
Q Consensus 450 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~--~~~-~~~~~~~~~Ev~~l~~l~--h~niv~~~~~~~~~---~~~~lV~ 521 (765)
..+.|+.|.++.||+....+ +.+++|+.. ... ......+.+|+.+++.|. +..+.+++.++.+. ...++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35679999999999998754 678888775 321 123456888999999997 45578888887766 3489999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcC------------------------------------
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS------------------------------------ 565 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~------------------------------------ 565 (765)
||+++..+.+.. ...++...+..++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998874322 123677888899999999999999831
Q ss_pred -------------------CCcEEecccCCCcEEEecCCC--Ceeccccccee
Q 004264 566 -------------------KLQVIHRDLKASNILLDINLN--PKISDFGLARI 597 (765)
Q Consensus 566 -------------------~~~ivH~Dlkp~NIll~~~~~--vkL~DFGla~~ 597 (765)
...++|+|++|.||+++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997753 58999999875
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.83 E-value=1e-08 Score=103.73 Aligned_cols=89 Identities=21% Similarity=0.275 Sum_probs=69.9
Q ss_pred CceEEEeeCCceEEEcCCCCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCCCCCcccCcCeecceee
Q 004264 87 NGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLK 166 (765)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~~ 166 (765)
.-.|.|..+|+|+|++. +.+||.+|+... ..+.+.|+++|||||++ ..+.+||+|+++
T Consensus 27 ~f~l~f~~~gnl~ly~~-~~~vW~an~~~~-~~~~l~l~~dGnLvl~d----~~~~~vW~s~~~---------------- 84 (236)
T 1dlp_A 27 SFRFTMQSDCNLVLFDS-DVRVWASNTAGA-TGCRAVLQSDGLLVILT----AQNTIRWSSGTK---------------- 84 (236)
T ss_dssp TEEEEECTTSCEEEEES-SSEEECCCCCSC-SCCBCCBCSSSCBCCBC----TTTCCSCCCCCC----------------
T ss_pred CEEEEECCCCcEEEEEC-CEEEEECCCCCC-CCeEEEEcCCCcEEEEc----CCCcEEEeCCcc----------------
Confidence 45788888999999987 789999997644 56788999999999998 456799999764
Q ss_pred cccceEEEeccCCCCCCCcceEEeecCCCCceEEEecCCeeeeeeCCCCC
Q 004264 167 TGFERYLTPWRSADDPTPGEFSLRLDISALPELVIISGSRKEARSGPWNG 216 (765)
Q Consensus 167 ~~~~~~l~S~~s~~dps~G~ysl~~~~~g~~~~~~~~~~~~~~~sg~w~g 216 (765)
.+.|.|.+.++.+|...++ . ..+|.+..+..
T Consensus 85 ---------------~~~~~~~~~l~d~Gnlvl~--~--~~~W~S~~~p~ 115 (236)
T 1dlp_A 85 ---------------GSIGNYVLVLQPDRTVTIY--G--PGLWDSGTSNK 115 (236)
T ss_dssp ---------------CCSSCCEEEECSSSCEEEE--C--SEEEECSCCCS
T ss_pred ---------------ccCCcEEEEEeCCCCEEEe--c--CCEEECCCCCC
Confidence 1245678999999986654 2 28999887753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.80 E-value=3.2e-09 Score=112.03 Aligned_cols=187 Identities=19% Similarity=0.230 Sum_probs=121.3
Q ss_pred ccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccc-cCc--eEeeeeeeeecC---ceEEEEEec
Q 004264 451 ANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-HRN--LVGLLGSCIEED---ERMLIYEYM 524 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~n--iv~~~~~~~~~~---~~~lV~E~~ 524 (765)
.+.++.|....||+.. +.+++|+.... .....+.+|+.+|+.+. +.. +.+++....... ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3468999999999863 56888886432 34567889999998884 322 344444433332 347899999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcC---------------------------------------
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS--------------------------------------- 565 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~--------------------------------------- 565 (765)
+|.+|..... ..++...+..++.++++.|..||+..
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9998865432 23567777888888888888888611
Q ss_pred ----------------CCcEEecccCCCcEEEec--CCCCeecccccceeeCCCCcccccc------------ccccccc
Q 004264 566 ----------------KLQVIHRDLKASNILLDI--NLNPKISDFGLARIFGGDDEEAQTE------------RVAGTHG 615 (765)
Q Consensus 566 ----------------~~~ivH~Dlkp~NIll~~--~~~vkL~DFGla~~~~~~~~~~~~~------------~~~gt~~ 615 (765)
...++|+|++|.||++++ +..+.|+||+.+..-.....-.... ......+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 134899999999999998 4567899999987642211100000 0001111
Q ss_pred ccC-cccccCCCCCccccchHHHHHHHHHHhCCCCC
Q 004264 616 YMS-PEYANDGTISMKSDVFSLGVLLVEIVSGKMNR 650 (765)
Q Consensus 616 Y~a-PE~~~~~~~s~k~DvwSlG~ll~elltG~~p~ 650 (765)
... |+.... .....+.|+++.+++.+.+|..++
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 112 222111 112368999999999999998653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=3.2e-06 Score=87.06 Aligned_cols=135 Identities=19% Similarity=0.119 Sum_probs=97.3
Q ss_pred ccccCCce-eEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccc-cCceEeeeeeeeecCceEEEEEecCCCCh
Q 004264 453 MIGKGGFG-PVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDERMLIYEYMPHKSL 529 (765)
Q Consensus 453 ~LG~G~fg-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~~~lV~E~~~~gsL 529 (765)
.+..|..+ .||+.... ++..+++|+-.. .....+.+|..+|+.|. +--+.+++.++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45555554 68988754 466789997643 23456888999998885 33367788888888999999999999888
Q ss_pred hHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhc---------------------------------------------
Q 004264 530 DYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD--------------------------------------------- 564 (765)
Q Consensus 530 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~--------------------------------------------- 564 (765)
.+.... .......+..++++.|..||+.
T Consensus 108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 765421 1223345666666777777653
Q ss_pred ----------CCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 565 ----------SKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 565 ----------~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
....++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112389999999999999877778999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=3.6e-06 Score=88.56 Aligned_cols=136 Identities=20% Similarity=0.169 Sum_probs=94.0
Q ss_pred ccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccC---ceEeeeeeee-ecCceEEEEEecCC
Q 004264 451 ANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHR---NLVGLLGSCI-EEDERMLIYEYMPH 526 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~---niv~~~~~~~-~~~~~~lV~E~~~~ 526 (765)
.+.++.|....||+. ++.+++|+-. .......+.+|+.+|+.|.+. .+.+++.+.. .....++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356788888899987 5778888853 233456789999999999742 3555665553 34567899999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhc------------------------------------------
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD------------------------------------------ 564 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~------------------------------------------ 564 (765)
.++..... ..++...+..++.++++.|..||+.
T Consensus 98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 98865321 1133444455555555555555542
Q ss_pred ---------------CCCcEEecccCCCcEEEec---CCCC-eeccccccee
Q 004264 565 ---------------SKLQVIHRDLKASNILLDI---NLNP-KISDFGLARI 597 (765)
Q Consensus 565 ---------------~~~~ivH~Dlkp~NIll~~---~~~v-kL~DFGla~~ 597 (765)
....++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2224799999999999987 4554 8999998875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=2.9e-06 Score=91.31 Aligned_cols=80 Identities=6% Similarity=-0.029 Sum_probs=55.8
Q ss_pred cccc-ccCCceeEEEEEeC-------CCcEEEEEEccccC---hhhHHHHHHHHHHHhcccc---CceEeeeeeeeec--
Q 004264 451 ANMI-GKGGFGPVYMGKLS-------TGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQH---RNLVGLLGSCIEE-- 514 (765)
Q Consensus 451 ~~~L-G~G~fg~Vy~~~~~-------~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h---~niv~~~~~~~~~-- 514 (765)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.|.. -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88888999988754 26788898765422 1012457789999988853 2466777776554
Q ss_pred -CceEEEEEecCCCChh
Q 004264 515 -DERMLIYEYMPHKSLD 530 (765)
Q Consensus 515 -~~~~lV~E~~~~gsL~ 530 (765)
...++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.93 E-value=3e-05 Score=82.51 Aligned_cols=141 Identities=17% Similarity=0.222 Sum_probs=81.2
Q ss_pred cccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccC--ceEeeee------eeeecCceEEEEEe
Q 004264 452 NMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHR--NLVGLLG------SCIEEDERMLIYEY 523 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~--niv~~~~------~~~~~~~~~lV~E~ 523 (765)
+.|+.|....||+....++ .+++|+.... ..++..|+.+++.|... .+.+++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999987554 5889988652 23445566666666421 2333443 12345677899999
Q ss_pred cCCCChh--------------HHhhcccc----C-------CCCChHHH-------------------------------
Q 004264 524 MPHKSLD--------------YFIFDRER----S-------KLLPWKKR------------------------------- 547 (765)
Q Consensus 524 ~~~gsL~--------------~~l~~~~~----~-------~~l~~~~~------------------------------- 547 (765)
++|..+. ..++.... . ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9987553 01111100 0 00112111
Q ss_pred HHHHHHHHHHHHHhhh----------cCCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 548 FSIITGIARGLLYLHQ----------DSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 548 ~~i~~qia~aL~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
..+..++.+++.+|++ .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223345666653 1234599999999999998888999999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=1.5e-05 Score=87.11 Aligned_cols=75 Identities=12% Similarity=0.123 Sum_probs=49.9
Q ss_pred ccccccCCceeEEEEEeC-CCcEEEEEEccccCh-------hhHHHHHHHHHHHhcccc--Cc-eEeeeeeeeecCceEE
Q 004264 451 ANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSG-------QGLEEFMNEVVLIGKLQH--RN-LVGLLGSCIEEDERML 519 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~Ev~~l~~l~h--~n-iv~~~~~~~~~~~~~l 519 (765)
.+.||.|..+.||++... .++.+++|....... ....++..|.++|+.+.+ +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999754 467899997643211 123456789989888742 33 3445533 4556789
Q ss_pred EEEecCCC
Q 004264 520 IYEYMPHK 527 (765)
Q Consensus 520 V~E~~~~g 527 (765)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00017 Score=74.94 Aligned_cols=80 Identities=18% Similarity=0.189 Sum_probs=58.7
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccC---ceEeeeeeeeecCceEEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHR---NLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~---niv~~~~~~~~~~~~~lV~E 522 (765)
.+....+.+|.|..+.||+.+..+|+.+++|+...........|..|+..|+.|... -+.++++. +..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 345667789999999999999999999999987655444445678899998888422 23444443 23478999
Q ss_pred ecCCCCh
Q 004264 523 YMPHKSL 529 (765)
Q Consensus 523 ~~~~gsL 529 (765)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00021 Score=74.94 Aligned_cols=75 Identities=13% Similarity=0.098 Sum_probs=60.2
Q ss_pred ccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhcccc---CceEeeeeeeeecCceEEEEEecCCC
Q 004264 451 ANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQH---RNLVGLLGSCIEEDERMLIYEYMPHK 527 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h---~niv~~~~~~~~~~~~~lV~E~~~~g 527 (765)
.+.|+.|....+|+... +++.+++|+.... ....+..|+..|+.|.. ..+.+++.+....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46789999999999986 4678889987532 35678899999998852 56788888887778899999999997
Q ss_pred Ch
Q 004264 528 SL 529 (765)
Q Consensus 528 sL 529 (765)
.+
T Consensus 117 ~~ 118 (312)
T 3jr1_A 117 KN 118 (312)
T ss_dssp CC
T ss_pred CC
Confidence 65
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00019 Score=78.93 Aligned_cols=79 Identities=8% Similarity=-0.006 Sum_probs=47.8
Q ss_pred CcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCC---CCccccchHHHHHHHHH
Q 004264 567 LQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGT---ISMKSDVFSLGVLLVEI 643 (765)
Q Consensus 567 ~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~k~DvwSlG~ll~el 643 (765)
..++|+|++|.|||++.++ ++|+||+.+..-.....-... ...-...|++|+...... -....++......+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAY-LGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHH-HHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHH-HHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4499999999999998776 999999998763211000000 000123466666553211 11234556777888887
Q ss_pred HhCC
Q 004264 644 VSGK 647 (765)
Q Consensus 644 ltG~ 647 (765)
+.++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00052 Score=75.54 Aligned_cols=73 Identities=21% Similarity=0.277 Sum_probs=50.0
Q ss_pred ccccccCCceeEEEEEeCC--------CcEEEEEEccccChhhHHHHHHHHHHHhccccCce-EeeeeeeeecCceEEEE
Q 004264 451 ANMIGKGGFGPVYMGKLST--------GQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNL-VGLLGSCIEEDERMLIY 521 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~ni-v~~~~~~~~~~~~~lV~ 521 (765)
.+.|+.|....+|+...++ ++.+++|+..... ....+..|..+++.|...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4568888899999998753 5789999884321 12455679999988864443 455655432 3899
Q ss_pred EecCCCCh
Q 004264 522 EYMPHKSL 529 (765)
Q Consensus 522 E~~~~gsL 529 (765)
||+++.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987555
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00049 Score=72.43 Aligned_cols=143 Identities=15% Similarity=0.104 Sum_probs=80.2
Q ss_pred cccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCc--eEeeeee------eeecCceEEEEEe
Q 004264 452 NMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRN--LVGLLGS------CIEEDERMLIYEY 523 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n--iv~~~~~------~~~~~~~~lV~E~ 523 (765)
+.|+.|....+|+....++ .+++|+..... ....+..|+.+++.|.... +.+++.. ....+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4577788899999987655 68899886521 1234567888888775322 2333321 1223567899999
Q ss_pred cCCCChhH----H----------hhccccC--CC----C---ChHHHHH------------HHHHHHHHHHHhhhc----
Q 004264 524 MPHKSLDY----F----------IFDRERS--KL----L---PWKKRFS------------IITGIARGLLYLHQD---- 564 (765)
Q Consensus 524 ~~~gsL~~----~----------l~~~~~~--~~----l---~~~~~~~------------i~~qia~aL~~LH~~---- 564 (765)
++|..+.. . ++..... .+ . .|...+. +...+.+.++.+++.
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99876421 0 1110000 00 0 1111100 001134445555432
Q ss_pred CCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 565 SKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 565 ~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
....++|+|+++.|||++.+..+.|+||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 123499999999999999876568999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00056 Score=71.40 Aligned_cols=138 Identities=13% Similarity=0.092 Sum_probs=76.6
Q ss_pred ccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCce-EeeeeeeeecCceEEEEEec-CCCC
Q 004264 451 ANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNL-VGLLGSCIEEDERMLIYEYM-PHKS 528 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~ni-v~~~~~~~~~~~~~lV~E~~-~~gs 528 (765)
.+.|+.|....+|+. +.+++|+....... .....+|+.+++.+....+ .++++. ..+..++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 567899999999998 56888887643221 1123568888887753333 344443 344567999999 7665
Q ss_pred hhHHh------------------hcccc--CCCCC-hHHHHHHHH--------------HHHHHH----HHhhh-cCCCc
Q 004264 529 LDYFI------------------FDRER--SKLLP-WKKRFSIIT--------------GIARGL----LYLHQ-DSKLQ 568 (765)
Q Consensus 529 L~~~l------------------~~~~~--~~~l~-~~~~~~i~~--------------qia~aL----~~LH~-~~~~~ 568 (765)
+.... +.... ..... +.....+.. .+.+.+ ..+.. .....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 53210 00000 00000 011111100 011111 11111 22334
Q ss_pred EEecccCCCcEEEecCCCCeeccccccee
Q 004264 569 VIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 569 ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
++|+|+.|.||+ ..++.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 6677889999998875
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0011 Score=71.32 Aligned_cols=141 Identities=20% Similarity=0.203 Sum_probs=82.7
Q ss_pred cccccCCceeEEEEEeC--------CCcEEEEEEccccChhhHHHHHHHHHHHhccccC-ceEeeeeeeeecCceEEEEE
Q 004264 452 NMIGKGGFGPVYMGKLS--------TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHR-NLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~-niv~~~~~~~~~~~~~lV~E 522 (765)
+.|..|-...+|+...+ +++.+++|+.-.. ......+.+|..+++.|... -..++++.+.+ -+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 46777888899999865 2478999986332 22345667899999888532 23456655543 29999
Q ss_pred ecCCCChhHH-h----------------hccc--cCCCCC--hHHHHHHHHHHHH-------------------HHHH--
Q 004264 523 YMPHKSLDYF-I----------------FDRE--RSKLLP--WKKRFSIITGIAR-------------------GLLY-- 560 (765)
Q Consensus 523 ~~~~gsL~~~-l----------------~~~~--~~~~l~--~~~~~~i~~qia~-------------------aL~~-- 560 (765)
|++|.+|..- + +... ..+... +..+.++..++.. .+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998766421 0 0000 011111 3444444443321 1222
Q ss_pred --hhhc-CCCcEEecccCCCcEEEecC----CCCeeccccccee
Q 004264 561 --LHQD-SKLQVIHRDLKASNILLDIN----LNPKISDFGLARI 597 (765)
Q Consensus 561 --LH~~-~~~~ivH~Dlkp~NIll~~~----~~vkL~DFGla~~ 597 (765)
|... ....++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2221 23459999999999999876 7899999998865
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0012 Score=73.18 Aligned_cols=74 Identities=14% Similarity=0.012 Sum_probs=47.8
Q ss_pred ccccccCCceeEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHhccccCce-EeeeeeeeecCceEEEEEecCCCC
Q 004264 451 ANMIGKGGFGPVYMGKLST-GQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNL-VGLLGSCIEEDERMLIYEYMPHKS 528 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~ni-v~~~~~~~~~~~~~lV~E~~~~gs 528 (765)
.+.|+.|-...+|+....+ ++.+++|+........ -...+|..+++.|...++ .++++.+. + .+|+||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3578888889999998765 4788888875432111 112578888988864444 45666552 2 35999999866
Q ss_pred h
Q 004264 529 L 529 (765)
Q Consensus 529 L 529 (765)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0013 Score=69.50 Aligned_cols=142 Identities=15% Similarity=0.081 Sum_probs=72.8
Q ss_pred cccccCCcee-EEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccC--ceEeeeeeeeecCceEEEEEecCCCC
Q 004264 452 NMIGKGGFGP-VYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHR--NLVGLLGSCIEEDERMLIYEYMPHKS 528 (765)
Q Consensus 452 ~~LG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~--niv~~~~~~~~~~~~~lV~E~~~~gs 528 (765)
+.|+.|.... +|+....+++.+++|....... ..+..|+.+++.+... .+.+++.+.. ...+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence 4566665444 6677654467788876543211 2345677777777532 2445555432 33378999998766
Q ss_pred hhHHhhccc---------------------c--CCCCChHHHH-------HH-------------HHHHHHHHHHhh---
Q 004264 529 LDYFIFDRE---------------------R--SKLLPWKKRF-------SI-------------ITGIARGLLYLH--- 562 (765)
Q Consensus 529 L~~~l~~~~---------------------~--~~~l~~~~~~-------~i-------------~~qia~aL~~LH--- 562 (765)
+.+.+.... . ...++..... .+ ...+.+.+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 643331100 0 0011111100 00 001112222221
Q ss_pred hcCCCcEEecccCCCcEEEecC----CCCeecccccceee
Q 004264 563 QDSKLQVIHRDLKASNILLDIN----LNPKISDFGLARIF 598 (765)
Q Consensus 563 ~~~~~~ivH~Dlkp~NIll~~~----~~vkL~DFGla~~~ 598 (765)
......++|+|+.+.||+++.+ ..+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1123459999999999999874 67899999988753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0038 Score=65.71 Aligned_cols=142 Identities=11% Similarity=0.105 Sum_probs=81.9
Q ss_pred cccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCc--eEeeeee-----eeecCceEEEEEec
Q 004264 452 NMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRN--LVGLLGS-----CIEEDERMLIYEYM 524 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n--iv~~~~~-----~~~~~~~~lV~E~~ 524 (765)
..|+ |....||+....+|+.+++|+..... .....+..|+.+++.|.... +.+++.. ....+..+++||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 77889999887778789999985321 13456777888888875322 3444443 12244567899999
Q ss_pred CCCChhH----H----------hhcccc------CCCCChHHH----HH---------------HHHHHHHHHHHhhhc-
Q 004264 525 PHKSLDY----F----------IFDRER------SKLLPWKKR----FS---------------IITGIARGLLYLHQD- 564 (765)
Q Consensus 525 ~~gsL~~----~----------l~~~~~------~~~l~~~~~----~~---------------i~~qia~aL~~LH~~- 564 (765)
+|..+.. . ++.... ....++... .. +...+.+.++.+.+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 9865421 0 111000 011111110 00 011111222233221
Q ss_pred ---CCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 565 ---SKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 565 ---~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234489999999999999 4 899999988764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0016 Score=70.07 Aligned_cols=74 Identities=15% Similarity=0.131 Sum_probs=45.0
Q ss_pred ccccccCCceeEEEEEeCC---------CcEEEEEEccccChhhHHHHHHHHHHHhccccCc-eEeeeeeeeecCceEEE
Q 004264 451 ANMIGKGGFGPVYMGKLST---------GQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRN-LVGLLGSCIEEDERMLI 520 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n-iv~~~~~~~~~~~~~lV 520 (765)
.+.|+.|....+|+....+ ++.+++|+....... ......|..+++.|...+ ..++++.. ...+|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence 3467888888999998654 267888887543221 122467888888886433 33555433 23689
Q ss_pred EEecCCCCh
Q 004264 521 YEYMPHKSL 529 (765)
Q Consensus 521 ~E~~~~gsL 529 (765)
|||+++..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999998654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0052 Score=65.22 Aligned_cols=68 Identities=9% Similarity=0.070 Sum_probs=44.0
Q ss_pred ccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhcccc---CceEeeeee------eeecCceEEEEEecC
Q 004264 455 GKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQH---RNLVGLLGS------CIEEDERMLIYEYMP 525 (765)
Q Consensus 455 G~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h---~niv~~~~~------~~~~~~~~lV~E~~~ 525 (765)
|.|....||+....++ .+++|+...... ..|+.+++.|.. +++.+++.. .......+++|||++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3334678999987777 899998765332 356666666642 224444432 223466789999999
Q ss_pred CCCh
Q 004264 526 HKSL 529 (765)
Q Consensus 526 ~gsL 529 (765)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8766
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0066 Score=59.08 Aligned_cols=103 Identities=12% Similarity=0.059 Sum_probs=67.2
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcccc
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQ 606 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~~ 606 (765)
-+|.+++. ..+.++++.++|.++.|.+.+|.-+-... . -..+=+.|..|+|..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc----------
Confidence 47888884 34578999999999999999987762211 1 11334567899999999988764 1110
Q ss_pred cccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCC
Q 004264 607 TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMN 649 (765)
Q Consensus 607 ~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p 649 (765)
.....+.|||... ...+.+.-|||||+++|.-+--..|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123467888763 4456788999999999999875443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.70 E-value=0.013 Score=63.96 Aligned_cols=73 Identities=15% Similarity=0.166 Sum_probs=47.7
Q ss_pred cccccCCceeEEEEEeCC--------CcEEEEEEccccChhhHHHHHHHHHHHhccccCc-eEeeeeeeeecCceEEEEE
Q 004264 452 NMIGKGGFGPVYMGKLST--------GQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRN-LVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n-iv~~~~~~~~~~~~~lV~E 522 (765)
+.|..|-...+|+....+ ++.+++++....... .-...+|..+++.|.... ..++++.+ ...+|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF----PEGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEEE
Confidence 467778888899998753 578999987543221 122357888888885333 34444422 2378999
Q ss_pred ecCCCCh
Q 004264 523 YMPHKSL 529 (765)
Q Consensus 523 ~~~~gsL 529 (765)
|+++.+|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9999765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.38 E-value=0.095 Score=56.77 Aligned_cols=30 Identities=27% Similarity=0.345 Sum_probs=25.4
Q ss_pred cEEecccCCCcEEE------ecCCCCeeccccccee
Q 004264 568 QVIHRDLKASNILL------DINLNPKISDFGLARI 597 (765)
Q Consensus 568 ~ivH~Dlkp~NIll------~~~~~vkL~DFGla~~ 597 (765)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36899999999999 3456799999998875
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=90.87 E-value=6.9 Score=39.33 Aligned_cols=73 Identities=18% Similarity=0.345 Sum_probs=46.1
Q ss_pred EEEEEeCCCCcEEEeecCCCC--CC----CCCceEEEeeCCceEEEcCCCCeEEEeccCCCcCccEEEEecCCCeeEeec
Q 004264 62 LGIWYKSSPRTVVWVANRNHP--IT----DKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDN 135 (765)
Q Consensus 62 ~~i~~~~~~~~~vW~an~~~p--~~----~~~~~l~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~ 135 (765)
+.+| +...+.++|....+.+ +. .+.+.+-++.++.+..+|.+|+.+|............+..+.+||+++-+.
T Consensus 17 v~~~-d~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~~ 95 (276)
T 3no2_A 17 IAII-NKDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAWC 95 (276)
T ss_dssp EEEE-ETTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEEE
T ss_pred EEEE-ECCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEec
Confidence 4444 3346788998877642 11 123445555566666778889999998764222334567788899888763
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=80.81 E-value=8.4 Score=38.68 Aligned_cols=41 Identities=12% Similarity=0.082 Sum_probs=29.3
Q ss_pred eeCCceEEEcCCCCeEEEeccCCCcCccEEEEecCCCeeEeec
Q 004264 93 SNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDN 135 (765)
Q Consensus 93 ~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~ 135 (765)
..+|.++.+|.+|+.+|+..... ....+..+.+||+++.+.
T Consensus 143 ~~~~~v~~~d~~G~~~w~~~~~~--~~~~~~~~~~g~~~v~~~ 183 (276)
T 3no2_A 143 FATSEVREIAPNGQLLNSVKLSG--TPFSSAFLDNGDCLVACG 183 (276)
T ss_dssp TTTTEEEEECTTSCEEEEEECSS--CCCEEEECTTSCEEEECB
T ss_pred cCCCEEEEECCCCCEEEEEECCC--CccceeEcCCCCEEEEeC
Confidence 34678888899999999987542 223345677899888663
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 765 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-47 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-22 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 3e-22 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 4e-15 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 5e-15 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 2e-14 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 2e-12 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 7e-09 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 1e-66
Identities = 70/286 (24%), Positives = 126/286 (44%), Gaps = 20/286 (6%)
Query: 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLV 505
+ IG G FG VY GK + ++ + Q L+ F NEV ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 506 GLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
+G + ++ ++ SL + + E K I A+G+ YLH S
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS 124
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA--- 622
+IHRDLK++NI L +L KI DFGLA + Q E+++G+ +M+PE
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 623 NDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682
+ S +SDV++ G++L E+++G + P N + G +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTG------QLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235
Query: 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGVTLPQ 728
+ ++ C++K ++RP ++ + +LP+
Sbjct: 236 SNCPKA-----MKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 4e-62
Identities = 83/274 (30%), Positives = 127/274 (46%), Gaps = 22/274 (8%)
Query: 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLV 505
+G G FG V+MG + ++A K L + S + F+ E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 506 GLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
L ++ +I EYM + SL F+ KL K + IA G+ ++ + +
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 129
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG 625
IHRDL+A+NIL+ L+ KI+DFGLAR+ D+E E + +PE N G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 626 TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDS 685
T ++KSDV+S G+LL EIV+ + G + D C E+
Sbjct: 186 TFTIKSDVWSFGILLTEIVTH------GRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE- 238
Query: 686 FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719
Q+ LC ++ PEDRP + +L
Sbjct: 239 --------LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 1e-60
Identities = 75/274 (27%), Positives = 123/274 (44%), Gaps = 22/274 (8%)
Query: 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLV 505
+ + IG G FG V++G ++A K + + + E+F+ E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 506 GLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
L G C+E+ L++E+M H L + R + L + + + G+ YL
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLE--- 118
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG 625
+ VIHRDL A N L+ N K+SDFG+ R DD+ + + SPE +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 626 TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDS 685
S KSDV+S GVL+ E+ S + P + ++ ++ + L L +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEG-----KIPYENRS---NSEVVEDISTGFRLYKPRLAST 229
Query: 686 FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719
Q+ C ++ PEDRP S ++ L
Sbjct: 230 -------HVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 2e-60
Identities = 63/288 (21%), Positives = 114/288 (39%), Gaps = 28/288 (9%)
Query: 454 IGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE 513
IGKG FG V+ GK G+E+A K S + E+ L+H N++G + + +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNK 68
Query: 514 ED----ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD----- 564
++ + L+ +Y H SL ++ + + + A GL +LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 565 SKLQVIHRDLKASNILLDINLNPKISDFGLARIF--GGDDEEAQTERVAGTHGYMSPEYA 622
K + HRDLK+ NIL+ N I+D GLA D + GT YM+PE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 623 ND------GTISMKSDVFSLGVLLVEIVSGKMNRG----FRHPGHRHNLIGHAWLLWNDG 672
+D ++D++++G++ EI G ++ P + +
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 673 RALGLMDTCLEDSFVESQVLRCI-QVGLLCVQKLPEDRPDMSSVVFLL 719
+ + + + + LR + ++ C R + L
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 4e-60
Identities = 62/271 (22%), Positives = 107/271 (39%), Gaps = 22/271 (8%)
Query: 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLV 505
+ +G G FG V GK ++A K + + S +EF+ E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 506 GLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
L G C ++ +I EYM + L ++ + ++ + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK- 119
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG 625
Q +HRDL A N L++ K+SDFGL+R DDE + + PE
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 626 TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDS 685
S KSD+++ GVL+ EI S + P + + + + L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLG-----KMP----------YERFTNSETAEHIAQGLRLY 221
Query: 686 FVESQVLRCIQVGLLCVQKLPEDRPDMSSVV 716
+ + C + ++RP ++
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILL 252
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 7e-60
Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 11/206 (5%)
Query: 444 ATNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGL-EEFMNEVVLIGKLQH 501
+ F + + +G G G V+ +G +A K + + + + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
+VG G+ + E + E+M SLD + R +P + + + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
K +++HRD+K SNIL++ K+ DFG++ ++ GT YMSPE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 622 ANDGTISMKSDVFSLGVLLVEIVSGK 647
S++SD++S+G+ LVE+ G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 2e-58
Identities = 78/288 (27%), Positives = 125/288 (43%), Gaps = 22/288 (7%)
Query: 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLV 505
+G+G FG V+MG + +A K L + E F+ E ++ KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 506 GLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
L E+ ++ EYM SL F+ E K L + + IA G+ Y+ +
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVER-- 131
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG 625
+ +HRDL+A+NIL+ NL K++DFGLAR+ D+E + + +PE A G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 626 TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDS 685
++KSDV+S G+LL E+ + R P + + L ++
Sbjct: 190 RFTIKSDVWSFGILLTELTTKG-----RVP----------YPGMVNREVLDQVERGYRMP 234
Query: 686 FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGVTLPQPRQPG 733
+ C +K PE+RP + L + + QPG
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (500), Expect = 5e-58
Identities = 71/275 (25%), Positives = 120/275 (43%), Gaps = 22/275 (8%)
Query: 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNL 504
+ + +G G +G VY G +A K L +++ + +EEF+ E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 505 VGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD 564
V LLG C E +I E+M + +L ++ + R + + + T I+ + YL +
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEK- 133
Query: 565 SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND 624
IHRDL A N L+ N K++DFGL+R+ GD A + +PE
Sbjct: 134 --KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 190
Query: 625 GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684
S+KSDV++ GVLL EI + + + + L + + C E
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATY------GMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 244
Query: 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719
++ C Q P DRP + +
Sbjct: 245 ---------VYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (501), Expect = 6e-58
Identities = 74/302 (24%), Positives = 117/302 (38%), Gaps = 46/302 (15%)
Query: 446 NHFSEANMIGKGGFGPVYMGKL------STGQEIAAKRLSKNSGQGLE-EFMNEVVLIGK 498
N+ IG+G FG V+ + +A K L + + ++ +F E L+ +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 499 LQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKL----------------- 541
+ N+V LLG C L++EYM + L+ F+ +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 542 ----LPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597
L ++ I +A G+ YL + + +HRDL N L+ N+ KI+DFGL+R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 598 FGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGH 657
D A +M PE + +SDV++ GV+L EI S P +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG-----LQPYY 244
Query: 658 RHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717
DG L + C + + LC KLP DRP S+
Sbjct: 245 GMAHE-EVIYYVRDGNILACPENCPLE---------LYNLMRLCWSKLPADRPSFCSIHR 294
Query: 718 LL 719
+L
Sbjct: 295 IL 296
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 3e-57
Identities = 72/275 (26%), Positives = 108/275 (39%), Gaps = 28/275 (10%)
Query: 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLV 505
IGKG FG V +G G ++A K + ++ + F+ E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 506 GLLGSCIEEDERM-LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD 564
LLG +EE + ++ EYM SL ++ R R +L + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 565 SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAND 624
+HRDL A N+L+ + K+SDFGL + + + +PE +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALRE 174
Query: 625 GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684
S KSDV+S G+LL EI S R P R L G + D C
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFG-----RVPYPRIPLK-DVVPRVEKGYKMDAPDGCPPA 228
Query: 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719
+V C RP + L
Sbjct: 229 ---------VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (496), Expect = 4e-57
Identities = 72/279 (25%), Positives = 116/279 (41%), Gaps = 34/279 (12%)
Query: 445 TNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQG---LEEFMNEVVLIGKLQ 500
FS+ IG G FG VY + + + +A K++S + Q ++ + EV + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 501 HRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLY 560
H N + G + E L+ EY + D ++ L + ++ G +GL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130
Query: 561 LHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE 620
LH +IHRD+KA NILL K+ DFG A I A GT +M+PE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181
Query: 621 YA---NDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677
++G K DV+SLG+ +E+ + P N + + + +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAER------KPPLFNMNAMSALYHIAQNESPALQ 235
Query: 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVV 716
E C+QK+P+DRP ++
Sbjct: 236 SGHWSEY---------FRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-56
Identities = 74/281 (26%), Positives = 119/281 (42%), Gaps = 30/281 (10%)
Query: 447 HFSEANMIGKGGFGPVYMGKL----STGQEIAAKRLSKNSGQG-LEEFMNEVVLIGKLQH 501
HF+E +IG+G FG VY G L A K L++ + G + +F+ E +++ H
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 502 RNLVGLLGSCIE-EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLY 560
N++ LLG C+ E +++ YM H L FI + + + F +
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG----- 142
Query: 561 LHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTER--VAGTHGYMS 618
+ + + +HRDL A N +LD K++DFGLAR + ++ + +M+
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 619 PEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678
E + KSDV+S GVLL E+++ P N L GR L
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRG-----APPYPDVNTFDITVYLLQ-GRRLLQP 256
Query: 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719
+ C + +V L C E RP S +V +
Sbjct: 257 EYCPDP---------LYEVMLKCWHPKAEMRPSFSELVSRI 288
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (490), Expect = 2e-56
Identities = 72/301 (23%), Positives = 120/301 (39%), Gaps = 37/301 (12%)
Query: 436 YDLATITTATNHFSEA---------NMIGKGGFGPVYMGKL----STGQEIAAKRLSKN- 481
+ A F++ +IG G FG V G L +A K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 482 SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKL 541
+ + +F++E ++G+ H N++ L G + M+I E+M + SLD F+ +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 542 LPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601
+ ++ GIA G+ YL + +HRDL A NIL++ NL K+SDFGL+R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 602 DEEAQTERVAG---THGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHR 658
+ G + +PE + SDV+S G+++ E++S P
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG-----ERP--- 233
Query: 659 HNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718
+ + + ++ Q+ L C QK RP +V
Sbjct: 234 -------YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 719 L 719
L
Sbjct: 287 L 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 3e-56
Identities = 69/281 (24%), Positives = 120/281 (42%), Gaps = 27/281 (9%)
Query: 446 NHFSEANMIGKGGFGPVYMGKLSTGQE-----IAAKRLSKNSGQG-LEEFMNEVVLIGKL 499
+ + +IG G FG VY G L T +A K L + +F+ E ++G+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 500 QHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLL 559
H N++ L G + M+I EYM + + F RE+ + ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 560 YLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTE-RVAGTHGYMS 618
YL + +HRDL A NIL++ NL K+SDFGL+R+ D E T + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 619 PEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678
PE + + SDV+S G+++ E+++ + ++ + +
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGE---------------RPYWELSNHEVMKAI 226
Query: 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719
+ Q+ + C Q+ RP + +V +L
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 6e-56
Identities = 67/268 (25%), Positives = 115/268 (42%), Gaps = 27/268 (10%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512
+G G FG VY + T AAK + S + LE++M E+ ++ H N+V LL +
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 513 EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHR 572
E+ ++ E+ ++D + + ER L + + L YLH ++IHR
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHD---NKIIHR 134
Query: 573 DLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA-----NDGTI 627
DLKA NIL ++ + K++DFG++ + + GT +M+PE D
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPY 192
Query: 628 SMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFV 687
K+DV+SLG+ L+E+ + +P I T + S
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK-----------SEPPTLAQPSRW 241
Query: 688 ESQVLRCIQVGLLCVQKLPEDRPDMSSV 715
S ++ C++K + R S +
Sbjct: 242 SSNFKDFLK---KCLEKNVDARWTTSQL 266
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-55
Identities = 67/284 (23%), Positives = 112/284 (39%), Gaps = 26/284 (9%)
Query: 454 IGKGGFGPVYMGKL---STGQEIAAKRLSKNSGQG-LEEFMNEVVLIGKLQHRNLVGLLG 509
+G G FG V G ++A K L + + + EE M E ++ +L + +V L+G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 510 SCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQV 569
C + + ML+ E L F+ + +P ++ ++ G+ YL +
Sbjct: 77 VC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEE---KNF 130
Query: 570 IHRDLKASNILLDINLNPKISDFGLARIFGGDDEE-AQTERVAGTHGYMSPEYANDGTIS 628
+HRDL A N+LL KISDFGL++ G DD + +PE N S
Sbjct: 131 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 190
Query: 629 MKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVE 688
+SDV+S GV + E +S + ++ G+ + C +
Sbjct: 191 SRSDVWSYGVTMWEALS------YGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE---- 240
Query: 689 SQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGVTLPQPRQP 732
+ C EDRPD +V + +L +
Sbjct: 241 -----LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 279
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-55
Identities = 69/303 (22%), Positives = 115/303 (37%), Gaps = 45/303 (14%)
Query: 446 NHFSEANMIGKGGFGPVYMG------KLSTGQEIAAKRLSKNSGQG-LEEFMNEVVLIGK 498
+ ++G G FG V K ++A K L + + E M+E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 499 L-QHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDR--------------------E 537
L H N+V LLG+C LI+EY + L ++ + E
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 538 RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARI 597
+L ++ +A+G+ +L +HRDL A N+L+ KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 598 FGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGH 657
D +M+PE +G ++KSDV+S G+LL EI S +P
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG-----VNPYP 268
Query: 658 RHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717
+ + + L +G + E+ + C RP ++
Sbjct: 269 GIPVDANFYKLIQNGFKMDQPFYATEE---------IYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 718 LLA 720
L
Sbjct: 320 FLG 322
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 1e-55
Identities = 69/278 (24%), Positives = 112/278 (40%), Gaps = 28/278 (10%)
Query: 450 EANMIGKGGFGPVYMGKL---STGQEIAAKRLSK--NSGQGLEEFMNEVVLIGKLQHRNL 504
E +G G FG V G + +A K L N +E + E ++ +L + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 505 VGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD 564
V ++G C E + ML+ E L+ ++ + K ++ ++ G+ YL +
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES 126
Query: 565 SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTE-RVAGTHGYMSPEYAN 623
+HRDL A N+LL KISDFGL++ D+ + + + +PE N
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 624 DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683
S KSDV+S GVL+ E S + P +L R +G C
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYG-----QKPYRGMKGSEVTAMLEKGER-MGCPAGCPR 237
Query: 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721
+ + LC E+RP ++V L N
Sbjct: 238 E---------MYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 3e-55
Identities = 70/297 (23%), Positives = 109/297 (36%), Gaps = 40/297 (13%)
Query: 446 NHFSEANMIGKGGFGPVYMGKL------STGQEIAAKRLSKNSGQG-LEEFMNEVVLIGK 498
N S +G G FG V +A K L ++ E M+E+ ++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 499 L-QHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKL---------------L 542
L H N+V LLG+C ++I EY + L F+ + S + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 543 PWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602
+ S +A+G+ +L IHRDL A NILL KI DFGLAR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLI 662
+M+PE + + +SDV+S G+ L E+ S P +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG-----SSPYPGMPVD 254
Query: 663 GHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719
+ + +G + + + + C P RP +V L+
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAE---------MYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 5e-54
Identities = 69/277 (24%), Positives = 113/277 (40%), Gaps = 26/277 (9%)
Query: 448 FSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNL 504
+ IG G +G + S G+ + K L S + ++EV L+ +L+H N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 505 VGLLGSCIEEDERML--IYEYMPHKSLDYFIFDRERSK-LLPWKKRFSIITGIARGLLYL 561
V I+ L + EY L I + + L + ++T + L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 562 HQ--DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSP 619
H+ D V+HRDLK +N+ LD N K+ DFGLARI D A+ GT YMSP
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSP 183
Query: 620 EYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679
E N + + KSD++SLG LL E+ + P + A + G+ +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCAL------MPPFTAFSQKELAGKIRE-GKFRRIPY 236
Query: 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVV 716
++ ++ + RP + ++
Sbjct: 237 RYSDE---------LNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 7e-54
Identities = 61/273 (22%), Positives = 110/273 (40%), Gaps = 23/273 (8%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSK-NSGQGLEEFMNEVVLIGKLQHRN 503
+ +G+G +G V + T + +A K + + E E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
+V G E + + L EY L I +P + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAN 623
+ + HRD+K N+LLD N KISDFGLA +F ++ E ++ GT Y++PE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 624 DGTI-SMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682
+ DV+S G++L +++G+ P + + + W + +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGE------LPWDQPSDSCQEYSDWKEKK-----TYLN 227
Query: 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSV 715
++S L + + + P R + +
Sbjct: 228 PWKKIDSAPLALLH---KILVENPSARITIPDI 257
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-53
Identities = 74/274 (27%), Positives = 110/274 (40%), Gaps = 28/274 (10%)
Query: 454 IGKGGFGPVYMGKL----STGQEIAAKRLSK---NSGQGLEEFMNEVVLIGKLQHRNLVG 506
+G G FG V G+ +A K L + + +++F+ EV + L HRNL+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSK 566
L G + +M + E P SL + + LL R+++ +A G+ YL
Sbjct: 76 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES--- 129
Query: 567 LQVIHRDLKASNILLDINLNPKISDFGLARIFG-GDDEEAQTERVAGTHGYMSPEYANDG 625
+ IHRDL A N+LL KI DFGL R DD E + +PE
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 626 TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDS 685
T S SD + GV L E+ + + P N + +G L + C +D
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYG-----QEPWIGLNGSQILHKIDKEGERLPRPEDCPQD- 243
Query: 686 FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719
V + C PEDRP ++ L
Sbjct: 244 --------IYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 4e-53
Identities = 62/271 (22%), Positives = 105/271 (38%), Gaps = 31/271 (11%)
Query: 454 IGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGS 510
IG+G F VY G T E+A L + + F E ++ LQH N+V S
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 511 CIEEDER----MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSK 566
+ +L+ E M +L ++ R K++ K S I +GL +LH +
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRTP 133
Query: 567 LQVIHRDLKASNILL-DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG 625
+IHRDLK NI + + KI D GLA + + V GT +M+PE
Sbjct: 134 -PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-E 187
Query: 626 TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDS 685
DV++ G+ ++E+ + +P + G D
Sbjct: 188 KYDESVDVYAFGMCMLEMATS------EYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241
Query: 686 FVESQVLRCIQVGLLCVQKLPEDRPDMSSVV 716
E + C+++ ++R + ++
Sbjct: 242 VKE--------IIEGCIRQNKDERYSIKDLL 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 3e-52
Identities = 63/282 (22%), Positives = 125/282 (44%), Gaps = 24/282 (8%)
Query: 435 LYDLATITTATNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEV 493
L + ++ ++ IG+G G VY ++TGQE+A ++++ E +NE+
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 494 VLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITG 553
+++ + ++ N+V L S + DE ++ EY+ SL + + + ++
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRE 124
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGT 613
+ L +LH QVIHRD+K+ NILL ++ + K++DFG E+++ + GT
Sbjct: 125 CLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGT 179
Query: 614 HGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR 673
+M+PE K D++SLG++ +E++ G P N + +L+ +G
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG------EPPYLNENPLRALYLIATNGT 233
Query: 674 ALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSV 715
+ + + C+ E R +
Sbjct: 234 -----PELQNPEKLSAIFRDFLN---RCLDMDVEKRGSAKEL 267
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 5e-52
Identities = 63/310 (20%), Positives = 128/310 (41%), Gaps = 41/310 (13%)
Query: 448 FSEANMIGKGGFGPVYMGK-LSTGQE----IAAKRLSK-NSGQGLEEFMNEVVLIGKLQH 501
F + ++G G FG VY G + G++ +A K L + S + +E ++E ++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
++ LLG C+ LI + MP L ++ + + + + + IA+G+ YL
Sbjct: 71 PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNYL 127
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
+++HRDL A N+L+ + KI+DFGLA++ G +++E E +M+ E
Sbjct: 128 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 622 ANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681
+ +SDV+S GV + E+++ P + +++
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFG-----SKP----------YDGIPASEISSILEKG 229
Query: 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVV--------------FLLANDGVTLP 727
+ + + C + RP ++ + ++ + LP
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP 289
Query: 728 QPRQPGFFTE 737
P F+
Sbjct: 290 SPTDSNFYRA 299
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 6e-52
Identities = 68/304 (22%), Positives = 119/304 (39%), Gaps = 34/304 (11%)
Query: 446 NHFSEANMIGKGGFGPVYMGKL------STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGK 498
+ + +G+G FG VY G +A K +++ S + EF+NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 499 LQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKL-------LPWKKRFSII 551
++V LLG + ++I E M L ++ + K +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 552 TGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVA 611
IA G+ YL+ + + +HRDL A N ++ + KI DFG+ R D + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 612 GTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWND 671
+MSPE DG + SDV+S GV+L EI + ++ +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL------AEQPYQGLSNEQVLRFVME 250
Query: 672 GRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGVTLPQPRQ 731
G L D C + ++ +C Q P+ RP ++ + P R+
Sbjct: 251 GGLLDKPDNCPDM---------LFELMRMCWQYNPKMRPSFLEIISSI--KEEMEPGFRE 299
Query: 732 PGFF 735
F+
Sbjct: 300 VSFY 303
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 1e-51
Identities = 67/275 (24%), Positives = 104/275 (37%), Gaps = 31/275 (11%)
Query: 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSK---NSGQGLEEFMNEVVLIGKLQH 501
F +GKG FG VY+ + + +A K L K + EV + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
N++ L G + LI EY P ++ + + ++ + IT +A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
H +VIHRD+K N+LL KI+DFG + + + GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEM 175
Query: 622 ANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681
K D++SLGVL E + GK + I + D G D
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-- 233
Query: 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVV 716
+ ++ P RP + V+
Sbjct: 234 ----LISR-----------LLKHNPSQRPMLREVL 253
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-51
Identities = 76/292 (26%), Positives = 118/292 (40%), Gaps = 39/292 (13%)
Query: 446 NHFSEANMIGKGGFGPVYMGKLSTG---QEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-Q 500
N ++IG+G FG V ++ + A KR+ + S +F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 501 HRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDR-------------ERSKLLPWKKR 547
H N++ LLG+C L EY PH +L F+ + L ++
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 548 FSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQT 607
+ARG+ YL Q Q IHRDL A NIL+ N KI+DFGL+R + +
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 608 ERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWL 667
+M+ E N + SDV+S GVLL EIVS + +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL------GGTPYCGMTCAELYE 237
Query: 668 LWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719
G L C ++ + C ++ P +RP + ++ L
Sbjct: 238 KLPQGYRLEKPLNCDDE---------VYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 9e-51
Identities = 76/298 (25%), Positives = 115/298 (38%), Gaps = 39/298 (13%)
Query: 446 NHFSEANMIGKGGFGPVYMG------KLSTGQEIAAKRLSKNSGQG-LEEFMNEV-VLIG 497
+ +G+G FG V K +T + +A K L + + M+E+ +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 498 KLQHRNLVGLLGSCIEEDER-MLIYEYMPHKSLDYFIFDRER-------------SKLLP 543
H N+V LLG+C + M+I E+ +L ++ + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 544 WKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603
+ +A+G+ +L + IHRDL A NILL KI DFGLAR D +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIG 663
+ +M+PE D +++SDV+S GVLL EI S P +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----LGASPYPGVKIDE 244
Query: 664 HAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721
+G + D + Q L C P RP S +V L N
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 172 bits (436), Expect = 3e-48
Identities = 58/273 (21%), Positives = 107/273 (39%), Gaps = 24/273 (8%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNL 504
+H+ +G G FG V+ +TG AAK + E E+ + L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 505 VGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD 564
V L + +++E ++IYE+M L + D + + + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141
Query: 565 SKLQVIHRDLKASNILLDINLNP--KISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA 622
+ +H DLK NI+ + K+ DFGL D + + GT + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 197
Query: 623 NDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682
+ +D++S+GVL ++SG G + + +D G+ +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257
Query: 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSV 715
+ F+ + P R +
Sbjct: 258 D--FIRK-----------LLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-47
Identities = 52/200 (26%), Positives = 94/200 (47%), Gaps = 10/200 (5%)
Query: 452 NMIGKGGFGPVYMGK-LSTGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGL 507
++G+G F V + + L+T +E A K L K + E ++ +L H V L
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
+ ++++ Y + L +I I L YLH
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH---GK 127
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTI 627
+IHRDLK NILL+ +++ +I+DFG A++ + ++A+ GT Y+SPE + +
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 628 SMKSDVFSLGVLLVEIVSGK 647
SD+++LG ++ ++V+G
Sbjct: 188 CKSSDLWALGCIIYQLVAGL 207
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-47
Identities = 62/272 (22%), Positives = 102/272 (37%), Gaps = 27/272 (9%)
Query: 453 MIGKGGFGPVYMGKL----STGQEIAAKRLSKNSGQGL-EEFMNEVVLIGKLQHRNLVGL 507
IG+G FG V+ G + +A K + + E+F+ E + + + H ++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 508 LGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKL 567
+G E+ +I E L F+ R+ S L ++ L YL
Sbjct: 74 IGVI-TENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLE---SK 127
Query: 568 QVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTI 627
+ +HRD+ A N+L+ N K+ DFGL+R D + + +M+PE N
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 628 SMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFV 687
+ SDV+ GV + EI+ P + N G L + C
Sbjct: 187 TSASDVWMFGVCMWEILMHG-----VKPFQGVKNNDVIGRIEN-GERLPMPPNCPPT--- 237
Query: 688 ESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719
+ C P RP + + L
Sbjct: 238 ------LYSLMTKCWAYDPSRRPRFTELKAQL 263
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 4e-47
Identities = 71/297 (23%), Positives = 123/297 (41%), Gaps = 41/297 (13%)
Query: 446 NHFSEANMIGKGGFGPVYMGKL--------STGQEIAAKRLSKN-SGQGLEEFMNEVVLI 496
+ +G+G FG V + + + ++A K L + + + L + ++E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 497 GKL-QHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKL-------------L 542
+ +H+N++ LLG+C ++ +I EY +L ++ R L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 543 PWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602
K S +ARG+ YL + IHRDL A N+L+ + KI+DFGLAR D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLI 662
+T +M+PE D + +SDV+S GVLL EI + + +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL------GGSPYPGVPV 243
Query: 663 GHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLL 719
+ L +G + C + + C +P RP +V L
Sbjct: 244 EELFKLLKEGHRMDKPSNCTNE---------LYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 167 bits (423), Expect = 2e-46
Identities = 51/273 (18%), Positives = 107/273 (39%), Gaps = 24/273 (8%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNL 504
+++ +G G FG V+ +TG+ AK ++ NE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 505 VGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD 564
+ L + ++ E +LI E++ L I + + + + GL ++H+
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHE- 145
Query: 565 SKLQVIHRDLKASNILLDINLNP--KISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYA 622
++H D+K NI+ + KI DFGLA D+ + T + +PE
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIV 200
Query: 623 NDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682
+ + +D++++GVL ++SG + +++ +
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260
Query: 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSV 715
+ F+++ +QK P R +
Sbjct: 261 D--FIKN-----------LLQKEPRKRLTVHDA 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 156 bits (396), Expect = 1e-43
Identities = 63/280 (22%), Positives = 116/280 (41%), Gaps = 28/280 (10%)
Query: 440 TITTATNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQG---LEEFMNEVVL 495
T + ++ + ++G GG V++ + L +++A K L + + F E
Sbjct: 1 TPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQN 60
Query: 496 IGKLQHRNLVGLLGSCIEEDER----MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSII 551
L H +V + + E ++ EY+ +L + + K+ +I
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVI 117
Query: 552 TGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG-GDDEEAQTERV 610
+ L + HQ +IHRD+K +NI++ K+ DFG+AR + QT V
Sbjct: 118 ADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 174
Query: 611 AGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWN 670
GT Y+SPE A ++ +SDV+SLG +L E+++G P + + + +
Sbjct: 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG------EPPFTGDSPVS---VAYQ 225
Query: 671 DGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRP 710
R + + + V L + K PE+R
Sbjct: 226 HVREDPIPPSARHEGLSAD----LDAVVLKALAKNPENRY 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (402), Expect = 2e-43
Identities = 65/225 (28%), Positives = 97/225 (43%), Gaps = 18/225 (8%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSK---NSGQGLEEFMNEVVLIGKLQ- 500
N FS +IG+GGFG VY + TG+ A K L K QG +NE +++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 501 --HRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGL 558
+V + + D+ I + M L Y + I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGL 120
Query: 559 LYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMS 618
++H V++RDLK +NILLD + + +ISD GLA F + GTHGYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMA 173
Query: 619 PEYANDGT-ISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLI 662
PE G +D FSLG +L +++ G +H +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 2e-43
Identities = 54/265 (20%), Positives = 104/265 (39%), Gaps = 25/265 (9%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512
+G+G FG V+ S+ + AK + K G E+ ++ +HRN++ L S
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 513 EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHR 572
+E ++I+E++ + I + L ++ S + + L +LH + H
Sbjct: 72 SMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHF 126
Query: 573 DLKASNILLDINLNP--KISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMK 630
D++ NI+ + KI +FG AR D + Y +PE +S
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTA 183
Query: 631 SDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQ 690
+D++SLG L+ ++SG I +A +++ + ++ FV+
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD--FVDR- 240
Query: 691 VLRCIQVGLLCVQKLPEDRPDMSSV 715
+ K + R S
Sbjct: 241 ----------LLVKERKSRMTASEA 255
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 8e-43
Identities = 55/222 (24%), Positives = 100/222 (45%), Gaps = 7/222 (3%)
Query: 445 TNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQG-LEEFMNEVVLIGKLQHR 502
++ + IG+G +G V +A K++S Q + + E+ ++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 503 NLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLH 562
N++G+ + Y+ + ++ +++ L + I RGL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 563 QDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTE-RVAGTHGYMSPEY 621
V+HRDLK SN+LL+ + KI DFGLAR+ D + T Y +PE
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 622 ANDGTISMKS-DVFSLGVLLVEIVSGKMNRGFRHPGHRHNLI 662
+ KS D++S+G +L E++S + +H + N I
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 225
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (385), Expect = 5e-42
Identities = 60/286 (20%), Positives = 108/286 (37%), Gaps = 39/286 (13%)
Query: 447 HFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGL---------EEFMNEVVLI 496
++ ++G+G V T +E A K + G E + EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 497 GKLQ-HRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIA 555
K+ H N++ L + L+++ M L ++ ++ L K+ I+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALL 120
Query: 556 RGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG 615
+ LH KL ++HRDLK NILLD ++N K++DFG + D + V GT
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPS 174
Query: 616 YMSPEYA------NDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLW 669
Y++PE N + D++S GV++ +++G R +I +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234
Query: 670 NDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSV 715
DT + V + P+ R
Sbjct: 235 GSPEWDDYSDTVKD--LVSR-----------FLVVQPQKRYTAEEA 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (384), Expect = 1e-41
Identities = 60/276 (21%), Positives = 111/276 (40%), Gaps = 27/276 (9%)
Query: 445 TNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEE-FMNEVVLIGKLQHR 502
+ + +++G G F V + + T + +A K ++K + +G E NE+ ++ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 503 NLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLH 562
N+V L LI + + L I ++ + +I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLH 124
Query: 563 QDSKLQVIHRDLKASNILL---DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSP 619
++HRDLK N+L D + ISDFGL+++ D + GT GY++P
Sbjct: 125 DL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAP 178
Query: 620 EYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679
E S D +S+GV+ ++ G + I A ++ + D
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 238
Query: 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSV 715
+ + F+ ++K PE R
Sbjct: 239 SAKD--FIRH-----------LMEKDPEKRFTCEQA 261
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (382), Expect = 2e-41
Identities = 54/285 (18%), Positives = 93/285 (32%), Gaps = 25/285 (8%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNL 504
N + IG G FG +Y+G ++ G+E+A K + + E + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 505 VGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD 564
+ + C E + ++ + SL+ S+ K + + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDL--FNFCSRKFSLKTVLLLADQMISRIEYIHS- 121
Query: 565 SKLQVIHRDLKASNIL---LDINLNPKISDFGLARIFGGDDEEA-----QTERVAGTHGY 616
IHRD+K N L I DFGLA+ + + + + GT Y
Sbjct: 122 --KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 617 MSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676
S S + D+ SLG +L+ G + +
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721
L + C +D+PD S + L N
Sbjct: 240 LCKGYPSE---------FATYLNFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 150 bits (379), Expect = 4e-41
Identities = 42/287 (14%), Positives = 91/287 (31%), Gaps = 27/287 (9%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNL 504
H+ IG+G FG ++ G L Q++A K + S + +E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 505 VGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD 564
+ + +E ++ + SL+ + + K + + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIHE- 119
Query: 565 SKLQVIHRDLKASNILLDINLNP-----KISDFGLARIFGGDDEEA-----QTERVAGTH 614
+++RD+K N L+ + + DFG+ + + + + + ++GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 615 GYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRA 674
YMS S + D+ +LG + + + G +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 675 LGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721
L E+ + + PD + L +
Sbjct: 238 RELCAGFPEE---------FYKYMHYARNLAFDATPDYDYLQGLFSK 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 7e-41
Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 13/201 (6%)
Query: 452 NMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSG---QGLEEFMNEV-VLIGKLQHRNLVG 506
M+GKG FG V++ + T Q A K L K+ +E M E VL +H L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 507 LLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSK 566
+ + ++ + EY+ L Y I + + I GL +LH
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLH---S 121
Query: 567 LQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGT 626
+++RDLK NILLD + + KI+DFG+ + D + T GT Y++PE
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQK 179
Query: 627 ISMKSDVFSLGVLLVEIVSGK 647
+ D +S GVLL E++ G+
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (378), Expect = 1e-40
Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQH 501
F +G G FG V++ + G+ A K L K + +E +E +++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
++ + G+ + + +I +Y+ L + +R K + + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
+I+RDLK NILLD N + KI+DFG A+ T + GT Y++PE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEV 172
Query: 622 ANDGTISMKSDVFSLGVLLVEIVSGK 647
+ + D +S G+L+ E+++G
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGY 198
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 4e-39
Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 17/208 (8%)
Query: 448 FSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVG 506
+++ +IG G FG VY KL +G+ +A K++ ++ E+ ++ KL H N+V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 507 LLGSCIEEDERM------LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLY 560
L E+ L+ +Y+P + LP + + R L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 561 LHQDSKLQVIHRDLKASNILLDIN-LNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSP 619
+H + HRD+K N+LLD + K+ DFG A+ E + +
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPE 192
Query: 620 EYANDGTISMKSDVFSLGVLLVEIVSGK 647
+ DV+S G +L E++ G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 5e-39
Identities = 64/281 (22%), Positives = 114/281 (40%), Gaps = 33/281 (11%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSK------NSGQGLEEFMNEVVLIGK 498
+++ +G G F V + STG + AAK + K G E+ EV ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 499 LQHRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGL 558
+QH N++ L + + +LI E + L F+ ++E L ++ + I G+
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGV 126
Query: 559 LYLHQDSKLQVIHRDLKASNILLD----INLNPKISDFGLARIFGGDDEEAQTERVAGTH 614
YLH LQ+ H DLK NI+L KI DFGLA D + + + GT
Sbjct: 127 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTP 180
Query: 615 GYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRA 674
+++PE N + +++D++S+GV+ ++SG + + D
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240
Query: 675 LGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSV 715
+ F+ + K P+ R +
Sbjct: 241 SNTSALAKD--FIRR-----------LLVKDPKKRMTIQDS 268
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 6e-39
Identities = 63/303 (20%), Positives = 115/303 (37%), Gaps = 33/303 (10%)
Query: 452 NMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEE-----FMNEVVLIGKLQHRNLV 505
+ +G+G F VY + +T Q +A K++ ++ + E+ L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 506 GLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS 565
GLL + + L++++M ++ S +L + + +GL YLHQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 566 KLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDG 625
++HRDLK +N+LLD N K++DFGLA+ FG T Y +PE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELLFGA 175
Query: 626 T-ISMKSDVFSLGVLLVEIVSGK-----------MNRGFRHPGHRHNLIGHAWLLWNDGR 673
+ D++++G +L E++ + R F G D
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 674 ALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVV---FL----LANDGVTL 726
+ + + P R + + + G L
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 295
Query: 727 PQP 729
P+P
Sbjct: 296 PRP 298
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 9/204 (4%)
Query: 447 HFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRN 503
+F + IG+G +G VY + TG+ +A K++ + + + E+ L+ +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
+V LL E++ L++E++ + D +P S + + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCH- 119
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAN 623
+V+HRDLK N+L++ K++DFGLAR F G T V
Sbjct: 120 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 624 DGTISMKSDVFSLGVLLVEIVSGK 647
S D++SLG + E+V+ +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-37
Identities = 53/272 (19%), Positives = 100/272 (36%), Gaps = 30/272 (11%)
Query: 453 MIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRNLVGLLGS 510
++G G G V T ++ A K L + EV L + Q ++V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 73
Query: 511 C----IEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSK 566
+++ E + L I DR + ++ I+ I + YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLH---S 129
Query: 567 LQVIHRDLKASNILLDINLNP---KISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAN 623
+ + HRD+K N+L K++DFG A+ + T Y++PE
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLG 186
Query: 624 DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683
D++SLGV++ ++ G P + ++ + + + R E
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCG------YPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSV 715
S V +V I+ ++ P R ++
Sbjct: 241 WSEVSEEVKMLIR---NLLKTEPTQRMTITEF 269
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 140 bits (353), Expect = 1e-37
Identities = 60/284 (21%), Positives = 108/284 (38%), Gaps = 21/284 (7%)
Query: 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAK--RLSKNSGQGLEEFMNEVVLIGKLQHRN 503
+ IG+G +G VY + + G+ A K RL K + E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 504 LVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ 563
+V L + +L++E++ L S + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118
Query: 564 DSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYAN 623
+V+HRDLK N+L++ KI+DFGLAR FG + +
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMG 174
Query: 624 DGTISMKSDVFSLGVLLVEIVSGK-----------MNRGFRHPGHRHN-LIGHAWLLWND 671
S D++S+G + E+V+G + R FR G ++ + L
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 672 GRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSV 715
+ + +SF++ I + ++ P R
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-37
Identities = 65/294 (22%), Positives = 114/294 (38%), Gaps = 30/294 (10%)
Query: 444 ATNHFSEANMIGKGGFGPVYMGK--LSTGQEIAAKRLSKNSGQG--LEEFMNEVVLIGKL 499
A + IG+G +G V+ + + G+ +A KR+ +G+ + EV ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 500 ---QHRNLVGLLGSCIEEDERMLIYEYMPHKSLD---YFIFDRERSKLLPWKKRFSIITG 553
+H N+V L C + + +D D+ +P + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 554 IARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGT 613
+ RGL +LH +V+HRDLK NIL+ + K++DFGLARI+ + V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 614 HGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLL----- 668
Y +PE + + D++S+G + E+ K FR L ++
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK--PLFRGSSDVDQLGKILDVIGLPGE 236
Query: 669 --WNDGRALGLMDTCLEDSFVESQVLRCIQVGLL-----CVQKLPEDRPDMSSV 715
W AL + + + + I C+ P R S
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-37
Identities = 61/281 (21%), Positives = 100/281 (35%), Gaps = 43/281 (15%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEE------FMNEVVLIGK 498
+ + ++G GGFG VY G +S +A K + K+ E EVVL+ K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 499 LQ--HRNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIAR 556
+ ++ LL D +LI E + + L + S +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLE 121
Query: 557 GLLYLHQDSKLQVIHRDLKASNILLDIN-LNPKISDFGLARIFGGDDEEAQTERVAGTHG 615
+ + H V+HRD+K NIL+D+N K+ DFG + ++ GT
Sbjct: 122 AVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRV 174
Query: 616 YMSPEY-ANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRA 674
Y PE+ + V+SLG+LL ++V G P I + + +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG------DIPFEHDEEIIRGQVFFRQRVS 228
Query: 675 LGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSV 715
+ C+ P DRP +
Sbjct: 229 SECQH------LIRW-----------CLALRPSDRPTFEEI 252
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 1e-35
Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 12/206 (5%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQH 501
N F ++GKG FG V + + +TG+ A K L K + + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
L L + D + EY L + + R ++ ++ I L YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
H V++RD+K N++LD + + KI+DFGL + D + GT Y++PE
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEV 176
Query: 622 ANDGTISMKSDVFSLGVLLVEIVSGK 647
D D + LGV++ E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 7e-35
Identities = 49/231 (21%), Positives = 99/231 (42%), Gaps = 26/231 (11%)
Query: 431 IEVPLYDLATITTATNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQG--LE 487
+E P D + + + IG+G FG V+ + TGQ++A K++ + +
Sbjct: 1 VECPFCD------EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI 54
Query: 488 EFMNEVVLIGKLQHRNLVGLLGSCIEEDERM--------LIYEYMPHKSLDYFIFDRERS 539
+ E+ ++ L+H N+V L+ C + L++++ H +
Sbjct: 55 TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK- 113
Query: 540 KLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599
+ ++ + GL Y+H++ +++HRD+KA+N+L+ + K++DFGLAR F
Sbjct: 114 --FTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 168
Query: 600 GDDEEAQTER--VAGTHGYMSPE-YANDGTISMKSDVFSLGVLLVEIVSGK 647
T Y PE + D++ G ++ E+ +
Sbjct: 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-34
Identities = 49/197 (24%), Positives = 86/197 (43%), Gaps = 10/197 (5%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSK--NSGQGLEEFMNEVVLIGKLQHRNLVGLLGS 510
IG+G +G V+ K T + +A KR+ + + E+ L+ +L+H+N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 511 CIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVI 570
+ + L++E+ YF L + S + + +GL + H V+
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHS---RNVL 123
Query: 571 HRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMK 630
HRDLK N+L++ N K+++FGLAR F G + V S
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 631 SDVFSLGVLLVEIVSGK 647
D++S G + E+ +
Sbjct: 183 IDMWSAGCIFAELANAG 199
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (329), Expect = 7e-34
Identities = 51/206 (24%), Positives = 84/206 (40%), Gaps = 15/206 (7%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQH 501
+ F +G G FG V + K +G A K L K + +E +NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
LV L S + ++ EY+ + + R I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYL 157
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
H L +I+RDLK N+L+D +++DFG A+ G + GT ++PE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEI 209
Query: 622 ANDGTISMKSDVFSLGVLLVEIVSGK 647
+ D ++LGVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 3e-32
Identities = 48/221 (21%), Positives = 93/221 (42%), Gaps = 11/221 (4%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSK--NSGQGLEEFMNEVVLIGKLQHR 502
+ + +G G +G V TG ++A K+L + S + E+ L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 503 NLVGLLGSCIEEDERMLIYE-YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
N++GLL ++ + Y+ + + + + L + ++ + +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEY 621
H +IHRDLK N+ ++ + KI DFGLAR + T V
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVI 190
Query: 622 ANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLI 662
N + D++S+G ++ E+++GK + I
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 231
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 9e-30
Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 446 NHFSEANMIGKGGFGPVYMGKL----STGQEIAAKRLSK----NSGQGLEEFMNEVVLIG 497
+F ++G G +G V++ + TG+ A K L K + E E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 498 KLQHR-NLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIAR 556
++ LV L + E + LI +Y+ L + RER + + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVL 140
Query: 557 GLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGY 616
L +LH KL +I+RD+K NILLD N + ++DFGL++ F D+ E + GT Y
Sbjct: 141 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196
Query: 617 MSPE--YANDGTISMKSDVFSLGVLLVEIVSGK 647
M+P+ D D +SLGVL+ E+++G
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-29
Identities = 54/232 (23%), Positives = 92/232 (39%), Gaps = 21/232 (9%)
Query: 440 TITTATNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSK--NSGQGLEEFMNEVVLI 496
+ T + IG G G V + +A K+LS+ + + E+VL+
Sbjct: 11 STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70
Query: 497 GKLQHRNLVGLLGSCI------EEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSI 550
+ H+N++ LL E + L+ E M + ++ +
Sbjct: 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYL 124
Query: 551 ITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERV 610
+ + G+ +LH +IHRDLK SNI++ + KI DFGLAR G
Sbjct: 125 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPY 178
Query: 611 AGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLI 662
T Y +PE D++S+G ++ E+V K+ R + N +
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 116 bits (292), Expect = 4e-29
Identities = 36/208 (17%), Positives = 84/208 (40%), Gaps = 21/208 (10%)
Query: 446 NHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-HRN 503
+ + +G+G + V+ ++ +++ K L ++ E+ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 504 LVGLLGSCIEEDERM--LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
++ L + R L++E++ + + L + I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145
Query: 562 HQDSKLQVIHRDLKASNILLDI-NLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPE 620
H + ++HRD+K N+++D + ++ D+GLA + E + + PE
Sbjct: 146 H---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPE 199
Query: 621 -YANDGTISMKSDVFSLGVLLVEIVSGK 647
+ D++SLG +L ++ K
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-27
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 11/212 (5%)
Query: 440 TITTATNHFSEANMIGKGGFGPVYMGK-LSTGQEIAAKRLSKN--SGQGLEEFMNEVVLI 496
TI + + +G G +G V TG +A K+LS+ S + E+ L+
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 497 GKLQHRNLVGLLGSCIEEDERMLI-YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIA 555
++H N++GLL Y+ + + + + + L +I I
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 556 RGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHG 615
RGL Y+H +IHRDLK SN+ ++ + KI DFGLAR + T VA
Sbjct: 132 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWY 184
Query: 616 YMSPEYANDGTISMKSDVFSLGVLLVEIVSGK 647
N + D++S+G ++ E+++G+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (280), Expect = 2e-27
Identities = 36/209 (17%), Positives = 77/209 (36%), Gaps = 18/209 (8%)
Query: 454 IGKGGFGPVYMGK-LSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCI 512
+G G F V++ K + +A K + + E +E+ L+ ++ +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 513 EEDERMLIYEYMPHKSLDYFIFDRE-------------RSKLLPWKKRFSIITGIARGLL 559
++L + + + + E + +P I + GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 560 YLHQDSKLQVIHRDLKASNILLDIN-LNPKISDFGLARIFGGDDEEAQTERVAGTHGYMS 618
Y+H+ + +IH D+K N+L++I + +A + + T Y S
Sbjct: 140 YMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 619 PEYANDGTISMKSDVFSLGVLLVEIVSGK 647
PE +D++S L+ E+++G
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.9 bits (230), Expect = 3e-22
Identities = 34/202 (16%), Positives = 66/202 (32%), Gaps = 27/202 (13%)
Query: 452 NMIGKGGFGPVYMGKLSTGQEIAAK--RLSKNSGQ--------GLEEFMNEVVLIGKLQH 501
++G+G V+ E K ++ S + G F + + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 502 RNLVGLLGSCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYL 561
R L L G + + Y + + L I +E ++ ++ I +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119
Query: 562 HQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEAQTER-VAGTHGYMSPE 620
+ ++H DL N+L+ I DF + G + ER V Y S
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT 175
Query: 621 YANDGTISMKSDVFSLGVLLVE 642
Y + D+ S +++
Sbjct: 176 Y------RTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 90.0 bits (223), Expect = 3e-22
Identities = 26/117 (22%), Positives = 52/117 (44%), Gaps = 12/117 (10%)
Query: 34 ITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFS 93
+T+GE L + QS ++ + + L ++ T VW +N K
Sbjct: 4 LTNGEGLYAG-QSLDVEPYHFIMQEDCNLVLYD---HSTSVWASNTGILG-KKGCKAVLQ 58
Query: 94 NNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDY 150
++G+ ++ + E ++W+S+S R N V L + GN+V+ + +W + Y
Sbjct: 59 SDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD-------IWSTGTY 108
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 69.7 bits (170), Expect = 4e-15
Identities = 27/125 (21%), Positives = 46/125 (36%), Gaps = 19/125 (15%)
Query: 26 DSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITD 85
+ L SG+ ++ GE L SF N L ++ P W N
Sbjct: 2 NILYSGETLSTGEFLNY--GSFVFIMQEDCN-----LVLYDVDKPI---WATNTGGL--S 49
Query: 86 KNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMW 145
++ L+ +G+L++ N IW+SN+ N V L N+V+ W
Sbjct: 50 RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD-------RW 102
Query: 146 QSFDY 150
+ +
Sbjct: 103 ATGTH 107
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 69.6 bits (170), Expect = 5e-15
Identities = 14/96 (14%), Positives = 33/96 (34%), Gaps = 8/96 (8%)
Query: 64 IWYKSSP-RTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVA 122
I Y + + + L+ + +L+L ++ +WS+N++ A
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRA 70
Query: 123 HLLDSGNLVLRDNISRSSEEYMWQSFD--YPSDTLL 156
L +G + + N +W S + +
Sbjct: 71 VLQPNGRMDVLTN----QNIAVWTSGNSRSAGRYVF 102
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 67.9 bits (165), Expect = 2e-14
Identities = 28/129 (21%), Positives = 53/129 (41%), Gaps = 17/129 (13%)
Query: 25 ADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPIT 84
+D L+SG + G +L + + N + Y VW + N +
Sbjct: 1 SDRLNSGHQLDTGGSLAEG--GYLFIIQNDCNL------VLY--DNNRAVWASGTNGKAS 50
Query: 85 DKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYM 144
VL N+G+L++ + ++ IW+SN++R N L N+V+ D +S +
Sbjct: 51 GC--VLKMQNDGNLVIYSGSRA-IWASNTNRQNGNYYLILQRDRNVVIYD----NSNNAI 103
Query: 145 WQSFDYPSD 153
W + +
Sbjct: 104 WATHTNVGN 112
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 62.3 bits (151), Expect = 2e-12
Identities = 14/112 (12%), Positives = 33/112 (29%), Gaps = 17/112 (15%)
Query: 39 TLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSL 98
++ + + N L ++ +W N +G L
Sbjct: 24 EILFGTHVYRFIMQTDCN-----LVLY---DNNNPIWATNTGGL--GNGCRAVLQPDGVL 73
Query: 99 LLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDY 150
+++ E +W S + + V L N+V+ + +W +
Sbjct: 74 VVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGDA-------LWATQTV 118
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 51.9 bits (124), Expect = 7e-09
Identities = 12/108 (11%), Positives = 29/108 (26%), Gaps = 31/108 (28%)
Query: 64 IWY-KSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQ------------------- 103
I + S + + + + T ++ +L+L +
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVL 62
Query: 104 -----------EKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSS 140
+ + WSS + ++ N V L + + S
Sbjct: 63 QSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDS 110
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 765 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.86 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.86 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.84 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.68 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.68 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.61 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.53 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.33 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.18 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.15 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.99 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.81 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.59 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.93 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.51 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.81 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.62 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.0 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 91.27 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 85.65 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 81.28 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-49 Score=406.52 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=204.8
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
++|++.++||+|+||+||+|+.. +++.||||++.... ....+++.+|+.++++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999874 68999999987543 33456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++++||+|||+|+.......
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999984 3456999999999999999999999999 99999999999999999999999999998755444
Q ss_pred ccccccccccccccCcccccCCCC-CccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTI-SMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
.......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... . ...........
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~----~~~~~~~~~~~----- 227 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--Y----SDWKEKKTYLN----- 227 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH--H----HHHHTTCTTST-----
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH--H----HHHhcCCCCCC-----
Confidence 444556789999999999988876 57899999999999999999999654432211 1 01111111100
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.......++.+|+.+||+.||++|||++|+++
T Consensus 228 ---~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 ---PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01112345678999999999999999999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=404.95 Aligned_cols=263 Identities=27% Similarity=0.401 Sum_probs=204.6
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
++|++.+.||+|+||.||+|+.+ ..||||++... .....+.|++|+.++++++|||||++++++.+ +..++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 57889999999999999999864 46999998643 45567889999999999999999999998754 568999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++|+|.+++... ...+++..++.++.||++||+|||+++ ||||||||+||||+.++.+||+|||+|+.......
T Consensus 85 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 85 CEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred CCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 9999999998533 345899999999999999999999998 99999999999999999999999999988755444
Q ss_pred ccccccccccccccCcccccC---CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYAND---GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~---~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
........||+.|+|||++.+ ..|+.++|||||||+||||+||+.||....+... .......+.....+.
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~~~~~~~p~~~- 232 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYLSPDLS- 232 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHHTSCCCCGG-
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCCCCCcch-
Confidence 444456789999999999864 3589999999999999999999999865432211 111111121111111
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCCCCC
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGVTLP 727 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~ 727 (765)
..+......+.+|+.+||+.||++|||+++|+++|+.....+|
T Consensus 233 ----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 233 ----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp ----GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ----hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 1112234568899999999999999999999999987544343
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=404.01 Aligned_cols=253 Identities=29% Similarity=0.417 Sum_probs=198.6
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecC
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
++|++.+.||+|+||.||+|++.+++.||||++.+.. ...++|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5788999999999999999999888899999997543 345789999999999999999999999999999999999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+|+|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||+++++++||+|||+++........
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence 9999998854 3356889999999999999999999999 999999999999999999999999999876433222
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCC-CCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMN-RGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
......||+.|+|||++.+..|+.++||||||+++|||+|+..| +..... ..+. .....+....
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~----~~i~~~~~~~-------- 222 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVV----EDISTGFRLY-------- 222 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHH----HHHHHTCCCC--------
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHH----HHHHhcCCCC--------
Confidence 22246789999999999999999999999999999999996544 332111 1111 1111221111
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.+.....++.+|+.+||+.||++||||++|+++|++
T Consensus 223 -~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 223 -KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 111223567899999999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=402.42 Aligned_cols=249 Identities=24% Similarity=0.393 Sum_probs=208.0
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
++|++.++||+|+||+||+|+. .+|+.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 5799999999999999999986 568999999997665556778999999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++|+|.+++.. +.+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.+....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-- 170 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--
Confidence 99999988743 35899999999999999999999999 9999999999999999999999999999874332
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
.......||+.|+|||++.+..|+.++|||||||++|||++|+.||......+ ........+.. .+
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~~~-~~------- 236 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTP-EL------- 236 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSC-CC-------
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCCCC-CC-------
Confidence 22345689999999999999999999999999999999999999996433211 11111111111 00
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
..+......+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122456789999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=399.49 Aligned_cols=245 Identities=26% Similarity=0.336 Sum_probs=205.4
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||.||+|+.+ +++.||+|++.+. .....+++.+|+.++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999975 6889999998653 2334678899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999853 345899999999999999999999999 999999999999999999999999999865322
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
......||+.|+|||++.+..++.++|||||||+||||++|+.||....+.+ ..........
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~------- 221 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEF------- 221 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC-------
T ss_pred ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC-------
Confidence 2335679999999999999999999999999999999999999996433211 1111111111
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
..+.....++.+|+.+||+.||++|||++|+++
T Consensus 222 ---~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 ---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 111122356778999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=401.30 Aligned_cols=254 Identities=30% Similarity=0.436 Sum_probs=206.2
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecC
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
++|++.+.||+|+||.||+|++++++.||||++.... ...++|.+|+.++++++|||||++++++.+ +..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 5788999999999999999999888899999997543 345789999999999999999999998754 56799999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+|+|.+++.... ...+++..++.|+.||++||.|||+.+ |+||||||+||||++++.+||+|||+|+....... .
T Consensus 91 ~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~ 165 (272)
T d1qpca_ 91 NGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T 165 (272)
T ss_dssp TCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred CCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc-c
Confidence 999998875433 235899999999999999999999998 99999999999999999999999999998754322 2
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCc
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDS 685 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 685 (765)
......||+.|+|||++.+..++.++|||||||++|||+||..|+...... . ........+.....
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~----~~~~~i~~~~~~~~-------- 231 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--P----EVIQNLERGYRMVR-------- 231 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--H----HHHHHHHTTCCCCC--------
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--H----HHHHHHHhcCCCCC--------
Confidence 233567899999999999999999999999999999999976654322111 1 11122222221111
Q ss_pred cCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 686 FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 686 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+.....++.+|+.+||+.||++||||++|+++|+.
T Consensus 232 -p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 232 -PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 11223467899999999999999999999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-48 Score=404.94 Aligned_cols=257 Identities=27% Similarity=0.384 Sum_probs=211.0
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
.++|++.++||+|+||+||+|++. +++.||||++.... ...++|.+|+.+|++++|||||++++++.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 367899999999999999999875 58889999987543 3467899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+||||++++++||+|||+++.......
T Consensus 95 ~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 9999999998643 3356899999999999999999999998 99999999999999999999999999987644322
Q ss_pred ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 604 EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
. ......|++.|+|||++.+..|+.++|||||||++|||++|..|+...... .........+...
T Consensus 171 ~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~------~~~~~~i~~~~~~-------- 235 (287)
T d1opja_ 171 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLEKDYRM-------- 235 (287)
T ss_dssp E-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHTTCCC--------
T ss_pred e-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH------HHHHHHHhcCCCC--------
Confidence 2 223456889999999999999999999999999999999987765322211 1111222222111
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
..+.....++.+|+.+||+.||++|||+++|++.|+..
T Consensus 236 -~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 236 -ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred -CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11222345688999999999999999999999999763
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-47 Score=404.29 Aligned_cols=255 Identities=28% Similarity=0.389 Sum_probs=197.4
Q ss_pred cCcccccccccCCceeEEEEEeCC-C---cEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLST-G---QEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
++|++.++||+|+||+||+|++.. + ..||||++... .....++|.+|+.+|++++|||||++++++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 567888999999999999998642 2 25889988654 445567899999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||+++|+|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+||||+.++++||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998753 2346899999999999999999999998 99999999999999999999999999997754
Q ss_pred CCcccc---cccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 601 DDEEAQ---TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 601 ~~~~~~---~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
...... .....+|+.|+|||.+.+..++.++|||||||+||||+| |+.||......+ + ......+...
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~----~~~i~~~~~~- 252 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---V----INAIEQDYRL- 252 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H----HHHHHTTCCC-
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCCC-
Confidence 322221 223457899999999999999999999999999999998 899986443221 1 1111122111
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..+......+.+|+.+||+.||++||||.+|++.|++
T Consensus 253 --------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 253 --------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1122234568899999999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=400.33 Aligned_cols=251 Identities=25% Similarity=0.352 Sum_probs=207.1
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
+.|++.+.||+|+||.||+|+. .+++.||+|++.+......+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4689999999999999999986 468899999998776667788999999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++|+|.+++... .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+|+..... .
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~ 164 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--I 164 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--H
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--c
Confidence 999999987532 346999999999999999999999999 999999999999999999999999999865321 1
Q ss_pred cccccccccccccCccccc-----CCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 605 AQTERVAGTHGYMSPEYAN-----DGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~-----~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
.......||+.|+|||++. +..|+.++|||||||++|||++|+.||....+.+. ... .. .+....+
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~~~---i~-~~~~~~~-- 235 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---LLK---IA-KSEPPTL-- 235 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHH---HH-HSCCCCC--
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---HHH---HH-cCCCCCC--
Confidence 2233578999999999984 45689999999999999999999999975443321 111 11 1111111
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
..+.....++.+|+.+||+.||++|||++|+++
T Consensus 236 -----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 -----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111123456789999999999999999999976
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=397.81 Aligned_cols=254 Identities=25% Similarity=0.305 Sum_probs=196.1
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeee--cCceEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE--EDERMLI 520 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~--~~~~~lV 520 (765)
++|++.+.||+|+||.||+|+. .+|+.||+|++... .....+.+.+|+.++++++|||||++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6799999999999999999986 46889999998754 34456778999999999999999999999875 4567899
Q ss_pred EEecCCCChhHHhhcc-ccCCCCChHHHHHHHHHHHHHHHHhhhcC--CCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 521 YEYMPHKSLDYFIFDR-ERSKLLPWKKRFSIITGIARGLLYLHQDS--KLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
|||+++|+|.+++... .....+++..++.++.||+.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998643 33457999999999999999999999875 23599999999999999999999999999998
Q ss_pred eCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 598 FGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 598 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
+.... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||......+ .......+....+
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-------~~~~i~~~~~~~~ 234 (269)
T d2java1 164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFRRI 234 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCCCC
T ss_pred cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCCCCC
Confidence 64322 22335789999999999999999999999999999999999999986433211 1112222222221
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
. .....++.+|+.+||+.||++|||++||++
T Consensus 235 ~---------~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 P---------YRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp C---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C---------cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1 122346789999999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=392.24 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=211.5
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecC
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
++|++.++||+|+||+||+|+.++++.||||++++.. ...++|++|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5789999999999999999999888899999997643 345789999999999999999999999999999999999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+|+|..++... ...+++..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 99999887543 345889999999999999999999998 999999999999999999999999999876543322
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......+ .......+.....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-------~~~~i~~~~~~~~------- 222 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGLRLYR------- 222 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTCCCCC-------
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-------HHHHHHhCCCCCC-------
Confidence 2334678999999999999999999999999999999998 898986544321 1112222221111
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+......+.+++.+||+.||++|||+++|++.|..
T Consensus 223 --p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 223 --PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp --CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred --cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 11223567899999999999999999999999854
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=407.23 Aligned_cols=257 Identities=26% Similarity=0.373 Sum_probs=207.8
Q ss_pred cCcccccccccCCceeEEEEEeCC-C-----cEEEEEEcccc-ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCce
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLST-G-----QEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDER 517 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~-~-----~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~ 517 (765)
++|++.++||+|+||+||+|+... + ..||+|++... .......+.+|+.+|.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578999999999999999998642 2 36899988654 334456789999999998 899999999999999999
Q ss_pred EEEEEecCCCChhHHhhcccc--------------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCC
Q 004264 518 MLIYEYMPHKSLDYFIFDRER--------------------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKAS 577 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~ 577 (765)
++||||+++|+|.+++..... ...+++..++.++.||++||+|||+++ |+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 999999999999999965421 235899999999999999999999998 999999999
Q ss_pred cEEEecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCC
Q 004264 578 NILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPG 656 (765)
Q Consensus 578 NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~ 656 (765)
|||++.++++||+|||+|+...............||+.|+|||++.+..++.++|||||||+||||++ |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987755444444446778999999999999999999999999999999998 89998654432
Q ss_pred CcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 004264 657 HRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLA 720 (765)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 720 (765)
.. .......+... ..+.....++.+|+.+||+.||++|||++||+++|.
T Consensus 274 ~~------~~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 AN------FYKLIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HH------HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH------HHHHHhcCCCC---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 21 11112222111 112223456889999999999999999999999995
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=400.82 Aligned_cols=248 Identities=22% Similarity=0.307 Sum_probs=203.1
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||+||+|+. .+++.||||++.+. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 6799999999999999999986 46899999998753 2334578999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++|+|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999988743 346999999999999999999999999 999999999999999999999999999987654
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
..........||+.|+|||++.+..|+.++|||||||++|||++|+.||....+.. + ......+.. .
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~----~~~i~~~~~-~----- 228 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---I----FQKIIKLEY-D----- 228 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHHTTCC-C-----
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---H----HHHHHcCCC-C-----
Confidence 44444456789999999999999999999999999999999999999997533211 1 111111111 1
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVV 716 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 716 (765)
++.....++.+|+.+||+.||++|||++|++
T Consensus 229 ----~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 229 ----FPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp ----CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred ----CCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 1112234578999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-47 Score=396.41 Aligned_cols=265 Identities=27% Similarity=0.380 Sum_probs=206.4
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecC
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMP 525 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 525 (765)
++|++.+.||+|+||.||+|++++++.||||++... ....+.|.+|+.++++++|||||++++++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 579999999999999999999988889999999654 3345789999999999999999999999854 56789999999
Q ss_pred CCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc
Q 004264 526 HKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA 605 (765)
Q Consensus 526 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~ 605 (765)
+|+|..++.... .+.+++..++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++....... .
T Consensus 95 ~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~ 169 (285)
T d1fmka3 95 KGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 169 (285)
T ss_dssp TCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence 999988885432 345899999999999999999999999 99999999999999999999999999987643322 2
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccCc
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLEDS 685 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 685 (765)
......||+.|+|||++.++.++.++||||||+++|||++|..|+...... .. .......+....
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~----~~~~i~~~~~~~--------- 234 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--RE----VLDQVERGYRMP--------- 234 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HH----HHHHHHTTCCCC---------
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HH----HHHHHHhcCCCC---------
Confidence 223467899999999999999999999999999999999977665432211 11 111111221111
Q ss_pred cCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 004264 686 FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGVTLPQPRQP 732 (765)
Q Consensus 686 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~p 732 (765)
.+.....++.+++.+||+.||++||+|++|+++|+..-...+.+..|
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p 281 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence 12223456889999999999999999999999998854434433333
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=394.21 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=207.3
Q ss_pred cCcccccc-cccCCceeEEEEEeC---CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 446 NHFSEANM-IGKGGFGPVYMGKLS---TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 446 ~~y~~~~~-LG~G~fg~Vy~~~~~---~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
++|.+.+. ||+|+||.||+|.+. ++..||||++... .....++|.+|+.+|++++|||||++++++.. +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 46777774 999999999999753 3457999999754 34456789999999999999999999999864 568999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||+++|+|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999998743 3346999999999999999999999998 99999999999999999999999999998754
Q ss_pred CCcc-cccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 601 DDEE-AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 601 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
.... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ .......+.....+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-------~~~~i~~~~~~~~p 234 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRMECP 234 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCCCCC
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCCCC
Confidence 4332 22334678999999999999999999999999999999998 899987543321 12222333322222
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.....++.+|+.+||+.+|++|||+.+|++.|+.
T Consensus 235 ---------~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 235 ---------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 2223567899999999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=404.43 Aligned_cols=263 Identities=23% Similarity=0.330 Sum_probs=204.2
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
.++|++.++||+|+||+||+|+. .+++.||+|++... .....+++.+|+.+|++++|||||+++++|.+.++.++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 57899999999999999999996 46889999998754 33445789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhc-CCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD-SKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
|+++|+|.+++... +.+++..+..++.||+.||.|||++ + |+||||||+|||++.++++||+|||+|+.+..
T Consensus 85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 99999999998543 4589999999999999999999974 7 99999999999999999999999999987532
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHH-HH--------Hhhc--
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGH-AW--------LLWN-- 670 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~-~~--------~~~~-- 670 (765)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.............. .. ....
T Consensus 158 ---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp ---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred ---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 223357899999999999999999999999999999999999999975433211000000 00 0000
Q ss_pred ------------cCCcccccccccc----CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 671 ------------DGRALGLMDTCLE----DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 671 ------------~~~~~~l~d~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.....+..+.... .........++.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000000000000 0000112346788999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=394.54 Aligned_cols=257 Identities=28% Similarity=0.425 Sum_probs=200.2
Q ss_pred cCcccccccccCCceeEEEEEeCCC-----cEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTG-----QEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~-----~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
+.|++.++||+|+||.||+|.++.. ..||||++... ......+|.+|+.++++++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 5688899999999999999986532 36999998754 34445679999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
||||+.++++.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999887743 3356899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCccc-ccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 600 GDDEEA-QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 600 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
...... ......||+.|+|||++.++.++.++||||||+++|||++|..|+...... ........++....
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~------~~~~~~i~~~~~~~-- 233 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVMKAINDGFRLP-- 233 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTCCCC--
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH------HHHHHHHhccCCCC--
Confidence 432222 223456899999999999999999999999999999999976665332211 11122222222211
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
.+.....++.+|+.+||+.+|++||||.+|+++|++.
T Consensus 234 -------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 234 -------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp -------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 1222345688999999999999999999999999763
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=392.37 Aligned_cols=247 Identities=26% Similarity=0.382 Sum_probs=198.8
Q ss_pred cccccCCceeEEEEEeC---CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEecCC
Q 004264 452 NMIGKGGFGPVYMGKLS---TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYMPH 526 (765)
Q Consensus 452 ~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~~~ 526 (765)
++||+|+||.||+|.+. .++.||||++... .....++|.+|+.+|++++|||||+++++|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999854 3467999999653 33345789999999999999999999999854 567899999999
Q ss_pred CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCccc-
Q 004264 527 KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEEA- 605 (765)
Q Consensus 527 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~~- 605 (765)
|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999853 345999999999999999999999998 9999999999999999999999999999875433322
Q ss_pred ccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccccccccC
Q 004264 606 QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLED 684 (765)
Q Consensus 606 ~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 684 (765)
......||+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ........+......
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-------~~~~~i~~~~~~~~p------ 232 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERMGCP------ 232 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCCCC------
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-------HHHHHHHcCCCCCCC------
Confidence 2334678999999999999999999999999999999998 89998653321 112222233322221
Q ss_pred ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 685 SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.....++.+|+.+||+.||++|||+++|+++|+.
T Consensus 233 ---~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 233 ---AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp ---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 1223567899999999999999999999998864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.1e-46 Score=400.68 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=209.1
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
-++|++.+.||+|+||.||+|+. .+|+.||||++.+......+.+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 36899999999999999999986 46899999999877767778899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec--CCCCeecccccceeeCCC
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI--NLNPKISDFGLARIFGGD 601 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~vkL~DFGla~~~~~~ 601 (765)
+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999988432 346999999999999999999999999 999999999999964 578999999999986433
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .... ....... ..
T Consensus 180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~----i~~~~~~-~~--- 245 (350)
T d1koaa2 180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLRN----VKSCDWN-MD--- 245 (350)
T ss_dssp S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH----HHHTCCC-SC---
T ss_pred c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH---HHHH----HHhCCCC-CC---
Confidence 2 2335689999999999999999999999999999999999999996443221 1111 1111110 00
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
..........+.+|+.+||+.||++|||++|+++.
T Consensus 246 --~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 --DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111123467889999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=386.95 Aligned_cols=246 Identities=24% Similarity=0.346 Sum_probs=196.0
Q ss_pred ccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeee----cCceEEEE
Q 004264 449 SEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE----EDERMLIY 521 (765)
Q Consensus 449 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~----~~~~~lV~ 521 (765)
+..++||+|+||+||+|++. +++.||+|++... .....+.+.+|+++|++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55678999999999999865 6789999998653 34456789999999999999999999999875 34578999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEe-cCCCCeecccccceeeCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD-INLNPKISDFGLARIFGG 600 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~vkL~DFGla~~~~~ 600 (765)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ .+|+||||||+|||++ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999853 346899999999999999999999875 3499999999999996 578999999999986432
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
.......||+.|+|||++.+ .++.++|||||||++|||++|+.||...... .........+.....
T Consensus 168 ----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~~~~~~--- 233 (270)
T d1t4ha_ 168 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPAS--- 233 (270)
T ss_dssp ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGG---
T ss_pred ----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcCCCCcc---
Confidence 22335689999999999875 5999999999999999999999998633221 111122222211111
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.+.....++.+|+.+||+.||++|||++|+++
T Consensus 234 -----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 -----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11112345778999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.5e-45 Score=396.54 Aligned_cols=255 Identities=21% Similarity=0.256 Sum_probs=210.0
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
++|++.+.||+|+||.||+|+. .+++.||||++.+......+.+.+|+.+|++++|||||++++++.+++..+|||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999986 478999999998776666778899999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEe--cCCCCeecccccceeeCCCC
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD--INLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~vkL~DFGla~~~~~~~ 602 (765)
++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+ .++++||+|||+|+.+....
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999887743 3346999999999999999999999999 99999999999998 57899999999999875332
Q ss_pred cccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ... ....+... .
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~----~i~~~~~~-~----- 247 (352)
T d1koba_ 184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQ----NVKRCDWE-F----- 247 (352)
T ss_dssp ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHH----HHHHCCCC-C-----
T ss_pred ---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHhCCCC-C-----
Confidence 2335678999999999999999999999999999999999999996433221 111 11111110 0
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhc
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL--LAN 721 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~ 721 (765)
..........++.+|+.+||+.||++|||++|+++. +++
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 011111223457799999999999999999999874 544
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-46 Score=393.84 Aligned_cols=252 Identities=21% Similarity=0.266 Sum_probs=190.4
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
.+.|++.+.||+|+||+||+|+.. +++.||||++.+.. ......+.+|+.+|++++||||+++++++.+++..+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999864 68899999997543 2334568899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEe---cCCCCeecccccceeeC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD---INLNPKISDFGLARIFG 599 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~vkL~DFGla~~~~ 599 (765)
|+++|+|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999853 346999999999999999999999999 99999999999994 57899999999998753
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
.. ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||....... . ......+... ..
T Consensus 162 ~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~----~~~i~~~~~~-~~- 229 (307)
T d1a06a_ 162 PG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---L----FEQILKAEYE-FD- 229 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H----HHHHHTTCCC-CC-
T ss_pred CC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---H----HHHHhccCCC-CC-
Confidence 22 22335689999999999999999999999999999999999999996433211 1 1111111110 00
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.........++.+|+.+||+.||++|||++|+++.
T Consensus 230 ----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 230 ----SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ----CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01111223567899999999999999999999984
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.2e-46 Score=391.45 Aligned_cols=259 Identities=28% Similarity=0.395 Sum_probs=210.9
Q ss_pred hcCcccccccccCCceeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHhccccCceEeeeeeeeecCce
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS------TGQEIAAKRLSKNS-GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDER 517 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~ 517 (765)
.++|++.+.||+|+||+||+|+.+ +++.||||++.... .+..++|.+|+.+|++++||||+++++++.+.+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 467999999999999999999853 35789999997643 34467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhccc---------------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCC
Q 004264 518 MLIYEYMPHKSLDYFIFDRE---------------------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKA 576 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp 576 (765)
++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ ||||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence 99999999999999986422 1234889999999999999999999999 99999999
Q ss_pred CcEEEecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCC-CCCCCCC
Q 004264 577 SNILLDINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKM-NRGFRHP 655 (765)
Q Consensus 577 ~NIll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~-p~~~~~~ 655 (765)
+||||+.++.+||+|||+++...............+++.|+|||.+.+..|+.++|||||||++|||++|.. ||....+
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 999999999999999999987654444444445778999999999999999999999999999999999964 5544322
Q ss_pred CCcccHHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 656 GHRHNLIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
.+ ......++......+ ....++.+|+.+||+.+|++||||.||+++|++.
T Consensus 249 ~e-------~~~~v~~~~~~~~p~---------~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 249 EE-------VIYYVRDGNILACPE---------NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp HH-------HHHHHHTTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HH-------HHHHHHcCCCCCCCc---------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 21 112233333322221 2234688999999999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-46 Score=394.21 Aligned_cols=245 Identities=29% Similarity=0.410 Sum_probs=201.0
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
+.|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4599999999999999999986 468889999987543 334567899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+.+|+|..++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 99999999766632 356999999999999999999999999 99999999999999999999999999986532
Q ss_pred CcccccccccccccccCcccccC---CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYAND---GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||...... ....... .+....+.
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~-~~~~~~~~ 235 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIA-QNESPALQ 235 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH-HSCCCCCS
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-hCCCCCCC
Confidence 234679999999999864 46899999999999999999999998643221 1111111 11111111
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
. ......+.+|+.+||+.||++|||++|+++
T Consensus 236 ~--------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 S--------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp C--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C--------CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 112346789999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=386.75 Aligned_cols=251 Identities=24% Similarity=0.304 Sum_probs=205.2
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC------hhhHHHHHHHHHHHhccccCceEeeeeeeeecCce
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS------GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDER 517 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~------~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~ 517 (765)
.++|++.+.||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999996 578999999986532 22467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC----CCeecccc
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL----NPKISDFG 593 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~vkL~DFG 593 (765)
+|||||+++|+|.+++... +.+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999998543 46999999999999999999999999 99999999999998776 59999999
Q ss_pred cceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC
Q 004264 594 LARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR 673 (765)
Q Consensus 594 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 673 (765)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ . ......+.
T Consensus 163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~----~~~i~~~~ 232 (293)
T d1jksa_ 163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---T----LANVSAVN 232 (293)
T ss_dssp TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHHTTC
T ss_pred hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---H----HHHHHhcC
Confidence 998864322 2334678999999999999999999999999999999999999996533221 1 11111111
Q ss_pred ccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 674 ALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 674 ~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.. .. ..........+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~-~~-----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 YE-FE-----DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CC-CC-----HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC-CC-----chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10 00 0011112346778999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=391.97 Aligned_cols=254 Identities=24% Similarity=0.407 Sum_probs=201.0
Q ss_pred cCcccccccccCCceeEEEEEeC-CCc----EEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQ----EIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERML 519 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~l 519 (765)
++|++.++||+|+||+||+|++. +|+ .||+|++... ..+..++|.+|+.++++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999864 343 5889988653 445678899999999999999999999999865 5678
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeC
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFG 599 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~ 599 (765)
++||+.+++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999888754 3456899999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccccc
Q 004264 600 GDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLM 678 (765)
Q Consensus 600 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 678 (765)
............||+.|+|||.+.++.|+.++||||||+++|||+| |+.||......+. . .....+...
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~---~----~~i~~~~~~--- 232 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---S----SILEKGERL--- 232 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH---H----HHHHHTCCC---
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH---H----HHHHcCCCC---
Confidence 5444444445678999999999999999999999999999999998 7888865443321 1 111122211
Q ss_pred cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 679 DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 679 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
..+......+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 233 ------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 233 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp ------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 1112233567899999999999999999999988765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-45 Score=385.15 Aligned_cols=259 Identities=28% Similarity=0.376 Sum_probs=200.7
Q ss_pred hcCcccccccccCCceeEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeec-C
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS------TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEE-D 515 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~-~ 515 (765)
.++|++.++||+|+||.||+|+.. .++.||||++... .....+++.+|+.++.++ +|+||+++++++.+. .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 368999999999999999999853 3468999999754 344566788888888887 689999999988765 4
Q ss_pred ceEEEEEecCCCChhHHhhcccc-------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEe
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRER-------------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD 582 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 582 (765)
..++||||+++|+|.+++..... ...+++..++.++.||++||+|||+++ |+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 68999999999999999965422 245889999999999999999999999 99999999999999
Q ss_pred cCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCC-CCCCCCCCCCcccH
Q 004264 583 INLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK-MNRGFRHPGHRHNL 661 (765)
Q Consensus 583 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~-~p~~~~~~~~~~~~ 661 (765)
+++++||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++|. .||.......
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~---- 244 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---- 244 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH----
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH----
Confidence 99999999999999876555555555678999999999999999999999999999999999975 4664332221
Q ss_pred HHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 662 IGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 662 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.......++......+ ....++.+++.+||+.||++|||++||+++|++
T Consensus 245 --~~~~~~~~~~~~~~~~---------~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 245 --EFCRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp --HHHHHHHHTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHHHHHhcCCCCCCCc---------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1112222232222221 223457899999999999999999999999975
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-45 Score=389.34 Aligned_cols=248 Identities=25% Similarity=0.325 Sum_probs=206.7
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
-++|++.+.||+|+||.||+|+. .+++.||+|++.+. .....+++.+|+.+|++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36799999999999999999986 57899999999754 233567889999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999998854 345899999999999999999999999 99999999999999999999999999987543
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
.. ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||....... + ......+.. .
T Consensus 158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~----~~~i~~~~~-~---- 223 (337)
T d1o6la_ 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---L----FELILMEEI-R---- 223 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHHHCCC-C----
T ss_pred CC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---H----HHHHhcCCC-C----
Confidence 22 23345789999999999999999999999999999999999999987543221 1 111111111 1
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPD-----MSSVVF 717 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 717 (765)
++.....++.+|+.+||+.||++||+ ++++++
T Consensus 224 -----~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 -----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 11122345778999999999999995 788875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=381.58 Aligned_cols=253 Identities=24% Similarity=0.322 Sum_probs=195.7
Q ss_pred cCcccccccccCCceeEEEEEeCC----CcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLST----GQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV 520 (765)
++|++.+.||+|+||.||+|++.. +..||||++... .....+.+.+|+.++++++||||+++++++. .+..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 579999999999999999998643 346889988654 3444677999999999999999999999986 4678999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||+++|+|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 86 ~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999988743 3346899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMD 679 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 679 (765)
... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||....+.+ +.. ....+....+
T Consensus 161 ~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~----~i~~~~~~~~-- 230 (273)
T d1mp8a_ 161 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG----RIENGERLPM-- 230 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCCCCC--
T ss_pred Ccc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHH----HHHcCCCCCC--
Confidence 322 22335678999999999999999999999999999999998 888886554432 111 1122222211
Q ss_pred ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 680 TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 680 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+......+.+|+.+||+.||++|||+++|++.|+.
T Consensus 231 -------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 231 -------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11223568899999999999999999999998865
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=379.62 Aligned_cols=248 Identities=27% Similarity=0.391 Sum_probs=197.3
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeec-CceEEEEEec
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE-DERMLIYEYM 524 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~-~~~~lV~E~~ 524 (765)
++|++.+.||+|+||.||+|++ .++.||||++++.. ..+++.+|++++++++||||+++++++.+. +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 5688889999999999999998 47889999997543 347899999999999999999999998754 5689999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++|+|.+++.... ...+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 9999999986432 235899999999999999999999998 999999999999999999999999999865322
Q ss_pred cccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCcccccccccc
Q 004264 605 AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCLE 683 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 683 (765)
.....++..|+|||++.+..+++++||||||+++|||+| |+.|+......+ +.. ....+....+
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~----~i~~~~~~~~------ 221 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP----RVEKGYKMDA------ 221 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHH----HHTTTCCCCC------
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCCCCCC------
Confidence 224567889999999999999999999999999999998 677765433222 111 1122222222
Q ss_pred CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 684 DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+.....++.+|+.+||+.||++|||+.+|+++|++
T Consensus 222 ---~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 222 ---PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 22223567899999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-44 Score=384.56 Aligned_cols=244 Identities=23% Similarity=0.286 Sum_probs=203.9
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||+||+|+. .+|+.||||++.+. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999996 46899999998753 2334678999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+++++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999888843 345788999999999999999999999 999999999999999999999999999986432
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
.....||+.|+|||++.+..|+.++|||||||++|||++|+.||......+ .. .....+..
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~----~~i~~~~~------- 218 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TY----EKILNAEL------- 218 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH----HHHHHCCC-------
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH---HH----HHHHcCCC-------
Confidence 235789999999999999999999999999999999999999996533221 11 11111111
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRP-----DMSSVVF 717 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 717 (765)
..+.....++.+++.+||+.||++|| |++++++
T Consensus 219 ---~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11111234577899999999999996 8999985
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=381.31 Aligned_cols=255 Identities=27% Similarity=0.355 Sum_probs=196.9
Q ss_pred cCcccccccccCCceeEEEEEeC--CC--cEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS--TG--QEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~--~~--~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~ 518 (765)
++|++.+.||+|+||.||+|+.. ++ ..||||++.+. .....++|.+|+.+|++++||||+++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 57999999999999999999853 22 36899998754 34456789999999999999999999999975 4678
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
+||||++++++.+++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999998887543 345999999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCcccc-cccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHhhccCCccc
Q 004264 599 GGDDEEAQ-TERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHNLIGHAWLLWNDGRALG 676 (765)
Q Consensus 599 ~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (765)
........ .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ........+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~------~~~~i~~~~~~~~ 235 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEGERLP 235 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSCCCCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH------HHHHHHhCCCCCC
Confidence 55443332 334567889999999999999999999999999999998 899986433221 1112222222111
Q ss_pred cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 677 LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 677 l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.. ......+.+|+.+||+.||++|||+++|+++|++
T Consensus 236 ~~---------~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 236 RP---------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Cc---------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11 1123457899999999999999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-44 Score=378.02 Aligned_cols=259 Identities=24% Similarity=0.349 Sum_probs=201.5
Q ss_pred HhcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHhccccCceEeeeeeeeecCc---
Q 004264 444 ATNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS---GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDE--- 516 (765)
Q Consensus 444 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~--- 516 (765)
..++|++.+.||+|+||.||+|+. .+++.||||++.+.. ....+.+.+|+.++++++||||+++++++...+.
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 357899999999999999999986 578999999997542 3445679999999999999999999999987653
Q ss_pred -eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccc
Q 004264 517 -RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA 595 (765)
Q Consensus 517 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla 595 (765)
.+|||||+++++|.+++.. .+.+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||.+
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred eEEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence 7899999999999988743 345899999999999999999999999 999999999999999999999999999
Q ss_pred eeeCCCCc-ccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCc
Q 004264 596 RIFGGDDE-EAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRA 674 (765)
Q Consensus 596 ~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (765)
+....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....+. ............
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCC
Confidence 87643322 22334578999999999999999999999999999999999999999643321 111112212111
Q ss_pred cccccccccCccCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhc
Q 004264 675 LGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRP-DMSSVVFLLAN 721 (765)
Q Consensus 675 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~ 721 (765)
. ... ........+.+++.+||+.||++|| |++++++.|.+
T Consensus 233 ~---~~~----~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 233 P---PSA----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp C---GGG----TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred C---Cch----hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 1 001 1111235678999999999999999 89999988864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-45 Score=383.93 Aligned_cols=259 Identities=27% Similarity=0.388 Sum_probs=209.6
Q ss_pred hcCcccccccccCCceeEEEEEeCC--------CcEEEEEEccccC-hhhHHHHHHHHHHHhcc-ccCceEeeeeeeeec
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLST--------GQEIAAKRLSKNS-GQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEE 514 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~ 514 (765)
.++|++.+.||+|+||.||+|+... +..||||++.+.. .....++.+|+.++.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3689999999999999999997532 2479999997654 34567889999999888 799999999999999
Q ss_pred CceEEEEEecCCCChhHHhhcccc-------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEE
Q 004264 515 DERMLIYEYMPHKSLDYFIFDRER-------------SKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILL 581 (765)
Q Consensus 515 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll 581 (765)
...++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999965432 245899999999999999999999999 9999999999999
Q ss_pred ecCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 004264 582 DINLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVS-GKMNRGFRHPGHRHN 660 (765)
Q Consensus 582 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~ellt-G~~p~~~~~~~~~~~ 660 (765)
+.++.+||+|||+++...............+++.|+|||.+.++.|+.++||||||+++|||++ |+.||......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---- 244 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 244 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH----
Confidence 9999999999999998765555555556789999999999999999999999999999999998 67787543321
Q ss_pred HHHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 661 LIGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 661 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
........+...... .....++.+|+.+||+.||++|||+.||+++|++.
T Consensus 245 ---~~~~~i~~~~~~~~p---------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 245 ---ELFKLLKEGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ---HHHHHHHTTCCCCCC---------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHcCCCCCCC---------ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 122233333322221 12234688999999999999999999999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-45 Score=385.44 Aligned_cols=258 Identities=27% Similarity=0.362 Sum_probs=211.0
Q ss_pred cCcccccccccCCceeEEEEEe------CCCcEEEEEEcccc-ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCce
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL------STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDER 517 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~ 517 (765)
++|++.++||+|+||.||+|++ ..++.||||++... ......++.+|+.+++++ +|||||++++++.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 6788999999999999999975 34568999999764 344556799999999999 699999999999999999
Q ss_pred EEEEEecCCCChhHHhhccc---------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEe
Q 004264 518 MLIYEYMPHKSLDYFIFDRE---------------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD 582 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 582 (765)
++||||+++|+|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence 99999999999999986532 2235889999999999999999999999 99999999999999
Q ss_pred cCCCCeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhC-CCCCCCCCCCCcccH
Q 004264 583 INLNPKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSG-KMNRGFRHPGHRHNL 661 (765)
Q Consensus 583 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG-~~p~~~~~~~~~~~~ 661 (765)
.++.+||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||+++ ++|+........
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~--- 256 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH---
Confidence 9999999999999987655555555567899999999999999999999999999999999995 444433322211
Q ss_pred HHHHHHhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 662 IGHAWLLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 662 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
.......+... ..+......+.+|+.+||+.||++||||++|+++|++
T Consensus 257 ---~~~~i~~~~~~---------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 257 ---FYKMIKEGFRM---------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp ---HHHHHHHTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HHHHHhcCCCC---------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11111122111 1112234568899999999999999999999999975
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.2e-44 Score=384.47 Aligned_cols=244 Identities=23% Similarity=0.253 Sum_probs=204.3
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN---SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~ 521 (765)
++|++.+.||+|+||.||+|+. .+|+.||||++.+. .....+.+.+|+.+|++++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5899999999999999999986 46899999998653 2334577899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGD 601 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~ 601 (765)
||+.+|+|..++... +.+++..+..++.||+.||.|||+.+ ||||||||+|||++.++++||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999888543 35899999999999999999999999 999999999999999999999999999986432
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....+. .... ....+..
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~----~i~~~~~------- 255 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYE----KIVSGKV------- 255 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCC-------
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH---HHHH----HHhcCCC-------
Confidence 23568999999999999999999999999999999999999999643321 1111 1111111
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRP-----DMSSVVF 717 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 717 (765)
..+.....++.+++.+||+.||.+|+ |+++|++
T Consensus 256 ---~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 01112234577999999999999994 8999985
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.6e-44 Score=373.15 Aligned_cols=251 Identities=21% Similarity=0.273 Sum_probs=204.3
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC---------hhhHHHHHHHHHHHhccc-cCceEeeeeeeeec
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS---------GQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEE 514 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---------~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~ 514 (765)
++|++.+.||+|+||+||+|+. .+++.||||++.+.. ....+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999986 578899999987542 112346889999999997 99999999999999
Q ss_pred CceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccc
Q 004264 515 DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGL 594 (765)
Q Consensus 515 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGl 594 (765)
+..+|||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999954 346999999999999999999999999 99999999999999999999999999
Q ss_pred ceeeCCCCcccccccccccccccCcccccC------CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHh
Q 004264 595 ARIFGGDDEEAQTERVAGTHGYMSPEYAND------GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLL 668 (765)
Q Consensus 595 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~ 668 (765)
++...... ......||..|+|||++.+ ..++.++||||+||++|||++|+.||....+.+ ....
T Consensus 157 a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~~~~ 226 (277)
T d1phka_ 157 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRM 226 (277)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHH
T ss_pred eeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-------HHHH
Confidence 99875422 2235689999999999853 457899999999999999999999997543221 1111
Q ss_pred hccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 669 WNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 669 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...+... .. .........++.+++.+||+.+|++|||++||++.
T Consensus 227 i~~~~~~-~~-----~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 227 IMSGNYQ-FG-----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHTCCC-CC-----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhCCCC-CC-----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111111 01 11111233568899999999999999999999763
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=378.96 Aligned_cols=263 Identities=22% Similarity=0.253 Sum_probs=197.3
Q ss_pred ccccccCCceeEEEEEeC-CCcEEEEEEccccChh-----hHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEec
Q 004264 451 ANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQ-----GLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEYM 524 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~~ 524 (765)
.++||+|+||+||+|+.. +++.||||++...... ..+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999964 6899999998654221 1346889999999999999999999999999999999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
.++++..+. .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 998877665 33456899999999999999999999999 99999999999999999999999999987643322
Q ss_pred cccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccc---cccc
Q 004264 605 AQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALG---LMDT 680 (765)
Q Consensus 605 ~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---l~d~ 680 (765)
......||+.|+|||++.+. .|+.++|||||||++|||++|+.||....+.+....+.............. ....
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence 22346799999999998754 689999999999999999999999865443222111111100000000000 0000
Q ss_pred c---ccCccC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhc
Q 004264 681 C---LEDSFV-----ESQVLRCIQVGLLCVQKLPEDRPDMSSVVF--LLAN 721 (765)
Q Consensus 681 ~---l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 721 (765)
. .....+ ......+.+|+.+||+.||++|||++|+++ .+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 0 000011 112356889999999999999999999997 3654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-44 Score=379.09 Aligned_cols=260 Identities=25% Similarity=0.336 Sum_probs=212.8
Q ss_pred cCcccccccccCCceeEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS------TGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~ 518 (765)
++|++.++||+|+||.||+|.+. +++.||||++++. .......|.+|+.++++++||||+++++++...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 67889999999999999999863 3578999999754 4445567899999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhccc-------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecc
Q 004264 519 LIYEYMPHKSLDYFIFDRE-------RSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISD 591 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~D 591 (765)
+||||+++|+|.+++.... ....+++..+..++.||++||.|||+++ |+||||||+|||++.++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 9999999999999886431 2235788999999999999999999998 99999999999999999999999
Q ss_pred cccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCC-CCCCCCCCCCcccHHHHHHHhhc
Q 004264 592 FGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGK-MNRGFRHPGHRHNLIGHAWLLWN 670 (765)
Q Consensus 592 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~-~p~~~~~~~~~~~~~~~~~~~~~ 670 (765)
||+++.+.............+|+.|+|||.+.+..++.++||||||+++|||++|. .|+...... + ......
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------~-~~~~i~ 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------Q-VLRFVM 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------H-HHHHHH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHH
Confidence 99998775544444455567899999999999999999999999999999999985 555432211 1 112222
Q ss_pred cCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCC
Q 004264 671 DGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLANDGV 724 (765)
Q Consensus 671 ~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 724 (765)
.+......+ .....+.+|+.+||+.+|++||||++|+++|++..+
T Consensus 250 ~~~~~~~p~---------~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 EGGLLDKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred hCCCCCCcc---------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 333222221 223468899999999999999999999999987533
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=383.37 Aligned_cols=255 Identities=29% Similarity=0.383 Sum_probs=202.3
Q ss_pred cCcccccccccCCceeEEEEEeCC-Cc--EEEEEEcccc-ChhhHHHHHHHHHHHhcc-ccCceEeeeeeeeecCceEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLST-GQ--EIAAKRLSKN-SGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~~~~~~lV 520 (765)
++|++.++||+|+||.||+|++.+ +. .||||++... .....+.+.+|+++|+++ +|||||++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678889999999999999998753 33 4778887543 344567899999999998 799999999999999999999
Q ss_pred EEecCCCChhHHhhcc-------------ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCC
Q 004264 521 YEYMPHKSLDYFIFDR-------------ERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNP 587 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~v 587 (765)
|||+++|+|.++++.. .....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998643 23457999999999999999999999998 9999999999999999999
Q ss_pred eecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCC-CCCCCCCCCcccHHHHHH
Q 004264 588 KISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKM-NRGFRHPGHRHNLIGHAW 666 (765)
Q Consensus 588 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~-p~~~~~~~~~~~~~~~~~ 666 (765)
||+|||+++.... ........||..|+|||.+.+..++.++||||||+++|||++|.. ||......+ ..
T Consensus 167 kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-------~~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LY 236 (309)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HH
T ss_pred EEccccccccccc---cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-------HH
Confidence 9999999986432 122234578999999999999999999999999999999999765 554322111 11
Q ss_pred HhhccCCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 667 LLWNDGRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 667 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
....++... ..+.....++.+|+.+||+.||++||||++|++.|++.
T Consensus 237 ~~i~~~~~~---------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 237 EKLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp HHGGGTCCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 122222211 11222345688999999999999999999999998773
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-43 Score=383.78 Aligned_cols=248 Identities=28% Similarity=0.324 Sum_probs=198.9
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHH---HHHHHhccccCceEeeeeeeeecCceE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNS---GQGLEEFMN---EVVLIGKLQHRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~---Ev~~l~~l~h~niv~~~~~~~~~~~~~ 518 (765)
++|++.+.||+|+||.||+|+.. +|+.||||++.+.. ......+.+ |+.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999864 68999999986431 222333444 467777888999999999999999999
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999854 345889999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccc
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGL 677 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 677 (765)
... ......||+.|+|||++.. ..|+.++|||||||+||||++|+.||......+...+. ... ......
T Consensus 158 ~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~~-~~~~~~- 227 (364)
T d1omwa3 158 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMT-LTMAVE- 227 (364)
T ss_dssp SSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH----HHS-SSCCCC-
T ss_pred CCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH----Hhc-ccCCCC-
Confidence 432 2335679999999999975 56899999999999999999999999765443221111 110 001111
Q ss_pred ccccccCccCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 004264 678 MDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPD-----MSSVVF 717 (765)
Q Consensus 678 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 717 (765)
.+.....++.+|+.+||+.||++||| ++|+++
T Consensus 228 --------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 228 --------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --------CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --------CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11112345789999999999999999 688874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=374.76 Aligned_cols=267 Identities=22% Similarity=0.300 Sum_probs=202.7
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
++|++.++||+|+||+||+|+. .+++.||||++.... ....+++.+|+.+|++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999986 568999999996542 2345788999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
|+.++.+..... .....+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 998665544332 23456999999999999999999999999 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccCCC-CCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC---ccc--
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGT-ISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR---ALG-- 676 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~-~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~-- 676 (765)
.......||+.|+|||.+.... ++.++||||+||++|+|++|+.||......+. ............ ...
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGG
T ss_pred --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH---HHHHHHhcCCCchhhccccc
Confidence 2233568999999999887765 58899999999999999999999965432211 111111100000 000
Q ss_pred -ccc------ccccCc---cCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcC
Q 004264 677 -LMD------TCLEDS---FVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL--LAND 722 (765)
Q Consensus 677 -l~d------~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 722 (765)
..+ ...... ........+.+++.+||+.||++|||++|+++. +++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 000 000000 011223567889999999999999999999985 6553
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=377.73 Aligned_cols=267 Identities=22% Similarity=0.275 Sum_probs=201.0
Q ss_pred hcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecC----ceEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED----ERMLI 520 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~----~~~lV 520 (765)
.++|.+.++||+|+||.||+|++ +|+.||||++..... .......|+..+.+++||||+++++++.+.+ ..++|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 46788899999999999999986 688999999865432 1222334555666789999999999998765 57899
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcC-----CCcEEecccCCCcEEEecCCCCeecccccc
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDS-----KLQVIHRDLKASNILLDINLNPKISDFGLA 595 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~vkL~DFGla 595 (765)
|||+++|+|.+++.. ..+++..++.++.|++.||+|||+.. ..+|+||||||+||||+.++++||+|||++
T Consensus 80 ~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 999999999999954 24899999999999999999999741 234999999999999999999999999999
Q ss_pred eeeCCCCccc--ccccccccccccCcccccCCC------CCccccchHHHHHHHHHHhCCCCCCCCCCCCcc--------
Q 004264 596 RIFGGDDEEA--QTERVAGTHGYMSPEYANDGT------ISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRH-------- 659 (765)
Q Consensus 596 ~~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~------~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~-------- 659 (765)
+......... ......||+.|+|||++.+.. ++.++|||||||+||||++|..|+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 9875443322 233578999999999987643 677899999999999999999887543322110
Q ss_pred cHHHHHHHhhccCCccccccccccC-ccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 660 NLIGHAWLLWNDGRALGLMDTCLED-SFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 660 ~~~~~~~~~~~~~~~~~l~d~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
............+.. ++.+.. ..+......+.+|+.+||+.||++|||+.||+++|++
T Consensus 236 ~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred chHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 111112222111111 111111 1233456678899999999999999999999999975
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=375.54 Aligned_cols=252 Identities=27% Similarity=0.391 Sum_probs=200.9
Q ss_pred ccccccCCceeEEEEEeCCC----cEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeec-CceEEEEEec
Q 004264 451 ANMIGKGGFGPVYMGKLSTG----QEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE-DERMLIYEYM 524 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~~~----~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~-~~~~lV~E~~ 524 (765)
.++||+|+||+||+|++.++ ..||||++++. .....++|.+|+++|++++||||+++++++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999986432 25899999753 555668899999999999999999999998764 5789999999
Q ss_pred CCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCcc
Q 004264 525 PHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDEE 604 (765)
Q Consensus 525 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~~ 604 (765)
++++|.+++.. ....+++..++.++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998854 3345778899999999999999999999 999999999999999999999999999976543322
Q ss_pred c--ccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccccc
Q 004264 605 A--QTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTCL 682 (765)
Q Consensus 605 ~--~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 682 (765)
. ......||..|+|||.+.+..++.++||||||+++|||++|+.|+....... .... ....+......
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~----~i~~g~~~~~p---- 256 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITV----YLLQGRRLLQP---- 256 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH----HHHTTCCCCCC----
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHH----HHHcCCCCCCc----
Confidence 2 2234678999999999999999999999999999999999888765432211 1111 11222221111
Q ss_pred cCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 004264 683 EDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAND 722 (765)
Q Consensus 683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 722 (765)
......+.+|+.+||+.||++||+|.||+++|++.
T Consensus 257 -----~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 257 -----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp -----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11234678999999999999999999999999874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=377.27 Aligned_cols=251 Identities=20% Similarity=0.231 Sum_probs=204.1
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
-++|++.+.||+|+||+||+|... +++.||+|++..... ....+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999875 688999999976543 345688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC--CCCeecccccceeeCCC
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN--LNPKISDFGLARIFGGD 601 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~--~~vkL~DFGla~~~~~~ 601 (765)
+++++|.+++.. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.+ .++||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999843 2346899999999999999999999999 9999999999999854 57999999999876432
Q ss_pred CcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcccccccc
Q 004264 602 DEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDTC 681 (765)
Q Consensus 602 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 681 (765)
. ......+|+.|+|||.+.+..|+.++||||+||++|+|++|+.||......+ .. .....+.. .+....
T Consensus 158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~~----~~i~~~~~-~~~~~~ 226 (321)
T d1tkia_ 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---II----ENIMNAEY-TFDEEA 226 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH----HHHHHTCC-CCCHHH
T ss_pred C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---HH----HHHHhCCC-CCChhh
Confidence 2 2334678999999999999999999999999999999999999996543221 11 11111110 000000
Q ss_pred ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 682 LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 682 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.. ....++.+++.+||+.||++|||++|+++
T Consensus 227 -~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 -FK----EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -HT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -cc----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 12345789999999999999999999997
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=379.92 Aligned_cols=247 Identities=26% Similarity=0.348 Sum_probs=202.0
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHh-ccccCceEeeeeeeeecCceEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN---SGQGLEEFMNEVVLIG-KLQHRNLVGLLGSCIEEDERMLI 520 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ev~~l~-~l~h~niv~~~~~~~~~~~~~lV 520 (765)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .....+.+..|+.++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999864 6889999999753 2334556777777665 68999999999999999999999
Q ss_pred EEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCC
Q 004264 521 YEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGG 600 (765)
Q Consensus 521 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~ 600 (765)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999854 345899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCccccccc
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRALGLMDT 680 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 680 (765)
.. .......||+.|+|||++.+..|+.++|||||||++|||++|+.||....+.. + ......+..
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~----~~~i~~~~~------ 220 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---L----FHSIRMDNP------ 220 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHHHCCC------
T ss_pred cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---H----HHHHHcCCC------
Confidence 32 22335689999999999999999999999999999999999999997543221 1 111111111
Q ss_pred cccCccCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 004264 681 CLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMS-SVVF 717 (765)
Q Consensus 681 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 717 (765)
..+.....++.+|+.+||+.||++||++. +|++
T Consensus 221 ----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 ----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11112234578999999999999999996 6753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-43 Score=375.29 Aligned_cols=253 Identities=19% Similarity=0.191 Sum_probs=198.6
Q ss_pred hcCccccc-ccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhcc-ccCceEeeeeeeee----cCce
Q 004264 445 TNHFSEAN-MIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKL-QHRNLVGLLGSCIE----EDER 517 (765)
Q Consensus 445 ~~~y~~~~-~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~~~~~~~~----~~~~ 517 (765)
.++|.+.+ .||+|+||.||+|+. .+++.||||++.+. ..+.+|+.++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36888875 599999999999986 57899999998642 4577899987655 89999999999875 4678
Q ss_pred EEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec---CCCCeeccccc
Q 004264 518 MLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI---NLNPKISDFGL 594 (765)
Q Consensus 518 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~vkL~DFGl 594 (765)
++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 99999999999999996432 346999999999999999999999999 999999999999975 46799999999
Q ss_pred ceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCc
Q 004264 595 ARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRA 674 (765)
Q Consensus 595 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (765)
++...... ......||+.|+|||++.+..|+.++|||||||+||+|++|+.||...........+ ......+..
T Consensus 161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~~i~~~~~ 234 (335)
T d2ozaa1 161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQY 234 (335)
T ss_dssp CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS
T ss_pred eeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HHHHhcCCC
Confidence 99764332 233568999999999999999999999999999999999999999755433221110 000000000
Q ss_pred cccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 675 LGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 675 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.+ ..........++.+|+.+||+.||++|||+.|+++.
T Consensus 235 -~~-----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 -EF-----PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -SC-----CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CC-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00 001111234568899999999999999999999983
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-43 Score=370.79 Aligned_cols=261 Identities=21% Similarity=0.278 Sum_probs=201.8
Q ss_pred cCcccccccccCCceeEEEEEeCCCcEEEEEEccccC--hhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEEe
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNS--GQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E~ 523 (765)
++|++.++||+|+||+||+|++++++.||||++.... ....+++.+|+.+|++++||||+++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999999999999999997542 33357899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCCc
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDDE 603 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~~ 603 (765)
+.++.+..+. ...+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9888777665 33456999999999999999999999998 99999999999999999999999999987643222
Q ss_pred ccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC---cc---c
Q 004264 604 EAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR---AL---G 676 (765)
Q Consensus 604 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~---~ 676 (765)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||....+.+. ............ .. .
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH---HHHHHHhhCCCChhhccchhh
Confidence 2234568999999999876 4579999999999999999999999965432211 111111100000 00 0
Q ss_pred ---------cccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 677 ---------LMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 677 ---------l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
.................+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000011112223456789999999999999999999984
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=367.42 Aligned_cols=266 Identities=24% Similarity=0.294 Sum_probs=198.2
Q ss_pred hcCcccccccccCCceeEEEEEe-CC-CcEEEEEEccccC--hhhHHHHHHHHHHHhcc---ccCceEeeeeeeee----
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-ST-GQEIAAKRLSKNS--GQGLEEFMNEVVLIGKL---QHRNLVGLLGSCIE---- 513 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~-~~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l---~h~niv~~~~~~~~---- 513 (765)
.++|++.++||+|+||+||+|++ .+ ++.||||++.... ......+.+|+.+|+.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999986 34 5678999986432 22234566788887776 79999999999864
Q ss_pred -cCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccc
Q 004264 514 -EDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDF 592 (765)
Q Consensus 514 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DF 592 (765)
....+++|||+.++.+..... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 346789999999987765442 33456899999999999999999999999 999999999999999999999999
Q ss_pred ccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccC
Q 004264 593 GLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDG 672 (765)
Q Consensus 593 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 672 (765)
|+++... .........||+.|+|||++.+..|+.++||||+||++|||++|+.||....+.+....+..........
T Consensus 161 g~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 161 GLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 9998643 2233346789999999999999999999999999999999999999997544322111111100000000
Q ss_pred Ccc---cccc-------ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 673 RAL---GLMD-------TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 673 ~~~---~l~d-------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
... .... ..............+.+|+.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 0000 000011111223457789999999999999999999863
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=365.85 Aligned_cols=241 Identities=26% Similarity=0.381 Sum_probs=194.8
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEccccCh------hhHHHHHHHHHHHhccc--cCceEeeeeeeeecC
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSG------QGLEEFMNEVVLIGKLQ--HRNLVGLLGSCIEED 515 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~~Ev~~l~~l~--h~niv~~~~~~~~~~ 515 (765)
.++|++.+.||+|+||.||+|+. .+++.||||++.+... ....++.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 36899999999999999999986 4789999999865311 12244678999999986 899999999999999
Q ss_pred ceEEEEEecCC-CChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecC-CCCeecccc
Q 004264 516 ERMLIYEYMPH-KSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDIN-LNPKISDFG 593 (765)
Q Consensus 516 ~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~vkL~DFG 593 (765)
..++||||+.+ +++.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 566666643 346899999999999999999999999 9999999999999854 789999999
Q ss_pred cceeeCCCCcccccccccccccccCcccccCCCC-CccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccC
Q 004264 594 LARIFGGDDEEAQTERVAGTHGYMSPEYANDGTI-SMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDG 672 (765)
Q Consensus 594 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 672 (765)
+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ... .+
T Consensus 157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---------~i~----~~ 219 (273)
T d1xwsa_ 157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EII----RG 219 (273)
T ss_dssp TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHH----HC
T ss_pred cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch---------HHh----hc
Confidence 99875322 2335689999999999987765 677999999999999999999985321 000 01
Q ss_pred CccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 673 RALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 673 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.. ..... ...++.+++.+||+.||++|||++|+++.
T Consensus 220 ~~------~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 QV------FFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CC------CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cc------CCCCC----CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 10 01111 23467899999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=361.55 Aligned_cols=267 Identities=19% Similarity=0.268 Sum_probs=197.8
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeee--------c
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE--------E 514 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~--------~ 514 (765)
++|++.++||+|+||+||+|+. .+|+.||||++... .....+++.+|+.+|++++||||+++++.+.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 7899999999999999999996 57899999998643 33345778999999999999999999998865 3
Q ss_pred CceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeeccccc
Q 004264 515 DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGL 594 (765)
Q Consensus 515 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGl 594 (765)
...++||||+.++.+.... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 4678999999988776554 33456889999999999999999999999 99999999999999999999999999
Q ss_pred ceeeCCCCcc--cccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhcc
Q 004264 595 ARIFGGDDEE--AQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWND 671 (765)
Q Consensus 595 a~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 671 (765)
++.+...... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||....+.+....+.........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9876533222 222346799999999998765 6899999999999999999999999654332221111111100000
Q ss_pred CCc--------cccccccccCccCHH-------HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 672 GRA--------LGLMDTCLEDSFVES-------QVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 672 ~~~--------~~l~d~~l~~~~~~~-------~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
... ............... ....+++|+.+||+.||++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000 000000001111111 12356789999999999999999999865
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.5e-41 Score=352.76 Aligned_cols=259 Identities=21% Similarity=0.247 Sum_probs=196.1
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccccCc-eEeeeeeeeecCceEEEEEe
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRN-LVGLLGSCIEEDERMLIYEY 523 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n-iv~~~~~~~~~~~~~lV~E~ 523 (765)
++|++.++||+|+||.||+|++ .+++.||||++..... ..++..|++++++++|+| |+.+..++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999986 5688999998865433 245789999999998766 55556666778888999999
Q ss_pred cCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEe---cCCCCeecccccceeeCC
Q 004264 524 MPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLD---INLNPKISDFGLARIFGG 600 (765)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~vkL~DFGla~~~~~ 600 (765)
+.+ +|...+. .....+++..+..++.||+.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~~~-~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LGP-SLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CCC-BHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cCC-chhhhhh--hccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 954 5545443 23346899999999999999999999999 99999999999985 455799999999998754
Q ss_pred CCcc-----cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcc
Q 004264 601 DDEE-----AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRAL 675 (765)
Q Consensus 601 ~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (765)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI- 237 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH-
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh-
Confidence 3322 1233568999999999999999999999999999999999999999765544333222211111000000
Q ss_pred ccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 676 GLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 676 ~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
+.+. .....++.+++..||+.+|++||+++++.+.|+.
T Consensus 238 ----~~~~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 238 ----EVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp ----HHHT----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred ----hHhc----cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 0011 1123457889999999999999999999888864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-41 Score=363.08 Aligned_cols=261 Identities=22% Similarity=0.245 Sum_probs=195.6
Q ss_pred CcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhccccCceEeeeeeeeec------CceEE
Q 004264 447 HFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE------DERML 519 (765)
Q Consensus 447 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~------~~~~l 519 (765)
+|++.++||+|+||+||+|++. +++.||||++.+... ...+|+.+|++++|+||+++++++... ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888999999999999999974 689999999976432 234799999999999999999998643 24689
Q ss_pred EEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC-CCeecccccceee
Q 004264 520 IYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL-NPKISDFGLARIF 598 (765)
Q Consensus 520 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~vkL~DFGla~~~ 598 (765)
||||++++.+..+.........+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987765555443445567999999999999999999999999 99999999999999775 8999999999876
Q ss_pred CCCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHH--------HHHHhh
Q 004264 599 GGDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIG--------HAWLLW 669 (765)
Q Consensus 599 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~--------~~~~~~ 669 (765)
.... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+. ..+...
T Consensus 174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 4332 2234679999999998765 578999999999999999999999996544322111110 011111
Q ss_pred ccC----CccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 670 NDG----RALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 670 ~~~----~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
... .....................+.+|+.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 000000000001111223446788999999999999999999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-41 Score=362.54 Aligned_cols=264 Identities=21% Similarity=0.279 Sum_probs=197.9
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc-ChhhHHHHHHHHHHHhccccCceEeeeeeeeecC----ceE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN-SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED----ERM 518 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~----~~~ 518 (765)
+.+|++.++||+|+||+||+|+. .+++.||||++.+. .....+++++|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46799999999999999999985 57999999999754 3445678899999999999999999999987653 335
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceee
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIF 598 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~ 598 (765)
++++|+.+++|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 56677789999999843 35899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCcc-cccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCcc-
Q 004264 599 GGDDEE-AQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRAL- 675 (765)
Q Consensus 599 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 675 (765)
...... .......||+.|+|||.+.. ..++.++||||+||++|||++|+.||......+....... ........
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG---ILGSPSQED 236 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---HHCSCCHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhh---hccCCChhh
Confidence 433222 22345679999999999854 5678999999999999999999999965443221111100 00000000
Q ss_pred --------------cccccc--ccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 676 --------------GLMDTC--LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 676 --------------~l~d~~--l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
...... ...........++++++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 0000001112357899999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-41 Score=360.64 Aligned_cols=263 Identities=21% Similarity=0.284 Sum_probs=194.6
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecC------
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEED------ 515 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~------ 515 (765)
.++|++.++||+|+||+||+|.. .+++.||||++.+. .....+.+.+|+.+|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 36899999999999999999986 46899999999753 3445678899999999999999999999998655
Q ss_pred ceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccc
Q 004264 516 ERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLA 595 (765)
Q Consensus 516 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla 595 (765)
..++||||+ +.+|..++. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 569999999 566766653 235999999999999999999999999 999999999999999999999999999
Q ss_pred eeeCCCCcccccccccccccccCcccccC-CCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------H
Q 004264 596 RIFGGDDEEAQTERVAGTHGYMSPEYAND-GTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHA--------W 666 (765)
Q Consensus 596 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~--------~ 666 (765)
+.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+........ +
T Consensus 169 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 169 RQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp EECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 87632 2235679999999999876 45789999999999999999999998654322111111000 0
Q ss_pred HhhccC-------CccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhc
Q 004264 667 LLWNDG-------RALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL--LAN 721 (765)
Q Consensus 667 ~~~~~~-------~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~ 721 (765)
...... ...+.....+ ..........+++|+.+||+.||++|||++|+++. ++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred hhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 000000 0000000000 00111123456789999999999999999999975 554
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.7e-40 Score=348.98 Aligned_cols=260 Identities=17% Similarity=0.182 Sum_probs=205.0
Q ss_pred hcCcccccccccCCceeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHhcccc-CceEeeeeeeeecCceEEEEE
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQH-RNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h-~niv~~~~~~~~~~~~~lV~E 522 (765)
.++|++.+.||+|+||+||+|++. +++.||||++..... ...+.+|+++++.|+| +|++++++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999964 688999998865432 2457789999999975 899999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEec-----CCCCeeccccccee
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDI-----NLNPKISDFGLARI 597 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~vkL~DFGla~~ 597 (765)
|+ +++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 6888888743 2346899999999999999999999999 999999999999974 57899999999998
Q ss_pred eCCCCcc-----cccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccC
Q 004264 598 FGGDDEE-----AQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDG 672 (765)
Q Consensus 598 ~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 672 (765)
+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 7543221 12335679999999999999999999999999999999999999997655443322222111111011
Q ss_pred CccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 004264 673 RALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFLLAN 721 (765)
Q Consensus 673 ~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 721 (765)
...++. ... ..++.+++..|++.+|++||+++.+.+.|+.
T Consensus 236 ~~~~l~-----~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 236 PLRELC-----AGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp CHHHHT-----TTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ChHHhc-----CCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 111111 111 2457889999999999999999998887754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-40 Score=347.26 Aligned_cols=262 Identities=22% Similarity=0.262 Sum_probs=203.1
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeecCceEEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEEDERMLIYE 522 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~~~~~lV~E 522 (765)
++|++.++||+|+||+||+|++ .+++.||||+++.. ......++++|+.+|++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5899999999999999999996 47888999998643 33456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccceeeCCCC
Q 004264 523 YMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLARIFGGDD 602 (765)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~~~~~~ 602 (765)
++.+++|..++. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999887774 3456889999999999999999999999 9999999999999999999999999999864332
Q ss_pred cccccccccccccccCcccccCCC-CCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCC---c---c
Q 004264 603 EEAQTERVAGTHGYMSPEYANDGT-ISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGR---A---L 675 (765)
Q Consensus 603 ~~~~~~~~~gt~~Y~aPE~~~~~~-~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~---~ 675 (765)
. ......++..|+|||.+.+.. ++.++||||+||++|||++|+.||...... ............... . .
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGG
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH--HHHHHHHHhhcCCCChhhhhhhh
Confidence 2 222456778899999987665 699999999999999999999997432211 111111111111000 0 0
Q ss_pred cccc---------ccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 676 GLMD---------TCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 676 ~l~d---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
...+ ..............+.+|+.+||+.||.+|||++||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00001111223346778999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=353.04 Aligned_cols=252 Identities=25% Similarity=0.326 Sum_probs=203.0
Q ss_pred cCcccccccccCCceeEEEEEe----CCCcEEEEEEcccc----ChhhHHHHHHHHHHHhcccc-CceEeeeeeeeecCc
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL----STGQEIAAKRLSKN----SGQGLEEFMNEVVLIGKLQH-RNLVGLLGSCIEEDE 516 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~----~~~~~~~~~~Ev~~l~~l~h-~niv~~~~~~~~~~~ 516 (765)
++|++.+.||+|+||+||+|+. .+|+.||||++.+. .....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999985 24789999998653 22345678899999999976 899999999999999
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
.++||||+.+++|.+++... +.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999998543 34788999999999999999999999 9999999999999999999999999998
Q ss_pred eeCCCCcccccccccccccccCcccccCC--CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHhhccCCc
Q 004264 597 IFGGDDEEAQTERVAGTHGYMSPEYANDG--TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLLWNDGRA 674 (765)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (765)
.+...... ......|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+....+...... ..
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~---~~- 252 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK---SE- 252 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH---CC-
T ss_pred hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc---CC-
Confidence 76433222 23356799999999999765 4788999999999999999999999776655433332221111 10
Q ss_pred cccccccccCccCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 004264 675 LGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRP-----DMSSVVF 717 (765)
Q Consensus 675 ~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 717 (765)
...+.....++.+++.+||++||++|| |++|+++
T Consensus 253 ---------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 ---------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ---------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111223345688899999999999999 4789886
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.8e-40 Score=349.61 Aligned_cols=257 Identities=15% Similarity=0.212 Sum_probs=196.4
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccc-cCceEeeeeeeeec--CceEEEE
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEE--DERMLIY 521 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~--~~~~lV~ 521 (765)
++|++.++||+|+||+||+|+. .+++.||||++++.. .+++.+|+.+|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 6899999999999999999986 568899999986543 467889999999995 99999999998754 5689999
Q ss_pred EecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCC-CCeecccccceeeCC
Q 004264 522 EYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINL-NPKISDFGLARIFGG 600 (765)
Q Consensus 522 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~vkL~DFGla~~~~~ 600 (765)
||+.+++|..+. +.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997654 35899999999999999999999999 99999999999999765 589999999987643
Q ss_pred CCcccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcc-cHHHH---------HHHhh
Q 004264 601 DDEEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRH-NLIGH---------AWLLW 669 (765)
Q Consensus 601 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~-~~~~~---------~~~~~ 669 (765)
.. ......+|+.|+|||.+.+. .++.++||||+||+++||++|+.||......... ..+.. .....
T Consensus 183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 32 23356789999999998765 5799999999999999999999998654432110 00000 00000
Q ss_pred ccCCcc---ccc--------cccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 004264 670 NDGRAL---GLM--------DTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF 717 (765)
Q Consensus 670 ~~~~~~---~l~--------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 717 (765)
...... ... ..............++++|+.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 000 000111111122346789999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-40 Score=352.98 Aligned_cols=261 Identities=22% Similarity=0.245 Sum_probs=191.8
Q ss_pred cCcccccccccCCceeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeee------cCc
Q 004264 446 NHFSEANMIGKGGFGPVYMGKLS-TGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIE------EDE 516 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~------~~~ 516 (765)
++|++.++||+|+||+||+|++. +|+.||||++.+. ......++.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999965 6899999999754 34455678999999999999999999999864 367
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
.++||||+.++.+.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999876665442 34889999999999999999999999 9999999999999999999999999988
Q ss_pred eeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHH--------HH--
Q 004264 597 IFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGH--------AW-- 666 (765)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~--------~~-- 666 (765)
..... .......+|+.|+|||++.+..+++++||||+||+++||++|+.||...+.......+.. .+
T Consensus 168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 75432 233356789999999999999999999999999999999999999965432211110000 00
Q ss_pred -----HhhccCC-------cccccccccc---CccCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 004264 667 -----LLWNDGR-------ALGLMDTCLE---DSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVFL 718 (765)
Q Consensus 667 -----~~~~~~~-------~~~l~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 718 (765)
.....+. .......... ..........+.+|+.+||+.||++|||++||++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 0001111111 11122345678899999999999999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=350.54 Aligned_cols=264 Identities=21% Similarity=0.264 Sum_probs=196.9
Q ss_pred hcCcccccccccCCceeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHhccccCceEeeeeeeeec-----Cc
Q 004264 445 TNHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKN--SGQGLEEFMNEVVLIGKLQHRNLVGLLGSCIEE-----DE 516 (765)
Q Consensus 445 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~~~~~~~~~-----~~ 516 (765)
.++|++.++||+|+||+||+|+. .+|+.||||++.+. .....+++.+|+.+|++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 47899999999999999999986 57899999999754 344556789999999999999999999998643 34
Q ss_pred eEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCeecccccce
Q 004264 517 RMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKISDFGLAR 596 (765)
Q Consensus 517 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~ 596 (765)
.+++++|+.+++|.+++.. +.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 5777888899999998843 35999999999999999999999999 9999999999999999999999999997
Q ss_pred eeCCCCcccccccccccccccCcccccCC-CCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHh-----hc
Q 004264 597 IFGGDDEEAQTERVAGTHGYMSPEYANDG-TISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGHAWLL-----WN 670 (765)
Q Consensus 597 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~-----~~ 670 (765)
... .......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||...........+...... ..
T Consensus 170 ~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 170 HTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 642 223356789999999987765 4689999999999999999999998654322111111000000 00
Q ss_pred c----------CCccccccccccCccCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhc
Q 004264 671 D----------GRALGLMDTCLEDSFVESQVLRCIQVGLLCVQKLPEDRPDMSSVVF--LLAN 721 (765)
Q Consensus 671 ~----------~~~~~l~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 721 (765)
. ..........+. .........+++|+.+||+.||++|||++|+++ .+.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hccchhhhhhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 0 000000000000 000112345778999999999999999999997 3544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-35 Score=319.72 Aligned_cols=282 Identities=18% Similarity=0.210 Sum_probs=203.3
Q ss_pred cCcccccccccCCceeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHhccc-----------cCceEeeeeeeee
Q 004264 446 NHFSEANMIGKGGFGPVYMGKL-STGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-----------HRNLVGLLGSCIE 513 (765)
Q Consensus 446 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-----------h~niv~~~~~~~~ 513 (765)
++|++.++||+|+||+||+|+. .+|+.||||++.+.. ...+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4699999999999999999986 578999999997543 33467888999998875 5789999988865
Q ss_pred c--CceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhh-cCCCcEEecccCCCcEEEecCCC----
Q 004264 514 E--DERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQ-DSKLQVIHRDLKASNILLDINLN---- 586 (765)
Q Consensus 514 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~---- 586 (765)
. ...+++++++.................+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3 4566777777666554444444555678999999999999999999998 77 999999999999987654
Q ss_pred --CeecccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHHHHHHhCCCCCCCCCCCCcccHHHH
Q 004264 587 --PKISDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLLVEIVSGKMNRGFRHPGHRHNLIGH 664 (765)
Q Consensus 587 --vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll~elltG~~p~~~~~~~~~~~~~~~ 664 (765)
++++|||.+..... ......||+.|+|||++....++.++||||+||++++|++|+.||..............
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 89999999986532 22356799999999999999999999999999999999999999875443222111111
Q ss_pred HH---Hhhc------------------cCCcccccccc----------ccCccCHHHHHHHHHHHHHccccCCCCCCCHH
Q 004264 665 AW---LLWN------------------DGRALGLMDTC----------LEDSFVESQVLRCIQVGLLCVQKLPEDRPDMS 713 (765)
Q Consensus 665 ~~---~~~~------------------~~~~~~l~d~~----------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 713 (765)
.. .... .......+... ............+.+|+.+||+.||++|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 00 0000 00000000000 01123455677899999999999999999999
Q ss_pred HHHHH--Hhc--CCCCCCCCCCCCccc
Q 004264 714 SVVFL--LAN--DGVTLPQPRQPGFFT 736 (765)
Q Consensus 714 evl~~--L~~--~~~~l~~p~~p~~~~ 736 (765)
|+++. +++ ....+..|+.|..-.
T Consensus 324 e~L~Hp~f~~~~~~~~~~~p~~~~~~~ 350 (362)
T d1q8ya_ 324 GLVNHPWLKDTLGMEEIRVPDRELYGS 350 (362)
T ss_dssp HHHTCGGGTTCTTCTTCCCTTSCTTCB
T ss_pred HHhcCcccCCCCCcccCCCCCcccCCC
Confidence 99974 442 233456666666543
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.86 E-value=4.8e-22 Score=175.16 Aligned_cols=112 Identities=26% Similarity=0.443 Sum_probs=96.8
Q ss_pred ccccCCCccccCCCeEEcCCCeEEEEEecCCCCCCeEEEEEEeCCCCcEEEeecCCCCCCCCCceEEEeeCCceEEEcCC
Q 004264 25 ADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQE 104 (765)
Q Consensus 25 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (765)
+|+|.+||.|..|++|+| |.|.|+|+.+|+ |.++. ..++||.||++.|. ..+.|.|+.||+|+|++.
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~~--~~~~l~l~~dGnLvl~~~- 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD---NNRAVWASGTNGKA--SGCVLKMQNDGNLVIYSG- 67 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCTTSC--SSEEEEECTTSCEEEEET-
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc---CCcEEEEccCccCC--CCcEEEEeccccEEEEec-
Confidence 489999999999999975 999999999998 66664 46899999999884 467899999999999996
Q ss_pred CCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCCCCC
Q 004264 105 KSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSD 153 (765)
Q Consensus 105 ~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PtD 153 (765)
+.++|++++.......+|+|+|+||||||+ ..+.++|||+.+|++
T Consensus 68 ~~~~w~s~t~~~~~~~~l~L~ddGNlvly~----~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYD----NSNNAIWATHTNVGN 112 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEEC----TTSCEEEECCCCCCC
T ss_pred CCeEEEEeeccCCCceEEEEcCCCCEEEEC----CCCcEEecCCCccCC
Confidence 567888887655566789999999999998 456789999999985
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.86 E-value=5.8e-22 Score=172.92 Aligned_cols=107 Identities=24% Similarity=0.395 Sum_probs=94.4
Q ss_pred ccccCCCccccCCCeEEcCCCeEEEEEecCCCCCCeEEEEEEeCCCCcEEEeecCCCCCCCCCceEEEeeCCceEEEcCC
Q 004264 25 ADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQE 104 (765)
Q Consensus 25 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (765)
+|+|.+||.|.+|++|. +|.|.|.|+.+|+ |.|+. ..++||.||++.| +..+.|.|+.+|+|+|++++
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~--~~~~~l~l~~~Gnlvl~~~~ 68 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGL--SRSCFLSMQTDGNLVVYNPS 68 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE---TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe---CCceeeEeCCCCC--CCccEEEEeccceEEEECCC
Confidence 47899999999999995 6999999999998 77764 4679999999988 45778999999999999999
Q ss_pred CCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCC
Q 004264 105 KSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDY 150 (765)
Q Consensus 105 ~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~ 150 (765)
|.+||+|++.......+|+|+||||||||+. .+||||+|
T Consensus 69 g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~-------~~W~S~t~ 107 (108)
T d1jpca_ 69 NKPIWASNTGGQNGNYVCILQKDRNVVIYGT-------DRWATGTH 107 (108)
T ss_dssp CCEEEECCCCCSCSCEEEEECTTSCEEEEEC-------CCCCCCCC
T ss_pred ccceEEccccCCCCcEEEEEcCCCCEEEeCC-------CcccCCCC
Confidence 9999999987666667899999999999962 59999987
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=3.1e-22 Score=195.17 Aligned_cols=170 Identities=17% Similarity=0.107 Sum_probs=122.6
Q ss_pred cccccccccCCceeEEEEEeCCCcEEEEEEccccC------------------hhhHHHHHHHHHHHhccccCceEeeee
Q 004264 448 FSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNS------------------GQGLEEFMNEVVLIGKLQHRNLVGLLG 509 (765)
Q Consensus 448 y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~------------------~~~~~~~~~Ev~~l~~l~h~niv~~~~ 509 (765)
+.+.++||+|+||.||+|+..+|+.||||++.... ......+.+|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 35678999999999999998899999999865310 011234567889999999999888775
Q ss_pred eeeecCceEEEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcEEecccCCCcEEEecCCCCee
Q 004264 510 SCIEEDERMLIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQDSKLQVIHRDLKASNILLDINLNPKI 589 (765)
Q Consensus 510 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkL 589 (765)
+. ..+++|||+++..+.. ++......++.|++++|.|||+.+ |+||||||+|||++++ .++|
T Consensus 82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred ec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence 52 3479999998865532 445566789999999999999999 9999999999999965 4899
Q ss_pred cccccceeeCCCCcccccccccccccccCcccccCCCCCccccchHHHHHH
Q 004264 590 SDFGLARIFGGDDEEAQTERVAGTHGYMSPEYANDGTISMKSDVFSLGVLL 640 (765)
Q Consensus 590 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k~DvwSlG~ll 640 (765)
+|||+|.............+ ... .-.|.+ ...|+.++|+||+.--+
T Consensus 144 iDFG~a~~~~~~~~~~~l~r---d~~-~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWREILER---DVR-NIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHHHHHHH---HHH-HHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcHHHHHH---HHH-HHHHHH-cCCCCCcccHHHHHHHH
Confidence 99999987532211111000 000 001111 35678899999986544
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.84 E-value=4.4e-21 Score=167.30 Aligned_cols=108 Identities=23% Similarity=0.404 Sum_probs=93.4
Q ss_pred ccccCCCccccCCCeEEcCCCeEEEEEecCCCCCCeEEEEEEeCCCCcEEEeecCCCCCCCCCceEEEeeCCceEEEcCC
Q 004264 25 ADSLSSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQE 104 (765)
Q Consensus 25 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (765)
.|+|.+||.|.+|++|.+ |.|.|+|+.+|+ |.++. ..++||+||++.|.. ..+.|.|+.||+|||+|++
T Consensus 1 ~~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~~---~~~~vW~ant~~~~~-~~~~l~l~~dGnLvl~~~~ 69 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYD---HSTSVWASNTGILGK-KGCKAVLQSDGNFVVYDAE 69 (109)
T ss_dssp CCEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTTC-CCCEEEECTTSCEEEECSS
T ss_pred CCCccCCCEEeCCCEEEe--CCEEEEecCCCe-----EEEEe---CCEEEEEeCCCCCCc-eeEEEEEcCCceEEEEeCC
Confidence 378999999999999964 889999999987 55553 467999999999974 4788999999999999999
Q ss_pred CCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCC
Q 004264 105 KSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDY 150 (765)
Q Consensus 105 ~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~ 150 (765)
|.+||+|+++.+.+..+|+|+||||||||+. .+|||+-|
T Consensus 70 g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~-------~~W~S~t~ 108 (109)
T d1kj1a_ 70 GRSLWASHSVRGNGNYVLVLQEDGNVVIYGS-------DIWSTGTY 108 (109)
T ss_dssp SCEEEECCCCCCSSCCEEEECTTSCEEEECC-------EEEECCCC
T ss_pred CcEEEEEeeECCCCCEEEEEeCCCcEEEECC-------CEecCCCc
Confidence 9999999987666677899999999999962 59999865
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.68 E-value=2.1e-17 Score=146.06 Aligned_cols=102 Identities=15% Similarity=0.241 Sum_probs=86.2
Q ss_pred EEEEe-CCCCcEEEeecCCCCCCCCCceEEEeeCCceEEEcCCCCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcc
Q 004264 63 GIWYK-SSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSE 141 (765)
Q Consensus 63 ~i~~~-~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~ 141 (765)
-|||. ++.++.+|++|+++|+.....+|.|+.||||||++. +.++|++++........|.|+++|||||++ ..+
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d----~~~ 85 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLT----NQN 85 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEE----TTT
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEc----CCC
Confidence 47887 788999999999999987788999999999999986 678999998766667789999999999998 457
Q ss_pred cceeeecCCCCCcccCcCeecceeecccceEEEeccCCCCCCCcceEEeecCCCCceEE
Q 004264 142 EYMWQSFDYPSDTLLPGMKLGWNLKTGFERYLTPWRSADDPTPGEFSLRLDISALPELV 200 (765)
Q Consensus 142 ~~~WqSFd~PtDtlLpg~klg~~~~~~~~~~l~S~~s~~dps~G~ysl~~~~~g~~~~~ 200 (765)
++|||||. +.++|.|.+.++++|.+.++
T Consensus 86 ~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 86 IAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp EEEEECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred CEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEEe
Confidence 89999973 34568899999999987665
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.68 E-value=1.4e-16 Score=140.16 Aligned_cols=101 Identities=16% Similarity=0.337 Sum_probs=83.1
Q ss_pred ccccCCCeE--EcCCCeEEEEEecCCCCCCeEEEEEEeCCCCcEEEeecCCCCCCCCCceEEEeeCCceEEEcCCCCeEE
Q 004264 32 KFITDGETL--VSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEKSAIW 109 (765)
Q Consensus 32 ~~l~~~~~l--~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w 109 (765)
|.|.++|+| .+..|.|.|.|+.+|+ |.++ + ..++||.+|+..+ +..+.|.|+.||+|+|+|++|.+||
T Consensus 15 ~~l~~~q~l~~~~~~~~y~l~mQ~DGN-----LVLy-~--~~~~vWssnt~~~--~~~~~l~l~~dGnLvL~d~~g~~vW 84 (119)
T d1b2pa_ 15 QILHATESLEILFGTHVYRFIMQTDCN-----LVLY-D--NNNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVW 84 (119)
T ss_dssp CEEETTCEEEEEETTEEEEEEECTTSC-----EEEE-E--TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTTCCEEE
T ss_pred CEEeCCCeEEEecCCceEEEEECCCCc-----EEEE-E--CCeEEEEecCCCC--CcceEEEEEeCCCEEEECCCCcEEE
Confidence 455555554 5678999999999998 5553 2 4679999999887 3468999999999999999999999
Q ss_pred EeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecC
Q 004264 110 SSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFD 149 (765)
Q Consensus 110 ~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd 149 (765)
++++.......+|+|+||||||||+ .++|||-.
T Consensus 85 sS~t~~~~~~~~l~Lq~DGNlvlYg-------~~~W~S~T 117 (119)
T d1b2pa_ 85 QSPVAGKAGHYVLVLQPDRNVVIYG-------DALWATQT 117 (119)
T ss_dssp ECSCCCCSSCEEEEECTTSCEEEEE-------SEEEECCC
T ss_pred ECCCcCCCCceEEEEcCCCCEEEEC-------CCEeccCC
Confidence 9998766666789999999999996 26999854
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.61 E-value=1.3e-16 Score=139.31 Aligned_cols=109 Identities=18% Similarity=0.236 Sum_probs=90.6
Q ss_pred EEEe-CCCCcEEEeecCCCCCCCCCceEEEeeCCceEEEcCCCCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCccc
Q 004264 64 IWYK-SSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEE 142 (765)
Q Consensus 64 i~~~-~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~ 142 (765)
|||. ..+.+..|+.+.++++.+...+|.|+.||||||+++ +.++|++++.+ ..+..|.|+++|||||++ ..++
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~-~~~vW~s~t~~-~~~~~l~l~~dGNLvl~d----~~~~ 76 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAG-ATGCRAVLQSDGLLVILT----AQNT 76 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEES-SSEEECCCCCS-CSCCBCCBCSSSCBCCBC----TTTC
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEcC-CeeEEEcccCC-CCceEEEEeccCCEEEEc----cCCC
Confidence 6776 566778899999999988888999999999999984 68999999763 456789999999999998 5677
Q ss_pred ceeeecCCCCCcccCcCeecceeecccceEEEeccCCCCCCCcceEEeecCCCCceEEEecCCeeeeeeCC
Q 004264 143 YMWQSFDYPSDTLLPGMKLGWNLKTGFERYLTPWRSADDPTPGEFSLRLDISALPELVIISGSRKEARSGP 213 (765)
Q Consensus 143 ~~WqSFd~PtDtlLpg~klg~~~~~~~~~~l~S~~s~~dps~G~ysl~~~~~g~~~~~~~~~~~~~~~sg~ 213 (765)
+||||+- +.++|.|.+.|+++|...++ +.++|.+|.
T Consensus 77 ~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlvlY----~~~~Wssgt 112 (115)
T d1dlpa1 77 IRWSSGT-------------------------------KGSIGNYVLVLQPDRTVTIY----GPGLWDSGT 112 (115)
T ss_dssp CSCCCCC-------------------------------CCCSSCCEEEECSSSCEEEE----CSEEEECSC
T ss_pred EEEEcCC-------------------------------CCCCCCEEEEECCCCcEEEe----CCCeecCCC
Confidence 9999752 34679999999999987554 457898875
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.53 E-value=5.5e-15 Score=128.91 Aligned_cols=100 Identities=21% Similarity=0.355 Sum_probs=82.5
Q ss_pred CCCccccCCCeEEcCCCeEEEEEecCCCCCCeEEEEEEeCCCCcEEEeecCCCCCCCCCceEEEeeCCceEEEcCCCCeE
Q 004264 29 SSGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEKSAI 108 (765)
Q Consensus 29 ~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~ 108 (765)
+..|+|.+++.| .+|.|.|.|+.+|+ |.++. ...+||.+|...+ ..+.+.|+.||||||+|.++.+|
T Consensus 12 ~~~~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~---~~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~v 78 (115)
T d1dlpa1 12 SHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD---SDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIR 78 (115)
T ss_dssp CSCSCCCTTCEE--CSTTEEEEECTTSC-----EEEEE---SSSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCS
T ss_pred CCcceecCCCcE--EcCCEEEEECCCCe-----EEEEc---CCeeEEEcccCCC---CceEEEEeccCCEEEEccCCCEE
Confidence 334667777777 57889999999998 66654 4678999998654 46789999999999999999999
Q ss_pred EEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeec
Q 004264 109 WSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSF 148 (765)
Q Consensus 109 w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSF 148 (765)
|++++....+..+++|++|||||||+ .++|+|-
T Consensus 79 WsS~t~~~~g~y~l~Lq~DGNlvlY~-------~~~Wssg 111 (115)
T d1dlpa1 79 WSSGTKGSIGNYVLVLQPDRTVTIYG-------PGLWDSG 111 (115)
T ss_dssp CCCCCCCCSSCCEEEECSSSCEEEEC-------SEEEECS
T ss_pred EEcCCCCCCCCEEEEECCCCcEEEeC-------CCeecCC
Confidence 99998766677789999999999996 2699984
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.33 E-value=1.1e-12 Score=115.28 Aligned_cols=99 Identities=20% Similarity=0.355 Sum_probs=78.6
Q ss_pred CCccccCCCeEEcCCCeEEEEEecCCCCCCeEEEEEEeCCCCcEEEeecCCCCCCCCCceEEEeeCCceEEEcCCCCeEE
Q 004264 30 SGKFITDGETLVSSFQSFELGFFSPGNSTNRYLGIWYKSSPRTVVWVANRNHPITDKNGVLTFSNNGSLLLLNQEKSAIW 109 (765)
Q Consensus 30 ~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w 109 (765)
+.+.|..++.| ..|.|.|.|..+|+ |.++. ...+||.++.... +..+.+.|..+|||||+|.++.++|
T Consensus 22 ~~~~l~~~q~l--~~g~y~L~~q~DGN-----LvL~~---~~~~vW~s~t~~~--~~~~~~~l~~~GnLvl~d~~~~~lW 89 (120)
T d1dlpa2 22 HPQTLHATQSL--QLSPYRLSMETDCN-----LVLFD---RDDRVWSTNTAGK--GTGCRAVLQPNGRMDVLTNQNIAVW 89 (120)
T ss_dssp CCCEECSSCCC--BCSSCEEEEETTTE-----EEEEB---TTBCCSCCCCCSS--CSSCEEEEETTTEEEEEETTTEEEE
T ss_pred cccEEcCCCee--EcCCEEEEEcCCCc-----EEEec---CCcEEEEEccccC--CCcEEEEEeCCeeEEEEcCCCCEEE
Confidence 34556666665 45779999999987 66653 4578899986544 4567899999999999999999999
Q ss_pred EeccCCCcCccEEEEecCCCeeEeeccCCCcccceeee
Q 004264 110 SSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQS 147 (765)
Q Consensus 110 ~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqS 147 (765)
+|++.......+++|++|||||||+ .++|.|
T Consensus 90 ~S~t~~~~~~~~l~Lq~DGnlvlY~-------~~~W~t 120 (120)
T d1dlpa2 90 TSGNSRSAGRYVFVLQPDRNLAIYG-------GALWTT 120 (120)
T ss_dssp ECCCCCSSSCCEEEECSSSCEEEEC-------CCCCBC
T ss_pred EeCCCCCCCcEEEEECCCCcEEEeC-------CCcccC
Confidence 9998766667789999999999995 268976
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.18 E-value=5.1e-11 Score=102.65 Aligned_cols=87 Identities=18% Similarity=0.325 Sum_probs=67.6
Q ss_pred CceEEEeeCCceEEEcCCCCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCCCCCcccCcCeecceee
Q 004264 87 NGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLK 166 (765)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~~ 166 (765)
.-+|.|+.||||||++. +.+||++++........+.|+++|||||++ ..+.+||+|
T Consensus 20 ~~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~----~~g~~vWsS------------------- 75 (108)
T d1jpca_ 20 SFVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYN----PSNKPIWAS------------------- 75 (108)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEEC----TTCCEEEEC-------------------
T ss_pred CEEEEECCCCeEEEEeC-CceeeEeCCCCCCCccEEEEeccceEEEEC----CCccceEEc-------------------
Confidence 34789999999999984 579999998766566789999999999998 467899986
Q ss_pred cccceEEEeccCCCCCCCcceEEeecCCCCceEEEecCCeeeeeeCC
Q 004264 167 TGFERYLTPWRSADDPTPGEFSLRLDISALPELVIISGSRKEARSGP 213 (765)
Q Consensus 167 ~~~~~~l~S~~s~~dps~G~ysl~~~~~g~~~~~~~~~~~~~~~sg~ 213 (765)
.+....+.|.+.|+++|...++ +.+.|.++.
T Consensus 76 ------------~t~~~~~~~~l~L~ddGNlVly----~~~~W~S~t 106 (108)
T d1jpca_ 76 ------------NTGGQNGNYVCILQKDRNVVIY----GTDRWATGT 106 (108)
T ss_dssp ------------CCCCSCSCEEEEECTTSCEEEE----ECCCCCCCC
T ss_pred ------------cccCCCCcEEEEEcCCCCEEEe----CCCcccCCC
Confidence 1122457888999999987665 335676653
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.15 E-value=5.5e-11 Score=103.91 Aligned_cols=85 Identities=19% Similarity=0.243 Sum_probs=67.8
Q ss_pred eEEEeeCCceEEEcCCCCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCCCCCcccCcCeecceeecc
Q 004264 89 VLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLKTG 168 (765)
Q Consensus 89 ~l~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~~~~ 168 (765)
.|.|+.||||||+++ +.++|++++.+......+.|+++|||||++ ..+.+||+|.
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d----~~g~~vWsS~-------------------- 87 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVIT----NENVTVWQSP-------------------- 87 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEEC----TTCCEEEECS--------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEEC----CCCcEEEECC--------------------
Confidence 688999999999976 568999998765566889999999999998 4677899862
Q ss_pred cceEEEeccCCCCCCCcceEEeecCCCCceEEEecCCeeeeeeCC
Q 004264 169 FERYLTPWRSADDPTPGEFSLRLDISALPELVIISGSRKEARSGP 213 (765)
Q Consensus 169 ~~~~l~S~~s~~dps~G~ysl~~~~~g~~~~~~~~~~~~~~~sg~ 213 (765)
+.-+.|.|.+.|+++|...++ ..+.|.++.
T Consensus 88 -----------t~~~~~~~~l~Lq~DGNlvlY----g~~~W~S~T 117 (119)
T d1b2pa_ 88 -----------VAGKAGHYVLVLQPDRNVVIY----GDALWATQT 117 (119)
T ss_dssp -----------CCCCSSCEEEEECTTSCEEEE----ESEEEECCC
T ss_pred -----------CcCCCCceEEEEcCCCCEEEE----CCCEeccCC
Confidence 112457889999999987765 356888764
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.99 E-value=8.6e-10 Score=94.81 Aligned_cols=88 Identities=19% Similarity=0.315 Sum_probs=67.1
Q ss_pred CceEEEeeCCceEEEcCCCCeEEEeccCCCc-CccEEEEecCCCeeEeeccCCCcccceeeecCCCCCcccCcCeeccee
Q 004264 87 NGVLTFSNNGSLLLLNQEKSAIWSSNSSRTL-ENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNL 165 (765)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~s~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~ 165 (765)
.-.|.|+.||||||+. .+.+||++|+.... ....+.|+++|||||++ +.+.++|+|
T Consensus 20 ~~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~----~~g~~vW~s------------------ 76 (109)
T d1kj1a_ 20 PYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYD----AEGRSLWAS------------------ 76 (109)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEEC----SSSCEEEEC------------------
T ss_pred CEEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEe----CCCcEEEEE------------------
Confidence 3578999999999987 45789999976433 35679999999999998 567889986
Q ss_pred ecccceEEEeccCCCCCCCcceEEeecCCCCceEEEecCCeeeeeeCCC
Q 004264 166 KTGFERYLTPWRSADDPTPGEFSLRLDISALPELVIISGSRKEARSGPW 214 (765)
Q Consensus 166 ~~~~~~~l~S~~s~~dps~G~ysl~~~~~g~~~~~~~~~~~~~~~sg~w 214 (765)
.+....|.|.+.|+++|...++ ..+.|.++.+
T Consensus 77 -------------~t~~~~~~~~l~L~ddGNlvly----~~~~W~S~t~ 108 (109)
T d1kj1a_ 77 -------------HSVRGNGNYVLVLQEDGNVVIY----GSDIWSTGTY 108 (109)
T ss_dssp -------------CCCCCSSCCEEEECTTSCEEEE----CCEEEECCCC
T ss_pred -------------eeECCCCCEEEEEeCCCcEEEE----CCCEecCCCc
Confidence 1112357789999999987654 3468877654
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.81 E-value=9.7e-09 Score=88.79 Aligned_cols=90 Identities=18% Similarity=0.304 Sum_probs=67.2
Q ss_pred CceEEEeeCCceEEEcCCCCeEEEeccCCCcCccEEEEecCCCeeEeeccCCCcccceeeecCCCCCcccCcCeecceee
Q 004264 87 NGVLTFSNNGSLLLLNQEKSAIWSSNSSRTLENPVAHLLDSGNLVLRDNISRSSEEYMWQSFDYPSDTLLPGMKLGWNLK 166 (765)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~s~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~~ 166 (765)
.-.|.|+.||||||++ .+.+||++++.....++.++|+.+|||||++. +..+|.|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~-----~~~~w~s------------------- 74 (112)
T d1xd5a_ 20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSG-----SRAIWAS------------------- 74 (112)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEET-----TEEEEEC-------------------
T ss_pred CEEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEec-----CCeEEEE-------------------
Confidence 4579999999999987 45799999977555667899999999999982 3456654
Q ss_pred cccceEEEeccCCCCCCCcceEEeecCCCCceEEEecCCeeeeeeCCC
Q 004264 167 TGFERYLTPWRSADDPTPGEFSLRLDISALPELVIISGSRKEARSGPW 214 (765)
Q Consensus 167 ~~~~~~l~S~~s~~dps~G~ysl~~~~~g~~~~~~~~~~~~~~~sg~w 214 (765)
.+.-..|.|.+.|+.+|...++- ....+.|.++.-
T Consensus 75 ------------~t~~~~~~~~l~L~ddGNlvly~-~~~~~~W~S~t~ 109 (112)
T d1xd5a_ 75 ------------NTNRQNGNYYLILQRDRNVVIYD-NSNNAIWATHTN 109 (112)
T ss_dssp ------------CCCCSCCCCEEEECTTSCEEEEC-TTSCEEEECCCC
T ss_pred ------------eeccCCCceEEEEcCCCCEEEEC-CCCcEEecCCCc
Confidence 11223467899999999876542 334678987653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.59 E-value=1.2e-07 Score=94.99 Aligned_cols=149 Identities=14% Similarity=-0.001 Sum_probs=103.7
Q ss_pred hHHHHhcCcccccccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccc-cCceEeeeeeeeecCceE
Q 004264 440 TITTATNHFSEANMIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQ-HRNLVGLLGSCIEEDERM 518 (765)
Q Consensus 440 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~~~~~~~~~~~~~ 518 (765)
++...-+.|.+.+..+.++.+.||+... +++.+++|+...........+.+|+.+++.++ +--+.+++.+...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4555567788776655555678998874 56678888886554444456778888888775 333567777778888899
Q ss_pred EEEEecCCCChhHHhhccccCCCCChHHHHHHHHHHHHHHHHhhhc----------------------------------
Q 004264 519 LIYEYMPHKSLDYFIFDRERSKLLPWKKRFSIITGIARGLLYLHQD---------------------------------- 564 (765)
Q Consensus 519 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~---------------------------------- 564 (765)
+||+++++.++...... ......++.++++.+..||+.
T Consensus 87 lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 99999999888654421 112233455555556666542
Q ss_pred ----------------------CCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 565 ----------------------SKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 565 ----------------------~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
....++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 112389999999999999876677999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.93 E-value=2.3e-05 Score=77.17 Aligned_cols=131 Identities=18% Similarity=0.132 Sum_probs=86.2
Q ss_pred ccccCCc-eeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccC--ceEeeeeeeeecCceEEEEEecCCCCh
Q 004264 453 MIGKGGF-GPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHR--NLVGLLGSCIEEDERMLIYEYMPHKSL 529 (765)
Q Consensus 453 ~LG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~--niv~~~~~~~~~~~~~lV~E~~~~gsL 529 (765)
.+..|.. ..||+...+.+..+++|....... ..+..|+..++.|... -+.+++.+..+++..++|||++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455543 678999988888899997654332 3467788888877532 356677777788889999999998776
Q ss_pred hHHhhccccCCCCChHHHHHHHHHHHHHHHHhh-----------------------------------------------
Q 004264 530 DYFIFDRERSKLLPWKKRFSIITGIARGLLYLH----------------------------------------------- 562 (765)
Q Consensus 530 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH----------------------------------------------- 562 (765)
.... .. ...++.++++.|.-||
T Consensus 94 ~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 4311 00 0111122222222332
Q ss_pred ----hc----CCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 563 ----QD----SKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 563 ----~~----~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
+. ....++|+|+.|.|||++++..+.|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 21 122389999999999999876678999998864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.51 E-value=0.00014 Score=76.52 Aligned_cols=77 Identities=13% Similarity=0.124 Sum_probs=49.9
Q ss_pred ccccccCCceeEEEEEeCC-CcEEEEEEcccc-------ChhhHHHHHHHHHHHhccc-c--CceEeeeeeeeecCceEE
Q 004264 451 ANMIGKGGFGPVYMGKLST-GQEIAAKRLSKN-------SGQGLEEFMNEVVLIGKLQ-H--RNLVGLLGSCIEEDERML 519 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~-------~~~~~~~~~~Ev~~l~~l~-h--~niv~~~~~~~~~~~~~l 519 (765)
.+.||.|....||+....+ ++.+++|.-... ......+...|++.|+.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3568999999999998754 678999964321 1122345567888887763 2 345555543 5567789
Q ss_pred EEEecCCCCh
Q 004264 520 IYEYMPHKSL 529 (765)
Q Consensus 520 V~E~~~~gsL 529 (765)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.81 E-value=0.0018 Score=65.83 Aligned_cols=136 Identities=13% Similarity=0.111 Sum_probs=78.4
Q ss_pred ceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCce--Eeee-----eeeeecCceEEEEEecCCCChhH
Q 004264 459 FGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNL--VGLL-----GSCIEEDERMLIYEYMPHKSLDY 531 (765)
Q Consensus 459 fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~ni--v~~~-----~~~~~~~~~~lV~E~~~~gsL~~ 531 (765)
.-.||+++.++|+.+++|+.... ....+++..|...+..|....+ +..+ ..+......+.++++++|..++.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 35799999999999999987542 2245678889888888753322 1111 12234556788999998754321
Q ss_pred ----Hh----------hcc------ccCCC-------------------CChHHHHHHHHHHHHHHHHhhh----cCCCc
Q 004264 532 ----FI----------FDR------ERSKL-------------------LPWKKRFSIITGIARGLLYLHQ----DSKLQ 568 (765)
Q Consensus 532 ----~l----------~~~------~~~~~-------------------l~~~~~~~i~~qia~aL~~LH~----~~~~~ 568 (765)
.. +.. ..... ++...+..+...+.+.++.+.. .....
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 00 000 00011 1111111122222223333322 22345
Q ss_pred EEecccCCCcEEEecCCCCeeccccccee
Q 004264 569 VIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 569 ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
+||+|+.|.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 46899998875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.62 E-value=0.0028 Score=66.23 Aligned_cols=73 Identities=21% Similarity=0.284 Sum_probs=49.1
Q ss_pred ccccccCCceeEEEEEeCC--------CcEEEEEEccccChhhHHHHHHHHHHHhccccCce-EeeeeeeeecCceEEEE
Q 004264 451 ANMIGKGGFGPVYMGKLST--------GQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNL-VGLLGSCIEEDERMLIY 521 (765)
Q Consensus 451 ~~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~ni-v~~~~~~~~~~~~~lV~ 521 (765)
++.|+.|-.-.+|+...++ .+.+++++.-.. .......+|..+++.+.-.++ .++++++.. .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3578888889999998653 345666665432 223456689999998864344 466666532 5899
Q ss_pred EecCCCCh
Q 004264 522 EYMPHKSL 529 (765)
Q Consensus 522 E~~~~gsL 529 (765)
||+++.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99988655
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.00 E-value=0.018 Score=57.56 Aligned_cols=156 Identities=13% Similarity=-0.009 Sum_probs=79.7
Q ss_pred HhHHHHhcCccccc-----ccccCCceeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHhccccCce--Eeeee--
Q 004264 439 ATITTATNHFSEAN-----MIGKGGFGPVYMGKLSTGQEIAAKRLSKNSGQGLEEFMNEVVLIGKLQHRNL--VGLLG-- 509 (765)
Q Consensus 439 ~~~~~~~~~y~~~~-----~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~ni--v~~~~-- 509 (765)
.++.....+|.+.+ .|..|---+.|+.+..+| .+++|+..... ..+++..|+.++..|.+.++ ...+.
T Consensus 6 ~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~ 82 (316)
T d2ppqa1 6 DELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRK 82 (316)
T ss_dssp HHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred HHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceec
Confidence 34555556665533 345666678899987665 58999886532 22455667777777753321 11111
Q ss_pred ----eeeecCceEEEEEecCCCChhHHh--------------hcc--c----cCC------------------CCChHHH
Q 004264 510 ----SCIEEDERMLIYEYMPHKSLDYFI--------------FDR--E----RSK------------------LLPWKKR 547 (765)
Q Consensus 510 ----~~~~~~~~~lV~E~~~~gsL~~~l--------------~~~--~----~~~------------------~l~~~~~ 547 (765)
..........++.++.+....... +.. . ... .......
T Consensus 83 ~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (316)
T d2ppqa1 83 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 162 (316)
T ss_dssp TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred CCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhH
Confidence 111234455666666654332100 000 0 000 0011111
Q ss_pred HHHHHHHHHHHHHhhhc-CCCcEEecccCCCcEEEecCCCCeeccccccee
Q 004264 548 FSIITGIARGLLYLHQD-SKLQVIHRDLKASNILLDINLNPKISDFGLARI 597 (765)
Q Consensus 548 ~~i~~qia~aL~~LH~~-~~~~ivH~Dlkp~NIll~~~~~vkL~DFGla~~ 597 (765)
...+..+...+...+.. -...+||+|+.++||+++.+...-|+||+.+..
T Consensus 163 ~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 163 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 12222222222222221 233499999999999999887778999999874
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.27 E-value=0.045 Score=34.09 Aligned_cols=33 Identities=30% Similarity=0.656 Sum_probs=26.3
Q ss_pred CCCccCCCCCCCccccCC-CCCceecCCCCccCCC
Q 004264 285 DTCDSYAQCGANDNCRIS-KTPICECLTGFISKSQ 318 (765)
Q Consensus 285 ~~C~~~g~CG~~g~C~~~-~~~~C~C~~Gf~~~~~ 318 (765)
|+|.+-..|| ||.|++- ..-.|.|..||+|..-
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepgpm 35 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGPM 35 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCSS
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCCcc
Confidence 7899999998 6889743 3556999999998753
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.65 E-value=0.15 Score=33.87 Aligned_cols=32 Identities=25% Similarity=0.652 Sum_probs=25.3
Q ss_pred CCCcc-CCCCCCCccccCCC-CCceecCCCCccC
Q 004264 285 DTCDS-YAQCGANDNCRISK-TPICECLTGFISK 316 (765)
Q Consensus 285 ~~C~~-~g~CG~~g~C~~~~-~~~C~C~~Gf~~~ 316 (765)
|+|.. ...|..+|.|.... .-.|.|++||+..
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~G~ 37 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYTGP 37 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEEST
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCcCC
Confidence 67875 57899999997643 5679999999754
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.28 E-value=0.43 Score=30.94 Aligned_cols=32 Identities=31% Similarity=0.800 Sum_probs=24.4
Q ss_pred CCCccCCCCCCCccccCCC-CCceecCCCCccCC
Q 004264 285 DTCDSYAQCGANDNCRISK-TPICECLTGFISKS 317 (765)
Q Consensus 285 ~~C~~~g~CG~~g~C~~~~-~~~C~C~~Gf~~~~ 317 (765)
|+|. ...|...|.|.... .-.|.|++||+...
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G~~ 33 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEGKN 33 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEETTT
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCCcCc
Confidence 4565 47899999997643 67899999997653
|